PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Slack, E; Hapfelmeier, S; Stecher, B; Velykoredko, Y; Stoel, M; Lawson, MAE; Geuking, MB; Beutler, B; Tedder, TF; Hardt, WD; Bercik, P; Verdu, EF; McCoy, KD; Macpherson, AJ				Slack, Emma; Hapfelmeier, Siegfried; Stecher, Baerbel; Velykoredko, Yuliya; Stoel, Maaike; Lawson, Melissa A. E.; Geuking, Markus B.; Beutler, Bruce; Tedder, Thomas F.; Hardt, Wolf-Dietrich; Bercik, Premysl; Verdu, Elena F.; McCoy, Kathy D.; Macpherson, Andrew J.			Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; CROHNS-DISEASE; INTESTINAL HOMEOSTASIS; CITROBACTER-RODENTIUM; COMMENSAL BACTERIA; RESPONSES; MYD88; MICE; SUSCEPTIBILITY; PATHOGENESIS	Commensal bacteria in the lower intestine of mammals are 10 times as numerous as the body's cells. We investigated the relative importance of different immune mechanisms in limiting the spread of the intestinal microbiota. Here, we reveal a flexible continuum between innate and adaptive immune function in containing commensal microbes. Mice deficient in critical innate immune functions such as Toll-like receptor signaling or oxidative burst production spontaneously produce high-titer serum antibodies against their commensal microbiota. These antibody responses are functionally essential to maintain host-commensal mutualism in vivo in the face of innate immune deficiency. Spontaneous hyper-activation of adaptive immunity against the intestinal microbiota, secondary to innate immune deficiency, may clarify the underlying mechanisms of inflammatory diseases where immune dysfunction is implicated.	[Slack, Emma; Hapfelmeier, Siegfried; Velykoredko, Yuliya; Stoel, Maaike; Lawson, Melissa A. E.; Geuking, Markus B.; Bercik, Premysl; Verdu, Elena F.; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada; [Stecher, Baerbel; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8032 Zurich, Switzerland; [Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92121 USA; [Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Slack, Emma; Hapfelmeier, Siegfried; Macpherson, Andrew J.] Univ Bern, UVCM, DKF Dept Clin Res, Maurice Muller Labs, CH-3008 Bern, Switzerland	McMaster University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; Duke University; University of Bern	Slack, E (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada.	emma.slack@dkf.unibe.ch; andrew.macpherson@insel.ch	Slack, Emma/AAD-5837-2019; Lawson, Melissa/K-5848-2014; Slack, Emma/B-1612-2016; Stecher, Bärbel/A-2911-2015; Hapfelmeier, Siegfried/B-6005-2011; Bercik, Premysl/ABF-3983-2020; McCoy, Kathy/ABD-5814-2021; Stecher, Barbel/B-9940-2019; Eckhardt, Erik/G-1567-2010	Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Stecher, Bärbel/0000-0002-7445-5193; Hapfelmeier, Siegfried/0000-0002-6913-7932; Lawson, Melissa/0000-0001-9882-8663; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Genome Canada; Canada Research Chairs; Canadian Association of Gastroenterology; NIH [CA105001, AI56363]; NATIONAL CANCER INSTITUTE [R01CA105001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Genome Canada(Genome Canada); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Association of Gastroenterology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant support: Canadian Institutes of Health Research, Crohn's and Colitis Foundation of Canada, Genome Canada, Canada Research Chairs, Canadian Association of Gastroenterology, NIH grant numbers CA105001 and AI56363.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mueller C, 2006, GUT, V55, P276, DOI 10.1136/gut.2004.054098; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	22	365	376	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					617	620		10.1126/science.1172747	http://dx.doi.org/10.1126/science.1172747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644121	Green Accepted			2022-12-24	WOS:000268493000052
J	Maines, TR; Jayaraman, A; Belser, JA; Wadford, DA; Pappas, C; Zeng, H; Gustin, KM; Pearce, MB; Viswanathan, K; Shriver, ZH; Raman, R; Cox, NJ; Sasisekharan, R; Katz, JM; Tumpey, TM				Maines, Taronna R.; Jayaraman, Akila; Belser, Jessica A.; Wadford, Debra A.; Pappas, Claudia; Zeng, Hui; Gustin, Kortney M.; Pearce, Melissa B.; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Cox, Nancy J.; Sasisekharan, Ram; Katz, Jacqueline M.; Tumpey, Terrence M.			Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice	SCIENCE			English	Article							INCREASED VIRULENCE; PANDEMIC INFLUENZA; HEMAGGLUTININ	Recent reports of mild to severe influenza-like illness in humans caused by a novel swine-origin 2009 A(H1N1) influenza virus underscore the need to better understand the pathogenesis and transmission of these viruses in mammals. In this study, selected 2009 A(H1N1) influenza isolates were assessed for their ability to cause disease in mice and ferrets and compared with a contemporary seasonal H1N1 virus for their ability to transmit to naive ferrets through respiratory droplets. In contrast to seasonal influenza H1N1 virus, 2009 A(H1N1) influenza viruses caused increased morbidity, replicated to higher titers in lung tissue, and were recovered from the intestinal tract of intranasally inoculated ferrets. The 2009 A(H1N1) influenza viruses exhibited less efficient respiratory droplet transmission in ferrets in comparison with the highly transmissible phenotype of a seasonal H1N1 virus. Transmission of the 2009 A(H1N1) influenza viruses was further corroborated by characterizing the binding specificity of the viral hemagglutinin to the sialylated glycan receptors (in the human host) by use of dose-dependent direct receptor-binding and human lung tissue-binding assays.	[Maines, Taronna R.; Belser, Jessica A.; Wadford, Debra A.; Pappas, Claudia; Zeng, Hui; Gustin, Kortney M.; Pearce, Melissa B.; Cox, Nancy J.; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Jayaraman, Akila; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jayaraman, Akila; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tft9@cdc.gov		Wadford, Debra/0000-0002-8630-427X	Singapore-MIT Alliance for Research and Technology; National Institute of General Medical Sciences of the NIH [GM 57073, U54 GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, R37GM057073, U54GM062116] Funding Source: NIH RePORTER	Singapore-MIT Alliance for Research and Technology; National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Blair (Naval Health Research Center, San Diego), G. J. Demmler (Texas Childrens Hospital, Houston), C. Alpuche-Aranda [Instituto de Diagnostico y Referencia Epidemiologicos, Mexico], and the WHO Collaborating Centre for Reference and Research on Influenza (Melbourne) for facilitating access to viruses. We also thank X. Lu and A. Balish for preparation of viruses and V. Veguilla for statistical analysis. R.S. acknowledges the consortium for functional glycomics for providing glycan standards and support from the Singapore-MIT Alliance for Research and Technology and the National Institute of General Medical Sciences of the NIH (GM 57073 and U54 GM62116). Confocal microscopy of the human lung tissue sections was performed at the W. M. Keck Foundation Biological Imaging Facility at the Whitehead Institute. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; DAWOOD FS, 2009, J MED, V360, P2605; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; TUMPEY TM, 2009, ANNU REV MICROBIOL, V63, P252; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	21	523	563	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					484	487		10.1126/science.1177238	http://dx.doi.org/10.1126/science.1177238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574347	Green Accepted, Green Submitted			2022-12-24	WOS:000268255100059
J	Brook, I				Brook, Itzhak			Rediscovering My Voice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ib6@georgetown.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					236	236		10.1001/jama.2009.981	http://dx.doi.org/10.1001/jama.2009.981			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602676				2022-12-24	WOS:000267948100001
J	Parmacek, MS; Epstein, JA				Parmacek, Michael S.; Epstein, Jonathan A.			Cardiomyocyte Renewal.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REGENERATION; CELLS		[Parmacek, Michael S.; Epstein, Jonathan A.] Univ Penn, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Parmacek, MS (corresponding author), Univ Penn, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.			Epstein, Jonathan/0000-0001-8637-4465; Parmacek, Michael/0000-0003-1449-4665	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075215] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL075215] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857	5	48	50	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					86	88		10.1056/NEJMcibr0903347	http://dx.doi.org/10.1056/NEJMcibr0903347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571289	Green Accepted			2022-12-24	WOS:000267533100016
J	Vargas-Perez, H; Kee, RTA; Walton, CH; Hansen, DM; Razavi, R; Clarke, L; Bufalino, MR; Allison, DW; Steffensen, SC; van der Kooy, D				Vargas-Perez, Hector; Kee, Ryan Ting-A; Walton, Christine H.; Hansen, D. Micah; Razavi, Rozita; Clarke, Laura; Bufalino, Mary Rose; Allison, David W.; Steffensen, Scott C.; van der Kooy, Derek			Ventral Tegmental Area BDNF Induces an Opiate-Dependent-Like Reward State in Naive Rats	SCIENCE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; NEUROTROPHIC FACTOR; GABA(A) RECEPTORS; PEDUNCULOPONTINE NUCLEUS; NEURONS; COCAINE; MECHANISMS; WITHDRAWAL; ADDICTION; LESIONS	The neural mechanisms underlying the transition from a drug-nondependent to a drug-dependent state remain elusive. Chronic exposure to drugs has been shown to increase brain-derived neurotrophic factor (BDNF) levels in ventral tegmental area (VTA) neurons. BDNF infusions into the VTA potentiate several behavioral effects of drugs, including psychomotor sensitization and cue-induced drug seeking. We found that a single infusion of BDNF into the VTA promotes a shift from a dopamine-independent to a dopamine-dependent opiate reward system, identical to that seen when an opiate-naive rat becomes dependent and withdrawn. This shift involves a switch in the gamma-aminobutyric acid type A (GABA(A)) receptors of VTA GABAergic neurons, from inhibitory to excitatory signaling.	[Vargas-Perez, Hector; Razavi, Rozita; van der Kooy, Derek] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Kee, Ryan Ting-A; Clarke, Laura; Bufalino, Mary Rose; van der Kooy, Derek] Univ Toronto, Inst Med Sci, Toronto, ON M5S 3E1, Canada; [Walton, Christine H.; Hansen, D. Micah; Allison, David W.; Steffensen, Scott C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA	University of Toronto; University of Toronto; Brigham Young University	Vargas-Perez, H (corresponding author), Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.	vargashector@yahoo.com	Vargas Perez, Hector/F-3176-2015		Canadian Institutes of Health Research; NIH [AA13666]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013666, R01AA020919] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the Canadian Institutes of Health Research. S.C.S. received funding from NIH (grant AA13666).	BECHARA A, 1992, BEHAV NEUROSCI, V106, P351, DOI 10.1037/0735-7044.106.2.351; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Grimm JW, 2003, J NEUROSCI, V23, P742; Horger BA, 1999, J NEUROSCI, V19, P4110; HYMAN C, 1994, J NEUROSCI, V14, P335; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kippin TE, 2003, EUR J NEUROSCI, V18, P2581, DOI 10.1046/j.1460-9568.2003.02918.x; Laviolette SR, 2004, EUR J NEUROSCI, V20, P2179, DOI 10.1111/j.1460-9568.2004.03665.x; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Narita M, 2003, NEUROSCIENCE, V119, P767, DOI 10.1016/S0306-4522(03)00099-X; Numan S, 1999, J COMP NEUROL, V403, P295, DOI 10.1002/(SICI)1096-9861(19990118)403:3<295::AID-CNE2>3.0.CO;2-L; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; Tsai SJ, 2007, MED HYPOTHESES, V68, P410, DOI 10.1016/j.mehy.2006.05.035; Vargas-Perez H, 2007, EUR J NEUROSCI, V25, P3713, DOI 10.1111/j.1460-9568.2007.05599.x; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007	20	148	156	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1732	1734		10.1126/science.1168501	http://dx.doi.org/10.1126/science.1168501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19478142	Green Accepted			2022-12-24	WOS:000267338200047
J	Iglehart, JK				Iglehart, John K.			A New Era of For-Profit Hospice Care - The Medicare Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Medicare Payment Advisory Commission, 2009, REP C MED PAYM POL; *NAT HOSP PALL CAR, NAT END OF LIF ORG R	3	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2701	2703		10.1056/NEJMp0902437	http://dx.doi.org/10.1056/NEJMp0902437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461RC	19553645				2022-12-24	WOS:000267286600004
J	Waters, DJ				Waters, Daniel J.			Heart, Attacked	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dwaters@mcclinic.com							0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2423	2423		10.1001/jama.2009.808	http://dx.doi.org/10.1001/jama.2009.808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531772				2022-12-24	WOS:000267028100001
J	Marx, CJ				Marx, Christopher J.			Getting in Touch with Your Friends	SCIENCE			English	Editorial Material							COOPERATION; SYMBIOSIS; EVOLUTION; ALTRUISM		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu						Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wanner G, 2008, J BACTERIOL, V190, P3721, DOI 10.1128/JB.00027-08	14	29	32	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1150	1151		10.1126/science.1173088	http://dx.doi.org/10.1126/science.1173088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478170				2022-12-24	WOS:000266410100029
J	Pocock, SJ; Smeeth, L				Pocock, Stuart J.; Smeeth, Liam			Insulin glargine and malignancy: an unwarranted alarm	LANCET			English	Editorial Material							RANDOMIZED-TRIALS		[Pocock, Stuart J.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Liam.Smeeth@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [082178] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; HEMKENS LG, 2009, DIABETOLOGIA, DOI DOI 10.1007/S00125-009-1418.4; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; *SDRN EP GROUP, US INS GLARG CANC IN; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	9	102	105	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					511	513		10.1016/S0140-6736(09)61307-6	http://dx.doi.org/10.1016/S0140-6736(09)61307-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19616841				2022-12-24	WOS:000269019400009
J	Bhala, N; Usherwood, T; George, J				Bhala, Neeraj; Usherwood, Tim; George, Jacob			10-Minute Consultation Non-alcoholic fatty liver disease	BRITISH MEDICAL JOURNAL			English	Editorial Material							NAFLD		[George, Jacob] Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2145, Australia; [Usherwood, Tim; George, Jacob] Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney		neeraj.bhala@ctsu.ox.ac.uk	George, jacob/P-1496-2014	Bhala, Neeraj/0000-0003-2502-1177				*AM LIV FDN, VOL NONPR HLTH AG US; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; *BRIT LIV TRUST, NONPR MED RES CHAR U; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094	5	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 16	2009	339								b2474	10.1136/bmj.b2474	http://dx.doi.org/10.1136/bmj.b2474			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BX	19608620				2022-12-24	WOS:000268105200001
J	Morch, LS; Lokkegaard, E; Andreasen, AH; Kruger-Kjaer, S; Lidegaard, O				Morch, Lina Steinrud; Lokkegaard, Ellen; Andreasen, Anne Helms; Kruger-Kjaer, Susanne; Lidegaard, Ojvind			Hormone Therapy and Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPLACEMENT THERAPY; SWEDISH WOMEN; RISK; DENMARK; REGISTRY; HEALTH	Context Studies have suggested an increased risk of ovarian cancer among women taking postmenopausal hormone therapy. Data are sparse on the differential effects of formulations, regimens, and routes of administration. Objective To assess risk of ovarian cancer in perimenopausal and postmenopausal women receiving different hormone therapies. Design and Setting Nationwide prospective cohort study including all Danish women aged 50 through 79 years from 1995 through 2005 through individual linkage to Danish national registers. Redeemed prescription data from the National Register of Medicinal Product Statistics provided individually updated exposure information. The National Cancer Register and Pathology Register provided ovarian cancer incidence data. Information on confounding factors and effect modifiers was from other national registers. Poisson regression analyses with 5-year age bands included hormone exposures as time-dependent covariates. Participants A total of 909 946 women without hormone-sensitive cancer or bilateral oophorectomy. Main Outcome Measure Ovarian cancer. Results In an average of 8.0 years of follow-up (7.3 million women-years), 3068 incident ovarian cancers, of which 2681 were epithelial cancers, were detected. Compared with women who never took hormone therapy, current users of hormones had incidence rate ratios for all ovarian cancers of 1.38 (95% confidence interval [CI], 1.26-1.51) and 1.44 ( 95% CI, 1.30-1.58) for epithelial ovarian cancer. The risk declined with years since last use: 0 to 2 years, 1.22 ( 95% CI, 1.02-1.46); more than 2 to 4 years, 0.98 ( 95% CI, 0.75-1.28); more than 4 to 6 years, 0.72 ( 95% CI, 0.50-1.05), and more than 6 years, 0.63 ( 95% CI, 0.41-0.96). For current users the risk of ovarian cancer did not differ significantly with different hormone therapies or duration of use. The incidence rates in current and never users of hormones were 0.52 and 0.40 per 1000 years, respectively, ie, an absolute risk increase of 0.12 ( 95% CI, 0.01-0.17) per 1000 years. This approximates 1 extra ovarian cancer for roughly 8300 women taking hormone therapy each year. Conclusion Regardless of the duration of use, the formulation, estrogen dose, regimen, progestin type, and route of administration, hormone therapy was associated with an increased risk of ovarian cancer. JAMA. 2009; 302(3):298-305 www.jama.com	[Morch, Lina Steinrud; Lidegaard, Ojvind] Univ Copenhagen, Gynaecol Clin, Rigshosp, DK-2100 Copenhagen, Denmark; [Lokkegaard, Ellen] Univ Copenhagen, Hillerod Hosp, Gynaecol Obstetr Dept, Copenhagen, Denmark; [Morch, Lina Steinrud; Andreasen, Anne Helms] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Kruger-Kjaer, Susanne] Danish Canc Soc, Dept Virus Hormones & Canc, Inst Canc Epidemiol, Osterbro, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Danish Cancer Society	Morch, LS (corresponding author), Univ Copenhagen, Gynaecol Clin, Rigshosp, Sect 3341,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	linamorch@yahoo.dk		Kjaer, Susanne/0000-0002-8347-1398; Andreasen, Anne Helms/0000-0002-2350-9884; Lokkegaard, Ellen/0000-0003-4149-5663; Morch, Lina/0000-0001-6506-2569	Danish Cancer Society [DP05006]	Danish Cancer Society(Danish Cancer Society)	This study was supported by grant J No. DP05006 from the Danish Cancer Society.	Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Danforth KN, 2007, BRIT J CANCER, V96, P151, DOI 10.1038/sj.bjc.6603527; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Hammar M, 1996, MATURITAS, V25, P193, DOI 10.1016/S0378-5122(96)01065-1; Hundrup YA, 2000, ACTA OBSTET GYN SCAN, V79, P194, DOI 10.1080/j.1600-0412.2000.079003194.x; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Kjaerbye-Thygesen Anette, 2007, Ugeskr Laeger, V169, P50; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lokkegaard E, 2007, ACTA OBSTET GYN SCAN, V86, P1342, DOI 10.1080/00016340701505523; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Soegaard M, 2007, CANCER EPIDEM BIOMAR, V16, P1160, DOI 10.1158/1055-9965.EPI-07-0089; STORM HH, 1988, INT J EPIDEMIOL, V17, P44, DOI 10.1093/ije/17.1.44; Storm HH, 1997, DAN MED BULL, V44, P535	16	139	144	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					298	305		10.1001/jama.2009.1052	http://dx.doi.org/10.1001/jama.2009.1052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602689	Bronze			2022-12-24	WOS:000267948100023
J	Agarwal, N; Lamichhane, G; Gupta, R; Nolan, S; Bishai, WR				Agarwal, Nisheeth; Lamichhane, Gyanu; Gupta, Radhika; Nolan, Scott; Bishai, William R.			Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; PHAGOSOME MATURATION; INFECTION; TRANSCRIPTION; MURINE; GENES; LUNGS; GRANULOMAS; EXPANSION; ARREST	With 8.9 million new cases and 1.7 million deaths per year, tuberculosis is a leading global killer that has not been effectively controlled(1,2). The causative agent, Mycobacterium tuberculosis, proliferates within host macrophages where it modifies both its intracellular and local tissue environment, resulting in caseous granulomas with incomplete bacterial sterilization(3,4). Although infection by various mycobacterial species produces a cyclic AMP burst within macrophages that influences cell signalling, the underlying mechanism for the cAMP burst remains unclear(5-7). Here we show that among the 17 adenylate cyclase genes present in M. tuberculosis, at least one (Rv0386) is required for virulence. Furthermore, we demonstrate that the Rv0386 adenylate cyclase facilitates delivery of bacterial-derived cAMP into the macrophage cytoplasm. Loss of Rv0386 and the intramacrophage cAMP it delivers results in reductions in TNF-alpha production via the protein kinase A and cAMP response-element-binding protein pathway, decreased immunopathology in animal tissues, and diminished bacterial survival. Direct intoxication of host cells by bacterial-derived cAMP may enable M. tuberculosis to modify both its intracellular and tissue environments to facilitate its long-term survival.	[Agarwal, Nisheeth; Lamichhane, Gyanu; Gupta, Radhika; Nolan, Scott; Bishai, William R.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Bishai, WR (corresponding author), Johns Hopkins Sch Med, Dept Med, CRB2,Room 1-08,1550 Orleans St, Baltimore, MD 21231 USA.	wbishai@jhmi.edu		Gupta, Radhika/0000-0002-0445-0194; Lamichhane, Gyanu/0000-0002-2214-0114	National Institutes of Health (NIH) [AI30036, AI36973, AI37856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036973, R01AI030036, R01AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The support of National Institutes of Health (NIH) awards AI30036, AI36973 and AI37856 is gratefully acknowledged.	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Bohme E, 1974, Methods Enzymol, V38, P27; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Higashida H, 2002, ANAL BIOCHEM, V308, P106, DOI 10.1016/S0003-2697(02)00237-3; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Roach SK, 2005, INFECT IMMUN, V73, P514, DOI 10.1128/IAI.73.1.514-522.2005; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; von Knethen A, 2000, MOL CELL BIOCHEM, V212, P35, DOI 10.1023/A:1007124203607; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; WRIGHT A, LANCET IN PRESS, DOI DOI 10.1016/S0140-6736(09)60331-7	34	161	168	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					98	U112		10.1038/nature08123	http://dx.doi.org/10.1038/nature08123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19516256				2022-12-24	WOS:000267545200037
J	Cho, Y; Challa, S; Moquin, D; Genga, R; Ray, TD; Guildford, M; Chan, FKM				Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Ray, Tathagat Dutta; Guildford, Melissa; Chan, Francis Ka-Ming			Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation	CELL			English	Article							NF-KAPPA-B; RECEPTOR-INTERACTING PROTEIN; DEATH DOMAIN KINASE; NONAPOPTOTIC CELL-DEATH; RIP-LIKE KINASE; TNF; APOPTOSIS; ACTIVATION; IDENTIFICATION; INDUCTION	Programmed necrosis is a form of caspase-independent cell death whose molecular regulation is poorly understood. The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-kappa B. We postulated that additional molecules are required to specifically activate programmed necrosis. Using a RNA interference screen, we identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection. RIP3 regulates necrosis-specific RIP1 phosphorylation. The phosphorylation of RIP1 and RIP3 stabilizes their association within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species production. The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection. Consequently, RIP3(-/-) mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication. Our findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.	[Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Ray, Tathagat Dutta; Guildford, Melissa; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Cho, YoungSik; Challa, Sreerupa; Moquin, David; Ray, Tathagat Dutta; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Immunol & Virol Program, Worcester, MA 01655 USA; [Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01655 USA; [Cho, YoungSik] Korea Res Inst Chem Technol, Ctr Metab Syndrome Therapeut, Bioorgan Sci Div, Taejon 305600, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Korea Research Institute of Chemical Technology (KRICT)	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; 	National Institutes of Health [AI065877, AI17672]; Diabetes Endocrinology Research Center [DK32520]; Smith Family Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017672, R21AI065877, R37AI017672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Smith Family Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI065877 (F. K. C.) and AI17672 (R. Welsh) and departmental startup fund (to F. K. C.). Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were also used. F. K. C. was a recipient of investigator awards from the Smith Family Foundation and the Cancer Research Institute. Wethank M. Wu and M. Harrington for the RIP3 cDNAs, V. Dixit for the RIP3<SUP>-/-</SUP> mice, and members of the Pathology Department, E. Baehrecke, and A. Winoto for discussion and critical reading of the manuscript.	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Ruby J, 1997, J EXP MED, V186, P1591, DOI 10.1084/jem.186.9.1591; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	40	1592	1671	4	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1112	1123		10.1016/j.cell.2009.05.037	http://dx.doi.org/10.1016/j.cell.2009.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524513	Green Accepted, Bronze			2022-12-24	WOS:000266916400022
J	Rogowski, K; Juge, F; van Dijk, J; Wloga, D; Strub, JM; Levilliers, N; Thomas, D; Bre, MH; Van Dorsselaer, A; Gaertig, J; Janke, C				Rogowski, Krzysztof; Juge, Francois; van Dijk, Juliette; Wloga, Dorota; Strub, Jean-Marc; Levilliers, Nicolette; Thomas, Daniel; Bre, Marie-Helene; Van Dorsselaer, Alain; Gaertig, Jacek; Janke, Carsten			Evolutionary Divergence of Enzymatic Mechanisms for Posttranslational Polyglycylation	CELL			English	Article							NUCLEOSOME ASSEMBLY PROTEIN; ALPHA-TUBULIN; AXONEMAL TUBULIN; BETA-TUBULIN; TETRAHYMENA-THERMOPHILA; MONOCLONAL-ANTIBODIES; MICROTUBULES; POLYGLUTAMYLATION; DIFFERENTIATION; GLYCYLATION	Polyglycylation is a posttranslational modification that generates glycine side chains on proteins. Here we identify a family of evolutionarily conserved glycine ligases that modify tubulin using different enzymatic mechanisms. In mammals, two distinct enzyme types catalyze the initiation and elongation steps of polyglycylation, whereas Drosophila glycylases are bifunctional. We further show that the human elongating glycylase has lost enzymatic activity due to two amino acid changes, suggesting that the functions of protein glycylation could be sufficiently fulfilled by monoglycylation. Depletion of a glycylase in Drosophila using RNA interference results in adult flies with strongly decreased total glycylation levels and male sterility associated with defects in sperm individualization and axonemal maintenance. A more severe RNAi depletion is lethal at early developmental stages, indicating that protein glycylation is essential. Together with the observation that multiple proteins are glycylated, our functional data point towards a general role of glycylation in protein functions.	[Rogowski, Krzysztof; van Dijk, Juliette; Janke, Carsten] Univ Montpellier 2, CRBM, CNRS, F-34293 Montpellier, France; [Rogowski, Krzysztof; van Dijk, Juliette; Janke, Carsten] Univ Montpellier I, CRBM, CNRS, F-34293 Montpellier, France; [Juge, Francois] Univ Montpellier 2, IGMM, CNRS, F-34293 Montpellier, France; [Wloga, Dorota; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Strub, Jean-Marc; Van Dorsselaer, Alain] Univ Strasbourg, LSMBO, CNRS, F-67087 Strasbourg, France; [Levilliers, Nicolette; Bre, Marie-Helene] Univ Paris 11, Lab Biol Cellulaire 4, CNRS, F-91405 Orsay, France; [Thomas, Daniel] Univ Rennes 1, CNRS, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Janke, C (corresponding author), Univ Montpellier 2, CRBM, CNRS, F-34293 Montpellier, France.	carsten.janke@crbm.cnrs.fr	Juge, François/P-2371-2017; THOMAS, Danniel/AAJ-5033-2020; Janke, Carsten/A-7279-2011; Włoga, Dorota/R-4078-2016; Gaertig, Jacek/F-1553-2010	THOMAS, Danniel/0000-0002-9650-0434; Janke, Carsten/0000-0001-7053-2000; Włoga, Dorota/0000-0003-3314-7773; Juge, Francois/0000-0001-5015-2019; Strub, Jean-Marc/0000-0001-6224-3428; Rogowski, Krzysztof/0000-0002-0206-3289	CNRS; Universities Montpellier 2 and 1; Association pour la Recherche sur le Cancer (ARC) [CR504/7817, CR504/3140, CR504/4894]; French National Research Agency (ANR) [05-JCJC-0035, 08-JCJC-0007]; Ligue contre le Cancer fellowship [JG/VP-5454]; EMBO long-term fellowship ALTF [5462006]; NSF [MBC-033965]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Montpellier 2 and 1; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); French National Research Agency (ANR)(French National Research Agency (ANR)); Ligue contre le Cancer fellowship; EMBO long-term fellowship ALTF; NSF(National Science Foundation (NSF))	This work was supported by the CNRS; the Universities Montpellier 2 and 1; the Association pour la Recherche sur le Cancer (ARC) awards CR504/7817 and 3140 (to C.J.) and 4894 (to F.J.); the French National Research Agency (ANR) awards 05-JCJC-0035 and 08-JCJC-0007 to C. J.; and the Ligue contre le Cancer fellowship JG/VP-5454, the EMBO long-term fellowship ALTF 5462006 to K. R. and NSF grant MBC-033965 to J. G. We thank J.-M. Donnay, G. Herrada-Aldrian, B. Lacroix, L. Linares, J.-C. Mazur, J. Miro, D. Moustapha Abba Moussa, Y. Thomas (CRBM, Montpellier, France), V. Backer, J. Cau, S. DeRossi, P. Travo (RIO Imaging facility at the CRBM), and U. Rothbauer (ChromoTek GmbH, Martinsried, Germany) for technical assistance and C. Cazevieille (CRIC, Montpellier, France) for technical assistance and helping us to interpret the ultrastructural data. We are grateful to M. Bosch-Grau, A. Burgess, B. Edde, B. Lacroix, M. M. Magiera, J. Miro, A. C. Seixas (CRBM), M. Bettencourt-Dias (Instituto Gulbenkian de Ciencia, Oeiras, Portugal), M. Knop, I. Mattaj (EMBL, Heidelberg, Germany), and C. Sardet (IGMM, Montpellier, France) for instructive discussions. The authors want to thank the following researchers for providing essential reagents: C. Dehay (Institute of Brain and Stem Cell Research, INSERM, Bron, France) for proving us with rhesus sperm samples, M. Gorovsky (University of Rochester, Rochester, NY, USA) for his generous gift of the polyG and polyE antibodies, and Y. Ishimi (MitsubishiKasei Institute of Life Sciences, Tokyo, Japan) for kindly providing mAb 4A8. The monoclonal antibody 12G10 developed by J. Frankel and M. Nelson was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa.	BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Bre MH, 1996, J CELL SCI, V109, P727; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; BRESSAC C, 1995, EUR J CELL BIOL, V67, P346; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; EDDE B, 1987, DEV BIOL, V123, P549, DOI 10.1016/0012-1606(87)90413-1; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; ISHIMI Y, 1985, CELL STRUCT FUNCT, V10, P373, DOI 10.1247/csf.10.373; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kann ML, 1998, CELL MOTIL CYTOSKEL, V41, P341; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; LEVILLIERS N, 1995, J CELL SCI, V108, P3013; Mans DA, 2008, BBA-REV CANCER, V1786, P114, DOI 10.1016/j.bbcan.2008.02.002; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; Schneider A, 1997, J CELL SCI, V110, P431; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097; Xie R, 2007, EUKARYOT CELL, V6, P388, DOI 10.1128/EC.00366-06	37	93	142	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1076	1087		10.1016/j.cell.2009.05.020	http://dx.doi.org/10.1016/j.cell.2009.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524510	Green Submitted, Bronze			2022-12-24	WOS:000266916400019
J	Blennow, M; Ewald, U; Fritz, T; Holmgren, PA; Jeppsson, A; Lindberg, E; Lundqvist, A; Lindeberg, SN; Olhager, E; Ostlund, I; Simic, M; Sjors, G; Stigson, L; Fellman, V; Hellstrom-Westas, L; Norman, M; Westgren, M; Holmstrom, G; Laurini, R; Stjernqvist, K; Kallen, K; Lagercrantz, H; Marsal, K; Serenius, F; Wennergren, M; Nilstun, T; Olausson, PO; Stromberg, B				Blennow, Mats; Ewald, Uwe; Fritz, Tomas; Holmgren, Per Ake; Jeppsson, Annika; Lindberg, Eva; Lundqvist, Anita; Lindeberg, Solveig Norden; Olhager, Elisabeth; Ostlund, Ingrid; Simic, Marija; Sjoers, Gunnar; Stigson, Lennart; Fellman, Vineta; Hellstrom-Westas, Lena; Norman, Mikael; Westgren, Magnus; Holmstrom, Gerd; Laurini, Ricardo; Stjernqvist, Karin; Kallen, Karin; Lagercrantz, Hugo; Marsal, Karel; Serenius, Fredrik; Wennergren, Margareta; Nilstun, Tore; Olausson, Petra Otterblad; Stromberg, Bo		EXPRESS Grp	One-Year Survival of Extremely Preterm Infants After Active Perinatal Care in Sweden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEEKS GESTATIONAL-AGE; INTENSIVE-CARE; BIRTH-WEIGHT; POPULATION; MORBIDITY; BORN; MORTALITY; LEVEL; MANAGEMENT; THRESHOLD	Context Up-to-date information on infant survival after extremely preterm birth is needed for assessing perinatal care services, clinical guidelines, and parental counseling. Objective To determine the 1-year survival in all infants born before 27 gestational weeks in Sweden during 2004-2007. Design, Setting, and Patients Population-based prospective observational study of extremely preterm infants (707 live-born and 304 stillbirths) born to 887 mothers in 904 deliveries (102 multiple births) in all obstetric and neonatal units in Sweden from April 1, 2004, to March 31, 2007. Main Outcome Measures Infant survival to 365 days and survival without major neonatal morbidity (intraventricular hemorrhage grade > 2, retinopathy of prematurity stage > 2, periventricular leukomalacia, necrotizing enterocolitis, severe bronchopulmonary dysplasia). Associations between perinatal interventions and survival. Results The incidence of extreme prematurity was 3.3 per 1000 infants. Overall perinatal mortality was 45% (from 93% at 22 weeks to 24% at 26 weeks), with 30% stillbirths, including 6.5% intrapartum deaths. Of live-born infants, 91% were admitted to neonatal intensive care and 70% survived to 1 year of age (95% confidence interval [CI], 67%-73%). The Kaplan-Meier survival estimates for 22, 23, 24, 25, and 26 weeks were 9.8% (95% CI, 4%-23%), 53% ( 95% CI, 44%-63%), 67% (95% CI, 59%-75%), 82% (95% CI, 76%-87%), and 85% ( 95% CI, 81%-90%), respectively. Lower risk of infant death was associated with tocolytic treatment (adjusted for gestational age odds ratio [ OR], 0.43; 95% CI, 0.36-0.52), antenatal corticosteroids (OR, 0.44; 95% CI, 0.24-0.81), surfactant treatment within 2 hours after birth ( OR, 0.47; 95% CI, 0.32-0.71), and birth at a level III hospital (OR, 0.49; 95% CI, 0.32-0.75). Among 1-year survivors, 45% had no major neonatal morbidity. Conclusion During 2004 to 2007, 1-year survival of infants born alive at 22 to 26 weeks of gestation in Sweden was 70% and ranged from 9.8% at 22 weeks to 85% at 26 weeks. JAMA. 2009;301(21):2225-2233 www.jama.com	[Blennow, Mats] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Blennow, Mats; Norman, Mikael] Karolinska Inst, Dept Clin Invest Intervent & Technol, Stockholm, Sweden; [Ewald, Uwe] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fritz, Tomas] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, S-41345 Gothenburg, Sweden; [Holmgren, Per Ake] Umea Univ, Dept Clin Sci Obstetr & Gynecol, Umea, Sweden; [Jeppsson, Annika] Linkoping Univ, Dept Obstet & Gynecol, Linkoping, Sweden; [Lindberg, Eva] Univ Orebro, Dept Pediat, Orebro, Sweden; [Lundqvist, Anita] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lindeberg, Solveig Norden] Uppsala Univ, Dept Obstet & Gynecol, Uppsala, Sweden; [Olhager, Elisabeth] Linkoping Univ, Dept Pediat, S-58183 Linkoping, Sweden; [Ostlund, Ingrid] Orebro Univ Hosp, Dept Obstet & Gynecol, Orebro, Sweden; [Simic, Marija] Karolinska Univ Hosp Solna, Dept Obstet & Gynecol, Stockholm, Sweden; [Sjoers, Gunnar; Stromberg, Bo] Uppsala Univ, Dept Pediat, Uppsala, Sweden; [Stigson, Lennart] Sahlgrens Univ Hosp, Dept Pediat, Gothenburg, Sweden; [Fellman, Vineta] Lund Univ, Dept Pediat, S-22100 Lund, Sweden; [Hellstrom-Westas, Lena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Norman, Mikael] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Westgren, Magnus] Karolinska Univ Hosp Huddinge, Dept Obstet & Gynecol, Stockholm, Sweden; [Holmstrom, Gerd] Uppsala Univ, Dept Ophthalmol, Uppsala, Sweden; [Laurini, Ricardo] Nordland Hosp, Dept Pathol, Bodo, Norway; [Stjernqvist, Karin] Lund Univ, Dept Psychol, S-22100 Lund, Sweden; [Kallen, Karin] Lund Univ, Ctr Reprod Epidemiol, S-22100 Lund, Sweden; [Lagercrantz, Hugo] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Lagercrantz, Hugo] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, S-22100 Lund, Sweden; [Serenius, Fredrik] Umea Univ, Dept Clin Sci, S-90187 Umea, Sweden; [Wennergren, Margareta] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Nilstun, Tore] Lund Univ, Dept Med Eth, S-22100 Lund, Sweden; [Olausson, Petra Otterblad] Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Sahlgrenska University Hospital; Umea University; Linkoping University; Orebro University; Lund University; Uppsala University; Linkoping University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Sahlgrenska University Hospital; Lund University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Lund University; Lund University; Karolinska Institutet; Lund University; Umea University; Sahlgrenska University Hospital; Lund University; National Board of Health & Welfare	Marsal, K (corresponding author), Univ Lund Hosp, Dept Obstet & Gynecol, S-22185 Lund, Sweden.	karel.marsal@med.lu.se	Blennow, Mats/AAX-6202-2021	Blennow, Mats/0000-0001-9517-0261; Simic, Marija/0000-0002-1804-4015; Norman, Mikael/0000-0003-4191-3781; Hellstrom-Westas, Lena/0000-0003-3498-6069	Swedish Research Council [521-2006-3858]; Swedish National Board of Health and Welfare; Swedish government; Evy and Gunnar Sandberg Foundation; Lund University and Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Board of Health and Welfare; Swedish government; Evy and Gunnar Sandberg Foundation; Lund University and Umea University	This study was supported by Swedish Research Council grant 521-2006-3858; and by grants from the Swedish National Board of Health and Welfare and from Grants to Researchers in the Public Health Care from the Swedish government. The grants were administered by Lund University and Umea University and used to compensate the 2 research administrators working part time with conduct of the study and collection and management of the data. Karin Kallen, PhD, reported grant support from the Evy and Gunnar Sandberg Foundation.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Chan K, 2001, AM J OBSTET GYNECOL, V185, P220, DOI 10.1067/mob.2001.115280; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cust A. E., 2003, Archives of Disease in Childhood, V88, pF15, DOI 10.1136/fn.88.1.F15; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Effer SB, 2002, BJOG-INT J OBSTET GY, V109, P740; El-Metwally D, 2000, J PEDIATR-US, V137, P616, DOI 10.1067/mpd.2000.109143; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Field DJ, 2008, BMJ-BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Herber-Jonat S, 2006, AM J OBSTET GYNECOL, V195, P16, DOI 10.1016/j.ajog.2006.02.043; Hoekstra RE, 2004, PEDIATRICS, V113, pE1, DOI 10.1542/peds.113.1.e1; Holmgren PA, 2001, ACTA OBSTET GYN SCAN, V80, P525, DOI 10.1034/j.1600-0412.2001.080006525.x; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Johansson S, 2004, PEDIATRICS, V113, P1230, DOI 10.1542/peds.113.5.1230; Kamper J, 2004, ACTA PAEDIATR, V93, P225, DOI 10.1080/08035250310022298; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lee SK, 2003, AM J OBSTET GYNECOL, V188, P617, DOI 10.1067/mob.2003.139; Levene M, 2004, ACTA PAEDIATR, V93, P149, DOI 10.1080/08035250310007745; Malloy MH, 2008, PEDIATRICS, V122, P285, DOI 10.1542/peds.2007-2620; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Morse SB, 2000, PEDIATRICS, V105, P1046, DOI 10.1542/peds.105.5.1046; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pignotti MS, 2008, PEDIATRICS, V121, pE193, DOI 10.1542/peds.2007-0513; Rautava L, 2007, PEDIATRICS, V119, pE257, DOI 10.1542/peds.2006-1964; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmitt SK, 2006, PEDIATRICS, V117, P154, DOI 10.1542/peds.2005-0484; Serenius F, 2004, ACTA PAEDIATR, V93, P1081, DOI [10.1080/08035250410027751, 10.1111/j.1651-2227.2004.tb02721.x]; Stark AR, 2007, PEDIATRICS, V119, P401, DOI 10.1542/peds.2006-3180; Sutton L, 1999, PAEDIATR PERINAT EP, V13, P288; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Vanpee M, 2007, ACTA PAEDIATR, V96, P10, DOI 10.1111/j.1651-2227.2007.00063.x; Vento M, 2008, PEDIATRICS, V122, P1113, DOI 10.1542/peds.2008-1422; World Health Organization, WORLD HLTH REP 2005	45	444	460	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2225	2233		10.1001/jama.2009.771	http://dx.doi.org/10.1001/jama.2009.771			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491184	Bronze			2022-12-24	WOS:000266554100020
J	Mol, A				Mol, Annemarie			The art of medicine Living with diabetes: care beyond choice and control	LANCET			English	Editorial Material									Univ Amsterdam, Dept Anthropol & Sociol, NL-1012 DK Amsterdam, Netherlands	University of Amsterdam	Mol, A (corresponding author), Univ Amsterdam, Dept Anthropol & Sociol, Oudezijds Achterburgwal 185, NL-1012 DK Amsterdam, Netherlands.	a.mol@uva.nl						[Anonymous], 2007, INCLUSION POLITICS D; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Moser I, 2008, GEOFORUM, V39, P98, DOI 10.1016/j.geoforum.2006.12.007; Pols J, 2006, SCI TECHNOL HUM VAL, V31, P409, DOI 10.1177/0162243906287544; Struhkamp R, 2009, SCI TECHNOL HUM VAL, V34, P55, DOI 10.1177/0162243907312954	5	52	52	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1756	1757		10.1016/S0140-6736(09)60971-5	http://dx.doi.org/10.1016/S0140-6736(09)60971-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480076				2022-12-24	WOS:000266337300016
J	Tattersall, GJ; Andrade, DV; Abe, AS				Tattersall, Glenn J.; Andrade, Denis V.; Abe, Augusto S.			Heat Exchange from the Toucan Bill Reveals a Controllable Vascular Thermal Radiator	SCIENCE			English	Article							SURFACE-TEMPERATURE; VASOMOTION; SLEEP; BIRDS	The toco toucan (Ramphastos toco), the largest member of the toucan family, possesses the largest beak relative to body size of all birds. This exaggerated feature has received various interpretations, from serving as a sexual ornament to being a refined adaptation for feeding. However, it is also a significant surface area for heat exchange. Here we show the remarkable capacity of the toco toucan to regulate heat distribution by modifying blood flow, using the bill as a transient thermal radiator. Our results indicate that the toucan's bill is, relative to its size, one of the largest thermal windows in the animal kingdom, rivaling elephants' ears in its ability to radiate body heat.	[Tattersall, Glenn J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Andrade, Denis V.; Abe, Augusto S.] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil	Brock University; Universidade Estadual Paulista	Tattersall, GJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.		Tattersall, Glenn J/D-3469-2009; Andrade, Denis/A-9145-2013; Fisiologia comparada, Inct/I-2427-2013	Tattersall, Glenn J/0000-0002-6591-6760; Andrade, Denis/0000-0002-7662-2848; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao para o Desenvolvimento da Unesp (FUNDUNESP); Natural Sciences and Engineering Research Council of Canada	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao para o Desenvolvimento da Unesp (FUNDUNESP); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to A.S.A. and D.V.A., from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao para o Desenvolvimento da Unesp (FUNDUNESP) to D.V.A., and the Natural Sciences and Engineering Research Council of Canada to G.J.T. M. Symonds kindly commented on the manuscript, and D. Skandalis, V. Cadena, and M. da Silva assisted with experiments.	ALFOLDI P, 1990, PFLUG ARCH EUR J PHY, V417, P336, DOI 10.1007/BF00371001; ALVARENGA H, 2004, TOUCANS AM; BUFFON GLL, 1780, HIST NATURELLE GEN P; Darwin G., 1871, P423; HAGAN AA, 1980, J THERM BIOL, V5, P95, DOI 10.1016/0306-4565(80)90006-6; HELLER HC, 1988, CAN J ZOOL, V66, P61, DOI 10.1139/z88-008; JONES JS, 1985, NATURE, V315, P182, DOI 10.1038/315182b0; KLIR JJ, 1990, COMP BIOCHEM PHYS A, V96, P141, DOI 10.1016/0300-9629(90)90055-W; Lancaster WC, 1997, J THERM BIOL, V22, P109, DOI 10.1016/S0306-4565(96)00039-3; McNab BK, 2001, AUK, V118, P916, DOI 10.1642/0004-8038(2001)118[0916:EOTABA]2.0.CO;2; MIDTGARD U, 1984, ZOOMORPHOLOGY, V104, P323, DOI 10.1007/BF00312014; PHILLIPS PK, 1994, J THERM BIOL, V19, P423, DOI 10.1016/0306-4565(94)90042-6; PHILLIPS PK, 1992, COMP BIOCHEM PHYS A, V101, P693, DOI 10.1016/0300-9629(92)90345-Q; Scott GR, 2008, J EXP BIOL, V211, P1326, DOI 10.1242/jeb.015958; Sick H, 2001, ORNITOLOGIA BRASILEI; SKUTCH ALEXANDER F., 1958, CONDOR, V60, P201, DOI 10.2307/1365190; Tattersall GJ, 2003, J EXP BIOL, V206, P33, DOI 10.1242/jeb.00057; TRAILL TS, 1815, T LINN SOC LOND, V11, P288; TUCKER VA, 1968, J EXP BIOL, V48, P67; Ulrich H, 1997, TROPICAL BIODIVERSIT, P305; Van Tyne J., 1929, LIFE HIST TOUCAN RAM; WALSBERG GE, 1978, J EXP BIOL, V76, P185; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	23	156	162	5	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					468	470		10.1126/science.1175553	http://dx.doi.org/10.1126/science.1175553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628866				2022-12-24	WOS:000268255100054
J	Stein, A; Weber, G; Wahl, MC; Jahn, R				Stein, Alexander; Weber, Gert; Wahl, Markus C.; Jahn, Reinhard			Helical extension of the neuronal SNARE complex into the membrane	NATURE			English	Article							JUXTAMEMBRANE REGION; SYNAPTIC EXOCYTOSIS; MOLECULAR-DYNAMICS; FUSION; SYNAPTOTAGMIN; PROTEINS; DETERMINANTS; MECHANISMS; ENDOSOMES; SYNTAXIN	Neurotransmission relies on synaptic vesicles fusing with the membrane of nerve cells to release their neurotransmitter content into the synaptic cleft, a process requiring the assembly of several members of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family. SNAREs represent an evolutionarily conserved protein family that mediates membrane fusion in the secretory and endocytic pathways of eukaryotic cells(1-3). On membrane contact, these proteins assemble in trans between the membranes as a bundle of four alpha-helices, with the energy released during assembly being thought to drive fusion(4-6). However, it is unclear how the energy is transferred to the membranes and whether assembly is conformationally linked to fusion. Here, we report the X-ray structure of the neuronal SNARE complex, consisting of rat syntaxin 1A, SNAP-25 and synaptobrevin 2, with the carboxy-terminal linkers and transmembrane regions at 3.4 angstrom resolution. The structure shows that assembly proceeds beyond the already known core SNARE complex(7), resulting in a continuous helical bundle that is further stabilized by side-chain interactions in the linker region. Our results suggest that the final phase of SNARE assembly is directly coupled to membrane merger.	[Stein, Alexander; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Max Planck Inst Biophys Chem, Res Grp Xray Crystallog, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Fachbereich Biol, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society; Free University of Berlin	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Stein, Alexander/I-4950-2012; Weber, Gert/I-1800-2013; Wahl, Markus C./D-6365-2017	Stein, Alexander/0000-0002-2696-0611; Weber, Gert/0000-0003-3624-1060; Wahl, Markus C./0000-0002-2811-5307; Jahn, Reinhard/0000-0003-1542-3498	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM072694, P01 GM072694-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelham HRB, 1995, COLD SPRING HARB SYM, V60, P105, DOI 10.1101/SQB.1995.060.01.013; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Su ZL, 2008, STRUCTURE, V16, P1138, DOI 10.1016/j.str.2008.03.018; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Van Komen JS, 2005, EUKARYOT CELL, V4, P2017, DOI 10.1128/EC.4.12.2017-2028.2005; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	296	301	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					525	U105		10.1038/nature08156	http://dx.doi.org/10.1038/nature08156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19571812	Green Accepted, Green Published			2022-12-24	WOS:000268257000041
J	Dyer, C				Dyer, Clare			Assisted suicide: the fight goes on	BRITISH MEDICAL JOURNAL			English	Editorial Material												ClareDyer@aol.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 16	2009	339								b2868	10.1136/bmj.b2868	http://dx.doi.org/10.1136/bmj.b2868			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BX	19608622				2022-12-24	WOS:000268105200003
J	Barrette, RW; Metwally, SA; Rowland, JM; Xu, LZ; Zaki, SR; Nichol, ST; Rollin, PE; Towner, JS; Shieh, WJ; Batten, B; Sealy, TK; Carrillo, C; Moran, KE; Bracht, AJ; Mayr, GA; Sirios-Cruz, M; Catbagan, DP; Lautner, EA; Ksiazek, TG; White, WR; McIntosh, MT				Barrette, Roger W.; Metwally, Samia A.; Rowland, Jessica M.; Xu, Lizhe; Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Carrillo, Consuelo; Moran, Karen E.; Bracht, Alexa J.; Mayr, Gregory A.; Sirios-Cruz, Magdalena; Catbagan, Davinio P.; Lautner, Elizabeth A.; Ksiazek, Thomas G.; White, William R.; McIntosh, Michael T.			Discovery of Swine as a Host for the Reston ebolavirus	SCIENCE			English	Article							VIRUS; BATS; PHILIPPINES; RESERVOIRS; INFECTION; VIRULENCE; EMERGENCE	Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic fatal outbreaks of disease in humans and nonhuman primates have given impetus to identification of host tropisms and potential reservoirs. Domestic swine in the Philippines, experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome, have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member of Filoviridae that has not been associated with disease in humans, its emergence in the human food chain is of concern. REBOV isolates were found to be more divergent from each other than from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been circulating since, and possibly before, the initial discovery of REBOV in monkeys.	[Barrette, Roger W.; Metwally, Samia A.; Rowland, Jessica M.; Xu, Lizhe; Carrillo, Consuelo; Moran, Karen E.; Bracht, Alexa J.; Mayr, Gregory A.; Lautner, Elizabeth A.; White, William R.; McIntosh, Michael T.] USDA, Plum Isl Anim Dis Ctr, US Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs,Foreign Anim Dis Diagnost Lab, Greenport, NY 11944 USA; [Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Ksiazek, Thomas G.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; [Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Ksiazek, Thomas G.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA 30333 USA; [Sirios-Cruz, Magdalena; Catbagan, Davinio P.] Dept Agr, Bur Anim Ind, Quezon City 1101, Philippines	United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Metwally, SA (corresponding author), USDA, Plum Isl Anim Dis Ctr, US Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs,Foreign Anim Dis Diagnost Lab, Greenport, NY 11944 USA.	samia.a.metwally@aphis.usda.gov; michael.t.mcintosh@aphis.usda.gov	Towner, Jonathan/ABC-3780-2020	Rollin, Pierre/0000-0002-4608-2641	USDA; APHIS; Department of Homeland Security	USDA(United States Department of Agriculture (USDA)); APHIS(United States Department of Agriculture (USDA)); Department of Homeland Security(United States Department of Homeland Security (DHS))	We thank members of the Diagnostic Services Section of FADDL (H. Petrowski, F. Mohamed, and M. Berninger), the CDC Special Pathogens Branch (D. Cannon, A. Comer, S. Dickerson, C. Manning, D. Miller, and Z. Reed), and the CDC Infectious Disease Pathology Branch (C. Paddock, P. Adem, and C. Goldsmith) for expert technical assistance. We are also grateful to P. Hauer (APHIS, USDA) for critical review of the manuscript and to T. Gomez and J. Willnow (USDA) for facilitating conversations between U.S. agencies and the Philippines. We thank G. Risatti for protocols for PRRSV RT-PCR. This work was funded by the USDA as part of an ongoing foreign animal disease diagnostic investigation. Support for microarray development and implementation is sponsored by the APHIS Science Fellows Program, USDA, and the Department of Homeland Security. R.W.B. is an award recipient of the APHIS Science Fellows Program. PRRSV NSP2 sequences are available at GenBank (accession numbers FJ641193, FJ641194, and FJ641195), as are Reston08-A, Reston08-C, and Reston08-E sequences (accession numbers FJ621583, FJ621584, and FJ621585, respectively). Microarray data and analyses are available for download from NCBI Gene Expression Omnibus (accession GSE15687 [NCBI GEO] ) at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15687. All authors declare that they have no competing interests.	Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Jahrling PB, 1996, ARCH VIROL, P115; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li YF, 2008, ARCH VIROL, V153, P1877, DOI 10.1007/s00705-008-0207-6; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Morikawa S, 2007, COMP IMMUNOL MICROB, V30, P391, DOI 10.1016/j.cimid.2007.05.005; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Peters CJ, 1999, J INFECT DIS, V179, pIX; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Strong JE, 2008, P NATL ACAD SCI USA, V105, P17982, DOI 10.1073/pnas.0809698105; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	21	255	282	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					204	206		10.1126/science.1172705	http://dx.doi.org/10.1126/science.1172705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590002	Green Published			2022-12-24	WOS:000267802000048
J	Svendsen, JM; Smogorzewska, A; Sowa, ME; O'Connell, BC; Gygi, SP; Elledge, SJ; Harper, JW				Svendsen, Jennifer M.; Smogorzewska, Agata; Sowa, Mathew E.; O'Connell, Brenda C.; Gygi, Steven P.; Elledge, Stephen J.; Harper, J. Wade			Mammalian BTBD12/SLX4 Assembles A Holliday Junction Resolvase and Is Required for DNA Repair	CELL			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; SACCHAROMYCES-CEREVISIAE; MEIOTIC CROSSOVERS; MUS81-EME1; IDENTIFICATION; RESOLUTION; MECHANISM; PROTEINS; DAMAGE; YEAST	Structure-specific endonucleases mediate cleavage of DNA structures formed during repair of collapsed replication forks and double-strand breaks (DSBs). Here, we identify BTBD12 as the human ortholog of the budding yeast DNA repair factor Slx4p and D. melanogaster MUS312. Human SLX4 forms a multiprotein complex with the ERCC4(XPF)-ERCC1, MUS81-EME1, and SLX1 endonucleases and also associates with MSH2/MSH3 mismatch repair complex, telomere binding complex TERF2(TRF2)-TERF2IP(RAP1), the protein kinase PLK1 and the uncharacterized protein C20orf94. Depletion of SLX4 causes sensitivity to mitomycin C and camptothecin and reduces the efficiency of DSB repair in vivo. SLX4 complexes cleave 3' flap, 5' flap, and replication fork structures; yet unlike other endonucleases associated with SLX4, the SLX1-SLX4 module promotes symmetrical cleavage of static and migrating Holliday junctions (HJs), identifying SLX1-SLX4 as a HJ resolvase. Thus, SLX4 assembles a modular toolkit for repair of specific types of DNA lesions and is critical for cellular responses to replication fork failure.	[Svendsen, Jennifer M.; Sowa, Mathew E.; O'Connell, Brenda C.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Med, Div Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Smogorzewska, Agata/B-8891-2011	Smogorzewska, Agata/0000-0001-6285-1562; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health; Centers for Medical Countermeasures Against Radiation; Stewart Trust; Burroughs Wellcome Fund; American Cancer Society;  [T32CA09216]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Medical Countermeasures Against Radiation; Stewart Trust; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Clare McGowan, Richard Wood, Orlando Scharer, Joyce Reardon, Laura Niedernhofer, Maria Jasin, Steve West, and Guang Hu for reagents, John Rouse, Jim Haber, Jeff Sekelsky, Monica Colaiacovo, and Pierre- Henri Gaillard for communicating results prior to publication, and Alberto Ciccia and Maria Jasin for discussions. This work was supported by grants from the National Institutes of Health to S.J.E., S.P.G., and J.W.H., a Centers for Medical Countermeasures Against Radiation grant to S.J.E., and by a grant from the Stewart Trust to J.W.H.A.S. is supported by T32CA09216 to the Pathology Department at the Massachusetts General Hospital and by an award from the Burroughs Wellcome Fund. B.C.O. is supported by a postdoctoral fellowship from the American Cancer Society. S.J.E. is an investigator of the Howard Hughes Medical Institute.	Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Coulon S, 2004, MOL BIOL CELL, V15, P71, DOI 10.1091/mbc.E03-08-0586; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FEKAIRI S, 2009, CELL IN PRESS; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; SOWA ME, 2009, CELL IN PRESS, DOI DOI 10.1016/J.CELL.2009.04.042; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; WEST SC, 1995, NATURE, V373, P27, DOI 10.1038/373027a0; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	34	348	362	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					63	77		10.1016/j.cell.2009.06.030	http://dx.doi.org/10.1016/j.cell.2009.06.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596235	Green Accepted, Bronze			2022-12-24	WOS:000267848600015
J	Cahill, KS; Chi, JH; Day, A; Claus, EB				Cahill, Kevin S.; Chi, John H.; Day, Arthur; Claus, Elizabeth B.			Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTERIOR CERVICAL DISKECTOMY; LUMBAR INTERBODY FUSION; ILIAC-CREST AUTOGRAFT; LENGTH-OF-STAY; UNITED-STATES; SURGERY; ICD-9-CM; IMPACT; SAFETY; GRAFT	Context No national data exist to examine use of bone-morphogenetic proteins (BMPs) in spinal fusion surgery. Objective To determine the patterns of use and rates of complications and financial charges associated with BMP use in spinal fusion nationally. Design, Setting, and Patients Retrospective cohort study of 328 468 patients undergoing spinal fusion procedures from 2002-2006 identified from the Nationwide Inpatient Sample database, a 20% sample of US community hospitals. Main Outcome Measures The rates of use of BMP among patients undergoing spinal fusion procedures are examined along with complications, length of stay, and hospital charges associated with use of this fusion adjunct. Results The nationwide usage of BMP has increased from 0.69% of all fusions in 2002 to 24.89% of all fusions in 2006. Use of BMP varied by patient sex, race, and primary payer with increased use seen in women (56.26% with BMP vs 53.35% without BMP; odds ratio [OR], 1.12; 95% confidence interval, [CI], 1.09-1.16) and Medicare patients (29.62% with BMP vs 27.16% without BMP; OR, 1.43; 95% CI, 1.311.56) and decreased use in nonwhite patients (8.69% with BMP vs 10.23% without BMP; OR, 0.80; 95% CI, 0.75-0.85). When comparing immediate postoperative, in-hospital rates of complications for the year 2006 among patients undergoing spinal fusion by BMP use status, no differences were seen for lumbar, thoracic, or posterior cervical procedures. On univariate analysis and after multivariable adjustment, the use of BMP in anterior cervical fusion procedures was associated with a higher rate of complication occurrence (7.09% with BMP vs 4.68% without BMP; adjusted OR, 1.43; 95% CI, 1.12-1.70) with the primary increases seen in wound-related complications (1.22% with BMP vs 0.65% without BMP; adjusted OR, 1.67; 95% CI, 1.10-2.53) and dysphagia or hoarseness (4.35% with BMP vs 2.45% without BMP; adjusted OR, 1.63; 95% CI, 1.30-2.05). Bone-morphogenetic protein use was associated with greater inpatient hospital charges across all categories of fusion. Increases between 11% and 41% of total hospital charges were reported, with the greatest percentage increase seen for anterior cervical fusion. Conclusion Bone-morphogenetic protein was used in approximately 25% of all spinal fusions nationally in 2006, with use associated with more frequent complications for anterior cervical fusions and with greater hospital charges for all categories of fusions. JAMA. 2009;302(1):58-66	[Cahill, Kevin S.; Chi, John H.; Day, Arthur; Claus, Elizabeth B.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Claus, Elizabeth B.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Harvard University; Brigham & Women's Hospital; Yale University	Cahill, KS (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, PBB 3,75 Francis St, Boston, MA 02115 USA.	kcahill3@partners.org			Brain Science Foundation	Brain Science Foundation	This work was supported by the Brain Science Foundation.	Ackerman SJ, 2002, SPINE, V27, pS94, DOI 10.1097/00007632-200208151-00017; Agency for Healthcare Research and Quality, HEALTHC UT PROJ OV N; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CYPRESS BK, 1983, AM J PUBLIC HEALTH, V73, P389, DOI 10.2105/AJPH.73.4.389; DAVIS H, 1994, SPINE, V19, P1117, DOI 10.1097/00007632-199405001-00003; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Dickerman RD, 2007, SPINE J, V7, P508, DOI 10.1016/j.spinee.2007.03.003; Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81; Friedman Bernard, 2002, J Health Care Finance, V29, P1; Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004; Lipson SJ, 2004, NEW ENGL J MED, V350, P643, DOI 10.1056/NEJMp038162; Liu JH, 2006, JAMA-J AM MED ASSOC, V296, P1973, DOI 10.1001/jama.296.16.1973; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b; Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Schmidt WP, 2003, CEREBROVASC DIS, V16, P247, DOI 10.1159/000071123; Shamji MF, 2008, J NEUROSURG-SPINE, V9, P10, DOI 10.3171/SPI/2008/9/7/010; Shamji MF, 2009, SPINE J, V9, P31, DOI 10.1016/j.spinee.2008.07.005; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Tumialan LM, 2008, J NEUROSURG-SPINE, V8, P529, DOI 10.3171/SPI/2008/8/6/529; URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371; *US FDA PUBL HLTH, 2008, LIF THREAT COMPL ASS; US Food and Drug Administration, INFUSE BON GRAFT LT; US Food and Drug Administration, OP 1 PUTT H020008; Vaccaro AR, 2008, SPINE J, V8, P457, DOI 10.1016/j.spinee.2007.03.012; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Wang MC, 2007, SPINE, V32, P342, DOI 10.1097/01.brs.0000254120.25411.ae; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	42	354	362	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					58	66		10.1001/jama.2009.956	http://dx.doi.org/10.1001/jama.2009.956			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567440	Bronze			2022-12-24	WOS:000267492800022
J	Dublin, S; Jackson, ML; Nelson, JC; Weiss, NS; Larson, EB; Jackson, LA				Dublin, Sascha; Jackson, Michael L.; Nelson, Jennifer C.; Weiss, Noel S.; Larson, Eric B.; Jackson, Lisa A.			Statin use and risk of community acquired pneumonia in older people: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVES SURVIVAL; MURINE MODEL; MORTALITY; SEPSIS; INFLUENZA; THERAPY; IMPACT; HOSPITALIZATION; INFLAMMATION; INHIBITION	Objective To test the hypothesis that hydroxymethyl glutaryl coenzyme A reductase inhibitors (statin s) may decrease the risk of community acquired pneumonia. Design Population based case-control study. Setting Group Health, a large integrated healthcare delivery system. Population Immunocompetent, community dwelling Group Health members aged 65 to 94; two matched controls for each case with pneumonia. Information on comorbid illnesses and functional and cognitive status, potential confounders of the association between statin use and risk of pneumonia, came from medical record review and computerised pharmacy data. Main outcome measure Adjusted estimates of risk of pneumonia in relation to current statin use. Results 1125 validated cases of pneumonia and 2235 matched controls were identified. Compared with controls, cases were more likely to have chronic lung and heart disease, especially severe disease, and functional or cognitive impairment. Current statin use was present in 16.1% (181/1125) of cases and 14.6% (327/2235) of controls (adjusted odds ratio 1.26, 95% confidence interval 1.01 to 1.56). Among cases admitted to hospital and matched controls, current statin use was present in 17.2% (68/395) of cases and 14.2% (112/788) of controls (adjusted odds ratio 1.61, 1.08 to 2.39, compared with non-use). In people in whom statins were indicated for secondary prevention, the adjusted odds ratio for risk of pneumonia in relation to current statin use was 1.25 (0.94 to 1.67); in those with no such indication, it was 0.81 (0.46 to 1.42). Conclusions Statin use was not associated with decreased risk of pneumonia among immunocompetent, community dwelling older people. Findings of previous studies may reflect "healthy user" bias.	[Dublin, Sascha; Jackson, Michael L.; Nelson, Jennifer C.; Larson, Eric B.; Jackson, Lisa A.] Grp Hlth Ctr Hlth Studies, Seattle, WA 98101 USA; [Dublin, Sascha; Weiss, Noel S.; Jackson, Lisa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nelson, Jennifer C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dublin, S (corresponding author), Grp Hlth Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	dublin.s@ghc.org			National Institute on Aging [K23AG028954]; Hartford and Starr Foundations; Atlantic Philanthropies; Group Health Center for Health Studies; NATIONAL INSTITUTE ON AGING [K23AG028954] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hartford and Starr Foundations; Atlantic Philanthropies; Group Health Center for Health Studies; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SD was funded by a Paul Beeson Career Development Award from the National Institute on Aging ( grant K23AG028954). The Beeson award is also supported by the Hartford and Starr Foundations and Atlantic Philanthropies. Group Health Center for Health Studies internal funds covered the data collection and analysis. The sponsors played no role in study design; the collection, analysis or interpretation of data; the writing of the report; or in the decision to submit the manuscript for publication.	Ahmed F, 2005, J CLIN EPIDEMIOL, V58, P624, DOI 10.1016/j.jclinepi.2004.11.020; Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chaudhry MZ, 2008, SURG INFECT, V9, P183, DOI 10.1089/sur.2006.077; CLAUSELL N, STATIN IMMUNOMUDULAT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DONNINO MW, STATIN THERAPY TREAT; Dunzendorfer S, 1997, CIRC RES, V81, P963; Farr BM, 2000, RESP MED, V94, P422, DOI 10.1053/rmed.1999.0743; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; Gambassi G, 1998, ARCH INTERN MED, V158, P2377, DOI 10.1001/archinte.158.21.2377; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; JACOBSON J, STATINS EARLY TREATM; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; LACROIX AZ, 1989, PUBLIC HEALTH REP, V104, P350; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mancini GBJ, 2007, CHEST, V131, P950, DOI 10.1378/chest.06-2838; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Novack V, 2006, CRIT CARE, V10, DOI 10.1186/cc3972; ORTIZCASTILLO F, EFFECT ROSUVASTATIN; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; SCHENK P, SIMVASTATIN PATIENTS; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; *US FDA, 2008, SENT SYST MON MED PR; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; ZAKYNTHINOS E, PRAVASTATIN VENTILAT	51	58	58	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2009	338								b2137	10.1136/bmj.b2137	http://dx.doi.org/10.1136/bmj.b2137			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UQ	19531550	hybrid, Green Published			2022-12-24	WOS:000267216600002
J	Dieffenbach, CW; Fauci, AS				Dieffenbach, Carl W.; Fauci, Anthony S.			Universal Voluntary Testing and Treatment for Prevention of HIV Transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; VIRAL LOAD		[Dieffenbach, Carl W.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dieffenbach, CW (corresponding author), NIAID, NIH, 6700-B Rockledge Dr, Bethesda, MD 20892 USA.	cdieffenba@niaid.nih.gov						Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza P, 2008, B MED SUISSES, V89, P165; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0	13	203	207	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2380	2382		10.1001/jama.2009.828	http://dx.doi.org/10.1001/jama.2009.828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509386				2022-12-24	WOS:000266773400032
J	Kamstrup, PR; Tybjaerg-Hansen, A; Steffensen, R; Nordestgaard, BG				Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Steffensen, Rolf; Nordestgaard, Borge G.			Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; PENTANUCLEOTIDE REPEAT POLYMORPHISM; MENDELIAN RANDOMIZATION; APOLIPOPROTEIN(A) SIZE; IN-VIVO; CARDIOVASCULAR EVENTS; LP(A) LIPOPROTEIN; AORTIC INTIMA; RABBIT AORTA; APO(A) SIZE	Context High levels of lipoprotein(a) are associated with increased risk of myocardial infarction (MI). Objective To assess whether genetic data are consistent with this association being causal. Design, Setting, and Participants Three studies of white individuals from Copenhagen, Denmark, were used: the Copenhagen City Heart Study (CCHS), a prospective general population study with 16 years of follow-up (1991-2007, n=8637, 599 MI events); the Copenhagen General Population Study (CGPS), a cross-sectional general population study (2003-2006, n=29 388, 994 MI events); and the Copenhagen Ischemic Heart Disease Study (CIHDS), a case-control study (1991-2004, n=2461, 1231 MI events). Main Outcome Measures Plasma lipoprotein(a) levels, lipoprotein(a) kringle IV type 2 (KIV-2) size polymorphism genotype, and MIs recorded from 1976 through July 2007 for all participants. Results In the CCHS, multivariable-adjusted hazard ratios (HRs) for MI for elevated lipoprotein( a) levels were 1.2 (95% confidence interval [CI], 0.9-1.6; events/10 000 person-years, 59) for levels between the 22nd and 66th percentile, 1.6 (95% CI, 1.1-2.2; events/10 000 person-years, 75) for the 67th to 89th percentile, 1.9 ( 95% CI, 1.2-3.0; events/10 000 person-years, 84) for the 90th to 95th percentile, and 2.6 ( 95% CI, 1.6-4.1; events/10 000 person-years, 108) for levels greater than the 95th percentile, respectively, vs levels less than the 22nd percentile (events/10 000 person-years, 55) (trend P<.001). Numbers of KIV-2 repeats (sum of repeats on both alleles) ranged from 6 to 99 and on analysis of variance explained 21% and 27% of all variation in plasma lipoprotein(a) levels in the CCHS and CGPS, respectively. Mean lipoprotein(a) levels were 56, 31, 20, and 15 mg/dL for the first, second, third, and fourth quartiles of KIV-2 repeats in the CCHS, respectively (trend P<.001); corresponding values in the CGPS were 60, 34, 22, and 19 mg/dL (trend P<.001). In the CCHS, multivariable-adjusted HRs for MI were 1.5 (95% CI, 1.2-1.9; events/10 000 person-years, 75), 1.3 (95% CI, 1.0-1.6; events/10 000 person-years, 66), and 1.1 (95% CI, 0.9-1.4; events/10 000 person-years, 57) for individuals in the first, second, and third quartiles, respectively, as compared with individuals in the fourth quartile of KIV-2 repeats (events/10 000 person-years, 51) (trend P<.001). Corresponding odds ratios were 1.3 (95% CI, 1.1-1.5), 1.1 (95% CI, 0.9-1.3), and 0.9 (95% CI, 0.8-1.1) in the CGPS (trend P=.005), and 1.4 (95% CI, 1.1-1.7), 1.2 ( 95% CI, 1.0-1.6), and 1.3 (95% CI, 1.0-1.6) in the CIHDS (trend P=.01). Genetically elevated lipoprotein(a) was associated with an HR of 1.22 (95% CI, 1.09-1.37) per doubling of lipoprotein(a) level on instrumental variable analysis, while the corresponding value for plasma lipoprotein(a) levels on Cox regression was 1.08 (95% CI, 1.03-1.12). Conclusion These data are consistent with a causal association between elevated lipoprotein(a) levels and increased risk of MI. JAMA. 2009; 301(22):2331-2339 www.jama.com	[Kamstrup, Pia R.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Steffensen, Rolf] Nordsjaellands Hosp Hillerod, Dept Internal Med, Hillerod, Denmark; [Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Girelli, Domenico/B-1183-2008; Nordestgaard, Borge Gronne/ABF-1310-2020	Girelli, Domenico/0000-0001-9684-1899; Nordestgaard, Borge/0000-0002-1954-7220	Danish Heart Foundation; IMK Almene Fund; Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry; Johan and Lise Boserup's Fund	Danish Heart Foundation; IMK Almene Fund; Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry; Johan and Lise Boserup's Fund	The present study was supported by the Danish Heart Foundation, IMK Almene Fund, Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry, and Johan and Lise Boserup's Fund.	Amemiya H, 1996, ATHEROSCLEROSIS, V123, P181, DOI 10.1016/0021-9150(96)05806-6; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Chimienti G, 2002, EXP MOL PATHOL, V73, P28, DOI 10.1006/exmp.2002.2445; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Deb A, 2004, CLIN CARDIOL, V27, P258, DOI 10.1002/clc.4960270503; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gazzaruso C, 1999, J AM COLL CARDIOL, V33, P157, DOI 10.1016/S0735-1097(98)00541-5; Geethanjali FS, 2003, ATHEROSCLEROSIS, V169, P121, DOI 10.1016/S0021-9150(03)00143-6; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Kamstrup PR, 2008, J CLIN ENDOCR METAB, V93, P3769, DOI 10.1210/jc.2008-0830; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; KARK JD, 1993, ATHEROSCLEROSIS, V98, P139, DOI 10.1016/0021-9150(93)90124-D; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; Kraft HG, 1996, ARTERIOSCL THROM VAS, V16, P713, DOI 10.1161/01.ATV.16.6.713; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Nielsen LB, 1996, CIRC RES, V78, P615, DOI 10.1161/01.RES.78.4.615; NIELSEN LB, 1995, ARTERIOSCL THROM VAS, V15, P1492, DOI 10.1161/01.ATV.15.9.1492; Nielsen LB, 1996, J CLIN INVEST, V98, P563, DOI 10.1172/JCI118824; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Nielsen LB, 1998, ARTERIOSCL THROM VAS, V18, P641, DOI 10.1161/01.ATV.18.4.641; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619, DOI 10.1161/01.ATV.20.12.2619; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; Rosby O, 2000, J INTERN MED, V247, P139, DOI 10.1046/j.1365-2796.2000.00628.x; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214, DOI 10.1161/01.ATV.12.10.1214; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tate JR, 1998, CLIN CHEM, V44, P1629; Utermann G., 2001, METABOLIC MOL BASES, V8th, P2753; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239	40	785	808	3	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2331	2339		10.1001/jama.2009.801	http://dx.doi.org/10.1001/jama.2009.801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509380	Bronze			2022-12-24	WOS:000266773400026
J	Schuur, EAG; Vogel, JG; Crummer, KG; Lee, H; Sickman, JO; Osterkamp, TE				Schuur, Edward A. G.; Vogel, Jason G.; Crummer, Kathryn G.; Lee, Hanna; Sickman, James O.; Osterkamp, T. E.			The effect of permafrost thaw on old carbon release and net carbon exchange from tundra	NATURE			English	Article							CLIMATE-CHANGE; SOIL CARBON; DYNAMICS; DECOMPOSITION; TEMPERATURE; RADIOCARBON; ECOSYSTEMS; FEEDBACKS; SINK	Permafrost soils in boreal and Arctic ecosystems store almost twice as much carbon(1,2) as is currently present in the atmosphere(3). Permafrost thaw and the microbial decomposition of previously frozen organic carbon is considered one of the most likely positive climate feedbacks from terrestrial ecosystems to the atmosphere in a warmer world(1,2,4-7). The rate of carbon release from permafrost soils is highly uncertain, but it is crucial for predicting the strength and timing of this carbon-cycle feedback effect, and thus how important permafrost thaw will be for climate change this century and beyond(1,2,4-7). Sustained transfers of carbon to the atmosphere that could cause a significant positive feedback to climate change must come from old carbon, which forms the bulk of the permafrost carbon pool that accumulated over thousands of years(8-11). Here we measure net ecosystem carbon exchange and the radiocarbon age of ecosystem respiration in a tundra landscape undergoing permafrost thaw(12) to determine the influence of old carbon loss on ecosystem carbon balance. We find that areas that thawed over the past 15 years had 40 per cent more annual losses of old carbon than minimally thawed areas, but had overall net ecosystem carbon uptake as increased plant growth offset these losses. In contrast, areas that thawed decades earlier lost even more old carbon, a 78 per cent increase over minimally thawed areas; this old carbon loss contributed to overall net ecosystem carbon release despite increased plant growth. Our data document significant losses of soil carbon with permafrost thaw that, over decadal timescales, overwhelms increased plant carbon uptake(13-15) at rates that could make permafrost a large biospheric carbon source in a warmer world.	[Schuur, Edward A. G.; Vogel, Jason G.; Crummer, Kathryn G.; Lee, Hanna] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Sickman, James O.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Osterkamp, T. E.] Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA	State University System of Florida; University of Florida; University of California System; University of California Riverside; University of Alaska System; University of Alaska Fairbanks	Schuur, EAG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	tschuur@ufl.edu		Lee, Hanna/0000-0002-2003-4377	NASA New Investigator Program; NSF Bonanza Creek LTER Program; NSF DEB Ecosystems Program; National Park Service; Directorate For Geosciences [0806271] Funding Source: National Science Foundation	NASA New Investigator Program(National Aeronautics & Space Administration (NASA)); NSF Bonanza Creek LTER Program(National Science Foundation (NSF)); NSF DEB Ecosystems Program(National Science Foundation (NSF)); National Park Service; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by assistance from G. Adema, T. Chapin, S. DeBiasio, L. Gutierrez, M. Mack, M. Schieber, E. Tissier, C. Trucco, W. Vicars, E. Wilson, C. Wuthrich, L. Yocum, and the researchers and technicians of the Bonanza Creek LTER. This work relied on funds from the following sources: NASA New Investigator Program, NSF Bonanza Creek LTER Program, NSF DEB Ecosystems Program, and a cooperative agreement with the National Park Service.	Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Delisle G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029323; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Field CB, 2007, 1 STATE CARBON CYCLE, P21; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Osterkamp TE, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000578; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Osterkamp TE, 2005, GLOBAL PLANET CHANGE, V49, P187, DOI 10.1016/j.gloplacha.2005.09.001; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Schirrmeister L, 2002, QUATERN INT, V89, P97, DOI 10.1016/S1040-6182(01)00083-0; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Vitt DH, 2000, CAN J FOREST RES, V30, P283, DOI 10.1139/x99-214; ZIMOV SA, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2006GL027484; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	30	761	805	27	678	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					556	559		10.1038/nature08031	http://dx.doi.org/10.1038/nature08031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478781				2022-12-24	WOS:000266370500036
J	Kim, JI; Ju, YS; Park, H; Kim, S; Lee, S; Yi, JH; Mudge, J; Miller, NA; Hong, D; Bell, CJ; Kim, HS; Chung, IS; Lee, WC; Lee, JS; Seo, SH; Yun, JY; Woo, HN; Lee, H; Suh, D; Lee, S; Kim, HJ; Yavartanoo, M; Kwak, M; Zheng, Y; Lee, MK; Park, H; Kim, JY; Gokcumen, O; Mills, RE; Zaranek, AW; Thakuria, J; Wu, X; Kim, RW; Huntley, JJ; Luo, S; Schroth, GP; Wu, TD; Kim, H; Yang, KS; Park, WY; Kim, H; Church, GM; Lee, C; Kingsmore, SF; Seo, JS				Kim, Jong-Il; Ju, Young Seok; Park, Hansoo; Kim, Sheehyun; Lee, Seonwook; Yi, Jae-Hyuk; Mudge, Joann; Miller, Neil A.; Hong, Dongwan; Bell, Callum J.; Kim, Hye-Sun; Chung, In-Soon; Lee, Woo-Chung; Lee, Ji-Sun; Seo, Seung-Hyun; Yun, Ji-Young; Woo, Hyun Nyun; Lee, Heewook; Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Lee, Mi Kyeong; Park, Hyunjun; Kim, Jeong Yeon; Gokcumen, Omer; Mills, Ryan E.; Zaranek, Alexander Wait; Thakuria, Joseph; Wu, Xiaodi; Kim, Ryan W.; Huntley, Jim J.; Luo, Shujun; Schroth, Gary P.; Wu, Thomas D.; Kim, HyeRan; Yang, Kap-Seok; Park, Woong-Yang; Kim, Hyungtae; Church, George M.; Lee, Charles; Kingsmore, Stephen F.; Seo, Jeong-Sun			A highly annotated whole-genome sequence of a Korean individual	NATURE			English	Article							MESSENGER-RNA	Recent advances in sequencing technologies have initiated an era of personal genome sequences. To date, human genome sequences have been reported for individuals with ancestry in three distinct geographical regions: a Yoruba African, two individuals of northwest European origin, and a person from China(1-4). Here we provide a highly annotated, whole-genome sequence for a Korean individual, known as AK1. The genome of AK1 was determined by an exacting, combined approach that included whole-genome shot-gun sequencing (27.8x coverage), targeted bacterial artificial chromosome sequencing, and high-resolution comparative genomic hybridization using custom microarrays featuring more than 24 million probes. Alignment to the NCBI reference, a composite of several ethnic clades(5,6), disclosed nearly 3.45 million single nucleotide polymorphisms ( SNPs), including 10,162 non-synonymous SNPs, and 170,202 deletion or insertion polymorphisms (indels). SNP and indel densities were strongly correlated genome-wide. Applying very conservative criteria yielded highly reliable copy number variants for clinical considerations. Potential medical phenotypes were annotated for non-synonymous SNPs, coding domain indels, and structural variants. The integration of several human whole-genome sequences derived from several ethnic groups will assist in understanding genetic ancestry, migration patterns and population bottlenecks.	[Kim, Jong-Il; Ju, Young Seok; Park, Hansoo; Yi, Jae-Hyuk; Hong, Dongwan; Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Park, Hyunjun; Kim, Jeong Yeon; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea; [Kim, Jong-Il; Ju, Young Seok; Suh, Dongwhan; Lee, Seungbok; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Coll Med, Dept Biochem & Mol Biol, Seoul 110799, South Korea; [Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Jong-Il; Kim, Sheehyun; Lee, Seonwook; Kim, Hye-Sun; Chung, In-Soon; Lee, Woo-Chung; Lee, Ji-Sun; Woo, Hyun Nyun; Lee, Heewook; Kim, HyeRan; Yang, Kap-Seok; Kim, Hyungtae; Seo, Jeong-Sun] Macrogen Inc, Seoul 153023, South Korea; [Kim, Jong-Il; Park, Hansoo; Seo, Seung-Hyun; Yun, Ji-Young; Lee, Mi Kyeong; Seo, Jeong-Sun] Psoma Therapeut Inc, Seoul 110799, South Korea; [Mudge, Joann; Miller, Neil A.; Bell, Callum J.; Mills, Ryan E.; Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Gokcumen, Omer; Mills, Ryan E.; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zaranek, Alexander Wait; Thakuria, Joseph; Wu, Xiaodi; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Huntley, Jim J.; Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Macrogen, Inc.; National Center for Genome Resources (NCGR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Illumina; Roche Holding; Genentech	Seo, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea.	jeongsun@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; Ju, Young Seok/E-1324-2012; park, woongyang/D-5727-2012; Lee, Mi Kyeong/C-3046-2017; KIM, JONG-IL/D-1019-2011; Mills, Ryan/F-4225-2010; Gokcumen, Omer/J-6984-2013	Ju, Young Seok/0000-0002-5514-4189; Lee, Mi Kyeong/0000-0002-3036-3684; KIM, JONG-IL/0000-0002-7240-3744; Mills, Ryan/0000-0003-3425-6998; Mudge, Joann/0000-0002-2972-1640; kingsmore, stephen/0000-0002-3758-4631; Seungbok, Lee/0000-0002-3145-8714; Gokcumen, Omer/0000-0003-4371-679X; Hong, Dongwan/0000-0002-7816-1299; church, george/0000-0001-6232-9969; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655; Kingsmore, Stephen/0000-0001-7180-2527; Kim, Sheehyun/0000-0002-4347-4420	Korean Ministry of Education, Science, and Technology [M10305030000]; Green Cross Therapeutics [0411-20080023]; Macrogen Inc. [MG2009001]; National Institutes of Health (NIH) [RR016480, HG004221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Green Cross Therapeutics; Macrogen Inc.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. Yi for her help during this work. We would like to thank D. Bentley and M. Ross for providing genotypes of NA18507, and S. Ham for his comment on BAC analysis. This work has been supported by the Korean Ministry of Education, Science, and Technology ( grant M10305030000), Green Cross Therapeutics ( 0411-20080023), and Macrogen Inc. (MG2009001). This work was also supported in part by National Institutes of Health (NIH) grants RR016480 ( S. F. K.) and HG004221 ( C. L.). We acknowledge G. D. May, J. E. Woodward and L. E. Clendenen for generation of some of the sequence data, and T. Ramaraj for assistance with data analysis.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen R, 2004, GENOME RES, V14, P679, DOI 10.1101/gr.2171704; Frijters ACJ, 1997, THEOR APPL GENET, V94, P390, DOI 10.1007/s001220050428; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Longman-Jacobsen N, 2003, GENE, V312, P257, DOI 10.1016/S0378-1119(03)00621-8; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Silva JC, 2002, TRENDS GENET, V18, P544, DOI 10.1016/S0168-9525(02)02757-9; Sokal R. R., 2012, BIOMETRY; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	22	242	259	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1011	U96		10.1038/nature08211	http://dx.doi.org/10.1038/nature08211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19587683	Green Accepted, hybrid			2022-12-24	WOS:000269085500034
J	Wang, YG; Vera, L; Fischer, WH; Montminy, M				Wang, Yiguo; Vera, Liliana; Fischer, Wolfgang H.; Montminy, Marc			The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; INSULIN; ATF6; TORC2; PROTEOLYSIS; OBESITY; CELLS; IRE1	In fasted mammals, circulating pancreatic glucagon stimulates hepatic gluconeogenesis in part through the CREB regulated transcription coactivator 2 (CRTC2, also referred to as TORC2)(1,2). Hepatic glucose production is increased in obesity, reflecting chronic increases in endoplasmic reticulum (ER) stress that promote insulin resistance(3). Whether ER stress also modulates the gluconeogenic program directly, however, is unclear. Here we show that CRTC2 functions as a dual sensor for ER stress and fasting signals. Acute increases in ER stress triggered the dephosphorylation and nuclear entry of CRTC2, which in turn promoted the expression of ER quality control genes through an association with activating transcription factor 6 alpha (ATF6 alpha, also known as ATF6)-an integral branch of the unfolded protein response(4-9). In addition to mediating CRTC2 recruitment to ER stress inducible promoters, ATF6 alpha also reduced hepatic glucose output by disrupting the CREB-CRTC2 interaction and thereby inhibiting CRTC2 occupancy over gluconeogenic genes. Conversely, hepatic glucose output was upregulated when hepatic ATF6 alpha protein amounts were reduced, either by RNA interference (RNAi)-mediated knockdown or as a result of persistent stress in obesity. Because ATF6 alpha overexpression in the livers of obese mice reversed CRTC2 effects on the gluconeogenic program and lowered hepatic glucose output, our results demonstrate how cross-talk between ER stress and fasting pathways at the level of a transcriptional coactivator contributes to glucose homeostasis.	[Wang, Yiguo; Vera, Liliana; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu			National Institutes of Health; Clayton Foundation for Medical Research; Keickhefer Foundation; Vincent J. Coates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064142, R37DK083834, R01DK083834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Medical Research; Keickhefer Foundation; Vincent J. Coates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health, by the Clayton Foundation for Medical Research, by the Keickhefer Foundation, and by the Vincent J. Coates Foundation. We thank N. Miller, S. Hedrick, and Y. Liu for technical assistance and helpful discussions.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	18	211	225	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					534	U116		10.1038/nature08111	http://dx.doi.org/10.1038/nature08111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19543265	Green Accepted			2022-12-24	WOS:000268257000043
J	Steinbrook, R				Steinbrook, Robert			A Higher Bar -- Vermont's New Law on Marketing Prescribed Products.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*COMM MASS, 105CMR970000 COMM MA; SORRELL WH, 2009, PHARM MARKETING DISC; *STAT VERM, ACT REL MARK PRESCR; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					8	9		10.1056/NEJMp0904719	http://dx.doi.org/10.1056/NEJMp0904719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19516028				2022-12-24	WOS:000267533100004
J	Kurth, T; de Jong, PE; Cook, NR; Buring, JE; Ridker, PM				Kurth, Tobias; de Jong, Paul E.; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.			Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; LOW-DOSE ASPIRIN; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; ASSOCIATION; EVENTS; DEATH; CLASSIFICATION; DYSFUNCTION	Objective To evaluate the association of kidney function with cardiovascular disease and mortality among apparently healthy women. Design Prospective cohort study. Setting Women's Health Study, United States. Participants 27 939 female health professionals aged >= 45 who were free of cardiovascular disease and other major disease and who provided a blood sample at study entry. Main outcome measures Time to cardiovascular disease (non-fatal stroke, non-fatal myocardial infarction, coronary revascularisation procedures, or death from cardiovascular cause), specific cardiovascular disease events, and all-cause mortality. End points were confirmed after review of medical records and death certificates. Results Glomerular filtration rate (GFR) was estimated with the abbreviated Modification of Diet in Renal Disease Study equation. At baseline, 1315 (4.7%) women had GFR <60 ml/min/1.73 m(2). During 12 years of follow-up, 1199 incident cardiovascular disease events and 856 deaths (179 from cardiovascular disease) occurred. Compared with women with GFR >= 90 ml/min/1.73 m(2), the multivariable adjusted hazard ratios for any first cardiovascular disease were 0.95 (95% CI 0.83 to 1.08), 0.84 (0.70 to 1.00), and 1.00 (0.79 to 1.27) among women with GFR of 75-89.9, 60-74.9, and <60 ml/min/1.73 m(2), respectively; the equivalent hazard ratios for all cause mortality were 0.93 (0.79 to 1.09), 1.03 (0.85 to 1.26), and 1.09 (0.83 to 1.45). Similar null findings were observed for myocardial infarction, stroke, coronary revascularisation, and non-cardiovascular death. However, an increased risk of death from cardiovascular disease was found among women with GFR <60 ml/min/1.73 m(2) (hazard ratio 1.68 (1.02 to 2.79)). Conclusions In this large cohort of women, a glomerular filtration rate <60 ml/min/1.73 m(2) was associated with increased risk of cardiovascular disease death but not other cardiovascular disease events or non-cardiovascular disease mortality. We observed no increase in risk of any of the outcomes among women with less severe impairment of kidney function.	[Kurth, Tobias] Hop La Pitie Salpetriere, INSERM, U708, F-75651 Paris 13, France; [Kurth, Tobias; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kurth, Tobias] Univ Paris 06, Fac Med, Paris, France; [de Jong, Paul E.; Ridker, Paul M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Cambridge, MA 02138 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Sorbonne Universite; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University	Kurth, T (corresponding author), Hop La Pitie Salpetriere, INSERM, U708, 47 Blvd Hop, F-75651 Paris 13, France.	tkurth@rics.bwh.harvard.edu	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-047988]; Donald W Reynolds Foundation; Leducq Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health Study is supported by grants and from the National Heart, Lung, and Blood Institute (HL-043851 and HL-080467), and the National Cancer Institute (CA-047988). The research for this work was supported by grants from the Donald W Reynolds Foundation, the Leducq Foundation, and the Doris Duke Charitable Foundation. The funding sources played no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; *M, 2016, USRDS ANN DAT REP EP; McCullough PA, 2007, ARCH INTERN MED, V167, P1122, DOI 10.1001/archinte.167.11.1122; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Schaeffner ES, 2003, J AM SOC NEPHROL, V14, P2084, DOI 10.1681/ASN.V1482084; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tokmakova MP, 2004, CIRCULATION, V110, P3667, DOI 10.1161/01.CIR.0000149806.01354.BF; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	32	43	47	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2009	339								b2392	10.1136/bmj.b2392	http://dx.doi.org/10.1136/bmj.b2392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QV	19564178	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000267678300002
J	Cheng, S; Keyes, MJ; Larson, MG; McCabe, EL; Newton-Cheh, C; Levy, D; Benjamin, EJ; Vasan, RS; Wang, TJ				Cheng, Susan; Keyes, Michelle J.; Larson, Martin G.; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Wang, Thomas J.			Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; ATRIAL-FIBRILLATION; RISK-FACTORS; NATURAL-HISTORY; WAVE DURATION; CONDUCTION; REGURGITATION; POPULATION; PROGNOSIS; FEATURES	Context Prolongation of the electrocardiographic PR interval, known as first-degree atrioventricular block when the PR interval exceeds 200 milliseconds, is frequently encountered in clinical practice. Objective To determine the clinical significance of PR prolongation in ambulatory individuals. Design, Setting, and Participants Prospective, community-based cohort including 7575 individuals from the Framingham Heart Study (mean age, 47 years; 54% women) who underwent routine 12-lead electrocardiography. The study cohort underwent prospective follow-up through 2007 from baseline examinations in 1968-1974. Multivariable-adjusted Cox proportional hazards models were used to examine the associations of PR interval with the incidence of arrhythmic events and death. Main Outcome Measures Incident atrial fibrillation (AF), pacemaker implantation, and all-cause mortality. Results During follow-up, 481 participants developed AF, 124 required pacemaker implantation, and 1739 died. At the baseline examination, 124 individuals had PR intervals longer than 200 milliseconds. For those with PR intervals longer than 200 milliseconds compared with those with PR intervals of 200 milliseconds or shorter, incidence rates per 10 000 person-years were 140 (95% confidence interval [CI], 95-208) vs 36 (95% CI, 32-39) for AF, 59 (95% CI, 40-87) vs 6 (95% CI, 5-7) for pacemaker implantation, and 334 (95% CI, 260-428) vs 129 (95% CI, 123-135) for all-cause mortality. Corresponding absolute risk increases were 1.04% (AF), 0.53% (pacemaker implantation), and 2.05% (all-cause mortality) per year. In multivariable analyses, each 20-millisecond increment in PR was associated with an adjusted hazard ratio (HR) of 1.11 (95% CI, 1.02-1.22; P = .02) for AF, 1.22 (95% CI, 1.14-1.30; P < .001) for pacemaker implantation, and 1.08 (95% CI, 1.02-1.13; P = .005) for all-cause mortality. Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted risk of pacemaker implantation (HR, 2.89; 95% CI, 1.83-4.57; P < .001), and 1.4-fold adjusted risk of all-cause mortality (HR, 1.44, 95% CI, 1.09-1.91; P = .01). Conclusion Prolongation of the PR interval is associated with increased risks of AF, pacemaker implantation, and all-cause mortality. JAMA. 2009; 301(24):2571-2577	[Cheng, Susan; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cheng, Susan; Keyes, Michelle J.; Larson, Martin G.; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Wang, Thomas J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cheng, Susan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02114 USA; [Cheng, Susan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Clin Investigator Training Program, Boston, MA 02114 USA; [Keyes, Michelle J.; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; [Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University	Wang, TJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, GRB 800,55 Fruit St, Boston, MA 02114 USA.	tjwang@partners.org	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Cheng, Susan/0000-0002-4977-036X; Wang, Thomas/0000-0003-4063-6508; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	National Institutes of Health [N01-HC-25195];  [K24-HL-04334]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, K24HL004334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: The Framingham Heart Study is funded by National Institutes of Health contract N01-HC-25195. Dr Vasan was supported in part by grant K24-HL-04334.	Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bjornstad HH, 2009, CARDIOLOGY, V112, P234, DOI 10.1159/000151435; BLACKBURN H, 1970, Circulation Research Supplement, V41, P154; Crouse SF, 2009, CLIN CARDIOL, V32, P37, DOI 10.1002/clc.20452; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Dilaveris PE, 2001, ANN NONINVAS ELECTRO, V6, P92, DOI 10.1111/j.1542-474X.2001.tb00092.x; ERIKSSEN J, 1984, CLIN CARDIOL, V7, P6, DOI 10.1002/clc.4960070104; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; Freed LA, 2002, J AM COLL CARDIOL, V40, P1298, DOI 10.1016/S0735-1097(02)02161-7; ISHIKAWA T, 1992, PACE, V15, P1927, DOI 10.1111/j.1540-8159.1992.tb02996.x; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KINOSHITA S, 1987, J ELECTROCARDIOL, V20, P272, DOI 10.1016/S0022-0736(87)80026-2; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAKATTA EG, 1975, CIRC RES, V36, P262, DOI 10.1161/01.RES.36.2.262; LEIER CV, 1978, CIRCULATION, V57, P213, DOI 10.1161/01.CIR.57.2.213; LEV M, 1964, AM J MED, V37, P742, DOI 10.1016/0002-9343(64)90022-1; LINDSAY J, 1974, CHEST, V66, P114, DOI 10.1378/chest.66.2.114; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; MYMIN D, 1986, NEW ENGL J MED, V315, P1183, DOI 10.1056/NEJM198611063151902; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; PERLAMN LV, 1971, CHEST, V59, P40, DOI 10.1378/chest.59.1.40; Psaty BM, 1997, CIRCULATION, V96, P2455; ROSE G, 1978, BRIT HEART J, V40, P636; *SAS I INC, 2004, SAS R ODBC DRIV 9 1; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2; Schwartzmann D, 2004, CARDIAC ELECTROPHYSI, P485; SIMPSON RJ, 1982, AM J CARDIOL, V50, P1331, DOI 10.1016/0002-9149(82)90471-4; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281; YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8	37	369	412	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2571	2577		10.1001/jama.2009.888	http://dx.doi.org/10.1001/jama.2009.888			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549974	Bronze, Green Accepted			2022-12-24	WOS:000267266500022
J	Boetius, A; Joye, S				Boetius, Antje; Joye, Samantha			Thriving in Salt	SCIENCE			English	Editorial Material							SEA; LIFE; DEEP; ANTARCTICA; DIVERSITY; BRINES; OCEAN; WATER; LAKES		[Boetius, Antje] Alfred Wegener Inst Polar & Marine Res, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, D-27515 Bremerhaven, Germany; [Boetius, Antje] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Joye, Samantha] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; University System of Georgia; University of Georgia	Boetius, A (corresponding author), Alfred Wegener Inst Polar & Marine Res, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, D-27515 Bremerhaven, Germany.	aboetius@mpi-bremen.de; mjoye@uga.edu	Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176; Joye, Samantha/0000-0003-1610-451X				Arahal DR, 1996, APPL ENVIRON MICROB, V62, P3779, DOI 10.1128/AEM.62.10.3779-3786.1996; Baas-Becking LGM, 1931, J GEN PHYSIOL, V14, P765, DOI 10.1085/jgp.14.6.765; Biddanda B. A., 2009, EOS T AM GEOPHYS UN, V90, P61, DOI [10.1029/2009EO080001, DOI 10.1029/2009EO080001]; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Green WJ, 2009, AQUAT GEOCHEM, V15, P321, DOI 10.1007/s10498-008-9052-1; Joye SB, 2009, NAT GEOSCI, V2, P349, DOI 10.1038/NGEO475; Mancinelli RL, 2004, ADV SPACE RES, V33, P1244, DOI 10.1016/j.asr.2003.08.034; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Siegert MJ, 2001, NATURE, V414, P603, DOI 10.1038/414603a; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Wilkansky B, 1936, NATURE, V138, P467, DOI [10.1038/138467a0, DOI 10.1038/138467A0]	17	29	31	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1523	1525		10.1126/science.1172979	http://dx.doi.org/10.1126/science.1172979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541984				2022-12-24	WOS:000267130600029
J	Cook, NR; Ridker, PM				Cook, Nancy R.; Ridker, Paul M.			Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures	ANNALS OF INTERNAL MEDICINE			English	Article							PENCINA,M.J. ET-AL.; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; ROC CURVE; AREA; ABILITY; MARKER; VALIDATION; SCORE; AGE	Models for risk prediction are widely used in clinical practice to stratify risk and assign treatment strategies. The contribution of new biomarkers has largely been based on the area under the receiver-operating characteristic curve, but this measure can be insensitive to important changes in absolute risk. Methods based on risk stratification have recently been proposed to compare predictive models. Such methods include the reclassification calibration statistic, the net reclassification improvement, and the integrated discrimination improvement. This article demonstrates the use of reclassification measures and illustrates their performance for well-known cardiovascular risk predictors in a cohort of women. These measures are targeted at evaluating the potential of new models and markers to change risk strata and alter treatment decisions.	[Cook, Nancy R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cook, NR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent,Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	ncook@rics.bwh.harvard.edu			National Heart, Lung, and Blood Institute; National Cancer Institute [HL-43851, CA-47988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Donald W. Reynolds Foundation (Dr. Ridker), and the Leducq Foundation (Dr. Ridker). The overall Women's Health Study is supported by grants from the National Heart, Lung, and Blood Institute and the National Cancer Institute (HL-43851 and CA-47988).	BAKER SG, 2009, J R STAT A IN PRESS; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING; Holme I, 2008, J INTERN MED, V264, P30, DOI 10.1111/j.1365-2796.2008.01925.x; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198	27	384	388	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					795	W143		10.7326/0003-4819-150-11-200906020-00007	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487714	Green Accepted			2022-12-24	WOS:000266530000006
J	Krum, H				Krum, Henry			Change page Consider beta blockers for patients with heart failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADRENERGIC-BLOCKADE; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; CARVEDILOL; TOLERABILITY; MORTALITY; XL		Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Monash University	Krum, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au						Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Franciosa JA, 2004, AM HEART J, V148, P718, DOI 10.1016/j.ahj.2004.04.006; Hjalmarson A, 1999, LANCET, V353, P2001; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Krum H, 2000, HEART, V84, P615, DOI 10.1136/heart.84.6.615; Krum H, 2006, EUR J HEART FAIL, V8, P302, DOI 10.1016/j.ejheart.2005.08.002; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Lechat P, 1999, LANCET, V353, P9; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Maggioni AP, 2003, HEART, V89, P299, DOI 10.1136/heart.89.3.299; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; SACKNERBERNSTEIN JD, 1995, JAMA-J AM MED ASSOC, V274, P1462, DOI 10.1001/jama.274.18.1462	15	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2009	338								b1728	10.1136/bmj.b1728	http://dx.doi.org/10.1136/bmj.b1728			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AA	19487328				2022-12-24	WOS:000266725700001
J	Kajimura, S; Seale, P; Kubota, K; Lunsford, E; Frangioni, JV; Gygi, SP; Spiegelman, BM				Kajimura, Shingo; Seale, Patrick; Kubota, Kazuishi; Lunsford, Elaine; Frangioni, John V.; Gygi, Steven P.; Spiegelman, Bruce M.			Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex	NATURE			English	Article							ADIPOSE-TISSUE; C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; OLIGONUCLEOTIDE ARRAYS; ADULT HUMANS; MICE LACKING; PPAR-GAMMA; PROTEIN; GENE; EXPRESSION	Brown adipose cells are specialized to dissipate chemical energy in the form of heat, as a physiological defence against cold and obesity(1). PRDM16 (PR domain containing 16) is a 140 kDa zinc finger protein that robustly induces brown fat determination and differentiation(2). Recent data suggests that brown fat cells arise in vivo from a Myf5-positive, myoblastic lineage by the action of PRDM16 (ref. 3); however, the molecular mechanisms responsible for this developmental switch is unclear. Here we show that PRDM16 forms a transcriptional complex with the active form of C/EBP-beta ( also known as LAP), acting as a critical molecular unit that controls the cell fate switch from myoblastic precursors to brown fat cells. Forced expression of PRDM16 and C/EBP-beta is sufficient to induce a fully functional brown fat program in naive fibroblastic cells, including skin fibroblasts from mouse and man. Transplantation of fibroblasts expressing these two factors into mice gives rise to an ectopic fat pad with the morphological and biochemical characteristics of brown fat. Like endogenous brown fat, this synthetic brown fat tissue acts as a sink for glucose uptake, as determined by positron emission tomography with fluorodeoxyglucose. These data indicate that the PRDM16-C/EBP-beta complex initiates brown fat formation from myoblastic precursors, and may provide opportunities for the development of new therapeutics for obesity and type-2 diabetes.	[Kajimura, Shingo; Seale, Patrick; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kajimura, Shingo; Seale, Patrick; Kubota, Kazuishi; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lunsford, Elaine; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	AHA [0930125N]; National Institutes of Health ( NIH) [DK081605, HG3456, GM67945]; Picower Foundation [DK31405]; NIH/NCRR [S10-RR-023010]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK081605, R37DK031405, K99DK087853, R00DK081605, R01DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	AHA(American Heart Association); National Institutes of Health ( NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. R. Farmer, J. Rheinwald and P. F. Johnson for providing cells and other reagents, R. Gupta for his critical comments on the manuscript, and J. Y. Choi and E. Naseri for their assistance. S. K. is supported by AHA scientist development grant (0930125N). P. S. is supported by a National Institutes of Health ( NIH) grant (DK081605). This work was supported by grants from the Picower Foundation and the NIH (DK31405) to B. M. S., NIH HG3456 and GM67945 to S. P. G., and NIH/NCRR shared instrumentation grant S10-RR-023010.	Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350	36	526	564	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1154	U125		10.1038/nature08262	http://dx.doi.org/10.1038/nature08262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19641492	Green Accepted			2022-12-24	WOS:000269314000044
J	Franzdottir, SR; Engelen, D; Yuva-Aydemir, Y; Schmidt, I; Aho, A; Klambt, C				Franzdottir, Sigridur Rut; Engelen, Daniel; Yuva-Aydemir, Yeliz; Schmidt, Imke; Aho, Annukka; Klaembt, Christian			Switch in FGF signalling initiates glial differentiation in the Drosophila eye	NATURE			English	Article							RECEPTOR TYROSINE KINASE; CELL MIGRATION; GROWTH-FACTOR; MESSENGER-RNA; RAP1; ACTIVATION; MESODERM; EMBRYO; MORPHOGENESIS; NEUREGULIN-1	The formation of a complex nervous system requires the intricate interaction of neurons and glial cells. Glial cells generally migrate over long distances before they initiate their differentiation, which leads to wrapping and insulation of axonal processes(1,2). The molecular pathways coordinating the switch from glial migration to glial differentiation are largely unknown(3). Here we demonstrate that, within the Drosophila eye imaginal disc, fibroblast growth factor (FGF) signalling coordinates glial proliferation, migration and subsequent axonal wrapping. Glial differentiation in the Drosophila eye disc requires a succession from glia-glia interaction to glia-neuron interaction(4). The neuronal component of the fly eye develops in the peripheral nervous system within the eye-antennal imaginal disc, whereas glial cells originate from a pool of central-nervous-system-derived progenitors and migrate onto the eye imaginal disc(5-8). Initially, glial-derived Pyramus, an FGF8-like ligand, modulates glial cell number and motility. A switch to neuronally expressed Thisbe, a second FGF8-like ligand, then induces glial differentiation. This switch is accompanied by an alteration in the intracellular signalling pathway through which the FGF receptor channels information into the cell. Our findings reveal how a switch from glia-glia interactions to glia-neuron interactions can trigger formation of glial membrane around axonal trajectories. These results disclose an evolutionarily conserved control mechanism of axonal wrapping(2), indicating that Drosophila might serve as a model to understand glial disorders in humans.	[Franzdottir, Sigridur Rut; Engelen, Daniel; Yuva-Aydemir, Yeliz; Schmidt, Imke; Aho, Annukka; Klaembt, Christian] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	klaembt@uni-muenster.de	Franzdottir, Sigridur/M-2534-2015		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Muller for providing flies and advice, M. Leptin, M. Freeman, the Bloomington stock centre and the Vienna Drosophila RNAi Center (VDRC) for sending flies and antibodies, H. Aberle, S. Bogdan, T. Hummel, E. Raz, M. Silies and R. Stephan for discussions. The work was funded through grants of the Deutsche Forschungsgemeinschaft.	Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Cafferty P, 2007, NEURON GLIA BIOL, V3, P45, DOI 10.1017/S1740925X07000634; CHOI KW, 1994, NEURON, V12, P423, DOI 10.1016/0896-6273(94)90282-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Edenfeld G, 2006, NEURON, V52, P969, DOI 10.1016/j.neuron.2006.10.029; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Meinertzhagen Ian A., 1993, P1363; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shishido E, 1997, DEVELOPMENT, V124, P2119; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stork T, 2009, DEVELOPMENT, V136, P1251, DOI 10.1242/dev.032847; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wolff Tanya, 1993, P1277; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	32	99	100	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					758	U106		10.1038/nature08167	http://dx.doi.org/10.1038/nature08167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19597479				2022-12-24	WOS:000268670300043
J	Norton, DA				Norton, David A.			Species Invasions and the Limits to Restoration: Learning from the New Zealand Experience	SCIENCE			English	Editorial Material							CONSERVATION; ISLANDS; ECOLOGY; FORESTS; BIRDS	Species invasions impose key biotic thresholds limiting the success of ecological restoration projects. These thresholds may be difficult to reverse and will have long-term consequences for restoration because of invasion legacies such as extinctions; because most invasive species cannot be eliminated given current technology and resources; and because even when controlled to low levels, invasive species continue to exert substantial pressure on native biodiversity. Restoration outcomes in the face of biological invasions are likely to be novel and will require long-term resource commitment, as any letup in invasive species management will result in the loss of the conservation gains achieved.	Univ Canterbury, Sch Forestry, Rural Ecol Res Grp, Christchurch 8140, New Zealand	University of Canterbury	Norton, DA (corresponding author), Univ Canterbury, Sch Forestry, Rural Ecol Res Grp, Private Bag 4800, Christchurch 8140, New Zealand.	david.norton@canterbury.ac.nz	Norton, David/D-6978-2011					Allen RB, 2006, BIOL INVASIONS NZ; CLOUT MN, 1989, NEW ZEAL J ECOL, V12, P27; Coomes DA, 2003, CONSERV BIOL, V17, P450, DOI 10.1046/j.1523-1739.2003.15099.x; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Heenan PB, 2004, NEW ZEAL J BOT, V42, P21, DOI 10.1080/0028825X.2004.9512888; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hoare JM, 2007, J WILDLIFE MANAGE, V71, P1576, DOI 10.2193/2006-488; MOLLOY BPJ, 1994, NEW ZEAL J BOT, V32, P37, DOI 10.1080/0028825X.1994.10410405; Saunders A, 2001, BIOL CONSERV, V99, P109, DOI 10.1016/S0006-3207(00)00192-0; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sullivan JJ, 2007, NEW ZEAL J ECOL, V31, P22; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006	15	88	92	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					569	571		10.1126/science.1172978	http://dx.doi.org/10.1126/science.1172978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644109				2022-12-24	WOS:000268493000037
J	Kalantry, S; Purushothaman, S; Bowen, RB; Starmer, J; Magnuson, T				Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry			Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation	NATURE			English	Article							DOSAGE COMPENSATION; LINKED GENES; MAMMALIAN X; EXPRESSION; METHYLATION; EED	XX female mammals undergo transcriptional silencing of most genes on one of their two X chromosomes to equalize X-linked gene dosage with XY males in a process referred to as X-chromosome inactivation (XCI). XCI is an example of epigenetic regulation(1). Once enacted in individual cells of the early female embryo, XCI is stably transmitted such that most descendant cells maintain silencing of that X chromosome(2). In eutherian mammals, XCI is thought to be triggered by the expression of the non-coding Xist RNA from the future inactive X chromosome (Xi)(3-5); Xist RNA in turn is proposed to recruit protein complexes that bring about heterochromatinization of the Xi(6,7). Here we test whether imprinted XCI, which results in preferential inactivation of the paternal X chromosome (Xp), occurs in mouse embryos inheriting an Xp lacking Xist. We find that silencing of Xp-linked genes can initiate in the absence of paternal Xist; Xist is, however, required to stabilize silencing along the Xp. Xp-linked gene silencing associated with mouse imprinted XCI, therefore, can initiate in the embryo independently of Xist RNA.	[Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu			American Cancer Society; US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD024462, K99HD055333] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Jaenisch for Xist<SUP>2lox</SUP> mice and G. Martin for Zp3 -Cre mice (Supplementary Methods). Wealso thank A. Fedoriw and K. Huynh, for advice on allele-specific RT -PCR, and are grateful to S. Malpani and L. Williams, for discussions; M. Calabrese, R. Chandler, D. Ciavatta, A. Fedoriw, C. Griffin, S. Malpani, J. Mugford, M. Pohlers, K. Shpargel and L. Williams, for critically reading the manuscript. We also acknowledge the Michael Hooker Microscopy Facility at the University of North Carolina at Chapel Hill for the use of their LeicaSP2 confocal microscope. This work was supported in part by an American Cancer Society Postdoctoral Fellowship to S. K. and by grants from the US National Institutes of Health to S. K. and T. M.	BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; COOPER DW, 1971, NATURE, V230, P292, DOI 10.1038/230292a0; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; SAMOLLOW PB, 1987, GENETICS, V115, P185; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Wallis MC, 2008, CELL MOL LIFE SCI, V65, P3182, DOI 10.1007/s00018-008-8109-z; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	30	106	114	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					647	651		10.1038/nature08161	http://dx.doi.org/10.1038/nature08161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19571810	Green Accepted, Green Submitted			2022-12-24	WOS:000268454300054
J	Carrano, AC; Liu, Z; Dillin, A; Hunter, T				Carrano, Andrea C.; Liu, Zheng; Dillin, Andrew; Hunter, Tony			A conserved ubiquitination pathway determines longevity in response to diet restriction	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; LIFE-SPAN; PHARYNGEAL DEVELOPMENT; TRANSCRIPTION FACTOR; GENETICS; DAF-16; LIGASE; INSULIN/IGF-1; DEGRADATION	Dietary restriction extends longevity in diverse species, suggesting that there is a conserved mechanism for nutrient regulation and prosurvival responses(1). Here we show a role for the HECT (homologous to E6AP carboxy terminus) E3 ubiquitin ligase WWP-1 as a positive regulator of lifespan in Caenorhabditis elegans in response to dietary restriction. We find that overexpression of wwp-1 in worms extends lifespan by up to 20% under conditions of ad libitum feeding. This extension is dependent on the FOXA transcription factor pha-4, and independent of the FOXO transcription factor daf-16. Reduction of wwp-1 completely suppresses the extended longevity of diet-restricted animals. However, the loss of wwp-1 does not affect the long lifespan of animals with compromised mitochondrial function or reduced insulin/IGF-1 signalling. Overexpression of a mutant form of WWP-1 lacking catalytic activity suppresses the increased lifespan of diet-restricted animals, indicating that WWP-1 ubiquitin ligase activity is essential for longevity. Furthermore, we find that the E2 ubiquitin conjugating enzyme, UBC-18, is essential and specific for diet-restriction-induced longevity. UBC-18 interacts with WWP-1 and is required for the ubiquitin ligase activity of WWP-1 and the extended longevity of worms overexpressing wwp-1. Taken together, our results indicate that WWP-1 and UBC-18 function to ubiquitinate substrates that regulate diet-restriction-induced longevity.	[Carrano, Andrea C.; Liu, Zheng; Dillin, Andrew; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Liu, Zheng; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Liu, Zheng; Dillin, Andrew] Glenn Ctr Aging Res, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Dillin@salk.edu	Liu, Zheng/E-6302-2012	Liu, Zheng/0000-0002-7968-3849	National Institutes of Health (NIH) National Center for Research Resources (NCRR); National Cancer Institute [CA 14195, CA 54418, CA 82683]; National Institute of Diabetes and Digestive and Kidney Diseases [DK 070696]; National Institute on Aging [AG 027463, AG 032560]; Ellison Medical and Glenn Medical Foundations; American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA082683, P01CA054418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, R21AG032560] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical and Glenn Medical Foundations; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Dillin laboratory for discussion, and P. Marks and H. Sun for their help. We thank A. Brunet for the solid-plate diet-restriction protocol. wwp-1(ok1102) was generated by the C. elegans Gene Knockout Consortium, and some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). This work was supported by grants from the National Cancer Institute (CA 14195, CA 54418 and CA 82683) to T. H., and grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK 070696) and the National Institute on Aging (AG 027463 and AG 032560), and the Ellison Medical and Glenn Medical Foundations to A. D. A. C. C. was supported by an American Cancer Society Postdoctoral Fellowship and The Rossi Endowment. T. H. is a Frank and Else Schilling American Cancer Society Professor.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Astin JW, 2008, DNA REPAIR, V7, P267, DOI 10.1016/j.dnarep.2007.10.004; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; Fay DS, 2004, DEV BIOL, V271, P11, DOI 10.1016/j.ydbio.2004.03.022; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; HOPE IA, 1999, C ELEGANS PRACTICAL, P62; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Qiu XH, 2006, DEV BIOL, V291, P239, DOI 10.1016/j.ydbio.2005.11.045; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	38	91	103	1	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					396	U113		10.1038/nature08130	http://dx.doi.org/10.1038/nature08130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553937	Green Accepted			2022-12-24	WOS:000267979000039
J	Pelupessy, P; Rennella, E; Bodenhausen, G				Pelupessy, Philippe; Rennella, Enrico; Bodenhausen, Geoffrey			High-Resolution NMR in Magnetic Fields with Unknown Spatiotemporal Variations	SCIENCE			English	Article							SINGLE-SCAN; INHOMOGENEOUS FIELDS; SPECTROSCOPY; SPECTRA; ACQUISITION	Nuclear magnetic resonance (NMR) experiments are usually carried out in homogeneous magnetic fields. In many cases, however, high-resolution spectra are virtually impossible to obtain because of the inherent heterogeneity of the samples or living organisms under investigation, as well as the poor homogeneity of the magnets (particularly when bulky samples must be placed outside their bores). Unstable power supplies and vibrations arising from cooling can lead to field fluctuations in time as well as space. We show how high-resolution NMR spectra can be obtained in inhomogeneous fields with unknown spatiotemporal variations. Our method, based on coherence transfer between spins, can accommodate spatial inhomogeneities of at least 11 gauss per centimeter and temporal fluctuations slower than 2 hertz.	[Pelupessy, Philippe; Bodenhausen, Geoffrey] Ecole Normale Super, Dept Chim, CNRS, F-75231 Paris 05, France; [Rennella, Enrico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Bodenhausen, Geoffrey] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Udine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pelupessy, P (corresponding author), Ecole Normale Super, Dept Chim, CNRS, 24 Rue Lhomond, F-75231 Paris 05, France.	philippe.pelupessy@ens.fr	Bodenhausen, Geoffrey/AAS-7726-2020		CNRS; Agence Nationale pour la Recherche; Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC [RII3-026145]; Fonds National de la Recherche Scientifique (Switzerland); Commission pour la Technologie et l Innovation (Switzerland)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC(European Commission); Fonds National de la Recherche Scientifique (Switzerland); Commission pour la Technologie et l Innovation (Switzerland)	Supported by CNRS, the Agence Nationale pour la Recherche, the Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC (contract RII3-026145, EU-NMR), the Fonds National de la Recherche Scientifique (Switzerland), and the Commission pour la Technologie et l Innovation (Switzerland).	Blumich B, 2008, PROG NUCL MAG RES SP, V52, P197, DOI 10.1016/j.pnmrs.2007.10.002; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; COX IJ, 1986, J MAGN RESON, V70, P163, DOI 10.1016/0022-2364(86)90373-2; Demas V, 2006, CONCEPT MAGN RESON B, V29B, P137, DOI 10.1002/cmr.b.20069; Eidmann G, 1996, J MAGN RESON SER A, V122, P104, DOI 10.1006/jmra.1996.0185; FREEMAN R, 1971, J CHEM PHYS, V54, P301, DOI 10.1063/1.1674608; Frydman L, 2002, P NATL ACAD SCI USA, V99, P15858, DOI 10.1073/pnas.252644399; Frydman L, 2003, J AM CHEM SOC, V125, P9204, DOI 10.1021/ja030055b; Galiana G, 2005, J AM CHEM SOC, V127, P17574, DOI 10.1021/ja054463m; Giraudeau P, 2008, J MAGN RESON, V195, P9, DOI 10.1016/j.jmr.2008.08.001; Giraudeau P, 2007, J MAGN RESON, V186, P352, DOI 10.1016/j.jmr.2007.03.007; HAHN EL, 1952, PHYS REV, V88, P1070, DOI 10.1103/PhysRev.88.1070; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; McDonald PJ, 1997, PROG NUCL MAG RES SP, V30, P69, DOI 10.1016/S0079-6565(96)01035-7; Meriles CA, 2001, SCIENCE, V293, P82, DOI 10.1126/science.1061498; Mountford CE, 2004, CHEM REV, V104, P3677, DOI 10.1021/cr030410g; NAGAYAMA K, 1979, BIOCHEM BIOPH RES CO, V90, P305, DOI 10.1016/0006-291X(79)91625-5; Pelupessy P, 2003, J AM CHEM SOC, V125, P12345, DOI 10.1021/ja034958g; Pelupessy P, 2008, J MAGN RESON, V194, P169, DOI 10.1016/j.jmr.2008.06.023; Perlo J, 2005, SCIENCE, V308, P1279, DOI 10.1126/science.1108944; Shapira B, 2004, J AM CHEM SOC, V126, P7184, DOI 10.1021/ja048859u; Shapira B, 2007, CHEM PHYS LETT, V442, P478, DOI 10.1016/j.cplett.2007.06.016; Shapira B, 2006, J MAGN RESON, V182, P12, DOI 10.1016/j.jmr.2006.04.012; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; VOLD RL, 1970, J CHEM PHYS, V53, P449, DOI 10.1063/1.1673804; WOKAUN A, 1977, CHEM PHYS LETT, V52, P407, DOI 10.1016/0009-2614(77)80476-4	27	66	70	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1693	1697		10.1126/science.1175102	http://dx.doi.org/10.1126/science.1175102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556503	Green Published			2022-12-24	WOS:000267338200034
J	Heath, I				Heath, Iona			Life and Death It is not wrong to say no	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 23	2009	338								b2529	10.1136/bmj.b2529	http://dx.doi.org/10.1136/bmj.b2529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549650				2022-12-24	WOS:000267436300017
J	Hanage, WP; Fraser, C; Tang, J; Connor, TR; Corander, J				Hanage, William Paul; Fraser, Christophe; Tang, Jing; Connor, Thomas Richard; Corander, Jukka			Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus	SCIENCE			English	Article							BINDING PROTEIN GENES; STREPTOCOCCUS-PNEUMONIAE; PENICILLIN RESISTANCE; POPULATION-STRUCTURE; HORIZONTAL TRANSFER; CONJUGATE VACCINE; BAYESIAN-ANALYSIS; SEROTYPES; EVOLUTION; STRAINS	Streptococcus pneumoniae is a pathogen of global importance that frequently transfers genetic material between strains and on occasion across species boundaries. In an analysis of 1930 pneumococcal genotypes from six housekeeping genes and 94 genotypes from related species, we identified mosaic genotypes representing admixture between populations and found that these were significantly associated with resistance to several classes of antibiotics. We hypothesize that these observations result from a history of hyper-recombination, which means that these strains are more likely to acquire both divergent genetic material and resistance determinants. This could have consequences for the reemergence of drug resistance after pneumococcal vaccination and also for our understanding of diversification and speciation in recombinogenic bacteria.	[Hanage, William Paul; Fraser, Christophe; Connor, Thomas Richard] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Tang, Jing; Corander, Jukka] Abo Akad Univ, Dept Math, FI-20500 Turku, Finland	Imperial College London; Abo Akademi University	Hanage, WP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	w.hanage@imperial.ac.uk	Connor, Thomas/ABD-6533-2021; tang, jing/HHR-9815-2022; Tang, Jing/W-1764-2019; Connor, Thomas/E-7135-2011; Hanage, Bill/CAF-1813-2022; Connor, Thomas/ABE-5989-2020; Tang, Jing/H-4084-2012; Fraser, Christophe/A-8109-2008	Tang, Jing/0000-0001-7480-7710; Connor, Thomas/0000-0003-2394-6504; Tang, Jing/0000-0001-7480-7710; Fraser, Christophe/0000-0003-2399-9657	Royal Society; Computational Biology, Bioinformatics, and Biometry graduate school; UK Biotechnology and Biological Sciences Research Council; Academy of Finland [121301]; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish	Royal Society(Royal Society of London); Computational Biology, Bioinformatics, and Biometry graduate school; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the support of the Royal Society (W.P.H. and C.F.); the Computational Biology, Bioinformatics, and Biometry graduate school (J.T.); a UK Biotechnology and Biological Sciences Research Council studentship (to T.R.C.); and the Academy of Finland (J.C., grant no. 121301). We thank B. Spratt for helpful discussions.	Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; del Campo R, 2005, J CLIN MICROBIOL, V43, P2207, DOI 10.1128/JCM.43.5.2207-2214.2005; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1990, P NATL ACAD SCI USA, V87, P5858, DOI 10.1073/pnas.87.15.5858; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; Enright MC, 1999, MOL BIOL EVOL, V16, P1687, DOI 10.1093/oxfordjournals.molbev.a026082; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Hakenbeck R, 1998, ELECTROPHORESIS, V19, P597, DOI 10.1002/elps.1150190423; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Negri MC, 2002, ANTIMICROB AGENTS CH, V46, P528, DOI 10.1128/AAC.46.2.528-530.2002; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	25	127	127	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1454	1457		10.1126/science.1171908	http://dx.doi.org/10.1126/science.1171908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520963				2022-12-24	WOS:000266878700049
J	Paterson, AM; Vanguri, VK; Sharpe, AH				Paterson, Alison M.; Vanguri, Vijay K.; Sharpe, Arlene H.			SnapShot: B7/CD28 Costimulation	CELL			English	Editorial Material							CO-STIMULATION; LIGANDS; CTLA-4; PD-1		[Paterson, Alison M.; Vanguri, Vijay K.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Paterson, AM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.							Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Freeman GJ, 2008, P NATL ACAD SCI USA, V105, P10275, DOI 10.1073/pnas.0805459105; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	9	32	35	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					974	U346		10.1016/j.cell.2009.05.015	http://dx.doi.org/10.1016/j.cell.2009.05.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490900	Bronze			2022-12-24	WOS:000266454800027
J	Hao, HX; Khalimonchuk, O; Schraders, M; Dephoure, N; Bayley, JP; Kunst, H; Devilee, P; Cremers, CWRJ; Schiffman, JD; Bentz, BG; Gygi, SP; Winge, DR; Kremer, H; Rutter, J				Hao, Huai-Xiang; Khalimonchuk, Oleh; Schraders, Margit; Dephoure, Noah; Bayley, Jean-Pierre; Kunst, Henricus; Devilee, Peter; Cremers, Cor W. R. J.; Schiffman, Joshua D.; Bentz, Brandon G.; Gygi, Steven P.; Winge, Dennis R.; Kremer, Hannie; Rutter, Jared			SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; COMPLEX-II; FLAVOPROTEIN SUBUNIT; MUTATIONS; PREVALENCE; SEQUENCE; DISEASES; CARRIER; FAD	Mammalian mitochondria contain about 1100 proteins, nearly 300 of which are uncharacterized. Given the well-established role of mitochondrial defects in human disease, functional characterization of these proteins may shed new light on disease mechanisms. Starting with yeast as a model system, we investigated an uncharacterized but highly conserved mitochondrial protein (named here Sdh5). Both yeast and human Sdh5 interact with the catalytic subunit of the succinate dehydrogenase (SDH) complex, a component of both the electron transport chain and the tricarboxylic acid cycle. Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor). Germline loss-of-function mutations in the human SDH5 gene, located on chromosome 11q13.1, segregate with disease in a family with hereditary paraganglioma, a neuroendocrine tumor previously linked to mutations in genes encoding SDH subunits. Thus, a mitochondrial proteomics analysis in yeast has led to the discovery of a human tumor susceptibility gene.	[Hao, Huai-Xiang; Khalimonchuk, Oleh; Winge, Dennis R.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Schiffman, Joshua D.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Schiffman, Joshua D.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Bentz, Brandon G.] Univ Utah, Sch Med, Dept Surg, Div Otolaryngol Head & Neck Surg, Salt Lake City, UT 84112 USA; [Schraders, Margit; Kunst, Henricus; Cremers, Cor W. R. J.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Donders Ctr Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bayley, Jean-Pierre; Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu	Cremers, C.W.R.J./L-4254-2015; Kunst, Henricus P.M./J-6456-2012; DEVILEE, PETER/ABR-2140-2022; Dephoure, Noah/N-7818-2014; Schraders, Margit/A-1607-2016; Khalimonchuk, Oleh/AAM-1194-2021; Kremer, Hannie/F-5126-2010; Devilee, Peter/GXV-8005-2022	Kunst, Henricus P.M./0000-0003-1162-6394; Dephoure, Noah/0000-0001-5802-2657; Khalimonchuk, Oleh/0000-0002-3972-8678; Kremer, Hannie/0000-0002-0841-8693; 	NIH [DK071962, GM087346]; Dutch Cancer Society [UL 2002-2723]; European Union 6th Framework Program [518200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071962, R56DK071962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); European Union 6th Framework Program(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rutter laboratory for helpful discussions; the J. Shaw and J. Kaplan laboratories for antibodies and technical assistance; J.-M. Heo, T. Smith, E. Taylor, E. van Wijk, S. van der Velde-Visser, and C. Beumer for technical assistance; B. Lemire for the antibodies to Sdh1 and Sdh2; C. Outten for the antiserum to Tim10; and J. Lindsley for critical reading of the manuscript. This work was funded by NIH grants DK071962 and GM087346 (to J.R.), by the Dutch Cancer Society (grant UL 2002-2723), and by the European Union 6th Framework Program, Project No. 518200 (to P.D.). J.R. and H.H. plan to file a patent related to genetic testing of the hSDH5 gene.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; CASCON A, 2009, HORM METAB RES  0402; CHAPMAN KB, 1992, GENE, V118, P131, DOI 10.1016/0378-1119(92)90260-V; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; GHEZZI D, 2009, NAT GENET       0524; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; McWhinney SR, 2007, NEW ENGL J MED, V357, P1054, DOI 10.1056/NEJMc071191; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; Robinson KM, 1996, J BIOL CHEM, V271, P4061; Romano JD, 2005, J BACTERIOL, V187, P940, DOI 10.1128/JB.187.3.940-948.2005; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; VANBAARS F, 1982, HUM GENET, V60, P305, DOI 10.1007/BF00569208; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	28	522	541	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1139	1142		10.1126/science.1175689	http://dx.doi.org/10.1126/science.1175689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628817	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000269382300044
J	Tiihonen, J; Lonnqvist, J; Wahlbeck, K; Klaukka, T; Niskanen, L; Tanskanen, A; Haukka, J				Tiihonen, Jari; Lonnqvist, Jouko; Wahlbeck, Kristian; Klaukka, Timo; Niskanen, Leo; Tanskanen, Antti; Haukka, Jari			11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)	LANCET			English	Article							ANTIPSYCHOTIC-DRUGS; NATIONWIDE COHORT; CLOZAPINE; DIAGNOSES; DISORDER; SUICIDE; TRIAL	Background The introduction of second-generation antipsychotic drugs during the 1990s is widely believed to have adversely affected mortality of patients with schizophrenia. Our aim was to establish the long-term contribution of antipsychotic drugs to mortality in such patients. Methods Nationwide registers in Finland were used to compare the cause-specific mortality in 66 881 patients versus the total population (5.2 million) between 1996, and 2006, and to link these data with the use of antipsychotic drugs. We measured the all-cause mortality of patients with schizophrenia in outpatient care during current and cumulative exposure to any antipsychotic drug versus no use of these drugs, and exposure to the six most frequently used antipsychotic drugs compared with perphenazine use. Findings Although the proportional use of second-generation antipsychotic drugs rose from 13% to 64% during follow-up the gap in life expectancy between patients with schizophrenia and the general popullation did not widen between 1996 (25 years), and 2006 (22.5 years). Compared with current use of perphenazine, the highest risk for overall mortality was recorded for quetiapine (adjusted hazard ratio [HR] 1.41, 95% CI 1.09-1.82), and the lowest risk for clozapine (0.74, 0.60-0.91; p=0.0045 for the difference between clozapine vs perphenazine, and p<0.0001 for an other antipsychotic drugs). Long-term cumulative exposure (7-11 years) to any antipsychotic treatment was associated with lower mortality than was no drug use (0.81, 0.77-0.84). In patients with one or more filled prescription for an antipsychotic drug, an inverse relation between mortality and duration of cumulative use was noted (HR for trend per exposure year 0.991; 0.985-0.997). Interpretation Long-term treatment with antipsychotic drugs is associated with lower mortality compared with no antipsychotic use. Second-generation drugs are a highly heterogeneous group, and clozapine seems to be associated with a substantially lower mortality than any other antipsychotics. Restrictions on the use of clozapine should be reassessed.	[Tiihonen, Jari] Univ Kuopio, Dept Forens Psychiat, FIN-70240 Kuopio, Finland; [Tiihonen, Jari] Niuvanniemi Hosp, Dept Clin Physiol, Kuopio, Finland; [Niskanen, Leo] Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland; [Tiihonen, Jari; Niskanen, Leo] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Tiihonen, Jari; Niskanen, Leo] Univ Helsinki, Cent Hosp, SF-00180 Helsinki, Finland; [Tiihonen, Jari; Lonnqvist, Jouko; Tanskanen, Antti; Haukka, Jari] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Wahlbeck, Kristian] Natl Res & Dev Ctr Welf & Hlth STAKES, Helsinki, Finland; [Klaukka, Timo] Social Insurance Inst Finland, Helsinki, Finland; [Wahlbeck, Kristian] Vaasa Cent Hosp, Psychiat Unit, Vaasa, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Vaasa Central Hospital	Tiihonen, J (corresponding author), Univ Kuopio, Dept Forens Psychiat, Niuvanniemi Hosp, FIN-70240 Kuopio, Finland.	jari.tiihonen@niuva.fi	Wahlbeck, Kristian/F-8394-2011; Tiihonen, Jari/G-3078-2012; Haukka, Jari/G-1484-2014	Wahlbeck, Kristian/0000-0003-3754-3933; Tiihonen, Jari/0000-0002-0400-6798; Haukka, Jari/0000-0003-1450-6208	Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland)	Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland)	This study was supported by funding from the Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland). The researchers were independent from the funder. We thank Simo Pelanteri (STAKES information) for his work with different registers in selection of and merging of data for this project, and Aija Rasanen for secretarial assistance.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Anonym, ATC DDD INDEX 2006; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; ELIAS M, 2007, US TODAY        0503; Freedman R, 2005, NEW ENGL J MED, V353, P1286, DOI 10.1056/NEJMe058200; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Klein DF, 2007, JAMA-J AM MED ASSOC, V298, P333, DOI 10.1001/jama.298.3.333; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Makikyro T, 1998, EUR PSYCHIAT, V13, P57, DOI 10.1016/S0924-9338(98)80019-9; Mantel-Teeuwisse AK, 2001, J CLIN EPIDEMIOL, V54, P1181, DOI 10.1016/S0895-4356(01)00396-1; MCEVOY JP, 2006, AM J PSYCHIAT, V163, P463; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Parks J., MORBIDITY MORTALITY; R Development Core Team, 2005, LANG ENV STAT COMP; Ray WA, 2005, NEW ENGL J MED, V353, P2319, DOI 10.1056/NEJMp058267; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Skrbo A, 1999, Med Arh, V53, P57; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; Toson B., 2003, NATL STAT METHODOL S, V33	27	830	848	3	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					620	627		10.1016/S0140-6736(09)60742-X	http://dx.doi.org/10.1016/S0140-6736(09)60742-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486TU	19595447				2022-12-24	WOS:000269222600022
J	Cronin, SJF; Nehme, NT; Limmer, S; Liegeois, S; Pospisilik, JA; Schramek, D; Leibbrandt, A; Simoes, RD; Gruber, S; Puc, U; Ebersberger, I; Zoranovic, T; Neely, GG; von Haeseler, A; Ferrandon, D; Penninger, JM				Cronin, Shane J. F.; Nehme, Nadine T.; Limmer, Stefanie; Liegeois, Samuel; Pospisilik, J. Andrew; Schramek, Daniel; Leibbrandt, Andreas; Simoes, Ricardo de Matos; Gruber, Susanne; Puc, Urszula; Ebersberger, Ingo; Zoranovic, Tamara; Neely, G. Gregory; von Haeseler, Arndt; Ferrandon, Dominique; Penninger, Josef M.			Genome-Wide RNAi Screen Identifies Genes Involved in Intestinal Pathogenic Bacterial Infection	SCIENCE			English	Article							IMMUNE-RESPONSE; HOST-DEFENSE; STEM-CELLS; SERRATIA-MARCESCENS; IN-VIVO; DROSOPHILA; INTERFERENCE; ACTIVATION; AUTOPHAGY; VIRULENCE	Innate immunity represents the first line of defense in animals. We report a genome-wide in vivo Drosophila RNA interference screen to uncover genes involved in susceptibility or resistance to intestinal infection with the bacterium Serratia marcescens. We first employed whole-organism gene suppression, followed by tissue-specific silencing in gut epithelium or hemocytes to identify several hundred genes involved in intestinal antibacterial immunity. Among the pathways identified, we showed that the JAK-STAT signaling pathway controls host defense in the gut by regulating stem cell proliferation and thus epithelial cell homeostasis. Therefore, we revealed multiple genes involved in antibacterial defense and the regulation of innate immunity.	[Nehme, Nadine T.; Limmer, Stefanie; Liegeois, Samuel; Ferrandon, Dominique] CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med, UPR 9022, F-67084 Strasbourg, France; [Cronin, Shane J. F.; Pospisilik, J. Andrew; Schramek, Daniel; Leibbrandt, Andreas; Gruber, Susanne; Puc, Urszula; Zoranovic, Tamara; Neely, G. Gregory; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Simoes, Ricardo de Matos; Ebersberger, Ingo; von Haeseler, Arndt] Univ Vet Med, Univ Vienna, Ctr Integrat Bioinformat CIBIV, Med Univ Vienna, A-1030 Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med, UPR 9022, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Schirmeier, Stefanie SM/V-9721-2017; neely, graham/A-6511-2011; Pryjda, Tamara/O-5714-2019; Penninger, Josef M/I-6860-2013; Schramek, Daniel/J-5792-2014; Schramek, Daniel/AAL-1470-2020; LIEGEOIS, Samuel/AGG-0452-2022; Cronin, Shane/AAC-9964-2020; Neely, Greg/AAB-4642-2020; von Haeseler, Arndt/HCI-9958-2022	Schirmeier, Stefanie SM/0000-0001-8431-9593; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; LIEGEOIS, Samuel/0000-0003-3228-7678; Neely, Greg/0000-0002-1957-9732; von Haeseler, Arndt/0000-0002-3366-4458; de Matos Simoes, Ricardo/0000-0002-1700-5276; FERRANDON, Dominique/0000-0001-7680-7773; zoranovic, tamara/0000-0002-5369-6385	CNRS; NIH [P01 AI44220]; Agence Nationale de la Recherche [DROSELEGANS]; Fondation pour la Recherche Medicale; IMBA; EuroThymaide; Austrian Science Fund Science Research Program (FWF-SFB); European Research Council; Austrian Ministry of Science; Vienna Science and Technology Fund (WWTF); German Research Foundation [Ha-1628/8-1]; Boehringer Ingelheim; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); IMBA; EuroThymaide(European Commission); Austrian Science Fund Science Research Program (FWF-SFB)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Austrian Ministry of Science; Vienna Science and Technology Fund (WWTF); German Research Foundation(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported financially by the CNRS, an NIH Program grant P01 AI44220, and a DROSELEGANS grant from the Programme Microbiologie, Immunologie, et Maladies Emergentes (MIME) of the Agence Nationale de la Recherche. The D.F. laboratory is an Equipe FRM, awarded by the Fondation pour la Recherche Medicale. J.M.P. is supported by IMBA, EuroThymaide, an Austrian Science Fund Science Research Program (FWF SFB) grant, an advanced European Research Council grant, and the Austrian Ministry of Science. R.M.S. and A.v.H. are supported by the Vienna Science and Technology Fund (WWTF) and the German Research Foundation (DFG) (Ha-1628/8-1). The screen was supported by Boehringer Ingelheim.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200	34	240	248	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					340	343		10.1126/science.1173164	http://dx.doi.org/10.1126/science.1173164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19520911	Green Accepted			2022-12-24	WOS:000268036600051
J	Stallings, CL; Stephanou, NC; Chu, L; Hochschild, A; Nickels, BE; Glickman, MS				Stallings, Christina L.; Stephanou, Nicolas C.; Chu, Linda; Hochschild, Ann; Nickels, Bryce E.; Glickman, Michael S.			CarD Is an Essential Regulator of rRNA Transcription Required for Mycobacterium tuberculosis Persistence	CELL			English	Article							REPAIR COUPLING FACTOR; ESCHERICHIA-COLI; DNA-REPAIR; BACILLUS-SUBTILIS; MYXOCOCCUS-XANTHUS; STRINGENT RESPONSE; STRUCTURAL BASIS; GENE-EXPRESSION; FACTOR MFD; POLYMERASE	Mycobacterium tuberculosis is arguably the world's most successful infectious agent because of its ability to control its own cell growth within the host. Bacterial growth rate is closely coupled to rRNA transcription, which in E. coli is regulated through DksA and (p) ppGpp. The mechanisms of rRNA transcriptional control in mycobacteria, which lack DksA, are undefined. Here we identify CarD as an essential mycobacterial protein that controls rRNA transcription. Loss of CarD is lethal for mycobacteria in culture and during infection of mice. CarD depletion leads to sensitivity to killing by oxidative stress, starvation, and DNA damage, accompanied by failure to reduce rRNA transcription. CarD can functionally replace DksA for stringent control of rRNA transcription, even though CarD associates with a different site on RNA polymerase. These findings highlight a distinct molecular mechanism for regulating rRNA transcription in mycobacteria that is critical for M. tuberculosis pathogenesis.	[Stallings, Christina L.; Stephanou, Nicolas C.; Chu, Linda; Glickman, Michael S.] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Memorial Sloan Kettering Cancer Center	Glickman, MS (corresponding author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	glickmam@mskcc.org	Nickels, Bryce/AAF-2549-2020	Nickels, Bryce/0000-0001-7449-8831; Glickman, Michael S/0000-0001-7918-5164	NIH [GM073829, GM44025, AI064693, AI075805]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI075805, R01AI064693, R01AI080619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM073829] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dirk Schnappinger and Sabine Ehrt for reagents and advice about the tet system, Alex Lash for assistance with bioinformatic analyses, Seth Darst for advice and design of the thermus b fragment, Nigel Savery for materials and assistance relating to the roadblock repression assays, the Genomics Core at MSKCC for microarray hybridization and processing, and Ken Marians for critical reading of the manuscript. M. smegmatis microarrays were provided by NIAID/PFGRC. This work was supported by NIH grant GM073829 to Seth Darst, GM44025 to A. H., AI064693 to M. S. G., and AI075805 to C. L. S.	ALFOLDI L, 1962, J MOL BIOL, V5, P348, DOI 10.1016/S0022-2836(62)80077-1; [Anonymous], 2009, GLOB TUB CONTR; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Avarbock D, 1999, GENE, V233, P261, DOI 10.1016/S0378-1119(99)00114-6; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dahl JL, 2005, J BACTERIOL, V187, P2439, DOI 10.1128/JB.187.7.2439-2447.2005; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; NENE V, 1983, FEBS LETT, V153, P307, DOI 10.1016/0014-5793(83)80630-9; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; NICOLAS FJ, 1994, GENE DEV, V8, P2375, DOI 10.1101/gad.8.19.2375; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Taverna P, 1996, J BACTERIOL, V178, P5105, DOI 10.1128/jb.178.17.5105-5111.1996; TEDIN K, 1992, J BIOL CHEM, V267, P2337; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	53	166	172	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					146	159		10.1016/j.cell.2009.04.041	http://dx.doi.org/10.1016/j.cell.2009.04.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596241	Green Accepted, Bronze			2022-12-24	WOS:000267848600021
J	Kripalani, M; Shawcross, J; Reilly, J; Main, J				Kripalani, Mukesh; Shawcross, James; Reilly, Joe; Main, John			Practice Pointer Lithium and chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reilly, Joe] Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Stockton On Tees TS17 6BH, England; [Kripalani, Mukesh] St Lukes Hosp, Tees Esk & Wear Valleys NHS Fdn Trust, Middlesbrough TS4 3AF, Cleveland, England; [Shawcross, James; Main, John] James Cook Univ Hosp, S Tees Acute Hosp NHS Trust, Middlesbrough TS4 3BW, Cleveland, England	Durham University; James Cook University Hospital	Reilly, J (corresponding author), Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Stockton On Tees TS17 6BH, England.	j.g.reilly@durham.ac.uk						Gitlin M, 1999, DRUG SAFETY, V20, P231, DOI 10.2165/00002018-199920030-00004; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; LEHMANN K, 1995, AM J KIDNEY DIS, V25, P82, DOI 10.1016/0272-6386(95)90632-0; Lepkifker E, 2004, J CLIN PSYCHIAT, V65, P850; Morriss R, 2008, BRIT J PSYCHIAT, V193, P93, DOI 10.1192/bjp.bp.108.051268; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V38; *NHS INF CTR, 2007, COR HEART DIS QUAL O; Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x; Rosa AR, 2007, PROG NEURO-PSYCHOPH, V31, P217, DOI 10.1016/j.pnpbp.2006.08.007; Schreiner A, 2000, AM J PSYCHIAT, V157, P834, DOI 10.1176/appi.ajp.157.5.834; Waring W Stephen, 2006, Toxicol Rev, V25, P221, DOI 10.2165/00139709-200625040-00003	12	24	24	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 3	2009	339								b2452	10.1136/bmj.b2452	http://dx.doi.org/10.1136/bmj.b2452			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466RB	19578086				2022-12-24	WOS:000267679000002
J	Ura, Y; Beierle, JM; Leman, LJ; Orgel, LE; Ghadiri, MR				Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Orgel, Leslie E.; Ghadiri, M. Reza			Self-Assembling Sequence-Adaptive Peptide Nucleic Acids	SCIENCE			English	Article							DYNAMIC COMBINATORIAL LIBRARIES; TEMPLATE-DIRECTED SYNTHESIS; BACKBONE; AMPLIFICATION; POLYMERIZATION; CHEMISTRY; EXCHANGE; POLYMERS; BINDING; ANALOGS	Several classes of nucleic acid analogs have been reported, but no synthetic informational polymer has yet proven responsive to selection pressures under enzyme-free conditions. Here, we introduce an oligomer family that efficiently self-assembles by means of reversible covalent anchoring of nucleobase recognition units onto simple oligo-dipeptide backbones [thioester peptide nucleic acids (tPNAs)] and undergoes dynamic sequence modification in response to changing templates in solution. The oligomers specifically self-pair with complementary tPNA strands and cross-pair with RNA and DNA in Watson-Crick fashion. Thus, tPNA combines base-pairing interactions with the side-chain functionalities of typical peptides and proteins. These characteristics might prove advantageous for the design or selection of catalytic constructs or biomaterials that are capable of dynamic sequence repair and adaptation.	[Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Ghadiri, M. Reza] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Ghadiri, M. Reza] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Orgel, Leslie E.] Salk Inst Biol Studies, San Diego, CA 92186 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu		Leman, Luke/0000-0002-1879-5900; Ura, Yasuyuki/0000-0003-0484-1299	Skaggs Institute for Chemical Biology; NASA Earth and Space Science Fellowship Program [NNX07AR35H]; NASA Science Mission Directorates Planetary Science Division [NRA NNH07ZDA001N]	Skaggs Institute for Chemical Biology; NASA Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); NASA Science Mission Directorates Planetary Science Division	Support was provided in part by the Skaggs Institute for Chemical Biology, the NASA Earth and Space Science Fellowship Program (grant NNX07AR35H to J.M.B.), and the NASA Science Mission Directorates Planetary Science Division (NRA NNH07ZDA001N).	Bean HD, 2006, ORIGINS LIFE EVOL B, V36, P39, DOI 10.1007/s11084-005-2082-4; BECK F, 2003, ARTIFICIAL DNA METHO, P91; Biron JP, 2005, ANGEW CHEM INT EDIT, V44, P6731, DOI 10.1002/anie.200501591; Corbett PT, 2008, CHEM-EUR J, V14, P2153, DOI 10.1002/chem.200701413; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Corbett PT, 2004, CHEM-EUR J, V10, P3139, DOI 10.1002/chem.200400300; De Duve Christian, 1998, P219; Diederichsen U, 1996, ANGEW CHEM INT EDIT, V35, P445, DOI 10.1002/anie.199604451; Eschenmoser A, 2005, CHIMIA, V59, P836, DOI 10.2533/000942905777675552; Fulton DA, 2008, ORG LETT, V10, P3291, DOI 10.1021/ol8011309; GOODWIN JT, 1992, J AM CHEM SOC, V114, P9197, DOI 10.1021/ja00049a067; Grote Z, 2003, ANGEW CHEM INT EDIT, V42, P3821, DOI 10.1002/anie.200351623; Hickman DT, 2008, HELV CHIM ACTA, V91, P1, DOI 10.1002/hlca.200890022; Higaki Y, 2004, MACROMOLECULES, V37, P1696, DOI 10.1021/ma035518c; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kleiner RE, 2008, J AM CHEM SOC, V130, P4646, DOI 10.1021/ja0753997; Ladame S, 2008, ORG BIOMOL CHEM, V6, P219, DOI 10.1039/b714599c; Larsson R, 2004, ANGEW CHEM INT EDIT, V43, P3716, DOI 10.1002/anie.200454165; Leclaire J, 2005, CHEM COMMUN, P1959, DOI 10.1039/b500638d; Li XY, 2002, ANGEW CHEM INT EDIT, V41, P4567, DOI 10.1002/1521-3773(20021202)41:23<4567::AID-ANIE4567>3.0.CO;2-6; Mittapalli GK, 2007, ANGEW CHEM INT EDIT, V46, P2478, DOI 10.1002/anie.200603209; Oh K, 2001, NATURE, V414, P889, DOI 10.1038/414889a; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Pascal R, 2005, TOP CURR CHEM, V259, P69, DOI 10.1007/b136707; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Severin K, 2004, CHEM-EUR J, V10, P2565, DOI 10.1002/chem.200305660; Skene WG, 2004, P NATL ACAD SCI USA, V101, P8270, DOI 10.1073/pnas.0401885101; Sreenivasachary N, 2006, CHEM-EUR J, V12, P8581, DOI 10.1002/chem.200600625; Woll MG, 2004, J AM CHEM SOC, V126, P11172, DOI 10.1021/ja046891i; Zhan ZYJ, 1997, J AM CHEM SOC, V119, P12420, DOI 10.1021/ja972870v; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z	32	147	150	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					73	77		10.1126/science.1174577	http://dx.doi.org/10.1126/science.1174577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	465NL	19520909				2022-12-24	WOS:000267594000037
J	Bilde, T; Foged, A; Schilling, N; Arnqvist, G				Bilde, Trine; Foged, Anne; Schilling, Nadia; Arnqvist, Goran			Postmating Sexual Selection Favors Males That Sire Offspring with Low Fitness	SCIENCE			English	Article							SPERM COMPETITION; GENETIC COMPATIBILITY; POLYANDROUS FEMALES; SEED BEETLES; EVOLUTION; BENEFITS; CONFLICT; BEHAVIOR	Despite the costs of mating, females of most taxa mate with multiple males. Polyandrous females are hypothesized to gain genetic benefits for their offspring, but this assumes paternity bias favoring male genotypes that enhance offspring viability. We determined net male genetic effects on female and offspring fitness in a seed beetle and then tested whether fertilization success was biased in favor of high-quality male genotypes in double mating experiments. Contrary to expectations, high-quality male genotypes consistently had a lower postmating fertilization success in two independent assays. Our results imply that sexually antagonistic adaptations have a major and unappreciated influence on male postmating fertilization success. Such genetic variation renders indirect genetic benefits an unlikely driver of the evolution of polyandry.	[Bilde, Trine; Arnqvist, Goran] Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Bilde, Trine; Foged, Anne; Schilling, Nadia] Univ Aarhus, Dept Biol Sci, DK-8000 Aarhus C, Denmark	Uppsala University; Aarhus University	Bilde, T (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	trine.bilde@biology.au.dk	Bilde, Trine/J-2872-2013; Arnqvist, Göran/E-6782-2015; Bilde, Trine/AAS-2098-2020	Bilde, Trine/0000-0002-0341-161X; Arnqvist, Göran/0000-0002-3501-3376; Bilde, Trine/0000-0002-0341-161X	Marie Curie fellowship [MC MEIF-CT-2006-023645]; Carlsberg Foundation; Swedish Research Council	Marie Curie fellowship(European Commission); Carlsberg Foundation(Carlsberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank E. B. Rasmussen for assistance; C. W. Fox for providing the beetle population used; and I. M. Horsman, D. Grand, and P. Schjerbeck at Aarhus University Hospital for their extensive help and flexibility with irradiating males. U. Friberg, T. Tregenza, M. Olsson, and J. Schneider provided valuable comments. Funded by a Marie Curie fellowship (MC MEIF-CT-2006-023645) (T.B.), the Carlsberg Foundation (T.B.), and the Swedish Research Council (G.A.).	Arnqvist G, 2005, BEHAV ECOL, V16, P123, DOI 10.1093/beheco/arh119; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 2005, MONOGRAPHS BEHAV ECO, P330; Bilde T, 2007, J EVOLUTION BIOL, V20, P1237, DOI 10.1111/j.1420-9101.2006.01280.x; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Birkhead TR, 1998, SPERM COMPETITION SE; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Dowling DK, 2007, J EVOLUTION BIOL, V20, P2113, DOI 10.1111/j.1420-9101.2007.01433.x; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Fox Charles W., 2007, P88; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Puurtinen M, 2005, TRENDS ECOL EVOL, V20, P157, DOI 10.1016/j.tree.2005.02.005; Roenn JL, 2008, J EVOLUTION BIOL, V21, P461, DOI 10.1111/j.1420-9101.2007.01493.x; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; Savalli UM, 1999, ETHOL ECOL EVOL, V11, P49, DOI 10.1080/08927014.1999.9522841; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wade MJ, 2003, AM NAT, V162, P403, DOI 10.1086/378211; Wilson N, 1997, P ROY SOC B-BIOL SCI, V264, P1491, DOI 10.1098/rspb.1997.0206; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260	30	44	44	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1705	1706		10.1126/science.1171675	http://dx.doi.org/10.1126/science.1171675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556506				2022-12-24	WOS:000267338200038
J	Tran, TH; Ruiz-Palacios, GM; Hayden, FG; Farrar, J				Tran Tinh Hien; Ruiz-Palacios, Guillermo M.; Hayden, Frederick G.; Farrar, Jeremy			Patient-oriented pandemic influenza research	LANCET			English	Editorial Material									[Tran Tinh Hien; Farrar, Jeremy] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Tinh Hien; Hayden, Frederick G.; Farrar, Jeremy] SE Asia Infect Dis Clin Res Network, Ho Chi Minh City, Vietnam; [Ruiz-Palacios, Guillermo M.] Mexico Emerging Infect Dis Clin Res Network, Mexico City, DF, Mexico; [Ruiz-Palacios, Guillermo M.] Natl Inst Med Sci & Nutr, Dept Infect Dis, Mexico City, DF, Mexico; [Hayden, Frederick G.] Univ Virginia, Charlottesville, VA USA; [Farrar, Jeremy] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Virginia; University of Oxford	Farrar, J (corresponding author), Hosp Trop Dis, 190 Ben Ham Tu,Quan 5, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Ruiz-Palacios, Guillermo/GYQ-5462-2022; Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; WHO, CLIN MAN HUM INF AV; World Health Organisation, WEEKL EP REC; World Health Organization, INFL A H1N1 UPD 49	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2085	2086						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541022				2022-12-24	WOS:000267229700004
J	Vassilopoulos, S; Esk, C; Hoshino, S; Funke, BH; Chen, CY; Plocik, AM; Wright, WE; Kucherlapati, R; Brodsky, FM				Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Funke, Birgit H.; Chen, Chih-Ying; Plocik, Alex M.; Wright, Woodring E.; Kucherlapati, Raju; Brodsky, Frances M.			A Role for the CHC22 Clathrin Heavy-Chain Isoform in Human Glucose Metabolism	SCIENCE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; COATED VESICLES; PLASMA-MEMBRANE; GLUT4; TRAFFICKING; GLUCOSE-TRANSPORTER-4; MECHANISMS	Intracellular trafficking of the glucose transporter GLUT4 from storage compartments to the plasma membrane is triggered in muscle and fat during the body's response to insulin. Clathrin is involved in intracellular trafficking, and in humans, the clathrin heavy-chain isoform CHC22 is highly expressed in skeletal muscle. We found a role for CHC22 in the formation of insulin-responsive GLUT4 compartments in human muscle and adipocytes. CHC22 also associated with expanded GLUT4 compartments in muscle from type 2 diabetic patients. Tissue-specific introduction of CHC22 in mice, which have only a pseudogene for this protein, caused aberrant localization of GLUT4 transport pathway components in their muscle, as well as features of diabetes. Thus, CHC22-dependent membrane trafficking constitutes a species-restricted pathway in human muscle and fat with potential implications for type 2 diabetes.	[Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Med, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, George Williams Hooper Fdn, Sch Med, San Francisco, CA 94143 USA; [Funke, Birgit H.; Plocik, Alex M.; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School	Brodsky, FM (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	frances.brodsky@ucsf.edu	Kucherlapati, Raju/ABC-8807-2021; vassilopoulos, stephane/AAF-3865-2021; vassilopoulos, stéphane/F-6041-2014	vassilopoulos, stephane/0000-0003-0172-330X; Esk, Christopher/0000-0003-1833-0801; Plocik, Alex/0000-0001-9489-6466; Brodsky, Frances/0000-0002-1334-9258	NIH [GM038093, HD47863]; Muscular Dystrophy Association award; Fondation Recherche Medicale, France; UCSF School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association award; Fondation Recherche Medicale, France(Fondation pour la Recherche Medicale); UCSF School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Ohkoshi, A. Ishii, and A. Tamaoka for providing tissue samples from the archives of the Department of Neurology, Institute of Clinical Medicine, University of Tsukuba; P. Ursell for providing tissue samples from the Department of Pathology, UCSF; M. Birnbaum, J. Pessin, J. Bonifacino, and J. Hopwood for antibodies; E. Unger (UCSF Diabetes Center) and M. Yuneva (George Williams Hooper Foundation) for technical advice; and A. Klip (University of Toronto) for helpful discussion. This work was supported by NIH grants GM038093 to F.M.B. and HD47863 to R.K.; a research grant and a career development award from the Muscular Dystrophy Association to W.E.W. and S.H., respectively; a grant from the Fondation Recherche Medicale, France to S.V.; and a Research Evaluation and Allocation Committee grant from the UCSF School of Medicine to F.M.B. Some images were acquired at the Nikon Imaging Center at UCSF.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gillingham AK, 1999, J CELL SCI, V112, P4793; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Liu SH, 2001, EMBO J, V20, P272, DOI 10.1093/emboj/20.1.272; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; MUNOZ P, 1995, BIOCHEM J, V312, P393, DOI 10.1042/bj3120393; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Towler MC, 2004, MOL BIOL CELL, V15, P3181, DOI 10.1091/mbc.E04-03-0249; Wakeham DE, 2005, P NATL ACAD SCI USA, V102, P7209, DOI 10.1073/pnas.0502058102; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	30	80	82	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1192	1196		10.1126/science.1171529	http://dx.doi.org/10.1126/science.1171529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478182	Green Accepted			2022-12-24	WOS:000266410100044
J	O'Dowd, A				O'Dowd, Adrian			A/H1N1 influenza update	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2009	339								b2977	10.1136/bmj.b2977	http://dx.doi.org/10.1136/bmj.b2977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475IN	19628526				2022-12-24	WOS:000268351900003
J	Okabe, Y; Sano, T; Nagata, S				Okabe, Yasutaka; Sano, Teruyuki; Nagata, Shigekazu			Regulation of the innate immune response by threonine-phosphatase of Eyes absent	NATURE			English	Article							PATTERN-RECOGNITION RECEPTORS; PROTEIN-TYROSINE-PHOSPHATASE; NF-KAPPA-B; BRANCHIOOTORENAL SYNDROME; ANTIVIRAL PATHWAY; VIRUS-INFECTION; MAMMALIAN DNA; GENE; TRANSCRIPTION; ACTIVATION	Innate immunity is stimulated not only by viral or bacterial components, but also by non-microbial danger signals (damage-associated molecular patterns)(1). One of the damage-associated molecular patterns is chromosomal DNA that escapes degradation. In programmed cell death and erythropoiesis, DNA from dead cells or nuclei expelled from erythroblasts is digested by DNase II in the macrophages after they are engulfed. DNase II-/- (also known as Dnase2a(-/-)) mice suffer from severe anaemia or chronic arthritis due to interferon-beta (IFN-beta) and tumour necrosis factor-alpha (TNF-alpha) produced from the macrophages carrying undigested DNA(2,3) in a Toll-like receptor (TLR)-independent mechanism(4). Here we show that Eyes absent 4 (EYA4), originally identified as a co-transcription factor, stimulates the expression of IFN-beta and CXCL10 in response to the undigested DNA of apoptotic cells. EYA4 enhanced the innate immune response against viruses (Newcastle disease virus and vesicular stomatitis virus), and could associate with signalling molecules (IPS-1 (also known as MAVS), STING (TMEM173) and NLRX1). Three groups have previously shown that EYA has phosphatase activity(5-7). We found that mouse EYA family members act as a phosphatase for both phosphotyrosine and phosphothreonine. The haloacid dehalogenase domain at the carboxy terminus contained the tyrosine-phosphatase, and the amino-terminal half carried the threonine-phosphatase. Mutations of the threonine-phosphatase, but not the tyrosine-phosphatase, abolished the ability of EYA4 to enhance the innate immune response, suggesting that EYA regulates the innate immune response by modulating the phosphorylation state of signal transducers for the intracellular pathogens.	[Okabe, Yasutaka; Sano, Teruyuki; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Okabe, Yasutaka; Nagata, Shigekazu] Japan Sci & Technol Corp, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Okabe, Yasutaka/0000-0002-1913-7280	Ministry of Education, Science, Sports, and Culture in Japan	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Fujita and M. Yoneyama for the NDV, A. Sehara-Fujisawa for the myogenin promoter, and M. Fujii and M. Harayama for secretarial assistance. This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture in Japan. T. S. is a Research Assistant for Kyoto University Global COE program (Center for Frontier Medicine).	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; FUJISAWASEHARA A, 1993, BIOCHEM BIOPH RES CO, V191, P351, DOI 10.1006/bbrc.1993.1224; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawane K, 1999, CELL DEATH DIFFER, V6, P745, DOI 10.1038/sj.cdd.4400547; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LAM KM, 1987, VET MICROBIOL, V15, P49, DOI 10.1016/0378-1135(87)90128-3; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Umeda IO, 2004, EXP EYE RES, V79, P385, DOI 10.1016/j.exer.2004.06.013; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	47	118	124	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					520	U99		10.1038/nature08138	http://dx.doi.org/10.1038/nature08138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19561593				2022-12-24	WOS:000268257000040
J	Sabin, LR; Zhou, R; Gruber, JJ; Lukinova, N; Bambina, S; Berman, A; Lau, CK; Thompson, CB; Cherry, S				Sabin, Leah R.; Zhou, Rui; Gruber, Joshua J.; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Lau, Chi-Kong; Thompson, Craig B.; Cherry, Sara			Ars2 Regulates Both miRNA- and siRNA-Dependent Silencing and Suppresses RNA Virus Infection in Drosophila	CELL			English	Article							CAP-BINDING COMPLEX; ANTIVIRAL IMMUNITY; ARGONAUTE PROTEINS; DISTINCT ROLES; MESSENGER-RNA; SERRATE; DICER-2; PATHWAY; INTERFERENCE; INITIATION	Intrinsic immune responses autonomously inhibit viral replication and spread. One pathway that restricts viral infection in plants and insects is RNA interference (RNAi), which targets and degrades viral RNA to limit infection. To identify additional genes involved in intrinsic antiviral immunity, we screened Drosophila cells for modulators of viral infection using an RNAi library. We identified Ars2 as a key component of Drosophila antiviral immunity. Loss of Ars2 in cells, or in flies, increases susceptibility to RNA viruses. Consistent with its antiviral properties, we found that Ars2 physically interacts with Dcr-2, modulates its activity in vitro, and is required for siRNA-mediated silencing. Furthermore, we show that Ars2 plays an essential role in miRNA-mediated silencing, interacting with the Microprocessor and stabilizing pri-miRNAs. The identification of Ars2 as a player in these small RNA pathways provides new insight into the biogenesis of small RNAs that may be extended to other systems.	[Sabin, Leah R.; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Zhou, Rui] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gruber, Joshua J.; Lau, Chi-Kong; Thompson, Craig B.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gruber, Joshua J.; Lau, Chi-Kong; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu	Lau, Terrence/ABB-7900-2021	Lau, Terrence/0000-0002-7505-7306; Sabin, Leah/0000-0003-1757-7415; cherry, sara/0000-0003-3956-6610	Leukemia and Lymphoma Society; NIH [T32 GM-07229, RO1AI07451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074951, R01AI074951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Bonini and M. Tudor for critically reading the manuscript; members of the Cherry laboratory for technical advice and helpful discussions; S. Poethig and M. Y. Park for technical advice; J. Rose for VSV-eGFP; D. Lyles for anti-VSV M; P. Ahlquist for anti-FHV B2; R. Hardy for SlN/GFP; R. Doms for Vaccinia; Harvard and VDRC for Ars2 transgenic flies; and The Bloomington Stock center for other fly stocks. R.Z. is supported by the Leukemia and Lymphoma Society. L. R. S. is supported by NIH training grant T32 GM-07229 and NIH grant RO1AI07451 to S. C.	ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DAMON IK, 2007, FIELDS VIROLOGY, P2948; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Friesen PD., 2007, FIELDS VIROLOGY, V1, P707; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lyles D, 2007, FIELDS VIROLOGY, P1364; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	48	162	169	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					340	351		10.1016/j.cell.2009.04.045	http://dx.doi.org/10.1016/j.cell.2009.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632183	Green Accepted, Bronze			2022-12-24	WOS:000268277000015
J	Furuyama, T; Henikoff, S				Furuyama, Takehito; Henikoff, Steven			Centromeric Nucleosomes Induce Positive DNA Supercoils	CELL			English	Article							HISTONE (H3-H4)(2) TETRAMER; SACCHAROMYCES-CEREVISIAE; CENP-A; YEAST CENTROMERE; BUDDING YEAST; FISSION YEAST; CHROMOSOME SEGREGATION; ARCHAEAL NUCLEOSOMES; CHROMATIN-STRUCTURE; COPY NUMBER	Centromeres of higher eukaryotes are epigenetically maintained; however, the mechanism that underlies centromere inheritance is unknown. Centromere identity and inheritance require the assembly of nucleosomes containing the CenH3 histone variant in place of canonical H3. Although H3 nucleosomes wrap DNA in a left-handed manner and induce negative supercoils, we show here that CenH3 nucleosomes reconstituted from Drosophila histones induce positive supercoils. Furthermore, we show that CenH3 likewise induces positive supercoils in functional centromeres in vivo, using a budding yeast minichromosome system and temperature-sensitive mutations in kinetochore proteins. The right-handed wrapping of DNA around the histone core implied by positive supercoiling indicates that centromere nucleosomes are unlikely to be octameric and that the exposed surfaces holding the nucleosome together would be available for kinetochore protein recruitment. The mutual incompatibility of nucleosomes with opposite topologies could explain how centromeres are efficiently maintained as unique loci on chromosomes.	[Furuyama, Takehito; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alilat M, 1999, J MOL BIOL, V291, P815, DOI 10.1006/jmbi.1999.2988; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bates A. D., 2005, DNA TOPOLOGY; BLOOM K, 1984, MOL BIOL CYTOSKELETO, P175; BLOOM KS, 1982, CELL, V29, P305, DOI 10.1016/0092-8674(82)90147-7; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HOOSER AV, 2001, J CELL SCI, V114, P3529; JEHN B, 1991, MOL CELL BIOL, V11, P5212, DOI 10.1128/MCB.11.10.5212; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malcolm A D, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P323; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; NELSON RG, 1979, P NATL ACAD SCI USA, V76, P6515, DOI 10.1073/pnas.76.12.6515; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pereira SL, 1997, P NATL ACAD SCI USA, V94, P12633, DOI 10.1073/pnas.94.23.12633; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; RESNICK MA, 1990, CHROMOSOMA, V99, P281, DOI 10.1007/BF01731704; SAAVEDRA RA, 1986, CELL, V45, P65, DOI 10.1016/0092-8674(86)90538-6; Sandman K, 1998, CELL MOL LIFE SCI, V54, P1350, DOI 10.1007/s000180050259; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; Tomonaga T, 2003, CANCER RES, V63, P3511; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	55	166	167	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					104	113		10.1016/j.cell.2009.04.049	http://dx.doi.org/10.1016/j.cell.2009.04.049			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596238	Green Accepted, Bronze			2022-12-24	WOS:000267848600018
J	Gostin, LO				Gostin, Lawrence O.			Influenza A(H1N1) and Pandemic Preparedness Under the Rule of International Law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PUBLIC-HEALTH		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2005, FED REGISTER, V70, p[71, 892]; [Anonymous], 2009, BBC NEWS        0505; Beitsch LM, 2006, HEALTH AFFAIR, V25, P911, DOI 10.1377/hlthaff.25.4.911; CAMPBELL C, 2005, SARS COMMISSION 2 IN; CHAN M, 2009, SWINE INFLUENZA STAT; CHAN M, 2009, INFLUENZA A H1N1 STA; CHENG J, 2009, WALL STREET J   0505, pA1; Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Oster S., 2009, WALL STREET J, pA10; *US DEP ED, H1N1 FLU US SCH ANSW; WHO, EP PAND AL RESP EPR; 2009, LOS ANGELES TIM 0502; 2009, ECONOMIST       0430	14	38	39	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2376	2378		10.1001/jama.2009.849	http://dx.doi.org/10.1001/jama.2009.849			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	455OT	19509384	Green Published			2022-12-24	WOS:000266773400030
J	Espinosa, EJ; Calero, M; Sridevi, K; Pfeffer, SR				Espinosa, Eric J.; Calero, Monica; Sridevi, Khambhampaty; Pfeffer, Suzanne R.			RhoBTB3: A Rho GTPase-Family ATPase Required for Endosome to Golgi Transport	CELL			English	Article							NUCLEOTIDE SPECIFICITY; ESCHERICHIA-COLI; RAB9 GTPASE; NETWORK; TRAFFICKING; PROTEINS; TIP47; EXPRESSION; MECHANISM; COMPLEX	Rho GTPases are key regulators of the actin-based cytoskeleton; Rab GTPases are key regulators of membrane traffic. We report here that the atypical Rho GTPase family member, RhoBTB3, binds directly to Rab9 GTPase and functions with Rab9 in protein transport from endosomes to the trans Golgi network. Gene replacement experiments show that RhoBTB3 function in cultured cells requires both RhoBTB30s N-terminal, Rho-related domain and C-terminal sequences that are important for Rab9 interaction. Biochemical analysis reveals that RhoBTB3 binds and hydrolyzes ATP rather than GTP. Rab9 binding opens the autoinhibited RhoBTB3 protein to permit maximal ATP hydrolysis. Because RhoBTB3 interacts with TIP47 on membranes, we propose that it may function to release this cargo selection protein from vesicles to permit their efficient docking and fusion at the Golgi.	[Espinosa, Eric J.; Calero, Monica; Sridevi, Khambhampaty; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pfeffer@stanford.edu			Leukemia and Lymphoma Society [NIDDK R37-37332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R37DK037332] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a grant ( NIDDK R37-37332) to S. R. P. K. S. was a fellow of the Leukemia and Lymphoma Society. We thank Dr. Jonathan Reddy for the original yeast two-hybrid screen, Garret Hayes and Leonie Kastner for screening 54 Rab GTPases, and Margaret Cooke and Humsa Venkatesan for help with RhoBTB3 mutagenesis. Drs. Tim Fenn and Maika Deffieu provided invaluable help with structure modeling and blue native gels, respectively.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; ALTMAN D, 2004, BIOCHEM J, V377, P327; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; HWANG YW, 1987, J BIOL CHEM, V262, P13081; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Salas-Vidal E, 2005, GENOMICS, V86, P25, DOI 10.1016/j.ygeno.2005.03.010; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Sincock PM, 2003, TRAFFIC, V4, P18, DOI 10.1034/j.1600-0854.2003.40104.x; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; SWAMY M, 2006, SCI STKE, V345, P14; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Ybe JA, 1996, PROTEIN SCI, V5, P814; ZHONG JM, 1995, J BIOL CHEM, V270, P10002, DOI 10.1074/jbc.270.17.10002	47	68	72	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					938	948		10.1016/j.cell.2009.03.043	http://dx.doi.org/10.1016/j.cell.2009.03.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490898	Green Accepted, Bronze			2022-12-24	WOS:000266454800023
J	Bischoff, EWMA; Uijen, A; van der Wel, M				Bischoff, Erik W. M. A.; Uijen, Annemarie; van der Wel, Mark			10-Minute Consultation Aphthous ulcers	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bischoff, Erik W. M. A.; Uijen, Annemarie; van der Wel, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bischoff, EWMA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	e.bischoff@elg.umcn.nl	Uijen, A.A./L-4701-2015; van der Wel, M.C./L-4750-2015; Bischoff, Erik W.M.A./L-4201-2015					McBride DR, 2000, AM FAM PHYSICIAN, V62, P149; Scully C, 2000, BRIT MED J, V321, P162, DOI 10.1136/bmj.321.7254.162; Scully C, 2005, BRIT DENT J, V199, P259, DOI 10.1038/sj.bdj.4812649	3	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2009	339								b2382	10.1136/bmj.b2382	http://dx.doi.org/10.1136/bmj.b2382			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633032				2022-12-24	WOS:000268352100001
J	Wheeler, TM; Sobczak, K; Lueck, JD; Osborne, RJ; Lin, XY; Dirksen, RT; Thornton, CA				Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.			Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA	SCIENCE			English	Article							EXPANDED CUG REPEAT; PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; CHLORIDE CHANNEL; TRINUCLEOTIDE REPEAT; MUSCLEBLIND PROTEINS; EXPANSION; TRANSCRIPTS; HAIRPINS; MODEL	Genomic expansions of simple tandem repeats can give rise to toxic RNAs that contain expanded repeats. In myotonic dystrophy, the expression of expanded CUG repeats (CUG(exp)) causes abnormal regulation of alternative splicing and neuromuscular dysfunction. We used a transgenic mouse model to show that derangements of myotonic dystrophy are reversed by a morpholino antisense oligonucleotide, CAG25, that binds to CUG(exp) RNA and blocks its interaction with muscleblind-like 1 (MBNL1), a CUG(exp)-binding protein. CAG25 disperses nuclear foci of CUG(exp) RNA and reduces the overall burden of this toxic RNA. As MBNL1 is released from sequestration, the defect of alternative splicing regulation is corrected, thereby restoring ion channel function. These findings suggest an alternative use of antisense methods, to inhibit deleterious interactions of proteins with pathogenic RNAs.	[Wheeler, Thurman M.; Sobczak, Krzysztof; Osborne, Robert J.; Lin, Xiaoyan; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.] Univ Rochester, Dept Physiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Thornton, CA (corresponding author), Univ Rochester, Dept Neurol, Rochester, NY 14642 USA.	charles_thornton@urmc.rochester.edu		Sobczak, Krzysztof/0000-0001-8352-9812; Lueck, John/0000-0002-1820-711X	University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center; Center for RNA Biology; NIH [AR046806, AR/NS48143, NIDCR-T32DE07202]; Muscular Dystrophy Association; Foundation for Polish Science; Run America Foundation; Saunders Family fund;  [U54NS48843]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046806, K24AR048143, R01AR049077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843, K08NS064293] Funding Source: NIH RePORTER	University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center; Center for RNA Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Run America Foundation; Saunders Family fund; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work comes from the University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center (U54NS48843) and Center for RNA Biology, with support from NIH (AR046806, AR/NS48143, and NIDCR-T32DE07202 to J.D.L.), the Muscular Dystrophy Association, and a postdoctoral fellowship to K.S. from the Foundation for Polish Science, Run America Foundation, and the Saunders Family fund. We appreciate help from L. Richardson and S. Leistman. The University of Rochester has applied for a patent based partly on the work described here.	Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	26	285	303	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					336	339		10.1126/science.1173110	http://dx.doi.org/10.1126/science.1173110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608921	Green Accepted			2022-12-24	WOS:000268036600050
J	Sepkowitz, KA				Sepkowitz, Kent A.			Forever Unprepared -- The Predictable Unpredictability of Pathogens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324	3	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					120	121		10.1056/NEJMp0902373	http://dx.doi.org/10.1056/NEJMp0902373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19587337				2022-12-24	WOS:000267748900004
J	Lee, BJ; Forbes, K				Lee, Brian J.; Forbes, Ken			Practice Quality Improvement Report The role of specialists in managing the health of populations with chronic illness: the example of chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Article							STAGE RENAL-DISEASE; IMPACT; CARE; MORTALITY; OUTCOMES; RISK; NEPHROLOGIST; NEPHROPATHY; MORBIDITY; REFERRALS	Problem Specialty care has been used to manage individual patients at the discretion of generalists but not to drive improvements at the population level. Design Observational longitudinal study. Setting Kaiser Permanente Hawaii, with more than 10 000 members with documented chronic kidney disease. Key measures for improvement Rate of late referrals to nephrology care, defined as occurring within four months of end stage renal disease and the proportions of patients starting haemodialysis with a mature arteriovenous fistula and starting dialysis in the outpatient setting. Strategies for change Risk stratification of the entire population and unsolicited consultations provided by nephrologists to generalists, based on patients' risk level, enabled by an electronic population management database. Effects of change Between 2004 and 2008, the proportion of referrals occurring within four months of onset of end stage renal disease dropped from 37 of 116 (32%) to 10 of 84 (12%), P=0.001. The proportion of patients starting haemodialysis with a mature arteriovenous fistula increased from 19 of 108 (18%) to 27 of 76 (36%), P=0.006. The proportion of patients who started haemodialysis as outpatients increased from 39 of 113 (35%) to 47 of 84 (56%), P=0.003. Lessons learnt Turning the traditional referral system on its head by providing unsolicited, risk driven nephrology consultations is an effective strategy for increasing the quality of medical management of patients with chronic kidney disease in the primary care setting and improving the cost effective use of nephrology services. This approach may be broadly applicable to other specialty areas.	[Lee, Brian J.] Kaiser Permanente, Moanalua Med Ctr, Hawaii Reg, Honolulu, HI 96819 USA; [Forbes, Ken] Kaiser Permanente, Care Management Inst, Hawaii Reg, Honolulu, HI 96819 USA	Kaiser Permanente; Kaiser Permanente	Lee, BJ (corresponding author), Kaiser Permanente, Moanalua Med Ctr, Hawaii Reg, 3288 Moanalua Rd, Honolulu, HI 96819 USA.	brian.j.lee@kp.org			Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region	Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region	This work was jointly supported by the Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region.	Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Chen SC, 2008, NEPHROLOGY, V13, P730, DOI 10.1111/j.1440-1797.2008.01023.x; Cheng ZQ, 2009, HYBRIDOMA, V28, P33, DOI 10.1089/hyb.2008.0069; *DELF GROUP LLC, 2007, DELF PROJ SHOWC NEPH; Ellis PA, 1998, QJM-MON J ASSOC PHYS, V91, P727, DOI 10.1093/qjmed/91.11.727; Ifudu O, 1996, AM J KIDNEY DIS, V28, P841, DOI 10.1016/S0272-6386(96)90383-2; Innes A, 2008, NEPHROL DIAL TRANSPL, V23, P2571, DOI 10.1093/ndt/gfn069; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Livaudais Gerard, 2006, Perm J, V10, P72; Martinez-Ramirez HR, 2006, AM J KIDNEY DIS, V47, P78, DOI 10.1053/j.ajkd.2005.09.015; Navaneethan SD, 2008, AM J MED, V121, pE17, DOI 10.1016/j.amjmed.2008.01.008; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; Ravani P, 2005, J NEPHROL, V18, P188; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Thorp ML, 2004, AM J MANAG CARE, V10, P417; Yang XL, 2006, DIABETOLOGIA, V49, P2299, DOI 10.1007/s00125-006-0376-3; 2002, AM J KIDNEY DIS S, V39, pS1	27	34	34	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2009	339								b2395	10.1136/bmj.b2395	http://dx.doi.org/10.1136/bmj.b2395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KY	19586983				2022-12-24	WOS:000267898300002
J	Van Horn, WD; Kim, HJ; Ellis, CD; Hadziselimovic, A; Sulistijo, ES; Karra, MD; Tian, CL; Sonnichsen, FD; Sanders, CR				Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Soennichsen, Frank D.; Sanders, Charles R.			Solution Nuclear Magnetic Resonance Structure of Membrane-Integral Diacylglycerol Kinase	SCIENCE			English	Article							KCSA POTASSIUM CHANNEL; ESCHERICHIA-COLI; DETERGENT MICELLES; OUTER-MEMBRANE; DGK GENE; PROTEIN; MECHANISM; OLIGOSACCHARIDES; DYNAMICS; REVEALS	Escherichia coli diacylglycerol kinase (DAGK) represents a family of integral membrane enzymes that is unrelated to all other phosphotransferases. We have determined the three-dimensional structure of the DAGK homotrimer with the use of solution nuclear magnetic resonance. The third transmembrane helix from each subunit is domain-swapped with the first and second transmembrane segments from an adjacent subunit. Each of DAGK's three active sites resembles a portico. The cornice of the portico appears to be the determinant of DAGK's lipid substrate specificity and overhangs the site of phosphoryl transfer near the water-membrane interface. Mutations to cysteine that caused severe misfolding were located in or near the active site, indicating a high degree of overlap between sites responsible for folding and for catalysis.	[Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Sanders, Charles R.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kim, Hak-Jun] Korea Polar Res Inst, Inchon 406840, South Korea; [Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany	Vanderbilt University; Vanderbilt University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Kiel	Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	chuck.sanders@vanderbilt.edu	Tian, Changlin/P-1469-2014; Sönnichsen, Frank D/D-8408-2011; Van Horn, Wade/GSN-2667-2022	Sönnichsen, Frank D/0000-0002-4539-3755; Van Horn, Wade/0000-0002-2493-5578	NIH [T32 NS007491]; National Institute of General Medical Sciences [RO1 GM47485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Bowie for providing the DAGK expression system, many of the mutants used in this work, and much discussion; M. Voehler, B. Gorzelle, P. Power, C. Kang, and J. Jacob for technical assistance; and K. Oxenoid, L. Kay, S. Prosser, M.-D. Tsai, T. Iverson, J. Meiler, A. Forster, J. Battiste, W. Chazin, and members of the Sanders lab for discussion. Supported by NIH training grant T32 NS007491 (W.V.H.) and National Institute of General Medical Sciences grant RO1 GM47485. C.R.S. is a consultant for Anatrace Inc. (now owned by Affymetrix), a company that markets high-purity biological detergents, including some of the detergents used in sample preparation in this work. The coordinates for DAGK have been deposited as PDB entry 2kdc in the Protein Data Bank. This work is dedicated to the fond memory of Anne Karpay.	Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bishop RE, 2008, BBA-BIOMEMBRANES, V1778, P1881, DOI 10.1016/j.bbamem.2007.07.021; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Kumar S, 1999, CELL BIOCHEM BIOPHYS, V31, P141, DOI 10.1007/BF02738169; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090; Ma DJ, 2008, P NATL ACAD SCI USA, V105, P16537, DOI 10.1073/pnas.0805501105; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Nagy JK, 2004, BIOCHEMISTRY-US, V43, P19, DOI 10.1021/bi035918s; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2004, J AM CHEM SOC, V126, P5048, DOI 10.1021/ja049916m; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Shibata Y, 2009, MICROBIOL-SGM, V155, P557, DOI 10.1099/mic.0.023812-0; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1992, METHOD ENZYMOL, V209, P153; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	34	182	182	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1726	1729		10.1126/science.1171716	http://dx.doi.org/10.1126/science.1171716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556511	Green Accepted			2022-12-24	WOS:000267338200045
J	Scher, AI; Gudmundsson, LS; Sigurdsson, S; Ghambaryan, A; Aspelund, T; Eiriksdottir, G; van Buchem, MA; Gudnason, V; Launer, LJ				Scher, Ann I.; Gudmundsson, Larus S.; Sigurdsson, Sigurdur; Ghambaryan, Anna; Aspelund, Thor; Eiriksdottir, Gudny; van Buchem, Mark A.; Gudnason, Vilmundur; Launer, Lenore J.			Migraine Headache in Middle Age and Late-Life Brain Infarcts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE/ENVIRONMENT SUSCEPTIBILITY-REYKJAVIK; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; GLOBAL BURDEN; RISK; WOMEN; EPIDEMIOLOGY; PATTERNS	Context Migraine is considered to be an episodic condition with no long-term consequences. However, recent studies suggest that migraine attacks may be associated with pathologic changes in the brain, particularly in the cerebellum. Objective To determine whether individuals not reporting headache compared with individuals reporting migraine symptoms, particularly aura, in midlife are at increased risk of late-life infarct-like lesions found on magnetic resonance imaging (MRI) without consideration of clinical symptoms. Design, Setting, and Participants A population-based study of men and women in Reykjavik, Iceland (cohort born 1907-1935; n = 4689; 57% women) were followed up since 1967, examined, and interviewed about migraine symptoms in midlife (mean age, 51 years; range, 33-65 years). Between 2002 and 2006, more than 26 years later, brain MRIs were performed. Participants reporting headaches once or more per month were asked about migraine symptoms including nausea, unilateral location, photophobia, visual disturbance, and numbness. These individuals with headache were classified as having migraine without aura, migraine with aura, or nonmigraine headache. A comprehensive cardiovascular risk assessment was performed at both examinations. Main Outcome Measure Presence of infarct-like lesions (total) and specifically located in the cortical, subcortical, and cerebellar regions. Results Infarct-like lesions were present in 39.3% of men and 24.6% of women. After adjusting for age, sex, and follow-up time, compared with those not reporting headaches once or more per month (n = 3243), those with midlife migraine with aura (n = 361) had an increased risk of late-life infarct-like lesions (adjusted odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8) that specifically reflected an association with cerebellar lesions in women (prevalence of infarcts 23.0% for women with migraine with aura vs 14.5% for women not reporting headaches; adjusted OR, 1.9; 95% CI, 1.4-2.6 vs a 19.3% prevalence of infarcts for men with migraine with aura vs 21.3% for men not reporting headaches; adjusted OR, 1.0; 95% CI, 0.6-1.8; P < .04 for interaction by sex). Migraine without aura and nonmigraine headache were not associated with an increased risk. Conclusions Migraine with aura in midlife was associated with late-life prevalence of cerebellar infarct-like lesions on MRI. This association was statistically significant only for women. This is consistent with the hypothesis that migraine with aura in midlife is associated with late-life vascular disease in the cerebellum and in women. JAMA. 2009; 301(24):2563-2570	[Launer, Lenore J.] NIA, LEDB, NIH, Bethesda, MD 20892 USA; [Scher, Ann I.; Ghambaryan, Anna] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gudmundsson, Larus S.] Univ Iceland, Dept Pharmacol & Toxicol, Reykjavik, Iceland; [Sigurdsson, Sigurdur; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uniformed Services University of the Health Sciences - USA; University of Iceland; Icelandic Heart Association; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Launer, LJ (corresponding author), NIA, LEDB, NIH, 7201 Wisconsin Ave,Ste 3C-309, Bethesda, MD 20892 USA.	launerl@nia.nih.gov	van Buchem, Mark/AAC-9843-2022; Aspelund, Thor/K-7022-2019; Gudmundsson, Larus S/K-2854-2019; Gudnason, Vilmundur/AAE-7126-2019; Launer, Lenore J/A-8218-2010; Gudnason, Vilmundur/K-6885-2015; Aspelund, Thor/F-4826-2011; Aspelund, Thor/C-5983-2008	van Buchem, Mark/0000-0003-1881-1998; Aspelund, Thor/0000-0002-7998-5433; Gudmundsson, Larus S/0000-0003-4660-1111; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Scher, Ann/0000-0003-4599-9834	National Institutes of Health [N01-AG-12100]; National Institute on Aging Intramural Research Program, Hjartavernd; Althingi; National Eye Institute; National Institute on Deafness and Other Communication Disorders; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE ON AGING [Z01AG007380, N01AG012100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program, Hjartavernd(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This study was funded by National Institutes of Health contract N01-AG-12100, the National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Components of the study were also supported by the National Eye Institute, the National Institute on Deafness and Other Communication Disorders, and the National Heart, Lung, and Blood Institute. Funding in support of this analysis was provided by the Migraine Research Foundation.	Bousser MG, 2005, LANCET NEUROL, V4, P533, DOI 10.1016/S1474-4422(05)70164-2; Burns R J, 1979, Clin Exp Neurol, V16, P69; Del Zotto E, 2008, J CEREBR BLOOD F MET, V28, P1399, DOI 10.1038/jcbfm.2008.36; Diener HC, 2007, CURR OPIN NEUROL, V20, P310, DOI 10.1097/WCO.0b013e328136c22d; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Elkind MSV, 2008, NEUROLOGY, V70, P1506, DOI 10.1212/01.wnl.0000310647.04081.3c; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Gudmundsson LS, 2006, CEPHALALGIA, V26, P436, DOI 10.1111/j.1468-2982.2005.01057.x; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 2003, INT PSYCHOGERIATR, V15, P99, DOI 10.1017/S1041610203009037; Lee SM, 2008, HORM RES, V70, P17; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Milhaud D, 2001, NEUROLOGY, V57, P1805, DOI 10.1212/WNL.57.10.1805; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; OPEENHEIM H, 1900, DIS NERVOUS SYSTEM T; Pezzini A, 2007, STROKE, V38, P3145, DOI 10.1161/STROKEAHA.107.491506; Qiu CX, 2008, DIABETES, V57, P1645, DOI 10.2337/db07-1455; Reid J, 2006, CEPHALALGIA, V26, P1247, DOI 10.1111/j.1468-2982.2006.01199.x; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tietjen GE, 2007, CEPHALALGIA, V27, P981; Vincent M, 2007, HEADACHE, V47, P820, DOI 10.1111/j.1526-4610.2006.00715.x; Welch KMA, 2003, FUNCT NEUROL, V18, P121	34	138	146	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2563	2570		10.1001/jama.2009.932	http://dx.doi.org/10.1001/jama.2009.932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549973	Green Accepted, Bronze			2022-12-24	WOS:000267266500021
J	Saint, S; Meddings, JA; Calfee, D; Kowalski, CP; Krein, SL				Saint, Sanjay; Meddings, Jennifer A.; Calfee, David; Kowalski, Christine P.; Krein, Sarah L.			Catheter-Associated Urinary Tract Infection and the Medicare Rule Changes	ANNALS OF INTERNAL MEDICINE			English	Article							INTERMITTENT SELF-CATHETERIZATION; NURSING-HOME PATIENTS; ASYMPTOMATIC BACTERIURIA; NOSOCOMIAL INFECTIONS; HOSPITALIZED-PATIENTS; UNITED-STATES; CARE; INTERVENTION; COMPLICATIONS; PREVENTION	Catheter-associated urinary tract infection, a common and potentially preventable complication of hospitalization, is 1 of the hospital-acquired complications chosen by the Centers for Medicare & Medicaid Services (CMS) for which hospitals no longer receive additional payment. To help readers understand the potential consequences of the recent CMS rule changes, the authors examine the preventability of catheter-associated infection, review the CMS rule changes regarding catheter-associated urinary tract infection, offer an assessment of the possible consequences of these changes, and provide guidance for hospital-based administrators and clinicians. Although the CMS rule changes related to catheter-associated urinary tract infection are controversial, they may do more good than harm, because hospitals are likely to redouble their efforts to prevent catheter-associated urinary tract infection, which may minimize unnecessary placement of indwelling catheters and facilitate prompt removal. However, even if forcing hospitals to increase efforts to prevent complications stemming from hospital-acquired infection is commendable, these efforts will have opportunity costs and may have unintended consequences. Therefore, how hospitals and physicians respond to the CMS rule changes must be monitored closely.	Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Vet Affairs Univ Michigan, Patient Safety Enhancement Program, Ann Arbor, MI USA; Mt Sinai Sch Med, New York, NY USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Icahn School of Medicine at Mount Sinai	Saint, S (corresponding author), Univ Michigan Hlth Syst, Div Gen Med, 300 N Ingalls,Room 7E08,Campus Box 0429, Ann Arbor, MI 48109 USA.	saint@med.umich.edu	Krein, Sarah L/E-2742-2014; Saint, Sanjay/AAF-5126-2019	Krein, Sarah L/0000-0003-2111-8131; Kowalski, Christine/0000-0001-6258-0221; Meddings, Jennifer/0000-0001-9503-0293	National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK078717]; National Institute of Nursing Research [R01-NR010700]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010700] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	By the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK078717; Dr. Saint) and the National Institute of Nursing Research (R01-NR010700; Drs. Saint and Krein). Salary support for Dr. Saint was also provided through an Advanced Career Development Award from the Health Services Research & Development Program of the Department of Veterans Affairs.	Apisarnthanarak A, 2007, INFECT CONT HOSP EP, V28, P791, DOI 10.1086/518453; Centers for Medicare and Medicaid Services (CMS), 2008, FED REGISTER, V73, P48433; Centers for Medicare & Medicaid Services, AC INP PROSP PAYM SY; Centers of Medicare and Medicaid Services (CMS), 2007, FED REGISTER, V72, P47129; *CMS HHS, 2008, FED REGISTER, V73, P23547; Cornia PB, 2003, AM J MED, V114, P404, DOI 10.1016/S0002-9343(02)01568-1; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; *CTR MED MED SERV, HOSP ACQ COND IN SUM; DIOKNO AC, 1983, J UROLOGY, V129, P1120, DOI 10.1016/S0022-5347(17)52599-9; Doyle B, 2001, Lippincotts Case Manag, V6, P127, DOI 10.1097/00129234-200105000-00007; Dumigan D G, 1998, Clin Perform Qual Health Care, V6, P172; Forster AJ, 2004, CAN MED ASSOC J, V170, P1235, DOI 10.1503/cmaj.1030683; Foxman B, 2002, AM J MED, V113, p5S; Goetz AM, 1999, AM J INFECT CONTROL, V27, P402, DOI 10.1016/S0196-6553(99)70005-2; Graves N, 2008, JAMA-J AM MED ASSOC, V300, P1577, DOI 10.1001/jama.300.13.1577; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; HIRSH DD, 1979, JAMA-J AM MED ASSOC, V242, P340, DOI 10.1001/jama.242.4.340; Huang WC, 2004, INFECT CONT HOSP EP, V25, P974, DOI 10.1086/502329; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; KUHN W, 1991, PARAPLEGIA, V29, P222, DOI 10.1038/sc.1991.33; LAPIDES J, 1972, Journal of Urology, V107, P458; Lin K, 2008, ANN INTERN MED, V149, pW20, DOI 10.7326/0003-4819-149-1-200807010-00009-w1; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Loeb M, 2008, J GEN INTERN MED, V23, P816, DOI 10.1007/s11606-008-0620-2; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; OUSLANDER JG, 1987, J UROLOGY, V138, P1191, DOI 10.1016/S0022-5347(17)43546-4; OUSLANDER JG, 1987, J AM GERIATR SOC, V35, P1063, DOI 10.1111/j.1532-5415.1987.tb04922.x; PEAR R, 2007, NY TIMES        0819; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Saint S, 2000, ARCH INTERN MED, V160, P2670, DOI 10.1001/archinte.160.17.2670; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 2008, INFECT CONT HOSP EP, V29, P333, DOI 10.1086/529589; Saint S, 2008, CLIN INFECT DIS, V46, P243, DOI 10.1086/524662; Saint S, 2006, J AM GERIATR SOC, V54, P1055, DOI 10.1111/j.1532-5415.2006.00785.x; SIMMONS BP, 1983, AM J INFECT CONTROL, V11, P183, DOI 10.1016/0196-6553(83)90079-2; Stephan F, 2006, CLIN INFECT DIS, V42, P1544, DOI 10.1086/503837; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Topal J, 2005, AM J MED QUAL, V20, P121, DOI 10.1177/1062860605276074; Wagenlehner FME, 2000, J HOSP INFECT, V46, P171, DOI 10.1016/S0195-6701(00)90821-1; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060; Zhan CL, 2007, MED CARE, V45, P288, DOI 10.1097/01.mlr.0000256969.34461.cf; Zhan CL, 2009, MED CARE, V47, P364, DOI 10.1097/MLR.0b013e31818af83d; [No title captured]	50	166	171	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					877	U82		10.7326/0003-4819-150-12-200906160-00013	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528567	Green Accepted			2022-12-24	WOS:000267164800008
J	Boguski, MS; Mandl, KD; Sukhatme, VP				Boguski, Mark S.; Mandl, Kenneth D.; Sukhatme, Vikas P.			Repurposing with a Difference	SCIENCE			English	Editorial Material							JANUARY-1 FEBRUARY 2005; DRUG DEVELOPMENT; ABANDONED DRUGS; PHARMACOVIGILANCE; COMMERCIALIZE; PHILADELPHIA; IDENTIFY; DEVELOP; USA; PA		[Boguski, Mark S.] Harvard Univ, Sch Med, Dept Pathobiol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Boguski, Mark S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Childrens Hosp Informat Program Harvard MIT, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Sukhatme, Vikas P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Boguski, MS (corresponding author), Harvard Univ, Sch Med, Dept Pathobiol, Beth Israel Deaconess Med Ctr, 10 Shattuck St, Boston, MA 02115 USA.	mark_boguski@hms.harvard.edu	Sukhatme, Vikas/W-2776-2019					Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bernoff, 2008, GROUNDSWELL WINNING; Boguski MS, 2009, GENOMIC AND PERSONALIZED MEDICINE, VOL 1, P252; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Brownstein JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000840; Carley DW, 2005, IDRUGS, V8, P310; Carley DW, 2005, IDRUGS, V8, P306; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Ferguson T., 2007, E PATIENTS THEY CAN; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Grabowski H, 2004, PHARMACOECONOMICS, V22, P15, DOI 10.2165/00019053-200422002-00003; Grossman J., 2008, INNOVATORS PRESCRIPT; Harmark L, 2008, EUR J CLIN PHARMACOL, V64, P743, DOI 10.1007/s00228-008-0475-9; Hauben M, 2009, DRUG DISCOV TODAY, V14, P343, DOI 10.1016/j.drudis.2008.12.012; Howe J., 2008, CROWDSOURCING WHY PO; Kaitin KI, 2008, CLIN PHARMACOL THER, V83, P210, DOI 10.1038/sj.clpt.6100462; Loughlin K.R., 2006, GUIDE OFF LABEL PRES; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; MCBRIDE WG, 1961, LANCET, V2, P1358; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; POLLACK A, 2009, NY TIMES        0312; Rehan HS, 2009, EUR J INTERN MED, V20, P3, DOI 10.1016/j.ejim.2008.04.019; Roin BN, 2009, TEX LAW REV, V87, P503; Slater R, 2003, MAGIC CANC BULLET TI; Weaver J, 2008, AAPS J, V10, P35, DOI 10.1208/s12248-007-9004-5; WHO, 2002, IMP PHARM SAF MON ME	28	147	151	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1394	1395		10.1126/science.1169920	http://dx.doi.org/10.1126/science.1169920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520944				2022-12-24	WOS:000266878700027
J	Hopkins, H; Asiimwe, C; Bell, D				Hopkins, Heidi; Asiimwe, Caroline; Bell, David			Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals	BRITISH MEDICAL JOURNAL			English	Editorial Material							MALARIA TREATMENT; COMBINATION THERAPY; FEBRILE ILLNESS; TESTS; TANZANIA; CHILDREN; AFRICA; IMPACT; POLICY; MORBIDITY		[Hopkins, Heidi; Asiimwe, Caroline] FIND, Kampala, Uganda; [Bell, David] WHO, Reg Off Western Pacific, New York, NY USA	Foundation For Innovative New Diagnostics; World Health Organization	Hopkins, H (corresponding author), FIND, Kampala, Uganda.	heidi.hopkins@finddiagnostics.org		Asiimwe, Caroline/0000-0001-6840-5985; Hopkins, Heidi/0000-0003-1076-6758				Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], MAL RAP DIAGN TESTS; [Anonymous], 2008, WORLD MAL REP 2008; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Djimde A, 1998, AM J TROP MED HYG, V59, P376, DOI 10.4269/ajtmh.1998.59.376; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Moerman F, 2003, LANCET INFECT DIS, V3, P99, DOI 10.1016/S1473-3099(03)00518-8; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *ROLL BACK MAL PAR, 2007, AFF MED FAC MAL AMFM; *ROLL BACK MAL WHO, GLOB STRAT PLAN 2005; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; United Nations, 2008, MILL DEV GOALS REP; WHO, 2006, GUID TREATM MAL; *WHO, 2008, GLOB MAL CONR EL REP; *WHO, FDN INN NEW DIAGN ME; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Zikusooka CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-176	28	29	29	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 7	2009	339								b2606	10.1136/bmj.b2606	http://dx.doi.org/10.1136/bmj.b2606			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KX	19584113				2022-12-24	WOS:000267898200003
J	Frohlich, A; Kisielow, J; Schmitz, I; Freigang, S; Shamshiev, AT; Weber, J; Marsland, BJ; Oxenius, A; Kopf, M				Froehlich, Anja; Kisielow, Jan; Schmitz, Iwana; Freigang, Stefan; Shamshiev, Abdijapar T.; Weber, Jacqueline; Marsland, Benjamin J.; Oxenius, Annette; Kopf, Manfred			IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection	SCIENCE			English	Article							HOMEOSTATIC PROLIFERATION; IN-VIVO; RESPONSES; EFFECTOR; HIV-1	Chronic viral infection is often associated with the dysfunction of virus-specific T cells. Our studies using Il21r-deficient (Il21r(-/-)) mice now suggest that interleukin-21 (IL-21) is critical for the long-term maintenance and functionality of CD8(+) T cells and the control of chronic lymphocytic choriomeningitis virus infection in mice. Cell-autonomous IL-21 receptor (IL-21R)-dependent signaling by CD8(+) T cells was required for sustained cell proliferation and cytokine production during chronic infection. Il21r(-/-) mice showed normal CD8(+) T cell expansion, effector function, memory homeostasis, and recall responses during acute and after resolved infection with several other nonpersistent viruses. These data suggest that IL-21R signaling is required for the maintenance of polyfunctional T cells during chronic viral infections and have implications for understanding the immune response to other persisting antigens, such as tumors.	[Froehlich, Anja; Kisielow, Jan; Schmitz, Iwana; Freigang, Stefan; Shamshiev, Abdijapar T.; Weber, Jacqueline; Marsland, Benjamin J.; Kopf, Manfred] ETH, Inst Integrat Biol, Zurich, Switzerland; [Oxenius, Annette] ETH, Inst Microbiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kopf, M (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	Manfred.Kopf@ethz.ch	Freigang, Stefan/A-8682-2013; Kopf, Manfred/B-6907-2009; Oxenius, Annette/G-7794-2015	Freigang, Stefan/0000-0003-4438-7828; Kopf, Manfred/0000-0002-0628-7140; Kisielow, Jan/0000-0002-4482-5202	Swiss National Science Foundation [310030_124922]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by Swiss National Science Foundation 310030_124922.	Altfeld M, 2000, CURR OPIN IMMUNOL, V12, P375, DOI 10.1016/S0952-7915(00)00103-5; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Picker LJ, 2000, CURR OPIN IMMUNOL, V12, P381, DOI 10.1016/S0952-7915(00)00104-7; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	17	340	354	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1576	1580		10.1126/science.1172815	http://dx.doi.org/10.1126/science.1172815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19478140				2022-12-24	WOS:000267130600048
J	Xu, X; Clark, JM; Mo, JY; Choiniere, J; Forster, CA; Erickson, GM; Hone, DWE; Sullivan, C; Eberth, DA; Nesbitt, S; Zhao, Q; Hernandez, R; Jia, CK; Han, FL; Guo, Y				Xu, Xing; Clark, James M.; Mo, Jinyou; Choiniere, Jonah; Forster, Catherine A.; Erickson, Gregory M.; Hone, David W. E.; Sullivan, Corwin; Eberth, David A.; Nesbitt, Sterling; Zhao, Qi; Hernandez, Rene; Jia, Cheng-kai; Han, Feng-lu; Guo, Yu			A Jurassic ceratosaur from China helps clarify avian digital homologies	NATURE			English	Article							ABELISAUROID DINOSAURIA; THEROPODA; EVOLUTION; EXPRESSION; REDUCTION; PATTERNS; BIRDS	Theropods have traditionally been assumed to have lost manual digits from the lateral side inward, which differs from the bilateral reduction pattern seen in other tetrapod groups. This unusual reduction pattern is clearly present in basal theropods, and has also been inferred in non-avian tetanurans based on identification of their three digits as the medial ones of the hand (I-II-III). This contradicts the many developmental studies indicating II-III-IV identities for the three manual digits of the only extant tetanurans, the birds. Here we report a new basal ceratosaur from the Oxfordian stage of the Jurassic period of China (156-161 million years ago), representing the first known Asian ceratosaur and the only known beaked, herbivorous Jurassic theropod. Most significantly, this taxon possesses a strongly reduced manual digit I, documenting a complex pattern of digital reduction within the Theropoda. Comparisons among theropod hands show that the three manual digits of basal tetanurans are similar in many metacarpal features to digits II-III-IV, but in phalangeal features to digits I-II-III, of more basal theropods. Given II-III-IV identities in avians, the simplest interpretation is that these identities were shared by all tetanurans. The transition to tetanurans involved complex changes in the hand including a shift in digit identities, with ceratosaurs displaying an intermediate condition.	[Xu, Xing; Hone, David W. E.; Sullivan, Corwin; Zhao, Qi; Han, Feng-lu; Guo, Yu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Clark, James M.; Choiniere, Jonah; Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Mo, Jinyou] Nat Hist Museum Guangxi, Nanning 530012, Guangxi, Peoples R China; [Mo, Jinyou] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Eberth, David A.] Royal Tyrrell Museum, Drumheller, AB T0J 0Y0, Canada; [Nesbitt, Sterling] Amer Museum Nat Hist, New York, NY 10024 USA; [Hernandez, Rene] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City 04510, DF, Mexico; [Jia, Cheng-kai] Xinjiang Oilfield Co, Res Inst Explorat & Dev, Karamay 834000, Xinjiang, Peoples R China; [Han, Feng-lu; Guo, Yu] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; George Washington University; China University of Geosciences; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Universidad Nacional Autonoma de Mexico; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xingxu@vip.sina.com	Benton, Michael J/A-5639-2008; Sullivan, Corwin/D-4563-2009	Benton, Michael J/0000-0002-4323-1824; Choiniere, Jonah/0000-0002-1008-0687; Mo, Jinyou/0000-0002-0126-2577; Sullivan, Corwin/0000-0002-5488-6797	Chinese Academy of Sciences; National Science Foundation Division of Earth Sciences of the USA; National Natural Science Foundation of China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation Division of Earth Sciences of the USA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank H.-J. Wang for organizing the fieldwork, R. S. Li for illustrations, L.-S. Xiang and X.-Q. Ding for preparing the specimens, X.-Q. Ding for editing the illustrations, M. Kundrat and J. Gauthier for critical comments, O. Rauhut, P. Makovicky and D. Chure for some theropod images, R.-S. Tykoski for references, and members of the Sino-American expedition team for collecting the fossil. The field work was supported by the National Natural Science Foundation of China, the National Science Foundation Division of Earth Sciences of the USA, the Chinese Academy of Sciences, the National Geographic Society, the Jurassic Foundation, the Hilmar Sallee bequest and George Washington University. Study of the specimens was supported by the Chinese Academy of Sciences, the National Science Foundation Division of Earth Sciences of the USA and the National Natural Science Foundation of China.	Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Bonaparte J.F., 1991, Historical Biology, V5, P1; Burch S, 2008, J VERTEBR PALEONTOL, V28, p58A; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Chatterjee S, 1998, SCIENCE, V280, DOI 10.1126/science.280.5362.355a; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Christiansen P, 2002, J ORNITHOL, V143, P356; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; CORTIA RA, 2002, J VERTEBR PALEONTOL, V22, P460; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Feduccia A, 2002, NATURWISSENSCHAFTEN, V89, P391, DOI 10.1007/s00114-002-0350-y; GALTON P M, 1971, Arnoldia (Rhodesia), V5, P1; GALTON P M, 1982, Palaeontologische Zeitschrift, V56, P265; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Kundrat M, 2002, J EXP ZOOL, V294, P152, DOI 10.1002/jez.10140; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Riedl R., 1975, ORDNUNG LEBENDIGEN S; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Shubin Neil H., 1994, P249; THULBORN RA, 1982, AUST J ZOOL, V30, P611, DOI 10.1071/ZO9820611; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; You Hailu, 2004, P478	44	160	175	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					940	944		10.1038/nature08124	http://dx.doi.org/10.1038/nature08124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536256	Green Published			2022-12-24	WOS:000267063500033
J	Sundrud, MS; Koralov, SB; Feuerer, M; Calado, DP; Kozhaya, AE; Rhule-Smith, A; Lefebvre, RE; Unutmaz, D; Mazitschek, R; Waldner, H; Whitman, M; Keller, T; Rao, A				Sundrud, Mark S.; Koralov, Sergei B.; Feuerer, Markus; Calado, Dinis Pedro; Kozhaya, Aimee ElHed; Rhule-Smith, Ava; Lefebvre, Rachel E.; Unutmaz, Derya; Mazitschek, Ralph; Waldner, Hanspeter; Whitman, Malcolm; Keller, Tracy; Rao, Anjana			Halofuginone Inhibits T(H)17 Cell Differentiation by Activating the Amino Acid Starvation Response	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; REGULATORY T-CELLS; NF-KAPPA-B; GENE-EXPRESSION; ROR-GAMMA; STRESS; INFLAMMATION; GENERATION; INITIATION; INDUCTION	A central challenge for improving autoimmune therapy is preventing inflammatory pathology without inducing generalized immunosuppression. T helper 17 (T(H)17) cells, characterized by their production of interleukin-17, have emerged as important and broad mediators of autoimmunity. Here we show that the small molecule halofuginone (HF) selectively inhibits mouse and human T(H)17 differentiation by activating a cytoprotective signaling pathway, the amino acid starvation response (AAR). Inhibition of T(H)17 differentiation by HF is rescued by the addition of excess amino acids and is mimicked by AAR activation after selective amino acid depletion. HF also induces the AAR in vivo and protects mice from T(H)17-associated experimental autoimmune encephalomyelitis. These results indicate that the AAR pathway is a potent and selective regulator of inflammatory T cell differentiation in vivo.	[Whitman, Malcolm; Keller, Tracy] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Sundrud, Mark S.; Koralov, Sergei B.; Calado, Dinis Pedro; Lefebvre, Rachel E.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sundrud, Mark S.; Koralov, Sergei B.; Calado, Dinis Pedro; Lefebvre, Rachel E.; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Feuerer, Markus] Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; [Kozhaya, Aimee ElHed; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Kozhaya, Aimee ElHed; Unutmaz, Derya] NYU, Sch Med, Microbial Pathogenesis Program, New York, NY 10016 USA; [Rhule-Smith, Ava; Waldner, Hanspeter] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Mazitschek, Ralph] Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Mazitschek, Ralph] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02142 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Joslin Diabetes Center, Inc.; New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Whitman, M (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.	whitman@hms.harvard.edu; tkeller@hms.harvard.edu; arao@idi.harvard.edu	Mazitschek, Ralph/E-3741-2013; Calado, Dinis/U-8379-2019	Mazitschek, Ralph/0000-0002-1105-689X; Calado, Dinis/0000-0001-8239-7184; Koralov, Sergei/0000-0002-4843-3791	NIH [T32, P01]; Juvenile Diabetes Research Foundation; Irvington Institute fellowship program of the Cancer Research Institute; Portuguese Foundation for Science and Technology fellowship; NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI048213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Irvington Institute fellowship program of the Cancer Research Institute; Portuguese Foundation for Science and Technology fellowship(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D. Littman and A. Rudensky provided reagents for this work, and K. Otipoby prepared recombinant TAT-Cre. We thank J. Hill and K. Leatherbee for technical assistance with microarray data analysis and members of the Rao lab for critical discussion. This work was supported by grants from NIH (to A.R., D.U., and M.W.) and the Juvenile Diabetes Research Foundation (to A.R.). M.S.S. was supported by the Irvington Institute fellowship program of the Cancer Research Institute. D.P.C. was supported by a fellowship from the Portuguese Foundation for Science and Technology. S.K. was supported by an NIH training grant (T32). Further support was provided by a P01 grant to K Rajewsky. M.S.S., A.R., T.K., and M.W. have filed patent applications concerning the use of HF and its derivatives to inhibit TH17 cell differentiation. Array data can be found at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15624 with the accession number of GSE15624 [NCBI GEO] .	Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gnainsky Y, 2007, CELL TISSUE RES, V328, P153, DOI 10.1007/s00441-006-0330-1; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KAMBEROV Y, 2008, THESIS HARVARD U; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	29	282	307	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1334	1338		10.1126/science.1172638	http://dx.doi.org/10.1126/science.1172638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498172	Green Accepted			2022-12-24	WOS:000266635100048
J	Tabak, AG; Jokela, M; Akbaraly, TN; Brunner, EJ; Kivimaki, M; Witte, DR				Tabak, Adam G.; Jokela, Markus; Akbaraly, Tasnime N.; Brunner, Eric J.; Kivimaki, Mika; Witte, Daniel R.			Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study	LANCET			English	Article							BETA-CELL FUNCTION; IMPAIRED GLUCOSE-TOLERANCE; NATURAL-HISTORY; PLASMA-GLUCOSE; LIFE-STYLE; HIGH-RISK; RESISTANCE; DYSFUNCTION; PROGRESSION; PREVENTION	Background Little is known about the timing of changes in glucose metabolism before occurrence of type 2 diabetes. We aimed to characterise trajectories of fasting and posdoad glucose, insulin sensitivity, and insulin secretion in individuals who develop type 2 diabetes. Methods We analysed data from our prospective occupational cohort study (Whitehall II study) of 6538 (71% male and 91% white) British civil servants without diabetes mellitus at baseline. During a median follow-up period of 9.7 years, 505 diabetes cases were diagnosed (49.1% on the basis of oral glucose tolerance test). We assessed retrospective trajectories of fasting and 2-h postload glucose, homoeostasis model assessment (HOMA) insulin sensitivity, and HOMA beta-cell function from up to 13 years before diabetes diagnosis (diabetic group) or at the end of follow-up (non-diabetics). Findings Multilevel models adjusted for age, sex, and ethnic origin confirmed that all metabolic measures followed linear trends in the group of non-diabetics (10989 measurements), except for insulin secretion that did not change during follow-up. In the diabetic group (801 measurements), a linear increase in fasting glucose was followed by a steep quadratic increase (from 5.79 mmol/L to 7.40 mmol/L) starting 3 years before diagnosis of diabetes. 2-h postload glucose showed a rapid increase starting 3 years before diagnosis (from 7.60 mmol/L to 11.90 mmol/L), and HOMA insulin sensitivity decreased steeply during the 5 years before diagnosis (to 86.7%). HOMA beta-cell function increased between years 4 and 3 before diagnosis (from 85.0% to 92.6%) and then decreased until diagnosis (to 62.4%). Interpretation In this study, we show changes in glucose concentrations, insulin sensitivity, and insulin secretion as much as 3-6 years before diagnosis of diabetes. The description of biomarker trajectories leading to diabetes diagnosis could contribute to more-accurate risk prediction models that use repeated measures available for patients through regular check-ups. Funding Medical Research Council (UK); Economic and Social Research Council (UK); British Heart Foundation (UK); Health and Safety Executive (UK); Department of Health (UK); National Institute of Health (USA); Agency for Health Care Policy Research (USA); the John D and Catherine T MacArthur Foundation (USA); and Academy of Finland (Finland).	[Tabak, Adam G.; Jokela, Markus; Akbaraly, Tasnime N.; Brunner, Eric J.; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Jokela, Markus] Univ Helsinki, Dept Psychol, SF-00100 Helsinki, Finland; [Akbaraly, Tasnime N.] INSERM, U888, Montpellier, France; [Akbaraly, Tasnime N.] Univ Montpellier I, Montpellier, France; [Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark	University of London; University College London; Semmelweis University; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Finnish Institute of Occupational Health; Steno Diabetes Center	Tabak, AG (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	a.tabak@ucl.ac.uk	Jokela, Markus/A-4669-2009; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Kivimaki, Mika/B-3607-2012; AKBARALY, Tasnime/H-1389-2018; Tabak, Adam/A-5007-2012; Brunner, Eric/H-2114-2011	Jokela, Markus/0000-0003-0117-0012; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Kivimaki, Mika/0000-0002-4699-5627; AKBARALY, Tasnime/0000-0002-2150-4190; Brunner, Eric/0000-0002-0595-4474; Tabak, Adam/0000-0002-6234-3936	Medical Research Council New Investigator Award [G0501184]; Medical Research Council, Economic and Social Research Council; British Heart Foundation; Health and Safety Executive, and Department of Health (UK); National Heart Lung and Blood institute [HL36310]; National Institute on Aging [AG13196]; Agency for Health Care Policy Research [HS06516]; The John D and Catherine T MacArthur Foundation (USA); Academy of Finland; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0501184, G0100222, G19/35, G8802774] Funding Source: researchfish; MRC [G0501184] Funding Source: UKRI; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER	Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, Economic and Social Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive, and Department of Health (UK); National Heart Lung and Blood institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); The John D and Catherine T MacArthur Foundation (USA); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank JE Ferrie for her comments on an early version ofthis manuscript. This work is funded by the Medical Research Council New Investigator Award (G0501184). The Whitehall II study is supported by the following bodies: Medical Research Council, Economic and Social Research Council, British Heart Foundation, Health and Safety Executive, and Department of Health (UK); and National Heart Lung and Blood institute (HL36310), National Institute on Aging (AG13196), Agency for Health Care Policy Research (HS06516), The John D and Catherine T MacArthur Foundation (USA). MK is supported by the Academy of Finland.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Ahren B, 2004, EUR J ENDOCRINOL, V150, P97, DOI 10.1530/eje.0.1500097; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALPERT L, 1976, LAB WORLD, V27, P8; ANDERSEN L, 1993, CLIN CHEM, V39, P578; Astles JR, 1996, CLIN BIOCHEM, V29, P27, DOI 10.1016/0009-9120(95)02010-1; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cooper G R, 1973, CRC Crit Rev Clin Lab Sci, V4, P101, DOI 10.3109/10408367309151554; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Guerrero-Romero F, 2006, EUR J CLIN INVEST, V36, P796, DOI 10.1111/j.1365-2362.2006.01728.x; HANNING I, 1985, DIABETOLOGIA, V28, P831, DOI 10.1007/BF00291073; Hong J, 2007, ENDOCRINE, V31, P93, DOI 10.1007/s12020-007-0002-2; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Laspa E, 2007, DIABETIC MED, V24, P1269, DOI 10.1111/j.1464-5491.2007.02225.x; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Mari A, 2005, CURR OPIN CLIN NUTR, V8, P529, DOI 10.1097/01.mco.0000171130.23441.59; Mari A, 2005, DIABETOLOGIA, V48, P748, DOI 10.1007/s00125-005-1683-9; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Qiao Q, 2003, DIABETES CARE, V26, P688; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Xiang AH, 2006, DIABETES, V55, P1074, DOI 10.2337/diabetes.55.04.06.db05-1109	44	545	561	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2215	2221		10.1016/S0140-6736(09)60619-X	http://dx.doi.org/10.1016/S0140-6736(09)60619-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463PQ	19515410	Green Accepted			2022-12-24	WOS:000267444500033
J	Whiteway, JA; Komguem, L; Dickinson, C; Cook, C; Illnicki, M; Seabrook, J; Popovici, V; Duck, TJ; Davy, R; Taylor, PA; Pathak, J; Fisher, D; Carswell, AI; Daly, M; Hipkin, V; Zent, AP; Hecht, MH; Wood, SE; Tamppari, LK; Renno, N; Moores, JE; Lemmon, MT; Daerden, F; Smith, PH				Whiteway, J. A.; Komguem, L.; Dickinson, C.; Cook, C.; Illnicki, M.; Seabrook, J.; Popovici, V.; Duck, T. J.; Davy, R.; Taylor, P. A.; Pathak, J.; Fisher, D.; Carswell, A. I.; Daly, M.; Hipkin, V.; Zent, A. P.; Hecht, M. H.; Wood, S. E.; Tamppari, L. K.; Renno, N.; Moores, J. E.; Lemmon, M. T.; Daerden, F.; Smith, P. H.			Mars Water-Ice Clouds and Precipitation	SCIENCE			English	Article							VAPOR; CYCLE	The light detection and ranging instrument on the Phoenix mission observed water-ice clouds in the atmosphere of Mars that were similar to cirrus clouds on Earth. Fall streaks in the cloud structure traced the precipitation of ice crystals toward the ground. Measurements of atmospheric dust indicated that the planetary boundary layer (PBL) on Mars was well mixed, up to heights of around 4 kilometers, by the summer daytime turbulence and convection. The water-ice clouds were detected at the top of the PBL and near the ground each night in late summer after the air temperature started decreasing. The interpretation is that water vapor mixed upward by daytime turbulence and convection forms ice crystal clouds at night that precipitate back toward the surface.	[Whiteway, J. A.; Komguem, L.; Dickinson, C.; Cook, C.; Illnicki, M.; Seabrook, J.; Popovici, V.; Davy, R.; Taylor, P. A.; Pathak, J.] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada; [Duck, T. J.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Fisher, D.] Nat Resources Canada, Geol Survey Canada, Natl Glaciol Grp, Ottawa, ON, Canada; [Carswell, A. I.] Optech, Vaughan, ON, Canada; [Daly, M.] MDA, Brampton, ON, Canada; [Hipkin, V.] CSA, St Hubert, PQ, Canada; [Zent, A. P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Hecht, M. H.; Tamppari, L. K.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Wood, S. E.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Renno, N.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Moores, J. E.; Smith, P. H.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Lemmon, M. T.] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX USA; [Daerden, F.] Belgian Inst Space Aeron BIRA IASB, Brussels, Belgium	York University - Canada; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Arizona; Texas A&M University System; Texas A&M University College Station	Whiteway, JA (corresponding author), York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada.	whiteway@yorku.ca	Davy, Richard/GWC-5040-2022; Davy, Richard/H-8387-2016; Lemmon, Mark/X-2333-2019; Lemmon, Mark T/E-9983-2010; Wood, Stephen/R-5592-2016; Davy, Richard/AAK-9303-2021; Daly, Michael/AAO-6623-2021; Moores, John E./AAO-6622-2021; Daerden, Frank/S-8759-2017	Davy, Richard/0000-0001-9639-5980; Davy, Richard/0000-0001-9639-5980; Lemmon, Mark/0000-0002-4504-5136; Lemmon, Mark T/0000-0002-4504-5136; Wood, Stephen/0000-0002-9330-434X; Daly, Michael/0000-0002-3733-2530; Moores, John E./0000-0001-9435-1095; Daerden, Frank/0000-0001-7433-1839; Hecht, Michael/0000-0002-4114-4583	CSA [9F007-070437/001/SR]; University of Arizona; Jet Propulsion Laboratory	CSA; University of Arizona; Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA))	This work was enabled by funding from the CSA under contract 9F007-070437/001/SR. The Phoenix mission was led by the University of Arizona, on behalf of NASA, and managed by the Jet Propulsion Laboratory.	DAVIES DW, 1979, J GEOPHYS RES, V84, P8335, DOI 10.1029/JB084iB14p08335; Davy R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010481; Field PR, 2006, ATMOS CHEM PHYS, V6, P2991, DOI 10.5194/acp-6-2991-2006; Fuchs N. A., 1964, MECH AEROSOLS; Gallagher MW, 2005, Q J ROY METEOR SOC, V131, P1143, DOI 10.1256/qj.03.138; Heymsfield AJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022742; KAHN R, 1990, J GEOPHYS RES-SOLID, V95, P14677, DOI 10.1029/JB095iB09p14677; RYAN JA, 1982, J GEOPHYS RES-OCEANS, V87, P7279, DOI 10.1029/JC087iC09p07279; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Smith PH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003083; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Titov DV, 1999, J GEOPHYS RES-PLANET, V104, P9019, DOI 10.1029/1998JE900046; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018; Whiteway J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021201; Whiteway J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003002; Zent AP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2007JE003052	16	149	149	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					68	70		10.1126/science.1172344	http://dx.doi.org/10.1126/science.1172344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574386				2022-12-24	WOS:000267594000035
J	Schneider, NM; Burger, MH; Schaller, EL; Brown, ME; Johnson, RE; Kargel, JS; Dougherty, MK; Achilleos, NA				Schneider, Nicholas M.; Burger, Matthew H.; Schaller, Emily L.; Brown, Michael E.; Johnson, Robert E.; Kargel, Jeffrey S.; Dougherty, Michele K.; Achilleos, Nicholas A.			No sodium in the vapour plumes of Enceladus	NATURE			English	Article							DISCOVERY; ATMOSPHERE; SPECTROMETER; ORIGIN	The discovery of water vapour and ice particles erupting from Saturn's moon Enceladus fuelled speculation that an internal ocean was the source(1-3). Alternatively, the source might be ice warmed, melted or crushed by tectonic motions(4). Sodium chloride (that is, salt) is expected to be present in a long-lived ocean in contact with a rocky core. Here we report a ground-based spectroscopic search for atomic sodium near Enceladus that places an upper limit on the mixing ratio in the vapour plumes orders of magnitude below the expected ocean salinity(5). The low sodium content of escaping vapour, together with the small fraction of salt-bearing particles(6), argues against a situation in which a near-surface geyser is fuelled by a salty ocean through cracks in the crust(1). The lack of observable sodium in the vapour is consistent with a wide variety of alternative eruption sources, including a deep ocean(6), a freshwater reservoir, or ice. The existing data may be insufficient to distinguish between these hypotheses.	[Schneider, Nicholas M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Burger, Matthew H.] Univ Maryland Baltimore Cty, Greenbelt, MD 20771 USA; [Burger, Matthew H.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Schaller, Emily L.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Brown, Michael E.] CALTECH, Pasadena, CA 91125 USA; [Johnson, Robert E.] Univ Virginia, Charlottesville, VA 22904 USA; [Kargel, Jeffrey S.] Univ Arizona, Tucson, AZ 85721 USA; [Dougherty, Michele K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Achilleos, Nicholas A.] UCL, London WC1E 6BT, England	University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Hawaii System; California Institute of Technology; University of Virginia; University of Arizona; Imperial College London; University of London; University College London	Schneider, NM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	nick.schneider@lasp.colorado.edu	Burger, Matthew/C-1310-2011	Achilleos, Nicholas/0000-0002-5886-3509; Brown, Michael E./0000-0002-8255-0545; Schaller, Emily/0000-0001-8967-5423; SCHNEIDER, NICHOLAS/0000-0001-6720-5519	W. M. Keck Foundation; National Science Foundation's Planetary Astronomy Program; NASA Postdoctoral Program; STFC [PP/D000912/1, PP/E001076/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000912/1, PP/E001076/1] Funding Source: researchfish	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation's Planetary Astronomy Program; NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the financial support of the W. M. Keck Foundation. We also acknowledge the Anglo-Australian Telescope and its staff. This work was supported by the National Science Foundation's Planetary Astronomy Program and the NASA Postdoctoral Program. This paper has benefited from discussions with M. Zolotov, J. Spencer, C. Porco, T. Johnson, A. Ingersoll, W. McKinnon, C. Mackay, F. Postberg, J. Schmidt, S. Kempf and R. Pappalardo.	Brown ME, 1996, NATURE, V380, P229, DOI 10.1038/380229a0; BROWN RA, 1974, IAU S, V65, P527; Burger MH, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012086; Burger MH, 2004, ICARUS, V171, P557, DOI 10.1016/j.icarus.2004.06.014; BURGER MH, 2003, THESIS U COLORADO; DIEGO F, 1990, P SOC PHOTO-OPT INS, V1235, P562, DOI 10.1117/12.19119; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Lellouch E, 2003, NATURE, V421, P45, DOI 10.1038/nature01292; LEVIN BJ, 1964, ICARUS, V4, P497; McKay CP, 2008, ASTROBIOLOGY, V8, P909, DOI 10.1089/ast.2008.0265; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Osterbrock DE, 1996, PUBL ASTRON SOC PAC, V108, P277, DOI 10.1086/133722; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Zolotov MY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031234	23	31	31	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1102	1104		10.1038/nature08070	http://dx.doi.org/10.1038/nature08070			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553993				2022-12-24	WOS:000267636700037
J	Matzke-Karasz, R; Smith, RJ; Symonova, R; Miller, CG; Tafforeau, P				Matzke-Karasz, R.; Smith, R. J.; Symonova, R.; Miller, C. G.; Tafforeau, P.			Sexual Intercourse Involving Giant Sperm in Cretaceous Ostracode	SCIENCE			English	Article									[Matzke-Karasz, R.] Univ Munich, Dept Environm & Geosci, D-80333 Munich, Germany; [Matzke-Karasz, R.] Univ Munich, GeoBioCtr, D-80333 Munich, Germany; [Smith, R. J.] Lake Biwa Museum, Shiga 5250001, Japan; [Symonova, R.] Charles Univ Prague, Dept Zool, CR-12844 Prague, Czech Republic; [Miller, C. G.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Tafforeau, P.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Munich; University of Munich; Charles University Prague; Natural History Museum London; European Synchrotron Radiation Facility (ESRF)	Matzke-Karasz, R (corresponding author), Univ Munich, Dept Environm & Geosci, D-80333 Munich, Germany.	r.matzke@lrz.uni-muenchen.de	Miller, Giles/C-5160-2012	Miller, Giles/0000-0001-9111-2136; Smith, Robin/0000-0002-9888-5323; Matzke-Karasz, Renate/0000-0002-8010-2028; Tafforeau, Paul/0000-0002-5962-1683	ESRF [ec-274]; European Union Marie Curie RTN SexAsex [FP6-512492]; LMU Palaeontology; Lake Biwa Museum (Japan)	ESRF; European Union Marie Curie RTN SexAsex(European Commission); LMU Palaeontology; Lake Biwa Museum (Japan)	Supported by the ESRF (proposal ec-274), the European Union Marie Curie RTN SexAsex (FP6-512492), LMU Palaeontology, the Lake Biwa Museum (Japan), and the Natural History Museum (by loan of fossil specimens).	Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; Do Carmo DA, 2008, J PALEONTOL, V82, P790, DOI 10.1666/07-008.1; Matzke-Karasz R, 2001, NATURWISSENSCHAFTEN, V88, P268, DOI 10.1007/s001140100234; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Smith RJ, 2000, PALAEONTOLOGY, V43, P63, DOI 10.1111/1475-4983.00119; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11	8	33	34	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1535	1535		10.1126/science.1173898	http://dx.doi.org/10.1126/science.1173898			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541990				2022-12-24	WOS:000267130600035
J	Jain, RK				Jain, Rakesh K.			A New Target for Tumor Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTI-ANGIOGENIC THERAPY; NORMALIZATION; OXYGENATION		[Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.		Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548	NCI NIH HHS [P01 CA080124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Jain RK, 2008, NAT REV CANCER, V8, P309, DOI 10.1038/nrc2346; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8	5	51	57	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2669	2671		10.1056/NEJMcibr0902054	http://dx.doi.org/10.1056/NEJMcibr0902054			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535806	Green Accepted			2022-12-24	WOS:000267060000015
J	Matok, I; Gorodischer, R; Koren, G; Sheiner, E; Wiznitzer, A; Levy, A				Matok, Ilan; Gorodischer, Rafael; Koren, Gideon; Sheiner, Eyal; Wiznitzer, Arnon; Levy, Amalia			The Safety of Metoclopramide Use in the First Trimester of Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-DEFECTS; NAUSEA; MEDICATIONS; POPULATION; PREVENTION; DELIVERY; THERAPY	BACKGROUND In various countries, metoclopramide is the antiemetic drug of choice in pregnant women, but insufficient information exists regarding its safety in pregnancy. METHODS We investigated the safety of metoclopramide use during the first trimester of pregnancy by linking a computerized database of medications dispensed between January 1, 1998, and March 31, 2007, to all women registered in the Clalit Health Services, southern district of Israel, with computerized databases containing maternal and infant hospital records from the district hospital during the same period. We assessed associations between the use of metoclopramide in pregnancy and adverse outcomes for the fetus, adjusting for parity, maternal age, ethnic group, presence or absence of maternal diabetes, smoking status, and presence or absence of peripartum fever. RESULTS There were 113,612 singleton births during the study period. A total of 81,703 of the infants (71.9%) were born to women registered in Clalit Health Services; 3458 of them (4.2%) were exposed to metoclopramide during the first trimester of pregnancy. Exposure to metoclopramide, as compared with no exposure to the drug, was not associated with significantly increased risks of major congenital malformations (5.3% and 4.9%, respectively; odds ratio, 1.04; 95% confidence interval [CI], 0.89 to 1.21), low birth weight (8.5% and 8.3%; odds ratio, 1.01; 95% CI, 0.89 to 1.14), pre-term delivery (6.3% and 5.9%; odds ratio, 1.15; 95% CI, 0.99 to 1.34), or perinatal death (1.5% and 2.2%; odds ratio, 0.87; 95% CI, 0.55 to 1.38). The results were materially unchanged when therapeutic abortions of exposed and unexposed fetuses were included in the analysis. CONCLUSIONS In this large cohort of infants, exposure to metoclopramide in the first trimester was not associated with significantly increased risks of any of several adverse outcomes. These findings provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy.	[Gorodischer, Rafael; Sheiner, Eyal; Wiznitzer, Arnon] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Matok, Ilan; Levy, Amalia] Ben Gurion Univ Negev, Dept Epidemiol & Hlth Serv Evaluat, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gorodischer, Rafael] Ben Gurion Univ Negev, Dept Pediat, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sheiner, Eyal; Wiznitzer, Arnon] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gorodischer, Rafael; Wiznitzer, Arnon] Clalit Hlth Serv So District, Beer Sheva, Israel; [Gorodischer, Rafael; Levy, Amalia] BeMORE Collaborat, Beer Sheva, Israel; [Koren, Gideon] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol, Motherisk Program, Toronto, ON M5G 1X8, Canada; [Koren, Gideon] BeMORE Collaborat, Toronto, ON, Canada; [Koren, Gideon] Univ Western Ontario, Dept Med, London, ON, Canada	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Clalit Health Services; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Gorodischer, R (corresponding author), Soroka Med Ctr, POB 151, IL-84101 Beer Sheva, Israel.	rafaelg@bgu.ac.il	Gorodischer, Rafael/AAQ-8132-2020; Matok, Ilan/H-1562-2016; Koren, Gideon/AAG-7726-2019; SHEINER, EYAL/F-1488-2012	Matok, Ilan/0000-0003-1559-9258; Koren, Gideon/0000-0002-9234-0875; Gorodischer, Rafael/0000-0002-7649-3353	Duchesnay	Duchesnay	Dr. Koren reports receiving consulting and lecture fees and grant support from Duchesnay. No other potential conflict of interest relevant to this article was reported.	American College of Obstetrics and Gynecology, 2004, Obstet Gynecol, V103, P803; BENJOSEPH R, 2008, J MATERN-FETAL NEO M, P1; Berkovitch M, 2000, NEW ENGL J MED, V343, P445, DOI 10.1056/NEJM200008103430616; Berkovitch M, 2002, AM J PERINAT, V19, P311, DOI 10.1055/s-2002-34469; Boneva RS, 1999, AM J EPIDEMIOL, V149, P717; Centers for Disease Control and Prevention, METR ATL CONG DEF PR; *CENTR BUR STAT, STAT ISR HOD LAIT; *CENTR BUR STAT, 59 CENTR BUR STAT; Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P617, DOI 10.1002/bdra.10111; DEUCHAR N, 1995, BRIT J OBSTET GYNAEC, V102, P6, DOI 10.1111/j.1471-0528.1995.tb09017.x; Einarson A, 1998, EUR J OBSTET GYN R B, V76, P1, DOI 10.1016/S0301-2115(97)00129-2; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gadsby R, 1993, BR J GEN PRACT, V43, P325; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KALLEN B, 1987, EUR J OBSTET GYN R B, V26, P291; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Louik C, 2006, PAEDIATR PERINAT EP, V20, P270, DOI 10.1111/j.1365-3016.2006.00723.x; Magee LA, 2002, AM J OBSTET GYNECOL, V186, pS256, DOI 10.1067/mob.2002.122596; Meyerovitch J, 2006, PEDIATRICS, V118, pE1055, DOI 10.1542/peds.2006-0024; Misset B, 2008, CRIT CARE, V12, DOI 10.1186/cc6969; Ofir D, 2008, EUR J OBSTET GYN R B, V141, P115, DOI 10.1016/j.ejogrb.2008.07.025; Pradalier A, 1999, HEADACHE, V39, P125, DOI 10.1046/j.1526-4610.1999.3902125.x; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; ROSA F, 2005, DRUGS PREGNANCY LACT, P1057; Sheiner E, 1998, EUR J OBSTET GYN R B, V76, P141, DOI 10.1016/S0301-2115(97)00178-4; Sheiner E, 1999, INT J GYNECOL OBSTET, V64, P227, DOI 10.1016/S0020-7292(98)00166-0; SIDHU MS, 1970, P OBSTET GYNAECOL SO, V1, P43; Sorensen HT, 2000, BRIT J CLIN PHARMACO, V49, P264, DOI 10.1046/j.1365-2125.2000.00127.x; Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P192, DOI 10.1016/j.jclinepi.2007.03.009; Van den Berg LTWDJ, 1999, TERATOLOGY, V60, P33; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; *WHO, WHO COLL CTR DURG ST	35	104	107	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2528	2535		10.1056/NEJMoa0807154	http://dx.doi.org/10.1056/NEJMoa0807154			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516033				2022-12-24	WOS:000266813800007
J	Putnam, CD; Hayes, TK; Kolodner, RD				Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.			Specific pathways prevent duplication-mediated genome rearrangements	NATURE			English	Article							GROSS CHROMOSOMAL REARRANGEMENTS; SACCHAROMYCES-CEREVISIAE HOMOLOG; BREAK-INDUCED REPLICATION; S-PHASE CHECKPOINT; DNA HELICASE; ALU REPEATS; MITOTIC RECOMBINATION; GENETIC INSTABILITY; REPAIR PROTEINS; CROSSING-OVER	We have investigated the ability of different regions of the left arm of Saccharomyces cerevisiae chromosome V to participate in the formation of gross chromosomal rearrangements (GCRs). We found that the 4.2-kilobase HXT13-DSF1 region sharing divergent homology with chromosomes IV, X and XIV, similar to mammalian segmental duplications, was 'at risk' for participating in duplication-mediated GCRs generated by homologous recombination. Numerous genes and pathways, including SGS1, TOP3, RMI1, SRS2, RAD6, SLX1, SLX4, SLX5, MSH2, MSH6, RAD10 and the DNA replication stress checkpoint requiring MRC1 and TOF1, were highly specific for suppressing these GCRs compared to GCRs mediated by single-copy sequences. These results indicate that the mechanisms for formation and suppression of rearrangements occurring in regions containing at-risk sequences differ from those occurring in regions of single-copy sequence. This explains how extensive genome instability is prevented in eukaryotic cells whose genomes contain numerous divergent repeated sequences.	[Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Putnam, Christopher/0000-0002-6145-1265	NIH [GM26017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank the UCSD Microarray Core Facility for assistance in the aCGH experiments and C. Smith, S. Shell and J. Petrini for comments on the manuscript. This work was supported by NIH grant GM26017.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gorringe KL, 2005, CARCINOGENESIS, V26, P923, DOI 10.1093/carcin/bgi032; HARRIS S, 1993, GENETICS, V135, P5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hwang JY, 2005, GENETICS, V169, P1927, DOI 10.1534/genetics.104.039768; *J HOPK U NAT CTR, 1999, ONL MEND INH MAN OMI; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mertens F., 1991, CATALOG CHROMOSOME A; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2001, GENETICS, V157, P103; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Ribas M, 2002, FASEB J, V16, P289, DOI 10.1096/fj.02-0425fje; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Stankiewicz P, 2006, GENOME DYN, V1, P1, DOI 10.1159/000092496; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Umezu K, 2002, GENETICS, V160, P97; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	52	100	100	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					984	U65		10.1038/nature08217	http://dx.doi.org/10.1038/nature08217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19641493	Green Accepted			2022-12-24	WOS:000269085500028
J	Palmer, MA; Filoso, S				Palmer, Margaret A.; Filoso, Solange			Restoration of Ecosystem Services for Environmental Markets	SCIENCE			English	Editorial Material							STREAM RESTORATION; WETLANDS; GOALS; NEED	Ecological restoration is an activity that ideally results in the return of an ecosystem to an undisturbed state. Ecosystem services are the benefits humans derive from ecosystems. The two have been joined to support growing environmental markets with the goal of creating restoration-based credits that can be bought and sold. However, the allure of these markets may be overshadowing shortcomings in the science and practice of ecological restoration. Before making risky investments, we must understand why and when restoration efforts fall short of recovering the full suite of ecosystem services, what can be done to improve restoration success, and why direct measurement of the biophysical processes that support ecosystem services is the only way to guarantee the future success of these markets. Without new science and an oversight framework to protect the ecosystem service assets on which people depend, markets could actually accelerate environmental degradation.	[Palmer, Margaret A.; Filoso, Solange] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Palmer, Margaret A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park	Palmer, MA (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	mpalmer@umd.edu	Filoso, Solange/G-4461-2015; Palmer, Margaret A/F-9648-2013	Palmer, Margaret A/0000-0003-1468-7993				AMBROSE RF, 2007, EVALUATION COMPENSAT; BenDor T, 2007, J AM PLANN ASSOC, V73, P263, DOI 10.1080/01944360708977977; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Helfield JM, 1997, ENVIRON MANAGE, V21, P329, DOI 10.1007/s002679900033; Hepburn C, 2007, ANNU REV ENV RESOUR, V32, P375, DOI 10.1146/annurev.energy.32.053006.141203; Hoeltje SM, 2009, ENVIRON MANAGE, V43, P597, DOI 10.1007/s00267-008-9180-9; King D, 2002, ENV LAW REV, V32, P11317; Lave R., 2008, ECOLOGICAL RESTORATI, V26, P287, DOI [10.3368/er.26.4.287, DOI 10.3368/ER.26.4.287]; Leopold A., 1949, S COUNTY ALMANAC; Palmer MA, 2009, ESTUAR COAST, V32, P1, DOI 10.1007/s12237-008-9129-5; Rumps JM, 2007, RESTOR ECOL, V15, P506, DOI 10.1111/j.1526-100X.2007.00246.x; Tischew S, 2010, RESTOR ECOL, V18, P467, DOI 10.1111/j.1526-100X.2008.00462.x; WAINGER LA, 2009, ECOSYSTEM BASED MANA, pCH6; ZINN JA, 2008, PUBL C RES SERVICE; 2008, FED REG, V73, P9594	19	193	206	11	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					575	576		10.1126/science.1172976	http://dx.doi.org/10.1126/science.1172976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644112				2022-12-24	WOS:000268493000040
J	Suzuki, HI; Yamagata, K; Sugimoto, K; Iwamoto, T; Kato, S; Miyazono, K				Suzuki, Hiroshi I.; Yamagata, Kaoru; Sugimoto, Koichi; Iwamoto, Takashi; Kato, Shigeaki; Miyazono, Kohei			Modulation of microRNA processing by p53	NATURE			English	Article							PROLINE-RICH DOMAIN; TUMOR-SUPPRESSOR; EXPRESSION; CANCER; ACTIVATION; APOPTOSIS; COMPLEX; CELLS; MICROPROCESSOR; TUMORIGENESIS	MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, involved in diverse physiological and pathological processes. Although miRNAs can function as both tumour suppressors and oncogenes in tumour development(1), a widespread downregulation of miRNAs is commonly observed in human cancers and promotes cellular transformation and tumorigenesis(2-4). This indicates an inherent significance of small RNAs in tumour suppression. However, the connection between tumour suppressor networks and miRNA biogenesis machineries has not been investigated in depth. Here we show that a central tumour suppressor, p53, enhances the post-transcriptional maturation of several miRNAs with growth-suppressive function, including miR-16-1, miR-143 and miR-145, in response to DNA damage. In HCT116 cells and human diploid fibroblasts, p53 interacts with the Drosha processing complex through the association with DEAD-box RNA helicase p68 (also known as DDX5) and facilitates the processing of primary miRNAs to precursor miRNAs. We also found that transcriptionally inactive p53 mutants interfere with a functional assembly between Drosha complex and p68, leading to attenuation of miRNA processing activity. These findings suggest that transcription-independent modulation of miRNA biogenesis is intrinsically embedded in a tumour suppressive program governed by p53. Our study reveals a previously unrecognized function of p53 in miRNA processing, which may underlie key aspects of cancer biology.	[Suzuki, Hiroshi I.; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Yamagata, Kaoru; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Yamagata, Kaoru; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchisi, Saitama 3320012, Japan; [Sugimoto, Koichi] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol,Bunkyo Ku, Tokyo 1138421, Japan; [Iwamoto, Takashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi 4878501, Japan; [Iwamoto, Takashi] Chubu Univ, Ctr Educ Lab Anim Res, Aichi 4878501, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Juntendo University; Chubu University; Chubu University	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp		Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI [17016011]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Matsuyama, K. Kiyono, S. Ehata and R. A. Saito for discussion; M. Saitoh, K. Miyazawa, T. Watabe, K. Horiguchi, T. Shirakihara, K. Harada, M. Oka, A. Mizutani, T. Yamazaki and Y. Yoshimatsu for technical advice and reagents; T. Yokochi and Y. Morishita for encouragement; and all members of the Department of Molecular Pathology, University of Tokyo for assistance. This work was supported by KAKENHI (Grant-in-Aid for Scientific Research no. 17016011) on priority areas 'New strategies for cancer therapy based on advancement of basic research' and the Global Center of Excellence Program for 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H. I. S. is supported by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Roth J, 2000, ONCOGENE, V19, P1834, DOI 10.1038/sj.onc.1203500; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Song H, 2007, CELL CYCLE, V6, P1570, DOI 10.4161/cc.6.13.4456; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	37	898	933	2	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					529	U111		10.1038/nature08199	http://dx.doi.org/10.1038/nature08199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626115				2022-12-24	WOS:000268257000042
J	Latimer, N; Lord, J; Grant, RL; O'Mahony, R; Dickson, J; Conaghan, PG				Latimer, Nicholas; Lord, Joanne; Grant, Robert L.; O'Mahony, Rachel; Dickson, John; Conaghan, Philip G.		Natl Inst Hlth; Clinical Excellence Osteoarthrit G	Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; THERAPEUTIC ARTHRITIS RESEARCH; PLACEBO-CONTROLLED TRIAL; CYCLO-OXYGENASE-2 INHIBITORS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; ECONOMIC-EVALUATION; RISK; OUTCOMES	Objectives To investigate the cost effectiveness of cyclooxygenase-2 (COX 2) selective inhibitors and traditional non-steroidal anti-inflammatory drugs (NSAIDs), and the addition of proton pump inhibitors to these treatments, for people with osteoarthritis. Design An economic evaluation using a Markov model and data from a systematic review was conducted. Estimates of cardiovascular and gastrointestinal adverse events were based on data from three large randomised controlled trials, and observational data were used for sensitivity analyses. Efficacy benefits from treatment were estimated from a meta-analysis of trials reporting total Western Ontario and McMaster Universities (WOMAC) osteoarthritis index score. Other model inputs were obtained from the relevant literature. The model was run for a hypothetical population of people with osteoarthritis. Subgroup analyses were conducted for people at high risk of gastrointestinal or cardiovascular adverse events. Comparators Licensed COX 2 selective inhibitors (celecoxib and etoricoxib) and traditional NSAIDs (diclofenac, ibuprofen, and naproxen) for which suitable data were available were compared. Paracetamol was also included, as was the possibility of adding a proton pump inhibitor (omeprazole) to each treatment. Main outcome measures The main outcome measure was cost effectiveness, which was based on quality adjusted life years gained. Quality adjusted life year scores were calculated from pooled estimates of efficacy and major adverse events (that is, dyspepsia; symptomatic ulcer; complicated gastrointestinal perforation, ulcer, or bleed; myocardial infarction; stroke; and heart failure). Results Addition of a proton pump inhibitor to both COX 2 selective inhibitors and traditional NSAIDs was highly cost effective for all patient groups considered (incremental cost effectiveness ratio less than 1000 pound ((sic)1175, $1650)). This finding was robust across a wide range of effectiveness estimates if the cheapest proton pump inhibitor was used. In our base case analysis, adding a proton pump inhibitor to a COX 2 selective inhibitor (used at the lowest licensed dose) was a cost effective option, even for patients at low risk of gastrointestinal adverse events (incremental cost effectiveness ratio approximately 10 pound 000). Uncertainties around relative adverse event rates meant relative cost effectiveness for individual COX 2 selective inhibitors and traditional NSAIDs was difficult to determine. Conclusions Prescribing a proton pump inhibitor for people with osteoarthritis who are taking a traditional NSAID or COX 2 selective inhibitor is cost effective. The cost effectiveness analysis was sensitive to adverse event data and the specific choice of COX 2 selective inhibitor or NSAID agent should, therefore, take into account individual cardiovascular and gastrointestinal risks.	[Conaghan, Philip G.] Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Lord, Joanne] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Grant, Robert L.] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England; [Dickson, John] Guisborough Primary Care Hosp, Redcar & Cleveland Primary Care Trust, Guisborough TS14 6HZ, N Yorkshire, England	University of Leeds; Brunel University; Royal College of Physicians	Conaghan, PG (corresponding author), Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England.	p.conaghan@leeds.ac.uk	Lord, Joanne/H-1417-2011	Lord, Joanne/0000-0003-1086-1624; Latimer, Nicholas/0000-0001-5304-5585; Conaghan, Philip/0000-0002-3478-5665; Birrell, Fraser/0000-0002-6163-6155	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Institute for Health and Clinical Excellence commissioned and funded this analysis.	Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Barton GR, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-51; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bloor K, 1996, PHARMACOECONOMICS, V9, P484, DOI 10.2165/00019053-199609060-00003; Briggs A, 1999, BRIT MED J, V319, P120, DOI 10.1136/bmj.319.7202.120; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; *CTR EV VAL RISK H, PREF WEIGHTS 1998 20; CURTIS L, 2006, UNIT COSTS HLTH HLTH; *DEP HLTH, 2006, NIHS REF COSTS 2005; Department of health, 1998, HLTH SURV ENGL; DIEPPE P, 1993, BRIT J RHEUMATOL, V32, P595; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; HEMANDEZDIAZ S, 2006, BASIC CLIN PHARMACOL, V98, P266; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V331, P1310, DOI 10.1136/bmj.331.7528.1310; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; LAINE L, 2006, AM COLL REHUM 2006 A; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Laine L, 2006, J CARDIOVASC PHARM, V47, pS60, DOI 10.1097/00005344-200605001-00011; Maetzel A, 1998, ARTHRITIS RHEUM, V41, P16, DOI 10.1002/1529-0131(199801)41:1<16::AID-ART3>3.3.CO;2-W; Maetzel A, 2001, 23 CAN COORD OFF HLT; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Mayor S, 2007, BRIT MED J, V334, P441, DOI 10.1136/bmj.39139.644664.DB; *MED HEALTHC PROD, 2006, PHARM WORK PART PHVW; *MED HEALTHC PROD, 2008, CARD SAF COX 2 INH N; *MHRA, 2006, PHARM WORK PART PHVM; *NAT HLTH SERV BUS, NAT HLTH SERV ENGL W; *NAT HLTH SERV NAT, 2007, CARD GASTR SAF NSAID; National Collaborating Centre for Chronic Conditions (NCCCC), 2008, OST NAT CLIN GUID CA; National Institute for Health and Clinical Excellence, 2007, GUID MAN; *NIH CLIN EXC, 2006, HYP MAN HYP AD PRIM; *NIH CLIN EXC, 2001, GUID US CYCL COX 2 S; *NOV, 2006, DRUG REG AFF CLIN DE; *PRESCR PRIC AUTH, 2005, PRESCR PRIC AUTH NEW; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P570; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Scott DL, 2000, RHEUMATOLOGY, V39, P1095, DOI 10.1093/rheumatology/39.10.1095; SEGAL L, 2003, PRIORITY SETTING OST; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon Pickard A, 2005, QUAL LIFE RES, V14, P207, DOI 10.1007/s11136-004-3928-3; Spiegel BMR, 2003, ANN INTERN MED, V138, P795, DOI 10.7326/0003-4819-138-10-200305200-00007; *US FDA, 2000, 20998S009 NDA US FDA; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; 2007, BRIT NATL FORMULARY	50	68	71	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2009	339								b2538	10.1136/bmj.b2538	http://dx.doi.org/10.1136/bmj.b2538			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602530	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000268104900003
J	Crabtree, GR; Schreiber, SL				Crabtree, Gerald R.; Schreiber, Stuart L.			SnapShot: Ca2+-Calcineurin-NFAT Signaling	CELL			English	Editorial Material							NF-ATC; CALCINEURIN		[Crabtree, Gerald R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Schreiber, Stuart L.] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA	Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060037-04, R01 AI060037-01, R01 AI060037-05, R01 AI060037-02, R01 AI060037-06, R01 AI060037-03, R01 AI060037-07, R01 AI060037] Funding Source: Medline; NICHD NIH HHS [R01 HD055391-03, R01 HD055391, R01 HD055391-04, R01 HD055391-02, R01 HD055391-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS046789, R01 NS046789-08, R01 NS046789-03, R01 NS046789-04, R01 NS046789-07, R01 NS046789-05, R01 NS046789-02, R01 NS046789-06, R01 NS046789-09, R01 NS046789-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015	10	83	91	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1							210.e1	10.1016/j.cell.2009.06.026	http://dx.doi.org/10.1016/j.cell.2009.06.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596245	Green Accepted, Bronze			2022-12-24	WOS:000267848600027
J	Moser, K; Patnick, J; Beral, V				Moser, Kath; Patnick, Julietta; Beral, Valerie			Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data	BRITISH MEDICAL JOURNAL			English	Article							PAP-SMEAR; CANCER; POPULATION; MORTALITY; ACCURACY; PROGRAM; HEALTH; WOMEN	Objective To investigate the relation between women's reported use of breast and cervical screening and sociodemographic characteristics. Design Cross sectional multipurpose survey. Setting Private households, Great Britain. Population 3185 women aged 40-74 interviewed in the National Statistics Omnibus Survey 2005-7. Main outcome measures Ever had a mammogram, ever had a cervical smear, and, for each, timing of most recent screen. Results 91% (95% confidence interval 90% to 92%) of women aged 40-74 years reported ever having had a cervical smear, and 93% (92% to 94%) of those aged 53-74 years reported ever having had a mammogram; 3% (2% to 4%) of women aged 53-74 years had never had either breast or cervical screening. Women were significantly more likely to have had a mammogram if they lived in households with cars (compared with no car: one car, odds ratio 1.67, 95% confidence interval 1.06 to 2.62; two or more cars, odds ratio 2.65, 1.34 to 5.26), and in owner occupied housing (compared with rented housing: own with mortgage, odds ratio 2.12, 1.12 to 4.00; own outright, odds ratio 2.19, 1.39 to 3.43), but no significant differences by ethnicity, education, occupation, or region were found. For cervical screening, ethnicity was the most important predictor; white British women were significantly more likely to have had a cervical smear than were women of other ethnicity (odds ratio 2.20, 1.41 to 3.42). Uptake of cervical screening was greater among more educated women but was not significantly associated with cars, housing tenure, or region. Conclusions Most (84%) eligible women report having had both breast and cervical screening, but 3% report never having had either. Some inequalities exist in the reported use of screening, which differ by screening type; indicators of wealth were important for breast screening and ethnicity for cervical screening. The routine collection within general practice of additional sociodemographic information would aid monitoring of inequalities in screening coverage and inform policies to correct them.	[Moser, Kath; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Patnick, Julietta] NHS Canc Screening Programmes, Sheffield S10 3TH, S Yorkshire, England	University of Oxford	Moser, K (corresponding author), Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England.	kath.moser@ceu.ox.ac.uk			NHS Breast Screening Programme; Cancer Research UK	NHS Breast Screening Programme; Cancer Research UK(Cancer Research UK)	This research was supported by the NHS Breast Screening Programme and Cancer Research UK. The funders had no involvement in this research.	Advisory Committee on Breast Cancer Screening, 2006, NHS BREAST SCREEN PR, V61; Ashworth M, 2005, FAM PRACT, V22, P529, DOI 10.1093/fampra/cmi057; Banks E, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr418; Bowman JA, 1997, SOC SCI MED, V44, P969, DOI 10.1016/S0277-9536(96)00222-5; Canfell K, 2006, J MED SCREEN, V13, P72, DOI 10.1258/096914106777589687; Chiu LF, 2003, CANC SCREENING SERIE, V1; Department of Health, 2007, CANC REF STRAT; DURRENT GB, 2007, MULTILEVEL MODELLING; FELL G, 2007, EQUALITY REV NATL SC; HAKAMA M, 1988, CANCER SURV, V7, P403; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; McGovern PG, 1998, AM J PREV MED, V14, P201, DOI 10.1016/S0749-3797(97)00076-7; Millett C, 2002, PUBLIC HEALTH, V116, P353, DOI 10.1038/sj.ph.1900880; MOSER K, 1994, BRIT MED J, V309, P476, DOI 10.1136/bmj.309.6952.476b; MOSER KA, 1988, BRIT MED J, V296, P1221, DOI 10.1136/bmj.296.6631.1221; *NHS HLTH SOC CAR, 2007, CERV SCREEN PROGR EN; *NHS HLTH SOC CAR, 2008, BREAST SCREEN PROGR; *OFF NAT STAT, OMN SURV; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Raleigh V., 2008, BMJ-BRIT MED J, V337, P645; Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032; Sutton S, 2005, SOC SCI MED, V61, P2460, DOI 10.1016/j.socscimed.2005.07.017	23	194	197	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2009	338								b2025	10.1136/bmj.b2025	http://dx.doi.org/10.1136/bmj.b2025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460UQ	19531549	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000267216600001
J	Tokuriki, N; Tawfik, DS				Tokuriki, Nobuhiko; Tawfik, Dan S.			Chaperonin overexpression promotes genetic variation and enzyme evolution	NATURE			English	Article							CARBONIC-ANHYDRASE-II; ESCHERICHIA-COLI; DIRECTED EVOLUTION; DELETERIOUS MUTATIONS; PROTEIN MUTATIONS; GROEL; STABILITY; HSP90; EVOLVABILITY; EXPRESSION	Most protein mutations, and mutations that alter protein functions in particular, undermine stability and are therefore deleterious. Chaperones, or heat-shock proteins, are often implicated in buffering mutations, and could thus facilitate the acquisition of neutral genetic diversity and the rate of adaptation. We examined the ability of the Escherichia coli GroEL/GroES chaperonins to buffer destabilizing and adaptive mutations. Here we show that mutational drifts performed in vitro with four different enzymes indicated that GroEL/GroES overexpression doubled the number of accumulating mutations, and promoted the folding of enzyme variants carrying mutations in the protein core and/or mutations with higher destabilizing effects (destabilization energies of >3.5 kcal mol(-1), on average, versus, similar to 1 kcal mol(-1) in the absence of GroEL/GroES). The divergence of modified enzymatic specificity occurred much faster under GroEL/GroES overexpression, in terms of the number of adapted variants (>= 2-fold) and their improved specificity and activity (>= 10-fold). These results indicate that protein stability is a major constraint in protein evolution, and buffering mechanisms such as chaperonins are key in alleviating this constraint.	[Tokuriki, Nobuhiko; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	TOKURIKI, NOBUHIKO/A-2968-2010		NIH [W81XWH-07-2-0020]; Israel Science Foundation; EU	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); EU(European Commission)	Financial support by the EU via the MiFEM consortium, NIH grant number W81XWH-07-2-0020, and Israel Science Foundation are gratefully acknowledged. We are thankful to P. Goloubinoff for his advice, V. Kolotonouv for technical assistance, L. Serrano for the use of FoldX, and A. Horovitz and S. Rutherford for their help in refining this manuscript.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Gould SM, 2005, BIOCHEMISTRY-US, V44, P5444, DOI 10.1021/bi0475471; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; MISSET O, 1984, EUR J BIOCHEM, V144, P475, DOI 10.1111/j.1432-1033.1984.tb08490.x; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noivirt-Brik O, 2007, BIOINFORMATICS, V23, P3276, DOI 10.1093/bioinformatics/btm513; Persson M, 1996, BBA-PROTEIN STRUCT M, V1298, P191, DOI 10.1016/S0167-4838(96)00125-2; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Roodveldt C, 2005, PROTEIN ENG DES SEL, V18, P51, DOI 10.1093/protein/gzi005; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sasidharan R, 2007, P NATL ACAD SCI USA, V104, P10080, DOI 10.1073/pnas.0703737104; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wilke CO, 2005, BIOPHYS J, V89, P3714, DOI 10.1529/biophysj.105.062125; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	45	254	259	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					668	U71		10.1038/nature08009	http://dx.doi.org/10.1038/nature08009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494908				2022-12-24	WOS:000266608600036
J	Comi, RJ				Comi, Richard J.			Glucose Control in the Intensive Care Unit: A Roller Coaster Ride or a Swinging Pendulum?	ANNALS OF INTERNAL MEDICINE			English	Article							DIABETIC-PATIENTS; MYOCARDIAL-INFARCTION; STRESS HYPERGLYCEMIA; INSULIN THERAPY; INFECTION; MORTALITY; TIGHT	Many studies of tight control of blood glucose in critically ill patients are associated with poor outcomes. However, randomized studies of tight glucose control in patients admitted to coronary care or surgical intensive care units showed a reduction in mortality rates; supported by recommendations from professional organizations, many intensive care units implemented protocols for tight glucose control. More recent studies in medical intensive care units did not confirm the benefits of tight control, however, and the most recent study suggests that tight control increases mortality rates. Furthermore, tight control significantly increases episodes of hypoglycemia. The sum of the recent literature suggests that a degree of glucose control lies between the extremes of the adverse outcomes related to poor glucose control and those related to overly aggressive glucose control.	Dartmouth Hitchcock Med Ctr, Hitchcock Clin, Lebanon, NH 03756 USA	Dartmouth College	Comi, RJ (corresponding author), Dartmouth Hitchcock Med Ctr, Hitchcock Clin, 1 Med Ctr Dr, Lebanon, NH 03756 USA.							Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; CERRA FB, 1987, SURGERY, V101, P1; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Inzucchi SE, 2009, NEW ENGL J MED, V360, P1346, DOI 10.1056/NEJMe0901507; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Solomon CG, 2003, NEW ENGL J MED, V348, P579, DOI 10.1056/NEJMp030006; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	17	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					809	811		10.7326/0003-4819-150-11-200906020-00009	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487715				2022-12-24	WOS:000266530000008
J	Finlay, I				Finlay, Ilora			The art of medicine Dying and choosing	LANCET			English	Editorial Material									House Lords, London SW1A 0PW, England		Finlay, I (corresponding author), House Lords, London SW1A 0PW, England.	FINLAYI@parliament.uk							0	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1840	1841		10.1016/S0140-6736(09)61012-6	http://dx.doi.org/10.1016/S0140-6736(09)61012-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504667	Green Submitted, Bronze			2022-12-24	WOS:000266616400015
J	Peterson, LR; Robicsek, A				Peterson, Lance R.; Robicsek, Ari			Does My Patient Have Clostridium difficile Infection?	ANNALS OF INTERNAL MEDICINE			English	Article							REAL-TIME PCR; ENZYME-IMMUNOASSAY; TOXIN-A; MULTICENTER EVALUATION; HOSPITALIZED-PATIENTS; LABORATORY DETECTION; LATEX AGGLUTINATION; FECAL SPECIMENS; CYTOTOXIN ASSAY; DIARRHEA	Clostridium difficile infection (CDI) seems to be changing-with increasing virulence and incidence, more resistance to metronidazole, and worse outcomes. Accurate diagnosis is critical, but 3 common misconceptions lead to misdiagnosis: Clostridium difficile infection is a possibility when the patient has fewer than 3 loose stools per day; the glutamate dehydrogenase test for CDI is sensitive and thus is a good initial test; and repeating an insensitive laboratory test for CDI is useful. These misconceptions can lead to missed diagnoses (for example, when tests with low sensitivity are used) and to false diagnoses (for example, when tests are done in patients who are unlikely to have CDI because they have minimal diarrhea or negative results on recent tests). Diagnoses of CDI will be more accurate if clinicians use tests with a higher sensitivity, reduce the frequency of testing for a single episode of diarrhea, and give more attention to key elements of the patient's history.	[Peterson, Lance R.] NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Evanston, IL 60201 USA; Northwestern Univ, Evanston, IL USA	NorthShore University Health System; Northwestern University	Peterson, LR (corresponding author), NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Walgreen SB525,2650 Ridge Ave, Evanston, IL 60201 USA.	lancer@northwestern.edu						Aichinger E, 2008, J CLIN MICROBIOL, V46, P3795, DOI 10.1128/JCM.00684-08; Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; Alcala L, 2008, J CLIN MICROBIOL, V46, P3833, DOI 10.1128/JCM.01060-08; *COLL AM PATH, 2008, D B BACT SAMPL D 13, P9; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Gilligan PH, 2008, J CLIN MICROBIOL, V46, P1523, DOI 10.1128/JCM.02100-07; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Katz DA, 1996, AM J MED, V100, P487, DOI 10.1016/S0002-9343(95)00016-X; Katz DA, 1997, J GEN INTERN MED, V12, P57; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MANABE YC, 1995, ANN INTERN MED, V123, P835, DOI 10.7326/0003-4819-123-11-199512010-00004; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; MUNDY LS, 1995, AM J CLIN PATHOL, V103, P52, DOI 10.1093/ajcp/103.1.52; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; PETERSON LR, 1986, AM J CLIN PATHOL, V86, P208, DOI 10.1093/ajcp/86.2.208; Peterson LR, 1996, EUR J CLIN MICROBIOL, V15, P330, DOI 10.1007/BF01695667; PETERSON LR, 1987, AM J CLIN PATHOL, V87, P298, DOI 10.1093/ajcp/87.2.298; PETERSON LR, 2001, SEMINARS INFECT CONT, V1, P172; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Reller ME, 2007, J CLIN MICROBIOL, V45, P3601, DOI 10.1128/JCM.01305-07; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Snell H, 2004, J CLIN MICROBIOL, V42, P4863, DOI 10.1128/JCM.42.10.4863-4865.2004; Stamper PD, 2009, J CLIN MICROBIOL, V47, P373, DOI 10.1128/JCM.01613-08; Staneck JL, 1996, J CLIN MICROBIOL, V34, P2718, DOI 10.1128/JCM.34.11.2718-2721.1996; Stoddart B, 2002, CURR OPIN INFECT DIS, V15, P513, DOI 10.1097/00001432-200210000-00010; Zheng L, 2004, J CLIN MICROBIOL, V42, P3837, DOI 10.1128/JCM.42.8.3837-3840.2004	29	86	89	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					176	W41		10.7326/0003-4819-151-3-200908040-00005	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19652187				2022-12-24	WOS:000268947800004
J	Wandzioch, E; Zaret, KS				Wandzioch, Ewa; Zaret, Kenneth S.			Dynamic Signaling Network for the Specification of Embryonic Pancreas and Liver Progenitors	SCIENCE			English	Article							EARLY MOUSE EMBRYO; HEPATIC SPECIFICATION; ENDODERM CELLS; INDUCTION; DISTINCT; MESENCHYME; INITIATION; PROX1; SMAD4; PDX-1	Studies of the formation of pancreas and liver progenitors have focused on individual inductive signals and cellular responses. Here, we investigated how bone morphogenetic protein, transforming growth factor-beta (TGF beta), and fibroblast growth factor signaling pathways converge on the earliest genes that elicit pancreas and liver induction in mouse embryos. The inductive network was found to be dynamic; it changed within hours. Different signals functioned in parallel to induce different early genes, and two permutations of signals induced liver progenitor domains, which revealed flexibility in cell programming. Also, the specification of pancreas and liver progenitors was restricted by the TGFb pathway. These findings may enhance progenitor cell specification from stem cells for biomedical purposes and can help explain incomplete programming in stem cell differentiation protocols.	[Wandzioch, Ewa; Zaret, Kenneth S.] Fox Chase Canc Ctr, Cell & Dev Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu			NIH [R37GM36477, U01DK072503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Robertson for SmadCA mice; K. Kaestner for FoxA3cre mice; A. Hines for help with breeding; the Fox Chase Cancer Center (FCCC) Laboratory Animal Facility; F. Roegiers, E. Robertson, H. Fan, R. Lake, and D. Freedman-Cass for comments on the manuscript; and E. Pytko for help in its preparation. E.W. was a Postdoctoral Fellow of the Swedish Research Council. The work was funded by NIH grants R37GM36477 and U01DK072503 to K.S.Z. K.S.Z. is on a Scientific Advisory Board for Johnson & Johnson in the area of embryonic stem cells.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Deutsch G, 2001, DEVELOPMENT, V128, P871; DICKSON MC, 1993, DEVELOPMENT, V117, P625; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; LEDOUARIN N, 1964, J EMBRYOL EXP MORPH, V12, P651; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Offield MF, 1996, DEVELOPMENT, V122, P983; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	31	180	189	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1707	1710		10.1126/science.1174497	http://dx.doi.org/10.1126/science.1174497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556507	Green Accepted			2022-12-24	WOS:000267338200039
J	Stewart, AM				Stewart, Alexandra M.			When Vaccine Injury Claims Go to Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Stewart, AM (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.								0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2498	2500		10.1056/NEJMp0902316	http://dx.doi.org/10.1056/NEJMp0902316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456BS	19516030				2022-12-24	WOS:000266813800003
J	Davies, NB; Welbergen, JA				Davies, Nicholas B.; Welbergen, Justin A.			Social Transmission of a Host Defense Against Cuckoo Parasitism	SCIENCE			English	Article							REED WARBLERS; BROOD PARASITISM; NEW-ZEALAND; RECOGNITION; EVOLUTION; NESTS	Coevolutionary arms races between brood parasites and hosts involve genetic adaptations and counter-adaptations. However, hosts sometimes acquire defenses too rapidly to reflect genetic change. Our field experiments show that observation of cuckoo (Cuculus canorus) mobbing by neighbors on adjacent territories induced reed warblers (Acrocephalus scirpaceus) to increase the mobbing of cuckoos but not of parrots (a harmless control) on their own territory. In contrast, observation of neighbors mobbing parrots had no effect on reed warblers' responses to either cuckoos or parrots. These results indicate that social learning provides a mechanism by which hosts rapidly increase their nest defense against brood parasites. Such enemy-specific social transmission enables hosts to track fine-scale spatiotemporal variation in parasitism and may influence the coevolutionary trajectories and population dynamics of brood parasites and hosts.	[Davies, Nicholas B.; Welbergen, Justin A.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Davies, NB (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	n.b.davies@zoo.cam.ac.uk	Welbergen, Justin/AGN-0091-2022	Welbergen, Justin/0000-0002-8085-5759	Natural Environment Research Council; National Trust; Wicken Fen Group; English Nature; Behavioural Ecology Group at Cambridge; NERC [NE/D001439/1] Funding Source: UKRI; Natural Environment Research Council [NE/D001439/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Trust; Wicken Fen Group; English Nature; Behavioural Ecology Group at Cambridge; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council, the National Trust, C. Thorne, and the Wicken Fen Group, English Nature, and M. Brooke, J. Davies, R. Kilner, O. Kruger, and the Behavioural Ecology Group at Cambridge.	Boyd R., 1989, Lectures on Mathematics in the Life Sciences, V20, P1; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; CURIO E, 1978, SCIENCE, V202, P899, DOI 10.1126/science.202.4370.899; Darwin C., 1877, DIFFERENT FORMS FLOW; Davies NB, 2008, P ROY SOC B-BIOL SCI, V275, P1817, DOI 10.1098/rspb.2008.0331; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Davies NB, 2003, ANIM BEHAV, V65, P285, DOI 10.1006/anbe.2003.2049; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hale K, 2007, J AVIAN BIOL, V38, P198, DOI 10.1111/j.0908-8857.2007.03734.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Lindholm AK, 1999, J ANIM ECOL, V68, P293, DOI 10.1046/j.1365-2656.1999.00286.x; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; MALONEY RF, 1995, ANIM BEHAV, V50, P1193, DOI 10.1016/0003-3472(95)80036-0; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; Nakamura H, 1998, OX ORN SER, V9, P94; Oien IJ, 1996, J ANIM ECOL, V65, P147, DOI 10.2307/5717; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rothstein SI, 1998, PARASITIC BIRDS THEI; TAKASU F, 1993, AM NAT, V142, P819, DOI 10.1086/285574; Welbergen JA, 2008, ANIM BEHAV, V76, P811, DOI 10.1016/j.anbehav.2008.03.020; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041	24	123	128	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1318	1320		10.1126/science.1172227	http://dx.doi.org/10.1126/science.1172227			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498167				2022-12-24	WOS:000266635100043
J	Leunissen, RWJ; Kerkhof, GF; Stijnen, T; Hokken-Koelega, A				Leunissen, Ralph W. J.; Kerkhof, Gerthe F.; Stijnen, Theo; Hokken-Koelega, Anita			Timing and Tempo of First-Year Rapid Growth in Relation to Cardiovascular and Metabolic Risk Profile in Early Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; FOR-GESTATIONAL-AGE; BODY-MASS INDEX; CATCH-UP GROWTH; GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; BLOOD-PRESSURE; INTRAVENOUS GLUCOSE; EARLY-CHILDHOOD; INFANT GROWTH	Context Growth during infancy appears to be an important determinant of cardiovascular disease and type 2 diabetes later in life. Objectives To specify which period in the first year of life is related to determinants of cardiovascular disease and type 2 diabetes in early adulthood and to investigate the association between tempo of first-year weight gain (>0.67 SDs) and these determinants. Design, Setting, and Participants Observational study using longitudinal data collected in the Programming Factors for Growth and Metabolism (PROGRAM) study of 217 healthy participants, aged 18 to 24 years, including a relatively large sample of participants born small for gestational age and participants with short stature, performed at a medical center in the Netherlands between August 2004 and September 2007. The association of cardiovascular disease and type 2 diabetes with tempo of weight gain was assessed in a subgroup of 87 participants. Main Outcome Measures Associations between periods of first-year growth and tempo of weight gain and determinants of cardiovascular disease and type 2 diabetes in early adulthood. Results Weight gain in the first 3 months of life was inversely associated with insulin sensitivity (beta, -0.223; 95% confidence interval [CI], -0.386 to -0.060) and serum high-density lipoprotein cholesterol level (beta, -0.053; 95% CI, -0.090 to -0.016) and positively associated with waist circumference (beta, 1.437; 95% CI, 0.066 to 2.808), acute insulin response (beta, 0.210; 95% CI, 0.024 to 0.395), ratio of total cholesterol to high-density lipoprotein cholesterol (beta, 0.052; 95% CI, 0.010 to 0.094), and level of triglycerides (beta, 0.066; 95% CI, 0.003 to 0.129) in early adulthood. Rapid weight gain during the first 3 months of life resulted in a higher percentage of body fat, more central adiposity, and reduced insulin sensitivity in early adulthood than when slower weight gain occurred during the entire first year. Conclusion Rapid weight gain in the first 3 months of life is associated with several determinants of cardiovascular disease and type 2 diabetes in early adulthood. JAMA. 2009;301(21):2234-2242 www.jama.com	[Leunissen, Ralph W. J.; Kerkhof, Gerthe F.; Hokken-Koelega, Anita] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, NL-3015 GJ Rotterdam, Netherlands; [Stijnen, Theo] Leids Univ, Med Ctr, Dept Epidemiol & Biostat, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Leunissen, RWJ (corresponding author), Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, Room Sb 2670,60 Molewaterpl Dr, NL-3015 GJ Rotterdam, Netherlands.	r.leunissen@erasmusmc.nl			Netherlands Organization for Scientific Research [015 000 088]; Revolving Fund 2001; Vereniging Trustfonds; Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching; Stichting De Drie Lichten, the Netherlands	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Revolving Fund 2001; Vereniging Trustfonds; Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching; Stichting De Drie Lichten, the Netherlands(Netherlands Government)	The Programming Factors for Growth and Metabolism (PROGRAM) study was financially supported by Netherlands Organization for Scientific Research grant 015 000 088, by grants from Revolving Fund 2001 and Vereniging Trustfonds awarded to Erasmus University, Rotterdam, the Netherlands, and by a grant from the Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching and the Stichting De Drie Lichten, the Netherlands.	Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Belfort MB, 2007, J PEDIATR-US, V151, P670, DOI 10.1016/j.jpeds.2007.05.010; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Fewtrell MS, 2001, AM J CLIN NUTR, V74, P516; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; LEUNISSEN RW, 2008, J CLIN ENDOCRINO AUG, P26; LEUNISSEN RW, 2008, CLIN ENDOCRINOL  JUN, P23; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6	31	368	383	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2234	2242		10.1001/jama.2009.761	http://dx.doi.org/10.1001/jama.2009.761			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491185	Bronze			2022-12-24	WOS:000266554100021
J	Vasseur, DA; Fox, JW				Vasseur, David A.; Fox, Jeremy W.			Phase-locking and environmental fluctuations generate synchrony in a predator-prey community	NATURE			English	Article							POPULATION-DYNAMICS; SPATIAL SYNCHRONY; DISPERSAL; PATTERNS; SYSTEMS; NOISE	Spatially synchronized fluctuations in system state are common in physical and biological systems ranging from individual atoms(1) to species as diverse as viruses, insects and mammals(2-10). Although the causal factors are well known for many synchronized phenomena, several processes concurrently have an impact on spatial synchrony of species, making their separate effects and interactions difficult to quantify. Here we develop a general stochastic model of predator-prey spatial dynamics to predict the outcome of a laboratory microcosm experiment testing for interactions among all known synchronizing factors: ( 1) dispersal of individuals between populations; ( 2) spatially synchronous fluctuations in exogenous environmental factors ( the Moran effect); and ( 3) interactions with other species ( for example, predators) that are themselves spatially synchronized. The Moran effect synchronized populations of the ciliate protist Tetrahymena pyriformis; however, dispersal only synchronized prey populations in the presence of the predator Euplotes patella. Both model and data indicate that synchrony depends on cyclic dynamics generated by the predator. Dispersal, but not the Moran effect, 'phase-locks' cycles, which otherwise become 'decoherent' and drift out of phase. In the absence of cycles, phase-locking is not possible and the synchronizing effect of dispersal is negligible. Interspecific interactions determine population synchrony, not by providing an additional source of synchronized fluctuations, but by altering population dynamics and thereby enhancing the action of dispersal. Our results are robust to wide variation in model parameters representative of many natural predator-prey or host-pathogen systems. This explains why cyclic systems provide many of the most dramatic examples of spatial synchrony in nature.	[Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Fox, Jeremy W.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Yale University; University of Calgary	Vasseur, DA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	david.vasseur@yale.edu	Vasseur, David/A-2545-2013	Vasseur, David/0000-0003-1706-9613	Alberta Ingenuity; NSERC	Alberta Ingenuity; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	A. Gonzalez, E. McCauley and P. Morin provided comments on an earlier version of the manuscript. J. Scharein, T. Janes and J. MacNeil provided laboratory assistance. Funding was provided by Alberta Ingenuity and NSERC postdoctoral fellowships to D. A. V. and by an NSERC Discovery Grant and an Alberta Ingenuity New Faculty Award to J. W. F.	Abbott KC, 2007, OIKOS, V116, P903, DOI 10.1111/j.0030-1299.2007.15856.x; Bjornstad ON, 2000, J ANIM ECOL, V69, P869, DOI 10.1046/j.1365-2656.2000.00444.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cattadori IM, 2005, NATURE, V433, P737, DOI 10.1038/nature03276; Cazelles B, 2001, AM NAT, V157, P670, DOI 10.1086/320624; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Engen S, 2005, AM NAT, V166, P603, DOI 10.1086/491690; Fox JW, 2002, AM NAT, V159, P305, DOI 10.1086/338543; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Jansen VAA, 1999, TRENDS ECOL EVOL, V14, P278, DOI 10.1016/S0169-5347(99)01654-7; Jansen VAA, 2001, THEOR POPUL BIOL, V59, P119, DOI 10.1006/tpbi.2000.1506; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Ranta E, 2000, P ROY SOC B-BIOL SCI, V267, P1851, DOI 10.1098/rspb.2000.1220; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; Ripa J, 2007, OIKOS, V116, P783, DOI 10.1111/j.2007.0030-1299.15497.x; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Strogatz S., 2003, SYNC ORDER EMERGES C; Vasseur DA, 2007, OIKOS, V116, P1726, DOI 10.1111/j.2007.0030-1299.16101.x; Vasseur DA, 2007, ECOL LETT, V10, P1066, DOI 10.1111/j.1461-0248.2007.01099.x; Vasseur DA, 2007, ECOLOGY, V88, P2058, DOI 10.1890/06-1899.1	31	105	106	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					1007	U90		10.1038/nature08208	http://dx.doi.org/10.1038/nature08208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19626006				2022-12-24	WOS:000269085500033
J	Coutsoudis, A; Coovadia, HM; King, J				Coutsoudis, Anna; Coovadia, Hoosen M.; King, Judith			The breastmilk brand: promotion of child survival in the face of formula-milk marketing	LANCET			English	Editorial Material									[Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Nelson R Mandela Sch Med, ZA-4013 Congella, South Africa; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Victor Daitz Unit HIV AIDS Res, ZA-4013 Congella, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Coutsoudis, A (corresponding author), Univ KwaZulu Natal, Dept Paediat & Child Hlth, Nelson R Mandela Sch Med, DDMRI Bldg,Private Bag 7, ZA-4013 Congella, South Africa.	coutsoud@ukzn.ac.za						ALLAIN A, 2006, STATE CODE COUNTRY; BRANCO HC, 1990, DEV COMMUN REP, V71, P7; Gottschang SK, 2000, FEEDING CHINA'S LITTLE EMPERORS, P160; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; *IBFAN, REP; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; *INT LAB ORG IC183, 2000, MAT PROT CONV; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KAUFMANN M, 2007, WASHINGTON POST 0831; Loewenberg S, 2008, LANCET, V372, P1209, DOI 10.1016/S0140-6736(08)61502-0; Xu FL, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-22; 2007, LOOK WHAT THEY RE DO; 2004, CHINA DAILY     0521	13	18	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					423	425		10.1016/S0140-6736(09)60661-9	http://dx.doi.org/10.1016/S0140-6736(09)60661-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19647609				2022-12-24	WOS:000268815200027
J	Kovacs, AM; Mehler, J				Kovacs, Agnes Melinda; Mehler, Jacques			Flexible Learning of Multiple Speech Structures in Bilingual Infants	SCIENCE			English	Article								Children acquire their native language according to a well-defined time frame. Surprisingly, although children raised in bilingual environments have to learn roughly twice as much about language as their monolingual peers, the speed of acquisition is comparable in monolinguals and bilinguals. Here, we show that preverbal 12-month-old bilingual infants have become more flexible at learning speech structures than monolinguals. When given the opportunity to simultaneously learn two different regularities, bilingual infants learned both, whereas monolinguals learned only one of them. Hence, bilinguals may acquire two languages in the time in which monolinguals acquire one because they quickly become more flexible learners.	[Kovacs, Agnes Melinda; Mehler, Jacques] Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Kovacs, AM (corresponding author), Scuola Int Super Studi Avanzati, Via Beirut 4, I-34014 Trieste, Italy.	agneskovacs@mtapi.hu		Kovacs, Agnes Melinda/0000-0003-3452-7727	NEST PATHFINDER; J.S. McDonnell Foundation; Maire Curie [035975]	NEST PATHFINDER; J.S. McDonnell Foundation; Maire Curie	This work was supported by the NEST PATHFINDER initiative "What it means to be human" (CALACEI), J.S. McDonnell Foundation, and Maire Curie 035975 DISCOS grants. A.M.K. is currently at the Hungarian Academy of Sciences and at the Central European University, Budapest, Hungary.	Bialystok E, 1999, CHILD DEV, V70, P636, DOI 10.1111/1467-8624.00046; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; PEARSON BZ, 1993, LANG LEARN, V43, P93, DOI 10.1111/j.1467-1770.1993.tb00174.x; Werker JF, 2008, TRENDS COGN SCI, V12, P144, DOI 10.1016/j.tics.2008.01.008	7	169	169	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					611	612		10.1126/science.1173947	http://dx.doi.org/10.1126/science.1173947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19589962				2022-12-24	WOS:000268493000050
J	Blow, N				Blow, Nathan			Untangling the protein web	NATURE			English	Editorial Material																		Feret J, 2009, P NATL ACAD SCI USA, V106, P6453, DOI 10.1073/pnas.0809908106; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; VIDAL M, 2009, NATURE METHODS, V6, P91; VIDAL M, 2009, NATURE METHODS, V6, P39; VIDAL M, 2009, NATURE METHODS, V6, P83; VIDAL M, 2009, NATURE METHODS, V6, P47	9	26	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					415	418		10.1038/460415a	http://dx.doi.org/10.1038/460415a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606149	Bronze			2022-12-24	WOS:000267979000043
J	Coureuil, M; Mikaty, G; Miller, F; Lecuyer, H; Bernard, C; Bourdoulous, S; Dumenil, G; Mege, RM; Weksler, BB; Romero, IA; Couraud, PO; Nassif, X				Coureuil, Mathieu; Mikaty, Guillain; Miller, Florence; Lecuyer, Herve; Bernard, Christine; Bourdoulous, Sandrine; Dumenil, Guillaume; Mege, Rene-Marc; Weksler, Babette B.; Romero, Ignacio A.; Couraud, Pierre-Olivier; Nassif, Xavier			Meningococcal Type IV Pili Recruit the Polarity Complex to Cross the Brain Endothelium	SCIENCE			English	Article							HUMAN EPITHELIAL-CELLS; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIA; TWITCHING MOTILITY; BARRIER; ADHESION; ADHERENS; RECEPTOR; CDC42; PAR3	Type IV pili mediate the initial interaction of many bacterial pathogens with their host cells. In Neisseria meningitidis, the causative agent of cerebrospinal meningitis, type IV pili-mediated adhesion to brain endothelial cells is required for bacteria to cross the blood-brain barrier. Here, type IV pili-mediated adhesion of N. meningitidis to human brain endothelial cells was found to recruit the Par3/Par6/PKC zeta polarity complex that plays a pivotal role in the establishment of eukaryotic cell polarity and the formation of intercellular junctions. This recruitment leads to the formation of ectopic intercellular junctional domains at the site of bacteria-host cell interaction and a subsequent depletion of junctional proteins at the cell-cell interface with opening of the intercellular junctions of the brain-endothelial interface.	[Coureuil, Mathieu; Mikaty, Guillain; Lecuyer, Herve; Bernard, Christine; Dumenil, Guillaume; Nassif, Xavier] Univ Paris 05, Fac Med, INSERM, U570, F-75015 Paris, France; [Miller, Florence; Bourdoulous, Sandrine; Couraud, Pierre-Olivier] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75015 Paris, France; [Miller, Florence; Bourdoulous, Sandrine; Couraud, Pierre-Olivier] INSERM, U567, F-75014 Paris, France; [Lecuyer, Herve; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Mege, Rene-Marc] Univ Paris 06, Inst Fer Moulin, INSERM, UMR S 839, F-75005 Paris, France; [Weksler, Babette B.] Weill Cornell Med Coll, New York, NY 10021 USA; [Romero, Ignacio A.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Cornell University; Open University - UK	Coureuil, M (corresponding author), Univ Paris 05, Fac Med, INSERM, U570, F-75015 Paris, France.	mathieu.coureuil@inserm.fr	Coureuil, Mathieu/D-4793-2017; Dumenil, Guillaume/F-7567-2015; Dumenil, Guillaume/N-3377-2019; Mege, Rene Marc/M-9569-2013	Coureuil, Mathieu/0000-0001-7655-9685; Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Romero, Ignacio/0000-0002-0322-9180; Mege, Rene-Marc/0000-0001-8128-5543	la Fondation pour la Recherche Medicale (FRM)	la Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	M.C. was funded by la Fondation pour la Recherche Medicale (FRM).	Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Eugene E, 2002, J CELL SCI, V115, P1231; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Madgula VLM, 2007, PLANTA MED, V73, P330, DOI 10.1055/s-2007-967137; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	26	155	164	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					83	87		10.1126/science.1173196	http://dx.doi.org/10.1126/science.1173196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19520910	Green Submitted, Green Accepted			2022-12-24	WOS:000267594000040
J	Fink, DW				Fink, Donald W., Jr.			FDA Regulation of Stem Cell-Based Products	SCIENCE			English	Editorial Material								Cell self-renewal and the capacity to differentiate into multiple cell types (pluripotency) are biological attributes casting stem cells as attractive candidates for development of therapies targeting indications that involve functional restoration of damaged tissues. In the United States, clinical trials designed to demonstrate the safety and effectiveness of stem cell-based products are regulated by the U. S. Food and Drug Administration (FDA). To ensure that subjects enrolled in a clinical study involving stem cell-based products are not exposed to significant and unreasonable risk, the FDA reviews medical and scientific information that encompasses delineation of product-specific characteristics and preclinical testing to determine whether there is sufficient safety assurance to permit initiation of human clinical studies.	US FDA, Cell Therapy Branch,Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Fink, DW (corresponding author), US FDA, Cell Therapy Branch,Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Ctr Biol Evaluat & Res, 1401 Rockville Pike,Suite 200N,Mail Code HFM 720, Rockville, MD 20852 USA.	donald.fink@fda.hhs.gov						Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; FINK DW, 2005, ESSENTIALS STEM CELL, P503; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Moos Malcolm Jr, 2008, Trends Pharmacol Sci, V29, P591, DOI 10.1016/j.tips.2008.09.003; Preynat-Seauve O, 2009, J CELL MOL MED, V13, P3556, DOI 10.1111/j.1582-4934.2009.00746.x; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	10	106	108	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1662	1663		10.1126/science.1173712	http://dx.doi.org/10.1126/science.1173712			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556496				2022-12-24	WOS:000267338200025
J	Majumder, MA; Cohen, CB				Majumder, Mary A.; Cohen, Cynthia B.			The NIH Draft Guidelines on Human Stem Cell Research	SCIENCE			English	Editorial Material							EMBRYOS; DONATE; LINES		[Majumder, Mary A.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Cohen, Cynthia B.] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA	Baylor College of Medicine; Georgetown University	Majumder, MA (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	majumder@bcm.edu						Cohen CB, 2009, STEM CELL REV REP, V5, P116, DOI 10.1007/s12015-009-9060-6; Holden C, 2009, SCIENCE, V323, P1412, DOI 10.1126/science.323.5920.1412; Hug K, 2008, FERTIL STERIL, V89, P263, DOI 10.1016/j.fertnstert.2007.09.017; Hynes RO, 2008, NAT REV MOL CELL BIO, V9, P993, DOI 10.1038/nrm2528; *I MED, 2002, RESP RES SYST APPR P; *INT SOC STEM CELL, 2009, ISCCR COMM NIH UNPUB; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; National Institute of Health (NIH), 2000, FED REGISTER, V65, P51976; *NBAC, 1999, ETH ISS HUM STEM CEL; *NRC, 2007, 2007 AM NAT AC GUID; *NRC, 2005, GUID HUM EMBR STEM C; NRC and IOM, 2008, 2008 AM NAT AC GUID; OBAMA BH, 2009, REMARKS DELIVERY STE; STEIN R, 2009, WASHINGTON POST 0525, pA9; Sugarman J, 2008, SCIENCE, V322, P379, DOI 10.1126/science.1164441; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; Taylor PL, 2009, CELL STEM CELL, V4, P479, DOI 10.1016/j.stem.2009.05.002; 2009, FED REG, V74, P18578	18	4	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1648	1649		10.1126/science.1176253	http://dx.doi.org/10.1126/science.1176253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556488				2022-12-24	WOS:000267338200017
J	Skaar, JR; D'Angiolella, V; Pagan, JK; Pagano, M				Skaar, Jeffrey R.; D'Angiolella, Vincenzo; Pagan, Julia K.; Pagano, Michele			SnapShot: F Box Proteins II	CELL			English	Editorial Material							CELL-CYCLE; PROTEOLYSIS; LIGASE; FAMILY		[Skaar, Jeffrey R.; D'Angiolella, Vincenzo; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Skaar, JR (corresponding author), NYU, Sch Med, New York, NY 10016 USA.		Pagan, Julia/O-1929-2016	Pagan, Julia/0000-0002-7079-6388; pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076584] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	10	95	99	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1358	U100	1358.e1	10.1016/j.cell.2009.05.040	http://dx.doi.org/10.1016/j.cell.2009.05.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563764	Bronze			2022-12-24	WOS:000267373400028
J	Aoki, ST; Settembre, EC; Trask, SD; Greenberg, HB; Harrison, SC; Dormitzer, PR				Aoki, Scott T.; Settembre, Ethan C.; Trask, Shane D.; Greenberg, Harry B.; Harrison, Stephen C.; Dormitzer, Philip R.			Structure of Rotavirus Outer-Layer Protein VP7 Bound with a Neutralizing Fab	SCIENCE			English	Article							RHESUS ROTAVIRUS; 3-DIMENSIONAL STRUCTURE; SEQUENCE; CALCIUM; HEMAGGLUTININ; ANTIBODIES; EPITOPES; VACCINE; BINDING	Rotavirus outer-layer protein VP7 is a principal target of protective antibodies. Removal of free calcium ions (Ca2+) dissociates VP7 trimers into monomers, releasing VP7 from the virion, and initiates penetration-inducing conformational changes in the other outer-layer protein, VP4. We report the crystal structure at 3.4 angstrom resolution of VP7 bound with the Fab fragment of a neutralizing monoclonal antibody. The Fab binds across the outer surface of the intersubunit contact, which contains two Ca2+ sites. Mutations that escape neutralization by other antibodies suggest that the same region bears the epitopes of most neutralizing antibodies. The monovalent Fab is sufficient to neutralize infectivity. We propose that neutralizing antibodies against VP7 act by stabilizing the trimer, thereby inhibiting the uncoating trigger for VP4 rearrangement. A disulfide-linked trimer is a potential subunit immunogen.	[Aoki, Scott T.; Settembre, Ethan C.; Trask, Shane D.; Harrison, Stephen C.; Dormitzer, Philip R.] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Harrison, Stephen C.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA.	harrison@crystal.harvard.edu; philip.dormitzer@novartis.com		greenberg, harry/0000-0002-2128-9080	NIH [CA-13202, AI-21362, DK-56339]; NATIONAL CANCER INSTITUTE [R37CA013202, R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI021362, R01AI021362, R37AI021362, R56AI021362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Babyonyshev for help with protein preparations, the staff of the Northeastern Collaborative Access Team (Advanced Photon Source, Argonne National Laboratory) for assistance with x-ray data collection, R. Stanfield for the library of Fab structures, and J. Patton for help with sequence variability analysis. Supported by NIH grant CA-13202 (S.C.H.), by a VA Merit Award and NIH grants AI-21362 and DK-56339 (H.B.G.), and by an Ellison Medical Foundation New Investigators in Infectious Diseases Award (P.R.D.). S.C.H. is an Investigator of the Howard Hughes Medical Institute. Atomic coordinates and structure factor amplitudes for the VP7-4F8 Fab complex have been deposited in the Protein Data Bank (www.rcsb.org) with accession code 3FMG.	ANDREW ME, 1990, J VIROL, V64, P4776, DOI 10.1128/JVI.64.10.4776-4783.1990; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Dormitzer PR, 2000, VIROLOGY, V277, P420, DOI 10.1006/viro.2000.0625; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; DORMITZER PR, 1994, VIROLOGY, V204, P391, DOI 10.1006/viro.1994.1543; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; FIORE L, 1991, VIROLOGY, V181, P553, DOI 10.1016/0042-6822(91)90888-I; Gajardo R, 1997, J VIROL, V71, P2211, DOI 10.1128/JVI.71.3.2211-2216.1997; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; GREEN KY, 1988, J VIROL, V62, P1819, DOI 10.1128/JVI.62.5.1819-1823.1988; Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Ludert JE, 2002, J VIROL, V76, P6643, DOI 10.1128/JVI.76.13.6643-6651.2002; MACKOW ER, 1988, VIROLOGY, V165, P511, DOI 10.1016/0042-6822(88)90595-8; MICHELANGELI F, 1995, J VIROL, V69, P3838, DOI 10.1128/JVI.69.6.3838-3847.1995; NISHIKAWA K, 1989, VIROLOGY, V171, P503, DOI 10.1016/0042-6822(89)90620-X; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Santos N, 2008, J CLIN MICROBIOL, V46, P462, DOI 10.1128/JCM.01361-07; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; SHAW RD, 1986, VIROLOGY, V155, P434, DOI 10.1016/0042-6822(86)90205-9; SVENSSON L, 1994, J VIROL, V68, P5204, DOI 10.1128/JVI.68.8.5204-5215.1994; Trask SD, 2006, J VIROL, V80, P11293, DOI 10.1128/JVI.01346-06; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133	29	173	185	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1444	1447		10.1126/science.1170481	http://dx.doi.org/10.1126/science.1170481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520960	Green Accepted			2022-12-24	WOS:000266878700046
J	Fuhrmann, J; Schmidt, A; Spiess, S; Lehner, A; Turgay, K; Mechtler, K; Charpentier, E; Clausen, T				Fuhrmann, Jakob; Schmidt, Andreas; Spiess, Silvia; Lehner, Anita; Turgay, Kuersad; Mechtler, Karl; Charpentier, Emmanuelle; Clausen, Tim			McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR	SCIENCE			English	Article							GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; NEGATIVE REGULATOR; STRESS-RESPONSE; 1ST GENE; REPRESSOR; ENCODES; OPERON; CLP	All living organisms face a variety of environmental stresses that cause the misfolding and aggregation of proteins. To eliminate damaged proteins, cells developed highly efficient stress response and protein quality control systems. We performed a biochemical and structural analysis of the bacterial CtsR/McsB stress response. The crystal structure of the CtsR repressor, in complex with DNA, pinpointed key residues important for high-affinity binding to the promoter regions of heat-shock genes. Moreover, biochemical characterization of McsB revealed that McsB specifically phosphorylates arginine residues in the DNA binding domain of CtsR, thereby impairing its function as a repressor of stress response genes. Identification of the CtsR/McsB arginine phospho-switch expands the repertoire of possible protein modifications involved in prokaryotic and eukaryotic transcriptional regulation.	[Fuhrmann, Jakob; Lehner, Anita; Mechtler, Karl; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schmidt, Andreas] Univ Vienna, Christian Doppler Lab Proteome Anal, A-1030 Vienna, Austria; [Spiess, Silvia; Charpentier, Emmanuelle] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Turgay, Kuersad] Free Univ Berlin, Inst Biol Microbiol, D-14195 Berlin, Germany; [Mechtler, Karl] Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Charpentier, Emmanuelle] Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Free University of Berlin; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Umea University	Clausen, T (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Turgay, Kürsad/D-4828-2011; Turgay, Kürşad/Q-5285-2019	Mechtler, Karl/0000-0002-3392-9946; Turgay, Kürsad/0000-0002-8959-492X; Turgay, Kürşad/0000-0002-8959-492X; Schmidt, Andreas/0000-0001-9369-3747; Clausen, Tim/0000-0003-1582-6924	Boehringer Ingelheim; Wiener Wissenschafts; Forschungs und Technologiefonds; Christian-Doppler-Society; Deutsche Forschungsgemeinschaft; European Molecular Biology Organization Young Investigator Program; Austrian Proteomics Platform (GEN-AU)	Boehringer Ingelheim(Boehringer Ingelheim); Wiener Wissenschafts; Forschungs und Technologiefonds; Christian-Doppler-Society; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Austrian Proteomics Platform (GEN-AU)	We thank D. Fiegen and D. Reinert (Boehringer Ingelheim) and the staff at Swiss Light Source for assistance with collecting synchrotron data, A. Carrieri for his contribution with the kinase assays, L. Becker for the NMR analysis of phosphopeptides, T. Krojer and D. Hellerschmied for their support in the structural analysis of CtsR, and C. Stingl and M. Mazanek for assisting MS analysis. The Research Institute of Molecular Pathology is funded by Boehringer Ingelheim. J.F., S.S., E.C., and T.C. were supported by Wiener Wissenschafts, Forschungs und Technologiefonds; A.S. by the Christian-Doppler-Society; K.T. by the Deutsche Forschungsgemeinschaft; and T.C. by the European Molecular Biology Organization Young Investigator Program. This work was further supported by the Austrian Proteomics Platform (GEN-AU). The Protein Data Bank accession number for the CtsR2/DNA complex is 3H0D.	Derre I, 1999, MOL MICROBIOL, V32, P581, DOI 10.1046/j.1365-2958.1999.01374.x; Derre I, 2000, MOL MICROBIOL, V38, P335, DOI 10.1046/j.1365-2958.2000.02124.x; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; JAMES TL, 1985, CRC CR REV BIOCH MOL, V18, P1, DOI 10.3109/10409238509082538; Kirstein J, 2005, J MOL MICROB BIOTECH, V9, P182, DOI 10.1159/000089646; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Kruger E, 1998, J BACTERIOL, V180, P6681; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schulz A, 1996, J BACTERIOL, V178, P1088, DOI 10.1128/jb.178.4.1088-1093.1996; SCHUMANN W, 2002, BACILLUS SUBTILIS IT; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; Tholey A, 1999, J MASS SPECTROM, V34, P117, DOI 10.1002/(SICI)1096-9888(199902)34:2<117::AID-JMS769>3.0.CO;2-V; WAKIM BT, 1994, J BIOL CHEM, V269, P2722; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888	20	129	134	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1323	1327		10.1126/science.1170088	http://dx.doi.org/10.1126/science.1170088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498169				2022-12-24	WOS:000266635100045
J	Kamiyama, D; Chiba, A				Kamiyama, Daichi; Chiba, Akira			Endogenous Activation Patterns of Cdc42 GTPase Within Drosophila Embryos	SCIENCE			English	Article							RHO-FAMILY GTPASES; NEURONAL DEVELOPMENT; IN-VIVO; CELLS; GUIDANCE; GROWTH; RAC	Knowing when and where a given protein is activated within intact animals assists in elucidating its in vivo function. With the use of a genetically encoded A-probe (activation bioprobe), we revealed that Cdc42 guanosine triphosphatase (GTPase) remains inactive within Drosophila embryos during the first two-thirds of embryogenesis. Within the central nervous system where Cdc42 activity first becomes up-regulated, individual neurons display patterns restricted to specific subcellular compartments. At both organismal and cellular levels, Cdc42's endogenous activation patterns in the wild type allow predictions of where loss-of-function phenotypes will emerge in cdc42/cdc42 mutants. Genetic tests support the importance of suppressing endogenous Cdc42 activities until needed. Thus, bioprobe-assisted analysis uncovers how ubiquitously expressed signaling proteins control cellular events through continual regulation of their activities within animals.	[Chiba, Akira] Univ Miami, Dept Biol, Coral Gables, FL 33146 USA; Univ Miami, Miami Inst Mol Imaging & Computat, Coral Gables, FL 33146 USA	University of Miami; University of Miami	Chiba, A (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33146 USA.	akira.chiba@miami.edu	Chiba, Akira/AAF-5073-2020		NIH/National Institute of Neurological Disorders and Stroke; NIH/National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079432, R01MH068650] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Hayden, K. Chittanon-Buranachai, R. Clegg, S. Rogers, S. Siechen, and I. Vasenkova for advice; S. Hsu, O. Alpcan, M. Furrer, S. Deng, and R. Kamiyama for technical assistance; Bloomington Drosophila Stock Center and Developmental Studies Hybridoma Bank for reagents; and E. Giniger, J. Baker, and M. Kim for comments on manuscript. Supported by grants from NIH/National Institute of Neurological Disorders and Stroke and NIH/National Institute of Mental Health (A.C.).	Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	21	31	31	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1338	1340		10.1126/science.1170615	http://dx.doi.org/10.1126/science.1170615			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498173	Green Accepted			2022-12-24	WOS:000266635100049
J	Hyde, R				Hyde, Rob			European children still at high risk of injury	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1752	1752		10.1016/S0140-6736(09)60967-3	http://dx.doi.org/10.1016/S0140-6736(09)60967-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480075				2022-12-24	WOS:000266337300014
J	Cohen, BE; Marmar, C; Ren, L; Bertenthal, D; Seal, KH				Cohen, Beth E.; Marmar, Charles; Ren, Li; Bertenthal, Daniel; Seal, Karen H.			Association of Cardiovascular Risk Factors With Mental Health Diagnoses in Iraq and Afghanistan War Veterans Using VA Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							POSTTRAUMATIC-STRESS-DISORDER		[Cohen, Beth E.; Ren, Li; Seal, Karen H.] Vet Affairs Med Ctr, San Francisco Dept, Dept Med, San Francisco, CA 94121 USA; [Marmar, Charles] Vet Affairs Med Ctr, San Francisco Dept, Dept Psychiat, San Francisco, CA 94121 USA; [Bertenthal, Daniel] Vet Affairs Med Ctr, San Francisco Dept, Hlth Serv Res Enhancement Award Program, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cohen, BE (corresponding author), Vet Affairs Med Ctr, San Francisco Dept, Dept Med, San Francisco, CA 94121 USA.	beth.cohen@va.gov	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607	NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NHLBI NIH HHS [K23 HL094765] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094765] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Dobie DJ, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00376.x; Elhai J. D., 2005, PSYCHOL SERV, V2, P3, DOI [10.1037/1541-1559.2.1.3, DOI 10.1037/1541-1559.2.1.3]; Kang HK, 2006, ANN EPIDEMIOL, V16, P381, DOI 10.1016/j.annepidem.2005.03.004; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004	6	128	131	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					489	492		10.1001/jama.2009.1084	http://dx.doi.org/10.1001/jama.2009.1084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479DS	19654382	Bronze			2022-12-24	WOS:000268640500012
J	Dixon, KW				Dixon, Kingsley W.			Pollination and Restoration	SCIENCE			English	Editorial Material							CROP POLLINATION; PLANT; BIODIVERSITY; CONSERVATION; DIVERSITY; NETWORKS; SERVICE; BEES	Pollination services underpin sustainability of restored ecosystems. Yet, outside of agri-environments, effective restoration of pollinator services in ecological restoration has received little attention. This deficiency in the knowledge needed to restore pollinator capability represents a major liability in restoration programs, particularly in regions where specialist invertebrate and vertebrate pollinators exist, such as global biodiversity hotspots. When compounded with the likely negative impacts of climate change on pollination services, the need to understand and manage pollinator services in restoration becomes paramount.	Univ Western Australia, Sch Plant Biol, Perth, WA 6005, Australia	University of Western Australia	Dixon, KW (corresponding author), Univ Western Australia, Sch Plant Biol, 6009 Kings Pk & Bot Garden, Perth, WA 6005, Australia.	kingsley.dixon@bgpa.wa.gov.au	Dixon, Kingsley W/B-1042-2011; Dixon, Kingsley W/A-8133-2016	Dixon, Kingsley W/0000-0001-5989-2929				Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; BROWN AD, 2008, ILLUSTRATED GUIDE OR; BROWN EM, 1997, W AUSTR NATURALISTS, V15; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; COX PA, 1983, OIKOS, V41, P195, DOI 10.2307/3544263; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Forup ML, 2005, RESTOR ECOL, V13, P265, DOI 10.1111/j.1526-100X.2005.00034.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; LAMONT BB, 1993, OECOLOGIA, V94, P446, DOI 10.1007/BF00317122; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; N.R.C. Committee on the Status of Pollinators in North America, 2007, STATUS POLLINATORS N; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103	28	131	135	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					571	573		10.1126/science.1176295	http://dx.doi.org/10.1126/science.1176295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644110				2022-12-24	WOS:000268493000038
J	Katija, K; Dabiri, JO				Katija, Kakani; Dabiri, John O.			A viscosity-enhanced mechanism for biogenic ocean mixing	NATURE			English	Article							DRIFT; TURBULENCE; FLOW	Recent observations of biologically generated turbulence in the ocean have led to conflicting conclusions regarding the significance of the contribution of animal swimming to ocean mixing. Measurements indicate elevated turbulent dissipation-comparable with levels caused by winds and tides-in the vicinity of large populations of planktonic animals swimming together(1). However, it has also been noted that elevated turbulent dissipation is by itself insufficient proof of substantial biogenic mixing, because much of the turbulent kinetic energy of small animals is injected below the Ozmidov buoyancy length scale, where it is primarily dissipated as heat by the fluid viscosity before it can affect ocean mixing(2). Ongoing debate regarding biogenic mixing has focused on comparisons between animal wake turbulence and ocean turbulence(3,4). Here, we show that a second, previously neglected mechanism of fluid mixing-first described over 50 years ago by Charles Darwin(5)-is the dominant mechanism of mixing by swimming animals. The efficiency of mixing by Darwin's mechanism is dependent on animal shape rather than fluid length scale and, unlike turbulent wake mixing, is enhanced by fluid viscosity. Therefore, it provides a means of biogenic mixing that can be equally effective in small zooplankton and large mammals. A theoretical model for the relative contributions of Darwinian mixing and turbulent wake mixing is created and validated by in situ field measurements of swimming jellyfish using a newly developed scuba-based laser velocimetry device(6). Extrapolation of these results to other animals is straightforward given knowledge of the animal shape and orientation during vertical migration. On the basis of calculations of a broad range of aquatic animal species, we conclude that biogenic mixing via Darwin's mechanism can be a significant contributor to ocean mixing and nutrient transport.	[Dabiri, John O.] CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA	California Institute of Technology	Dabiri, JO (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	kakani@caltech.edu; jodabiri@caltech.edu	Katija, Kakani/R-4935-2019		National Science Foundation Biological Oceanography Program; NSF; Office of Naval Research; NDSEG; Charles Lee Powell Foundation	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NDSEG; Charles Lee Powell Foundation	We acknowledge W. M. Graham, J. H. Costello and H. Swift for assistance in field measurements and M. Schaadt for preparatory dive assistance. Additional logistical support was provided by the Coral Reef Research Foundation. Field work in Palau was supported by the National Science Foundation Biological Oceanography Program (to M. N. Dawson and J. O. D.). Additional support (to J. O. D.) from NSF Biological Oceanography, Ocean Technology, Fluid Dynamics, and Energy for Sustainability and from the Office of Naval Research (K.-H. Kim) is acknowledged, as are NSF and NDSEG fellowships (to K. K.) and the Charles Lee Powell Foundation.	Dabiri JO, 2006, J FLUID MECH, V547, P105, DOI 10.1017/S0022112005007585; DARWIN C, 1953, P CAMB PHILOS SOC, V49, P342, DOI 10.1017/S0305004100028449; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Eames I, 2003, PHILOS T R SOC A, V361, P2951, DOI 10.1098/rsta.2003.1277; Eames I, 2003, J FLUID MECH, V485, P67, DOI 10.1017/S0022112003004361; Eames I, 1999, P ROY SOC A-MATH PHY, V455, P3665, DOI 10.1098/rspa.1999.0471; EAMES I, 1994, J FLUID MECH, V275, P201, DOI 10.1017/S0022112094002338; ECKART C, 1948, J MAR RES, V7, P265; Fish FE, 1998, J EXP BIOL, V201, P2867; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Katija K, 2008, LIMNOL OCEANOGR-METH, V6, P162, DOI 10.4319/lom.2008.6.162; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Lamb H, 1993, HYDRODYNAMICS, V6th; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Tennekes H., 1972, 1 COURSE TURBULENCE; Thorpe S. A, 2005, TURBULENT OCEAN; TURNER JS, 1964, J FLUID MECH, V18, P195, DOI 10.1017/S0022112064000155; WILLERT CE, 1991, EXP FLUIDS, V10, P181	20	124	125	7	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					624	U87		10.1038/nature08207	http://dx.doi.org/10.1038/nature08207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641595				2022-12-24	WOS:000268454300049
J	McDonald, A				McDonald, Anne			A Patient's Journey Living with a benign brain tumour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												somerledmcd@btinternet.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2886	10.1136/bmj.b2886	http://dx.doi.org/10.1136/bmj.b2886			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479PG	19638372				2022-12-24	WOS:000268672800008
J	Plotkin, SR; Stemmer-Rachamimov, AO; Barker, FG; Halpin, C; Padera, TP; Tyrrell, A; Sorensen, AG; Jain, RK; di Tomaso, E				Plotkin, Scott R.; Stemmer-Rachamimov, Anat O.; Barker, Fred G., II; Halpin, Chris; Padera, Timothy P.; Tyrrell, Alex; Sorensen, A. Gregory; Jain, Rakesh K.; di Tomaso, Emmanuelle			Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACIAL-NERVE FUNCTION; PHASE-II TRIAL; VESTIBULAR-SCHWANNOMA; TUMOR VASCULATURE; ACOUSTIC NEUROMAS; KINASE INHIBITOR; ANGIOGENESIS; EXPRESSION; MANAGEMENT	Background Profound hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated with bilateral vestibular schwannomas, benign tumors that arise from the eighth cranial nerve. There is no medical treatment for such tumors. Methods We determined the expression pattern of vascular endothelial growth factor (VEGF) and three of its receptors, VEGFR-2, neuropilin-1, and neuropilin-2, in paraffin-embedded samples from 21 vestibular schwannomas associated with neurofibromatosis type 2 and from 22 sporadic schwannomas. Ten consecutive patients with neurofibromatosis type 2 and progressive vestibular schwannomas who were not candidates for standard treatment were treated with bevacizumab, an anti-VEGF monoclonal antibody. An imaging response was defined as a decrease of at least 20% in tumor volume, as compared with baseline. A hearing response was defined as a significant increase in the word-recognition score, as compared with baseline. Results VEGF was expressed in 100% of vestibular schwannomas and VEGFR-2 in 32% of tumor vessels on immunohistochemical analysis. Before treatment, the median annual volumetric growth rate for 10 index tumors was 62%. After bevacizumab treatment in the 10 patients, tumors shrank in 9 patients, and 6 patients had an imaging response, which was maintained in 4 patients during 11 to 16 months of follow-up. The median best response to treatment was a volumetric reduction of 26%. Three patients were not eligible for a hearing response; of the remaining seven patients, four had a hearing response, two had stable hearing, and one had progressive hearing loss. There were 21 adverse events of grade 1 or 2. Conclusions VEGF blockade with bevacizumab improved hearing in some, but not all, patients with neurofibromatosis type 2 and was associated with a reduction in the volume of most growing vestibular schwannomas.	[Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat O.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Padera, Timothy P.; Tyrrell, Alex; Jain, Rakesh K.; di Tomaso, Emmanuelle] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Plotkin, Scott R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA; [Sorensen, A. Gregory] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Halpin, Chris] Massachusetts Eye & Ear Infirm, Dept Audiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary	Plotkin, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Yawkey 9E,55 Fruit St, Boston, MA 02114 USA.	splotkin@partners.org	Padera, Timothy/R-2982-2019; Tyrrell, James/A-6359-2010; Jain, Rakesh K/I-1384-2017	Padera, Timothy/0000-0002-3453-9384; Jain, Rakesh K/0000-0001-7571-3548; Plotkin, Scott/0000-0002-6109-6419	Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; Children's Tumor Foundation [NF050202]; Neurofibromatosis Research Program of the Department of Defense [P01NS024279, P01CA80124]; National Institutes of Health; Federal Share/National Cancer Institute Proton Beam Program; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER	Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; Children's Tumor Foundation; Neurofibromatosis Research Program of the Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federal Share/National Cancer Institute Proton Beam Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; the Children's Tumor Foundation; a grant (NF050202, to Dr. Plotkin) from the Neurofibromatosis Research Program of the Department of Defense; a Claflin Award (to Dr. di Tomaso); grants (P01NS024279, to Dr. Stemmer- Rachamimov; and P01CA80124, to Dr. Jain) from the National Institutes of Health; and grants from the Federal Share/National Cancer Institute Proton Beam Program (to Drs. di Tomaso and Jain).	Babovic-Vuksanovic D, 2006, NEUROLOGY, V67, P1860, DOI 10.1212/01.wnl.0000243231.12248.67; Babovic-Vuksanovic D, 2007, PEDIATR NEUROL, V36, P293, DOI 10.1016/j.pediatrneurol.2007.01.009; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Brackmann DE, 2001, NEUROSURGERY, V49, P274, DOI 10.1097/00006123-200108000-00007; Brieger J, 2003, ACTA OTO-LARYNGOL, V123, P1040, DOI 10.1080/00016480310005101; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caye-Thomasen P, 2005, OTOL NEUROTOL, V26, P98, DOI 10.1097/00129492-200501000-00017; Caye-Thomasen P, 2007, AUDIOL NEURO-OTOL, V12, P1, DOI 10.1159/000096152; Combs SE, 2005, INT J RADIAT ONCOL, V63, P75, DOI 10.1016/j.ijrobp.2005.01.055; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; Fine HA, 2000, J CLIN ONCOL, V18, P708, DOI 10.1200/JCO.2000.18.4.708; Flickinger JC, 2001, J NEUROSURG, V94, P1, DOI 10.3171/jns.2001.94.1.0001; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Halpin C, 2006, OTOL NEUROTOL, V27, P110, DOI 10.1097/00129492-200601000-00020; Harris GJ, 2008, NEUROSURGERY, V62, P1314, DOI 10.1227/01.neu.0000333303.79931.83; Hirsh IJ, 1952, J SPEECH HEAR DISORD, V17, P321, DOI 10.1044/jshd.1703.321; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P176, DOI 10.1016/S0194-5998(95)70100-1; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Plotkin SR, 2008, NAT CLIN PRACT ONCOL, V5, P487, DOI 10.1038/ncponc1157; Plotkin SR, 2009, J NEURO-ONCOL, V93, P61, DOI 10.1007/s11060-009-9867-7; Saito K, 2003, CLIN NEUROPATHOL, V22, P30; Samii M, 1997, NEUROSURGERY, V40, P696, DOI 10.1097/00006123-199704000-00007; Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527; TAKAMIYA Y, 1994, NEUROSURGERY, V34, P869, DOI 10.1227/00006123-199405000-00013; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Uesaka T, 2007, J NEURO-ONCOL, V83, P259, DOI 10.1007/s11060-007-9336-0; Uzun C, 2003, LARYNGOSCOPE, V113, P1751, DOI 10.1097/00005537-200310000-00017	30	296	307	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					358	367		10.1056/NEJMoa0902579	http://dx.doi.org/10.1056/NEJMoa0902579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19587327	Green Accepted, Green Published			2022-12-24	WOS:000268184500006
J	Sfeir, A; Kosiyatrakul, ST; Hockemeyer, D; MacRae, SL; Karlseder, J; Schildkraut, CL; de Lange, T				Sfeir, Agnel; Kosiyatrakul, Settapong T.; Hockemeyer, Dirk; MacRae, Sheila L.; Karlseder, Jan; Schildkraut, Carl L.; de lange, Titia			Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication	CELL			English	Article							SISTER CHROMATID EXCHANGES; DNA-BINDING DOMAIN; G4 DNA; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; CHROMOSOME ENDS; ESSENTIAL GENE; PROTEINS TRF1; POT1 PROTEINS; LENGTH	Telomeres protect chromosome ends through the interaction of telomeric repeats with shelterin, a protein complex that represses DNA damage signaling and DNA repair reactions. The telomeric repeats are maintained by telomerase, which solves the end replication problem. We report that the TTAGGG repeat arrays of mammalian telomeres pose a challenge to the DNA replication machinery, giving rise to replication-dependent defects that resemble those of aphidicolin-induced common fragile sites. Gene deletion experiments showed that efficient duplication of telomeres requires the shelterin component TRF1. Without TRF1, telomeres activate the ATR kinase in S phase and show a fragile-site phenotype in metaphase. Single-molecule analysis of replicating telomeres showed that TRF1 promotes efficient replication of TTAGGG repeats and prevents fork stalling. Two helicases implicated in the removal of G4 DNA structures, BLM and RTEL1, were required to repress the fragile-telomere phenotype. These results identify a second telomere replication problem that is solved by the shelterin component TRF1.	[Sfeir, Agnel; Hockemeyer, Dirk; MacRae, Sheila L.; Karlseder, Jan; de lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA; [Kosiyatrakul, Settapong T.; Schildkraut, Carl L.] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Hockemeyer, Dirk/0000-0002-5598-5092	NCI NIH HHS [R01 CA076027-11, R01 CA076027] Funding Source: Medline; NIA NIH HHS [R01 AG016642, R01 AG016642-10] Funding Source: Medline; NIGMS NIH HHS [R37 GM049046, R37 GM049046-17] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AK, 1996, MOL CELL BIOL, V16, P4614; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Falaschi A, 2007, CELL CYCLE, V6, P1705, DOI 10.4161/cc.6.14.4495; FEICHTINGER W, 1989, HUM GENET, V83, P145, DOI 10.1007/BF00286707; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Musio A, 1996, CYTOGENET CELL GENET, V75, P159, DOI 10.1159/000134469; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Philippe C, 1999, ANN GENET-PARIS, V42, P202; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Undarmaa B, 2004, BIOCHEM BIOPH RES CO, V315, P51, DOI 10.1016/j.bbrc.2004.01.014; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	71	691	700	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					90	103		10.1016/j.cell.2009.06.021	http://dx.doi.org/10.1016/j.cell.2009.06.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596237	Bronze, Green Accepted			2022-12-24	WOS:000267848600017
J	Sharam, GJ; Sinclair, ARE; Turkington, R				Sharam, Gregory J.; Sinclair, A. R. E.; Turkington, Roy			Serengeti Birds Maintain Forests by Inhibiting Seed Predators	SCIENCE			English	Article							TANZANIA		[Sharam, Gregory J.; Sinclair, A. R. E.; Turkington, Roy] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Turkington, R (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	royt@interchange.ubc.ca			Natural sciences and Engineering Research Council of Canada	Natural sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural sciences and Engineering Research Council of Canada.	Chapman CA, 1999, CONSERV BIOL, V13, P1301, DOI 10.1046/j.1523-1739.1999.98229.x; Mduma SAR, 2007, J ECOL, V95, P184, DOI 10.1111/j.1365-2745.2006.01188.x; PELLEW RA, 1984, AFR J ECOL, V22, P73, DOI 10.1111/j.1365-2028.1984.tb00679.x; SHARAM G, 2005, THESIS U BRIT COLUMB; Sharam G, 2006, BIOTROPICA, V38, P599, DOI 10.1111/j.1744-7429.2006.00195.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397	6	18	18	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					51	51		10.1126/science.1173805	http://dx.doi.org/10.1126/science.1173805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574381				2022-12-24	WOS:000267594000030
J	Laybourn-Parry, J				Laybourn-Parry, Johanna			No Place Too Cold	SCIENCE			English	Editorial Material									Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas 7001, Australia	University of Tasmania	Laybourn-Parry, J (corresponding author), Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas 7001, Australia.	Jo.Laybourn-Parry@utas.edu.au						Foreman CM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000358; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Laybourn-Parry J, 2005, FRESHWATER BIOL, V50, P830, DOI 10.1111/j.1365-2427.2005.01369.x; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; PEARCE DA, 2008, POLAR LAKES RIVERS, P231; Priscu J. C, 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Sawstrom C, 2008, EXTREMOPHILES, V12, P167, DOI 10.1007/s00792-007-0134-6; Skidmore ML, 2000, APPL ENVIRON MICROB, V66, P3214, DOI 10.1128/AEM.66.8.3214-3220.2000; Stackebrandt E, 2004, CELL MOL BIOL, V50, P517; Stibal M, 2008, BIOGEOCHEMISTRY, V90, P1, DOI 10.1007/s10533-008-9226-3; TRANVIK LJ, 1989, OECOLOGIA, V78, P473, DOI 10.1007/BF00378736	11	34	34	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1521	1522		10.1126/science.1173645	http://dx.doi.org/10.1126/science.1173645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541982				2022-12-24	WOS:000267130600027
J	Harris, J				Harris, John			Is it acceptable for people to take methylphenidate to enhance performance? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRAIN		Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England	University of Manchester	Harris, J (corresponding author), Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England.	john.harris@manchester.ac.uk						Almeida SS, 2002, NUTR NEUROSCI, V5, P311, DOI 10.1080/1028415021000033776; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Greely H., 2008, NATURE, V456, P18, DOI DOI 10.1196/ANNALS.1382.021; Harris J., 2007, ENHANCING EVOLUTION; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645	8	15	15	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2009	338								b1955	10.1136/bmj.b1955	http://dx.doi.org/10.1136/bmj.b1955			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460US	19541705				2022-12-24	WOS:000267216800001
J	Kota, J; Chivukula, RR; O'Donnell, KA; Wentzel, EA; Montgomery, CL; Hwang, HW; Chang, TC; Vivekanandan, P; Torbenson, M; Clark, KR; Mendell, JR; Mendell, JT				Kota, Janaiah; Chivukula, Raghu R.; O'Donnell, Kathryn A.; Wentzel, Erik A.; Montgomery, Chrystal L.; Hwang, Hun-Way; Chang, Tsung-Cheng; Vivekanandan, Perumal; Torbenson, Michael; Clark, K. Reed; Mendell, Jerry R.; Mendell, Joshua T.			Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model	CELL			English	Article							ADENOASSOCIATED VIRUS VECTORS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; GENE-THERAPY; AAV VECTORS; EXPRESSION; P53; MYC; TRANSDUCTION; APOPTOSIS	Therapeutic strategies based on modulation of microRNA (miRNA) activity hold great promise due to the ability of these small RNAs to potently influence cellular behavior. In this study, we investigated the efficacy of a miRNA replacement therapy for liver cancer. We demonstrate that hepatocellular carcinoma (HCC) cells exhibit reduced expression of miR-26a, a miRNA that is normally expressed at high levels in diverse tissues. Expression of this miRNA in liver cancer cells in vitro induces cell-cycle arrest associated with direct targeting of cyclins D2 and E2. Systemic administration of this miRNA in a mouse model of HCC using adeno-associated virus (AAV) results in inhibition of cancer cell proliferation, induction of tumor-specific apoptosis, and dramatic protection from disease progression without toxicity. These findings suggest that delivery of miRNAs that are highly expressed and therefore tolerated in normal tissues but lost in disease cells may provide a general strategy for miRNA replacement therapies.	[Kota, Janaiah; Montgomery, Chrystal L.; Clark, K. Reed; Mendell, Jerry R.] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA; [Chivukula, Raghu R.; Wentzel, Erik A.; Hwang, Hun-Way; Chang, Tsung-Cheng; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [O'Donnell, Kathryn A.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [O'Donnell, Kathryn A.; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Vivekanandan, Perumal; Torbenson, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Clark, K. Reed; Mendell, Jerry R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mendell, Jerry R.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mendell, JR (corresponding author), Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA.	jerry.mendell@nationwidechildrens.org; jmendell@jhmi.edu	Chang, Tsung-Cheng/C-2761-2008; Clark, Kelly/E-2900-2011	Chang, Tsung-Cheng/0000-0003-4706-0468; Hwang, Hun-Way/0000-0003-0522-1577	US National Institutes of Health [R01CA120185]; Sol Goldman Center for Pancreatic Cancer Research; Research Institute at Nationwide Children's Hospital; Damon Runyon Cancer Research Foundation [DRG-1918-06]; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA120185] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sol Goldman Center for Pancreatic Cancer Research; Research Institute at Nationwide Children's Hospital(Ohio State University); Damon Runyon Cancer Research Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Michael Bishop for tet-o-MYC mice, Terri Shaffer and Lucia Rosas for help with virus administration, and the staff at Nationwide Children's Hospital Viral Vector Core facility. This work was supported by US National Institutes of Health grant R01CA120185 (to J.T.M.),the Sol Goldman Center for Pancreatic Cancer Research ( J.T.M.), and the Research Institute at Nationwide Children's Hospital (J.R.M.). J.T.M. is a Rita Allen Foundation Scholar and a Leukemia and Lymphoma Society Scholar. K.A.O. is a fellow of the Damon Runyon Cancer Research Foundation (DRG-1918-06). R. R. C. is supported by the Medical Scientist Training Program.	Alexander IE, 2008, GENE THER, V15, P831, DOI 10.1038/gt.2008.64; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm Dirk, 2007, Hematology Am Soc Hematol Educ Program, P473; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Love TM, 2008, J ALLERGY CLIN IMMUN, V121, P309, DOI 10.1016/j.jaci.2007.12.1167; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CELL CYCLE, V6, P1455; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Park K, 2008, FRONT BIOSCI-LANDMRK, V13, P2653, DOI 10.2741/2872; Pathak A, 2008, INT J NANOMED, V3, P31; Peng DC, 2000, J HEPATOL, V32, P975, DOI 10.1016/S0168-8278(00)80102-6; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roberts LR, 2008, NEW ENGL J MED, V359, P420, DOI 10.1056/NEJMe0802241; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shen Z, 2008, CANCER LETT, V272, P268, DOI 10.1016/j.canlet.2008.03.064; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	65	1376	1513	5	307	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1005	1017		10.1016/j.cell.2009.04.021	http://dx.doi.org/10.1016/j.cell.2009.04.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524505	Green Accepted, Bronze			2022-12-24	WOS:000266916400014
J	Skaar, JR; Pagan, JK; Pagano, M				Skaar, Jeffrey R.; Pagan, Julia K.; Pagano, Michele			SnapShot: F Box Proteins I	CELL			English	Editorial Material							SCF UBIQUITIN-LIGASE; COMPLEX; PROTEOLYSIS; INSIGHTS; SKP1		[Skaar, Jeffrey R.; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Skaar, JR (corresponding author), NYU, Sch Med, New York, NY 10016 USA.		Pagan, Julia/O-1929-2016	Pagan, Julia/0000-0002-7079-6388; pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076584] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1	10	69	71	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6								10.1016/j.cell.2009.05.039	http://dx.doi.org/10.1016/j.cell.2009.05.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524517	Bronze			2022-12-24	WOS:000266916400026
J	Tubbs, JL; Latypov, V; Kanugula, S; Butt, A; Melikishvili, M; Kraehenbuehl, R; Fleck, O; Marriott, A; Watson, AJ; Verbeek, B; McGown, G; Thorncroft, M; Santibanez-Koref, MF; Millington, C; Arvai, AS; Kroeger, MD; Peterson, LA; Williams, DM; Fried, MG; Margison, GP; Pegg, AE; Tainer, JA				Tubbs, Julie L.; Latypov, Vitaly; Kanugula, Sreenivas; Butt, Amna; Melikishvili, Manana; Kraehenbuehl, Rolf; Fleck, Oliver; Marriott, Andrew; Watson, Amanda J.; Verbeek, Barbara; McGown, Gail; Thorncroft, Mary; Santibanez-Koref, Mauro F.; Millington, Christopher; Arvai, Andrew S.; Kroeger, Matthew D.; Peterson, Lisa A.; Williams, David M.; Fried, Michael G.; Margison, Geoffrey P.; Pegg, Anthony E.; Tainer, John A.			Flipping of alkylated DNA damage bridges base and nucleotide excision repair	NATURE			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ESCHERICHIA-COLI; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; STRUCTURAL BASIS; ENDONUCLEASE-V; PROTEIN; RECOGNITION; BINDING; GENOME; SUBSTRATE	Alkyltransferase-like proteins (ATLs) share functional motifs with the cancer chemotherapy target O-6-alkylguanine-DNA alkyltransferase (AGT) and paradoxically protect cells from the biological effects of DNA alkylation damage, despite lacking the reactive cysteine and alkyltransferase activity of AGT. Here we determine Schizosaccharomyces pombe ATL structures without and with damaged DNA containing the endogenous lesion O-6-methylguanine or cigarette-smoke-derived O-6-4-(3-pyridyl)-4-oxobutylguanine. These results reveal non-enzymatic DNA nucleotide flipping plus increased DNA distortion and binding pocket size compared to AGT. Our analysis of lesion-binding site conservation identifies new ATLs in sea anemone and ancestral archaea, indicating that ATL interactions are ancestral to present-day repair pathways in all domains of life. Genetic connections to mammalian XPG (also known as ERCC5) and ERCC1 in S. pombe homologues Rad13 and Swi10 and biochemical interactions with Escherichia coli UvrA and UvrC combined with structural results reveal that ATLs sculpt alkylated DNA to create a genetic and structural intersection of base damage processing with nucleotide excision repair.	[Tubbs, Julie L.; Arvai, Andrew S.; Kroeger, Matthew D.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Arvai, Andrew S.; Kroeger, Matthew D.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Latypov, Vitaly; Butt, Amna; Marriott, Andrew; Watson, Amanda J.; Verbeek, Barbara; McGown, Gail; Thorncroft, Mary; Margison, Geoffrey P.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Carcinogenesis Grp, Manchester M20 4BX, Lancs, England; [Kanugula, Sreenivas; Pegg, Anthony E.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, Lexington, KY 40536 USA; [Kraehenbuehl, Rolf; Fleck, Oliver] Bangor Univ, NWCRF Inst, Bangor LL57 2UW, Gwynedd, Wales; [Santibanez-Koref, Mauro F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Millington, Christopher; Williams, David M.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; [Peterson, Lisa A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Peterson, Lisa A.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; Paterson Institute for Cancer Research; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kentucky; Bangor University; Newcastle University - UK; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tainer, JA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	aep1@psu.edu; jat@scripps.edu	Tainer, John/GWQ-4878-2022; Margison, Geoff/E-4146-2019; Williams, David M/J-9627-2013	Tainer, John/0000-0003-1659-2429; Kraehenbuehl, Rolf/0000-0003-2578-5601; Peterson, Lisa/0000-0001-8715-4480; Fleck, Oliver/0000-0003-0550-6513; Williams, David/0000-0002-5618-182X	US Department of Energy; NIH [CA097209, CA018137, GM070662, CA59887]; Skaggs Institute for Chemical Biology; North West Cancer Research Fund [CR675]; Cancer Research-UK; CHEMORES; NATIONAL CANCER INSTITUTE [R37CA018137, R01CA059887, R01CA097209, R01CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; North West Cancer Research Fund; Cancer Research-UK(Cancer Research UK); CHEMORES; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. C. Vu and J. Gong for aiding in the synthesis of O<SUP>6</SUP>-pobG oligomers, M. N. Boddy, J. Prudden and A. Sarker for performing genetics and biochemical experiments, G. Guenther, S. Pebernard, R. S. Williams, J. J. Perry, B. R. Chapados, M. Bjora s, D. S. Shin, K. Hitomi, C. Hitomi, E. D. Getzoff, G. Williams, S. Tsutakawa and P. K. Cooper for suggestions, and the staff at the Advanced Light Source (ALS) SIBYLS beamline and the Stanford Synchrotron Radiation Laboratory (SSRL). Operations at SSRL and ALS are supported by the US Department of Energy and NIH. This work was supported by National Institutes of Health grants CA097209 (J. A. T., A. E. P.), CA018137 (A. E. P.), GM070662 (M. G. F.), and CA59887 (L. A. P.), The Skaggs Institute for Chemical Biology (J. L. T.), North West Cancer Research Fund grant CR675 (O. F.), Cancer Research-UK (G. P. M.) and CHEMORES (G. P. M.).	Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Daniels DS, 2000, MUTAT RES-DNA REPAIR, V460, P151, DOI 10.1016/S0921-8777(00)00024-0; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1999, CARCINOGENESIS, V20, P103, DOI 10.1093/carcin/20.1.103; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Kanugula S, 2005, P NATL ACAD SCI USA, V102, P3617, DOI 10.1073/pnas.0408719102; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; MAZON G, 2006, DNA REPAIR IN PRESS; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Pauly GT, 1998, CARCINOGENESIS, V19, P457, DOI 10.1093/carcin/19.3.457; Pearson SJ, 2005, NUCLEIC ACIDS RES, V33, P3837, DOI 10.1093/nar/gki696; Pearson SJ, 2006, NUCLEIC ACIDS RES, V34, P2347, DOI 10.1093/nar/gkl270; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; Scharer OD, 2009, NAT STRUCT MOL BIOL, V16, P102, DOI 10.1038/nsmb0209-102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	50	99	101	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					808	813		10.1038/nature08076	http://dx.doi.org/10.1038/nature08076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516334	Green Accepted			2022-12-24	WOS:000267084500031
J	Scholl, C; Frohling, S; Dunn, IF; Schinzel, AC; Barbie, DA; Kim, SY; Silver, SJ; Tamayo, P; Wadlow, RC; Ramaswamy, S; Dohner, K; Bullinger, L; Sandy, P; Boehm, JS; Root, DE; Jacks, T; Hahn, WC; Gilliland, DG				Scholl, Claudia; Froehling, Stefan; Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Wadlow, Raymond C.; Ramaswamy, Sridhar; Doehner, Konstanze; Bullinger, Lars; Sandy, Peter; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary			Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells	CELL			English	Article							LENTIVIRAL RNAI LIBRARY; K-RAS ONCOGENE; MULTIPLE-MYELOMA; TUMOR-CELLS; N-RAS; GROWTH; SCREEN; MUTATIONS; SURVIVAL; GENES	An alternative to therapeutic targeting of oncogenes is to perform "synthetic lethality'' screens for genes that are essential only in the context of specific cancer-causing mutations. We used high-throughput RNA interference (RNAi) to identify synthetic lethal interactions in cancer cells harboring mutant KRAS, the most commonly mutated human oncogene. We find that cells that are dependent on mutant KRAS exhibit sensitivity to suppression of the serine/threonine kinase STK33 irrespective of tissue origin, whereas STK33 is not required by KRAS-independent cells. STK33 promotes cancer cell viability in a kinase activity-dependent manner by regulating the suppression of mitochondrial apoptosis mediated through S6K1-induced inactivation of the death agonist BAD selectively in mutant KRAS-dependent cells. These observations identify STK33 as a target for treatment of mutant KRAS-driven cancers and demonstrate the potential of RNAi screens for discovering functional dependencies created by oncogenic mutations that may enable therapeutic intervention for cancers with "undruggable'' genetic alterations.	[Scholl, Claudia; Froehling, Stefan; Hahn, William C.; Gilliland, D. Gary] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Dunn, Ian F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.; Gilliland, D. Gary] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Ramaswamy, Sridhar; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary] Broad Inst Harvard, Cambridge, MA 02142 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Ramaswamy, Sridhar; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary] MIT, Cambridge, MA 02142 USA; [Barbie, David A.; Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; [Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Boston, MA 02114 USA; [Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Ramaswamy, Sridhar; Gilliland, D. Gary] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Doehner, Konstanze; Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Sandy, Peter; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sandy, Peter; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gilliland, D. Gary] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Ulm University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hahn, WC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; ggilliland@rics.bwh.harvard.edu	Bullinger, Lars/AAL-7965-2020	Boehm, Jesse/0000-0002-6795-6336; Wadlow, Raymond/0000-0003-1959-5406; Bullinger, Lars/0000-0002-5890-5510	National Institutes of Health [R33 CA128625, U54 CA112962, P01 CA095616, P01 CA66996]; Starr Cancer Consortium; Doris Duke Charitable Foundation; MPD Foundation; Leukemia and Lymphoma Society; Deutsche Forschungsgemeinschaft [SCHO 1215/1-1, FR 2113/1-1]; Brain Science Foundation; NATIONAL CANCER INSTITUTE [R33CA128625, RC2CA148268, P01CA095616, U54CA112962, P01CA066996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MPD Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Brain Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Maricel Gozo for technical support, the Broad Institute RNAi Platform for assistance with high-throughput screening, and John Blenis, Benjamin G. Neel, Demetrios Kalaitzidis, Michael G. Kharas, Thomas Kindler, Steven W. Lane, Stephen M. Sykes, and members of the Gilliland and Hahn laboratories for valuable discussions and reagents. This work was supported by National Institutes of Health grants R33 CA128625, U54 CA112962, P01 CA095616 ( to W. C. H.), and P01 CA66996 ( to D. G. G.), and grants from the Starr Cancer Consortium ( to W. C. H. and D. G. G.), the Doris Duke Charitable Foundation ( to D. G. G.), the MPD Foundation ( to D. G. G), and the Leukemia and Lymphoma Society ( to D. G. G.). C. S. and S. F. were supported by grants SCHO 1215/1-1 and FR 2113/1-1 from the Deutsche Forschungsgemeinschaft. I. F. D. was supported by the Brain Science Foundation.	BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Crowder C, 2003, ONCOGENE, V22, P649, DOI 10.1038/sj.onc.1206180; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Demunter A, 2001, CANCER RES, V61, P4916; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin SR, 1998, BRIT J CANCER, V77, P1060, DOI 10.1038/bjc.1998.177; Lin SR, 2000, BRIT J CANCER, V82, P1035; LUCCHESI JC, 1968, GENETICS, V59, P37; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mujica AO, 2001, GENE, V280, P175, DOI 10.1016/S0378-1119(01)00780-6; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEI L, 1994, J CLIN ENDOCR METAB, V78, P842, DOI 10.1210/jc.78.4.842; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simons A, 2001, GENOME RES, V11, P266, DOI 10.1101/gr.154201; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; SUZUKI Y, 1990, ONCOGENE, V5, P1037; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Wang JY, 2006, ONCOL REP, V16, P1245; Westbrook TF, 2005, COLD SH Q B, V70, P435, DOI 10.1101/sqb.2005.70.031; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	63	428	449	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					821	834		10.1016/j.cell.2009.03.017	http://dx.doi.org/10.1016/j.cell.2009.03.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490892	Bronze, Green Published			2022-12-24	WOS:000266454800014
J	Schulte, DM; Burke, RP; Lipcius, RN				Schulte, David M.; Burke, Russell P.; Lipcius, Romuald N.			Unprecedented Restoration of a Native Oyster Metapopulation	SCIENCE			English	Article							CHESAPEAKE BAY; CRASSOSTREA-VIRGINICA; HABITAT; REEF; SURVIVAL; PERFORMANCE; ECOSYSTEMS; COLLAPSE; GROWTH	Native oyster species were once vital ecosystem engineers, but their populations have collapsed worldwide because of overfishing and habitat destruction. In 2004, we initiated a vast (35-hectare) field experiment by constructing native oyster reefs of three types (high-relief, low-relief, and unrestored) in nine protected sanctuaries throughout the Great Wicomico River in Virginia, United States. Upon sampling in 2007 and 2009, we found a thriving metapopulation comprising 185 million oysters of various age classes. Oyster density was fourfold greater on high-relief than on low-relief reefs, explaining the failure of past attempts. Juvenile recruitment and reef accretion correlated with oyster density, facilitating reef development and population persistence. This reestablished metapopulation is the largest of any native oyster worldwide and validates ecological restoration of native oyster species.	[Schulte, David M.; Burke, Russell P.; Lipcius, Romuald N.] Coll William & Mary, Dept Fisheries Sci, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Lipcius, RN (corresponding author), Coll William & Mary, Dept Fisheries Sci, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.	rom@vims.edu			U.S. Army Corps of Engineers, Norfolk District; National Oceanic and Atmospheric Administration, Chesapeake Bay Office	U.S. Army Corps of Engineers, Norfolk District; National Oceanic and Atmospheric Administration, Chesapeake Bay Office(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank Col. D. Hansen, Col. D. Anninos, S. Tosi, M. Hudgins, K. Groth, M. Hamor, M. Mansfield, B. Rheinhart, and C. Seltzer of the U.S. Army Corps of Engineers, Norfolk District, for support; D. Bushey of Commonwealth Pro-Dive, the Bristow brothers, S. Hardaway, J. Dowdy, D. McCulloch, R. Gill, M. Seebo, W. C. Long, J. van Montfrans, A. Smith, and C. Bovery for field assistance; G. Saluta for photo production; and J. Hoenig, C. Peterson, and R. Seitz for constructive comments on the manuscript. Funding was provided by the U.S. Army Corps of Engineers, Norfolk District, and the Blue Crab Advanced Research Consortium through the National Oceanic and Atmospheric Administration, Chesapeake Bay Office.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; BERMAN MS, 2002, VIRGINIA OYSTER REEF; DEALTERIS JT, 1988, ESTUARIES, V11, P240, DOI 10.2307/1352010; Encomio VG, 2005, J SHELLFISH RES, V24, P143; Grabowski JH, 2007, THEOR ECOL SER, P281; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; Lenihan HS, 2004, FISH B-NOAA, V102, P298; LIPCIUS RN, 2005, 390 COLL WILL MAR VI; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MANN R, 1991, Journal of Shellfish Research, V10, P379; Mitchell IM, 2000, AQUACULTURE, V191, P309, DOI 10.1016/S0044-8486(00)00441-5; Nestlerode JA, 2007, RESTOR ECOL, V15, P273, DOI 10.1111/j.1526-100X.2007.00210.x; Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHULTE DM, 2009, USE ALTERNATIVE MAT; Smith GF, 2005, N AM J FISH MANAGE, V25, P1569, DOI 10.1577/M04-058.1; Tarnowski M, 2007, MARYLAND OYSTER POPU; Taylor J, 2008, MAR ECOL PROG SER, V361, P301, DOI 10.3354/meps07429; *USA CORPS ENG, 2003, CHES BAY OYST REC PH; *USA CORPS ENG, 2008, 11216 USA CORPS ENG; WINSLOW F, 1881, POP SCI MONTHLY, V12, P29	28	232	236	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1124	1128		10.1126/science.1176516	http://dx.doi.org/10.1126/science.1176516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19644073	Green Submitted			2022-12-24	WOS:000269382300040
J	Moynihan, R				Moynihan, Ray			Drug Safety Battle over popular bone drug Fosamax bursts into court	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; JAW					Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					*AM DENT ASS, 2008, DENT MAN PAT REC OR; *DEP HLTH HUM SERV, 2004, ODS POST MARK SAF RE; Khan AA, 2008, J RHEUMATOL, V35, P1391; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Landis BN, 2006, BMJ-BRIT MED J, V333, P982, DOI 10.1136/bmj.39024.647558.BE; LO JC, J ORAL MAXILLOFAC SU; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; 2009, MERCK PRODUCT NEWS	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2009	339								b3155	10.1136/bmj.40024.494213.4D	http://dx.doi.org/10.1136/bmj.40024.494213.4D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KE	19661142				2022-12-24	WOS:000268808100003
J	Mills, EJ; Ford, N; Mugyenyi, P				Mills, Edward J.; Ford, Nathan; Mugyenyi, Peter			Expanding HIV care in Africa: making men matter	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; FOLLOW-UP; GENDER; SETTINGS; LOST		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON V5Z 4B4, Canada; [Ford, Nathan] Med Sans Frontieres, Cape Town, WA, South Africa; [Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda	University of Ottawa; Joint Clinic Research Center - United Arab Emirates	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON V5Z 4B4, Canada.	emills@cfenet.ubc.ca						Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; JOHNSON W, 2008, COMMUNICATION   0319; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Lewis S., 2006, 16 INT AIDS C TOR CA; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; NATTRASS N, 2006, AIDS GENDER ACCESS A; *UNAIDS, WOM HIV TRIALS; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; 2006, ACTION HIV AIDS HUMA	11	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 25	2009	374	9686					275	276		10.1016/S0140-6736(09)61348-9	http://dx.doi.org/10.1016/S0140-6736(09)61348-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477GW	19632481				2022-12-24	WOS:000268508200009
J	Andreae, DA; Andreae, MH				Andreae, D. A.; Andreae, M. H.			Uncertainties Page Should antihistamines be used to treat anaphylaxis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENT VISITS; EPINEPHRINE; MANAGEMENT; H-1-ANTIHISTAMINES; MULTICENTER; ANTAGONISTS; GUIDELINES; ALLERGIES; DRUG; FOOD		[Andreae, D. A.] St Josefs Hosp, Freiburg, Germany; [Andreae, M. H.] Vienna Med Univ, Vienna, Austria	Medical University of Vienna	Andreae, DA (corresponding author), St Josefs Hosp, Freiburg, Germany.	adriana@andreae.org	Andreae, Michael/AAE-5558-2022	Andreae, Michael/0000-0002-9052-0936				ALASTAIR JJ, 2004, NEW ENGL J MED, V350, P1013; Alrasbi M, 2007, ALLERGY, V62, P838, DOI 10.1111/j.1398-9995.2007.01434.x; *AM AC ALL ASTHM I, 2005, J ALLERGY CLIN IMMUN, V115, pS483; Bautista E, 2002, INT ARCH ALLERGY IMM, V128, P151, DOI 10.1159/000059406; Brown SGA, 2006, MED J AUSTRALIA, V185, P283, DOI 10.5694/j.1326-5377.2006.tb00563.x; Clark S, 2005, J ALLERGY CLIN IMMUN, V116, P643, DOI 10.1016/j.jaci.2005.06.026; Clark S, 2004, J ALLERGY CLIN IMMUN, V113, P347, DOI 10.1016/j.jaci.2003.10.053; Gonzalez SK, 2008, J TRAUMA, V64, P1665, DOI 10.1097/TA.0b013e31817156ce; Kemp SF, 2008, ALLERGY, V63, P1061, DOI 10.1111/j.1398-9995.2008.01733.x; Lin RY, 2000, ANN EMERG MED, V36, P462, DOI 10.1067/mem.2000.109445; RUNGE JW, 1992, ANN EMERG MED, V21, P237, DOI 10.1016/S0196-0644(05)80881-9; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sheikh A, 2007, ALLERGY, V62, P830, DOI 10.1111/j.1398-9995.2007.01435.x; Sheikh A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006312.pub2; Simons FER, 2007, ALLERGY, V62, P827, DOI 10.1111/j.1398-9995.2007.01433.x; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P837, DOI 10.1016/j.jaci.2004.01.079; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Soar J, 2008, RESUSCITATION, V77, P157, DOI 10.1016/j.resuscitation.2008.02.001; Soldovieri MV, 2008, CHEM RES TOXICOL, V21, P997, DOI 10.1021/tx800020c; WINBERY SL, 2002, HISTAMINE H1 ANTIHIS, P287	20	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2009	339								b2489	10.1136/bmj.b2489	http://dx.doi.org/10.1136/bmj.b2489			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LC	19592404				2022-12-24	WOS:000267898700001
J	Jaiswal, JK; Rivera, VM; Simon, SM				Jaiswal, Jyoti K.; Rivera, Victor M.; Simon, Sanford M.			Exocytosis of Post-Golgi Vesicles Is Regulated by Components of the Endocytic Machinery	CELL			English	Article							KISS-AND-RUN; FUSION PORE; CONSTITUTIVE EXOCYTOSIS; CALCIUM; DYNAMIN; CELLS; TRANSPORT; PROTEIN; SECRETION; KINETICS	Post-Golgi vesicles target and deliver most biosynthetic cargoes to the cell surface. However, the molecules and mechanisms involved in fusion of these vesicles are not well understood. We have employed a system to simultaneously monitor release of luminal and membrane biosynthetic cargoes from individual post-Golgi vesicles. Exocytosis of these vesicles is not calcium triggered. Release of luminal cargo can be accompanied by complete, partial, or no release of membrane cargo. Partial and no release of membrane cargo of a fusing vesicle are fates associated with kiss-and-run exocytosis, and we find that these are the predominant mode of post-Golgi vesicle exocytosis. Partial cargo release by post-Golgi vesicles occurs because of premature closure of the fusion pore and is modulated by the activity of clathrin, actin, and dynamin. Our results demonstrate that these components of the endocytic machinery modulate the nature and extent of biosynthetic cargo delivery by post-Golgi vesicles at the cell membrane.	[Rivera, Victor M.] ARIAD Gene Therapeut Inc, Cambridge, MA 02139 USA; [Jaiswal, Jyoti K.; Simon, Sanford M.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Jaiswal, JK (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	jaiswaj@rockefeller.edu; simon@rockefeller.edu	Jaiswal, Jyoti/ABI-1666-2020; Jaiswal, JK/M-5891-2013; Jaiswal, Jyoti/AAD-5386-2020	Jaiswal, Jyoti/0000-0002-5992-5185; Jaiswal, JK/0000-0002-5992-5185; Simon, Sanford/0000-0002-8615-4224; Rivera, Victor/0000-0002-7258-3001	National Science Foundation [BES-0620813]; National Institutes of Health [P20 GM072015, R01AR055686]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072015, R01GM087977] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Thomas Kirschhausen for providing us with dynasore and DsRed-CLC, Jennifer Lippincott-Schwartz for VSVG<INF>ts</INF>, and Claire Atkinson for Dynamin2(aa)-mCherry. We thank lab members and others who offered helpful suggestions during the course of this work and Patrick Bhola for comments on the manuscript. Knut Wittkowski helped us with some of the statistical analysis, and the work was funded by grants from the National Science Foundation (BES-0620813) and the National Institutes of Health (P20 GM072015 to S. M. S. and R01AR055686 to J.K.J.). J.K.J. designed the research, performed the experiments, analyzed data, and wrote the paper, all with help from S. M. S. V.M.R. contributed new reagents.	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Antonny B, 2004, CELL, V119, P581, DOI 10.1016/j.cell.2004.11.026; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Cao H, 2000, J CELL SCI, V113, P1993; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; EDWARDSON JM, 1992, BIOCHEM J, V285, P383, DOI 10.1042/bj2850383; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jaiswal JK, 2007, P NATL ACAD SCI USA, V104, P14151, DOI 10.1073/pnas.0704935104; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; LEW DJ, 1991, J MEMBRANE BIOL, V123, P261, DOI 10.1007/BF01870409; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schmoranzer J, 2003, MOL BIOL CELL, V14, P1558, DOI 10.1091/mbc.E02-08-0500; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891	52	90	91	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1308	1319		10.1016/j.cell.2009.04.064	http://dx.doi.org/10.1016/j.cell.2009.04.064			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563761	Green Accepted, Bronze			2022-12-24	WOS:000267373400023
J	Tan, CSH; Pasculescu, A; Lim, WA; Pawson, T; Bader, GD; Linding, R				Tan, Chris Soon Heng; Pasculescu, Adrian; Lim, Wendell A.; Pawson, Tony; Bader, Gary D.; Linding, Rune			Positive Selection of Tyrosine Loss in Metazoan Evolution	SCIENCE			English	Article							PHOSPHORYLATION NETWORKS; BIOLOGICAL COMPLEXITY; MONOSIGA-BREVICOLLIS; GENOME	John Nash showed that within a complex system, individuals are best off if they make the best decision that they can, taking into account the decisions of the other individuals. Here, we investigate whether similar principles influence the evolution of signaling networks in multicellular animals. Specifically, by analyzing a set of metazoan species we observed a striking negative correlation of genomically encoded tyrosine content with biological complexity (as measured by the number of cell types in each organism). We discuss how this observed tyrosine loss correlates with the expansion of tyrosine kinases in the evolution of the metazoan lineage and how it may relate to the optimization of signaling systems in multicellular animals. We propose that this phenomenon illustrates genome-wide adaptive evolution to accommodate beneficial genetic perturbation.	[Tan, Chris Soon Heng; Pasculescu, Adrian; Pawson, Tony; Bader, Gary D.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tan, Chris Soon Heng; Pawson, Tony; Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tan, Chris Soon Heng; Bader, Gary D.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Linding, Rune] Inst Canc Res, Cellular & Mol Log Team, Sect Cell & Mol Biol, London SW3 6JB, England	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca; gary.bader@utoronto.ca; linding@icr.ac.uk	Pawson, Tony J/E-4578-2013; Bader, Gary/C-1176-2009; Tan, Soon Heng/C-1177-2009	Bader, Gary/0000-0003-0185-8861; Tan, Soon Heng/0000-0002-8172-5235; Linding, Rune/0000-0003-0420-4839	Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research [MOP-84324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Jorgensen, J. Zhang, K. Colwill, T. J. Gibson, J. Jin, and K. Lindorff-Larsen for suggestions and fruitful discussions. This project was in part supported by Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research (MOP-84324). C. S. H. T. conceived the project. C. S. H. T., W. A. L., G. D. B., T. P., and R. L. designed the experiments. C. S. H. T., R. L., and A. P. performed the experiments. C. S. H. T., G. D. B., W. A. L., T. P., and R. L. wrote the paper. R. L. managed the project.	Bonner JT, 1998, INTEGR BIOL, V1, P28; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jorgensen Claus, 2008, Briefings in Functional Genomics & Proteomics, V7, P17, DOI 10.1093/bfgp/eln001; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; NASH JF, 1950, THESIS PRINCETON U P; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wright S, 1931, GENETICS, V16, P0097; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	17	78	79	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1686	1688		10.1126/science.1174301	http://dx.doi.org/10.1126/science.1174301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19589966	Green Accepted			2022-12-24	WOS:000270131800045
J	Gaspar-Maia, A; Alajem, A; Polesso, F; Sridharan, R; Mason, MJ; Heidersbach, A; Ramalho-Santos, J; McManus, MT; Plath, K; Meshorer, E; Ramalho-Santos, M				Gaspar-Maia, Alexandre; Alajem, Adi; Polesso, Fanny; Sridharan, Rupa; Mason, Mike J.; Heidersbach, Amy; Ramalho-Santos, Joao; McManus, Michael T.; Plath, Kathrin; Meshorer, Eran; Ramalho-Santos, Miguel			Chd1 regulates open chromatin and pluripotency of embryonic stem cells	NATURE			English	Article							SELF-RENEWAL; EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; FIBROBLASTS; GENERATION; LYSINE-4; PROTEIN	An open chromatin largely devoid of heterochromatin is a hallmark of stem cells. It remains unknown whether an open chromatin is necessary for the differentiation potential of stem cells, and which molecules are needed to maintain open chromatin. Here we show that the chromatin remodelling factor Chd1 is required to maintain the open chromatin of pluripotent mouse embryonic stem cells. Chd1 is a euchromatin protein that associates with the promoters of active genes, and downregulation of Chd1 leads to accumulation of heterochromatin. Chd1-deficient embryonic stem cells are no longer pluripotent, because they are incapable of giving rise to primitive endoderm and have a high propensity for neural differentiation. Furthermore, Chd1 is required for efficient reprogramming of fibroblasts to the pluripotent stem cell state. Our results indicate that Chd1 is essential for open chromatin and pluripotency of embryonic stem cells, and for somatic cell reprogramming to the pluripotent state.	[Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Ob Gyn, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Pathol, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Heidersbach, Amy; McManus, Michael T.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre] Univ Coimbra, PhD Programme Biomed & Expt Biol, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Alajem, Adi; Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Sridharan, Rupa; Mason, Mike J.; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Mason, Mike J.; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Coimbra; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Dept Ob Gyn, 513 Parnassus Ave, San Francisco, CA 94143 USA.	mrsantos@diabetes.ucsf.edu	Ramalho-Santos, João/F-8641-2012; mcmanus, michael/AAB-1239-2020; Ramalho-Santos, Miguel/L-9092-2018; Santos, João/HHZ-5595-2022; Gaspar-Maia, Alexandre/AAY-5416-2020	Ramalho-Santos, João/0000-0002-1172-4018; mcmanus, michael/0000-0003-3013-6569; Ramalho-Santos, Miguel/0000-0003-0177-5556; Gaspar-Maia, Alexandre/0000-0001-8528-5575; Mason, Michael/0000-0002-5652-7739; Plath, Kathrin/0000-0001-7796-3372; Meshorer, Eran/0000-0003-4777-986X	Sandler Family; CIRM Young Investigator Award; NIH Director's New Innovator Award; Israel Science Foundation [ISF 215/07]; European Union [IRG-206872]; Alon Fellowship; California Institute for Regenerative Medicine; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	Sandler Family; CIRM Young Investigator Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Alon Fellowship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank A. Smith for Oct4-GiP ES cells, M. S. Parmacek for Gata6<SUP>-/-</SUP> ES cells, R. P. Perry and D. G. Stokes for the Chd1 antibody, M. Bigos and V. Stepps at the Flow Cytometry Core Facility and L. Ta and C. Barker at the Genomics Core Facility of the Gladstone Institutes for expert assistance, C. Chiu for technical assistance, members of the Santos laboratory, in particular M. Grskovic for advice, and A. Kriegstein, D. Melton, A. Alvarez-Buylla, D. Stainier, R. Blelloch, B. Panning, J. Reiter and M. Grskovic for discussions and critical reading of the manuscript. A. G.-M. was the recipient of a predoctoral fellowship from the Foundation for Science and Technology (POCI2010/FSE), Portugal. R. S. was the recipient of a CIRM postdoctoral training grant. This work was supported by grants from the Sandler Family to M. T. M., CIRM Young Investigator Award and NIH Director's New Innovator Award to K. P., Israel Science Foundation (ISF 215/07), European Union (IRG-206872) and Alon Fellowship to E. M., and NIH Director's New Innovator Award, California Institute for Regenerative Medicine and Juvenile Diabetes Research Foundation to M. R.-S.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	39	378	385	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					863	U97		10.1038/nature08212	http://dx.doi.org/10.1038/nature08212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19587682	Green Accepted			2022-12-24	WOS:000268938300031
J	Sanchez, PA; Ahamed, S; Carre, F; Hartemink, AE; Hempel, J; Huising, J; Lagacherie, P; McBratney, AB; McKenzie, NJ; Mendonca-Santos, MD; Minasny, B; Montanarella, L; Okoth, P; Palm, CA; Sachs, JD; Shepherd, KD; Vagen, TG; Vanlauwe, B; Walsh, MG; Winowiecki, LA; Zhang, GL				Sanchez, Pedro A.; Ahamed, Sonya; Carre, Florence; Hartemink, Alfred E.; Hempel, Jonathan; Huising, Jeroen; Lagacherie, Philippe; McBratney, Alex B.; McKenzie, Neil J.; Mendonca-Santos, Maria de Lourdes; Minasny, Budiman; Montanarella, Luca; Okoth, Peter; Palm, Cheryl A.; Sachs, Jeffrey D.; Shepherd, Keith D.; Vagen, Tor-Gunnar; Vanlauwe, Bernard; Walsh, Markus G.; Winowiecki, Leigh A.; Zhang, Gan-Lin			Digital Soil Map of the World	SCIENCE			English	Editorial Material							CLASSIFICATION		[Sanchez, Pedro A.; Ahamed, Sonya; Palm, Cheryl A.; Sachs, Jeffrey D.; Walsh, Markus G.; Winowiecki, Leigh A.] Columbia Univ, Earth Inst, Palisades, NY 10964 USA; [Carre, Florence; Montanarella, Luca] European Commiss, Joint Res Ctr, I-21020 Ispra, VA, Italy; [Hartemink, Alfred E.] ISRIC World Soil Informat, NL-6700 AJ Wageningen, Netherlands; [Hempel, Jonathan] Nat Resources Conservat Serv, Natl Soil Survey Ctr, USDA, Lincoln, NE 68508 USA; [Huising, Jeroen; Okoth, Peter; Vanlauwe, Bernard] Ctr Int Agr Trop, Trop Soil Biol & Fertil Inst, Nairobi, Kenya; [Lagacherie, Philippe] INRA, Inst Rech Dev, Lab Etud Interact Sols Agrosyst Hydrosyst, F-34060 Montpellier 1, France; [McBratney, Alex B.; Minasny, Budiman] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia; [McKenzie, Neil J.] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Mendonca-Santos, Maria de Lourdes] EMBRAPA, Brazilian Agr Res Corp, Natl Ctr Soil Res, BR-22460000 Rio De Janeiro, Brazil; [Shepherd, Keith D.; Vagen, Tor-Gunnar] World Agroforestry Ctr, Nairobi 00100, Kenya; [Zhang, Gan-Lin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Peoples R China	Columbia University; European Commission Joint Research Centre; EC JRC ISPRA Site; United States Department of Agriculture (USDA); Alliance; International Center for Tropical Agriculture - CIAT; INRAE; Institut de Recherche pour le Developpement (IRD); University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; World Agroforestry (ICRAF); Chinese Academy of Sciences; Institute of Soil Science, CAS	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, 61 Route 9W, Palisades, NY 10964 USA.	psanchez@ei.columbia.edu	Zhang, Gan-Lin/V-9261-2017; Carre, Florence/GQZ-4297-2022; Hartemink, Alfred/G-1149-2011; Minasny, Budiman/B-4744-2011; McBratney, Alex B/C-2199-2011; McKenzie, Neil J/A-9921-2011; Montanarella, Luca/AAE-7112-2019; Lagacherie, Philippe/F-9019-2010; Ahamed, Sonya/AAN-1997-2020; de Lourdes Mendonca Santos Brefin, Maria/I-6078-2016	Zhang, Gan-Lin/0000-0002-6189-5018; Hartemink, Alfred/0000-0002-5797-6798; Minasny, Budiman/0000-0002-1182-2371; McKenzie, Neil J/0000-0003-3803-3492; Lagacherie, Philippe/0000-0002-2948-1966; de Lourdes Mendonca Santos Brefin, Maria/0000-0001-5424-5028; Ahamed, Sonya/0000-0002-8734-6041; Vagen, Tor-Gunnar/0000-0002-8699-731X; McBratney, Alex/0000-0003-0913-2643; Carre, Florence/0000-0002-3594-8139				[Anonymous], 2008, GUIDELINES SURVEYING; Carre F, 2007, GEODERMA, V142, P69, DOI 10.1016/j.geoderma.2007.08.015; FAO/UNESCO, 1988, 60 FAOUNESCO; Hartemink AE, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P53, DOI 10.1007/978-1-4020-8592-5_5; Jenny H., 1941, FACTORS SOIL FORMATI; JENNY HANS, 1961, SOIL SCI SOC AMER PROC, V25, P385; Lagacherie P, 2007, DEV SOIL SCI, V31, P1; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Minasny B., 2008, ENCY SOIL SCI; Minasny B, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P15, DOI 10.1007/978-1-4020-8592-5_2; Nachtergaele F, 2003, EVOLUTION TROPICAL S, P107; Oldeman LR, 1991, GLOBAL ASSESSMENT SO; Palm C, 2007, ANNU REV ENV RESOUR, V32, P99, DOI 10.1146/annurev.energy.31.020105.100307; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; SANCHEZ PA, 1982, GEODERMA, V27, P283, DOI 10.1016/0016-7061(82)90019-2; WEBSTER R, 1972, J SOIL SCI, V23, P210, DOI 10.1111/j.1365-2389.1972.tb01654.x; 2008, 3 GLOB WORKSH DIG SO	18	355	372	5	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					680	681		10.1126/science.1175084	http://dx.doi.org/10.1126/science.1175084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480HF	19661405				2022-12-24	WOS:000268723700022
J	Shelton, JD				Shelton, James D.			Why multiple sexual partners?	LANCET			English	Editorial Material							AIDS		US Agcy Int Dev, Bur Global Heath, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Heath, Washington, DC 20523 USA.	JShelton@usaid.gov						GOURVENEC D, 2007, PSI BOTSWANA MULTIPL; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Leclerc-Madlala S, 2004, SOCIAL DYNAMICS, V29, P1; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; *NAT AIDS COORD AG, 2009, NAT CAMP PLAN MULT C; *ONE LOV, 2008, MULT CONC SEX PARTN; Parker W, 2007, CONCURRENT SEXUAL PA; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; Tawfik L, 2007, SOC SCI MED, V64, P1090, DOI 10.1016/j.socscimed.2006.10.002; *UNAID SUPP TEAM E, STRAT CONS COMM MULT; Watkins SC, 2004, POPUL DEV REV, V30, P673, DOI 10.1111/j.1728-4457.2004.00037.x; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001; 2008, RES REPORT CONCURREN	14	37	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					367	369		10.1016/S0140-6736(09)61399-4	http://dx.doi.org/10.1016/S0140-6736(09)61399-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647597				2022-12-24	WOS:000268815200008
J	Sarrazin, S; Mossadegh-Keller, N; Fukao, T; Aziz, A; Mourcin, F; Vanhille, L; Modis, LK; Kastner, P; Chan, S; Duprez, E; Otto, C; Sieweke, MH				Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Kastner, Philippe; Chan, Susan; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.			MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells	CELL			English	Article							COLONY-STIMULATING FACTOR; LINEAGE COMMITMENT; SELF-RENEWAL; PROGENITOR CELLS; GENE-EXPRESSION; BONE-MARROW; C-FMS; DIFFERENTIATION; MACROPHAGE; CYTOKINES	While hematopoietic stem cell (HSC) self-renewal is well studied, it remains unknown whether distinct control mechanisms enable HSC divisions that generate progeny cells with specific lineage bias. Here, we report that the monocytic transcription factor MafB specifically restricts the ability of M-CSF to instruct myeloid commitment divisions in HSCs. MafB deficiency specifically enhanced sensitivity to M-CSF and caused activation of the myeloid master-regulator PU.1 in HSCs in vivo. Single-cell analysis revealed that reduced MafB levels enabled M-CSF to instruct divisions producing asymmetric daughter pairs withone PU.1(+) cell. Asaconsequence, MafB(-/-) HSCs showed a PU.1 and M-CSF receptor-dependent competitive repopulation advantage specifically in the myelomonocytic, but not T lymphoid or erythroid, compartment. Lineage-biased repopulation advantage was progressive, maintained long term, and serially transplantable. Together, this indicates that an integrated transcription factor/cytokine circuit can control the rate of specific HSC commitment divisions without compromising other lineages or self-renewal.	[Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] Univ Aix Marseille, CIML, F-13288 Marseille 09, France; [Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] INSERM, U631, F-13258 Marseille, France; [Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] CNRS, UMR6102, Marseille, France; [Kastner, Philippe; Chan, Susan] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Fukao, Taro/I-3246-2014; Sieweke, Michael/AAR-7515-2020; Mourcin, Frederic/C-5511-2017; duprez, estelle a/R-2357-2016	Sieweke, Michael/0000-0002-3228-9537; Mourcin, Frederic/0000-0002-5344-9632; Duprez, Estelle/0000-0003-3810-5740; Mossadegh-Keller, Noushin/0000-0002-7088-3676	Association pour la Recherche sur le Cancer [3857, 3422]; Association for International Cancer Research [05-0079]; FdF [2004004150]; Agence Nationale de la Recherche [BLAN07-1_205752]; Fondation de France (FdF); Societe Francaise d'Hematologie; European Molecular Biology Organisation; INSERM	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association for International Cancer Research; FdF; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France (FdF)(Fondation de France); Societe Francaise d'Hematologie; European Molecular Biology Organisation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	S.S. received fellowships from the Fondation de France (FdF) and Societe Francaise d'Hematologie, T. F. from the European Molecular Biology Organisation and INSERM, and A. A. and L. V. from the French Ministere de l'Enseignement Superieur et de la Recherche. We gratefully acknowledge financial support by grants from the Association pour la Recherche sur le Cancer (3857 and 3422), Association for International Cancer Research (05-0079), FdF (2004004150), and Agence Nationale de la Recherche (BLAN07-1_205752). We thank L. Rohrschneider, R. P. Bourette, G. Mouchiroud, and R. Tsien for reagents, P. Grenot, M. Barad, N. Brun, and A. Zouine for expert flow cytometry, L. Chasson from RIO/Marseille-Nice Genopole platform for histology support, F. Diaz and the Maina group for mouse handling, E. Bertosio for blood counts, and F. Rossi, T. Graf, M. Djabali, U. Nehrbass, F. Morle, and M. H. S. group members for fruitful discussions.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bourette RP, 2007, ONCOGENE, V26, P234, DOI 10.1038/sj.onc.1209777; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Gemelli C, 2006, CELL DEATH DIFFER, V13, P1686, DOI 10.1038/sj.cdd.4401860; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KRIEGLER AB, 1994, EXP HEMATOL, V22, P432; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; MCARTHUR GA, 1994, BLOOD, V83, P972; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pawlak G, 2000, EXP HEMATOL, V28, P1164, DOI 10.1016/S0301-472X(00)00522-1; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Xie Y, 2001, CELL BIOCHEM BIOPHYS, V34, P1, DOI 10.1385/CBB:34:1:001; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	52	112	122	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					300	313		10.1016/j.cell.2009.04.057	http://dx.doi.org/10.1016/j.cell.2009.04.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632180	Bronze			2022-12-24	WOS:000268277000012
J	Corcoran, AJ; Barber, JR; Conner, WE				Corcoran, Aaron J.; Barber, Jesse R.; Conner, William E.			Tiger Moth Jams Bat Sonar	SCIENCE			English	Article							BIG BROWN BAT; ARCTIID MOTHS; EPTESICUS-FUSCUS; ECHOLOCATION; CLICKS; RESPONSES; PREY; APOSEMATISM; DEFENSES; BEHAVIOR	In response to sonar-guided attacking bats, some tiger moths make ultrasonic clicks of their own. The lepidopteran sounds have previously been shown to alert bats to some moths' toxic chemistry and also to startle bats unaccustomed to sonic prey. The moth sounds could also interfere with, or "jam," bat sonar, but evidence for such jamming has been inconclusive. Using ultrasonic recording and high-speed infrared videography of bat-moth interactions, we show that the palatable tiger moth Bertholdia trigona defends against attacking big brown bats (Eptesicus fuscus) using ultrasonic clicks that jam bat sonar. Sonar jamming extends the defensive repertoire available to prey in the long-standing evolutionary arms race between bats and insects.	[Corcoran, Aaron J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA; [Barber, Jesse R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Wake Forest University; Colorado State University	Conner, WE (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA.	corcaj8@wfu.edu; conner@wfu.edu			National Science Foundation [IOB-0615164]; WFU	National Science Foundation(National Science Foundation (NSF)); WFU	Funding for research was provided by National Science Foundation Grant IOB-0615164 to W.E.C. and a W.F.U. Dean's Fellowship to A.J.C.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; BATES DL, 1990, CAN J ZOOL, V68, P49, DOI 10.1139/z90-009; BLEST A. D., 1964, ZOOLOGICA [N Y], V49, P161; Davis M., 1984, P287; Dunning D. C., 1968, Zeitschrift fuer Tierpsychologie, V25, P129; DUNNING DC, 1965, SCIENCE, V147, P173, DOI 10.1126/science.147.3654.173; DUNNING DC, 1992, CAN J ZOOL, V70, P2218, DOI 10.1139/z92-298; FULLARD JH, 1979, CAN J ZOOL, V57, P647, DOI 10.1139/z79-076; FULLARD JH, 1994, J EXP BIOL, V194, P285; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; KICK SA, 1984, J NEUROSCI, V4, P2725; Marples NM, 1998, OIKOS, V83, P161, DOI 10.2307/3546557; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MILLER LA, 1991, J COMP PHYSIOL A, V168, P571, DOI 10.1007/BF00215079; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; ROEDER KD, 1964, J INSECT PHYSIOL, V10, P529, DOI 10.1016/0022-1910(64)90025-3; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SURLYKKE A, 1985, J COMP PHYSIOL A, V156, P831, DOI 10.1007/BF00610835; Tougaard J, 1998, J COMP PHYSIOL A, V182, P203, DOI 10.1007/s003590050171; Tougaard J., 2004, ECHOLOCATION BATS DO, P365; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; WILSON WW, 2004, ECHOLOCATION BATS DO, P365	26	91	93	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					325	327		10.1126/science.1174096	http://dx.doi.org/10.1126/science.1174096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608920				2022-12-24	WOS:000268036600047
J	Nimura, K; Ura, K; Shiratori, H; Ikawa, M; Okabe, M; Schwartz, RJ; Kaneda, Y				Nimura, Keisuke; Ura, Kiyoe; Shiratori, Hidetaka; Ikawa, Masato; Okabe, Masaru; Schwartz, Robert J.; Kaneda, Yasufumi			A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome	NATURE			English	Article							CHROMATIN; GENE; METHYLATION; PROTEIN; HEART; SALL4; SET2; TBX5; METHYLTRANSFERASE; PURIFICATION	Diverse histone modifications are catalysed and recognized by various specific proteins, establishing unique modification patterns that act as transcription signals(1,2). In particular, histone H3 trimethylation at lysine 36 (H3K36me3) is associated with actively transcribed regions and has been proposed to provide landmarks for continuing transcription(3,4); however, the control mechanisms and functions of H3K36me3 in higher eukaryotes are unknown. Here we show that the H3K36me3-specific histone methyltransferase (HMTase) Wolf-Hirschhorn syndrome candidate 1 (WHSC1, also known as NSD2 or MMSET) functions in transcriptional regulation together with developmental transcription factors whose defects overlap with the human disease Wolf Hirschhorn syndrome (WHS)(5,6). We found that mouse Whsc1, one of five putative Set2 homologues(2,7,8), governed H3K36me3 along euchromatin by associating with the cell-type-specific transcription factors Sall1, Sall4 and Nanog in embryonic stem cells, and Nkx2-5 in embryonic hearts, regulating the expression of their target genes. Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies. The effects of Whsc1 haploin sufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link. We propose that WHSC1 functions together with developmental transcription factors to prevent the inappropriate transcription that can lead to various pathophysiologies.	[Nimura, Keisuke; Ura, Kiyoe; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan; [Shiratori, Hidetaka] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Ikawa, Masato; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Schwartz, Robert J.] Ctr Mol Dev & Dis, Inst Biosci & Technol, Houston, TX 77030 USA	Osaka University; Osaka University; Osaka University	Ura, K (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	kiyoeura@gts.med.osaka-u.ac.jp; kaneday@gts.med.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Nimura, Keisuke/AAE-9925-2020; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Naito Foundation; Osaka University	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Osaka University	Acknowledgements We thank T. Richmond, R. Nishinakamura, H. Kurumizaka and M. Shirai for providing reagents and mice; S. Khochbin, S. Hirose, J. Godde and J. Takeuchi for their critical reading of the manuscript; and H. Niwa, H. Hamada, M. Yamamoto, S. Ohishi, H. Nakagami and members of the GTS laboratory for discussion and support. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Naito Foundation, and by funds from Osaka University for female researchers.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; HIRSCHHORN K, 1961, AM J MED, V31, P442, DOI 10.1016/0002-9343(61)90128-0; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; URA K, 2002, METH MOL B, V181, P309; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200	38	274	288	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					287	U157		10.1038/nature08086	http://dx.doi.org/10.1038/nature08086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19483677				2022-12-24	WOS:000267761000047
J	Lee, SSJ; Bolnick, DA; Duster, T; Ossorio, P; TallBear, K				Lee, Sandra Soo-Jin; Bolnick, Deborah A.; Duster, Troy; Ossorio, Pilar; TallBear, Kimberly			The Illusive Gold Standard in Genetic Ancestry Testing	SCIENCE			English	Editorial Material									[Lee, Sandra Soo-Jin] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Duster, Troy] New York Univ, Dept Sociol, New York, NY 10012 USA; [Duster, Troy] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; [Ossorio, Pilar] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [TallBear, Kimberly] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Stanford University; University of Texas System; University of Texas Austin; New York University; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Lee, SSJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	sandra.lee@stanford.edu		Lee, Sandra Soo-Jin/0000-0002-2312-9814	NHGRI NIH HHS [P50 HG003389, R01 HG005086] Funding Source: Medline; NHLBI NIH HHS [K01 HL72465] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; *ASHG, 2008, ANC TEST STAT; Bolnick DA, 2007, SCIENCE, V318, P399, DOI 10.1126/science.1150098; Budowle B, 2008, BIOTECHNIQUES, V44, P603, DOI 10.2144/000112806; Burke W, 2008, AM J BIOETHICS, V8, P54, DOI 10.1080/15265160802109488; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Dalton R, 2002, NATURE, V420, P111, DOI 10.1038/420111a; Flack J M, 1999, J Hypertens Suppl, V17, pS19; Goering S, 2008, HASTINGS CENT REP, V38, P43, DOI 10.1353/hcr.2008.0027; Hart S., 2003, INVESTIGATIVE REPORT; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; TALLBEAR K, NATIVE AM D IN PRESS; WINICKOFF D, 2008, 68 CTR STUD LAW SOC; Wiwchar D., 2004, HA SHILTH SA NEWSL, V31, P1	16	49	49	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					38	39		10.1126/science.1173038	http://dx.doi.org/10.1126/science.1173038			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574373				2022-12-24	WOS:000267594000022
J	Webby, CJ; Wolf, A; Gromak, N; Dreger, M; Kramer, H; Kessler, B; Nielsen, ML; Schmitz, C; Butler, DS; Yates, JR; Delahunty, CM; Hahn, P; Lengeling, A; Mann, M; Proudfoot, NJ; Schofield, CJ; Bottger, A				Webby, Celia J.; Wolf, Alexander; Gromak, Natalia; Dreger, Mathias; Kramer, Holger; Kessler, Benedikt; Nielsen, Michael L.; Schmitz, Corinna; Butler, Danica S.; Yates, John R., III; Delahunty, Claire M.; Hahn, Phillip; Lengeling, Andreas; Mann, Matthias; Proudfoot, Nicholas J.; Schofield, Christopher J.; Boettger, Angelika			Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing	SCIENCE			English	Article							PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; NUCLEAR-PROTEIN; CLEARANCE	The finding that the metazoan hypoxic response is regulated by oxygen-dependent posttranslational hydroxylations, which regulate the activity and lifetime of hypoxia-inducible factor (HIF), has raised the question of whether other hydroxylases are involved in the regulation of gene expression. We reveal that the splicing factor U2 small nuclear ribonucleoprotein auxiliary factor 65-kilodalton subunit (U2AF65) undergoes posttranslational lysyl-5-hydroxylation catalyzed by the Fe(II) and 2-oxoglutarate-dependent dioxygenase Jumonji domain-6 protein (Jmjd6). Jmjd6 is a nuclear protein that has an important role in vertebrate development and is a human homolog of the HIF asparaginyl-hydroxylase. Jmjd6 is shown to change alternative RNA splicing of some, but not all, of the endogenous and reporter genes, supporting a specific role for Jmjd6 in the regulation of RNA splicing.	[Webby, Celia J.; Butler, Danica S.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Webby, Celia J.; Butler, Danica S.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Wolf, Alexander; Schmitz, Corinna; Boettger, Angelika] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Gromak, Natalia; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Dreger, Mathias] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Kramer, Holger; Kessler, Benedikt] Univ Oxford, Oxford OX3 7BN, England; [Nielsen, Michael L.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Yates, John R., III; Delahunty, Claire M.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Hahn, Phillip; Lengeling, Andreas] Helmholtz Ctr Infect Res, Res Grp Infect Genet, D-38124 Braunschweig, Germany; [Lengeling, Andreas] Univ Edinburgh, Roslin Inst, EBVC, Roslin EH25 9RG, Midlothian, Scotland; [Lengeling, Andreas] Univ Edinburgh, Royal Dick Sch Vet Studies, EBVC, Roslin EH25 9RG, Midlothian, Scotland	University of Oxford; University of Oxford; University of Munich; University of Oxford; University of Oxford; University of Oxford; Max Planck Society; Scripps Research Institute; Helmholtz Association; Helmholtz-Center for Infection Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; boettger@zi.biologie.uni-muenchen.de	Hu, Ruogu/B-2203-2008; Hahn, Phillip/A-4812-2012; Kessler, Benedikt/AAY-8614-2021; Mann, Matthias/A-3454-2013; Wolf, Alexander/K-2178-2013; Kramer, Holger/AAL-4433-2020; Gromak, Natalia/F-6475-2014; Nielsen, Michael/C-4418-2008	Hahn, Phillip/0000-0002-8741-3603; Kessler, Benedikt/0000-0002-8160-2446; Mann, Matthias/0000-0003-1292-4799; Kramer, Holger/0000-0002-6400-0945; Dreger, Mathias/0000-0002-0453-6414; Nielsen, Michael/0000-0002-0067-9039; Proudfoot, Nicholas/0000-0001-8646-3222; Schofield, Christopher/0000-0002-0290-6565; Wolf, Alexander/0000-0003-0649-3363; Gromak, Natalia/0000-0002-4158-3586; Bottger, Angelika/0000-0003-3273-9558	Glasstone Fellowship; Deutsche Forschungsgemeinschaft [BO1748-3, LE2130/2-1]; UK Biotechnology and Biological Sciences Research Council; European Union; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; Medical Research Council [G9826944] Funding Source: researchfish; BBSRC [BB/D011523/1] Funding Source: UKRI; MRC [G9826944] Funding Source: UKRI	Glasstone Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Glasstone Fellowship (to C.W.), Deutsche Forschungsgemeinschaft grants BO1748-3 awarded to A.B. and LE2130/2-1 awarded to A.L., the UK Biotechnology and Biological Sciences Research Council, the European Union, and the Wellcome Trust (to N.P.R.). C.J.S is a cofounder of ReOx.	Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gromak N, 2002, NUCLEIC ACIDS RES, V30, P3548, DOI 10.1093/nar/gkf480; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Nishii Y, 2000, FEBS LETT, V465, P153, DOI 10.1016/S0014-5793(99)01744-5; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, GENE DEV, V14, P1983; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolf A, 2007, EMBO REP, V8, P465, DOI 10.1038/sj.embor.7400956; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	18	301	312	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					90	93		10.1126/science.1175865	http://dx.doi.org/10.1126/science.1175865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574390	Green Submitted			2022-12-24	WOS:000267594000042
J	Hua, SJ; Kittler, R; White, KP				Hua, Sujun; Kittler, Ralf; White, Kevin P.			Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer	CELL			English	Article							NUCLEAR RECEPTORS; IN-VITRO; RESPONSE ELEMENTS; BINDING-SITES; CELL-GROWTH; EXPRESSION; REVEALS; GENES; FOXA1; RAR	Retinoic acid (RA) triggers antiproliferative effects in tumor cells, and therefore RA and its synthetic analogs have great potential as anticarcinogenic agents. Retinoic acid receptors (RARs) mediate RA effects by directly regulating gene expression. To define the genetic network regulated by RARs in breast cancer, we identified RAR genomic targets using chromatin immunoprecipitation and expression analysis. We found that RAR binding throughout the genome is highly coincident with estrogen receptor alpha (ER alpha) binding, resulting in a widespread crosstalk of RA and estrogen signaling to antagonistically regulate breast cancer-associated genes. ER alpha- and RAR-binding sites appear to be coevolved on a large scale throughout the human genome, often resulting in competitive binding activity at nearby or overlapping cis-regulatory elements. The highly coordinated intersection between these two critical nuclear hormone receptor signaling pathways provides a global mechanism for balancing gene expression output via local regulatory	[Hua, Sujun; Kittler, Ralf; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Hua, Sujun; Kittler, Ralf; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hua, Sujun] Yale Univ, Interdepartmental Program Computat Biol & Bioinfo, New Haven, CT 06520 USA	University of Chicago; University of Chicago; Yale University	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, 920 E 58th St, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Kittler, Ralf/AAD-4258-2020; Kittler, Ralf/I-4662-2013	Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792	National Institutes of Health [1R01HG004428, 1P50GM081892]; The Searle Funds at the Chicago Community Trust; International Human Frontier Science Program Organization; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004428, RC2HG005679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Searle Funds at the Chicago Community Trust; International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Pendleton and all members of the Functional Genomics Facility of The University of Chicago for technical assistance, T. Hyman and F. Buchholz for providing the LAP-IRES-neo/kan cassette, and D. Drechsel for the production of the goat eGFP antibody. This work was supported by grants 1R01HG004428 and 1P50GM081892 to K. P. W. from the National Institutes of Health and by a grant to K. P. W. from the Chicago Biomedical Consortium (CBC) with support from The Searle Funds at the Chicago Community Trust. R. K. is supported by a long-term fellowship of the International Human Frontier Science Program Organization.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Glass CK, 2000, GENE DEV, V14, P121; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Joyeux A, 1996, J STEROID BIOCHEM, V58, P507, DOI 10.1016/0960-0760(96)00082-9; Klinge CM, 1997, NUCLEIC ACIDS RES, V25, P1903, DOI 10.1093/nar/25.10.1903; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Levenson AS, 1997, CANCER RES, V57, P3071; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mangelsdorf David J., 1994, P319; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r; Zhou Q, 1997, ONCOGENE, V15, P107, DOI 10.1038/sj.onc.1201142	43	226	230	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1259	1271		10.1016/j.cell.2009.04.043	http://dx.doi.org/10.1016/j.cell.2009.04.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563758	Green Accepted, Bronze			2022-12-24	WOS:000267373400019
J	Barends, TRM; Hartmann, E; Griese, JJ; Beitlich, T; Kirienko, NV; Ryjenkov, DA; Reinstein, J; Shoeman, RL; Gomelsky, M; Schlichting, I				Barends, Thomas R. M.; Hartmann, Elisabeth; Griese, Julia J.; Beitlich, Thorsten; Kirienko, Natalia V.; Ryjenkov, Dmitri A.; Reinstein, Jochen; Shoeman, Robert L.; Gomelsky, Mark; Schlichting, Ilme			Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; MEDIATED SIGNAL-TRANSDUCTION; FAD-BINDING DOMAIN; BLUF DOMAIN; DENSITY MODIFICATION; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURES; NMR SYSTEM; PHOTORECEPTOR; PROTEIN	The ability to respond to light is crucial for most organisms. BLUF is a recently identified photoreceptor protein domain that senses blue light using a FAD chromophore(1). BLUF domains are present in various proteins from the Bacteria, Euglenozoa and Fungi. Although structures of single-domain BLUF proteins have been determined(2-4), none are available for a BLUF protein containing a functional output domain; the mechanism of light activation in this new class of photoreceptors has thus remained poorly understood. Here we report the biochemical, structural and mechanistic characterization of a full-length, active photoreceptor, BlrP1 (also known as KPN_01598), from Klebsiella pneumoniae(5). BlrP1 consists of a BLUF sensor domain and a phosphodiesterase EAL output domain which hydrolyses cyclic dimeric GMP (c-di-GMP). This ubiquitous second messenger controls motility, biofilm formation, virulence and antibiotic resistance in the Bacteria(6-9). Crystal structures of BlrP1 complexed with its substrate and metal ions involved in catalysis or in enzyme inhibition provide a detailed understanding of the mechanism of the EAL-domain c-di-GMP phosphodiesterases. These structures also sketch out a path of light activation of the phosphodiesterase output activity. Photon absorption by the BLUF domain of one subunit of the antiparallel BlrP1 homodimer activates the EAL domain of the second subunit through allosteric communication transmitted through conserved domain-domain interfaces.	[Kirienko, Natalia V.; Ryjenkov, Dmitri A.; Gomelsky, Mark] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Barends, Thomas R. M.; Hartmann, Elisabeth; Griese, Julia J.; Beitlich, Thorsten; Reinstein, Jochen; Shoeman, Robert L.; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	University of Wyoming; Max Planck Society	Gomelsky, M (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	gomelsky@uwyo.edu; ilme.schlichting@mpimf-heidelberg.mpg.de	gomelsky, mark/F-6209-2010; Schlichting, Ilme/I-1339-2013; Griese, Julia Johanna/GQB-0023-2022	Griese, Julia Johanna/0000-0003-3686-3062; Kirienko, Natalia/0000-0002-1537-4967	Deutsche Forschungsgemeinschaft [FOR 526]; US National Science Foundation [MCB 0645876]; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Science Foundation(National Science Foundation (NSF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank A. Jung and A. Schmidt for help during the initial stages of the project, C. Fang for c-di-GMP purification and Q. Wu and K. H. Gardner for discussions and for sharing unpublished data. We are grateful to I. Vetter for advice and support for the crystallographic software. Diffraction data were collected at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. We thank the Dortmund-Heidelberg team for data collection and E. Pohl, A. Pauluhn and C. Schulze-Briese for their support in setting up the beamline. The K. pneumoniae genome was sequenced at the School of Medicine of the Washington University in St Louis. We acknowledge financial support from the Deutsche Forschungsgemeinschaft (Research Group FOR 526 'Sensory Blue Light Receptors') to I. S., the US National Science Foundation (MCB 0645876) to M. G. and the Boehringer Ingelheim Fonds to J. J. G. I. S. and J. R. are members of the Cluster of Excellence Cell Networks, Heidelberg.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANG C, 2007, RCSB PDB STRUCTURE E; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; DeLano W.L., 2002, PYMOL MOL VIEWER; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P5172, DOI 10.1021/bi00473a025; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hur S, 2003, J AM CHEM SOC, V125, P1472, DOI 10.1021/ja0293047; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MINASOV B, J BIOL CHEM IN PRESS, DOI DOI 10.1074/JBC.M808221200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; ROSS P, 1990, J BIOL CHEM, V265, P18933; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Salter EA, 2007, J PHYS CHEM B, V111, P4547, DOI 10.1021/jp066582+; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Tyagi A, 2008, CHEM PHYS, V354, P130, DOI 10.1016/j.chemphys.2008.10.003; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wu Q, 2008, BIOCHEMISTRY-US, V47, P10271, DOI 10.1021/bi8011687; Wu Q, 2009, BIOCHEMISTRY-US, V48, P2620, DOI 10.1021/bi802237r; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Zhan CG, 2001, J AM CHEM SOC, V123, P2835, DOI 10.1021/ja005529a	40	223	238	8	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1015	U150		10.1038/nature07966	http://dx.doi.org/10.1038/nature07966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536266				2022-12-24	WOS:000267063500049
J	Buonamici, S; Trimarchi, T; Ruocco, MG; Reavie, L; Cathelin, S; Mar, BG; Klinakis, A; Lukyanov, Y; Tseng, JC; Sen, F; Gehrie, E; Li, ML; Newcomb, E; Zavadil, J; Meruelo, D; Lipp, M; Ibrahim, S; Efstratiadis, A; Zagzag, D; Bromberg, JS; Dustin, ML; Aifantis, I				Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Mar, Brenton G.; Klinakis, Apostolos; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Gehrie, Eric; Li, Mengling; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Lipp, Martin; Ibrahim, Sherif; Efstratiadis, Argiris; Zagzag, David; Bromberg, Jonathan S.; Dustin, Michael L.; Aifantis, Iannis			CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SECONDARY LYMPHOID ORGANS; IN-VIVO; MOLECULAR PATHOGENESIS; CHEMOKINE RECEPTORS; MULTIPLE-SCLEROSIS; BREAST-CANCER; ACTIVATION; IMMUNITY; INFLAMMATION	T-cell acute lymphoblastic leukaemia (T-ALL) is a blood malignancy afflicting mainly children and adolescents(1). T-ALL patients present at diagnosis with increased white cell counts and hepatosplenomegaly, and are at an increased risk of central nervous system (CNS) relapse(2,3). For that reason, T-ALL patients usually receive cranial irradiation in addition to intensified intrathecal chemotherapy. The marked increase in survival is thought to be worth the considerable side-effects associated with this therapy. Such complications include secondary tumours, neurocognitive deficits, endocrine disorders and growth impairment(3). Little is known about the mechanism of leukaemic cell infiltration of the CNS, despite its clinical importance(4). Here we show, using T-ALL animal modelling and gene-expression profiling, that the chemokine receptor CCR7 (ref. 5) is the essential adhesion signal required for the targeting of leukaemic T-cells into the CNS. Ccr7 gene expression is controlled by the activity of the T-ALL oncogene Notch1 and is expressed in human tumours carrying Notch1-activating mutations. Silencing of either CCR7 or its chemokine ligand CCL19 (ref. 6) in an animal model of T-ALL specifically inhibits CNS infiltration. Furthermore, murine CNS-targeting by human T-ALL cells depends on their ability to express CCR7. These studies identify a single chemokine-receptor interaction as a CNS 'entry' signal, and open the way for future pharmacological targeting. Targeted inhibition of CNS involvement in T-ALL could potentially decrease the intensity of CNS-targeted therapy, thus reducing its associated short- and long-term complications.	[Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Ibrahim, Sherif; Zagzag, David; Dustin, Michael L.; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Ibrahim, Sherif; Zagzag, David; Dustin, Michael L.; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Buonamici, Silvia; Trimarchi, Thomas; Reavie, Linsey; Cathelin, Severine; Sen, Filiz; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Stem Cell Ctr, New York, NY 10016 USA; [Ruocco, Maria Grazia; Dustin, Michael L.] NYU, Sch Med, Program Mol Pathogenesis,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Mar, Brenton G.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Klinakis, Apostolos; Efstratiadis, Argiris] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Gehrie, Eric; Bromberg, Jonathan S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Gehrie, Eric; Bromberg, Jonathan S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Li, Mengling] NYU, Inst Canc, Div Biostat, New York, NY 10016 USA; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, D-13092 Berlin, Germany	New York University; New York University; New York University; New York University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Zavadil, Jiri/ABG-1780-2020; Dustin, Michael/AAM-4611-2020; Gehrie, Eric Abraham/H-9196-2019; Lipp, Martin/G-2235-2010	Zavadil, Jiri/0000-0003-0640-5562; Gehrie, Eric Abraham/0000-0002-5354-3899; Lipp, Martin/0000-0002-0087-2672; Dustin, Michael/0000-0003-4983-6389; Mar, Brenton/0000-0002-3857-9324; Liu, Mengling/0000-0001-9758-8522	National Institutes of Health [RO1CA105129, RO1CA133379, R56AI070310, P30CA016087, RO1AI41428, RO1AI072039]; American Cancer Society [RSG0806801]; Dana Foundation; Chemotherapy Foundation; Alex's Lemonade Stand Foundation; Lauri Strauss Leukemia Foundation; GP Foundation; NYU Molecular Oncology and Immunology; American Society of Hematology; Juvenile Diabetes Research Foundation [JDRFI1-2008-90, 5-2008-236]; National Cancer Institute [1 P01 CA97403]; Berrie Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE [P01CA097403, P30CA016087, R01CA133379, R21CA141399, R01CA105129, R01CA149655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041428, R01AI072039, R01AI062765, R56AI070310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dana Foundation; Chemotherapy Foundation; Alex's Lemonade Stand Foundation; Lauri Strauss Leukemia Foundation; GP Foundation; NYU Molecular Oncology and Immunology; American Society of Hematology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Berrie Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to G. Randolph, E. Kuan and T. Vilimas for technical help and discussions. We would like to thank P. Lopez and G. De La Cruz for cell sorting; D. Littman, W. Carroll, E. Raetz, S. Lira and S. Schwab for advice and illuminating discussions; C. Loomis and the Histology Facility for advice and troubleshooting tips. This work was supported by the National Institutes of Health (RO1CA105129, RO1CA133379, R56AI070310, P30CA016087 to I. A., RO1AI41428, RO1AI072039 to J.S. B.), the American Cancer Society (RSG0806801 to I. A.), the Dana Foundation, The Chemotherapy Foundation, the Alex's Lemonade Stand Foundation (to I. A.), the Lauri Strauss Leukemia Foundation (to F. S.), the G&P Foundation, NYU Molecular Oncology and Immunology training grant (to S. B.), American Society of Hematology (to S. B.), Juvenile Diabetes Research Foundation (JDRFI1-2008-90 and 5-2008-236 to J. S. B.), the National Cancer Institute (1 P01 CA97403, Project 2 to A. E.) and a gift from the Berrie Foundation (to A. E.). A. K. was supported by a Fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Cardona AE, 2008, J LEUKOCYTE BIOL, V84, P587, DOI 10.1189/jlb.1107763; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tseng JC, 2006, J NUCL MED, V47, P1136; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	29	191	198	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1000	U129		10.1038/nature08020	http://dx.doi.org/10.1038/nature08020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536265	Green Accepted			2022-12-24	WOS:000267063500046
J	Masur, H; Kaplan, JE				Masur, Henry; Kaplan, Jonathan E.			New Guidelines for the Management of HIV-Related Opportunistic Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RECOMMENDATIONS		[Masur, Henry] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Kaplan, Jonathan E.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Centers for Disease Control & Prevention - USA	Masur, H (corresponding author), NIH, Ctr Clin, 10 Ctr Dr,Bldg 10,Room 2C145, Bethesda, MD 20892 USA.	hmasur@nih.gov						*AIDSINFO, 2008, GUID PREV TREATM OPP; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Benson Constance A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; *DISTR COL DEP HLT, 2007, DISTR COL HIV AIDS E; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; *HJ KAIS FAM FDN, 2007, HIV AIDS POL FACT SH; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; MASUR H, 1993, NEW ENGL J MED, V329, P898, DOI 10.1056/NEJM199309163291228; Mofenson Lynne M., 2004, Morbidity and Mortality Weekly Report, V53, P1; USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1999, MMWR RECOMM REP, V48, P61	15	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2378	2380		10.1001/jama.2008.865	http://dx.doi.org/10.1001/jama.2008.865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509385				2022-12-24	WOS:000266773400031
J	Bowles, S				Bowles, Samuel			Did Warfare Among Ancestral Hunter-Gatherers Affect the Evolution of Human Social Behaviors?	SCIENCE			English	Article							GROUP SELECTION; WAR; CHIMPANZEES; COEVOLUTION; ALTRUISM; DIFFERENTIATION; POPULATION; DIVERSITY	Since Darwin, intergroup hostilities have figured prominently in explanations of the evolution of human social behavior. Yet whether ancestral humans were largely "peaceful" or "warlike" remains controversial. I ask a more precise question: If more cooperative groups were more likely to prevail in conflicts with other groups, was the level of intergroup violence sufficient to influence the evolution of human social behavior? Using a model of the evolutionary impact of between-group competition and a new data set that combines archaeological evidence on causes of death during the Late Pleistocene and early Holocene with ethnographic and historical reports on hunter-gatherer populations, I find that the estimated level of mortality in intergroup conflicts would have had substantial effects, allowing the proliferation of group-beneficial behaviors that were quite costly to the individual altruist.	[Bowles, Samuel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	samuel.bowles@gmail.com			Behavioral Sciences Program of the Santa Fe Institute; U.S. National Science Foundation; European Science Foundation; University of Siena	Behavioral Sciences Program of the Santa Fe Institute; U.S. National Science Foundation(National Science Foundation (NSF)); European Science Foundation(European Science Foundation (ESF)European Commission); University of Siena	Thanks to I. Levina and A. Vereshchagina for translating the Russian and Ukrainian archaeological materials; P. Lambert and K. Kennedy for assistance with the Californian and Indian archaeological evidence; M. Alexander, K. Ames, B. Bertram, L. Luigi Cavalli-Sforza, T. Clutton-Brock, W. Cote, E. Einhorn, D. Wood Gordon, H. Kaplan, K. Hill, K. Howard, S.-H. Hwang, K. Langergraber, S. Le Blanc, J. Mitani, C. Resnicke, R. Rowthorn, P. Seabright, E. Alden Smith, T. Taylor, D. Ulibarri, L. Vigilant, E. Wood, and R. Wrangham for valuable contributions; and the Behavioral Sciences Program of the Santa Fe Institute, the U.S. National Science Foundation, the European Science Foundation, and the University of Siena for support of this work. The author declares no competing interests.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; AOKI K, 1982, EVOLUTION, V36, P832, DOI [10.2307/2407896, 10.1111/j.1558-5646.1982.tb05449.x]; BILL JH, 1862, AM J MED SCI, V40, P365; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; BOORMAN SA, 1973, THEOR POPUL BIOL, V4, P85, DOI 10.1016/0040-5809(73)90007-5; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Burch, 2005, ALLIANCE CONFLICT WO, DOI 10.2307/j.ctv6gqqgg; CAMPBELL C, 1986, WORLD ARCHAEOL, V18, P255, DOI 10.1080/00438243.1986.9980002; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; COHEN MN, 1980, BIOSOCIAL MECHANISMS, P275; Darwin C., 1873, DESCENT MAN; EMBER CR, 1992, J CONFLICT RESOLUT, V36, P242, DOI 10.1177/0022002792036002002; FERGUSON B, 1997, TROUBLED TIMES VIOLE, P321; Formicola V, 2007, CURR ANTHROPOL, V48, P446, DOI 10.1086/517592; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hassan F., 1980, BIOSOCIAL MECHANISMS, P305; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; JOHANSSON SR, 1986, AM J PHYS ANTHROPOL, V71, P233, DOI 10.1002/ajpa.1330710211; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keeley LH., 1996, WAR CIVILIZATION; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; Lambert PM., 2014, TROUBLED TIMES VIOLE, V3, P77; LANCHESTER FW, 1916, AIRCRAFT WARFARE DAW, P222; LeBlanc SA, 2003, CONSTANT BATTLES; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lourandos H., 1997, CONTINENT HUNTER GAT; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; MELBYE J, 1994, ARCTIC ANTHROPOL, V31, P57; Milner GR, 2005, AM ANTIQUITY, V70, P144, DOI 10.2307/40035273; Morgan J, 1979, LIFE ADVENTURES W BU; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schapera I., 1930, KHOISAN PEOPLES S AF; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Ta?on P., 1994, CAMB ARCHAEOL J, V4, P211, DOI DOI 10.1017/S0959774300001086; Tenny J. M., 1990, HUMAN EVOLUTION, V5, P397; Walsh SJ, 2007, J HUM GENET, V52, P712, DOI 10.1007/s10038-007-0172-z; Wendorf F, 1968, PREHISTORY NUBIA; Williams JM, 2004, ANIM BEHAV, V68, P523, DOI 10.1016/j.anbehav.2003.09.015; Woodburn J., 1982, DEATH REGENERATION L, P187; Wrangham RW, 2006, PRIMATES, V47, P14, DOI 10.1007/s10329-005-0140-1	44	409	416	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1293	1298		10.1126/science.1168112	http://dx.doi.org/10.1126/science.1168112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453TF	19498163				2022-12-24	WOS:000266635100036
J	Hamilton, F; Car, J; Layton, A				Hamilton, Fiona; Car, Josip; Layton, Alison			10-Minute Consultation Acne vulgaris	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, Fiona; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England; [Layton, Alison] Harrogate & Dist NHS Fdn Trust, Harrogate, N Yorkshire, England; [Layton, Alison] N Yorkshire & York Primary Care Trust, Harrogate, England	Imperial College London	Car, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Charing Cross Campus, London W6 8RP, England.	josip.car@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X; Layton, Alison/0000-0003-0473-3319	National Institute for Health Research [ACF-2006-21-033] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 5	2009	338								a2738	10.1136/bmj.a2738	http://dx.doi.org/10.1136/bmj.a2738			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AJ	19502277				2022-12-24	WOS:000266726600001
J	Kliiman, K; Altraja, A				Kliiman, Kai; Altraja, Alan			Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIDRUG-RESISTANT; RISK-FACTORS; TREATMENT OUTCOMES; TB PATIENTS; COUNTRIES; RUSSIA	Background: About 40 000 cases of extensively drug-resistant tuberculosis emerge worldwide annually, but the predictors of extensive drug resistance are unclear. Objective: To identify risk factors for extensively drug-resistant tuberculosis and multidrug-resistant but non-extensively drug-resistant tuberculosis in patients with culture-confirmed pulmonary tuberculosis. Design: Cross-sectional, countrywide study. Setting: Estonia, a country with 1 of the world's highest rates of extensively drug-resistant and multidrug-resistant tuberculosis. Patients: All patients with culture-confirmed pulmonary tuberculosis with clinical or radiologic evidence of active disease detected from January 2003 to December 2005. Measurements: Risk determinants from patients' demographic characteristics, socioeconomic variables, and tuberculosis-related data or HIV status. Results: Of 1163 patients, 60 (5.2%) had extensively drug-resistant tuberculosis and 196 (16.9%) had multidrug-resistant but non-extensively drug-resistant tuberculosis. Previous antituberculosis treatment (adjusted odds ratio [OR], 10.54 [95% CI, 5.97 to 18.62]), HIV infection (OR, 3.12 [CI, 1.31 to 7.41]), homelessness (OR, 2.73 [CI, 1.15 to 6.48]), and alcohol abuse (OR, 1.98 [CI, 1.08 to 3.64]) increased risk for extensive drug resistance. Previous treatment (OR, 4.11 [CI, 2.77 to 6.08]) and age 24 years or younger (OR, 2.57 [CI, 1.09 to 6.06]), 25 to 44 years (OR, 2.64 [CI, 1.35 to 5.16]), and 45 to 64 years (OR, 2.06 [CI, 1.06 to 3.99]) were determinants of multidrug resistance. In patients age 24 years or younger, female sex (OR, 6.23 [CI, 1.02 to 37.99]) and birth outside of Estonia (OR, 82.04 [CI, 3.46 to 1945.47]) increased risk for multidrug resistance. Limitation: Patients' comorbid conditions and drug abuse history were not incorporated into analyses because of inconsistent source data. Conclusion: Previous treatment is a common risk factor for extensively drug-resistant and multidrug-resistant tuberculosis. Reducing relapses; screening persons younger than 65 years and immigrants; and combating against HIV infection, alcoholism, and homelessness are key issues for decreasing the spread of highly drug-resistant tuberculosis.	[Kliiman, Kai] Univ Tartu, Dept Pulm Med, EE-51014 Tartu, Estonia	University of Tartu	Kliiman, K (corresponding author), Univ Tartu, Dept Pulm Med, Riia 167, EE-51014 Tartu, Estonia.	kai.kliiman@kliinikum.ee			Estonian Health Insurance Fund	Estonian Health Insurance Fund	By the Estonian Health Insurance Fund.	[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P387; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Clark CM, 2005, INT J TUBERC LUNG D, V9, P964; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Falzon D, 2006, INT J TUBERC LUNG D, V10, P954; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Granich RM, 2005, JAMA-J AM MED ASSOC, V293, P2732, DOI 10.1001/jama.293.22.2732; HARO S, 1994, TUBERCLE LUNG DIS, V75, P271, DOI 10.1016/0962-8479(94)90132-5; HOLLO V, 2007, TUBERCULOSIS INCIDEN; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Mdivani N, 2008, INT J INFECT DIS, V12, P635, DOI 10.1016/j.ijid.2008.03.012; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; *UNAIDS WHO, 2006, AIDS DEP UPD; *WHO, 2006, ALC CONTR SER WHO, V4; *WHO, GLOB MAP INF XDR TB; World Health Organization (WHO), 2008, 4 WHOIUATLD; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	30	43	47	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					766	W137		10.7326/0003-4819-150-11-200906020-00004	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487711				2022-12-24	WOS:000266530000003
J	Sanada, M; Suzuki, T; Shih, LY; Otsu, M; Kato, M; Yamazaki, S; Tamura, A; Honda, H; Sakata-Yanagimoto, M; Kumano, K; Oda, H; Yamagata, T; Takita, J; Gotoh, N; Nakazaki, K; Kawamata, N; Onodera, M; Nobuyoshi, M; Hayashi, Y; Harada, H; Kurokawa, M; Chiba, S; Mori, H; Ozawa, K; Omine, M; Hirai, H; Nakauchi, H; Koeffler, HP; Ogawa, S				Sanada, Masashi; Suzuki, Takahiro; Shih, Lee-Yung; Otsu, Makoto; Kato, Motohiro; Yamazaki, Satoshi; Tamura, Azusa; Honda, Hiroaki; Sakata-Yanagimoto, Mamiko; Kumano, Keiki; Oda, Hideaki; Yamagata, Tetsuya; Takita, Junko; Gotoh, Noriko; Nakazaki, Kumi; Kawamata, Norihiko; Onodera, Masafumi; Nobuyoshi, Masaharu; Hayashi, Yasuhide; Harada, Hiroshi; Kurokawa, Mineo; Chiba, Shigeru; Mori, Hiraku; Ozawa, Keiya; Omine, Mitsuhiro; Hirai, Hisamaru; Nakauchi, Hiromitsu; Koeffler, H. Phillip; Ogawa, Seishi			Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; RETROVIRAL VECTOR GCDNSAP; MYELODYSPLASTIC SYNDROMES; NEGATIVE REGULATION; UBIQUITIN LIGASES; V-CBL; MUTATIONS; PROTEIN; P53; TRANSFORMATION	Acquired uniparental disomy(aUPD) is a common feature of cancer genomes, leading to loss of heterozygosity. aUPD is associated not only with loss-of-function mutations of tumour suppressor genes(1), but also with gain-of-function mutations of proto-oncogenes(2). Here we show unique gain-of-function mutations of the C-CBL (also known as CBL) tumour suppressor that are tightly associated with aUPD of the 11q arm in myeloid neoplasms showing myeloproliferative features. The C-CBL proto-oncogene, a cellular homologue of v-Cbl, encodes an E3 ubiquitin ligase and negatively regulates signal transduction of tyrosine kinases(3-6). Homozygous C-CBL mutations were found in most 11q-aUPD-positive myeloid malignancies. Although the C-CBL mutations were oncogenic in NIH3T3 cells, c-Cbl was shown to functionally and genetically act as a tumour suppressor. C-CBL mutants did not have E3 ubiquitin ligase activity, but inhibited that of wild-type C-CBL and CBL-B (also known as CBLB), leading to prolonged activation of tyrosine kinases after cytokine stimulation. c-Cbl(-/-) haematopoietic stem/progenitor cells (HSPCs) showed enhanced sensitivity to a variety of cytokines compared to c-Cbl(+/+) HSPCs, and transduction of C-CBL mutants into c-Cbl(-/-) HSPCs further augmented their sensitivities to a broader spectrum of cytokines, including stem-cell factor (SCF, also known as KITLG), thrombopoietin (TPO, also known as THPO), IL3 and FLT3 ligand (FLT3LG), indicating the presence of a gain-of-function that could not be attributed to a simple loss-of-function. The gain-of-function effects of C-CBL mutants on cytokine sensitivity of HSPCs largely disappeared in a c-Cbl(-/-) background or by co-transduction of wild-type C-CBL, which suggests the pathogenic importance of loss of wild-type C-CBL alleles found in most cases of C-CBL-mutated myeloid neoplasms. Our findings provide a new insight into a role of gain-of-function mutations of a tumour suppressor associated with aUPD in the pathogenesis of some myeloid cancer subsets.	[Sanada, Masashi; Kato, Motohiro; Tamura, Azusa; Takita, Junko; Nakazaki, Kumi; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, Motohiro; Takita, Junko] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kumano, Keiki; Takita, Junko; Nakazaki, Kumi; Kurokawa, Mineo; Hirai, Hisamaru] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Sanada, Masashi; Yamazaki, Satoshi; Nakauchi, Hiromitsu; Ogawa, Seishi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Suzuki, Takahiro; Nobuyoshi, Masaharu; Ozawa, Keiya] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi 3290498, Japan; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taipei 105, Taiwan; [Otsu, Makoto; Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell & Regenerat Med, Minato Ku, Tokyo 1088639, Japan; [Gotoh, Noriko] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Honda, Hiroaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dev Biol, Minami Ku, Hiroshima 7348553, Japan; [Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Inst Clin Med, Dept Clin & Expt Hematol, Tsukuba, Ibaraki 3058571, Japan; [Oda, Hideaki] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; [Yamagata, Tetsuya] Dokkyo Univ, Sch Med, Dept Hematol, Mibu, Tochigi 3210293, Japan; [Kawamata, Norihiko; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Dept Genet, Setagaya Ku, Tokyo 1578535, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa, Gunma 3778577, Japan; [Harada, Hiroshi; Mori, Hiraku; Omine, Mitsuhiro] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Kanagawa 2278501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Jichi Medical University; Chang Gung Memorial Hospital; Chang Gung University; University of Tokyo; University of Tokyo; Hiroshima University; University of Tsukuba; Tokyo Women's Medical University; Dokkyo Medical University; Cedars Sinai Medical Center; National Center for Child Health & Development - Japan; Gunma Children's Medical Centre; Showa University	Ogawa, S (corresponding author), Univ Tokyo, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sly7012@adm.cgmh.org.tw; sogawa-tky@umin.ac.jp	GOTOH, Noriko/D-8430-2015; Furukawa, Yusuke/Y-1342-2018; Ogawa, Seishi/AAE-7088-2019; Mamiko, Sakata-yanagimoto/AAP-3298-2020	Furukawa, Yusuke/0000-0002-7249-6418; Kato, Motohiro/0000-0001-5145-1774; Otsu, Makoto/0000-0002-9769-0217; Gotoh, Noriko/0000-0003-3733-260X	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; National Health Research Institute, Taiwan [NHRI-EX96-9434SI, NIH-2R01CA026038-30]; Grants-in-Aid for Scientific Research [21390316] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology, and a grant from National Health Research Institute, Taiwan, NHRI-EX96-9434SI, and NIH-2R01CA026038-30. We thank W. Y. Langdon for providing a human C-CBL cDNA. A mast-cell cell line expressing c-KIT V3MC was a gift from M. F. Gurish. We also thank Y. Ogino and K. Fujita for their technical assistance.	Abbas S, 2008, HAEMATOL-HEMATOL J, V93, P1595, DOI 10.3324/haematol.13187; BLAKE TJ, 1991, ONCOGENE, V6, P653; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Haase D, 2008, ANN HEMATOL, V87, P515, DOI 10.1007/s00277-008-0483-y; Hamanaka S, 2007, MOL THER, V15, P560, DOI 10.1038/sj.mt.6300063; Honda H, 2000, BLOOD, V95, P1144, DOI 10.1182/blood.V95.4.1144.004k04_1144_1150; JAFFE E, 2002, WHO CLASSIFICATION T, P62; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sanuki S, 2008, J GENE MED, V10, P965, DOI 10.1002/jgm.1232; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	36	326	333	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					904	U145		10.1038/nature08240	http://dx.doi.org/10.1038/nature08240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19620960				2022-12-24	WOS:000268938300041
J	Zhang, CL; Katoh, M; Shibasaki, T; Minami, K; Sunaga, Y; Takahashi, H; Yokoi, N; Iwasaki, M; Miki, T; Seino, S				Zhang, Chang-Liang; Katoh, Megumi; Shibasaki, Tadao; Minami, Kohtaro; Sunaga, Yasuhiro; Takahashi, Harumi; Yokoi, Norihide; Iwasaki, Masahiro; Miki, Takashi; Seino, Susumu			The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs	SCIENCE			English	Article							PANCREATIC BETA-CELLS; K-ATP CHANNELS; INSULIN-SECRETION; B-CELLS; RECEPTOR; STIMULATION; EXOCYTOSIS; GRANULE; MICE; ACTIVATION	Epac2, a guanine nucleotide exchange factor for the small guanosine triphosphatase Rap1, is activated by adenosine 3',5'-monophosphate. Fluorescence resonance energy transfer and binding experiments revealed that sulfonylureas, widely used antidiabetic drugs, interact directly with Epac2. Sulfonylureas activated Rap1 specifically through Epac2. Sulfonylurea-stimulated insulin secretion was reduced both in vitro and in vivo in mice lacking Epac2, and the glucose-lowering effect of the sulfonylurea tolbutamide was decreased in these mice. Epac2 thus contributes to the effect of sulfonylureas to promote insulin secretion. Because Epac2 is also required for the action of incretins, gut hormones crucial for potentiating insulin secretion, it may be a promising target for antidiabetic drug development.	[Zhang, Chang-Liang; Katoh, Megumi; Shibasaki, Tadao; Minami, Kohtaro; Sunaga, Yasuhiro; Takahashi, Harumi; Yokoi, Norihide; Iwasaki, Masahiro; Miki, Takashi; Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cellular & Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Seino, Susumu] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST)	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cellular & Mol Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Minami, Kohtaro/0000-0003-4698-6250	Japan Science and Technology Agency; Global Centers of Excellence; Ministry of Education, Culture, Sports, Science and Technology	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global Centers of Excellence; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a CREST grant from the Japan Science and Technology Agency and Grant-in-Aid for Scientific Research and by a grant for the Global Centers of Excellence Program "Global Center of Excellence for Education and research on Signal Transduction Medicine in the Coming Generation" from the Ministry of Education, Culture, Sports, Science and Technology.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Eliasson L, 1996, SCIENCE, V271, P813, DOI 10.1126/science.271.5250.813; FLATT PR, 1994, DIABETES METAB, V20, P157; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Geng XH, 2007, AM J PHYSIOL-ENDOC M, V293, pE293, DOI 10.1152/ajpendo.00016.2007; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; OZANNE SE, 1995, DIABETOLOGIA, V38, P277; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Sunaga Y, 2001, EUR J PHARMACOL, V431, P119, DOI 10.1016/S0014-2999(01)01412-1	28	167	172	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					607	610		10.1126/science.1172256	http://dx.doi.org/10.1126/science.1172256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644119				2022-12-24	WOS:000268493000049
J	Greenbaum, DC; FitzGerald, GA				Greenbaum, Doron C.; FitzGerald, Garret A.			Platelets, Pyrexia, and Plasmodia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Greenbaum, DC (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010					Clark I, 2001, LANCET, V357, P625, DOI 10.1016/S0140-6736(00)04061-7; Looney MR, 2009, NAT MED, V15, P364, DOI 10.1038/nm0409-364; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Rocca B, 1997, CIRCULATION, V95, P11, DOI 10.1161/01.CIR.95.1.11; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003	5	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					526	528		10.1056/NEJMcibr0903050	http://dx.doi.org/10.1056/NEJMcibr0903050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641212				2022-12-24	WOS:000268443900017
J	Samarasekera, U				Samarasekera, Udani			Countries race to contain resistance to key antimalarial	LANCET			English	News Item																			0	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 25	2009	374	9686					277	280		10.1016/S0140-6736(09)61349-0	http://dx.doi.org/10.1016/S0140-6736(09)61349-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19639670	Bronze			2022-12-24	WOS:000268508200010
J	Fjerstad, M; Trussell, J; Sivin, I; Lichtenberg, ES; Cullins, V				Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa			Rates of Serious Infection after Changes in Regimens for Medical Abortion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLOSTRIDIUM-SORDELLII; UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TRIAL	Background: From 2001 through March 2006, Planned Parenthood health centers throughout the United States provided medical abortion (abortion by means of medication) principally by a regimen of oral mifepristone followed 24 to 48 hours later by vaginal misoprostol. In response to concern about serious infections, in early 2006 Planned Parenthood changed the route of misoprostol administration from vaginal to buccal and required either routine provision of antibiotics or universal screening and treatment for chlamydia; in July 2007, Planned Parenthood began requiring routine treatment with antibiotics for all medical abortions. Methods: We performed a retrospective analysis assessing the rates of serious infection after medical abortion during a time when misoprostol was administered vaginally (through March 2006), as compared with rates after a change to buccal administration of misoprostol and after initiation of additional infection-reduction measures. Results: Rates of serious infection dropped significantly after the joint change to buccal misoprostol from vaginal misoprostol and to either testing for sexually transmitted infection or routine provision of antibiotics as part of the medical abortion regimen. The rate declined 73%, from 0.93 per 1000 abortions to 0.25 per 1000 (absolute reduction, 0.67 per 1000; 95% confidence interval [CI], 0.44 to 0.94; P<0.001). The subsequent change to routine provision of antibiotics led to a further significant reduction in the rate of serious infection -- a 76% decline, from 0.25 per 1000 abortions to 0.06 per 1000 (absolute reduction, 0.19 per 1000; 95% CI, 0.02 to 0.34; P=0.03). Conclusions: The rate of serious infection after medical abortion declined by 93% after a change from vaginal to buccal administration of misoprostol combined with routine administration of antibiotics. N Engl J Med 2009;361:145-51.	[Fjerstad, Mary; Cullins, Vanessa] Planned Parenthood Federat Amer, New York, NY USA; [Sivin, Irving] Populat Council, Reprod Hlth Program, New York, NY 10021 USA; [Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Trussell, James] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Lichtenberg, E. Steve] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Population Council; Princeton University; University of Hull; University of York - UK; Northwestern University; Feinberg School of Medicine	Fjerstad, M (corresponding author), Ipas, POB 5027, Chapel Hill, NC 27514 USA.	fjerstadm@ipas.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NICHD NIH HHS [R24 HD047879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; [Anonymous], 2005, OBSTET GYNECOL, V106, P871; *CDCP, 2008, SEX TRANSM DIS SURV; Darney PD, 2005, CONTRACEPTION, V72, P319, DOI 10.1016/j.contraception.2005.07.009; Fischer M, 2005, NEW ENGL J MED, V353, P2352, DOI 10.1056/NEJMoa051620; FJERSTAD M, 1996, OBSTET GYNECOL, V87, P884; *FOOD DRUG ADM, 2007, MIF MIF INF; Hausknecht R, 2003, CONTRACEPTION, V67, P463, DOI 10.1016/S0010-7824(03)00049-0; Henderson JT, 2005, CONTRACEPTION, V72, P175, DOI 10.1016/j.contraception.2005.03.011; Middleton T, 2005, CONTRACEPTION, V72, P328, DOI 10.1016/j.contraception.2005.05.017; Sawaya GF, 1996, OBSTET GYNECOL, V87, P884; Shannon C, 2004, CONTRACEPTION, V70, P183, DOI 10.1016/j.contraception.2004.04.009; Spitz IM, 1998, NEW ENGL J MED, V338, P1241, DOI 10.1056/NEJM199804303381801; Winikoff B, 2008, OBSTET GYNECOL, V112, P1303, DOI 10.1097/AOG.0b013e31818d8eb4	14	60	61	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					145	151		10.1056/NEJMoa0809146	http://dx.doi.org/10.1056/NEJMoa0809146			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587339	Green Accepted			2022-12-24	WOS:000267748900007
J	Tu, XM; Manohar, S; Jagota, A; Zheng, M				Tu, Xiaomin; Manohar, Suresh; Jagota, Anand; Zheng, Ming			DNA sequence motifs for structure-specific recognition and separation of carbon nanotubes	NATURE			English	Article							SINGLE-STRANDED-DNA; MOLECULAR-DYNAMICS; HYBRIDS; DISPERSION; SIMULATION; POLYMERS; ENERGY	Single-walled carbon nanotubes (SWNTs) are a family of molecules that have the same cylindrical shape but different chiralities(1). Many fundamental studies and technological applications(2) of SWNTs require a population of tubes with identical chirality that current syntheses cannot provide. The SWNT sorting problem-that is, separation of a synthetic mixture of tubes into individual single-chirality components-has attracted considerable attention in recent years. Intense efforts so far have focused largely on, and resulted in solutions for, a weaker version of the sorting problem: metal/semiconductor separation(3,4). A systematic and general method to purify each and every single-chirality species of the same electronic type from the synthetic mixture of SWNTs is highly desirable, but the task has proven to be insurmountable to date. Here we report such a method, which allows purification of all 12 major single-chirality semiconducting species from a synthetic mixture, with sufficient yield for both fundamental studies and application development. We have designed an effective search of a DNA library of similar to 10(60) in size, and have identified more than 20 short DNA sequences, each of which recognizes and enables chromatographic purification of a particular nanotube species from the synthetic mixture. Recognition sequences exhibit a periodic purine-pyrimidines pattern, which can undergo hydrogen-bonding to form a two-dimensional sheet, and fold selectively on nanotubes into a well-ordered three-dimensional barrel. We propose that the ordered two-dimensional sheet and three-dimensional barrel provide the structural basis for the observed DNA recognition of SWNTs.	[Tu, Xiaomin; Zheng, Ming] DuPont Co Inc, Cent Res & Dev, Wilmington, DE 19880 USA; [Manohar, Suresh; Jagota, Anand] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA; [Jagota, Anand] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	DuPont; Lehigh University; Lehigh University	Zheng, M (corresponding author), DuPont Co Inc, Cent Res & Dev, Wilmington, DE 19880 USA.	ming.zheng@usa.dupont.com			US National Science Foundation [CMS-060950]	US National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the US National Science Foundation (grant CMS-060950). We thank T. Devine for technical assistance.	[Anonymous], 1999, PHYS PROPERTIES CARB; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Chen FM, 2007, NANO LETT, V7, P3013, DOI 10.1021/nl071349o; Frischknecht AL, 2008, J PHYS CHEM C, V112, P6271, DOI 10.1021/jp077522m; Gowtham S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125701; Haroz EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125405; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Johnson RR, 2008, NANO LETT, V8, P69, DOI 10.1021/nl071909j; Johnson RR, 2009, NANO LETT, V9, P537, DOI 10.1021/nl802645d; Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148; Kim WJ, 2009, J AM CHEM SOC, V131, P3128, DOI 10.1021/ja807989d; Lustig SR, 2005, J PHYS CHEM B, V109, P2559, DOI 10.1021/jp0452913; Manohar S, 2007, J PHYS CHEM C, V111, P17835, DOI 10.1021/jp071316x; Manohar S, 2008, NANO LETT, V8, P4365, DOI 10.1021/nl8022143; Marquis R, 2008, NANO LETT, V8, P1830, DOI 10.1021/nl0803141; Martin W, 2008, J PHYS CHEM B, V112, P16076, DOI 10.1021/jp8040567; Meng S, 2007, NANO LETT, V7, P45, DOI 10.1021/nl0619103; Ming Z, 2004, J AM CHEM SOC, V126, P15490, DOI 10.1021/ja0457967; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Tu XM, 2008, NANO RES, V1, P185, DOI 10.1007/s12274-008-8022-7; Yao YG, 2009, NANO LETT, V9, P1673, DOI 10.1021/nl900207v; Zhang L, 2009, J AM CHEM SOC, V131, P2454, DOI 10.1021/ja8096674; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Zheng M, 2007, J AM CHEM SOC, V129, P6084, DOI 10.1021/ja071577k	28	864	893	9	397	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					250	253		10.1038/nature08116	http://dx.doi.org/10.1038/nature08116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587767				2022-12-24	WOS:000267761000039
J	Goldston, D				Goldston, David			Climate future	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com						2009, NATURE, V459, P493	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					628	628		10.1038/459628a	http://dx.doi.org/10.1038/459628a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494887	Bronze			2022-12-24	WOS:000266608600011
J	Cahoon, LA; Seifert, HS				Cahoon, Laty A.; Seifert, H. Steven			An Alternative DNA Structure Is Necessary for Pilin Antigenic Variation in Neisseria gonorrhoeae	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; G-QUADRUPLEX; NUCLEOTIDE-SEQUENCES; G4 DNA; GENE; REPAIR; PATHWAYS; PROTEIN; PATHOGENS; BACTERIAL	Pathogens can use DNA recombination to promote antigenic variation (Av) of surface structures to avoid immune detection. We identified a cis-acting DNA sequence near the antigenically variable pilin locus of the human pathogen, Neisseria gonorrhoeae. This 16-base pair guanine (G)-rich sequence was required for pilin Av and formed a guanine quartet (G4) structure in vitro. Individual mutations that disrupted the structure also blocked pilin Av and prevented nicks required for recombination from occurring within the G4 region. A compound that binds and stabilizes G4 structures also inhibited pilin Av and prevented nicks from occurring on the G-rich strand. This site constitutes a recombination initiation sequence/structure that directs gene conversion to a specific chromosomal locus.	[Cahoon, Laty A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Seifert, HS (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	h-seifert@northwestern.edu		Cahoon, Laty/0000-0003-2061-319X	NIH [R37AI033493, R01AI055977, R01AI044239, T32GM08061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R37AI033493, R01AI055977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R37AI033493, R01AI055977, and R01AI044239 to H.S.S. L.A.C. was partially supported by NIH grant T32GM08061.	Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; Kline KA, 2007, J BACTERIOL, V189, P3462, DOI 10.1128/JB.01911-06; Kong QZ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e33; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; SCHIERER T, 1994, BIOCHEMISTRY-US, V33, P2240, DOI 10.1021/bi00174a034; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; SWANSON J, 1987, A VAN LEEUW J MICROB, V53, P441, DOI 10.1007/BF00415500; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; Wu X, 2001, NUCLEIC ACIDS RES, V29, P1765, DOI 10.1093/nar/29.8.1765	28	232	234	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					764	767		10.1126/science.1175653	http://dx.doi.org/10.1126/science.1175653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661435	Green Accepted			2022-12-24	WOS:000268723700054
J	Burikhanov, R; Zhao, YM; Goswami, A; Qiu, S; Schwarze, SR; Rangnekar, VM				Burikhanov, Ravshan; Zhao, Yanming; Goswami, Anindya; Qiu, Shirley; Schwarze, Steven R.; Rangnekar, Vivek M.			The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis	CELL			English	Article							PROSTATE-CANCER; PROTEIN PAR-4; STRESS; EXPRESSION; CELLS; INDUCTION; KINASE; GRP78; PHOSPHORYLATION; BINDING	Prostate apoptosis response-4 (Par-4) is a proapoptotic protein with intracellular functions in the cytoplasm and nucleus. Unexpectedly, we noted Par-4 protein is spontaneously secreted by normal and cancer cells in culture, and by Par-4 transgenic mice that are resistant to spontaneous tumors. Short exposure to endoplasmic reticulum (ER) stress-inducing agents further increased cellular secretion of Par-4 by a brefeldin A-sensitive pathway. Secretion occurred independently of caspase activation and apoptosis. Interestingly, extracellular Par-4 induced apoptosis by binding to the stress response protein, glucose-regulated protein-78 (GRP78), expressed at the surface of cancer cells. The interaction of extracellular Par-4 and cell surface GRP78 led to apoptosis via ER stress and activation of the FADD/caspase-8/caspase-3 pathway. Moreover, apoptosis inducible by TRAIL, which also exerts cancer cell-specific effects, is dependent on extracellular Par-4 signaling via cell surface GRP78. Thus, Par-4 activates an extrinsic pathway involving cell surface GRP78 receptor for induction of apoptosis.	[Burikhanov, Ravshan; Zhao, Yanming; Goswami, Anindya; Qiu, Shirley; Rangnekar, Vivek M.] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA; [Schwarze, Steven R.] Univ Kentucky, Dept Biochem & Mol Biol, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Rangnekar, VM (corresponding author), Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA.	vmrang01@email.uky.edu	Burikhanov, Ravshan/AAF-4895-2021		NIH/NCI [CA60872, CA105453, CA84511]; NATIONAL CANCER INSTITUTE [R01CA116658, R01CA060872, R01CA084511, R01CA105453] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grants CA60872, CA105453, and CA84511 (to V. M. R.). We thank Krishna Murthi Vasudevan (Dana-Farber Cancer Institute) for critical reading of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Chakraborty M, 2001, CANCER RES, V61, P7255; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Cook J, 1999, ONCOGENE, V18, P1205, DOI 10.1038/sj.onc.1202416; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; El-Guendy N, 2003, MOL CELL BIOL, V23, P5516, DOI 10.1128/MCB.23.16.5516-5525.2003; Garcia-Cao I, 2005, EMBO REP, V6, P577, DOI 10.1038/sj.embor.7400421; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; GOSWAMI A, 2008, CANCER RES, V68, P1; Gurumurthy S, 2005, MOL CELL BIOL, V25, P1146, DOI 10.1128/MCB.25.3.1146-1161.2005; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Moreno-Bueno G, 2007, CANCER RES, V67, P1927, DOI 10.1158/0008-5472.CAN-06-2687; Page G, 1999, ONCOGENE, V18, P7265, DOI 10.1038/sj.onc.1203170; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Zhao YM, 2007, CANCER RES, V67, P9276, DOI 10.1158/0008-5472.CAN-07-2124	24	178	187	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					377	388		10.1016/j.cell.2009.05.022	http://dx.doi.org/10.1016/j.cell.2009.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632185	Green Accepted, Bronze			2022-12-24	WOS:000268277000018
J	Nakanishi, H; Bishop, KJM; Kowalczyk, B; Nitzan, A; Weiss, EA; Tretiakov, KV; Apodaca, MM; Klajn, R; Stoddart, JF; Grzybowski, BA				Nakanishi, Hideyuki; Bishop, Kyle J. M.; Kowalczyk, Bartlomiej; Nitzan, Abraham; Weiss, Emily A.; Tretiakov, Konstantin V.; Apodaca, Mario M.; Klajn, Rafal; Stoddart, J. Fraser; Grzybowski, Bartosz A.			Photoconductance and inverse photoconductance in films of functionalized metal nanoparticles	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; CHARGE-LIMITED CURRENTS; MOLECULAR JUNCTIONS; HYDRATED ELECTRON; ALKANETHIOLS; RESISTANCE; TRANSPORT; CELLS	In traditional photoconductors(1-3), the impinging light generates mobile charge carriers in the valence and/or conduction bands, causing the material's conductivity to increase(4). Such positive photoconductance is observed in both bulk and nanostructured(5,6) photoconductors. Here we describe a class of nanoparticle-based materials whose conductivity can either increase or decrease on irradiation with visible light of wavelengths close to the particles' surface plasmon resonance. The remarkable feature of these plasmonic materials is that the sign of the conductivity change and the nature of the electron transport between the nanoparticles depend on the molecules comprising the self-assembled monolayers (SAMs)(7,8) stabilizing the nanoparticles. For SAMs made of electrically neutral (polar and non-polar) molecules, conductivity increases on irradiation. If, however, the SAMs contain electrically charged (either negatively or positively) groups, conductivity decreases. The optical and electrical characteristics of these previously undescribed inverse photoconductors can be engineered flexibly by adjusting the material properties of the nanoparticles and of the coating SAMs. In particular, in films comprising mixtures of different nanoparticles or nanoparticles coated with mixed SAMs, the overall photoconductance is a weighted average of the changes induced by the individual components. These and other observations can be rationalized in terms of light-induced creation of mobile charge carriers whose transport through the charged SAMs is inhibited by carrier trapping in transient polaron-like states(9,10). The nanoparticle-based photoconductors we describe could have uses in chemical sensors and/or in conjunction with flexible substrates.	[Nakanishi, Hideyuki; Kowalczyk, Bartlomiej; Nitzan, Abraham; Weiss, Emily A.; Apodaca, Mario M.; Stoddart, J. Fraser; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Nakanishi, Hideyuki; Bishop, Kyle J. M.; Kowalczyk, Bartlomiej; Tretiakov, Konstantin V.; Klajn, Rafal; Grzybowski, Bartosz A.] Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; [Nitzan, Abraham] Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Northwestern University; Northwestern University; Tel Aviv University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Tretiakov, Konstantin V./A-3594-2008; Grzybowski, Bartosz A/H-5741-2017; Kowalczyk, Bartlomiej/C-4919-2008; Weiss, Emily A/B-4718-2009; Stoddart, James Fraser/H-1518-2011; Bishop, Kyle J M/F-1742-2010	Tretiakov, Konstantin V./0000-0003-4620-2807; Stoddart, James Fraser/0000-0003-3161-3697; Grzybowski, Bartosz/0000-0001-6613-4261	Alfred P. Sloan Fellowship; Dreyfus Teacher-Scholar Award	Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Dreyfus Teacher-Scholar Award	We thank M. Ratner, G. C. Schatz and R. van Duyne for discussions and advice. This work was supported by the Alfred P. Sloan Fellowship and the Dreyfus Teacher-Scholar Award (to B. A. G.).	ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; [Anonymous], 1981, PHYS SEMICONDUCTOR D; Bozano LD, 2005, ADV FUNCT MATER, V15, P1933, DOI 10.1002/adfm.200500130; Engelkes VB, 2004, J AM CHEM SOC, V126, P14287, DOI 10.1021/ja046274u; Galperin M, 2005, NANO LETT, V5, P125, DOI 10.1021/nl048216c; Han S, 2004, CHEM PHYS LETT, V389, P176, DOI 10.1016/j.cplett.2004.03.083; Hayden O, 2006, NAT MATER, V5, P352, DOI 10.1038/nmat1635; JORTNER J, 1966, J PHYS CHEM-US, V70, P770, DOI 10.1021/j100875a026; Joshi N.V., 1990, PHOTOCONDUCTIVITY AR; Kalsin AM, 2007, J AM CHEM SOC, V129, P6664, DOI 10.1021/ja068329t; Kalsin AM, 2006, J AM CHEM SOC, V128, P15046, DOI 10.1021/ja0642966; Kalsin AM, 2006, NANO LETT, V6, P1896, DOI 10.1021/nl060967m; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kuznetsov AM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770725; LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648; Lee JS, 2007, NAT NANOTECHNOL, V2, P790, DOI 10.1038/nnano.2007.380; Lee T, 2004, J PHYS CHEM B, V108, P8742, DOI 10.1021/jp049541r; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; MANY A, 1962, PHYS REV, V126, P1980, DOI 10.1103/PhysRev.126.1980; Nguyen TD, 2005, P NATL ACAD SCI USA, V102, P10029, DOI 10.1073/pnas.0504109102; Nitzan A., 2006, CHEM DYNAMICS CONDEN; Novembre C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2896602; Pinchuk AO, 2007, J PHYS CHEM C, V111, P11816, DOI 10.1021/jp073403v; SCHNITKER J, 1987, J CHEM PHYS, V86, P3471, DOI 10.1063/1.452003; Weiss EA, 2005, J AM CHEM SOC, V127, P11842, DOI 10.1021/ja052901j; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Witt D, 2004, CURR ORG CHEM, V8, P1763, DOI 10.2174/1385272043369421; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhan CG, 2003, J PHYS CHEM B, V107, P4403, DOI 10.1021/jp022326v; Zou SL, 2006, TOP APPL PHYS, V103, P67	30	212	214	8	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					371	375		10.1038/nature08131	http://dx.doi.org/10.1038/nature08131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606145				2022-12-24	WOS:000267979000033
J	Bajoghli, B; Aghaallaei, N; Hess, I; Rode, I; Netuschil, N; Tay, BH; Venkatesh, B; Yu, JK; Kaltenbach, SL; Holland, ND; Diekhoff, D; Happe, C; Schorpp, M; Boehm, T				Bajoghli, Baubak; Aghaallaei, Narges; Hess, Isabell; Rode, Immanuel; Netuschil, Nikolai; Tay, Boon-Hui; Venkatesh, Byrappa; Yu, Jr-Kai; Kaltenbach, Stacy L.; Holland, Nicholas D.; Diekhoff, Dagmar; Happe, Christiane; Schorpp, Michael; Boehm, Thomas			Evolution of Genetic Networks Underlying the Emergence of Thymopoiesis in Vertebrates	CELL			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; T-CELL DEVELOPMENT; DELTA-LIKE 4; THYMUS COLONIZATION; CHEMOKINE RECEPTOR; LAMPREY; BCL11B; DIFFERENTIATION; EXPRESSION; EPITHELIUM	About 500 million years ago, a new type of adaptive immune defense emerged in basal jawed vertebrates, accompanied by morphological innovations, including the thymus. Did these evolutionary novelties arise de novo or from elaboration of ancient genetic networks? We reconstructed the genetic changes underlying thymopoiesis by comparative genome and expression analyses in chordates and basal vertebrates. The derived models of genetic networks were experimentally verified in bony fishes. Ancestral networks defining circumscribed regions of the pharyngeal epithelium of jawless vertebrates expanded in cartilaginous fishes to incorporate novel genes, notably those encoding chemokines. Correspondingly, novel networks evolved in lymphocytes of jawed vertebrates to control the expression of additional chemokine receptors. These complementary changes enabled unprecedented Delta/Notch signaling between pharyngeal epithelium and lymphoid cells that was exploited for specification to the T cell lineage. Our results provide a framework elucidating the evolution of key features of the adaptive immune system in jawed vertebrates.	[Bajoghli, Baubak; Aghaallaei, Narges; Hess, Isabell; Rode, Immanuel; Netuschil, Nikolai; Diekhoff, Dagmar; Happe, Christiane; Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol, Dept Dev Immunol, D-79108 Freiburg, Germany; [Tay, Boon-Hui; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore; [Yu, Jr-Kai; Kaltenbach, Stacy L.; Holland, Nicholas D.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego; Scripps Institution of Oceanography	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de	Yu, Jr-Kai/H-4822-2019; Bajoghli, Baubak/AAF-8388-2020	Yu, Jr-Kai/0000-0001-8591-0529; Bajoghli, Baubak/0000-0002-7368-7523; Aghaallaei, Narges/0000-0002-9890-3229; Venkatesh, Byrappa/0000-0003-3620-0277; Bajoghli, Baubak/0000-0003-1395-6362	Max-Planck Society; Deutsche Forschungsgemeinschaft; Biomedical Research Council of the A*STAR, Singapore	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biomedical Research Council of the A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	We thank C. Burgtorf, M. Cooper, S. Kuratani, B. Appel, and J. Shin for reagents and J. Wittbrodt, T. Nolting, N. Schmidt, E. Nold, M. Leicht, M. Held, C. Strohmeier, A. Haas- Assenbaum, C. Thomas, P. Kindle, and A. Wu " rch for their help during various phases of the project. The lamprey (P. marinus) genome assembly was provided by the Genome Sequencing Center at Washington University St. Louis School of Medicine. T. B.'s laboratory is supported by the Max-Planck Society and the Deutsche Forschungsgemeinschaft; B.V.'s laboratory is supported by the Biomedical Research Council of the A*STAR, Singapore.	Aghaallaei N, 2007, DEV BIOL, V307, P408, DOI 10.1016/j.ydbio.2007.04.022; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; BESMER P, 1993, DEVELOPMENT, P125; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2006, NAT REV IMMUNOL, V6, P79, DOI 10.1038/nri1749; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Carl M, 2002, DEVELOPMENT, V129, P4057; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Holland Linda Z., 1996, P267; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kang JS, 2004, CURR OPIN IMMUNOL, V16, P180, DOI 10.1016/j.coi.2004.02.002; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuroda N, 2003, IMMUNOGENETICS, V54, P884, DOI 10.1007/s00251-002-0531-z; Li SG, 2005, P NATL ACAD SCI USA, V102, P10688, DOI 10.1073/pnas.0504799102; Litman GW, 2007, NAT IMMUNOL, V8, P547, DOI 10.1038/ni0607-547; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pastoret P.-P., 1998, HDB VERTEBRATE IMMUN; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rasmussen SLK, 2007, GENESIS, V45, P113, DOI 10.1002/dvg.20278; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; ROUSSET D, 1995, J MOL EVOL, V41, P421, DOI 10.1007/BF00160313; Ruppert EE, 1997, MICROSCOPIC ANATOMY, V15, P349; Savvides SN, 2000, NAT STRUCT BIOL, V7, P486; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wallin IE, 1917, AM J ANAT, V22, P127, DOI 10.1002/aja.1000220106; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO	59	142	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					186	197		10.1016/j.cell.2009.04.017	http://dx.doi.org/10.1016/j.cell.2009.04.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19559469	Bronze			2022-12-24	WOS:000267848600024
J	Boynton, WV; Ming, DW; Kounaves, SP; Young, SMM; Arvidson, RE; Hecht, MH; Hoffman, J; Niles, PB; Hamara, DK; Quinn, RC; Smith, PH; Sutter, B; Catling, DC; Morris, RV				Boynton, W. V.; Ming, D. W.; Kounaves, S. P.; Young, S. M. M.; Arvidson, R. E.; Hecht, M. H.; Hoffman, J.; Niles, P. B.; Hamara, D. K.; Quinn, R. C.; Smith, P. H.; Sutter, B.; Catling, D. C.; Morris, R. V.			Evidence for Calcium Carbonate at the Mars Phoenix Landing Site	SCIENCE			English	Article							EVOLVED GAS ANALYZER; MARTIAN METEORITES; CLIMATE; IDENTIFICATION; ASSEMBLAGES; EVAPORITES; MINERALS; ROCKS; ICE	Carbonates are generally products of aqueous processes and may hold important clues about the history of liquid water on the surface of Mars. Calcium carbonate (approximately 3 to 5 weight percent) has been identified in the soils around the Phoenix landing site by scanning calorimetry showing an endothermic transition beginning around 725 degrees C accompanied by evolution of carbon dioxide and by the ability of the soil to buffer pH against acid addition. Based on empirical kinetics, the amount of calcium carbonate is most consistent with formation in the past by the interaction of atmospheric carbon dioxide with liquid water films on particle surfaces.	[Boynton, W. V.; Hamara, D. K.; Smith, P. H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Ming, D. W.; Niles, P. B.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Kounaves, S. P.; Young, S. M. M.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Arvidson, R. E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Hecht, M. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hoffman, J.] Univ Texas Dallas, Dept Phys, Richardson, TX 75083 USA; [Quinn, R. C.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Catling, D. C.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Sutter, B.] NASA, Lyndon B Johnson Space Ctr, Jacobs Engn & Sci Contract Grp, Houston, TX 77058 USA	University of Arizona; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Tufts University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Texas System; University of Texas Dallas; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Bristol; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Boynton, WV (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	wboynton@LPL.Arizona.edu	Catling, David C/D-2082-2009	Hecht, Michael/0000-0002-4114-4583; Kounaves, Samuel/0000-0002-2629-4831; Catling, David/0000-0001-5646-120X	University of Arizona, Tucson; California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	University of Arizona, Tucson; California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	The Phoenix Mission was led by the University of Arizona, Tucson, on behalf of NASA and was managed by NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA. The spacecraft was developed by Lockheed Martin Space Systems, Denver.	ANDERSON DM, 1972, ANTARCT J, V30, P114; ARVIDSON RE, 2009, 40 LUN PLAN SCI C WO; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; BOOTH MC, 1978, J GEOPHYS RES, V83, P1809, DOI 10.1029/JB083iB04p01809; Boynton WV, 2001, J GEOPHYS RES-PLANET, V106, P17683, DOI 10.1029/1999JE001153; Bridges JC, 2000, EARTH PLANET SC LETT, V176, P267, DOI 10.1016/S0012-821X(00)00019-4; Bridges JC, 1999, METEORIT PLANET SCI, V34, P407, DOI 10.1111/j.1945-5100.1999.tb01349.x; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Doner Harvey E., 2002, P199; Ehlmann BL, 2008, SCIENCE, V322, P1828, DOI 10.1126/science.1164759; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Gooding J.L., 1986, INT WORKSH ANT MET, P48; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; HETT TL, 2009, 40 LUN PLAN SCI C WO; Hoffman JH, 2008, J AM SOC MASS SPECTR, V19, P1377, DOI 10.1016/j.jasms.2008.07.015; KELLER HU, 2009, 40 LUN PLAN SCI C WO; Kounaves SP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003084; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; MCCLELLA.AL, 1967, J COLLOID INTERF SCI, V23, P577, DOI 10.1016/0021-9797(67)90204-4; Papelis C, 2003, COLLOID SURFACE A, V215, P221, DOI 10.1016/S0927-7757(02)00448-X; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; STEPHENS SK, 1995, P LUNAR PLANET SCI C, V26, P1355; STEPHENS SK, 1995, THESIS CALTECH PASAD; Zent A, 2008, ICARUS, V196, P385, DOI 10.1016/j.icarus.2007.12.028	28	254	256	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					61	64		10.1126/science.1172768	http://dx.doi.org/10.1126/science.1172768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574384				2022-12-24	WOS:000267594000033
J	Hecht, MH; Kounaves, SP; Quinn, RC; West, SJ; Young, SMM; Ming, DW; Catling, DC; Clark, BC; Boynton, WV; Hoffman, J; DeFlores, LP; Gospodinova, K; Kapit, J; Smith, PH				Hecht, M. H.; Kounaves, S. P.; Quinn, R. C.; West, S. J.; Young, S. M. M.; Ming, D. W.; Catling, D. C.; Clark, B. C.; Boynton, W. V.; Hoffman, J.; DeFlores, L. P.; Gospodinova, K.; Kapit, J.; Smith, P. H.			Detection of Perchlorate and the Soluble Chemistry of Martian Soil at the Phoenix Lander Site	SCIENCE			English	Article							CHEMICAL-COMPOSITION; MARS; SURFACE; SPECTROMETER; ORIGIN; ROCKS	The Wet Chemistry Laboratory on the Phoenix Mars Lander performed aqueous chemical analyses of martian soil from the polygon-patterned northern plains of the Vastitas Borealis. The solutions contained similar to 10 mM of dissolved salts with 0.4 to 0.6% perchlorate (ClO4) by mass leached from each sample. The remaining anions included small concentrations of chloride, bicarbonate, and possibly sulfate. Cations were dominated by Mg2+ and Na+, with small contributions from K+ and Ca2+. A moderately alkaline pH of 7.7 +/- 0.5 was measured, consistent with a carbonate-buffered solution. Samples analyzed from the surface and the excavated boundary of the similar to 5-centimeter-deep ice table showed no significant difference in soluble chemistry.	[Hecht, M. H.; DeFlores, L. P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kounaves, S. P.; Young, S. M. M.; Gospodinova, K.; Kapit, J.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Quinn, R. C.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [West, S. J.] Invensys Proc Syst, Foxboro, MA 02035 USA; [Ming, D. W.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Catling, D. C.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Boynton, W. V.; Smith, P. H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hoffman, J.] Univ Texas Dallas, Dept Phys, Richardson, TX 75080 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Tufts University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Schneider Electric; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Bristol; University of Washington; University of Washington Seattle; University of Arizona; University of Texas System; University of Texas Dallas	Hecht, MH (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	michael.h.hecht@jpl.nasa.gov	Catling, David C/D-2082-2009	Catling, David/0000-0001-5646-120X; Hecht, Michael/0000-0002-4114-4583; Kounaves, Samuel/0000-0002-2629-4831	University of Arizona, Tucson; NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	University of Arizona, Tucson; NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	The Phoenix Mission was led by the University of Arizona, Tucson, on behalf of NASA and was managed by NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA. The spacecraft was developed by Lockheed Martin Space Systems, Denver.	Ader M, 2008, EARTH PLANET SC LETT, V269, P604, DOI 10.1016/j.epsl.2008.03.023; BANIN A., 2000, MARS, P594; Bao HM, 2004, ENVIRON SCI TECHNOL, V38, P5073, DOI 10.1021/es049516z; BARTH CA, 1973, SCIENCE, V179, P795, DOI 10.1126/science.179.4075.795; Besley L.M., 1969, J CHEM THERMODYN, V1, P13, DOI [10.1016/0021-9614(69)90032-9, DOI 10.1016/0021-9614(69)90032-9]; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Biemann K, 2007, P NATL ACAD SCI USA, V104, P10310, DOI 10.1073/pnas.0703732104; Bohlke JK, 2005, ANAL CHEM, V77, P7838, DOI 10.1021/ac051360d; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; DEVLIN DJ, 1986, THERMOCHIM ACTA, V104, P159, DOI 10.1016/0040-6031(86)85195-4; ERIKSEN GE, 1981, 1188 US GEOL SURV; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Hecht MH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003077; HUNTEN DM, 1979, J MOL EVOL, V14, P71, DOI 10.1007/BF01732369; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; Keller JM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002679; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Kounaves SP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003084; Kounaves SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001978; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; LAUER HV, 2009, LUNAR PLANET SCI C, V40; Lee MH, 2002, ANAL CHEM, V74, P2603, DOI 10.1021/ac011160b; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; MING DW, 2009, LUNAR PLANET SCI C, V40; Murphy DM, 2000, GEOPHYS RES LETT, V27, P3217, DOI 10.1029/1999GL011267; Orris G.J., 2003, 03314 US GEOL SURV; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; PERRIER S, 2006, J GEOPHYS RES, V111; Pestova ON, 2005, RUSS J APPL CHEM+, V78, P409, DOI 10.1007/s11167-005-0306-z; QUINN R, 1993, GEOCHIM COSMOCHIM AC, V57, P4611, DOI 10.1016/0016-7037(93)90186-Z; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SIMONAITIS R, 1975, PLANET SPACE SCI, V23, P1567, DOI 10.1016/0032-0633(75)90010-0; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; Zahnle K, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003160; Zent AP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2007JE003052	44	732	743	7	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					64	67		10.1126/science.1172466	http://dx.doi.org/10.1126/science.1172466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574385				2022-12-24	WOS:000267594000034
J	Wang, TT; Palese, P				Wang, Taia T.; Palese, Peter			Unraveling the Mystery of Swine Influenza Virus	CELL			English	Editorial Material								Influenza virus outbreaks occur with regularity, but the severity of outbreaks is not consistent. The recent flu epidemic caused by an H1N1 swine influenza virus presents an opportunity to examine what is known about virulence factors and the spread of infection to better prepare for major influenza outbreaks in the future.	[Wang, Taia T.; Palese, Peter] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Hosp, Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	peter.palese@mssm.edu		Palese, Peter/0000-0002-0337-5823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, U01AI070469, U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057158, T32 AI007647, U01 AI70469, U01 AI1074539] Funding Source: Medline; NIGMS NIH HHS [T32 GM007280] Funding Source: Medline; PHS HHS [HHSN266200700010C] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Butler D, 2009, NATURE, V459, P14, DOI 10.1038/459014a; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PALESE P, 1976, NATURE, V263, P528, DOI 10.1038/263528a0; Palese P., 2007, FIELDS VIROLOGY, P1647; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	10	78	89	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					983	985		10.1016/j.cell.2009.05.032	http://dx.doi.org/10.1016/j.cell.2009.05.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524497	Bronze			2022-12-24	WOS:000266916400006
J	Eldar, A; Chary, VK; Xenopoulos, P; Fontes, ME; Loson, OC; Dworkin, J; Piggot, PJ; Elowitz, MB				Eldar, Avigdor; Chary, Vasant K.; Xenopoulos, Panagiotis; Fontes, Michelle E.; Loson, Oliver C.; Dworkin, Jonathan; Piggot, Patrick J.; Elowitz, Michael B.			Partial penetrance facilitates developmental evolution in bacteria	NATURE			English	Article							BACILLUS-SUBTILIS SPORULATION; REPLICATION INITIATION; GENE-EXPRESSION; SPORE FORMATION; HSP90; DNA; DIFFERENTIATION; ROBUSTNESS; SEPTATION; CAPACITOR	Development normally occurs similarly in all individuals within an isogenic population, but mutations often affect the fates of individual organisms differently(1-4). This phenomenon, known as partial penetrance, has been observed in diverse developmental systems. However, it remains unclear how the underlying genetic network specifies the set of possible alternative fates and how the relative frequencies of these fates evolve(5-8). Here we identify a stochastic cell fate determination process that operates in Bacillus subtilis sporulation mutants and show how it allows genetic control of the penetrance of multiple fates. Mutations in an intercompartmental signalling process generate a set of discrete alternative fates not observed in wild-type cells, including rare formation of two viable 'twin' spores, rather than one within a single cell. By genetically modulating chromosome replication and septation, we can systematically tune the penetrance of each mutant fate. Furthermore, signalling and replication perturbations synergize to significantly increase the penetrance of twin sporulation. These results suggest a potential pathway for developmental evolution between monosporulation and twin sporulation through states of intermediate twin penetrance. Furthermore, time-lapse microscopy of twin sporulation in wild-type Clostridium oceanicum shows a strong resemblance to twin sporulation in these B. subtilis mutants(9,10). Together the results suggest that noise can facilitate developmental evolution by enabling the initial expression of discrete morphological traits at low penetrance, and allowing their stabilization by gradual adjustment of genetic parameters.	[Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Chary, Vasant K.; Xenopoulos, Panagiotis; Piggot, Patrick J.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Dworkin, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Eldar, Avigdor/0000-0001-8485-9370	US National Institutes of Health (NIH) [GM43577]; NIH [R01GM079771, P50 GM068763]; US National Science Foundation CAREER Award [0644463]; Packard Foundation; International Human Frontier Science Organization; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, R01GM043577, P50GM068763] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation CAREER Award(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); International Human Frontier Science Organization; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Leadbetter and E. Matson for their help with the anaerobic species. We thank R. Losick, A. Grossman, M. Fujita and A. Arkin for strains and advice. Wethank R. Kishony, D. Jones, Wolfgang Schwarz, G. Suel, J.- G. Ojalvo, B. Shraiman, J. Levine, J. C. W. Locke, D. Sprinzak, L. Cai and other members of M. B. E. and P. J. P. labs for helpful discussions. Work in the P. J. P.'s lab was supported by Public Health Service Grant GM43577 from the US National Institutes of Health (NIH). Work in M. B. E.'s lab was supported by NIH grants R01GM079771 and P50 GM068763, US National Science Foundation CAREER Award 0644463 and the Packard Foundation. A. E. was supported by the International Human Frontier Science Organization and the European Molecular Biology Organization.	Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Angert ER, 1998, P NATL ACAD SCI USA, V95, P10218, DOI 10.1073/pnas.95.17.10218; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; COOTE JG, 1972, J GEN MICROBIOL, V71, P1; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HORVITZ HR, 1980, GENETICS, V96, P435; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095, DOI 10.1099/00207713-51-6-2095; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; KIRSCHNER M, 2005, PLAUSIBILITY LIFE RE, P71; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rutherford SL, 2003, NAT GENET, V33, P6, DOI 10.1038/ng0103-6; Rutherford S, 2007, CRIT REV BIOCHEM MOL, V42, P355, DOI 10.1080/10409230701597782; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; SMITH LD, 1970, J BACTERIOL, V103, P811, DOI 10.1128/JB.103.3.811-813.1970; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	34	97	99	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					510	U86		10.1038/nature08150	http://dx.doi.org/10.1038/nature08150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19578359	Green Accepted			2022-12-24	WOS:000268257000038
J	Yadav, AK; Renfrow, JJ; Scholtens, DM; Xie, H; Duran, GE; Bredel, C; Vogel, H; Chandler, JP; Chakravarti, A; Robe, PA; Das, S; Scheck, AC; Kessler, JA; Soares, MB; Sikic, BI; Harsh, GR; Bredel, M				Yadav, Ajay K.; Renfrow, Jaclyn J.; Scholtens, Denise M.; Xie, Hehuang; Duran, George E.; Bredel, Claudia; Vogel, Hannes; Chandler, James P.; Chakravarti, Arnab; Robe, Pierre A.; Das, Sunit; Scheck, Adrienne C.; Kessler, John A.; Soares, Marcelo B.; Sikic, Branimir I.; Harsh, Griffith R.; Bredel, Markus			Monosomy of Chromosome 10 Associated With Dysregulation of Epidermal Growth Factor Signaling in Glioblastomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-SUPPRESSOR GENE; ANNEXIN-VII; IN-SITU; EXPRESSION; ANX7; HAPLOINSUFFICIENCY; BREAST; EGF; BENEFIT; GENOME	Context Glioblastomas-uniformly fatal brain tumors-often have both monosomy of chromosome 10 and gains of the epidermal growth factor receptor ( EGFR) gene locus on chromosome 7, an association for which the mechanism is poorly understood. Objectives To assess whether coselection of EGFR gains on 7p12 and monosomy 10 in glioblastomas promotes tumorigenic epidermal growth factor (EGF) signaling through loss of the annexin A7 (ANXA7) gene on 10q21.1-q21.2 and whether ANXA7 acts as a tumor suppressor gene by regulating EGFR in glioblastomas. Design, Setting, and Patients Multidimensional analysis of gene, coding sequence, promoter methylation, messenger RNA ( mRNA) transcript, protein data for ANXA7 ( and EGFR), and clinical patient data profiles of 543 high-grade gliomas from US medical centers and The Cancer Genome Atlas pilot project (made public 2006-2008; and unpublished, tumors collected 2001-2008). Functional analyses using LN229 and U87 glioblastoma cells. Main Outcome Measures Associations among ANXA7 gene dosage, coding sequence, promoter methylation, mRNA transcript, and protein expression. Effect of ANXA7 haploinsufficiency on EGFR signaling and patient survival. Joint effects of loss of ANXA7 and gain of EGFR expression on tumorigenesis. Results Heterozygous ANXA7 gene deletion is associated with significant loss of ANXA7 mRNA transcript expression (P=1 x 10(-15); linear regression) and a reduction (mean[SEM]) of 91.5% (2.3%) of ANXA7 protein expression compared with ANXA7 wild-type glioblastomas (P=.004; unpaired t test). ANXA7 loss of function stabilizes the EGFR protein (72%-744% increase in EGFR protein abundance) and augments EGFR transforming signaling in glioblastoma cells. ANXA7 haploinsufficiency doubles tumorigenic potential of glioblastoma cells, and combined ANXA7 knockdown and EGFR overexpression promotes tumorigenicity synergistically. The heterozygous loss of ANXA7 in approximate to 75% of glioblastomas in the The Cancer Genome Atlas plus infrequency of ANXA7 mutation (approximate to 6% of tumors) indicates its role as a haploinsufficiency gene. ANXA7 mRNA transcript expression, dichotomized at the median, associates with patient survival in 191 glioblastomas (log-rank P=.008; hazard ratio [HR], 0.667; 95% confidence interval [CI], 0.493-0.902; 46.9 vs 74.8 deaths/100 person-years for high vs low ANXA7 mRNA expression) and with a separate group of 180 high-grade gliomas (log-rank P=.00003; HR, 0.476; 95% CI, 0.333-0.680; 21.8 vs 50.0 deaths/100 person-years for high vs low ANXA7 mRNA expression). Deletion of the ANXA7 gene associates with poor patient survival in 189 glioblastomas (log-rank P=. 042; HR, 0.686; 95% CI, 0.476-0.989; 54.0 vs 80.1 deaths/100 person-years for wild-type ANXA7 vs ANXA7 deletion). Conclusion Haploinsufficiency of the tumor suppressor ANXA7 due to monosomy of chromosome 10 provides a clinically relevant mechanism to augment EGFR signaling in glioblastomas beyond that resulting from amplification of the EGFR gene. JAMA. 2009; 302(3):276-289 www.jama.com	[Bredel, Markus] Northwestern Univ, Feinberg Sch Med,Childrens Mem Res Ctr, Dept Neurol Surg,Robert H Lurie Comprehens Canc C, Lurie Ctr Canc Genet Res,NW Brain Tumor Inst, Chicago, IL 60611 USA; [Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Das, Sunit; Bredel, Markus] Northwestern Univ, Ctr Genet Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Dept Prevent Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Kessler, John A.] Northwestern Univ, Dept Neurol, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Xie, Hehuang; Soares, Marcelo B.] Northwestern Univ, Dept Pediat, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Harsh, Griffith R.; Bredel, Markus] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Bredel, Claudia; Sikic, Branimir I.; Bredel, Markus] Stanford Univ, Sch Med, Div Oncol, Dept Med, Palo Alto, CA 94304 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Bredel, Claudia; Bredel, Markus] Univ Freiburg, Dept Gen Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Claudia; Bredel, Markus] Univ Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Chakravarti, Arnab] Ohio State Univ, Sch Med, Dept Radiat Oncol, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Chakravarti, Arnab] Ohio State Univ, Sch Med, Richard L Solove Res Inst, Columbus, OH 43210 USA; [Robe, Pierre A.] Univ Liege, Dept Neurosurg, B-4000 Liege, Belgium; [Robe, Pierre A.] Univ Liege, Dept Human Genet, B-4000 Liege, Belgium; [Scheck, Adrienne C.] St Josephs Med Ctr, Barrow Neurol Inst, Ina Levine Brain Tumor Ctr, Phoenix, AZ USA	Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; University of Freiburg; University of Freiburg; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Liege; University of Liege; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Bredel, M (corresponding author), Northwestern Univ, Feinberg Sch Med,Childrens Mem Res Ctr, Dept Neurol Surg,Robert H Lurie Comprehens Canc C, Lurie Ctr Canc Genet Res,NW Brain Tumor Inst, 303 E Super St,Lurie Room 6-111, Chicago, IL 60611 USA.	m-bredel@northwestern.edu	Das, Sunit/J-3903-2015; Scheck, Adrienne/AAH-5040-2020	Das, Sunit/0000-0002-2146-4168; Vogel, Otto Hannes/0000-0002-0960-3508; Yadav, Ajay/0000-0003-3321-4198; Scheck, Adrienne/0000-0003-3497-1895	State of Illinois Excellence in Academic Medicine Program [211]; NIH/ NCI [RO1CA108633]; The Ohio State University-James Comprehensive Cancer Center; RTOG [U10CA21661]; CCOP [U10CA37422]; NATIONAL CANCER INSTITUTE [U10CA021661, U10CA037422, R01CA108633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020778, R01NS020013] Funding Source: NIH RePORTER	State of Illinois Excellence in Academic Medicine Program; NIH/ NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Ohio State University-James Comprehensive Cancer Center(Ohio State University); RTOG; CCOP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the State of Illinois Excellence in Academic Medicine Program (EAM Award 211 to Dr M. Bredel), by NIH/ NCI RO1CA108633 and funds from The Ohio State University-James Comprehensive Cancer Center ( both to Dr Chakravarti), by RTOG U10CA21661 and by CCOP U10CA37422. The results published here are in part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov.	Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; EARP HS, 1986, J BIOL CHEM, V261, P4777; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furge LL, 1999, J BIOL CHEM, V274, P33504, DOI 10.1074/jbc.274.47.33504; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Leighton X, 2004, CANCER LETT, V210, P239, DOI 10.1016/j.canlet.2004.01.018; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martin V, 2009, J CLIN PATHOL, V62, P314, DOI 10.1136/jcp.2008.059592; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pfisterer WK, 2004, NEURO-ONCOLOGY, V6, P290, DOI 10.1215/S1152851704000158; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SHIRVAN A, 1994, BIOCHEMISTRY-US, V33, P6888, DOI 10.1021/bi00188a019; Smilenov LB, 2006, CANCER LETT, V240, P17, DOI 10.1016/j.canlet.2005.08.015; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Srivastava M, 2004, CLIN CANCER RES, V10, P2344, DOI 10.1158/1078-0432.CCR-03-0278; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2002, MOL MED, V8, P781, DOI 10.1007/BF03402083; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Torosyan Y, 2006, CANCER RES, V66, P9609, DOI 10.1158/0008-5472.CAN-06-1574; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	40	46	51	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					276	289		10.1001/jama.2009.1022	http://dx.doi.org/10.1001/jama.2009.1022			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602687	Bronze, Green Accepted			2022-12-24	WOS:000267948100021
J	O'Flaherty, M; Bishop, J; Redpath, A; McLaughlin, T; Murphy, D; Chalmers, J; Capewell, S				O'Flaherty, Martin; Bishop, Jennifer; Redpath, Adam; McLaughlin, Terry; Murphy, David; Chalmers, James; Capewell, Simon			Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; CARDIOVASCULAR MORTALITY; US ADULTS; ENGLAND; DEATHS; RATES	Objective To examine recent trends and social inequalities in age specific coronary heart disease mortality. Design Time trend analysis using joinpoint regression. Setting Scotland, 1986-2006. Participants Men and women aged 35 years and over. Main outcome measures Age adjusted and age, sex, and deprivation specific coronary heart disease mortality. Results Persistent sixfold social differentials in coronary heart disease mortality were seen between the most deprived and the most affluent groups aged 35-44 years. These differentials diminished with increasing age but equalised only above 85 years. Between 1986 and 2006, overall, age adjusted coronary heart disease mortality decreased by 61% in men and by 56% in women. Among middle aged and older adults, mortality continued to decrease fairly steadily throughout the period. However, coronary heart disease mortality levelled from 1994 onwards among young men and women aged 35-44 years. Rates in men and women aged 45-54 showed similar flattening from about 2003. Rates in women aged 55-64 may also now be flattening. The flattening of coronary heart disease mortality in younger men and women was confined to the two most deprived fifths. Conclusions Premature death from coronary heart disease remains a major contributor to social inequalities. Furthermore, the flattening of the decline in mortality for coronary heart disease among younger adults may represent an early warning sign. The observed trends were confined to the most deprived groups. Marked deterioration in medical management of coronary heart disease seems implausible. Unfavourable trends in the major risk factors for coronary heart disease (smoking and poor diet) thus provide the most likely explanation for these inequalities.	[Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; [Redpath, Adam] ISD Scotland, CHD & Stroke Programme, Edinburgh EH12 9ED, Midlothian, Scotland	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131	UK Medical Research Council; MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MO'F is supported by the UK Medical Research Council.	Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Benjamin-Garner Ruby, 2002, Ethnicity and Disease, V12, P124; BOYCE J, 2008, SCOTTISH INDEX MULTI; Bromley C, 2008, SCOTTISH HLTH SURVEY; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Capewell S, 2001, LANCET, V358, P1213, DOI 10.1016/S0140-6736(01)06343-7; Critchley JA, 2003, J CLIN EPIDEMIOL, V56, P583, DOI 10.1016/S0895-4356(03)00059-3; Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Harald K, 2008, J EPIDEMIOL COMMUN H, V62, P251, DOI 10.1136/jech.2007.060707; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; *NHS NAT SERV SCOT, 2007, BETT DAT SCOTT HOSP; Norris RM, 1998, HEART, V80, P121; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; *OFF NAT STAT, 2008, NAT FOOD SURV 2006; *SCOTT EX, 2008, SCOTT IND MULT DEPR; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; SPROSTON K, 2003, HLTH SURVEY ENGLAND; Tobias Martin, 2006, N Z Med J, V119, pU1932; Waterhouse J, 1976, CANC INCIDENCE 5 CON; WILSON A, 1995, INT J EPIDEMIOL, V24, P678, DOI 10.1093/ije/24.4.678	27	78	79	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2009	339								b2613	10.1136/bmj.b2613	http://dx.doi.org/10.1136/bmj.b2613			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602713	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000268104900005
J	Garbin, CP; Deacon, JP; Rowan, MK; Hartmann, PE; Geddes, DT				Garbin, Catherine P.; Deacon, Jane P.; Rowan, Marnie K.; Hartmann, Peter E.; Geddes, Donna T.			Association of Nipple Piercing With Abnormal Milk Production and Breastfeeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Garbin, Catherine P.; Deacon, Jane P.; Rowan, Marnie K.; Hartmann, Peter E.; Geddes, Donna T.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia	University of Western Australia	Garbin, CP (corresponding author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia.	cgarbin@cyllene.uwa.edu.au	Geddes, Donna/H-9254-2014	Geddes, Donna/0000-0002-0431-7078; Hartmann, Peter/0000-0002-7709-0740				Armstrong Myrna L, 2006, AWHONN Lifelines, V10, P212; Kaatz M, 2008, CLIN DERMATOL, V26, P35, DOI 10.1016/j.clindermatol.2007.10.004; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Meltzer DI, 2005, AM FAM PHYSICIAN, V72, P2029; Peaker M, 1996, J MAMMARY GLAND BIOL, V1, P307, DOI 10.1007/BF02018083; Prosser CG, 1996, J DAIRY SCI, V79, P1184, DOI 10.3168/jds.S0022-0302(96)76472-X	6	8	8	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2550	2551						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549971				2022-12-24	WOS:000267266500019
J	Jones, R; Rubin, G				Jones, Roger; Rubin, Greg			Diagnosis in General Practice Acute diarrhoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; GASTROENTERITIS; DISEASE; NETHERLANDS; COMMUNITY; ETIOLOGY		[Jones, Roger] Kings Coll London, Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Rubin, Greg] Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Durham DH1 3HP, England	University of London; King's College London; Durham University	Jones, R (corresponding author), Kings Coll London, Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk	Schneider, Stephane/G-9511-2011	Schneider, Stephane/0000-0001-6256-8169				Almond SC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1878; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; De Wit MAS, 2001, EPIDEMIOL INFECT, V127, P389, DOI 10.1017/S0950268801006082; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; DEBRUYN G, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002242; DUNCAN A, 1992, J ROY SOC MED, V85, P203; FELDMAN RA, 1994, EPIDEMIOL INFECT, V113, P41, DOI 10.1017/S095026880005144X; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; *HLTH PROT AG, 2008, GEN INF GASTR INF; Jones R, 2007, BRIT MED J, V334, P704, DOI 10.1136/bmj.39170.410347.80; Mangiarotti P, 1999, ACTA PAEDIATR, V88, P592, DOI 10.1080/08035259950169206; MASSEY B, 1999, DIAGNOSTIC STRATEGIE, P149; Shelton JH, 2007, CLIN CHEM, V53, P85, DOI 10.1373/clinchem.2006.077883; Spiller RC, 2003, GASTROENTEROLOGY, V124, P1662, DOI 10.1016/S0016-5085(03)00324-X; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thomas P. D., 2003, Gut, V52, pv1, DOI 10.1136/gut.52.suppl_5.v1; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	21	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2009	338								b1877	10.1136/bmj.b1877	http://dx.doi.org/10.1136/bmj.b1877			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UP	19528114				2022-12-24	WOS:000267216500002
J	Yazdanpanah, B; Wiegmann, K; Tchikov, V; Krut, O; Pongratz, C; Schramm, M; Kleinridders, A; Wunderlich, T; Kashkar, H; Utermohlen, O; Bruning, JC; Schutze, S; Kronke, M				Yazdanpanah, Benjamin; Wiegmann, Katja; Tchikov, Vladimir; Krut, Oleg; Pongratz, Carola; Schramm, Michael; Kleinridders, Andre; Wunderlich, Thomas; Kashkar, Hamid; Utermoehlen, Olaf; Bruening, Jens C.; Schuetze, Stefan; Kroenke, Martin			Riboflavin kinase couples TNF receptor 1 to NADPH oxidase	NATURE			English	Article							REACTIVE OXYGEN; CELL-DEATH; SUPEROXIDE-PRODUCTION; INDUCED ACTIVATION; PROTEIN; NECROSIS; TRADD; SPHINGOMYELINASE; PHOSPHORYLATION; INDUCTION	Reactive oxygen species (ROS) produced by NADPH oxidase function as defence and signalling molecules related to innate immunity and various cellular responses(1,2). The activation of NADPH oxidase in response to plasma membrane receptor activation depends on the phosphorylation of cytoplasmic oxidase subunits, their translocation to membranes and the assembly of all NADPH oxidase components(3). Tumour necrosis factor (TNF) is a prominent stimulus of ROS production, but the molecular mechanisms by which TNF activates NADPH oxidase are poorly understood. Here we identify riboflavin kinase (RFK, formerly known as flavokinase(4)) as a previously unrecognized TNF-receptor-1 (TNFR1)-binding protein that physically and functionally couples TNFR1 to NADPH oxidase. In mouse and human cells, RFK binds to both the TNFR1-death domain and to p22(phox), the common subunit of NADPH oxidase isoforms. RFK-mediated bridging of TNFR1 and p22(phox) is a pre-requisite for TNF-induced but not for Toll-like-receptor-induced ROS production. Exogenous flavin mononucleotide or FAD was able to substitute fully for TNF stimulation of NADPH oxidase in RFK-deficient cells. RFK is rate-limiting in the synthesis of FAD, an essential prosthetic group of NADPH oxidase. The results suggest that TNF, through the activation of RFK, enhances the incorporation of FAD in NADPH oxidase enzymes, a critical step for the assembly and activation of NADPH oxidase.	[Yazdanpanah, Benjamin; Wiegmann, Katja; Krut, Oleg; Pongratz, Carola; Schramm, Michael; Kashkar, Hamid; Utermoehlen, Olaf; Kroenke, Martin] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Yazdanpanah, Benjamin; Krut, Oleg; Kashkar, Hamid; Utermoehlen, Olaf; Bruening, Jens C.; Kroenke, Martin] Univ Cologne, Ctr Mol Med Cologne, D-50935 Cologne, Germany; [Kleinridders, Andre; Wunderlich, Thomas; Bruening, Jens C.] Univ Cologne, Inst Genet, D-50935 Cologne, Germany; [Tchikov, Vladimir; Schuetze, Stefan] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany; [Kashkar, Hamid; Bruening, Jens C.; Kroenke, Martin] Cologne Cluster Excellence Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Kiel; University of Cologne	Kronke, M (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany.	m.kroenke@uni-koeln.de	Schütze, Stefan/C-8596-2011	Kleinridders, Andre/0000-0002-4248-6366	Deutsche Forschungsgemeinschaft [SFB670, SFB415, 733/7-1]; DFG Leibniz programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Leibniz programme(German Research Foundation (DFG))	We thank M. Pasparakis for TRADD-deficient and TNFR1-deficient MEFs, R. Brandes for gp91-deficient mice and helpful discussions, and D. Mannel for TNFR1 and TNFR2 doubly deficient MEFs and for recombinant TNF. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB670 to O. K., J. C. B., O. U. and M. K., and SFB415 to S. S.), DFG grant 733/7-1 to S. S., and a grant from the DFG Leibniz programme to J. C. B. and M. K.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Ho A, 2001, CANCER RES, V61, P474; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; KRUISBEEK AM, 1999, CURRENT PROTOCOLS IM, V3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Merrill A H Jr, 1980, Methods Enzymol, V66, P287; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSS NS, 1992, BIOFACTORS, V3, P185; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tsao DHH, 2007, J BIOMOL NMR, V39, P337, DOI 10.1007/s10858-007-9198-y; TSUNAWAKI S, 1984, J BIOL CHEM, V259, P4305; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; White DJ, 2001, MOL MICROBIOL, V42, P503, DOI 10.1046/j.1365-2958.2001.02659.x; Wiegmann K, 1999, J BIOL CHEM, V274, P5267, DOI 10.1074/jbc.274.9.5267; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	30	154	156	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1159	U132		10.1038/nature08206	http://dx.doi.org/10.1038/nature08206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19641494				2022-12-24	WOS:000269314000045
J	Ray, M; Hester, J				Ray, Mary; Hester, Joan			A Patient's Journey Persistent pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ray, Mary; Hester, Joan] Kings Coll Hosp London, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Hester, J (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	Joan.hester@kch.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2009	339								b2786	10.1136/bmj.b2786	http://dx.doi.org/10.1136/bmj.b2786			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633040				2022-12-24	WOS:000268352100006
J	Tung, J; Primus, A; Bouley, AJ; Severson, TF; Alberts, SC; Wray, GA				Tung, Jenny; Primus, Alexander; Bouley, Andrew J.; Severson, Tonya F.; Alberts, Susan C.; Wray, Gregory A.			Evolution of a malaria resistance gene in wild primates	NATURE			English	Article							DUFFY-BLOOD-GROUP; PLASMODIUM-VIVAX; NATURAL-SELECTION; GROUP LOCUS; EXPRESSION; POLYMORPHISM; POPULATION; HUMANS; REGION; CIS	The ecology, behaviour and genetics of our closest living relatives, the nonhuman primates, should help us to understand the evolution of our own lineage. Although a large amount of data has been amassed on primate ecology and behaviour, much less is known about the functional and evolutionary genetic aspects of primate biology, especially in wild primates. As a result, even in well-studied populations in which nongenetic factors that influence adaptively important characteristics have been identified, we have almost no understanding of the underlying genetic basis for such traits. Here, we report on the functional consequences of genetic variation at the malaria-related FY (DARC) gene in a well-studied population of yellow baboons (Papio cynocephalus) living in Amboseli National Park in Kenya. FY codes for a chemokine receptor normally expressed on the erythrocyte surface that is the known entry point for the malarial parasite Plasmodium vivax(1-3). We identified variation in the cis-regulatory region of the baboon FY gene that was associated with phenotypic variation in susceptibility to Hepatocystis, a malaria-like pathogen that is common in baboons(4,5). Genetic variation in this region also influenced gene expression in vivo in wild individuals, a result we confirmed using in vitro reporter gene assays. The patterns of genetic variation in and around this locus were also suggestive of non-neutral evolution, raising the possibility that the evolution of the FY cis-regulatory region in baboons has exhibited both mechanistic and selective parallels with the homologous region in humans(6-8). Together, our results represent the first reported association and functional characterization linking genetic variation and a complex trait in a natural population of nonhuman primates.	[Tung, Jenny; Primus, Alexander; Bouley, Andrew J.; Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tung, Jenny; Primus, Alexander; Severson, Tonya F.; Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya	Duke University; Duke University; Duke University	Tung, J (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jt5@duke.edu			National Science Foundation; American Society of Primatologists; Duke University and the Duke chapter of Sigma Xi; Duke Institute for Genome Sciences and Policy	National Science Foundation(National Science Foundation (NSF)); American Society of Primatologists; Duke University and the Duke chapter of Sigma Xi; Duke Institute for Genome Sciences and Policy	We thank the Office of the President of the Republic of Kenya and the Kenya Wildlife Service for permission to work in Amboseli National Park, and the Institute of Primate Research for local sponsorship. We thank the wardens and staff of Amboseli National Park, and the pastoral communities of Amboseli and Longido for cooperation. We thank J. Altmann for providing access to long-term data and contributing samples, and J. Altmann and Y. Gilad for providing comments on the manuscript. R. S. Mututua, S. Sayialel, and J. K. Warutere assisted with sample collection. The Integrated Primate Biomaterials and Information Resource, the Coriell Institute, J. Rogers and R. Sapolsky provided access to DNA samples from Mikumi and Masai Mara respectively. G. Gibson, T. F. C. Mackay, L. Goering and D. Tan provided access to a pyrosequencer at NC State University. M. Akinyi assisted with sample collection and analysis. A. D. Pfefferle assisted with sequencing. S. Mukherjee advised and assisted with statistical tests. Financial support came from the National Science Foundation (to S. C. A. and J. T.); the American Society of Primatologists (to J. T.); Duke University and the Duke chapter of Sigma Xi (to J. T.); and the Duke Institute for Genome Sciences and Policy (to G. A. W.).	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GARNHAM PC, 1961, NATURE, V190, P739, DOI 10.1038/190739b0; Garnham PCC, 1966, MALARIA PARASITES OT; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; LOISEL D, 2007, THESIS DUKE U; Loisel DA, 2006, P NATL ACAD SCI USA, V103, P16331, DOI 10.1073/pnas.0607662103; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MOORE JA, 1975, J MED PRIMATOL, V4, P1; Myers B. J., 1965, Primates, V6, P137, DOI 10.1007/BF01730965; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Seixas S, 2002, MOL BIOL EVOL, V19, P1802, DOI 10.1093/oxfordjournals.molbev.a004003; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	30	55	56	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					388	U103		10.1038/nature08149	http://dx.doi.org/10.1038/nature08149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553936				2022-12-24	WOS:000267979000037
J	Baker, SJK; Wass, JAH				Baker, Sarah J. K.; Wass, John A. H.			A Patient's Journey Addison's disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wass, John A. H.] Univ Oxford, Churchill Hosp, Oxford OX2 7LJ, England	University of Oxford	Wass, JAH (corresponding author), Univ Oxford, Churchill Hosp, Oxford OX2 7LJ, England.	john.wass@noc.anglox.nhs.uk							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 2	2009	339								b2384	10.1136/bmj.b2384	http://dx.doi.org/10.1136/bmj.b2384			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QZ	19574314				2022-12-24	WOS:000267678700003
J	Ehlers, L; Overvad, K; Sorensen, J; Christensen, S; Bech, M; Kjolby, M				Ehlers, Lars; Overvad, Kim; Sorensen, Jan; Christensen, Soren; Bech, Merete; Kjolby, Mette			Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; METAANALYSIS	Objective To assess the cost effectiveness of screening men aged 65 for abdominal aortic aneurysm. Design Cost effectiveness analysis based on a probabilistic, enhanced economic decision analytical model from screening to death. Population and setting Hypothetical population of men aged 65 invited (or not invited) for ultrasound screening in the Danish healthcare system. Data sources Published results from randomised trials and observational epidemiological studies retrieved from electronic bibliographic databases, and supplementary data obtained from the Danish Vascular Registry. Data synthesis A hybrid decision tree and Markov model was developed to simulate the short term and long term effects of screening for abdominal aortic aneurysm compared with no systematic screening on clinical and cost effectiveness outcomes. Probabilistic sensitivity analyses using Monte Carlo simulation were carried out. Results were presented in a cost effectiveness acceptability curve, an expected value of perfect information curve, and a curve showing the expected (net) number of avoided deaths from abdominal aortic aneurysm over time after the introduction of screening. The model was validated by calibrating base case health outcomes and expected activity levels against evidence from the recent Cochrane review of screening for abdominal aortic aneurysm. Results The estimated costs per quality adjusted life year (QALY) gained discounted at 3% per year over a lifetime for costs and QALYs was 43 pound 485 ((sic)54 852; $71 160). At a willingness to pay threshold of 30 pound 000 the probability of screening for abdominal aortic aneurysm being cost effective was less than 30%. One way sensitivity analyses showed the incremental cost effectiveness ratio varying from 32 pound 640 to 66 pound 001 per QALY. Conclusion Screening for abdominal aortic aneurysm does not seem to be cost effective. Further research is needed on long term quality of life outcomes and costs.	[Ehlers, Lars; Kjolby, Mette] Aarhus Univ, Inst Publ Hlth, DK-8000 Aarhus C, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Sorensen, Jan] Univ So Denmark, Ctr Appl Hlth Serv Res & Technol Assessment, Odense, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; University of Southern Denmark	Ehlers, L (corresponding author), Aarhus Univ, Inst Publ Hlth, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.	le@folkesundhed.au.dk	Ehlers, Lars/P-7531-2019; Sorensen, Jan/AAN-3738-2020	Sorensen, Jan/0000-0003-0857-9267; Overvad, Kim/0000-0001-6429-7921; Ehlers, Lars Holger/0000-0001-6512-5566	Centre for Public Health, Central Denmark Region	Centre for Public Health, Central Denmark Region	Centre for Public Health, Central Denmark Region.	Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Bergqvist D, 2008, EUR J VASC ENDOVASC, V35, P13, DOI 10.1016/j.ejvs.2007.06.012; Boll APM, 2003, EUR J VASC ENDOVASC, V26, P74, DOI 10.1053/ejvs.2002.1773; Briggs A, 2006, DECISION MODELLING H; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Campbell Helen, 2007, J Health Serv Res Policy, V12, P11, DOI 10.1258/135581907779497594; Connelly JB, 2002, CLIN INVEST MED, V25, P127; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; COSFORD RA, 2007, COCHRANE DB SYST REV; Cronenwett JL, 2007, J VASC SURG, V46, P1093, DOI 10.1016/j.jvs.2007.08.012; *DAN VASC REG, ANN REP 2006; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 2005, METHODS EVALUATION H; Ehlers L, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-32; Henriksson M, 2005, BRIT J SURG, V92, P976, DOI 10.1002/bjs.5122; Kaper J, 2006, PHARMACOECONOMICS, V24, P453, DOI 10.2165/00019053-200624050-00004; Kim LG, 2007, J MED SCREEN, V14, P46, DOI 10.1258/096914107780154477; Laustsen J, 2004, EUR J VASC ENDOVASC, V27, P216, DOI 10.1016/j.ejvs.2003.11.011; Lee TY, 2002, SURGERY, V132, P399, DOI 10.1067/msy.2002.126510; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lovegrove RE, 2008, BRIT J SURG, V95, P677, DOI 10.1002/bjs.6240; *MED ADV SECR MIN, 2005, ULTR SCREEN ABD AORT; Michaels JA, 2005, BRIT J SURG, V92, P960, DOI 10.1002/bjs.5119; Pentikainen TJ, 2000, INT J TECHNOL ASSESS, V16, P22, DOI 10.1017/S0266462300016135; Rasmussen SR, 2004, EUR J PUBLIC HEALTH, V14, P95, DOI 10.1093/eurpub/14.1.95; Silverstein Marc D, 2005, Proc (Bayl Univ Med Cent), V18, P345; Soisalon-Soininen S, 2001, VASA-J VASCULAR DIS, V30, P262, DOI 10.1024/0301-1526.30.4.262; *STATBANK DENM, SUMM VIT STAT 2005; Wanhainen A, 2005, J VASC SURG, V41, P741, DOI 10.1016/j.jvs.2005.01.055; 2007, DANISH DRG CASEMIX S	30	42	42	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2009	338								b2243	10.1136/bmj.b2243	http://dx.doi.org/10.1136/bmj.b2243			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553267	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000267436500004
J	Mathew, R; Karp, CM; Beaudoin, B; Vuong, N; Chen, GH; Chen, HY; Bray, K; Reddy, A; Bhanot, G; Gelinas, C; DiPaola, RS; Karantza-Wadsworth, V; White, E				Mathew, Robin; Karp, Cristina M.; Beaudoin, Brian; Vuong, Nhan; Chen, Guanghua; Chen, Hsin-Yi; Bray, Kevin; Reddy, Anupama; Bhanot, Gyan; Gelinas, Celine; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen			Autophagy Suppresses Tumorigenesis through Elimination of p62	CELL			English	Article							GENE-EXPRESSION; CELL-SURVIVAL; DEFICIENT; STEATOHEPATITIS; PATHOGENESIS; DEGRADATION; MANAGEMENT; APOPTOSIS; BECLIN-1; STRESS	Allelic loss of the essential autophagy gene beclin1 occurs in human cancers and renders mice tumor-prone suggesting that autophagy is a tumor-suppression mechanism. While tumor cells utilize autophagy to survive metabolic stress, autophagy also mitigates the resulting cellular damage that may limit tumorigenesis. In response to stress, autophagy-defective tumor cells preferentially accumulated p62/SQSTM1 (p62), endoplasmic reticulum (ER) chaperones, damaged mitochondria, reactive oxygen species (ROS), and genome damage. Moreover, suppressing ROS or p62 accumulation prevented damage resulting from autophagy defects indicating that failure to regulate p62 caused oxidative stress. Importantly, sustained p62 expression resulting from autophagy defects was sufficient to alter NF-kappa B regulation and gene expression and to promote tumorigenesis. Thus, defective autophagy is a mechanism for p62 upregulation commonly observed in human tumors that contributes directly to tumorigenesis likely by perturbing the signal transduction adaptor function of p62-controlling pathways critical for oncogenesis.	[Mathew, Robin; Gelinas, Celine; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Med Oncol, Piscataway, NJ 08854 USA; [Beaudoin, Brian; Chen, Guanghua; Gelinas, Celine; White, Eileen] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Karp, Cristina M.; Beaudoin, Brian; Vuong, Nhan; Chen, Hsin-Yi; Bray, Kevin; Bhanot, Gyan; White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Mathew, Robin; Karp, Cristina M.; Bhanot, Gyan; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Reddy, Anupama] Rutgers State Univ, RUTCOR, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	White, E (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Med Oncol, Piscataway, NJ 08854 USA.	whiteei@umdnj.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	National Institutes of Health [R37 CA53370, RO1 CA130893, W81XWH06-1-0514, W81XWH05]; NATIONAL CANCER INSTITUTE [R00CA133181, R37CA053370, K99CA133181, R01CA130893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Heintz, Yue, and Jin for providing beclin1<SUP>+/+</SUP> and beclin1<SUP>+/-</SUP> mice, Dr. Mizushima for providing atg5<SUP>+/+</SUP> and atg5<SUP>-/-</SUP> mice, Dr. Zimmermann for GRp170 antibody and Dr. Moscat for myc-p62 and p62-EGFP plasmids. This work was supported by grants from the National Institutes of Health (R37 CA53370 and RO1 CA130893) to E. W., (K99CA133181) to V. K. W., and Department of Defense (W81XWH06-1-0514 and W81XWH05) to E. W. and R. S.	Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	42	1314	1383	0	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1062	1075		10.1016/j.cell.2009.03.048	http://dx.doi.org/10.1016/j.cell.2009.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524509	Green Accepted, Bronze			2022-12-24	WOS:000266916400018
J	Donald, PR; van Helden, PD				Donald, Peter R.; van Helden, Paul D.			The Global Burden of Tuberculosis - Combating Drug Resistance in Difficult Times	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Donald, Peter R.] Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7600 Stellenbosch, South Africa; [van Helden, Paul D.] Univ Stellenbosch, MRC,Ctr Mol & Cellular Biol, Div Human Genet & Mol Biol,Fac Hlth Sci, Natl Res Fdn,Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Donald, PR (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7600 Stellenbosch, South Africa.							Global Initiative for Asthma, 2009, PUBL WHO, V02-3659; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; van Helden Paul D, 2006, Expert Rev Anti Infect Ther, V4, P759, DOI 10.1586/14787210.4.5.759; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; 2006, MMWR MORB MORTAL WKL, V55, P301	5	101	106	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2393	2395		10.1056/NEJMp0903806	http://dx.doi.org/10.1056/NEJMp0903806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494214	Bronze			2022-12-24	WOS:000266590500004
J	Savigny, P; Watson, P; Underwood, M				Savigny, Pauline; Watson, Paul; Underwood, Martin		Guideline Dev Grp	Guidelines Early management of persistent non-specific low back pain: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Underwood, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Savigny, Pauline] Royal Coll Gen Practitioners, Natl Collaborating Ctr Primary Care, London SW7 1PU, England; [Watson, Paul] Univ Leicester, Acad Unit, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University of Warwick; University of Leicester	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Underwood, Martin/D-6364-2015	Underwood, Martin/0000-0002-0309-1708				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; *ARTHR RES CAMP, 2002, ARTHR BIG PICT; Macfarlane GJ, 2006, PAIN, V122, P219, DOI 10.1016/j.pain.2006.03.013; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V59; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V88; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003	6	171	177	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2009	338								b1805	10.1136/bmj.b1805	http://dx.doi.org/10.1136/bmj.b1805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502217				2022-12-24	WOS:000266726400001
J	Sorefan, K; Girin, T; Liljegren, SJ; Ljung, K; Robles, P; Galvan-Ampudia, CS; Offringa, R; Friml, J; Yanofsky, MF; Ostergaard, L				Sorefan, Karim; Girin, Thomas; Liljegren, Sarah J.; Ljung, Karin; Robles, Pedro; Galvan-Ampudia, Carlos S.; Offringa, Remko; Friml, Jiri; Yanofsky, Martin F.; Ostergaard, Lars			A regulated auxin minimum is required for seed dispersal in Arabidopsis	NATURE			English	Article							DEHISCENCE ZONE; PROTEIN; EXPRESSION; INITIATION; FRUITFULL; GRADIENTS; SYSTEM; GENES	Local hormone maxima are essential for the development of multicellular structures and organs. For example, steroid hormones accumulate in specific cell types of the animal fetus to induce sexual differentiation(1) and concentration peaks of the plant hormone auxin direct organ initiation and mediate tissue patterning(2-4). Here we provide an example of a regulated local hormone minimum required during organogenesis. Our results demonstrate that formation of a local auxin minimum is necessary for specification of the valve margin separation layer where Arabidopsis fruit opening takes place. Consequently, ectopic production of auxin, specifically in valve margin cells, leads to a complete loss of proper cell fate determination. The valve margin identity factor INDEHISCENT (IND) is responsible for forming the auxin minimum by coordinating auxin efflux in separation-layer cells. We propose that the simplicity of formation and maintenance make local hormone minima particularly well suited to specify a small number of cells such as the stripes at the valve margins.	[Sorefan, Karim; Girin, Thomas; Ostergaard, Lars] John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich NR4 7UH, Norfolk, England; [Liljegren, Sarah J.; Robles, Pedro; Yanofsky, Martin F.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Liljegren, Sarah J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ljung, Karin] Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Robles, Pedro] Univ Miguel Hernandez, Div Genet, Alicante 03202, Spain; [Robles, Pedro] Univ Miguel Hernandez, Inst Bioingn, Alicante 03202, Spain; [Galvan-Ampudia, Carlos S.; Offringa, Remko] Leiden State Univ, Inst Biol, Dept Mol & Dev Genet, NL-2333 AL Leiden, Netherlands; [Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, VIB, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent VIB, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; Umea University; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; Leiden University; Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Ostergaard, L (corresponding author), John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	lars.ostergaard@bbsrc.ac.uk	Ljung, Karin/AAE-8691-2019; Friml, Jiri/D-9511-2012; Robles, Pedro/L-5104-2014; Ostergaard, Lars/AAA-3020-2020	Ljung, Karin/0000-0003-2901-189X; Friml, Jiri/0000-0002-8302-7596; Robles, Pedro/0000-0002-4539-5435; Ostergaard, Lars/0000-0003-2459-0511; Girin, Thomas/0000-0002-5738-7731; Ostergaard, Lars/0000-0002-7619-605X	Spanish government; FWO; Netherlands Organisation for Scientific Research; National Science Foundation; Biotechnological and Biological Sciences Research Council; John Innes Centre; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000613] Funding Source: researchfish	Spanish government(Spanish GovernmentEuropean Commission); FWO(FWO); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. York and K. Findlay for assistance on SEM analysis, G. Calder for assistance with confocal microscopy, P. Pople for graphics assistance, and H. F. Klee for the pMON518 plasmid containing the iaaM gene. We also wish to thank G. S. Ditta, L. Dolan, S. Fuentes, J. Kleine-Vehn, R. Sablowski, P. Stephenson and T. Wood for carefully reading the manuscript and constructive criticism. P. R was the recipient of a postdoctoral fellowship from the Spanish government. This work was supported by grants from FWO (Odysseus program) to J. F., from The Netherlands Organisation for Scientific Research (ALW-NWO) to R. O., from the National Science Foundation to M. F. Y., and from the Biotechnological and Biological Sciences Research Council as well as core strategic funds from the John Innes Centre to L. O.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chauvaux N, 1997, J EXP BOT, V48, P1423, DOI 10.1093/jxb/48.7.1423; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ostergaard L, 2006, PLANT BIOTECHNOL J, V4, P45, DOI 10.1111/j.1467-7652.2005.00156.x; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Petersen M, 1996, PLANT MOL BIOL, V31, P517, DOI 10.1007/BF00042225; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; ROMANO CP, 1991, GENE DEV, V5, P438, DOI 10.1101/gad.5.3.438; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; WU Z, 2007, J CELL PHYSL, V213, P429; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286	39	200	209	6	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					583	U114		10.1038/nature07875	http://dx.doi.org/10.1038/nature07875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478783				2022-12-24	WOS:000266370500042
J	van Stelten, J; Silva, F; Belin, D; Silhavy, TJ				van Stelten, Johna; Silva, Filo; Belin, Dominique; Silhavy, Thomas J.			Effects of Antibiotics and a Proto-Oncogene Homolog on Destruction of Protein Translocator SecY	SCIENCE			English	Article							BAX INHIBITOR-1; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; CHLORAMPHENICOL; DEGRADATION; SUPPRESSES; ACTIVATION; SECRETION; TOXICITY; ANIMALS	Protein secretion occurs via translocation by the evolutionarily conserved Sec complex. LacZ hybrid proteins have long been used to study translocation in Escherichia coli. Some LacZ hybrids were thought to block secretion by physically jamming the Sec complex, leading to cell death. We found that jammed Sec complexes caused the degradation of essential translocator components by the protease FtsH. Increasing the amounts or the stability of the membrane protein YccA, a known inhibitor of FtsH, counteracted this destruction. Antibiotics that inhibit translation elongation also jammed the translocator and caused the degradation of translocator components, which may contribute to their effectiveness. Intriguingly, YccA is a functional homolog of the proto-oncogene product Bax Inhibitor-1, which may share a similar mechanism of action in regulating apoptosis upon prolonged secretion stress.	[van Stelten, Johna; Silhavy, Thomas J.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Silva, Filo; Belin, Dominique] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland	Princeton University; University of Geneva	Silhavy, TJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	tsilhavy@princeton.edu		Silhavy, Thomas/0000-0001-7672-5153	National Institute of General Medical Sciences; New Jersey Commission on Cancer Research; Canton de Geneve; Swiss National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034821] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New Jersey Commission on Cancer Research; Canton de Geneve; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (T.J.S.), the New Jersey Commission on Cancer Research (J.v.S.), and the Canton de Geneve and the Swiss National Science Foundation (F.S. and D.B.).	AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; FELDMAN WE, 1983, ANTIMICROB AGENTS CH, V23, P551, DOI 10.1128/AAC.23.4.551; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; SILHAVY TJ, 1977, P NATL ACAD SCI USA, V74, P5411, DOI 10.1073/pnas.74.12.5411; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Walsh C., 2003, ANTIBIOTICS ACTIONS; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024	22	84	88	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					753	756		10.1126/science.1172221	http://dx.doi.org/10.1126/science.1172221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661432	Green Accepted			2022-12-24	WOS:000268723700051
J	Dickerson, EH; Raghunath, AS; Atkin, SL				Dickerson, E. H.; Raghunath, A. S.; Atkin, S. L.			Rational Testing Initial investigation of amenorrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREMATURE OVARIAN FAILURE		[Raghunath, A. S.; Atkin, S. L.] Hull York Med Sch, Kingston Upon Hull HU3 2RW, N Humberside, England	University of Hull; University of York - UK	Atkin, SL (corresponding author), Hull York Med Sch, Kingston Upon Hull HU3 2RW, N Humberside, England.	Stephen.Atkin@hyms.ac.uk	atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	atkin, stephen/0000-0002-5887-7257; 				Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS219, DOI 10.1016/j.fertnstert.2008.08.038; Bidet M, 2008, CURR OPIN OBSTET GYN, V20, P416, DOI 10.1097/GCO.0b013e328306a06b; Conway GS, 1996, FERTIL STERIL, V65, P337, DOI 10.1016/S0015-0282(16)58095-9; CRITCHLEY H, 2004, CONSENSUS VIEWS ARIS, P345; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1987, BRIT MED J, V294, P815, DOI 10.1136/bmj.294.6575.815; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; LAUFER MR, 1995, GYNECOL OBSTET INVES, V40, P200, DOI 10.1159/000292335; Ledger W. L., 2004, CURRENT OBSTET GYNAE, V14, P254; LOUCKS AB, 1985, MED SCI SPORT EXER, V17, P56, DOI 10.1249/00005768-198502000-00010; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; SCHACHTER M, 1994, FERTIL STERIL, V62, P1; SINGH KB, 1981, AM J OBSTET GYNECOL, V140, P299, DOI 10.1016/0002-9378(81)90277-5	14	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2009	339								b2184	10.1136/bmj.b2184	http://dx.doi.org/10.1136/bmj.b2184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KB	19654161				2022-12-24	WOS:000268807800009
J	Hardwick, JM; Youle, RJ				Hardwick, J. Marie; Youle, Richard J.			SnapShot: BCL-2 Proteins	CELL			English	Editorial Material									[Hardwick, J. Marie] Johns Hopkins, Baltimore, MD 21205 USA; NINDS, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hardwick, JM (corresponding author), Johns Hopkins, Baltimore, MD 21205 USA.				NIGMS NIH HHS [R01 GM077875, R01 GM077875-04] Funding Source: Medline; NINDS NIH HHS [R01 NS037402] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037402, ZIANS002859] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	54	59	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					404	404						1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632186	Green Accepted, Bronze			2022-12-24	WOS:000268277000020
J	Tilman, D; Socolow, R; Foley, JA; Hill, J; Larson, E; Lynd, L; Pacala, S; Reilly, J; Searchinger, T; Somerville, C; Williams, R				Tilman, David; Socolow, Robert; Foley, Jonathan A.; Hill, Jason; Larson, Eric; Lynd, Lee; Pacala, Stephen; Reilly, John; Searchinger, Tim; Somerville, Chris; Williams, Robert			Beneficial Biofuels-The Food, Energy, and Environment Trilemma	SCIENCE			English	Editorial Material							CROPPING SYSTEMS; LAND-USE; BIOENERGY; BIOMASS; EMISSIONS; CLIMATE; CARBON; CORN; OPPORTUNITIES; AGRICULTURE		[Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Larson, Eric; Williams, Robert] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Foley, Jonathan A.; Hill, Jason] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Lynd, Lee] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Pacala, Stephen] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reilly, John] MIT, Ctr Energy & Environm Policy Res, Cambridge, MA 02142 USA; [Searchinger, Tim] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; Princeton University; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Princeton University; Massachusetts Institute of Technology (MIT); Princeton University; University of California System; University of California Berkeley	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Noojipady, Praveen/B-2511-2010; Molina, Carolina/E-3898-2015; Foley, Jonathan A/GRS-5522-2022; Tilman, David/ABD-5309-2021; Lynd, Lee R/N-1260-2013; Somerville, Christopher R/A-4048-2009; Hill, Jason/A-8919-2008	Molina, Carolina/0000-0001-6659-994X; Lynd, Lee R/0000-0002-5642-668X; Somerville, Christopher R/0000-0003-4647-0094; Hill, Jason/0000-0001-7609-6713				Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; Antizar-Ladislao B, 2008, BIOFUEL BIOPROD BIOR, V2, P455, DOI 10.1002/bbb.97; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Cantrell KB, 2008, BIORESOURCE TECHNOL, V99, P7941, DOI 10.1016/j.biortech.2008.02.061; Dale BE, 2009, BIOFUEL BIOPROD BIOR, V3, P219, DOI 10.1002/bbb.132; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Firbank LG, 2008, BIOENERG RES, V1, P12, DOI 10.1007/s12155-007-9000-8; Gibbs HK, 2008, ENVIRON RES LETT, V3; Heggenstaller AH, 2008, AGRON J, V100, P1740, DOI 10.2134/agronj2008.0087; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; National Academy of Sciences National Academy of Engineering National Research Council, 2009, LIQ TRANSP FUELS COA; O'Hare M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024001; Pineiro G, 2009, ECOL APPL, V19, P277, DOI 10.1890/08-0645.1; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Solomon B, 2009, ROUTL EXPLOR ENVIRON, P1; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	26	1134	1171	12	610	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					270	271		10.1126/science.1177970	http://dx.doi.org/10.1126/science.1177970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608900				2022-12-24	WOS:000268036600027
J	Nayar, A				Nayar, Anjali			A lakeful of trouble	NATURE			English	Editorial Material							KIVU											HABERYAN KA, 1987, PALAEOGEOGR PALAEOCL, V61, P169, DOI 10.1016/0031-0182(87)90048-4; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M., 2002, ACTA VULCANOL, V14, P115; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tedesco D, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004762	7	16	16	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					321	323		10.1038/460321a	http://dx.doi.org/10.1038/460321a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606123	Bronze			2022-12-24	WOS:000267979000012
J	Gambetta, MC; Oktaba, K; Muller, J				Gambetta, Maria Cristina; Oktaba, Katarzyna; Mueller, Juerg			Essential Role of the Glycosyltransferase Sxc/Ogt in Polycomb Repression	SCIENCE			English	Article							LINKED N-ACETYLGLUCOSAMINE; X-CHROMOSOME; GENE; GLYCOSYLATION; LOCALIZATION; PROTEINS; NUCLEAR; PATTERN	Polycomb group proteins are conserved transcriptional repressors that control animal and plant development. Here, we found that the Drosophila Polycomb group gene super sex combs (sxc) encodes Ogt, the highly conserved glycosyltransferase that catalyzes the addition of N-acetylglucosamine (GlcNAc) to proteins in animals and plants. Genome-wide profiling in Drosophila revealed that GlcNAc-modified proteins are highly enriched at Polycomb response elements. Among different Polycomb group proteins, Polyhomeotic is glycosylated by Sxc/Ogt in vivo. sxc/Ogt-null mutants lacked O-linked GlcNAcylation and failed to maintain Polycomb transcriptional repression even though Polycomb group protein complexes were bound at their target sites. Polycomb repression appears to be a critical function of Sxc/Ogt in Drosophila and may be mediated by the glycosylation of Polyhomeotic.	[Gambetta, Maria Cristina; Oktaba, Katarzyna; Mueller, Juerg] EMBL, Gene Express Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Muller, J (corresponding author), EMBL, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	juerg.mueller@embl.de	Oktaba, Katarzyna/A-7737-2018; Gambetta, Maria Cristina/P-8511-2016; Müller, Jürg/ABB-3007-2020	Oktaba, Katarzyna/0000-0002-3950-5626; Gambetta, Maria Cristina/0000-0002-9450-3551; Müller, Jürg/0000-0003-2391-4641	EMBL; Deutsche Forschungsgemeinschaft	EMBL; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are supported by EMBL and by grants from the Deutsche Forschungsgemeinschaft. The microarray data have been deposited in the ArrayExpress database under the accession number E-TABM-697.	Beuchle D, 2001, DEVELOPMENT, V128, P993; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; FAUVARQUE MO, 1995, MECH DEVELOP, V52, P343, DOI 10.1016/0925-4773(95)00412-T; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1986, J BIOL CHEM, V261, P8049; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; INGHAM PW, 1985, COLD SPRING HARB SYM, V50, P201, DOI 10.1101/SQB.1985.050.01.026; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608	22	241	245	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					93	96		10.1126/science.1169727	http://dx.doi.org/10.1126/science.1169727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19478141				2022-12-24	WOS:000267594000043
J	Webster, P				Webster, Paul			Profile Toakase Fakakovikaetau: pioneering paediatrician in Tonga	LANCET			English	Biographical-Item												pcwebster@sympatico.ca							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2103	2103		10.1016/S0140-6736(09)61138-7	http://dx.doi.org/10.1016/S0140-6736(09)61138-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460YQ	19541025				2022-12-24	WOS:000267229700013
J	McElwain, JC; Wagner, PJ; Hesselbo, SP				McElwain, Jennifer C.; Wagner, Peter J.; Hesselbo, Stephen P.			Fossil Plant Relative Abundances Indicate Sudden Loss of Late Triassic Biodiversity in East Greenland	SCIENCE			English	Article							JURASSIC BOUNDARY; EXTINCTION EVENT; NORTHERN; DISTRIBUTIONS; STRATIGRAPHY; TERRESTRIAL; TRANSITION; VEGETATION	The pace of Late Triassic (LT) biodiversity loss is uncertain, yet it could help to decipher causal mechanisms of mass extinction. We investigated relative abundance distributions (RADs) of six LT plant assemblages from the Kap Stewart Group, East Greenland, to determine the pace of collapse of LT primary productivity. RADs displayed not simply decreases in the number of taxa, but decreases in the number of common taxa. Likelihood tests rejected a hypothesis of continuously declining diversity. Instead, the RAD shift occurred over the upper two-to-four fossil plant assemblages and most likely over the last three (final 13 meters), coinciding with increased atmospheric carbon dioxide concentration and global warming. Thus, although the LT event did not induce mass extinction of plant families, it accompanied major and abrupt change in their ecology and diversity.	[McElwain, Jennifer C.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland; [Wagner, Peter J.] Natl Museum Nat Hist, Dept Paleobiol, Smithsonian Inst, Washington, DC 20560 USA; [Hesselbo, Stephen P.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University College Dublin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	McElwain, JC (corresponding author), Natl Univ Ireland Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland.	jennifer.mcelwain@ucd.ie	Wagner, Peter/A-5514-2009; McElwain, Jennifer/AAX-1605-2020; McElwain, Jennifer/B-1735-2009	Wagner, Peter/0000-0002-9083-9787; McElwain, Jennifer/0000-0002-1729-6755	Marie Curie [MEXT-CT- 2006-042531, NSF-EAR-0207874]	Marie Curie(European Commission)	J.C.M. collected plant paleoecological data, S.P.H collected isotopic and stratigraphic data, and P.J.W. undertook data analyses. J.C.M and P.J.W cowrote the paper, and all authors contributed equally to interpretation. We gratefully acknowledge funding from a Marie Curie Excellence Grant (MEXT-CT- 2006-042531) to J.C.M. and NSF-EAR-0207874 to P.J.W. This is Paleobiology Database contribution 95.	Beerling DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001637; Burnham KP, 2002, MULTIMODEL INFERENCE; BURNHAM RJ, 1989, REV PALAEOBOT PALYNO, V58, P5, DOI 10.1016/0034-6667(89)90054-7; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Edwards AWF, 1992, LIKELIHOOD EXPANDED; Galli MT, 2007, PALAEOGEOGR PALAEOCL, V244, P52, DOI 10.1016/j.palaeo.2006.06.023; Gomez JJ, 2007, PALAEOGEOGR PALAEOCL, V244, P89, DOI 10.1016/j.palaeo.2006.06.025; Gray J.S., 1987, P53; HAMES WE, 2002, AM GEOPHYS UNION MON, V136, P241; Harris T.M., 1937, MEDD GRON, V112, P82; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hesselbo SP, 2007, PALAEOGEOGR PALAEOCL, V244, P1, DOI 10.1016/j.palaeo.2006.06.020; Hubbell Stephen P., 2001, V32, pi; KEMPTON RA, 1979, BIOMETRICS, V35, P307, DOI 10.2307/2529952; Kosnik MA, 2006, EVOL ECOL RES, V8, P195; Kuerschner WM, 2007, PALAEOGEOGR PALAEOCL, V244, P257, DOI 10.1016/j.palaeo.2006.06.031; MANDER L, 2008, COMMUNICATION; Mander L, 2008, J GEOL SOC LONDON, V165, P319, DOI 10.1144/0016-76492007-029; May Robert M., 2007, P111; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; SIGNOR PW, 1982, 190 GEOL SOC AM, P291; van de Schootbrugge B, 2007, PALAEOGEOGR PALAEOCL, V244, P126, DOI 10.1016/j.palaeo.2006.06.026; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Wang SC, 2007, PALEOBIOLOGY, V33, P324, DOI 10.1666/06056.1; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035	28	91	93	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1554	1556		10.1126/science.1171706	http://dx.doi.org/10.1126/science.1171706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541995				2022-12-24	WOS:000267130600042
J	Ciochon, RL				Ciochon, Russell L.			The mystery ape of Pleistocene Asia	NATURE			English	Editorial Material							TEETH; HOMO		Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Ciochon, RL (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	russell-ciochon@uiowa.edu						Ciochon RL, 2009, NATURE, V458, P153, DOI 10.1038/458153a; Etler D.A., 2001, Human Evolution, V16, P1, DOI 10.1007/BF02438918; HUANG WP, 1995, NATURE, V378, P275; Huang WP, 1996, NATURE, V381, P202; Jin CZ, 2009, CHINESE SCI BULL, V54, P788, DOI 10.1007/s11434-008-0531-y; Schwartz Jeffrey H., 1995, Anthropological Papers of the American Museum of Natural History, V76, P1; Schwartz JH, 1996, NATURE, V381, P201, DOI 10.1038/381201a0; Wu Xinzhi, 2000, Acta Anthropologica Sinica, V19, P1	8	53	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					910	911		10.1038/459910a	http://dx.doi.org/10.1038/459910a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458XS	19536242	Bronze			2022-12-24	WOS:000267063500019
J	Hawton, K; Bergen, H; Simkin, S; Brock, A; Griffiths, C; Romeri, E; Smith, KL; Kapur, N; Gunnell, D				Hawton, Keith; Bergen, Helen; Simkin, Sue; Brock, Anita; Griffiths, Clare; Romeri, Ester; Smith, Karen L.; Kapur, Navneet; Gunnell, David			Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE-PREVENTION; UK	Objective To assess the effect of the UK Committee on Safety of Medicines' announcement in January 2005 of withdrawal of co-proxamol on analgesic prescribing and poisoning mortality. Design Interrupted time series analysis for 1998-2007. Setting England and Wales. Data sources Prescribing data from the prescription statistics department of the Information Centre for Health and Social Care (England) and the Prescribing Services Unit, Health Solutions Wales (Wales). Mortality data from the Office for National Statistics. Main outcome measures Prescriptions. Deaths from drug poisoning (suicides, open verdicts, accidental poisonings) involving single analgesics. Results A steep reduction in prescribing of co-proxamol occurred in the post-intervention period 2005-7, such that number of prescriptions fell by an average of 859 (95% confidence interval 653 to 1065) thousand per quarter, equating to an overall decrease of about 59%. Prescribing of some other analgesics (co-codamol, paracetamol, co-dydramol, and codeine) increased significantly during this time. These changes were associated with a major reduction in deaths involving co-proxamol compared with the expected number of deaths (an estimated 295 fewer suicides and 349 fewer deaths including accidental poisonings), but no statistical evidence for an increase in deaths involving either other analgesics or other drugs. Conclusions Major changes in prescribing after the announcement of the withdrawal of co-proxamol have had a marked beneficial effect on poisoning mortality involving this drug, with little evidence of substitution of suicide method related to increased prescribing of other analgesics.	[Hawton, Keith; Bergen, Helen; Simkin, Sue] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; [Brock, Anita; Griffiths, Clare; Romeri, Ester] Off Natl Stat, London EC1R 1UW, England; [Smith, Karen L.] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England; [Kapur, Navneet] Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Oxford; University of Oxford; University of Manchester; University of Bristol	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234	National Institute of Health Research (NIHR) [RP-PG-0606-1247]; Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; Department of Health; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by a National Institute of Health Research (NIHR) Programme Grant for Applied Research (RP-PG-0606-1247). The views and opinions expressed in this paper do not necessarily reflect those of the Department of Health/NIHR or NHS. The funders played no role in the analysis or write up of this paper. KH is also supported by Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust and HB by the Department of Health.	ADELSTEIN AM, 1975, POPULATION TRENDS, V2, P13; Bateman DN, 2003, BRIT MED J, V327, P287, DOI 10.1136/bmj.327.7409.287; BROCK A, 2006, HLTH STAT Q, V31, P6; Committee on Safety of Medicines, 2006, CURR PROBL PHARMACOV, V31, P11; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; FINKLE BS, 1984, HUMAN TOXICOL, V3, P115; Gottlieb S, 2005, BRIT MED J, V330, P9, DOI 10.1136/bmj.330.7481.9-c; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2005, BRIT J CLIN PHARMACO, V59, P207, DOI 10.1111/j.1365-2125.2004.02252.x; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2003, BMJ-BRIT MED J, V326, P1006, DOI 10.1136/bmj.326.7397.1006; Hawton K, 2007, CRISIS, V28, P4, DOI 10.1027/0227-5910.28.S1.4; *INF CTR HLTH SOC, 2006, PRESCR COST AN ENGL; *INF CTR HLTH SOC, 2007, PRESCR COST AN ENGL; Jonasson U, 2004, RESTRICTIONS PRESCRI; *MED HEALTHC PROD, CEMCMO20052 MED HEAL; *OFF NAT STAT, 2007, HLTH STAT Q, V33, P82; *OFF NAT STAT, 2008, HLTH STAT Q, V39, P82; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Sandilands EA, 2008, BRIT J CLIN PHARMACO, V66, P290, DOI 10.1111/j.1365-2125.2008.03206.x; Segest E, 1993, Med Law, V12, P141; Simkin S, 2005, QJM-INT J MED, V98, P159, DOI 10.1093/qjmed/hci026; *STAT CORP, 2007, STAT STAT SOFTW REL; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; ZHANG F, 15 ANN NESUG NE SAS; 1983, DTB, V21, P17	26	45	45	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 18	2009	338								b2270	10.1136/bmj.b2270	http://dx.doi.org/10.1136/bmj.b2270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460US	19541707	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000267216800005
J	Wheeler, MJ; de Graaf, BHJ; Hadjiosif, N; Perry, RM; Poulter, NS; Osman, K; Vatovec, S; Harper, A; Franklin, FCH; Franklin-Tong, VE				Wheeler, Michael J.; de Graaf, Barend H. J.; Hadjiosif, Natalie; Perry, Ruth M.; Poulter, Natalie S.; Osman, Kim; Vatovec, Sabina; Harper, Andrea; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.			Identification of the pollen self-incompatibility determinant in Papaver rhoeas	NATURE			English	Article							PROGRAMMED CELL-DEATH; GENE; CLONING; ACTIN; DEPOLYMERIZATION; POLYMORPHISM; LOCUS	Higher plants produce seed through pollination, using specific interactions between pollen and pistil. Self-incompatibility is an important mechanism used in many species to prevent inbreeding; it is controlled by a multi-allelic S locus(1,2). 'Self' (incompatible) pollen is discriminated from 'non-self' (compatible) pollen by interaction of pollen and pistil S locus components, and is subsequently inhibited. In Papaver rhoeas, the pistil S locus product is a small protein that interacts with incompatible pollen, triggering a Ca2+-dependent signalling network, resulting in pollen inhibition and programmed cell death(3-7). Here we have cloned three alleles of a highly polymorphic pollen-expressed gene, PrpS (Papaver rhoeas pollen S), from Papaver and provide evidence that this encodes the pollen S locus determinant. PrpS is a single-copy gene linked to the pistil S gene (currently called S, but referred to hereafter as PrsS for Papaver rhoeas stigma S determinant). Sequence analysis indicates that PrsS and PrpS are equally ancient and probably co-evolved. PrpS encodes a novel similar to 20-kDa protein. Consistent with predictions that it is a transmembrane protein, PrpS is associated with the plasma membrane. We show that a predicted extracellular loop segment of PrpS interacts with PrsS and, using PrpS antisense oligonucleotides, we demonstrate that PrpS is involved in S-specific inhibition of incompatible pollen. Identification of PrpS represents a major advance in our understanding of the Papaver self-incompatibility system. As a novel cell-cell recognition determinant it contributes to the available information concerning the origins and evolution of cell-cell recognition systems involved in discrimination between self and non-self, which also include histocompatibility systems in primitive chordates and vertebrates.	[Wheeler, Michael J.; de Graaf, Barend H. J.; Hadjiosif, Natalie; Perry, Ruth M.; Poulter, Natalie S.; Osman, Kim; Vatovec, Sabina; Harper, Andrea; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	V.E.Franklin-Tong@bham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012; De Graaf, Barend HJ/A-5880-2010	de Graaf, Barend H J/0000-0003-0542-5510; Poulter, Natalie/0000-0002-3187-2130; Franklin-Tong, Noni/0000-0003-1782-8413; Vatovec, Sabina/0000-0002-7991-2840; Franklin, F. Chris H./0000-0003-3507-722X; Harper, Andrea/0000-0003-3859-1152	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C501325/1]; Biotechnology and Biological Sciences Research Council [BB/C501325/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Chen-Ying for contributing preliminary data and horticultural staff for growing and collecting plant material. We also thank J. Kohn for help and advice on sequence analysis, and A. Lovering and T. Hakoshima for advice regarding structural predictions. We wish to acknowledge the long-term contribution from M. Lawrence, who initiated studies on Papaver self-incompatibility. Work in the laboratories of F. C. H. F. and V. E. F.-T. is funded by the Biotechnology and Biological Sciences Research Council (BBSRC); this work was supported by grant BB/C501325/1.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey N.T.J., 1959, STAT METHODS BIOL, P33; Biris N, 2003, EUR J BIOCHEM, V270, P3760, DOI 10.1046/j.1432-1033.2003.03762.x; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Graaf BHJ, 2006, NATURE, V444, P490, DOI 10.1038/nature05311; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Fisher R.A., 1956, STAT METHODS SCI INF; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; FRANKLINTONG VE, 1988, HEREDITY, V61, P286; FRANKLINTONG VE, 1993, PLANT J, V4, P163, DOI 10.1046/j.1365-313X.1993.04010163.x; Geitmann A, 2000, PLANT CELL, V12, P1239, DOI 10.1105/tpc.12.7.1239; Hearn MJ, 1996, PLANT J, V9, P467, DOI 10.1046/j.1365-313X.1996.09040467.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jordan ND, 2000, PLANT J, V23, P471, DOI 10.1046/j.1365-313x.2000.00811.x; Kohn J. R., 2008, P103, DOI 10.1007/978-3-540-68486-2_5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurup S, 1998, SEX PLANT REPROD, V11, P192, DOI 10.1007/s004970050141; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moutinho A, 2001, SEX PLANT REPROD, V14, P101, DOI 10.1007/s004970100086; Newbigin E, 2008, PLANT CELL, V20, P2286, DOI 10.1105/tpc.108.060327; Poulter NS, 2008, PLANT PHYSIOL, V146, P1358, DOI 10.1104/pp.107.107052; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Walker EA, 1996, PLANT MOL BIOL, V30, P983, DOI 10.1007/BF00020809; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173	39	142	160	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					992	U118		10.1038/nature08027	http://dx.doi.org/10.1038/nature08027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19483678	Green Accepted			2022-12-24	WOS:000267063500044
J	Chakrabarti, O; Hegde, RS				Chakrabarti, Oishee; Hegde, Ramanujan S.			Functional Depletion of Mahogunin by Cytosolically Exposed Prion Protein Contributes to Neurodegeneration	CELL			English	Article							ENDOPLASMIC-RETICULUM; DISEASE; SCRAPIE; PRP; NEUROTOXICITY; TRANSLOCATION; DEGRADATION; PATHWAY; TRANSMISSION; PURIFICATION	The pathways leading from aberrant Prion protein (PrP) metabolism to neurodegeneration are poorly understood. Some familial PrP mutants generate increased (PrP)-Pr-Ctm, a transmembrane isoform associated with disease. In other disease situations, a potentially toxic cytosolic form (termed cyPrP) might be produced. However, the mechanisms by which (PrP)-Pr-Ctm or cyPrP cause selective neuronal dysfunction are unknown. Here, we show that both (PrP)-Pr-Ctm and cyPrP can interact with and disrupt the function of Mahogunin (Mgrn), a cytosolic ubiquitin ligase whose loss causes spongiform neurodegeneration. Cultured cells and transgenic mice expressing either (PrP)-Pr-Ctm-producing mutants or cyPrP partially phenocopy Mgrn depletion, displaying aberrant lysosomal morphology and loss of Mgrn in selected brain regions. These effects were rescued by either Mgrn overexpression, competition for PrP-binding sites, or prevention of cytosolic PrP exposure. Thus, transient or partial exposure of PrP to the cytosol leads to inappropriate Mgrn sequestration that contributes to neuronal dysfunction and disease.	[Chakrabarti, Oishee; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X	NICHD at the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008835] Funding Source: NIH RePORTER	NICHD at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to N. Rane for providing transgenic mouse tissues and constructs, E. Whiteman for making the initial Mgrn constructs, Y. Abebe for expert animal care, L. Greene and H. Lorenz for constructs and sharing unpublished results, G. Patterson for help with microscopy, and L. DaSilva, G. Mardones, and P. Burgos for advice and reagents. This work was supported by the Intramural Research Program of the NICHD at the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BENDHEIM PE, 1988, J INFECT DIS, V158, P1198, DOI 10.1093/infdis/158.6.1198; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	35	96	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1136	1147		10.1016/j.cell.2009.03.042	http://dx.doi.org/10.1016/j.cell.2009.03.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524515	Green Accepted, Bronze			2022-12-24	WOS:000266916400024
J	Cicchillo, RM; Zhang, HJ; Blodgett, JAV; Whitteck, JT; Li, GY; Nair, SK; van der Donk, WA; Metcalf, WW				Cicchillo, Robert M.; Zhang, Houjin; Blodgett, Joshua A. V.; Whitteck, John T.; Li, Gongyong; Nair, Satish K.; van der Donk, Wilfred A.; Metcalf, William W.			An unusual carbon-carbon bond cleavage reaction during phosphinothricin biosynthesis	NATURE			English	Article							ISOPENICILLIN N-SYNTHASE; MYOINOSITOL OXYGENASE; MECHANISM; ACTIVATION; FOSFOMYCIN; ENZYME; PRODUCTS; INSIGHT; WATER	Natural products containing phosphorus-carbon bonds have found widespread use in medicine and agriculture(1). One such compound, phosphinothricin tripeptide, contains the unusual amino acid phosphinothricin attached to two alanine residues. Synthetic phosphinothricin (glufosinate) is a component of two top-selling herbicides (Basta and Liberty), and is widely used with resistant transgenic crops including corn, cotton and canola. Recent genetic and biochemical studies showed that during phosphinothricin tripeptide biosynthesis 2-hydroxyethylphosphonate (HEP) is converted to hydroxymethylphosphonate (HMP)(2). Here we report the in vitro reconstitution of this unprecedented C(sp(3))-C(sp(3)) bond cleavage reaction and X-ray crystal structures of the enzyme. The protein is a mononuclear non-haem iron(II)-dependent dioxygenase that converts HEP to HMP and formate. In contrast to most other members of this family, the oxidative consumption of HEP does not require additional cofactors or the input of exogenous electrons. The current study expands the scope of reactions catalysed by the 2-His-1-carboxylate mononuclear non-haem iron family of enzymes.	[Cicchillo, Robert M.; Zhang, Houjin; Whitteck, John T.; Nair, Satish K.; van der Donk, Wilfred A.; Metcalf, William W.] Univ Illinois, Inst Genom Biol, Urbana, IL 61802 USA; [Cicchillo, Robert M.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61802 USA; [Zhang, Houjin; Nair, Satish K.; van der Donk, Wilfred A.] Univ Illinois, Dept Biochem, Urbana, IL 61802 USA; [Blodgett, Joshua A. V.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA; [Cicchillo, Robert M.; Whitteck, John T.; Li, Gongyong; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61802 USA.	s-nair@life.uiuc.edu; vddonk@illinois.edu; metcalf@illinois.edu	Blodgett, Joshua/AAW-8242-2020; van der Donk, Wilfred/K-2961-2015; Blodgett, Joshua/G-9355-2011; Nair, Satish/AAY-2510-2021	Blodgett, Joshua/0000-0002-7080-5870; van der Donk, Wilfred/0000-0002-5467-7071; Blodgett, Joshua/0000-0002-7080-5870; 	National Institutes of Health [PO1 GM077596, RO1 GM59334]; University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059334, P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Griffin, J. M. Bollinger, S. E. Denmark and T. Begley for discussions. This work was supported by grants from the National Institutes of Health (PO1 GM077596 to W. W. M., W. A. v. d. D. and S. K. N., and NIH RO1 GM59334 to W. W. M.) and by the University of Illinois.	BALDWIN JE, 1993, TETRAHEDRON, V49, P7499, DOI 10.1016/S0040-4020(01)87226-4; Beinert H, 1978, Methods Enzymol, V54, P435; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Grogan G, 2005, BIOCHEM J, V388, P721, DOI 10.1042/BJ20042038; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; KIKUCHI Y, 1983, BIOCHEM J, V213, P507, DOI 10.1042/bj2130507; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Lieberman S, 2001, J STEROID BIOCHEM, V78, P1, DOI 10.1016/S0960-0760(01)00068-1; LINDBLAD B, 1970, J AM CHEM SOC, V92, P7446, DOI 10.1021/ja00728a032; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Pestovsky O, 2006, INORG CHEM, V45, P814, DOI 10.1021/ic051868z; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7468; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Shyadehi AZ, 1996, J BIOL CHEM, V271, P12445, DOI 10.1074/jbc.271.21.12445; WACKETT LP, 1988, BIOCHEMISTRY-US, V27, P1360, DOI 10.1021/bi00404a041; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Xing G, 2006, P NATL ACAD SCI USA, V103, P6130, DOI 10.1073/pnas.0508473103; Xing G, 2006, BIOCHEMISTRY-US, V45, P5402, DOI 10.1021/bi0526276	22	102	104	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					871	U10		10.1038/nature07972	http://dx.doi.org/10.1038/nature07972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516340	Green Accepted			2022-12-24	WOS:000267084500045
J	Marodi, L; Casanova, JL				Marodi, Laszlo; Casanova, Jean-Laurent			Primary immunodeficiency diseases: the J Project	LANCET			English	Editorial Material							GENE-THERAPY		[Marodi, Laszlo] Univ Debrecen, Dept Infect & Pediat Immunol, H-4032 Debrecen, Hungary; [Casanova, Jean-Laurent] Paris Descartes Univ, INSERM, Necker Med Sch, Lab Human Genet Infect Dis, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Univ Hosp, Lab Human Genet Infect Dis, New York, NY 10021 USA	University of Debrecen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University	Marodi, L (corresponding author), Univ Debrecen, Dept Infect & Pediat Immunol, H-4032 Debrecen, Hungary.	lmarodi@dote.hu	Casanova, Jean-Laurent/I-3418-2017; Marodi, Laszlo/AAU-9915-2020	Casanova, Jean-Laurent/0000-0002-7782-4169				Alapi K, 2006, CLIN CHEM, V52, P901, DOI 10.1373/clinchem.2005.064816; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Knerr V, 2007, CURR OPIN ALLERGY CL, V7, P475, DOI 10.1097/ACI.0b013e3282f2162c; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nri2195; Toth B, 2009, MOL IMMUNOL, V46, P2140, DOI 10.1016/j.molimm.2009.03.012	8	24	27	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2179	2181		10.1016/S0140-6736(09)61171-5	http://dx.doi.org/10.1016/S0140-6736(09)61171-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560586				2022-12-24	WOS:000267444500008
J	Sever, P				Sever, Peter			Is systolic blood pressure all that matters? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER		Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1NY, England	Imperial College London	Sever, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1NY, England.	p.sever@imperial.ac.uk			National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 1991, JAMA, V265, P3255; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mackenzie J, 1926, PRINCIPLES DIAGNOSIS; OROURKE M, 1995, HYPERTENSION, V26, P2, DOI 10.1161/01.HYP.26.1.2; Primatesta P, 2004, J HYPERTENS, V22, P1093, DOI 10.1097/00004872-200406000-00008; Sever P, 1999, BRIT MED J, V318, P1773, DOI 10.1136/bmj.318.7200.1773; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	11	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2009	339								b2665	10.1136/bmj.b2665	http://dx.doi.org/10.1136/bmj.b2665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LC	19592405				2022-12-24	WOS:000267898700002
J	Zanoni, I; Ostuni, R; Capuano, G; Collini, M; Caccia, M; Ronchi, AE; Rocchetti, M; Mingozzi, F; Foti, M; Chirico, G; Costa, B; Zaza, A; Ricciardi-Castagnoli, P; Granucci, F				Zanoni, Ivan; Ostuni, Renato; Capuano, Giusy; Collini, Maddalena; Caccia, Michele; Ronchi, Antonella Ellena; Rocchetti, Marcella; Mingozzi, Francesca; Foti, Maria; Chirico, Giuseppe; Costa, Barbara; Zaza, Antonio; Ricciardi-Castagnoli, Paola; Granucci, Francesca			CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; T-CELLS; IL-2 PRODUCTION; RECEPTORS; INDUCTION; MACROPHAGES; RESISTANCE; PROTEINS; BACTERIA; IMMUNITY	Toll-like receptors (TLRs) are the best characterized pattern recognition receptors(1). Individual TLRs recruit diverse combinations of adaptor proteins, triggering signal transduction pathways and leading to the activation of various transcription factors, including nuclear factor kappa B, activation protein 1 and interferon regulatory factors(2). Interleukin-2 is one of the molecules produced by mouse dendritic cells after stimulation by different pattern recognition receptor agonists(3-6). By analogy with the events after T-cell receptor engagement leading to interleukin-2 production, it is therefore plausible that the stimulation of TLRs on dendritic cells may lead to activation of the Ca2+/calcineurin and NFAT (nuclear factor of activated T cells) pathway. Here we show that mouse dendritic cell stimulation with lipopolysaccharide (LPS) induces Src-family kinase and phospholipase C gamma 2 activation, influx of extracellular Ca2+ and calcineurin-dependent nuclear NFAT translocation. The initiation of this pathway is independent of TLR4 engagement, and dependent exclusively on CD14. We also show that LPS-induced NFAT activation via CD14 is necessary to cause the apoptotic death of terminally differentiated dendritic cells, an event that is essential for maintaining self-tolerance and preventing autoimmunity(7,8). Consequently, blocking this pathway in vivo causes prolonged dendritic cell survival and an increase in T-cell priming capability. Our findings reveal novel aspects of molecular signalling triggered by LPS in dendritic cells, and identify a new role for CD14: the regulation of the dendritic cell life cycle through NFAT activation. Given the involvement of CD14 in disease, including sepsis and chronic heart failure(9,10), the discovery of signal transduction pathways activated exclusively via CD14 is an important step towards the development of potential treatments involving interference with CD14 functions.	[Zanoni, Ivan; Ostuni, Renato; Capuano, Giusy; Ronchi, Antonella Ellena; Rocchetti, Marcella; Mingozzi, Francesca; Foti, Maria; Costa, Barbara; Zaza, Antonio; Ricciardi-Castagnoli, Paola; Granucci, Francesca] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Collini, Maddalena; Caccia, Michele; Chirico, Giuseppe] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Granucci, F (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, Italy.	francesca.granucci@unimib.it	Castagnoli, Paola/E-8288-2010; Caccia, Michele/AAW-2808-2021; Ostuni, Renato/AAB-8832-2022; Costa, Barbara/AAB-4181-2021; GRANUCCI, Francesca/K-6150-2019; Caccia, Michele/Q-5623-2018; Zaza, Antonio/N-2646-2019; Foti, Maria/AAB-9961-2022	Caccia, Michele/0000-0002-2968-5635; Ostuni, Renato/0000-0003-0460-3426; Zaza, Antonio/0000-0001-9355-4958; FOTI, MARIA/0000-0002-4481-1900; RONCHI, ANTONELLA ELLENA/0000-0002-3905-1038; COSTA, BARBARA SIMONA/0000-0002-2910-6736; CHIRICO, Giuseppe/0000-0001-6578-6460; Zanoni, Ivan/0000-0002-3423-7474; granucci, francesca/0000-0002-7046-4914	CARIPLO Foundation; European Commission; Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Education and Research (COFIN)	CARIPLO Foundation(Fondazione Cariplo); European Commission(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education and Research (COFIN)(Ministry of Education, Universities and Research (MIUR))	We thank S. Akira, C. Kirschning and K. Miyake for mutant mice; M. Colonna for mutant mice and advice on PLC-gamma 2 activation; E. Serfling for mutant mice and advice on NFAT activation; A. Rao for the VIVIT peptide. We also thank Genopolis-Consorzio di Genomica Funzionale for microarray hybridization and data analysis and K. Mahnke for the anti-DEC205-OVA conjugate. This work was supported by grants from the CARIPLO Foundation, the European Commission 6th Framework Program (MUGEN and DC-THERA contracts), the European Commission 7th Framework Program (TOLERAGE and ENCITE contracts), the Associazione Italiana per la Ricerca sul Cancro (AIRC) and the and the Italian Ministry of Education and Research (COFIN).	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Dendorfer U, 1996, ARTIF ORGANS, V20, P437, DOI 10.1111/j.1525-1594.1996.tb04529.x; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Genth-Zotz S, 2006, EUR J HEART FAIL, V8, P366, DOI 10.1016/j.ejheart.2005.10.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422	33	228	240	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					264	U130		10.1038/nature08118	http://dx.doi.org/10.1038/nature08118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19525933				2022-12-24	WOS:000267761000042
J	Heysell, SK				Heysell, Scott K.			The Quiet Storm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT					scott.heysell@gmail.com						Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; BRUST JCM, 2008, INT AIDS SOC AUG 3 8; MOLL AP, 2009, S AFR AIDS C MARCH 3; MOODLEY P, 2007, 38 WORLD C LUNG HLTH; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					13	14		10.1001/jama.2009.952	http://dx.doi.org/10.1001/jama.2009.952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567425				2022-12-24	WOS:000267492800001
J	Patel, M; Pedreira, C; De Oliveira, LH; Tate, J; Orozco, M; Mercado, J; Gonzalez, A; Malespin, O; Amador, JJ; Umana, J; Balmaseda, A; Perez, MC; Gentsch, J; Kerin, T; Hull, J; Mijatovic, S; Andrus, J; Parashar, U				Patel, Manish; Pedreira, Cristina; De Oliveira, Lucia Helena; Tate, Jacqueline; Orozco, Maribel; Mercado, Juan; Gonzalez, Alcides; Malespin, Omar; Amador, Juan Jose; Umana, Jazmina; Balmaseda, Angel; Perez, Maria Celina; Gentsch, Jon; Kerin, Tara; Hull, Jennifer; Mijatovic, Slavica; Andrus, Jon; Parashar, Umesh			Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL POLIOVIRUS VACCINE; CHOLERA VACCINE; NEW-DELHI; REASSORTANT; EFFICACY; IMMUNOGENICITY; INFECTION; SAFETY; PROTECTION; STRAINS	Context Pentavalent rotavirus vaccine (RV5), a live, oral attenuated vaccine, prevented 98% of severe rotavirus diarrhea in a trial conducted mainly in Finland and the United States. Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country. Objective To assess the association between RV5 vaccination and subsequent rotavirus diarrhea requiring overnight admission or intravenous hydration. Design, Setting, and Participants Case-control evaluation in 4 hospitals in Nicaragua from June 2007 to June 2008. Cases were children age-eligible to receive RV5 who were admitted or required intravenous hydration for laboratory-confirmed rotavirus diarrhea. For each case (n=285), 1 to 3 neighborhood (n=840) and hospital (n=690) controls were selected. Main Outcome Measures Primary outcome was the association of RV5 and rotavirus diarrhea requiring overnight admission or intravenous hydration in the emergency department. Secondary analysis further classified disease as severe and very severe. We computed the matched odds ratio of vaccination in cases vs controls. Vaccine effectiveness was estimated using the formula 1-matched odds ratio x 100%. Results Of the 285 rotavirus cases, 265 (93%) required hospitalization; 251 (88%) received intravenous hydration. A single rotavirus strain (G2P[ 4]) was identified in 88% of the cases. Among cases and controls, respectively, 18% and 12% were unvaccinated, 12% and 15% received 1 dose of RV5, 15% and 17% received 2 doses, and 55% and 57% received 3 doses. Vaccination with 3 doses was associated with a lower risk of rotavirus diarrhea requiring overnight admission or intravenous hydration (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.36-0.82). Of the 285 rotavirus cases, 191 (67%) were severe and 54 (19%) were very severe. A progressively lower risk of severe (OR, 0.42; 95% CI, 0.26-0.70) and very severe rotavirus diarrhea (OR, 0.23; 95% CI, 0.08-0.61) was observed after RV5 vaccination. Thus, effectiveness of 3 doses of RV5 against rotavirus disease requiring admission or treatment with intravenous hydration was 46% (95% CI, 18%-64%); against severe rotavirus diarrhea, 58% ( 95% CI, 30%-74%); and against very severe rotavirus diarrhea, 77% (95% CI, 39%-92%). Conclusion Vaccination with RV5 was associated with a lower risk of severe rotavirus diarrhea in children younger than 2 years in Nicaragua but to a lesser extent than that seen in clinical trials in industrialized countries. JAMA. 2009;301(21):2243-2251 www.jama.com	[Patel, Manish] Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA; [Pedreira, Cristina] Pan Amer Hlth Org, Managua, Nicaragua; [De Oliveira, Lucia Helena; Andrus, Jon] Pan Amer Hlth Org, Washington, DC USA; [Orozco, Maribel; Mercado, Juan; Gonzalez, Alcides; Malespin, Omar; Umana, Jazmina; Balmaseda, Angel; Perez, Maria Celina] Minist Salud, Managua, Nicaragua; [Amador, Juan Jose] Program Appropriate Technol Hlth, Managua, Nicaragua	Centers for Disease Control & Prevention - USA; Pan American Health Organization; Pan American Health Organization	Patel, M (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, MS A47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	aul3@cdc.gov			Global Alliance for Vaccines and Immunization	Global Alliance for Vaccines and Immunization	This study was conducted under a collaborative arrangement with the Program for Appropriate Technology in Health and was funded in part by the Global Alliance for Vaccines and Immunization.	Amador JJ, 2008, REV PANAM SALUD PUBL, V23, P277, DOI 10.1590/S1020-49892008000400008; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; BOOM J, 2008, 48 INT C ANT AG CHEM; Bresee JS, 2005, PEDIATR INFECT DIS J, V24, P947, DOI 10.1097/01.inf.0000186295.18969.e6; Bresee JS, 2005, J INFECT DIS, V192, pS1, DOI 10.1086/431515; Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780; Cunliffe NA, 2001, LANCET, V358, P550, DOI 10.1016/S0140-6736(01)05706-3; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; de Oliveira LH, 2008, EXPERT REV VACCINES, V7, P345, DOI 10.1586/14760584.7.3.345; ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; GOTUZZO E, 1993, INFECT IMMUN, V61, P3994, DOI 10.1128/IAI.61.9.3994-3997.1993; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Griffin DD, 2002, VIROLOGY, V294, P256, DOI 10.1006/viro.2001.1333; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; HANLON P, 1987, LANCET, V1, P1342; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Linhares AC, 1999, PEDIATR INFECT DIS J, V18, P1001, DOI 10.1097/00006454-199911000-00013; MIGASENA S, 1995, VACCINE, V13, P168, DOI 10.1016/0264-410X(95)93131-R; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; SATTEN GA, 1990, J CLIN EPIDEMIOL, V43, P55, DOI 10.1016/0895-4356(90)90056-U; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; VODOPIJA I, 1986, VACCINE, V4, P233, DOI 10.1016/0264-410X(86)90135-0; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285	40	210	215	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2243	2251		10.1001/jama.2009.756	http://dx.doi.org/10.1001/jama.2009.756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491186	Bronze			2022-12-24	WOS:000266554100022
J	Guo, M; Chong, YE; Beebe, K; Shapiro, R; Yang, XL; Schimmel, P				Guo, Min; Chong, Yeeting E.; Beebe, Kirk; Shapiro, Ryan; Yang, Xiang-Lei; Schimmel, Paul			The C-Ala Domain Brings Together Editing and Aminoacylation Functions on One tRNA	SCIENCE			English	Article							AMINO-ACID; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; BINDING DOMAIN; SYNTHETASE; DISCRIMINATION; RECOGNITION; COMPLEX; MISTRANSLATION; DETERMINANTS	Protein synthesis involves the accurate attachment of amino acids to their matching transfer RNA (tRNA) molecules. Mistranslating the amino acids serine or glycine for alanine is prevented by the function of independent but collaborative aminoacylation and editing domains of alanyl-tRNA synthetases (AlaRSs). We show that the C-Ala domain plays a key role in AlaRS function. The C-Ala domain is universally tethered to the editing domain both in AlaRS and in many homologous free-standing editing proteins. Crystal structure and functional analyses showed that C-Ala forms an ancient single-stranded nucleic acid binding motif that promotes cooperative binding of both aminoacylation and editing domains to tRNA(Ala). In addition, C-Ala may have played an essential role in the evolution of AlaRSs by coupling aminoacylation to editing to prevent mistranslation.	[Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, BCC-379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	NIH [GM 15539]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM 15539 and by a fellowship from the National Foundation for Cancer Research. The atomic coordinates have been deposited in the Protein Data Bank (PDB ID:3G98).	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Beebe K, 2003, J BIOL CHEM, V278, P45056, DOI 10.1074/jbc.M307080200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; BUECHTER DD, 1993, BIOCHEMISTRY-US, V32, P5267, DOI 10.1021/bi00070a039; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2007, BIOCHEMISTRY-US, V46, P4985, DOI 10.1021/bi6024935; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Gale AJ, 1996, BIOCHEMISTRY-US, V35, P608, DOI 10.1021/bi9520904; HOU YM, 1989, BIOCHEMISTRY-US, V28, P4942, DOI 10.1021/bi00438a005; Hsu JL, 2008, J MOL BIOL, V376, P482, DOI 10.1016/j.jmb.2007.11.065; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nomanbhoy T, 2001, NAT STRUCT BIOL, V8, P344, DOI 10.1038/86228; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Ribas De Pouplana L, 2005, AMINOACYL TRNA SYNTH, P241; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099	32	57	62	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					744	747		10.1126/science.1174343	http://dx.doi.org/10.1126/science.1174343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661429	Green Accepted			2022-12-24	WOS:000268723700048
J	Bard, E; Rickaby, REM				Bard, Edouard; Rickaby, Rosalind E. M.			Migration of the subtropical front as a modulator of glacial climate	NATURE			English	Article							ATLANTIC OVERTURNING CIRCULATION; INDIAN-OCEAN; ORGANIC-MATTER; SOUTH ATLANTIC; RECORD; SEDIMENTS; MODEL; FLUCTUATIONS; TEMPERATURE; VARIABILITY	Ice cores extracted from the Antarctic ice sheet suggest that glacial conditions, and the relationship between isotopically derived temperatures and atmospheric p(CO2) have been constant over the last 800,000 years of the Late Pleistocene epoch(1). But independent lines of evidence, such as the extent of Northern Hemisphere ice sheets(2), sea level(3) and other temperature records(4), point towards a fluctuating severity of glacial periods, particularly during the more extreme glacial stadials centred around 340,000 and 420,000 years ago (marine isotope stages 10 and 12). Previously unidentified mechanisms therefore appear to have mediated the relationship between insolation, CO2 and climate. Here we test whether northward migration of the subtropical front (STF) off the southeastern coast of South Africa acts as a gatekeeper for the Agulhas current(5,6), which controls the transport of heat and salt from the Indo-Pacific Ocean to the Atlantic Ocean. Using a new 800,000-year record of sea surface temperature and ocean productivity from ocean sediment core MD962077, we demonstrate that during cold stadials (particularly marine isotope stages 10 and 12), productivity peaked and sea surface temperature was up to 6 degrees C cooler than modern temperatures. This suggests that during these cooler stadials, the STF moved northward by up to 76 latitude, nearly shutting off the Agulhas current. Our results, combined with faunal assemblages from the south Atlantic(7,8) show that variable northwards migration of the Southern Hemisphere STF can modulate the severity of each glacial period by altering the strength of the Agulhas current carrying heat and salt to the Atlantic meridional overturning circulation. We show hence that the degree of northwards migration of the STF can partially decouple global climate from atmospheric partial pressure of carbon dioxide, p(CO2), and help to resolve the long-standing puzzle of differing glacial amplitudes within a consistent range of atmospheric p(CO2).	[Bard, Edouard] Univ Paul Cezanne Aix Marseille, CNRS, IRD, Coll France,CEREGE,UMR 6635, F-13545 Aix En Provence 4, France; [Rickaby, Rosalind E. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Oxford	Bard, E (corresponding author), Univ Paul Cezanne Aix Marseille, CNRS, IRD, Coll France,CEREGE,UMR 6635, Europole Arbois BP 80, F-13545 Aix En Provence 4, France.	bard@cerege.fr; rosr@earth.ox.ac.uk	Bard, Edouard/G-7717-2014	Rickaby, Rosalind/0000-0002-6095-8419	Gary Comer Foundation; CNRS; College de France	Gary Comer Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); College de France	We thank D. P. Schrag and E. Goddard for their help with analyses in the early stages of this work. We thank C. Sonzogni, F. Rostek, N. Thouveny and J. Carignan for help with analyses and age model, and D. Sansom for help with the figures. We also thank H. Gildor, Y. Ashkenazy, R. Toggweiler, M. Meredith, M.-F. Loutre, P. Huybers and N. Edwards for comments and discussion on an earlier version of this manuscript. R. E. M. R. is grateful to the Royal Society for the International Outgoing Visit award for the exchange visits to CEREGE, which facilitated the development of the ideas and the manuscript. Palaeoclimate work at CEREGE is supported by grants from the Gary Comer Foundation, the CNRS and the College de France. Core MD962077 was collected by the RV Marion Dufresne supported by the Institut Polaire Francais (IPEV).	Ashkenazy Y, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001436; Bard E, 2001, PALEOCEANOGRAPHY, V16, P235, DOI 10.1029/2000PA000537; BE AWH, 1976, SCIENCE, V194, P419, DOI 10.1126/science.194.4263.419; Berger A, 2006, CLIM PAST, V2, P131, DOI 10.5194/cp-2-131-2006; Berger WH, 1996, SOUTH ATLANTIC, P363; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Conte MH, 1998, GEOCHIM COSMOCHIM AC, V62, P51, DOI 10.1016/S0016-7037(97)00327-X; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Howard WR, 1992, PALEOCEANOGRAPHY, V7, P79, DOI 10.1029/91PA02994; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; KUHLBRODT K, 2004, REV GEOPHYS, V45, pG2001; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125; MASSONDELMOTTE V, QUAT SCI RE IN PRESS; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001604; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Pailler D, 2002, GEOCHIM COSMOCHIM AC, V66, P849, DOI 10.1016/S0016-7037(01)00817-1; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rau A, 2006, QUATERN INT, V148, P65, DOI 10.1016/j.quaint.2005.11.007; Raymo ME, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000921; Rickaby REM, 2007, EARTH PLANET SC LETT, V253, P83, DOI 10.1016/j.epsl.2006.10.016; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rojas M, 2009, CLIM DYNAM, V32, P525, DOI 10.1007/s00382-008-0421-7; Rosell-Mele A, 2001, GEOCHEM GEOPHY GEOSY, V2; ROSENTHAL Y, 1995, PALEOCEANOGRAPHY, V10, P395, DOI 10.1029/95PA00310; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; Schmittner A, 2002, SCIENCE, V295, P1489, DOI 10.1126/science.1066174; Schulte S, 2003, QUATERNARY SCI REV, V22, P1757, DOI 10.1016/S0277-3791(03)00172-0; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; SIJP WP, J CLIM IN PRESS; Sonzogni C, 1997, DEEP-SEA RES PT II, V44, P1445, DOI 10.1016/S0967-0645(97)00010-6; Stoll HM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000015; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taylor S.R., 1985, CONTINENTAL CRUST IT; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Williams GP, 2006, J CLIMATE, V19, P1706, DOI 10.1175/JCLI3766.1; Zheng Y, 2002, GEOCHIM COSMOCHIM AC, V66, P1759, DOI 10.1016/S0016-7037(01)00886-9; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8	47	158	164	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					380	U93		10.1038/nature08189	http://dx.doi.org/10.1038/nature08189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606147				2022-12-24	WOS:000267979000035
J	Li, F; Tsien, JZ				Li, Fei; Tsien, Joe Z.			Memory and the NMDA Receptors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Li, Fei] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China	University System of Georgia; Augusta University; Shanghai Jiao Tong University	Li, F (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.				NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034663-01, R01 AG034663] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Jiang HQ, 2009, NEUROSCI LETT, V450, P356, DOI 10.1016/j.neulet.2008.10.075; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Tsien JZ, 2000, SCI AM, V282, P62, DOI 10.1038/scientificamerican0400-62	5	213	224	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					302	303		10.1056/NEJMcibr0902052	http://dx.doi.org/10.1056/NEJMcibr0902052			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605837	Green Accepted			2022-12-24	WOS:000267976100015
J	Hauser, MD				Hauser, Marc D.			The possibility of impossible cultures	NATURE			English	Article							GRAMMAR; EVOLUTION; LINGUISTICS; LANGUAGE		[Hauser, Marc D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Hauser, Marc D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hauser, Marc D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh102559@gmail.com			US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	I dedicate this paper to Noam Chomsky and Peter Marler for their insights into the many problems discussed here, as well as their friendship and advice over several years. For support during the writing of this article, and for research funds, I thank Harvard University's Mind/Brain/Behavior Interfaculty Initiative, J. Epstein, S. Shuman and the US National Science Foundation (Human & Social Dynamics priority area). For comments and discussion on drafts, I thank A. Abzhanov, A. Bejan, C. Boeckx, N. Chomsky, D. Dennett, B. Huebner, R. Jackendoff, N. Kanwisher, M. Kinsbourne, M. Kirschner, J. Junge, F. Lerdahl, G. McGhee, D. Roy, G. Striedter and F. Tsao.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Barner D, 2008, COGNITION, V107, P603, DOI 10.1016/j.cognition.2007.11.010; BARYOSEF O, 2005, J ISRAEL PREHIST SOC, V35, P467; Boeckx C, 2005, LINGUIST REV, V22, P447, DOI 10.1515/tlir.2005.22.2-4.447; CALL J, 2004, GESTURAL COMMUNICATI; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cases I, 2002, ENVIRON MICROBIOL, V4, P623, DOI 10.1046/j.1462-2920.2002.00346.x; Changeux JP, 1985, NEURONAL MAN; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Cheney DL., 2008, BABOON METAPHYSICS; Chomsky N., 2000, NATURE LANGUAGE; Chomsky N, 1980, RULES REPRESENTATION; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deacon T., 1997, SYMBOLIC SPECIES; Dehaene S., 2005, MONKEY BRAIN HUMAN B, P133; Dwyer S., 1999, PHILOS LINGUISTICS, P169; EDELMAN G, 1990, NEURAL DARWINISM; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Gallistel C. R., 1990, ORG LEARNING; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Grant P.R., 2007, WHY SPECIES MULTIPLY; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Harman G, 1999, PROCEEDINGS OF THE TWENTIETH WORLD CONGRESS OF PHILOSOPHY, VOL 1, P107; Hauser M., 2006, MORAL MINDS; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2000, WILD MINDS; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; JACKENDOFF R, 2000, FDN LANGUAGE; JACKENDOFF R, 2008, LANGUAGE CONSCIOUSNE; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Jacob Francois, 1976, LOGIC LIFE; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; Kelemen D, 1999, TRENDS COGN SCI, V3, P461, DOI 10.1016/S1364-6613(99)01402-3; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Klein R., 2002, DAWN HUMAN CULTURE; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; LAHIRI A, 2008, UNIVERSALS LANG, P31; Lerdahl F., 1992, CONTEMP MUSIC REV, V6, P97, DOI [10.1080/07494469200640161, DOI 10.1080/07494469200640161]; Lerdahl F., 2001, TONAL PITCH SPACE; Lerdahl F., 1983, GENERATIVE THEORY TO; Lightfoot DW, 2002, LANGUAGE ORGAN; Marler Peter, 1992, Seminars in the Neurosciences, V4, P415, DOI 10.1016/1044-5765(92)90050-C; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McGhee GR, 1999, PERS PALEOB; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mithen S., 1996, PREHISTORY MIND; Monod J., 1974, CHANCE NECESSITY; Moro A., 2008, BOUNDARIES BABEL; Nettl Bruno, 2005, STUDY ETHNOMUSICOLOG; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nisbett Richard E., 2004, GEOGRAPHY THOUGHT; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Pinker S., 1997, MIND WORKS; Pinker Steven, 1994, LANGUAGE INSTINCT; Premack D, 2007, P NATL ACAD SCI USA, V104, P13861, DOI 10.1073/pnas.0706147104; Raup D. M., 1967, Journal of Paleontology, V41, P43; Rawls J, 2000, THEORY JUSTICE; Ristau C.A., 1991, P91; Rozin P, 2000, AM BEHAV SCI, V43, P970, DOI 10.1177/0002764200043006006; Savage-Rumbaugh E S, 1993, Monogr Soc Res Child Dev, V58, P1; Shettleworth, 2010, COGNITION EVOLUTION; Shweder R. A., 2003, WHY DO MEN BARBECUE; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Thomas RDK, 2000, SCIENCE, V288, P1239, DOI 10.1126/science.288.5469.1239; Thompson SP, 2007, LANG LEARN DEV, V3, P1, DOI 10.1080/15475440709336999; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Tomasello M, 1997, PRIMATE COGNITION; Tomasello M., 2003, CONSTRUCTING LANGUAG; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	80	47	50	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					190	196		10.1038/460190a	http://dx.doi.org/10.1038/460190a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587759				2022-12-24	WOS:000267761000028
J	Thomson, M; Gunawardena, J				Thomson, Matthew; Gunawardena, Jeremy			Unlimited multistability in multisite phosphorylation systems	NATURE			English	Article							PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; HISTONE CODE; TRANSCRIPTION; KINASE; ULTRASENSITIVITY; MEMORY; SWITCH	Reversible phosphorylation on serine, threonine and tyrosine is the most widely studied posttranslational modification of proteins(1,2). The number of phosphorylated sites on a protein (n) shows a significant increase from prokaryotes, with n <= 7 sites, to eukaryotes, with examples having n >= 150 sites(3). Multisite phosphorylation has many roles(4,5) and site conservation indicates that increasing numbers of sites cannot be due merely to promiscuous phosphorylation. A substrate with n sites has an exponential number (2(n)) of phospho-forms and individual phospho-forms may have distinct biological effects(6,7). The distribution of these phospho-forms and how this distribution is regulated have remained unknown. Here we show that, when kinase and phosphatase act in opposition on a multisite substrate, the system can exhibit distinct stable phospho-form distributions at steady state and that the maximum number of such distributions increases with n. Whereas some stable distributions are focused on a single phospho-form, others are more diffuse, giving the phosphoproteome the potential to behave as a fluid regulatory network able to encode information and flexibly respond to varying demands. Such plasticity may underlie complex information processing in eukaryotic cells(8) and suggests a functional advantage in having many sites. Our results follow from the unusual geometry of the steady-state phospho-form concentrations, which we show to constitute a rational algebraic curve, irrespective of n. We thereby reduce the complexity of calculating steady states from simulating 3 x 2(n) differential equations to solving two algebraic equations, while treating parameters symbolically. We anticipate that these methods can be extended to systems with multiple substrates and multiple enzymes catalysing different modifications, as found in posttranslational modification 'codes'(9) such as the histone code(10,11). Whereas simulations struggle with exponentially increasing molecular complexity, mathematical methods of the kind developed here can provide a new language in which to articulate the principles of cellular information processing(12).	[Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomson, Matthew] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu			NIH [R01-GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the NIH under grant R01-GM081578. We thank A. Manrai for scientific discussions, R. Ward for editorial help and HMS RITG for support with cluster computing. We acknowledge the encouragement of the late Stephen Thomson (1946-2006) and Charles Gunawardena (1929-2007).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P23; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Walsh C., 2006, POSTTRANSLATIONAL MO; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019	30	180	180	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					274	277		10.1038/nature08102	http://dx.doi.org/10.1038/nature08102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19536158	Green Accepted, Green Submitted			2022-12-24	WOS:000267761000044
J	Schmid, P; Nagai, Y; Agarwal, R; Hancock, B; Savage, PM; Sebire, NJ; Lindsay, I; Wells, M; Fisher, RA; Short, D; Newlands, ES; Wischnewsky, MB; Seckl, MJ				Schmid, Peter; Nagai, Yutaka; Agarwal, Roshan; Hancock, Barry; Savage, Philip M.; Sebire, Neil J.; Lindsay, Iain; Wells, Michael; Fisher, Rosemary A.; Short, Delia; Newlands, Edward S.; Wischnewsky, Manfred B.; Seckl, Michael J.			Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study	LANCET			English	Article							HYDATIDIFORM MOLE; MANAGEMENT; CHEMOTHERAPY; FERTILITY; NEOPLASIA; HYSTERECTOMY; PSEUDOTUMOR; EXPERIENCE	Background Placental-site trophoblastic tumours are a rare form of gestational trophoblastic disease and consequently information about optimum management or prognostic factors is restricted. We aimed to assess the long-term outcome of stage-adapted management by surgery, chemotherapy, or both for patients with the disorder. Methods 35550 women were registered with gestational trophoblastic disease in the UK (1976-2006), of whom 62 were diagnosed with placental-site trophoblastic tumours and included, retrospectively, in the study. Patients were treated by surgery, chemotherapy, or both. We estimated the probabilities of overall survival and survival without recurrence of disease 5 and 10 years after the date of first treatment, and calculated the association of these endpoints with prognostic factors, including time since antecedent pregnancy, serum concentration of beta-human chorionic gonadotropin, and stage of disease, with both univariate and multivariate analyses. Findings Probabilities of overall and recurrence-free survival 10 years after first treatment were 70% (95% CI 54-82) and 73% (54-85), respectively. Patients with stage I disease had a 10-year probability of overall survival of 90% (77-100) and did not benefit from postoperative chemotherapy. By contrast, patients with stage II, III, and IV disease required combined treatment with surgery and chemotherapy; probability of overall survival at 10 years was 52% (3-100) for patients with stage II disease and 49% (26-72) for stage III or IV disease. Outcome for patients who had recurrent or refractory disease was poor: only four (22%) patients achieved long-term survival beyond 60 months. Multivariate analysis showed that the only significant independent predictor of overall and recurrence-free survival was time since antecedent pregnancy. A cutoff point of 48 months since antecedent pregnancy could differentiate between patients' probability of survival (<48 months) or death (>= 48 months) with 93% specificity and 100% sensitivity, and with a positive predictive value of 100% and a negative predictive value of 98%. Interpretation Stage-adapted management with surgery for stage I disease, and combined surgery and chemotherapy for stage II, III, and IV disease could improve the effectiveness of treatment for placental-site trophoblastic tumours. Use of 48 months since antecedent pregnancy as a prognostic indicator of survival could help select patients for risk-adapted treatment.	[Schmid, Peter] Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, London W6 8RF, England; [Schmid, Peter; Agarwal, Roshan; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Nagai, Yutaka] Univ Ryukyus, Okinawa, Japan; [Hancock, Barry; Wells, Michael] Weston Pk Hosp, Gestat Trophoblast Dis Ctr, Sheffield, S Yorkshire, England; [Wells, Michael] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Wischnewsky, Manfred B.] Univ Bremen, Bremen, Germany	Imperial College London; University of the Ryukyus; Weston Park Hospital; University of Sheffield; University of Bremen	Schmid, P (corresponding author), Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, Charing Cross Hosp Campus,Fulham Palace Rd, London W6 8RF, England.	p.schmid@imperial.ac.uk; m.seckl@imperial.ac.uk	Schmid, Peter/AAE-2788-2019	Fisher, Rosemary/0000-0002-2721-8726; Savage, Philip/0000-0002-4792-6869; Sebire, Neil/0000-0001-5348-9063	National Commissioning Group; Cancer Research UK; Department of Health Imperial College London Experimental Cancer Medicine Centre; Biomedical Research Centre at Impefial College London	National Commissioning Group; Cancer Research UK(Cancer Research UK); Department of Health Imperial College London Experimental Cancer Medicine Centre; Biomedical Research Centre at Impefial College London	This study was funded by the National Commissioning Group. We thank Cancer Research UK, the Department of Health Imperial College London Experimental Cancer Medicine Centre, and our Biomedical Research Centre at Impefial College London for grant support; and John Tidy, Richard Smith, and Angus McIndoe for their surgical management.	Baergen RN, 2006, GYNECOL ONCOL, V100, P511, DOI 10.1016/j.ygyno.2005.08.058; Berkowitz RS, 2009, GYNECOL ONCOL, V112, P654, DOI 10.1016/j.ygyno.2008.09.005; Bower M, 1997, J CLIN ONCOL, V15, P2636, DOI 10.1200/JCO.1997.15.7.2636; Chang YL, 1999, GYNECOL ONCOL, V73, P216, DOI 10.1006/gyno.1999.5344; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ECKSTEIN RP, 1982, HISTOPATHOLOGY, V6, P211, DOI 10.1111/j.1365-2559.1982.tb02716.x; Feltmate CM, 2001, GYNECOL ONCOL, V82, P415, DOI 10.1006/gyno.2001.6265; FISHER RA, 1992, BRIT J CANCER, V65, P355, DOI 10.1038/bjc.1992.72; Hassadia A, 2005, GYNECOL ONCOL, V99, P603, DOI 10.1016/j.ygyno.2005.06.054; KURMAN RJ, 1976, CANCER, V38, P1214, DOI 10.1002/1097-0142(197609)38:3<1214::AID-CNCR2820380323>3.0.CO;2-J; Leiserowitz GS, 1996, OBSTET GYNECOL, V88, P696, DOI 10.1016/0029-7844(96)00124-X; Machtinger R, 2005, GYNECOL ONCOL, V96, P56, DOI 10.1016/j.ygyno.2004.08.049; Newlands ES, 1998, J REPROD MED, V43, P53; Newlands ES, 2000, J CLIN ONCOL, V18, P854, DOI 10.1200/JCO.2000.18.4.854; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Papadopoulos AJ, 2002, J REPROD MED, V47, P460; Pfeffer PE, 2007, LANCET ONCOL, V8, P744, DOI 10.1016/S1470-2045(07)70243-7; Powles T, 2006, BRIT J CANCER, V94, P51, DOI 10.1038/sj.bjc.6602899; Savage P, 2008, J REPROD MED, V53, P774; SCULLY RE, 1981, AM J SURG PATHOL, V5, P75, DOI 10.1097/00000478-198101000-00010; Tsuji Y, 2002, GYNECOL ONCOL, V87, P303, DOI 10.1006/gyno.2002.6827; TWIGGS LB, 1981, GYNECOL ONCOL, V12, P238, DOI 10.1016/0090-8258(81)90153-0; Wang J, 2008, ANN ONCOL, V19, P1578, DOI 10.1093/annonc/mdn181	24	148	160	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					48	55		10.1016/S0140-6736(09)60618-8	http://dx.doi.org/10.1016/S0140-6736(09)60618-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19552948				2022-12-24	WOS:000267768800033
J	Ringstad, N; Abe, N; Horvitz, HR				Ringstad, Niels; Abe, Namiko; Horvitz, H. Robert			Ligand-Gated Chloride Channels Are Receptors for Biogenic Amines in C-elegans	SCIENCE			English	Article							ION CHANNELS; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; IDENTIFICATION; SUPERFAMILY; MEMBRANE; SYNAPSE	Biogenic amines such as serotonin and dopamine are intercellular signaling molecules that function widely as neurotransmitters and neuromodulators. We have identified in the nematode Caenorhabditis elegans three ligand-gated chloride channels that are receptors for biogenic amines: LGC-53 is a high-affinity dopamine receptor, LGC-55 is a high-affinity tyramine receptor, and LGC-40 is a low-affinity serotonin receptor that is also gated by choline and acetylcholine. lgc-55 mutants are defective in a behavior that requires endogenous tyramine, which indicates that this ionotropic tyramine receptor functions in tyramine signaling in vivo. Our studies suggest that direct activation of membrane chloride conductances is a general mechanism of action for biogenic amines in the modulation of C. elegans behavior.	[Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NIH [GM24663]; Howard Hughes Medical Institute; Life Sciences Research Foundation; The Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Life Sciences Research Foundation; The Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM24663. N.R. received support from the Howard Hughes Medical Institute, the Life Sciences Research Foundation and The Medical Foundation. H.R.H. is an Investigator of the Howard Hughes Medical Institute.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529; Cooper J., 2003, BIOCH BASIS NEUROPHA; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Green KA, 1997, PFLUG ARCH EUR J PHY, V434, P313, DOI 10.1007/s004240050402; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Magoski NS, 1999, J NEUROPHYSIOL, V81, P1330, DOI 10.1152/jn.1999.81.3.1330; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; TECOTT LH, 2003, COMPREHENSIVE TXB PS, P49; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	21	75	79	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					96	100		10.1126/science.1169243	http://dx.doi.org/10.1126/science.1169243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574391	Green Submitted, Green Accepted			2022-12-24	WOS:000267594000044
J	Smith, PH; Tamppari, LK; Arvidson, RE; Bass, D; Blaney, D; Boynton, WV; Carswell, A; Catling, DC; Clark, BC; Duck, T; DeJong, E; Fisher, D; Goetz, W; Gunnlaugsson, HP; Hecht, MH; Hipkin, V; Hoffman, J; Hviid, SF; Keller, HU; Kounaves, SP; Lange, CF; Lemmon, MT; Madsen, MB; Markiewicz, WJ; Marshall, J; Mckay, CP; Mellon, MT; Ming, DW; Morris, RV; Pike, WT; Renno, N; Staufer, U; Stoker, C; Taylor, P; Whiteway, JA; Zent, AP				Smith, P. H.; Tamppari, L. K.; Arvidson, R. E.; Bass, D.; Blaney, D.; Boynton, W. V.; Carswell, A.; Catling, D. C.; Clark, B. C.; Duck, T.; DeJong, E.; Fisher, D.; Goetz, W.; Gunnlaugsson, H. P.; Hecht, M. H.; Hipkin, V.; Hoffman, J.; Hviid, S. F.; Keller, H. U.; Kounaves, S. P.; Lange, C. F.; Lemmon, M. T.; Madsen, M. B.; Markiewicz, W. J.; Marshall, J.; Mckay, C. P.; Mellon, M. T.; Ming, D. W.; Morris, R. V.; Pike, W. T.; Renno, N.; Staufer, U.; Stoker, C.; Taylor, P.; Whiteway, J. A.; Zent, A. P.			H2O at the Phoenix Landing Site	SCIENCE			English	Article							MARS; ICE; DIFFUSION; BEHAVIOR	The Phoenix mission investigated patterned ground and weather in the northern arctic region of Mars for 5 months starting 25 May 2008 (solar longitude between 76.5 degrees and 148 degrees). A shallow ice table was uncovered by the robotic arm in the center and edge of a nearby polygon at depths of 5 to 18 centimeters. In late summer, snowfall and frost blanketed the surface at night; H2O ice and vapor constantly interacted with the soil. The soil was alkaline (pH = 7.7) and contained CaCO3, aqueous minerals, and salts up to several weight percent in the indurated surface soil. Their formation likely required the presence of water.	[Smith, P. H.; Boynton, W. V.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Tamppari, L. K.; Bass, D.; Blaney, D.; DeJong, E.; Hecht, M. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Arvidson, R. E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Carswell, A.] Optech Inc, Vaughan, ON L4K 5Z8, Canada; [Catling, D. C.] Univ Bristol, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Duck, T.] Dalhousie Univ, Halifax, NS B3H 1Z9, Canada; [Fisher, D.] Geol Survey Canada, Ottawa, ON K1A 0E8, Canada; [Fisher, D.] Univ Ottawa, Ottawa, ON K1A 0E8, Canada; [Goetz, W.; Hviid, S. F.; Keller, H. U.; Markiewicz, W. J.] Max Planck Inst Solar Syst Res, D-31791 Katlenburg Lindau, Germany; [Gunnlaugsson, H. P.] Univ Aarhus, Inst Phys & Astron, DK-8000 Aarhus C, Denmark; [Hipkin, V.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Hoffman, J.] Univ Texas Dallas, Richardson, TX 75080 USA; [Kounaves, S. P.] Tufts Univ, Medford, MA 02155 USA; [Lange, C. F.] Univ Alberta, Edmonton, AB T6G 2H1, Canada; [Lemmon, M. T.] Texas A&M Univ, College Stn, TX 77843 USA; [Madsen, M. B.] Univ Copenhagen, DK-2100 Copenhagen, Denmark; [Marshall, J.] SETI Inst, Mountain View, CA 94043 USA; [Mckay, C. P.; Stoker, C.; Zent, A. P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Mellon, M. T.] Univ Colorado, Boulder, CO 80309 USA; [Ming, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Pike, W. T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Renno, N.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Staufer, U.] Univ Neuchatel, Inst Microtechnol, CH-2002 Neuchatel, Switzerland; [Staufer, U.] Delft Univ Technol, Micro & Nano Engn Lab, NL-2628 CD Delft, Netherlands; [Taylor, P.; Whiteway, J. A.] York Univ, Toronto, ON M3J 1P3, Canada	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Washington University (WUSTL); University of Bristol; University of Washington; University of Washington Seattle; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Ottawa; Max Planck Society; Aarhus University; Canadian Space Agency; University of Texas System; University of Texas Dallas; Tufts University; University of Alberta; Texas A&M University System; Texas A&M University College Station; University of Copenhagen; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Michigan System; University of Michigan; Imperial College London; University of Neuchatel; Delft University of Technology; York University - Canada	Smith, PH (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	psmith@lpl.arizona.edu	Lemmon, Mark T/E-9983-2010; Blaney, Diana/M-1756-2019; Stoker, Carol/ABE-1381-2021; Mellon, Michael/C-3456-2016; Catling, David C/D-2082-2009; Lemmon, Mark/X-2333-2019; Staufer, Urs/J-6866-2016; Madsen, Morten Bo/D-2082-2011; Gunnlaugsson, Haraldur/L-6535-2016	Lemmon, Mark T/0000-0002-4504-5136; Blaney, Diana/0000-0002-4267-7939; Stoker, Carol/0000-0001-7265-292X; Lemmon, Mark/0000-0002-4504-5136; Staufer, Urs/0000-0002-3519-6467; Madsen, Morten Bo/0000-0001-8909-5111; Gunnlaugsson, Haraldur/0000-0002-8958-0245; Kounaves, Samuel/0000-0002-2629-4831; Hecht, Michael/0000-0002-4114-4583; Catling, David/0000-0001-5646-120X	NASA; Canadian Space Agency; STFC [PP/D002354/1, PP/D002192/1, ST/G008485/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G008485/1, PP/D002354/1, PP/D002192/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Canadian Space Agency(Canadian Space Agency); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Funding for Research came from NASA and the Canadian Space Agency.	Arvidson R, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003021; Bonitz RG, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003030; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Feldman WC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028936; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Mellon MT, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003039; Mellon MT, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003067; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mitrofanov IG, 2003, SCIENCE, V300, P2081, DOI 10.1126/science.1084350; RENNO N, 2009, LUNAR PLANET SCI C, V40; Seelos KD, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003088; Smith PH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003083; Tanaka K.L., 2005, 2888 US GEOL SURV SC; Whiteway JA, 2009, SCIENCE, V325, P68, DOI 10.1126/science.1172344; Whiteway J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003002; Zent A, 2008, ICARUS, V196, P385, DOI 10.1016/j.icarus.2007.12.028; [No title captured]	23	380	389	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					58	61		10.1126/science.1172339	http://dx.doi.org/10.1126/science.1172339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574383				2022-12-24	WOS:000267594000032
J	Checkley, DM; Dickson, AG; Takahashi, M; Radich, JA; Eisenkolb, N; Asch, R				Checkley, David M., Jr.; Dickson, Andrew G.; Takahashi, Motomitsu; Radich, J. Adam; Eisenkolb, Nadine; Asch, Rebecca			Elevated CO2 Enhances Otolith Growth in Young Fish	SCIENCE			English	Article							OCEAN ACIDIFICATION		[Checkley, David M., Jr.; Dickson, Andrew G.; Takahashi, Motomitsu; Radich, J. Adam; Eisenkolb, Nadine; Asch, Rebecca] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Checkley, DM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA.	dcheckley@ucsd.edu			Academic Senate of the University of California, San Diego; Division Of Ocean Sciences [0752972] Funding Source: National Science Foundation	Academic Senate of the University of California, San Diego; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Hubbs-SeaWorld Research Institute for providing fertilized fish eggs. E. York assisted with electron microscopy. V. Fabry, G. Somero, V. Vaquier, and two anonymous reviewers improved the manuscript. Supported by the Academic Senate of the University of California, San Diego. Data available at http://repositories.cdlib.org/sio/techreport/97/.	Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gagliano M, 2008, P R SOC B, V275, P527, DOI 10.1098/rspb.2007.1388; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelster B, 1999, COMP BIOCHEM PHYS A, V124, P407, DOI 10.1016/S1095-6433(99)00132-4; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156	6	159	166	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1683	1683		10.1126/science.1169806	http://dx.doi.org/10.1126/science.1169806			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556502				2022-12-24	WOS:000267338200031
J	Subramaniam, S; Sixt, KM; Barrow, R; Snyder, SH				Subramaniam, Srinivasa; Sixt, Katherine M.; Barrow, Roxanne; Snyder, Solomon H.			Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity	SCIENCE			English	Article							KNOCK-IN MICE; BEHAVIORAL ABNORMALITIES; INTRANUCLEAR INCLUSIONS; NEURONAL DEATH; MOUSE MODEL; CELL-DEATH; DISEASE; DEXRAS1; NUCLEAR; RAS	Huntington's disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD neuropathology is largely restricted to the corpus striatum. We report that the small guanine nucleotide-binding protein Rhes, which is localized very selectively to the striatum, binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt, which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized neuropathology of HD.	[Subramaniam, Srinivasa; Sixt, Katherine M.; Barrow, Roxanne; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			USPHS [MH18501]; Research Scientist Award [DA00074]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank I. Rao, A. Hayashi, K. Ishizuka and M. Chakraborty for technical support. We thank N. Shahani and R. Mealer for critically reading the manuscript. We thank E. Fossale and M. Macdonald for generously providing striatal cell lines. We thank M. Matunis for providing SUMO-related constructs, H. Zoghbi for ataxin constructs, S. Li and X. J.Li for purified Htt, J. Nathans for use of his cell culture facility and Alessandro Usiello for providing antibody to Rhes. Supported by USPHS grant MH18501 and Research Scientist Award DA00074 (SHS).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; USUI H, 1994, J NEUROSCI, V14, P4915; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	29	242	252	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1327	1330		10.1126/science.1172871	http://dx.doi.org/10.1126/science.1172871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498170	Green Accepted			2022-12-24	WOS:000266635100046
J	Sudlow, C; Warlow, C				Sudlow, Cathie; Warlow, Charles			Getting the priorities right for stroke care	BRITISH MEDICAL JOURNAL			English	Editorial Material							CASE-FATALITY; POPULATION; MORTALITY; UK		[Sudlow, Cathie; Warlow, Charles] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sudlow, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk	Sudlow, Cathie LM/F-3420-2010	Sudlow, Cathie/0000-0002-7725-7520	Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYLE R, 2009, NATL STROKE STRATEGY; Coombes R, 2005, BRIT MED J, V331, P1161, DOI 10.1136/bmj.331.7526.1161; Department of Health, 2007, NAT STROK STRAT; Department of Health, 2005, RED BRAIN DAM FAST A; Dudley N, 2008, AGE AGEING, V37, P236, DOI 10.1093/ageing/afm199; Govan L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub2; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; Healthcare for London, 2008, STROK STRAT LOND; *KINGS COLL LOND, 2005, EC BURD STROK ENGL; Markus H, 2007, BRIT MED J, V335, P359, DOI 10.1136/bmj.39296.711563.AD; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; *ROYAL COLL PHYS C, 2009, NAT SENT STROK AUD P; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; WARLOW C, 2008, STROKE PRACTICAL MAN, P509; 2009, BMJ, V57; 3 INT STROKE TRIAL; 2009, DRUG THER B, V47, P14	22	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 4	2009	338								b2083	10.1136/bmj.b2083	http://dx.doi.org/10.1136/bmj.b2083			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502221				2022-12-24	WOS:000266726400004
J	Wakabi, W				Wakabi, Wairagala			West African meningitis outbreak strains vaccine supplies	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1836	1836		10.1016/S0140-6736(09)61008-4	http://dx.doi.org/10.1016/S0140-6736(09)61008-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504666				2022-12-24	WOS:000266616400013
J	Liu, Y; Ye, XC; Jiang, F; Liang, CY; Chen, DM; Peng, JM; Kinch, LN; Grishin, NV; Liu, QH				Liu, Ying; Ye, Xuecheng; Jiang, Feng; Liang, Chunyang; Chen, Dongmei; Peng, Junmin; Kinch, Lisa N.; Grishin, Nick V.; Liu, Qinghua			C3PO, an Endoribonuclease That Promotes RNAi by Facilitating RISC Activation	SCIENCE			English	Article							DROSOPHILA TRANSLIN; SIRNA; MECHANISMS; ARGONAUTE2; COMPLEXES; PROTEIN; CLEAVES; MUTANT; STRAND; R2D2	The catalytic engine of RNA interference (RNAi) is the RNA-induced silencing complex (RISC), wherein the endoribonuclease Argonaute and single-stranded small interfering RNA (siRNA) direct target mRNA cleavage. We reconstituted long double-stranded RNA-and duplex siRNA-initiated RISC activities with the use of recombinant Drosophila Dicer-2, R2D2, and Ago2 proteins. We used this core reconstitution system to purify an RNAi regulator that we term C3PO (component 3 promoter of RISC), a complex of Translin and Trax. C3PO is a Mg2+-dependent endoribonuclease that promotes RISC activation by removing siRNA passenger strand cleavage products. These studies establish an in vitro RNAi reconstitution system and identify C3PO as a key activator of the core RNAi machinery.	[Liu, Ying; Ye, Xuecheng; Jiang, Feng; Liang, Chunyang; Kinch, Lisa N.; Grishin, Nick V.; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, QH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	qinghua.liu@utsouthwestern.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Kinch, Lisa/0000-0003-3041-2615	Sara and Frank McKnight fellowship; Welch [I-1608, AG025688, GM078163, GM084010]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078163, R01GM084010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Sara and Frank McKnight fellowship; Welch(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a Sara and Frank McKnight fellowship (Y.L.), Welch grant I-1608 and NIH grant AG025688 (J.P.), and NIH grants GM078163 and GM084010 (Q.L.).	Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Paroo Z, 2007, CELL RES, V17, P187, DOI 10.1038/sj.cr.7310148; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiura I, 2004, ACTA CRYSTALLOGR D, V60, P674, DOI 10.1107/S0907444904002549; Suseendranathan K, 2007, EUR J CELL BIOL, V86, P173, DOI 10.1016/j.ejcb.2006.11.005; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l	19	180	187	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					750	753		10.1126/science.1176325	http://dx.doi.org/10.1126/science.1176325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661431	Green Accepted			2022-12-24	WOS:000268723700050
J	Carlile, A				Carlile, Alex			Assisted Suicide The law as it stands on assisted suicide could not be clearer	BRITISH MEDICAL JOURNAL			English	Editorial Material												carlileqc@aol.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 5	2009	339								b3169	10.1136/bmj.b3169	http://dx.doi.org/10.1136/bmj.b3169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481KD	19656830				2022-12-24	WOS:000268808000009
J	Kalaszczynska, I; Geng, Y; Iino, T; Mizuno, SI; Choi, Y; Kondratiuk, I; Silver, DP; Wolgemuth, DJ; Akashi, K; Sicinski, P				Kalaszczynska, Ilona; Geng, Yan; Iino, Tadafumi; Mizuno, Shin-ichi; Choi, Yoon; Kondratiuk, Ilona; Silver, Daniel P.; Wolgemuth, Debra J.; Akashi, Koichi; Sicinski, Piotr			Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells	CELL			English	Article							DEPENDENT KINASES; C-MYC; EXPRESSION; PROGRESSION; GENE; MICE; MOUSE; PROLIFERATION; ACCUMULATION; PROGENITOR	Cyclins are regulatory subunits of cyclin-dependent kinases. Cyclin A, the first cyclin ever cloned, is thought to be an essential component of the cell-cycle engine. Mammalian cells encode two A-type cyclins, testis-specific cyclin A1 and ubiquitously expressed cyclin A2. Here, we tested the requirement for cyclin A function using conditional knockout mice lacking both A-type cyclins. We found that acute ablation of cyclin A in fibroblasts did not affect cell proliferation, but led to prolonged expression of another cyclin, cyclin E, across the cell cycle. However, combined ablation of all A- and E-type cyclins extinguished cell division. In contrast, cyclin A function was essential for cell-cycle progression of hematopoietic and embryonic stem cells. Expression of cyclin A is particularly high in these compartments, which might render stem cells dependent on cyclin A, whereas in fibroblasts cyclins A and E play redundant roles in cell proliferation.	[Kalaszczynska, Ilona; Geng, Yan; Choi, Yoon; Kondratiuk, Ilona; Sicinski, Piotr] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Iino, Tadafumi; Mizuno, Shin-ichi; Akashi, Koichi] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Silver, Daniel P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kalaszczynska, Ilona; Geng, Yan; Iino, Tadafumi; Mizuno, Shin-ichi; Choi, Yoon; Kondratiuk, Ilona; Akashi, Koichi; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Silver, Daniel P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wolgemuth, Debra J.] Columbia Univ, Ctr Med, Dept Genet & Dev, New York, NY 10032 USA; [Wolgemuth, Debra J.] Columbia Univ, Ctr Med, Dept Obstet & Gynecol, New York, NY 10032 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	peter_sicinski@dfci.harvard.edu	Silver, Daniel/P-3443-2019; Kalaszczynska, Ilona/AAG-4832-2021; Kondratiuk, Ilona/M-7078-2018	Kalaszczynska, Ilona/0000-0001-6698-1372; Kondratiuk, Ilona/0000-0002-7740-8923	National Institutes of Health [R01CA132740, R01CA108950, R01 HD34915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034915] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA132740, R01CA108950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Sicinski lab, R. Bronson, E. Sicinska, M. A. Ciemerych-Litwinienko, A. Minamishima, S. Kobayashi, and B. Will for help and advice, B. Clurman for anti-cyclin E1 antibody, and F. Liu for anti-phospho Smad3 antibodies. This work was supported by R01CA132740 and R01CA108950 grants from the National Institutes of Health (to P. S.) and R01 HD34915 (to D. J. W.). P. S. is a Scholar of The Leukemia and Lymphoma Society.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BARRETT JF, 1995, J BIOL CHEM, V270, P15923, DOI 10.1074/jbc.270.27.15923; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LI W, 2009, TRANSGENIC IN PRESS, DOI DOI 10.1007/S11248-009-9276-X; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nieduszynski CA, 2002, GENOME BIOL, V3; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Sweeney C, 1996, DEVELOPMENT, V122, P53; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; van der Meer T, 2004, REPRODUCTION, V127, P503, DOI 10.1530/rep.1.00131; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang JJ, 1997, J BIOL CHEM, V272, P3103, DOI 10.1074/jbc.272.5.3103; Yang R, 1997, CANCER RES, V57, P913; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G	48	156	159	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					352	365		10.1016/j.cell.2009.04.062	http://dx.doi.org/10.1016/j.cell.2009.04.062			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19592082	Green Accepted, Bronze			2022-12-24	WOS:000268277000016
J	Neuman, P; Cubanski, J				Neuman, Patricia; Cubanski, Juliette			Medicare Part D Update - Lessons Learned and Unfinished Business	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRESCRIPTION-DRUG BENEFIT; NATIONAL-SURVEY; COVERAGE; BENEFICIARIES; NONADHERENCE; SENIORS		[Neuman, Patricia; Cubanski, Juliette] Henry J Kaiser Family Fdn, Medicare Policy Project, Washington, DC USA		Neuman, P (corresponding author), Henry J Kaiser Family Fdn, Medicare Policy Project, Washington, DC USA.							Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; Altman DE, 2004, NEW ENGL J MED, V350, P9, DOI 10.1056/NEJMp038224; [Anonymous], 2007, 2007 ANN REP BOARDS; *AV HLTH, 2008, AV BEN TOP 10 PDPS F; BERNDT ER, 2007, SURV CURR BUS, V87, P59; *CTR MED MED SERV, 2009, 2009 ENR INF; *CTR MED MED SERV, 2008, THINGS THINK YOU COM; Cubanski J, 2007, HEALTH AFFAIR, V26, pW1, DOI 10.1377/hlthaff.26.1.w1; DANZON P, 2004, HLTH AFF MILLWOOD S; *DAT CTR MED MED S, 2004, PRESCR MED MOD MED D; DUGGAN M, 2008, 13917 NBER; Dulio A., 2007, VOICES BENEFICIARIES; *FAM US, 2007, NO BARG MED DRUG PLA; Frank RG, 2008, HEALTH AFFAIR, V27, P33, DOI 10.1377/hlthaff.27.1.33; GRUBER J, 2009, MEDICARE BENEFICIARI; HARGRAVE E, 2009, 091 MED PAYM ADV COM; HARGRAVE E, 2009, MEDICARE PRESCRIPTIO; HEATON E, 2006, ASSESSING MEDICARE P; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; HOADLEY J, 2008, MED PAY ADV COMM DEC; Hoadley J, 2008, MEDICARE D; Iglehart JK, 2004, NEW ENGL J MED, V350, P826, DOI 10.1056/NEJMhpr045002; Ketcham J. D., 2008, 14326 NBER; LEVY H, 2009, 14692 NBER; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Neuman P, 2007, HEALTH AFFAIR, V26, pW630, DOI 10.1377/hlthaff.26.5.w630; *OFF INSP GEN, 2009, PUBL OFF INSP GEN; PEAR R, 2003, NY TIMES        0607; Raebel MA, 2008, MED CARE, V46, P1116, DOI 10.1097/MLR.0b013e318185cddd; Regan JF, 2007, HEALTH CARE FINANC R, V29, P119; RICE T, 2008, ACADEMYHEALTH ANN RE; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Schneeweiss S, 2009, HEALTH AFFAIR, V28, pW305, DOI 10.1377/hlthaff.28.2.w305; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Summer L, 2008, MEDICARE D; The Boards of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2004, 2004 ANN REP BOARDS; The Boards of Trustees Federal Hospital Insurance and Federal Supplemetary Medical Insurance Trust Funds, 2008, 2008 ANN REP BOARDS; US House of Representatives. Committee on Oversight and Government Reform, 2008, MED D; WILL GF, 2008, WASHINGTON POST 0921, pB7; Yin W, 2008, ANN INTERN MED, V148, P169, DOI 10.7326/0003-4819-148-3-200802050-00200; Zhang Y, 2009, HEALTH AFFAIR, V28, pW317, DOI 10.1377/hlthaff.28.2.w317; 2008, NY TIMES        0902	44	37	37	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					406	414		10.1056/NEJMhpr0809949	http://dx.doi.org/10.1056/NEJMhpr0809949			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DC	19625722				2022-12-24	WOS:000268184500014
J	Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM				Chew, Su Kit; Chen, Po; Link, Nichole; Galindo, Kathleen A.; Pogue, Kristi; Abrams, John M.			Genome-wide silencing in Drosophila captures conserved apoptotic effectors	NATURE			English	Article							APICAL CASPASE DRONC; CELL-DEATH; CYTOCHROME-C; RNA INTERFERENCE; ACTIVATION; PROTEIN; PATHWAYS; GROWTH; ASSAYS; DIAP1	Apoptosis is a conserved form of programmed cell death firmly established in the aetiology, pathogenesis and treatment of many human diseases. Central to the core machinery of apoptosis are the caspases and their proximal regulators. Current models for caspase control involve a balance of opposing elements, with variable contributions from positive and negative regulators among different cell types and species(1). To advance a comprehensive view of components that support caspase-dependent cell death, we conducted a genome-wide silencing screen in the Drosophila model. Our strategy used a library of double-stranded RNAs together with a chemical antagonist of Inhibitor of apoptosis proteins (IAPs) that simulates the action of native regulators in the Reaper and Smac (also known as Diablo) families(2). Here we present a highly validated set of targets that is necessary for death provoked by several stimuli. Among these, Tango7 is identified as a new effector. Cells depleted for this gene resisted apoptosis at a step before the induction of effector caspase activity, and the directed silencing of Tango7 in Drosophila prevented caspase-dependent programmed cell death. Unlike known apoptosis regulators in this model system(3), Tango7 activity did not influence stimulus-dependent loss of Drosophila DIAP1 (also known as th and IAP1), but instead regulated levels of the apical caspase Dronc (Nc). Similarly, the human Tango7 counterpart, PCID1 (also known as EIF3M), impinged on caspase 9, revealing a new regulatory axis affecting the apoptosome.	[Chew, Su Kit; Chen, Po; Link, Nichole; Galindo, Kathleen A.; Pogue, Kristi; Abrams, John M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu			National Institute of General Medical Sciences; National Institute on Alcohol Abuse and Alcoholism; UTSW High Impact/High Risk Grant Program; National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124, R56GM072124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017328] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); UTSW High Impact/High Risk Grant Program; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank X. Tu, L. Durham, L. Lum, P. Beachy, M. Roth, X. Wang, P. Harran, Y. Lazebnik, D. Dorris, the University of Texas Southwestern Medical Center (UTSW) High Throughput Screening laboratory and the Live Cell Imaging facility for technical and material support; Bloomington Stock Center, K. Basler, National Institute of Genetics (NIG) stock center (Japan) for fly lines; K. White, B. Hay and the Hybridoma Bank for antibodies; V. Malhotra for the pMT-Tango7 plasmid; J. Seeman and the Wang laboratory for discussions; and M. Allen for administrative support. This work was supported by grants from the National Institute of General Medical Sciences, the National Institute on Alcohol Abuse and Alcoholism and the UTSW High Impact/High Risk Grant Program. N. L. is supported by a National Research Service Award.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Link N, 2007, J CELL BIOL, V178, P567, DOI 10.1083/jcb.200702125; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matapurkar A, 2006, CELL DEATH DIFFER, V13, P2062, DOI 10.1038/sj.cdd.4401968; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Perez A, 2005, J VIROL, V79, P7419, DOI 10.1128/JVI.79.12.7419-7430.2005; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Weinmann L, 2008, CELL DEATH DIFFER, V15, P718, DOI 10.1038/sj.cdd.4402301; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	29	27	30	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					123	U141		10.1038/nature08087	http://dx.doi.org/10.1038/nature08087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19483676	Green Accepted			2022-12-24	WOS:000267545200042
J	Roth, J				Roth, Jesse			Evolutionary Speculation About Tuberculosis and the Metabolic and Inflammatory Processes of Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION		[Roth, Jesse] Yeshiva Univ, Albert Einstein Coll Med, Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA	Northwell Health; Yeshiva University	Roth, J (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, 149-37 Powells Cove Blvd, Whitestone, NY 11357 USA.	jesserothmd@hotmail.com						BALDWIN ER, 1907, MODERN MED ITS THEOR, V3, P137; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Osler W, 1892, PRINCIPLES PRACTICE; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Ryan F, 1994, FORGOTTEN PLAGUE BAT; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	15	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2586	2588		10.1001/jama.2009.930	http://dx.doi.org/10.1001/jama.2009.930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549976				2022-12-24	WOS:000267266500024
J	Desai, M; Nolte, E; Mays, N; Nikolentzos, A				Desai, Monica; Nolte, Ellen; Mays, Nicholas; Nikolentzos, Athanasios			International experience of paying for expensive medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CELL LUNG-CANCER; CHEMOTHERAPY		[Nolte, Ellen; Mays, Nicholas] Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Nolte, E (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	enolte@rand.org		Nolte, Ellen/0000-0002-2289-117X	National Institute for Health Research [ACF-2008-20-002] Funding Source: researchfish; Department of Health [0510002] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		APPLEBY J, 2008, BMJ-BRIT MED J, V337, P1122; Chu DT, 2007, LUNG CANCER, V56, P433, DOI 10.1016/j.lungcan.2007.01.028; Clarke R, 2008, CLIN ONCOL-UK, V20, P771, DOI 10.1016/j.clon.2008.09.005; Department of Health, 2009, GUID NHS PAT WHO WIS; Department of Health, 2004, COD COND PRIV PRACT; DoHSC (Department of Health & Social Care), 2021, NHS CONST ENGL; FLOOD C, 2007, MCGILL HLTH LAW PUBL, V1, P7; Gubb J, 2008, BMJ-BRIT MED J, V336, P1104, DOI [10.1136/bmj.39563.453183.AD, 10.1136/bmj.39563.493218.AD]; KHOO K, 2007, REPORT CARD CANC CAN, V10, P40; *NAT I HLTH CLIN E, APPR LIF EXT END LIF; NIKOLENTZOS A, PAYING EXPENSIVE DRU; *PROV WORK GROUP, 2006, REP PROV WORK GROUP; *RAR CANC FOR, 2008, TAK EXC AUD POL PROC; Richards M, 2008, IMPROVING ACCESS MED; SATCHELL G, 2008, BBC NEWS        1223; Silvestri G, 1998, BRIT MED J, V317, P771, DOI 10.1136/bmj.317.7161.771; TEMPLETON S, 2008, SUNDAY TIMES    0601; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	18	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2009	338								b1993	10.1136/bmj.b1993	http://dx.doi.org/10.1136/bmj.b1993			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WV	19482871	Green Accepted			2022-12-24	WOS:000266502500003
J	Gao, CQ				Gao, Chang-Qing			Taking Responsibility for Lung Cancer	ANNALS OF INTERNAL MEDICINE			English	Article									Cent S Univ, Third Hosp Xiangya Sch Med, Changsha, Hunan 410013, Peoples R China	Central South University	Gao, CQ (corresponding author), Cent S Univ, Third Hosp Xiangya Sch Med, Tongzipo Rd 138, Changsha, Hunan 410013, Peoples R China.	cgao9@yahoo.com							0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					214	215		10.7326/0003-4819-151-3-200907210-00012	http://dx.doi.org/10.7326/0003-4819-151-3-200907210-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19652189				2022-12-24	WOS:000268947800016
J	Nagpal, P; Lindquist, NC; Oh, SH; Norris, DJ				Nagpal, Prashant; Lindquist, Nathan C.; Oh, Sang-Hyun; Norris, David J.			Ultrasmooth Patterned Metals for Plasmonics and Metamaterials	SCIENCE			English	Article							SURFACE-PLASMONS; NANOSTRUCTURES; SPECTROSCOPY; POLARITONS; INDEX; LIGHT	Surface plasmons are electromagnetic waves that can exist at metal interfaces because of coupling between light and free electrons. Restricted to travel along the interface, these waves can be channeled, concentrated, or otherwise manipulated by surface patterning. However, because surface roughness and other inhomogeneities have so far limited surface-plasmon propagation in real plasmonic devices, simple high-throughput methods are needed to fabricate high-quality patterned metals. We combined template stripping with precisely patterned silicon substrates to obtain ultrasmooth pure metal films with grooves, bumps, pyramids, ridges, and holes. Measured surface-plasmon-propagation lengths on the resulting surfaces approach theoretical values for perfectly flat films. With the use of our method, we demonstrated structures that exhibit Raman scattering enhancements above 10(7) for sensing applications and multilayer films for optical metamaterials.	[Nagpal, Prashant; Norris, David J.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Lindquist, Nathan C.; Oh, Sang-Hyun] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Norris, DJ (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	dnorris@umn.edu	Nagpal, Prashant/G-7802-2012; Norris, David J/F-4022-2010	Norris, David J/0000-0002-3765-0678; Oh, Sang-Hyun/0000-0002-6992-5007; NAGPAL, PRASHANT/0000-0002-7966-2554	U.S. Department of Energy [DE-FG02- 06ER46438]; Institute of Technology at the University of Minnesota; Minnesota Partnership for Biotechnology; 3M; University of Minnesota; NIH	U.S. Department of Energy(United States Department of Energy (DOE)); Institute of Technology at the University of Minnesota(University of Minnesota System); Minnesota Partnership for Biotechnology; 3M(3M); University of Minnesota(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. Department of Energy (grant DE-FG02- 06ER46438) and used resources in the Institute of Technology at the University of Minnesota, including the Nanofabrication Center, which receives partial support from NSF through the National Nanotechnology Infrastructure Network program, and the Characterization Facility, which has received capital equipment funding from NSF through the Materials Research Science and Engineering Center, Major Research Instrumentation, and Engineering Research Center programs. S.-H.O. acknowledges support from a Minnesota Partnership for Biotechnology Award and a 3M Non-Tenured Faculty Award. P.N. and N.C.L. acknowledge support from a University of Minnesota doctoral dissertation fellowship and an NIH Biotechnology training grant, respectively. The authors have applied for a patent on the fabricationmethods described.	Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Bantz KC, 2008, LANGMUIR, V24, P5862, DOI 10.1021/la800103b; Dolling G, 2007, OPT LETT, V32, P551, DOI 10.1364/OL.32.000551; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Frey W, 2000, ADV MATER, V12, P1515, DOI 10.1002/1521-4095(200010)12:20<1515::AID-ADMA1515>3.0.CO;2-J; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Genet C, 2007, NATURE, V445, P39, DOI 10.1038/nature05350; Graca M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777125; Haes AJ, 2005, MRS BULL, V30, P368, DOI 10.1557/mrs2005.100; Haynes CL, 2003, J PHYS CHEM B, V107, P7426, DOI 10.1021/jp027749b; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Henzie J, 2005, NANO LETT, V5, P1199, DOI 10.1021/nl0506148; Jung B, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145303; Kumar G, 2009, NATURE, V457, P868, DOI 10.1038/nature07718; Kuttge M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2987458; Loo YL, 2002, J AM CHEM SOC, V124, P7654, DOI 10.1021/ja026355v; MILLS DL, 1975, PHYS REV B, V12, P4036, DOI 10.1103/PhysRevB.12.4036; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Polman A, 2008, SCIENCE, V322, P868, DOI 10.1126/science.1163959; Raether H., 1988, SURFACE PLASMONS; Samori P, 1999, LANGMUIR, V15, P2592, DOI 10.1021/Ia981414x; SARID D, 1981, PHYS REV LETT, V47, P1927, DOI 10.1103/PhysRevLett.47.1927; SHIBA H, 1994, J PHYS SOC JPN, V63, P1400, DOI 10.1143/JPSJ.63.1400; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Temnov VV, 2007, OPT LETT, V32, P1235, DOI 10.1364/OL.32.001235; van Wijngaarden JT, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208556; Vesseur EJR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885344; Xu QB, 2004, NANO LETT, V4, P2509, DOI 10.1021/nl0484797; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m	29	702	723	16	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					594	597		10.1126/science.1174655	http://dx.doi.org/10.1126/science.1174655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644116				2022-12-24	WOS:000268493000045
J	Houghton, AM; Hartzell, WO; Robbins, CS; Gomis-Ruth, FX; Shapiro, SD				Houghton, A. McGarry; Hartzell, William O.; Robbins, Clinton S.; Xavier Gomis-Rueth, F.; Shapiro, Steven D.			Macrophage elastase kills bacteria within murine macrophages	NATURE			English	Article							NEUTROPHIL ELASTASE; MATRIX METALLOPROTEINASES; HOST-DEFENSE; GELATINASE-A; MICE; CLEAVAGE; ANGIOGENESIS; DEGRADATION; ACTIVATION; MECHANISMS	Macrophages are aptly positioned to function as the primary line of defence against invading pathogens in many organs, including the lung and peritoneum. Their ability to phagocytose and clear microorganisms has been well documented(1,2). Macrophages possess several substances with which they can kill bacteria, including reactive oxygen species, nitric oxide, and antimicrobial proteins(3-9). We proposed that macrophage-derived proteinases may contribute to the antimicrobial properties of macrophages. Macrophage elastase (also known as matrix metalloproteinase 12 or MMP12) is an enzyme predominantly expressed in mature tissue macrophages(10) and is implicated in several disease processes, including emphysema(11). Physiological functions for MMP12 have not been described. Here we show that Mmp12(-/-) mice exhibit impaired bacterial clearance and increased mortality when challenged with both Gram-negative and Gram-positive bacteria at macrophage-rich portals of entry, such as the peritoneum and lung. Intracellular stores of MMP12 are mobilized to macrophage phagolysosomes after the ingestion of bacterial pathogens. Once inside phagolysosomes, MMP12 adheres to bacterial cell walls where it disrupts cellular membranes resulting in bacterial death. The antimicrobial properties of MMP12 do not reside within its catalytic domain, but rather within the carboxyterminal domain. This domain contains a unique four amino acid sequence on an exposed beta loop of the protein that is required for the observed antimicrobial activity. The present study represents, to our knowledge, the first report of direct antimicrobial activity by a matrix metallopeptidase, and describes a new antimicrobial peptide that is sequentially and structurally unique in nature.	[Houghton, A. McGarry; Robbins, Clinton S.; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Hartzell, William O.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, E-08028 Barcelona, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Houghton, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.	houghtonm@dom.pitt.edu		Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Robbins, Clinton/0000-0001-9848-1495	National Institutes of Health (NIH); National Heart, Lung and Blood Institute (NHLBI); Spanish and European public agencies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082541] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Spanish and European public agencies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) (S. D. S.) and Spanish and European public agencies (F. X. G.-R.).	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; BIGGAR WD, 1977, INFECT IMMUN, V16, P974, DOI 10.1128/IAI.16.3.974-982.1977; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; GREEN GM, 1964, J EXP MED, V119, P167, DOI 10.1084/jem.119.1.167; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; HIEMSTRA PS, 1993, INFECT IMMUN, V61, P3038, DOI 10.1128/IAI.61.7.3038-3046.1993; Hiemstra PS, 1999, J LEUKOCYTE BIOL, V66, P423, DOI 10.1002/jlb.66.3.423; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; LEHRER RI, 1990, BLOOD, V76, P2169; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lijnen HR, 1999, THROMB HAEMOSTASIS, V81, P799; Limb GA, 2005, AM J PATHOL, V166, P1555, DOI 10.1016/S0002-9440(10)62371-1; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Raza SL, 2000, J BIOL CHEM, V275, P41243, DOI 10.1074/jbc.M005788200; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	30	118	122	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 30	2009	460	7255					637	U106		10.1038/nature08181	http://dx.doi.org/10.1038/nature08181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19536155	Green Accepted			2022-12-24	WOS:000268454300052
J	Hyder, AA; Merritt, MW				Hyder, Adnan A.; Merritt, Maria W.			Ancillary Care for Public Health Research in Developing Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL RESEARCHERS; CLINICAL CARE; RESPONSIBILITIES		[Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Ste E-8132, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Hyder, Adnan/AAT-9503-2021	Hyder, Adnan/0000-0002-7292-577X	FIC NIH HHS [D43 TW007292, R25 TW001604, R25-TW01604] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007292, R25TW001604] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2008, PLOS MED, V5, pe90; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Dickert N, 2007, LANCET, V369, P874, DOI 10.1016/S0140-6736(07)60416-4; Richardson HS, 2007, AM J PUBLIC HEALTH, V97, P1956, DOI 10.2105/AJPH.2006.093658; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Watkins Kevin., 2007, HUMAN DEV REPORT 200	6	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					429	431		10.1001/jama.2009.1072	http://dx.doi.org/10.1001/jama.2009.1072			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472NQ	19622822	Green Accepted			2022-12-24	WOS:000268139200026
J	Krasuski, RA; Hart, SA; Allen, D; Qureshi, A; Pettersson, G; Houghtaling, PL; Batizy, LH; Blackstone, E				Krasuski, Richard A.; Hart, Stephen A.; Allen, Drew; Qureshi, Athar; Pettersson, Gosta; Houghtaling, Penny L.; Batizy, Lillian H.; Blackstone, Eugene			Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL SEPTAL ANEURYSM; CRYPTOGENIC STROKE; PARADOXICAL EMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CEREBROVASCULAR EVENTS; UNEXPLAINED STROKE; ISCHEMIC-STROKE; RISK; FIBRILLATION; HYPOXEMIA	Context A recent survey suggested that cardiothoracic surgeons may alter planned procedures to repair incidentally discovered patent foramen ovale (PFO). How frequently this occurs and the impact on outcomes remain unknown. Objective To measure the frequency of incidentally discovered PFO closure during cardiothoracic surgery and determine its perioperative and long-term impact. Design, Setting, and Patients We reviewed the intraoperative transesophageal echocardiograms of 13 092 patients without prior diagnosis of PFO or atrial septal defect undergoing surgery at the Cleveland Clinic, Cleveland, Ohio, from 1995 through 2006. Postoperative outcomes were prospectively collected until discharge. Main Outcome Measures All- cause hospital mortality and stroke were predetermined primary outcomes; length of hospital stay, length of intensive care unit stay, and time on cardiopulmonary bypass were secondary outcomes. Results Intraoperative PFO was diagnosed in 2277 patients in the study population (17%), and risk factors for stroke were similar in patients with and without PFO. After propensity matching was performed with the comparator groups, patients with PFO demonstrated similar rates of in-hospital death (3.4% vs 2.6%, P=.11) and postoperative stroke (2.3% vs 2.3%, P=.84). Surgical closure was performed in 639 PFO patients (28%), and surgeons were more likely to close defects in patients who were younger (mean [SD] age, 61.1 [ 14] vs 64.4 [ 13] years; P<.001), were undergoing mitral or tricuspid valve surgery (51% vs 32%, P<.001), or had history of transient ischemic attack or stroke (16% vs 10%, P<.001). Patients with repaired PFO demonstrated a 2.47-times greater odds (95% confidence interval, 1.02-6.00) of having a postoperative stroke compared with those with unrepaired PFO (2.8% vs 1.2%, P=.04). Long-term analysis demonstrated that PFO repair was associated with no survival difference (P=.12). Conclusions Incidental PFO is common in patients undergoing cardiothoracic surgery but is not associated with increased perioperative morbidity or mortality. Surgical closure appears unrelated to long-term survival and may increase postoperative stroke risk. JAMA. 2009; 302(3):290-297 www.jama.com	[Krasuski, Richard A.] Cleveland Clin, Dept Cardiovasc Med, Sect Clin Cardiol, Cleveland, OH 44195 USA; [Hart, Stephen A.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Allen, Drew] Cleveland Clin, Dept Internal Med, Cleveland, OH 44195 USA; [Qureshi, Athar] Cleveland Clin, Dept Pediat Cardiol, Cleveland, OH 44195 USA; [Houghtaling, Penny L.; Batizy, Lillian H.; Blackstone, Eugene] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Pettersson, Gosta; Blackstone, Eugene] Cleveland Clin, Dept Cardiothorac Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Krasuski, RA (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Sect Clin Cardiol, J2-4,9500 Euclid Ave, Cleveland, OH 44195 USA.	krasusr@ccf.org	Krasuski, Richard/AAI-8177-2020	Hart, Stephen/0000-0002-1651-4511; Krasuski, Richard/0000-0003-3150-5215				Aggarwal K, 2002, J AM SOC ECHOCARDIOG, V15, P1021, DOI 10.1067/mje.2002.121279; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; BALDWIN RT, 1991, ANN THORAC SURG, V52, P865, DOI 10.1016/0003-4975(91)91230-S; Banks TA, 2002, ANN THORAC SURG, V73, P296, DOI 10.1016/S0003-4975(01)02855-7; BERGSTRALH EJ, 56 MAYO FDN; Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; Cohnheim J, 1877, THROMBOSE EMBOLIE VO; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Efron B, 1998, INTRO BOOTSTRAP; FEDULLO AJ, 1985, AM J MED SCI, V289, P164, DOI 10.1097/00000441-198504000-00007; Ferrari E, 1999, J AM COLL CARDIOL, V33, P1317, DOI 10.1016/S0735-1097(99)00003-0; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hansen A, 2008, EUR J ECHOCARDIOGR, V9, P692, DOI 10.1093/ejechocard/jen013; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hart RG, 2007, NEUROLOGY, V69, P546; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; JONES EF, 1995, STROKE, V26, P218; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; Koullias GJ, 2004, CIRCULATION, V109, P3056, DOI 10.1161/01.CIR.0000132371.91318.6D; Krasuski RA, 2007, CLEV CLIN J MED, V74, P137, DOI 10.3949/ccjm.74.2.137; Lakshminarayan K, 2008, NEUROLOGIST, V14, P143, DOI 10.1097/NRL.0b013e31815cffae; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0; Matsumura Y, 2002, Eur J Echocardiogr, V3, P8, DOI 10.1053/euje.2001.0113; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Molina Carlos A, 2007, Cerebrovasc Dis, V24 Suppl 1, P84, DOI 10.1159/000107382; Morewood GH, 2001, ANESTHESIOLOGY, V95, P1507, DOI 10.1097/00000542-200112000-00033; Opotowsky AR, 2008, JAMA-J AM MED ASSOC, V299, P521, DOI 10.1001/jama.299.5.521; Ouseph R, 1997, J AM SOC ECHOCARDIOG, V10, P973, DOI 10.1016/S0894-7317(97)80014-4; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Rigatelli G, 2008, CATHETER CARDIO INTE, V71, P573, DOI 10.1002/ccd.21390; Srivastava TN, 1997, NEW ENGL J MED, V337, P681, DOI 10.1056/NEJM199709043371005; Sukernik MR, 2007, ANESTH ANALG, V105, P602, DOI 10.1213/01.ane.0000278735.06194.0c; Sukernik MR, 2005, J CARDIOTHOR VASC AN, V19, P150, DOI 10.1053/j.jvca.2005.01.022; Thanigaraj S, 2006, EUR J ECHOCARDIOGR, V7, P179, DOI 10.1016/j.euje.2005.05.004; VANCAMP G, 1993, AM J CARDIOL, V71, P596, DOI 10.1016/0002-9149(93)90518-H; Weiss SJ, 1996, ANESTHESIOLOGY, V84, P721, DOI 10.1097/00000542-199603000-00028	41	47	47	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					290	297		10.1001/jama.2009.1012	http://dx.doi.org/10.1001/jama.2009.1012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602688	Bronze			2022-12-24	WOS:000267948100022
J	Gupta, A; Urquhart, DS; Devaraj, A; Balfour-Lynn, IM				Gupta, A.; Urquhart, D. S.; Devaraj, A.; Balfour-Lynn, I. M.			Endgames Picture quiz A 2 year old with fever and cough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMPYEMA; MANAGEMENT; CHILDREN; PNEUMONIA		[Gupta, A.; Urquhart, D. S.; Balfour-Lynn, I. M.] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England; [Devaraj, A.] Royal Brompton Hosp, Dept Radiol, London SW3 6NP, England	Royal Brompton Hospital; Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk						Bai K J, 1998, Respirology, V3, P261, DOI 10.1111/j.1440-1843.1998.tb00132.x; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Chang AB, 1996, PEDIATR PULM, V22, P207, DOI 10.1002/(SICI)1099-0496(199609)22:3<207::AID-PPUL11>3.3.CO;2-D; Clark J, 2009, ADV EXP MED BIOL, V634, P61, DOI 10.1007/978-0-387-79838-7_6; Eastham KM, 2004, THORAX, V59, P522, DOI 10.1136/thx.2003.016105; Fitzpatrick M, 2002, THORAX, V57, P1, DOI 10.1136/thorax.57.1.1; FREIJ BJ, 1984, PEDIATR INFECT DIS J, V3, P578, DOI 10.1097/00006454-198411000-00021; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Hardie W, 1996, CLIN INFECT DIS, V22, P1057, DOI 10.1093/clinids/22.6.1057; Jaffe A, 2008, THORAX, V63, P897, DOI 10.1136/thx.2007.094250; Jaffe A, 2005, PEDIATR PULM, V40, P148, DOI 10.1002/ppul.20251; King S, 2002, BRIT MED BULL, V61, P203, DOI 10.1093/bmb/61.1.203; Saglani S, 2005, ARCH DIS CHILD, V90, P70, DOI 10.1136/adc.2003.042176; Sonnappa S, 2007, PAEDIATR RESPIR REV, V8, P164, DOI 10.1016/j.prrv.2007.05.002; Spencer DA, 2006, BRIT MED J, V332, P1333, DOI 10.1136/bmj.332.7553.1333; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Thomson AH, 2002, THORAX, V57, P343, DOI 10.1136/thorax.57.4.343	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2009	339								b2150	10.1136/bmj.b2150	http://dx.doi.org/10.1136/bmj.b2150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KY	19586972				2022-12-24	WOS:000267898300001
J	Rodrigues, ASL; Ewers, RM; Parry, L; Souza, C; Verissimo, A; Balmford, A				Rodrigues, Ana S. L.; Ewers, Robert M.; Parry, Luke; Souza, Carlos, Jr.; Verissimo, Adalberto; Balmford, Andrew			Boom-and-Bust Development Patterns Across the Amazon Deforestation Frontier	SCIENCE			English	Article							LAND-USE; FOREST DEGRADATION; BRAZILIAN AMAZONIA; CONSERVATION; ENVIRONMENT; EMISSIONS; SERVICES; PASTURE; CLIMATE; BASIN	The Brazilian Amazon is globally important for biodiversity, climate, and geochemical cycles, but is also among the least developed regions in Brazil. Economic development is often pursued through forest conversion for cattle ranching and agriculture, mediated by logging. However, on the basis of an assessment of 286 municipalities in different stages of deforestation, we found a boom-and-bust pattern in levels of human development across the deforestation frontier. Relative standards of living, literacy, and life expectancy increase as deforestation begins but then decline as the frontier evolves, so that pre- and postfrontier levels of human development are similarly low. New financial incentives and policies are creating opportunities for a more sustained development trajectory that is not based on the depletion of nature and ecosystem services.	[Rodrigues, Ana S. L.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Rodrigues, Ana S. L.] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier, France; [Ewers, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Parry, Luke] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Souza, Carlos, Jr.; Verissimo, Adalberto] IMAZON Amazon Inst People & Environm, Belem, Para, Brazil	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Imperial College London; University of East Anglia	Rodrigues, ASL (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England.	ana.rodrigues@cefe.cnrs.fr	Rodrigues, Ana/GYQ-6273-2022; Parry, Luke/ABD-4194-2021; Parry, Luke/E-8244-2012; Rodrigues, Ana S.L./A-5914-2009; Souza, CARLOS/AAK-8207-2021	Parry, Luke/0000-0003-0330-9516; Rodrigues, Ana S.L./0000-0003-4775-0127; Souza, CARLOS/0000-0002-0205-6134; Balmford, Andrew/0000-0002-0144-3589	Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme; Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.); Gordon and Betty Moore Foundation; Leverhulme Trust	Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme(European Commission); Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Leverhulme Trust(Leverhulme Trust)	Supported by a Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme and by a Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.), the Gordon and Betty Moore Foundation (C.S. and A.V.), and the "Valuing the Arc" program of the Leverhulme Trust (A.B.). We thank J. Barlow, T. Gardner, R. Green, B. Strassburg, and three anonymous reviewers for valuable and constructive comments.	Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Bhattarai M, 2001, WORLD DEV, V29, P995, DOI 10.1016/S0305-750X(01)00019-5; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Celentano D., 2007, AVANCO FRONTEIRA AMA; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Diamond J, 2004, NATURE, V429, P616, DOI 10.1038/429616a; Fearnside Philip M., 1998, Forest Ecology and Management, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fearnside PM, 2008, ECOL SOC, V13; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hall A., 2008, Journal of International Development, V20, P965, DOI 10.1002/jid.1456; Hall A, 2006, J LAT AM STUD, V38, P689, DOI 10.1017/S0022216X0600157X; INPE, 2008, PROJ PRODES MON FLOR; Jacoby HG, 2000, ECON J, V110, P713, DOI 10.1111/1468-0297.00562; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; *MMA, 2009, AC MMA MUN; Muller MML, 2004, AGR ECOSYST ENVIRON, V103, P279, DOI 10.1016/j.agee.2003.12.003; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; NEPSTAD DC, 2007, COSTS BENEFITS REDUC; Rudel T., 2005, TROPICAL FORESTS REG; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Schneider R., 2000, SUSTAINABLE AMAZON L; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Tollefson J, 2008, NATURE, V452, P134, DOI 10.1038/452134a; UNDP, 2008, HUM DEV IND; *UNDP BRAZ, 2003, ATL DES HUM BRAZ; Verissimo A, 2002, SCIENCE, V297, P1478, DOI 10.1126/science.1072807; White D, 2001, AGRICULTURAL TECHNOLOGIES AND TROPICAL DEFORESTATION, P91, DOI 10.1079/9780851994512.0091	33	167	176	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1435	1437		10.1126/science.1174002	http://dx.doi.org/10.1126/science.1174002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520958				2022-12-24	WOS:000266878700043
J	Wise, M; Calvin, K; Thomson, A; Clarke, L; Bond-Lamberty, B; Sands, R; Smith, SJ; Janetos, A; Edmonds, J				Wise, Marshall; Calvin, Katherine; Thomson, Allison; Clarke, Leon; Bond-Lamberty, Benjamin; Sands, Ronald; Smith, Steven J.; Janetos, Anthony; Edmonds, James			Implications of Limiting CO2 Concentrations for Land Use and Energy	SCIENCE			English	Article							INTEGRATED ASSESSMENT; AGRICULTURE; REDUCTION	Limiting atmospheric carbon dioxide (CO2) concentrations to low levels requires strategies to manage anthropogenic carbon emissions from terrestrial systems as well as fossil fuel and industrial sources. We explore the implications of fully integrating terrestrial systems and the energy system into a comprehensive mitigation regime that limits atmospheric CO2 concentrations. We find that this comprehensive approach lowers the cost of meeting environmental goals but also carries with it profound implications for agriculture: Unmanaged ecosystems and forests expand, and food crop and livestock prices rise. Finally, we find that future improvement in food crop productivity directly affects land-use change emissions, making the technology for growing crops potentially important for limiting atmospheric CO2 concentrations.	[Wise, Marshall; Calvin, Katherine; Thomson, Allison; Clarke, Leon; Bond-Lamberty, Benjamin; Sands, Ronald; Smith, Steven J.; Janetos, Anthony; Edmonds, James] Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park	Edmonds, J (corresponding author), Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	jae@pnl.gov	Smith, Steven/F-4502-2010; Thomson, Allison/GRO-3207-2022; Thomson, Allison M/B-1254-2010; Bond-Lamberty, Benjamin/C-6058-2008; Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0003-3248-5607; Thomson, Allison M/0000-0001-5326-1755; Bond-Lamberty, Benjamin/0000-0001-9525-4633; Sands, Ronald/0000-0002-2864-0339; Calvin, Katherine/0000-0003-2191-4189	U.S. Department of Energys Office of Science; Electric Power Research Institute	U.S. Department of Energys Office of Science(United States Department of Energy (DOE)); Electric Power Research Institute	The authors are grateful to the U.S. Department of Energys Office of Science and to the Electric Power Research Institute for financial support for the research the results of which are reported here. The authors also thank E. Malone for helpful comments on an earlier draft. Of course, the opinions expressed here are the authors alone.	[Anonymous], 2007, J AGR FOOD IND ORG; Brenkert A., 2003, PNNL14337; Bruinsma J, 2003, WORLD AGR 2015 2030; Clarke L, 2007, CCSP SYNTHESIS ASS A; Clarke L., 2007, PNNL16735; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Edmonds J., 1985, GLOBAL ENERGY ASSESS; Edmonds JA, 2003, GREENHOUSE GAS CONTROL TECHNOLOGIES, VOLS I AND II, PROCEEDINGS, P1427; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gillingham KT, 2008, MITIG ADAPT STRAT GL, V13, P675, DOI 10.1007/s11027-007-9122-5; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Kim SH, 2006, ENERG J, P63; Lucas PL, 2007, ENVIRON SCI POLICY, V10, P85, DOI 10.1016/j.envsci.2006.10.007; Metz ORDB, 2007, CLIMATE CHANGE 2007; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; ROSE S, LAND CLIMATE STABILI; Sands RD, 2003, CLIMATIC CHANGE, V56, P185, DOI 10.1023/A:1021344614845; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tavoni M, 2007, ENERG POLICY, V35, P5346, DOI 10.1016/j.enpol.2006.01.036; Wise M., 2009, PNNL18341	23	612	632	8	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1183	1186		10.1126/science.1168475	http://dx.doi.org/10.1126/science.1168475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478180				2022-12-24	WOS:000266410100041
J	Bhatt, DL				Bhatt, Deepak L.			Prasugrel in Clinical Practice.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STENTS		[Bhatt, Deepak L.] VA Boston Healthcare Syst, Dept Cardiol, Boston, MA USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Integrated Intervent Cardiovasc Program, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, Dept Cardiol, Boston, MA USA.							Bavry AA, 2008, LANCET, V372, P536; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Curfman GD, 2007, NEW ENGL J MED, V356, P1059, DOI 10.1056/NEJMe068306; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	6	66	68	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					940	942		10.1056/NEJMp0806848	http://dx.doi.org/10.1056/NEJMp0806848			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19605807				2022-12-24	WOS:000269480400002
J	Parker, HG; VonHoldt, BM; Quignon, P; Margulies, EH; Shao, S; Mosher, DS; Spady, TC; Elkahloun, A; Cargill, M; Jones, PG; Maslen, CL; Acland, GM; Sutter, NB; Kuroki, K; Bustamante, CD; Wayne, RK; Ostrander, EA				Parker, Heidi G.; VonHoldt, Bridgett M.; Quignon, Pascale; Margulies, Elliott H.; Shao, Stephanie; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Cargill, Michele; Jones, Paul G.; Maslen, Cheryl L.; Acland, Gregory M.; Sutter, Nathan B.; Kuroki, Keiichi; Bustamante, Carlos D.; Wayne, Robert K.; Ostrander, Elaine A.			An Expressed Fgf4 Retrogene Is Associated with Breed-Defining Chondrodysplasia in Domestic Dogs	SCIENCE			English	Article							GENE DUPLICATION; GENOME; EVOLUTION; ACHONDROPLASIA; MUTATIONS; ELEMENTS; DNA	Retrotransposition of processed mRNAs is a common source of novel sequence acquired during the evolution of genomes. Although the vast majority of retroposed gene copies, or retrogenes, rapidly accumulate debilitating mutations that disrupt the reading frame, a small percentage become new genes that encode functional proteins. By using a multibreed association analysis in the domestic dog, we demonstrate that expression of a recently acquired retrogene encoding fibroblast growth factor 4 (fgf4) is strongly associated with chondrodysplasia, a short-legged phenotype that defines at least 19 dog breeds including dachshund, corgi, and basset hound. These results illustrate the important role of a single evolutionary event in constraining and directing phenotypic diversity in the domestic dog.	[Parker, Heidi G.; Quignon, Pascale; Shao, Stephanie; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [VonHoldt, Bridgett M.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Margulies, Elliott H.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cargill, Michele] Affymetrix Corp, Santa Clara, CA 95051 USA; [Jones, Paul G.] WALTHAM Ctr Pet Nutr, Melton Mowbray LE14 4RT, Leics, England; [Maslen, Cheryl L.] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA; [Acland, Gregory M.] Cornell Univ, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Acland, Gregory M.; Sutter, Nathan B.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Kuroki, Keiichi] Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA; [Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Mars; WALTHAM Petcare Science Institute; Oregon Health & Science University; Cornell University; Cornell University; University of Missouri System; University of Missouri Columbia; Cornell University	Ostrander, EA (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Ostrander, Elaine/0000-0001-6075-9738; Bustamante, Carlos D./0000-0002-4187-7920; Parker, Heidi G./0000-0002-9707-6380	NSF [0733033, 516310]; NIH [5R01EY006855, 1R24GM082910, 1R01GM83606]; NATIONAL EYE INSTITUTE [R01EY006855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536, ZICHG200365, ZIAHG200325, ZIAHG200341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM082910, R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NSF grants 0733033 (R.K.W.) and 516310 (C.D.B.) and NIH grants 5R01EY006855 and 1R24GM082910 (G.M.A.) and 1R01GM83606 (C.D.B.).	*AM KENN CLUB, 1998, COMPL DOG BOOK OFF P; Betran E, 2006, MOL BIOL EVOL, V23, P2191, DOI 10.1093/molbev/msl090; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; COLBY C, 1995, GENETICS, V140, P1129; Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Fraidenraich D, 1998, DEV BIOL, V204, P197, DOI 10.1006/dbio.1998.9053; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Heuertz S, 2006, EUR J HUM GENET, V14, P1240, DOI 10.1038/sj.ejhg.5201700; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Horton William A, 2002, Rev Endocr Metab Disord, V3, P381, DOI 10.1023/A:1020914026829; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; PALMER N, 1993, PATHOLOGY DOMESTIC A, V1; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; SIMONSEN KL, 1995, GENETICS, V141, P413; Stockard CR., 1941, AM ANAT MEM; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	220	224	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					995	998		10.1126/science.1173275	http://dx.doi.org/10.1126/science.1173275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608863	Green Accepted			2022-12-24	WOS:000269242800046
J	Cheng, N; Tsunenari, T; Yau, KW				Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai			Intrinsic light response of retinal horizontal cells of teleosts	NATURE			English	Article							SUSTAINED CALCIUM CURRENT; GAMMA-AMINOBUTYRIC-ACID; GANGLION-CELLS; MELANOPSIN; OPSIN; MODULATION; RECEPTORS; ZEBRAFISH; GOLDFISH; TISSUE	The discovery of intrinsically photosensitive retinal ganglion cells has overthrown the long-held belief that rods and cones are the exclusive retinal photoreceptors(1,2). Intrinsically photosensitive retinal ganglion cells use melanopsin(3) as the photopigment, and mediate non-image-forming visual functions such as circadian photoentrainment. In fish, in situ hybridization studies indicated that melanopsin is present in retinal horizontal cells(4-6)-lateral association neurons critical for creating the centre-surround receptive fields of visual neurons. This raises the question of whether fish horizontal cells are intrinsically photosensitive. This notion was examined previously in flat-mount roach retina, but all horizontal-cell light response disappeared after synaptic transmission was blocked(6), making any conclusion difficult to reach. To examine this question directly, we have now recorded from single, acutely dissociated horizontal cells from catfish and goldfish. We found that light induced a response in catfish cone horizontal cells, but not rod horizontal cells, consisting of a modulation of the nifedipine-sensitive, voltage-gated calcium current. The light response was extremely slow, lasting for many minutes. Similar light responses were observed in a high percentage of goldfish horizontal cells. We have cloned two melanopsin genes and one vertebrate ancient (VA) opsin gene from catfish. In situ hybridization indicated that melanopsin, but less likely VA opsin, was expressed in the horizontal-cell layer of catfish retina. This intrinsic light response may serve to modulate, over a long time-scale, lateral inhibition mediated by these cells. Thus, at least in some vertebrates, there are retinal non-rod/non-cone photoreceptors involved primarily in image-forming vision.	[Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheng, N (corresponding author), NINDS, Unit Dev Neural Plast, NIH, Bethesda, MD 20892 USA.	chengn2@mail.nih.gov; kwyau@mail.jhmi.edu			NIH; Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837, R01EY014596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant and the Antonio Champalimaud Vision Award (Portugal) to K.-W. Y. We thank R. Johnson, C. Liu and D. Liu for advice on molecular cloning and in situ hybridization staining, Y. Shen, C. Linn and G. Matthews for suggestions on retinal dissociation. D. Bergles, P. Fuchs and J. Nathans offered comments throughout the work. L. Belluscio let N. C. take a brief leave of absence from her postdoctoral work to return to Hopkins in order to complete some experiments. Members of the Yau laboratory, especially M. Do and D.-G. Luo, as well as K. Murari, have provided comments on the manuscript.	AYOUB GS, 1984, J PHYSIOL-LONDON, V355, P191, DOI 10.1113/jphysiol.1984.sp015414; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BEAN BP, 1992, METHOD ENZYMOL, V207, P181; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davis SF, 2003, AM J PHYSIOL-CELL PH, V284, pC757, DOI 10.1152/ajpcell.00252.2002; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DONG CJ, 1994, J NEUROSCI, V14, P2648; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Kojima D, 2000, J NEUROSCI, V20, P2845; Linn CL, 1999, J NEUROPHYSIOL, V81, P425, DOI 10.1152/jn.1999.81.2.425; McMahon DG, 1996, BRAIN RES, V718, P89, DOI 10.1016/0006-8993(96)00043-1; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; NAKA KI, 1975, J NEUROPHYSIOL, V38, P53, DOI 10.1152/jn.1975.38.1.53; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P1097, DOI 10.1152/jn.1989.61.6.1097; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SHINGAI R, 1986, J NEUROPHYSIOL, V56, P32, DOI 10.1152/jn.1986.56.1.32; Soni BG, 1998, NATURE, V394, P27, DOI 10.1038/27794; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; TACHIBANA M, 1981, J PHYSIOL-LONDON, V321, P141, DOI 10.1113/jphysiol.1981.sp013976; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	30	37	38	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 13	2009	460	7257					899	U139		10.1038/nature08175	http://dx.doi.org/10.1038/nature08175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633653	Green Accepted			2022-12-24	WOS:000268938300040
J	Brackbill, RM; Hadler, JL; DiGrande, L; Ekenga, CC; Farfel, MR; Friedman, S; Perlman, SE; Stellman, SD; Walker, DJ; Wu, D; Yu, SC; Thorpe, LE				Brackbill, Robert M.; Hadler, James L.; DiGrande, Laura; Ekenga, Christine C.; Farfel, Mark R.; Friedman, Stephen; Perlman, Sharon E.; Stellman, Steven D.; Walker, Deborah J.; Wu, David; Yu, Shengchao; Thorpe, Lorna E.			Asthma and Posttraumatic Stress Symptoms 5 to 6 Years Following Exposure to the World Trade Center Terrorist Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-CITY; CENTER HEALTH REGISTRY; DISASTER VICTIMS SPEAK; 11 SEPTEMBER 2001; PSYCHOMETRIC PROPERTIES; RESPIRATORY SYMPTOMS; RECOVERY WORKERS; PTSD CHECKLIST; RISK-FACTORS; CENTER SITE	Context The World Trade Center Health Registry provides a unique opportunity to examine long-term health effects of a large-scale disaster. Objective To examine risk factors for new asthma diagnoses and event-related post-traumatic stress (PTS) symptoms among exposed adults 5 to 6 years following exposure to the September 11, 2001, World Trade Center (WTC) terrorist attack. Design, Setting, and Participants Longitudinal cohort study with wave 1 (W1) enrollment of 71 437 adults in 2003-2004, including rescue/recovery worker, lower Manhattan resident, lower Manhattan office worker, and passersby eligibility groups; 46 322 adults (68%) completed the wave 2 (W2) survey in 2006-2007. Main Outcome Measures Self-reported diagnosed asthma following September 11; event-related current PTS symptoms indicative of probable posttraumatic stress disorder (PTSD), assessed using the PTSD Checklist (cutoff score >= 44). Results Of W2 participants with no stated asthma history, 10.2% (95% confidence interval [CI], 9.9%-10.5%) reported new asthma diagnoses postevent. Intense dust cloud exposure on September 11 was a major contributor to new asthma diagnoses for all eligibility groups: for example, 19.1% vs 9.6% in those without exposure among rescue/recovery workers (adjusted odds ratio, 1.5 [ 95% CI, 1.4-1.7]). Asthma risk was highest among rescue/recovery workers on the WTC pile on September 11 (20.5% [ 95% CI, 19.0%-22.0%]). Persistent risks included working longer at the WTC site, not evacuating homes, and experiencing a heavy layer of dust in home or office. Of participants with no PTSD history, 23.8% ( 95% CI, 23.4%-24.2%) reported PTS symptoms at either W1(14.3%) or W2 (19.1%). Nearly 10% ( 9.6% [ 95% CI, 9.3%-9.8%]) had PTS symptoms at both surveys, 4.7% ( 95% CI, 4.5%-4.9%) had PTS symptoms at W1 only, and 9.5% ( 95% CI, 9.3%-9.8%) had PTS symptoms at W2 only. At W2, passersby had the highest rate of PTS symptoms (23.2% [ 95% CI, 21.4%-25.0%]). Event-related loss of spouse or job was associated with PTS symptoms at W2. Conclusion Acute and prolonged exposures were both associated with a large burden of asthma and PTS symptoms 5 to 6 years after the September 11 WTC attack. JAMA. 2009;302(5):502-516 www.jama.com	[Hadler, James L.; DiGrande, Laura; Ekenga, Christine C.; Farfel, Mark R.; Friedman, Stephen; Perlman, Sharon E.; Stellman, Steven D.; Walker, Deborah J.; Wu, David; Yu, Shengchao; Thorpe, Lorna E.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Brackbill, Robert M.] Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Atlanta, GA USA; [Stellman, Steven D.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; Columbia University	Thorpe, LE (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,Room 315, New York, NY 10013 USA.	lthorpe@health.nyc.gov	Walker, Deborah/GSE-2426-2022	DiGrande, Laura/0000-0002-7742-0164	Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC) [U50/ATU272750]; National Center for Environmental Health (NCEH); New York City Department of Health and Mental Hygiene (NYCDOHMH)	Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health (NCEH); New York City Department of Health and Mental Hygiene (NYCDOHMH)	This study was supported by Cooperative Agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC), which included support from the National Center for Environmental Health (NCEH), and by the New York City Department of Health and Mental Hygiene (NYCDOHMH).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brackbill Robert M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Buyantseva LV, 2007, J OCCUP ENVIRON MED, V49, P310, DOI 10.1097/JOM.0b013e318032256e; Daly ES, 2008, J TRAUMA STRESS, V21, P227, DOI 10.1002/jts.20311; de la Hoz RE, 2008, INT ARCH OCC ENV HEA, V81, P479, DOI 10.1007/s00420-007-0240-x; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Fagan J, 2003, PSYCHOSOM MED, V65, P993, DOI 10.1097/01.PSY.0000097334.48556.5F; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Friedman S, 2008, CITY HLTH INFORM, V27, P41; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Galea S, 2008, EPIDEMIOLOGY, V19, P47, DOI 10.1097/EDE.0b013e31815c1dbf; GAUTRIN D, 2006, ASTHMA WORKPLACE REL; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Herbstman JB, 2005, ENVIRON RES, V99, P85, DOI 10.1016/j.envres.2004.08.010; Hobfoll SE, 2006, J TRAUMA STRESS, V19, P867, DOI 10.1002/jts.20166; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lin S, 2007, J ASTHMA, V44, P325, DOI 10.1080/02770900701344181; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lioy PJ, 2006, ENVIRON SCI TECHNOL, V40, P6876, DOI 10.1021/es062980e; Lioy PJ, 2006, ANN NY ACAD SCI, V1076, P54, DOI 10.1196/annals.1371.002; Litz B.T, 1993, PTSD CHECKL PCL REL; Lombardo LJ, 2000, ENVIRON HEALTH PERSP, V108, P697, DOI 10.2307/3454406; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; Nandi A, 2004, J OCCUP ENVIRON MED, V46, P1057, DOI 10.1097/01.jom.0000141663.22902.0a; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 2002, J URBAN HEALTH, V79, P383, DOI 10.1093/jurban/79.3.383; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Rodriguez JJ, 2008, CURR OPIN PSYCHIATR, V21, P370, DOI 10.1097/YCO.0b013e328304d984; Rudd RA, 2007, J ASTHMA, V44, P65, DOI 10.1080/02770900601125896; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; Thomas PA, 2008, ENVIRON HEALTH PERSP, V116, P1383, DOI 10.1289/ehp.11205; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Wagner VL, 2005, J URBAN HEALTH, V82, P76, DOI 10.1093/jurban/jti010; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; *WORLD TRAD CTR HL, 2006, SAMPL BUILD DEN EST	52	260	260	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					502	516		10.1001/jama.2009.1121	http://dx.doi.org/10.1001/jama.2009.1121			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654385	Green Published			2022-12-24	WOS:000268640500015
J	Imai, T; Yamazaki, T; Kobayakawa, R; Kobayakawa, K; Abe, T; Suzuki, M; Sakano, H				Imai, Takeshi; Yamazaki, Takahiro; Kobayakawa, Reiko; Kobayakawa, Ko; Abe, Takaya; Suzuki, Misao; Sakano, Hitoshi			Pre-Target Axon Sorting Establishes the Neural Map Topography	SCIENCE			English	Article							MOUSE OLFACTORY SYSTEM; GANGLION-CELL AXONS; ODORANT RECEPTORS; BULB; EXPRESSION; PROJECTIONS; GUIDANCE; NEURONS; GENE; MICE	Sensory information detected by the peripheral nervous system is represented as a topographic map in the brain. It has long been thought that the topography of the map is determined by graded positional cues that are expressed by the target. Here, we analyzed the pre-target axon sorting for olfactory map formation in mice. In olfactory sensory neurons, an axon guidance receptor, Neuropilin-1, and its repulsive ligand, Semaphorin-3A, are expressed in a complementary manner. We found that expression levels of Neuropilin-1 determined both pre-target sorting and projection sites of axons. Olfactory sensory neuron-specific knockout of Semaphorin-3A perturbed axon sorting and altered the olfactory map topography. Thus, pre-target axon sorting plays an important role in establishing the topographic order based on the relative levels of guidance molecules expressed by axons.	[Imai, Takeshi; Yamazaki, Takahiro; Kobayakawa, Reiko; Kobayakawa, Ko; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Suzuki, Misao] Kumamoto Univ, Ctr Anim Resources & Dev, Div Transgen Technol, Kumamoto 8600081, Japan	University of Tokyo; RIKEN; Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080; Kobayakawa, Reiko/0000-0001-6613-5969; Kobayakawa, Ko/0000-0001-6406-5610	Japan Science and Technology Agency; Global COE program; Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the PREST program of the Japan Science and Technology Agency (R.K.), the Global COE program (K.K.), the Mitsubishi Foundation, and a Specially Promoted Research Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; NARUSE I, 1990, DEV BRAIN RES, V51, P253, DOI 10.1016/0165-3806(90)90283-5; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SATODA M, 1995, J NEUROSCI, V15, P942; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; YOON MG, 1977, J PHYSIOL-LONDON, V264, P379, DOI 10.1113/jphysiol.1977.sp011674; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	38	160	160	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					585	590		10.1126/science.1173596	http://dx.doi.org/10.1126/science.1173596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19589963				2022-12-24	WOS:000268493000043
J	Hatton, R; Patel, M; Devendra, D				Hatton, Rebecca; Patel, Madhukar; Devendra, Devasenan			Practice 10-Minute Consultation Thyroid swellings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Devendra, Devasenan] Brent Teaching Primary Care Trust, London W12 0NN, England; [Devendra, Devasenan] Cent Middlesex Hosp, London W12 0NN, England; [Devendra, Devasenan] Univ London Imperial Coll Sci Technol & Med, Div Invest Sci, London W12 0NN, England; [Hatton, Rebecca] Cent Middlesex Hosp, London NW10 7NS, England; [Patel, Madhukar] Brent Teaching Primary Care Trust, London HA0 4UZ, England	Imperial College London; Imperial College London; Imperial College London	Devendra, D (corresponding author), Brent Teaching Primary Care Trust, London W12 0NN, England.	d.devendra@imperial.ac.uk						Gharib Hossein, 2006, Endocr Pract, V12, P63; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; National Institute for Health and Clinical Excellence, 2011, NAT I HLTH CLIN EXC; Polyzos Stergios A, 2007, Hormones (Athens), V6, P101	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2009	339								b2563	10.1136/bmj.b2563	http://dx.doi.org/10.1136/bmj.b2563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BS	19596720				2022-12-24	WOS:000268104700003
J	Carbone, F; Kwon, OH; Zewail, AH				Carbone, Fabrizio; Kwon, Oh-Hoon; Zewail, Ahmed H.			Dynamics of Chemical Bonding Mapped by Energy-Resolved 4D Electron Microscopy	SCIENCE			English	Article							LOSS SPECTROSCOPY; TIME; REAL; XANES; SPACE; EELS	Chemical bonding dynamics are fundamental to the understanding of properties and behavior of materials and molecules. Here, we demonstrate the potential of time-resolved, femtosecond electron energy loss spectroscopy (EELS) for mapping electronic structural changes in the course of nuclear motions. For graphite, it is found that changes of milli-electron volts in the energy range of up to 50 electron volts reveal the compression and expansion of layers on the subpicometer scale (for surface and bulk atoms). These nonequilibrium structural features are correlated with the direction of change from sp(2) [two-dimensional (2D) graphene] to sp(3) (3D-diamond) electronic hybridization, and the results are compared with theoretical charge-density calculations. The reported femtosecond time resolution of four-dimensional (4D) electron microscopy represents an advance of 10 orders of magnitude over that of conventional EELS methods.	[Carbone, Fabrizio; Kwon, Oh-Hoon; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Kwon, Oh-Hoon/B-3324-2015; Carbone, Fabrizio/A-2969-2012	Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	National Science Foundation; Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the National Science Foundation and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. We thank B. Barwick for helpful and stimulating discussion.	Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Bressler C, 2008, Z KRISTALLOGR, V223, P307, DOI 10.1524/zkri.2008.0030; Calliari L, 2008, SURF INTERFACE ANAL, V40, P814, DOI 10.1002/sia.2652; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Carbone F, 2009, CHEM PHYS LETT, V468, P107, DOI 10.1016/j.cplett.2008.12.027; Eberlein T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.233406; Egerton R.F., 2011, ELECT ENERGY LOSS SP; ELLIS TH, 1985, SCIENCE, V230, P256, DOI 10.1126/science.230.4723.256; FAHY S, 1986, PHYS REV B, V34, P1191, DOI 10.1103/PhysRevB.34.1191; Flannigan DJ, 2009, NANO LETT, V9, P875, DOI 10.1021/nl803770e; Hitchcock AP, 2008, MICRON, V39, P311, DOI 10.1016/j.micron.2007.09.008; Ishioka K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121402; Jeschke HO, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015003; Kampfrath T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.187403; Kaplan A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073401; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Lenner M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721392; Marinopoulos AG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245419; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; Petek H, 2000, SCIENCE, V288, P1402, DOI 10.1126/science.288.5470.1402; Raman RK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077401; Savrasov SY, 2005, Z KRISTALLOGR, V220, P555, DOI 10.1524/zkri.220.5.555.65067; SEIBERT K, 1990, PHYS REV B, V42, P2842, DOI 10.1103/PhysRevB.42.2842; THOMAS JM, 1985, ACCOUNTS CHEM RES, V18, P324, DOI 10.1021/ar00119a001; Yurtsever A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.217402; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587; ZEWAIL AH, 2000, PRIX NOBEL NOBEL PRI; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403	32	141	146	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					181	184		10.1126/science.1175005	http://dx.doi.org/10.1126/science.1175005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589997				2022-12-24	WOS:000267802000041
J	Rieger, MA; Hoppe, PS; Smejkal, BM; Eitelhuber, AC; Schroeder, T				Rieger, Michael A.; Hoppe, Philipp S.; Smejkal, Benjamin M.; Eitelhuber, Andrea C.; Schroeder, Timm			Hematopoietic Cytokines Can Instruct Lineage Choice	SCIENCE			English	Article							STIMULATING FACTOR-RECEPTOR; CELLS; COMMITMENT; MACROPHAGE; DIFFERENTIATION; GRANULOCYTE; PROGENITORS; EXPRESSION	The constant regeneration of the blood system during hematopoiesis requires tightly controlled lineage decisions of hematopoietic progenitor cells (HPCs). Because of technical limitations, differentiation of individual HPCs could not previously be analyzed continuously. It was therefore disputed whether cell-extrinsic cytokines can instruct HPC lineage choice or only allow survival of cells that are already lineage-restricted. Here, we used bioimaging approaches that allow the continuous long-term observation of individual differentiating mouse HPCs. We demonstrate that the physiological cytokines, macrophage colony-stimulating factor and granulocyte colony-stimulating factor, can instruct hematopoietic lineage choice.	[Rieger, Michael A.; Hoppe, Philipp S.; Smejkal, Benjamin M.; Eitelhuber, Andrea C.; Schroeder, Timm] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010; Rieger, Michael A/L-8324-2017	Schroeder, Timm/0000-0001-9320-0252; Rieger, Michael A/0000-0002-4158-5872	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Graf for the LysM::GFP mice; A. Roth, C. Raithel, and K. Azadov for technical assistance; and B. Schauberger for programming contributions. This study was supported by the Deutsche Forschungsgemeinschaft. Authors contributions: M.A.R. designed and performed experiments, discussed results, and wrote the paper with T.S.; P.S.H., B.M.S., and A.C.E. performed experiments and commented on the manuscript; and T.S. developed the time-lapse imaging and cell-tracking technology, advanced it with all the authors, and designed the study.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Faust N, 2000, BLOOD, V96, P719; Goldsmith MA, 1998, P NATL ACAD SCI USA, V95, P7006, DOI 10.1073/pnas.95.12.7006; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; KINASHI T, 1991, J EXP MED, V173, P1267, DOI 10.1084/jem.173.5.1267; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; MCARTHUR GA, 1994, BLOOD, V83, P972; METCALF D, 1982, J CELL PHYSIOL, V111, P275, DOI 10.1002/jcp.1041110308; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Robb L, 2007, ONCOGENE, V26, P6715, DOI 10.1038/sj.onc.1210756; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Stadtfeld M, 2004, METH MOLEC MED, V105, P395; Stoffel R, 1999, P NATL ACAD SCI USA, V96, P698, DOI 10.1073/pnas.96.2.698; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	28	298	309	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					217	218		10.1126/science.1171461	http://dx.doi.org/10.1126/science.1171461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590005				2022-12-24	WOS:000267802000052
J	Takeda, A; Baffi, JZ; Kleinman, ME; Cho, WG; Nozaki, M; Yamada, K; Kaneko, H; Albuquerque, RJC; Dridi, S; Saito, K; Raisler, BJ; Budd, SJ; Geisen, P; Munitz, A; Ambati, BK; Green, MG; Ishibashi, T; Wright, JD; Humbles, AA; Gerard, CJ; Ogura, Y; Pan, YZ; Smith, JR; Grisanti, S; Hartnett, ME; Rothenberg, ME; Ambati, J				Takeda, Atsunobu; Baffi, Judit Z.; Kleinman, Mark E.; Cho, Won Gil; Nozaki, Miho; Yamada, Kiyoshi; Kaneko, Hiroki; Albuquerque, Romulo J. C.; Dridi, Sami; Saito, Kuniharu; Raisler, Brian J.; Budd, Steven J.; Geisen, Pete; Munitz, Ariel; Ambati, Balamurali K.; Green, Martha G.; Ishibashi, Tatsuro; Wright, John D.; Humbles, Alison A.; Gerard, Craig J.; Ogura, Yuichiro; Pan, Yuzhen; Smith, Justine R.; Grisanti, Salvatore; Hartnett, M. Elizabeth; Rothenberg, Marc E.; Ambati, Jayakrishna			CCR3 is a target for age-related macular degeneration diagnosis and therapy	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; GENE-EXPRESSION PROFILES; MAST-CELLS; EOSINOPHIL RECRUITMENT; VISUAL FUNCTION; EOTAXIN; VEGF; MODEL	Age-related macular degeneration (AMD), a leading cause of blindness worldwide, is as prevalent as cancer in industrialized nations. Most blindness in AMD results from invasion of the retina by choroidal neovascularisation (CNV). Here we show that the eosinophil/mast cell chemokine receptor CCR3 is specifically expressed in choroidal neovascular endothelial cells in humans with AMD, and that despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV. Genetic or pharmacological targeting of CCR3 or eotaxins inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation because it occurred in mice lacking eosinophils or mast cells, and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor A (VEGF-A) neutralization, which is in clinical use at present, and, unlike VEGF-A blockade, is not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting might reduce vision loss due to AMD through early detection and therapeutic angioinhibition.	[Takeda, Atsunobu; Baffi, Judit Z.; Kleinman, Mark E.; Cho, Won Gil; Nozaki, Miho; Yamada, Kiyoshi; Kaneko, Hiroki; Albuquerque, Romulo J. C.; Dridi, Sami; Saito, Kuniharu; Raisler, Brian J.; Green, Martha G.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Albuquerque, Romulo J. C.; Raisler, Brian J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Nozaki, Miho; Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan; [Budd, Steven J.; Geisen, Pete; Wright, John D.; Hartnett, M. Elizabeth] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27599 USA; [Munitz, Ariel; Rothenberg, Marc E.] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Div Allergy & Immunol,Dept Pediat, Cincinnati, OH 45229 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Humbles, Alison A.; Gerard, Craig J.] Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02215 USA; [Pan, Yuzhen; Smith, Justine R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Grisanti, Salvatore] Med Univ Lubeck, Dept Ophthalmol, D-23538 Lubeck, Germany	University of Kentucky; University of Kentucky; Nagoya City University; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Kyushu University; Harvard University; Boston Children's Hospital; Harvard Medical School; Oregon Health & Science University; University of Lubeck	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Smith, Justine/Y-9044-2019; Pan, YZ/GVS-2269-2022; Dridi, Sami/Q-8207-2019; Kaneko, Hiroki/O-7695-2015; Kaneko, Hiroki/AHA-2461-2022	Smith, Justine/0000-0002-4756-5493; Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; Kleinman, Mark/0000-0001-8557-7949	National Eye Institute/National Institutes of Health (NIH) [EY015422, EY018350, EY018836]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Awar; Macula Vision Research Foundation; E. Matilda Ziegler Foundation for the Blind; American Health Assistance Foundation; NIH [EY017182, EY017950, AI45898, DK076893, AI039759, EY017011, EY015130, EY010572]; VA Merit Award and the Department of Defense; RPB Career Development Award; NATIONAL EYE INSTITUTE [R56EY015130, R01EY015422, R01EY017182, R01EY018836, R01EY015130, R01EY017011, R01EY017950, R01EY018350, P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI045898, R01AI039759, R01AI045898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	National Eye Institute/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Awar(Burroughs Wellcome Fund); Macula Vision Research Foundation; E. Matilda Ziegler Foundation for the Blind; American Health Assistance Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award and the Department of Defense; RPB Career Development Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Acknowledgements We thank R. King, L. Xu, M. McConnell, K. Emerson, G. R. Pattison and M. Mingler for technical assistance, J. M. Farber for the gift of a reagent, R. J. Kryscio for statistical guidance, and B. Appukuttan, M. W. Fannon, R. Mohan, A. P. Pearson, A. M. Rao, G. S. Rao and K. Ambati for discussions. J. A. was supported by National Eye Institute/National Institutes of Health (NIH) grants EY015422, EY018350 and EY018836, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, the Macula Vision Research Foundation, the E. Matilda Ziegler Foundation for the Blind, the Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, the Lew R. Wassermann Merit & Physician Scientist Awards ( Research to Prevent Blindness, RPB), the American Health Assistance Foundation, and a departmental unrestricted grant from the RPB. J. Z. B. was supported by the University of Kentucky Physician Scientist Award. M. E. K. was supported by the International Retinal Research Foundation Dr. Charles Kelman Postdoctoral Scholar Award. R. J. C. A. was supported by Fight for Sight. B. K. A. was supported by NIH grants EY017182 and EY017950, the VA Merit Award and the Department of Defense. M. E. R. was supported by NIH grants AI45898 and DK076893. C. J. G. was supported by NIH grant AI039759. M. E. H. was supported by NIH grants EY017011 and EY015130 and a RPB departmental unrestricted grant. J. R. S. was supported by NIH grant EY010572, and RPB Career Development Award and a departmental unrestricted grant.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Famiglietti EV, 2003, BRAIN RES, V969, P195, DOI 10.1016/S0006-8993(02)03766-6; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fulkerson PC, 2005, BLOOD, V106, P436, DOI 10.1182/blood-2005-02-0489; Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Grossniklaus HE, 2005, ARCH OPHTHALMOL-CHIC, V123, P914; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; KITAMURA Y, 1978, BLOOD, V52, P447; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Puxeddu A, 2005, INT J BIOCHEM CELL B, V37, P628, DOI 10.1016/j.biocel.2004.09.001; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Sayanagi K, 2009, BRIT J OPHTHALMOL, V93, P622, DOI 10.1136/bjo.2008.151977; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; St Croix B, 2000, SCIENCE, V289, P1197; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Yodoi Y, 2009, AM J OPHTHALMOL, V147, P816, DOI 10.1016/j.ajo.2008.11.020; Zamora DO, 2007, MOL VIS, V13, P2058; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhou JH, 2005, MOL VIS, V11, P414	47	189	213	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					225	U87		10.1038/nature08151	http://dx.doi.org/10.1038/nature08151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19525930	Green Accepted, Green Submitted			2022-12-24	WOS:000267761000034
J	Raya, A; Rodriguez-Piza, I; Guenechea, G; Vassena, R; Navarro, S; Barrero, MJ; Consiglio, A; Castella, M; Rio, P; Sleep, E; Gonzalez, F; Tiscornia, G; Garreta, E; Aasen, T; Veiga, A; Verma, IM; Surralles, J; Bueren, J; Belmonte, JCI				Raya, Angel; Rodriguez-Piza, Ignasi; Guenechea, Guillermo; Vassena, Rita; Navarro, Susana; Jose Barrero, Maria; Consiglio, Antonella; Castella, Maria; Rio, Paula; Sleep, Eduard; Gonzalez, Federico; Tiscornia, Gustavo; Garreta, Elena; Aasen, Trond; Veiga, Anna; Verma, Inder M.; Surralles, Jordi; Bueren, Juan; Izpisua Belmonte, Juan Carlos			Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells	NATURE			English	Article							LENTIVIRAL VECTORS; GENE-THERAPY; GENERATION; MOUSE; EFFICIENT; FIBROBLASTS; MOSAICISM; PROMOTER; FANCD2; DAMAGE	The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and provided valuable experimental platforms to model human disease. Patient-specific iPS cells are also thought to hold great therapeutic potential, although direct evidence for this is still lacking. Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells. These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals. Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free. These data offer proof-of-concept that iPS cell technology can be used for the generation of disease-corrected, patient-specific cells with potential value for cell therapy applications.	[Raya, Angel; Rodriguez-Piza, Ignasi; Navarro, Susana; Jose Barrero, Maria; Sleep, Eduard; Gonzalez, Federico; Tiscornia, Gustavo; Garreta, Elena; Aasen, Trond; Veiga, Anna; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Raya, Angel] ICREA, Madrid 28040, Spain; [Raya, Angel; Sleep, Eduard; Garreta, Elena; Aasen, Trond] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Madrid 28040, Spain; [Guenechea, Guillermo; Navarro, Susana; Rio, Paula; Bueren, Juan] CIEMAT, Hematopoiesis & Gene Therapy Div, E-28040 Madrid, Spain; [Guenechea, Guillermo; Navarro, Susana; Castella, Maria; Rio, Paula; Surralles, Jordi; Bueren, Juan] Networking Ctr Biomed Res Rare Dis CIBERER, I-25123 Brescia, Italy; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Castella, Maria; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra 08193, Spain; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of Brescia; Autonomous University of Barcelona; Salk Institute; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Raya, Angel/E-6205-2010; Aasen, Trond/B-5279-2013; Bueren, Juan/L-6112-2014; consiglio, antonella/AAA-5864-2019; Rio, Paula/G-8681-2015; Surrallés, Jordi/AAE-7667-2020; consiglio, antonella/G-1815-2016; Garreta, Elena/AAQ-4739-2020; Guenechea, Guillermo/L-6119-2014; Tiscornia, Gustavo/F-4423-2012; Barrero, Maria J./Q-1785-2017; Navarro, Susana/L-9300-2014; Castella, Maria/J-8304-2015	Raya, Angel/0000-0003-2189-9775; Aasen, Trond/0000-0003-0763-2695; Bueren, Juan/0000-0002-3228-7013; consiglio, antonella/0000-0002-3988-6254; Rio, Paula/0000-0002-5424-5543; consiglio, antonella/0000-0002-3988-6254; Garreta, Elena/0000-0002-1071-9794; Guenechea, Guillermo/0000-0001-7679-0895; Barrero, Maria J./0000-0002-5990-7040; Navarro, Susana/0000-0002-0764-5384; Tiscornia, Gustavo/0000-0002-1841-5330; Veiga, Anna/0000-0002-0943-9904; Surralles, Jordi/0000-0002-4041-7519; Gonzalez Grassi, Federico/0000-0002-7147-2246; Vassena, Rita/0000-0002-0846-0365	MEC; DIUE; Ramon y Cajal program; ICREA-Academia program; Ministerio de Educacion y Ciencia [BFU2006-12251, SAF2005-00058, SAF2006-3440]; Genoma Espana (FANCOGENE); European Commission 'Marie-Curie Reintegration Grant' [MIRG-CT-2007-046523]; European Program CONSERT [LSHB-CT-2004-5242]; Fondo de Investigaciones Sanitarias [RETIC-RD06/0010/0016, PI061897, PI061099]; Marato de TV3 [063430]; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Marcelino Botin; Fundacion Cellex; ICREA Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	MEC(European Commission); DIUE; Ramon y Cajal program(Spanish Government); ICREA-Academia program(ICREA); Ministerio de Educacion y Ciencia(Spanish Government); Genoma Espana (FANCOGENE); European Commission 'Marie-Curie Reintegration Grant'(European CommissionEuropean Commission Joint Research Centre); European Program CONSERT; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Marato de TV3; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Marcelino Botin; Fundacion Cellex(Foundation CELLEX); ICREA(ICREA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are indebted to FA patients and their families for their cooperation. We are grateful to I. Badell, J. Couselo, A. Almeida and D. Schindler for collaboration in providing samples from FA patients, J. A. Casado for subtyping studies, M. Edel, J. Bilic, V. Pekarik and members of the laboratory for comments on the manuscript, J. M. Andres-Vaquero for assistance with flow cytometry, R. Pujol for assistance with cytogenetics, M. J. Ramirez for immunofluorescence studies, B. Aran, M. Carrio and Y. Munoz for assistance with cell culture techniques, E. Melo, L. Mulero and M. Marti for bioimaging assistance, and Y. Richaud, T. Lopez Rovira and M. L. Lozano for technical assistance. I. R.-P. and E. S. were recipients of pre-doctoral fellowships from MEC and DIUE, respectively. M. J. B. and G. T. were partially supported by the Ramon y Cajal program, and J. S. by the ICREA-Academia program. This work was partially supported by the Ministerio de Educacion y Ciencia grants BFU2006-12251, SAF2005-00058, SAF2006-3440, and Genoma Espana (FANCOGENE), European Commission 'Marie-Curie Reintegration Grant' MIRG-CT-2007-046523 and European Program CONSERT LSHB-CT-2004-5242, the Fondo de Investigaciones Sanitarias (RETIC-RD06/0010/0016, PI061897, PI061099), Marato de TV3 (063430), the G. Harold and Leila Y. Mathers Charitable Foundation, Fundacion Marcelino Botin, and Fundacion Cellex.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Almarza E, 2007, MOL THER, V15, P1487, DOI 10.1038/sj.mt.6300213; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gonzalez-Murillo A, 2008, BLOOD, V112, P3138, DOI 10.1182/blood-2008-03-142661; Gregory JJ, 2001, P NATL ACAD SCI USA, V98, P2532, DOI 10.1073/pnas.051609898; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Guardiola P, 2000, BLOOD, V95, P422; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; JACOME A, MOL THER IN PRESS; Ji JF, 2008, STEM CELLS, V26, P2485, DOI 10.1634/stemcells.2008-0642; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kelly PF, 2007, MOL THER, V15, P211, DOI 10.1038/sj.mt.6300033; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Larghero J, 2002, BLOOD, V100, P3051, DOI 10.1182/blood-2002-07-2069; Liu JM, 1999, HUM GENE THER, V10, P2337, DOI 10.1089/10430349950016988; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; RAYA A, COLD SPRING IN PRESS; Rio P, 2008, BLOOD, V112, P4853, DOI 10.1182/blood-2008-05-156356; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wagner JE, 2007, BLOOD, V109, P2256, DOI 10.1182/blood-2006-07-036657; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	48	528	566	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					53	U61		10.1038/nature08129	http://dx.doi.org/10.1038/nature08129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19483674	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000267545200028
J	Peters, A				Peters, Anne			Clinic of Tears	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												momofmax@mac.com		Peters, Anne/0000-0003-0520-0776					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2309	2309		10.1001/jama.2009.806	http://dx.doi.org/10.1001/jama.2009.806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509369				2022-12-24	WOS:000266773400001
J	Rubin, EJ				Rubin, Eric J.			The Granuloma in Tuberculosis - Friend or Foe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rubin, Eric/0000-0001-5120-962X				Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072	4	38	40	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2471	2473		10.1056/NEJMcibr0902539	http://dx.doi.org/10.1056/NEJMcibr0902539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494225				2022-12-24	WOS:000266590500017
J	Moncrieff, J; Cohen, D				Moncrieff, Joanna; Cohen, David			How do psychiatric drugs work?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHIZOPHRENIA; SSRIS		[Moncrieff, Joanna] UCL, Dept Psychiat & Behav Sci, London W1N 8AA, England; [Cohen, David] Florida Int Univ, Sch Social Work, Miami, FL 33199 USA	University of London; University College London; State University System of Florida; Florida International University	Moncrieff, J (corresponding author), UCL, Dept Psychiat & Behav Sci, Mortimer St, London W1N 8AA, England.	j.moncrieff@ucl.ac.uk						ABSE DW, 1960, AM J PSYCHIAT, V116, P973, DOI 10.1176/ajp.116.11.973; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Cohen D., 1997, PLACEBO PANACEA PUTT, P173; Cohen D., 2007, DEBATES NEUROSCIENCE, V1, P44; DENIKER P, 1960, COMPR PSYCHIAT, V1, P92, DOI 10.1016/S0010-440X(60)80013-2; Dumont GJH, 2005, BRIT J CLIN PHARMACO, V59, P495, DOI 10.1111/j.1365-2125.2005.02342.x; HEALY D, 1989, J ROY SOC MED, V82, P615, DOI 10.1177/014107688908201018; Jacobs D., 1999, INT J RISK SAFETY ME, V12, P37; JOHNSON RH, 1988, VET MICROBIOL, V16, P25, DOI 10.1016/0378-1135(88)90124-1; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Mizrahi R, 2005, PROG NEURO-PSYCHOPH, V29, P859, DOI 10.1016/j.pnpbp.2005.03.001; Moncrieff J, 2005, BMJ-BRIT MED J, V331, P155, DOI 10.1136/bmj.331.7509.155; Moncrieff J, 1997, BRIT J PSYCHIAT, V171, P113, DOI 10.1192/bjp.171.2.113; Moncrieff J., 2008, MYTH CHEM CURE CRITI; MONCRIEFF J, HARV REV PS IN PRESS; MONCRIEFF J, 2009, ACTA PSYCHIAT S 0212; Opbroek A, 2002, INT J NEUROPSYCHOPH, V5, P147, DOI 10.1017/S1461145702002870; PRIEN RF, 1972, ARCH GEN PSYCHIAT, V26, P146; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714	19	25	26	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 29	2009	338								b1963	10.1136/bmj.b1963	http://dx.doi.org/10.1136/bmj.b1963			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WV	19482870	Green Published, Green Submitted			2022-12-24	WOS:000266502500002
J	Keele, BF; Jones, JH; Terio, KA; Estes, JD; Rudicell, RS; Wilson, ML; Li, YY; Learn, GH; Beasley, TM; Schumacher-Stankey, J; Wroblewski, E; Mosser, A; Raphael, J; Kamenya, S; Lonsdorf, EV; Travis, DA; Mlengeya, T; Kinsel, MJ; Else, JG; Silvestri, G; Goodall, J; Sharp, PM; Shaw, GM; Pusey, AE; Hahn, BH				Keele, Brandon F.; Jones, James Holland; Terio, Karen A.; Estes, Jacob D.; Rudicell, Rebecca S.; Wilson, Michael L.; Li, Yingying; Learn, Gerald H.; Beasley, T. Mark; Schumacher-Stankey, Joann; Wroblewski, Emily; Mosser, Anna; Raphael, Jane; Kamenya, Shadrack; Lonsdorf, Elizabeth V.; Travis, Dominic A.; Mlengeya, Titus; Kinsel, Michael J.; Else, James G.; Silvestri, Guido; Goodall, Jane; Sharp, Paul M.; Shaw, George M.; Pusey, Anne E.; Hahn, Beatrice H.			Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz	NATURE			English	Article							GOMBE NATIONAL-PARK; IMMUNODEFICIENCY VIRUS-INFECTION; IMMUNE ACTIVATION; HIV-INFECTION; T-CELLS; TRANSMISSION; RESISTANCE; COMMUNITY; ABSENCE; TISSUE	African primates are naturally infected with over 40 different simian immunodeficiency viruses (SIVs), two of which have crossed the species barrier and generated human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2)(1,2). Unlike the human viruses, however, SIVs do not generally cause acquired immunodeficiency syndrome (AIDS) in their natural hosts(3). Here we show that SIVcpz, the immediate precursor of HIV-1, is pathogenic in free-ranging chimpanzees. By following 94 members of two habituated chimpanzee communities in Gombe National Park, Tanzania, for over 9 years, we found a 10- to 16-fold higher age-corrected death hazard for SIVcpz-infected (n = 17) compared to uninfected (n = 77) chimpanzees. We also found that SIVcpz-infected females were less likely to give birth and had a higher infant mortality rate than uninfected females. Immunohistochemistry and in situ hybridization of post-mortem spleen and lymph node samples from three infected and two uninfected chimpanzees revealed significant CD4(+) T-cell depletion in all infected individuals, with evidence of high viral replication and extensive follicular dendritic cell virus trapping in one of them. One female, who died within 3 years of acquiring SIVcpz, had histopathological findings consistent with end-stage AIDS. These results indicate that SIVcpz, like HIV-1, is associated with progressive CD4(+) T-cell loss, lymphatic tissue destruction and premature death. These findings challenge the prevailing view that all natural SIV infections are non-pathogenic and suggest that SIVcpz has a substantial negative impact on the health, reproduction and lifespan of chimpanzees in the wild.	[Keele, Brandon F.; Li, Yingying; Learn, Gerald H.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rudicell, Rebecca S.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Jones, James Holland] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Terio, Karen A.; Kinsel, Michael J.] Univ Illinois, Zool Pathol Program, Maywood, IL 60153 USA; [Estes, Jacob D.] NCI, Sci Applicat Int Corp Frederick Inc, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; [Wilson, Michael L.; Schumacher-Stankey, Joann; Wroblewski, Emily; Pusey, Anne E.] Univ Minnesota, Dept Ecol Evolut & Behav, Jane Goodall Inst Ctr Primate Studies, St Paul, MN 55108 USA; [Mosser, Anna; Raphael, Jane; Kamenya, Shadrack] Jane Goodall Inst, Gombe Stream Res Ctr, Kigoma, Tanzania; [Lonsdorf, Elizabeth V.] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Travis, Dominic A.] Lincoln Pk Zoo, Dept Conservat & Sci, Chicago, IL 60614 USA; [Mlengeya, Titus] Tanzania Natl Pk, Arusha, Tanzania; [Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Div Anim Resources, Atlanta, GA 30322 USA; [Silvestri, Guido] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19107 USA; [Goodall, Jane] Jane Goodall Inst, Arlington, VA 22203 USA; [Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; University of Pennsylvania; University of Edinburgh	Hahn, BH (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul/Y-3787-2019; Sharp, Paul M/F-5783-2010; Wilson, Michael Lawrence/AAC-9154-2020; Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011; Terio, Karen/AAC-5376-2019; Sharp, Paul M/GPX-1497-2022	Sharp, Paul M/0000-0001-9771-543X; Wilson, Michael Lawrence/0000-0003-3073-4518; Learn, Gerald H/0000-0003-0434-7733; Sharp, Paul M/0000-0001-9771-543X; Pusey, Anne/0000-0002-2280-8954; Jones, James/0000-0003-1680-6757; Hahn, Beatrice/0000-0002-9400-9887	National Institutes of Health [R01 AI50529, R01 AI58715, U19 AI067854, T32 GM008111]; National Cancer Institute [HHSN266200400088C]; UAB Center for AIDS Research [P30 AI 27767]; Yerkes National Primate Research Center [RR-00165]; National Science Foundation [DBS-9021946, SBR-9319909, BSC-0452315, IIS-0431141, BSC-0648481]; Jane Goodall Institute; Harris Steel Group; University of Minnesota; University of Illinois; US Fish and Wildlife Service Great Ape Conservation Fund; Windibrow, Arcus, Guthman and Davee Foundations; Lincoln Park Zoo; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R01AI050529, R01AI058715, P30AI027767, R37AI050529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Center for AIDS Research; Yerkes National Primate Research Center; National Science Foundation(National Science Foundation (NSF)); Jane Goodall Institute; Harris Steel Group; University of Minnesota(University of Minnesota System); University of Illinois; US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Windibrow, Arcus, Guthman and Davee Foundations; Lincoln Park Zoo; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the field staff at the Gombe Stream Research Centre for collecting behavioural data as well as urine and faecal samples from wild chimpanzees; E. Kaaya for help with necropsies; A. Collins for logistical support; the Tanzania Commission for Science and Technology, the Tanzania Wildlife Research Institute, and the Tanzania National Parks for permission to conduct research in Gombe; I. White for discussions; L. Lowenstine for histological consultation; M. Salazar and Y. Chen for technical assistance; and J. C. White for artwork and manuscript preparation. This work was supported by grants from the National Institutes of Health (R01 AI50529, R01 AI58715, U19 AI067854, T32 GM008111), the National Cancer Institute (contract HHSN266200400088C), the UAB Center for AIDS Research (P30 AI 27767), the Yerkes National Primate Research Center (RR-00165), the National Science Foundation (DBS-9021946, SBR-9319909, BSC-0452315, IIS-0431141, BSC-0648481), the Jane Goodall Institute, the Harris Steel Group, the University of Minnesota, the University of Illinois, the US Fish and Wildlife Service Great Ape Conservation Fund, the Windibrow, Arcus, Guthman and Davee Foundations, and the Lincoln Park Zoo. R. S. R. was funded by a Howard Hughes Medical Institute Med-into-Grad Fellowship. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gougeon ML, 1997, J IMMUNOL, V158, P2964; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KING NW, 1993, NONHUMAN PRIMATES, V1, P5; Koopman G, 1999, AIDS RES HUM RETROV, V15, P365, DOI 10.1089/088922299311330; MULDER DW, 1994, LANCET, V343, P1021, DOI 10.1016/S0140-6736(94)90133-3; Pandrea I, 2009, CURR HIV RES, V7, P57, DOI 10.2174/157016209787048456; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schindler M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000107; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Silvestri G, 2009, J INTERN MED, V265, P97, DOI 10.1111/j.1365-2796.2008.02049.x; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573	29	245	248	0	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					515	519		10.1038/nature08200	http://dx.doi.org/10.1038/nature08200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626114	Green Accepted			2022-12-24	WOS:000268257000039
J	Moore, SW; Biais, N; Sheetz, MP				Moore, Simon W.; Biais, Nicolas; Sheetz, Michael P.			Traction on Immobilized Netrin-1 Is Sufficient to Reorient Axons	SCIENCE			English	Article							COMMISSURAL AXONS; RECEPTOR; DCC; GUIDANCE; GROWTH		[Moore, Simon W.; Biais, Nicolas; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ms2001@columbia.edu		Moore, Simon/0000-0003-1330-8381	NIH [PN2 EY016586-02, AI079030]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. E. Kennedy for critical reading, N. Gauthier for discussion, and support from NIH grants PN2 EY016586-02 (S.W.M. and M.P.S.) and AI079030 (N.B.).	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0	9	69	70	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					166	166		10.1126/science.1173851	http://dx.doi.org/10.1126/science.1173851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589994	Green Accepted			2022-12-24	WOS:000267802000036
J	Stebe, KJ; Lewandowski, E; Ghosh, M				Stebe, Kathleen J.; Lewandowski, Eric; Ghosh, Moniraj			Oriented Assembly of Metamaterials	SCIENCE			English	Editorial Material							INDEX		[Stebe, Kathleen J.; Lewandowski, Eric] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Ghosh, Moniraj] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	University of Pennsylvania; Johns Hopkins University	Stebe, KJ (corresponding author), Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	kstebe@seas.upenn.edu						Aizenberg J, 2000, PHYS REV LETT, V84, P2997, DOI 10.1103/PhysRevLett.84.2997; DENKOV ND, 1992, LANGMUIR, V8, P3183, DOI 10.1021/la00048a054; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Harris DJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.148301; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; John BS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819091; Lee JH, 2009, OPT LETT, V34, P443, DOI 10.1364/OL.34.000443; Loudet JC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018301; Ming T, 2008, ANGEW CHEM INT EDIT, V47, P9685, DOI 10.1002/anie.200803642; Rycenga M, 2008, ADV MATER, V20, P2416, DOI 10.1002/adma.200800360; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Zhao K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.268301	16	161	162	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					159	160		10.1126/science.1174401	http://dx.doi.org/10.1126/science.1174401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589992				2022-12-24	WOS:000267802000034
J	de Waal, FBM				de Waal, Frans B. M.			Darwin's last laugh	NATURE			English	Editorial Material							EVOLUTION		Emory Univ, Yerkes Natl Primate Res Ctr, Living Links Ctr, Atlanta, GA 30322 USA	Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Living Links Ctr, 954 N Gatewood Rd, Atlanta, GA 30322 USA.	dewaal@emory.edu						Bolhuis JJ, 2009, NATURE, V458, P832, DOI 10.1038/458832a; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048	5	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					175	175		10.1038/460175a	http://dx.doi.org/10.1038/460175a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587747				2022-12-24	WOS:000267761000017
J	Guarda, G; Dostert, C; Staehli, F; Cabalzar, K; Castillo, R; Tardivel, A; Schneider, P; Tschopp, J				Guarda, Greta; Dostert, Catherine; Staehli, Francesco; Cabalzar, Katrin; Castillo, Rosa; Tardivel, Aubry; Schneider, Pascal; Tschopp, Juerg			T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes	NATURE			English	Article							DENDRITIC CELLS; LYMPH-NODES; MICE; ACTIVATION; DEFICIENT; CRYSTALS; MEMBERS; FAMILY; MOUSE	Inflammation is a protective attempt by the host to remove injurious stimuli and initiate the tissue healing process(1). The inflammatory response must be actively terminated, however, because failure to do so can result in 'bystander' damage to tissues and diseases such as arthritis or type-2 diabetes. Yet the mechanisms controlling excessive inflammatory responses are still poorly understood. Here we show that mouse effector and memory CD4(+) T cells abolish macrophage inflammasome-mediated caspase-1 activation and subsequent interleukin 1 beta release in a cognate manner. Inflammasome inhibition is observed for all tested NLRP1 (commonly called NALP1) and NLRP3 (NALP3 or cryopyrin) activators, whereas NLRC4 (IPAF) inflammasome function and release of other inflammatory mediators such as CXCL2, interleukin 6 and tumour necrosis factor are not affected. Suppression of the NLRP3 inflammasome requires cell-to-cell contact and can be mimicked by macrophage stimulation with selected ligands of the tumour necrosis factor family, such as CD40L (also known as CD40LG). In a NLRP3-dependent peritonitis model, effector CD4(+) T cells are responsible for decreasing neutrophil recruitment in an antigen-dependent manner. Our findings reveal an unexpected mechanism of inflammasome inhibition, whereby effector and memory T cells suppress potentially damaging inflammation, yet leave the primary inflammatory response, crucial for the onset of immunity, intact.	[Guarda, Greta; Dostert, Catherine; Staehli, Francesco; Cabalzar, Katrin; Castillo, Rosa; Tardivel, Aubry; Schneider, Pascal; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemim Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Guarda, Greta/G-1921-2011; Staehli, Francesco/B-1350-2009; Dostert, Catherine/AAJ-5473-2020	Schneider, Pascal/0000-0003-0677-9409; Guarda, Greta/0000-0001-9243-6116	Swiss National Science foundation; NCCR Molecular Oncology; EMBO	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO))	We thank H. Acha-Orbea, P. Launois, E. Luescher, H. R. MacDonald, P. Romero, M. Kopf and R. Flavell for knockout and transgenic mice; H. Acha-Orbea and M. Eckert for critical reading and comments; A. Yazdi for discussions; and M. Braun and D. Labes for technical help. This work was in part supported by the 4 Swiss National Science foundation and the NCCR Molecular Oncology. C. D. is supported by an EMBO long-term fellowship.	Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Palm NW, 2007, NAT MED, V13, P1142, DOI 10.1038/nm1007-1142b; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	29	195	213	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					269	U136		10.1038/nature08100	http://dx.doi.org/10.1038/nature08100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19494813				2022-12-24	WOS:000267761000043
J	Melander, O; Newton-Cheh, C; Almgren, P; Hedblad, B; Berglund, G; Engstrom, G; Persson, M; Smith, JG; Magnusson, M; Christensson, A; Struck, J; Morgenthaler, NG; Bergmann, A; Pencina, MJ; Wang, TJ				Melander, Olle; Newton-Cheh, Christopher; Almgren, Peter; Hedblad, Bo; Berglund, Goeran; Engstrom, Gunnar; Persson, Margaretha; Smith, J. Gustav; Magnusson, Martin; Christensson, Anders; Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas; Pencina, Michael J.; Wang, Thomas J.			Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; PROATRIAL NATRIURETIC PEPTIDE; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; MULTIPLE BIOMARKERS; PHOSPHOLIPASE A(2); RISK PREDICTION; PRO-ADRENOMEDULLIN; CASE-FATALITY; PREVENTION	Context Prior studies have demonstrated conflicting results regarding how much information novel biomarkers add to cardiovascular risk assessment. Objective To evaluate the utility of contemporary biomarkers for predicting cardiovascular risk when added to conventional risk factors. Design, Setting, and Participants Cohort study of 5067 participants (mean age, 58 years; 60% women) without cardiovascular disease from Malmo, Sweden, who attended a baseline examination between 1991 and 1994. Participants underwent measurement of C-reactive protein (CRP), cystatin C, lipoprotein-associated phospholipase 2, midregional proadrenomedullin (MR-proADM), midregional proatrial natriuretic peptide, and N-terminal pro-B-type natriuretic peptide (N-BNP) and underwent follow-up until 2006 using the Swedish national hospital discharge and cause-of-death registers and the Stroke in Malmo register for first cardiovascular events (myocardial infarction, stroke, coronary death). Main Outcome Measures Incident cardiovascular and coronary events. Results During median follow-up of 12.8 years, there were 418 cardiovascular and 230 coronary events. Models with conventional risk factors had C statistics of 0.758 (95% confidence interval [CI], 0.734 to 0.781) and 0.760 (0.730 to 0.789) for cardiovascular and coronary events, respectively. Biomarkers retained in backward-elimination models were CRP and N-BNP for cardiovascular events and MR-proADM and N-BNP for coronary events, which increased the C statistic by 0.007 (P = .04) and 0.009 (P = .08), respectively. The proportion of participants reclassified was modest (8% for cardiovascular risk, 5% for coronary risk). Net reclassification improvement was nonsignificant for cardiovascular events (0.0%; 95% CI, -4.3% to 4.3%) and coronary events (4.7%; 95% CI, -0.76% to 10.1%). Greater improvements were observed in analyses restricted to intermediate-risk individuals (cardiovascular events: 7.4%; 95% CI, 0.7% to 14.1%; P = .03; coronary events: 14.6%; 95% CI, 5.0% to 24.2%; P = .003). However, correct reclassification was almost entirely confined to down-classification of individuals without events rather than up-classification of those with events. Conclusions Selected biomarkers may be used to predict future cardiovascular events, but the gains over conventional risk factors are minimal. Risk classification improved in intermediate-risk individuals, mainly through the identification of those unlikely to develop events. JAMA. 2009;302(1):49-57	[Melander, Olle; Almgren, Peter; Hedblad, Bo; Berglund, Goeran; Engstrom, Gunnar; Persson, Margaretha; Smith, J. Gustav; Magnusson, Martin; Christensson, Anders] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Newton-Cheh, Christopher; Smith, J. Gustav] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas] BRAHMS AG, Res Dept, Hennigsdorf, Germany; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA	Lund University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Thermo Fisher Scientific; Brahms AG; Boston University	Melander, O (corresponding author), Lund Univ, Clin Res Ctr, Dept Clin Sci, Malmo Univ Hosp, Entrance 72,Bldg 91,Floor 12, SE-20502 Malmo, Sweden.	olle.melander@med.lu.se; tjwang@partners.org	Magnusson, Martin/AAE-1185-2020	Magnusson, Martin/0000-0003-1710-5936; Pencina, Michael/0000-0001-5798-8855; Engstrom, Gunnar/0000-0002-8618-9152; Melander, Olle/0000-0002-2581-484X; Persson, Margaretha/0000-0001-8188-5792; Christensson, Anders/0000-0002-7328-8418; Wang, Thomas/0000-0003-4063-6508	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Wallenberg Foundation; National Institutes of Health (NIH) [K23-HL-080025, R01-HL-086875, R01-HL083197, R01-DK-081572]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL080025, R01HL083197, R01HL086875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Wallenberg Foundation(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Melander was supported by grants from the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund, and the Wallenberg Foundation. Dr Newton-Cheh was supported by National Institutes of Health (NIH) grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. Dr Wang was supported by NIH grants R01-HL-086875, R01-HL083197, and R01-DK-081572 and by a grant from the American Heart Association.	Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Corson MA, 2008, AM J CARDIOL, V101, p41F, DOI 10.1016/j.amjcard.2008.04.018; D'Agostino RB, 2004, HDB STAT, P1; de Lemos JA, 2008, NEW ENGL J MED, V358, P2172, DOI 10.1056/NEJMe0801721; Di Serio F, 2005, CLIN CHEM LAB MED, V43, P1263, DOI 10.1515/CCLM.2005.217; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Garza CA, 2007, MAYO CLIN PROC, V82, P159; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Khan SQ, 2008, J AM COLL CARDIOL, V51, P1857, DOI 10.1016/j.jacc.2008.01.041; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; *NAT BOARD HLTH WE, 2000, EV QUAL DIAGN AC MYO; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2007, JAMA-J AM MED ASSOC, V298, P176, DOI 10.1001/jama.298.2.176-a; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	40	435	465	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					49	57		10.1001/jama.2009.943	http://dx.doi.org/10.1001/jama.2009.943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567439	Bronze, Green Accepted			2022-12-24	WOS:000267492800021
J	Degos, L; Amalberti, R; Bacou, J; Carlet, J; Bruneau, C				Degos, Laurent; Amalberti, Rene; Bacou, Jean; Carlet, Jean; Bruneau, Charles			Breaking the mould in patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; PRIMARY-CARE; HEALTH; PROPHYLAXIS; ANESTHESIA; MORTALITY; SYSTEMS		[Degos, Laurent; Amalberti, Rene; Bacou, Jean; Carlet, Jean; Bruneau, Charles] HAS, F-93218 La Plaine St Denis, France		Amalberti, R (corresponding author), HAS, 2 Ave Stade France, F-93218 La Plaine St Denis, France.	r.amalberti@has-sante.fr						Auroy Y, 2009, ANESTHESIOLOGY, V110, P209, DOI 10.1097/ALN.0b013e318194caea; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bellam S, 2008, ARCH INTERN MED, V168, P2404, DOI 10.1001/archinte.168.22.2404; Berry LL, 2003, ANN INTERN MED, V139, P568, DOI 10.7326/0003-4819-139-7-200310070-00009; Botney R, 2008, INT J RADIAT ONCOL, V71, pS182, DOI 10.1016/j.ijrobp.2007.05.095; Bramhall SR, 2001, WORLD J GASTROENTERO, V7, P602; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Cameron JI, 2008, STROKE, V39, P2637, DOI 10.1161/STROKEAHA.107.501064; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Donnan Geoffrey A, 2003, Adv Neurol, V92, P347; Dorner D., 1996, LOGIC FAILURE WHY TH; FABRY J, 2002, HELICS FINAL REPORT; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gusmano MK, 2006, HEALTH AFFAIR, V25, P510, DOI 10.1377/hlthaff.25.2.510; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lester H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2095; Lienhart A, 2006, ANESTHESIOLOGY, V105, P1087, DOI 10.1097/00000542-200612000-00008; Longo DR, 2005, JAMA-J AM MED ASSOC, V294, P2858, DOI 10.1001/jama.294.22.2858; Michel P, 2007, QUAL SAF HEALTH CARE, V16, P369, DOI 10.1136/qshc.2005.016964; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Olsson Lars-Eric, 2006, J Orthop Surg Res, V1, P3, DOI 10.1186/1749-799X-1-3; *ORG EC COOP DEV, 2006, HLTH CAR QUAL IND PR; OVRETVEIT J, 2005, WHICH INTERVENTIONS; Royal S, 2006, QUAL SAF HEALTH CARE, V15, P23, DOI 10.1136/qshc.2004.012153; Schiele F, 2005, EUR HEART J, V26, P873, DOI 10.1093/eurheartj/ehi107; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Smith PC, 2005, JAMA-J AM MED ASSOC, V293, P565, DOI 10.1001/jama.293.5.565; STUART B, 2008, DIS BURDEN INFLUENCE; VINCENT C, 2001, CLIN RISK MANAGEMENT; Vincent C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2426; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225	35	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2009	339								b2585	10.1136/bmj.b2585	http://dx.doi.org/10.1136/bmj.b2585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QV	19564180				2022-12-24	WOS:000267678300005
J	Moloney, A				Moloney, Anastasia			Caring for Colombia's landmine survivors	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2013	2014		10.1016/S0140-6736(09)61095-3	http://dx.doi.org/10.1016/S0140-6736(09)61095-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19533833	Bronze			2022-12-24	WOS:000267080100012
J	Zaridze, D; Brennan, P; Boreham, J; Boroda, A; Karpov, R; Lazarev, A; Konobeevskaya, I; Igitov, V; Terechova, T; Boffetta, P; Peto, R				Zaridze, David; Brennan, Paul; Boreham, Jillian; Boroda, Alex; Karpov, Rostislav; Lazarev, Alexander; Konobeevskaya, Irina; Igitov, Vladimir; Terechova, Tatiana; Boffetta, Paolo; Peto, Richard			Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths	LANCET			English	Article							BINGE DRINKING; RISK-FACTOR; CONSUMPTION; DISEASE; TRENDS; RATES	Background Alcohol is an important determinant of the high and fluctuating adult mortality rates in Russia, but cause-specific detail is lacking. Our case-control study investigated the effects of alcohol consumption on male and female cause-specific mortality. Methods In three Russian industrial cities with typical 1990s mortality patterns (Tomsk, Bamaul, Biysk), the addresses of 60416 residents who had died at ages 15-74 years in 1990-2001 were visited in 2001-05. Family members were present for 50 066 decedents; for 48 557 (97%), the family gave proxy information on the decedents' past alcohol use and on potentially confounding factors. Cases (n=43082) were those certified as dying from causes we judged beforehand might be substantially affected by alcohol or tobacco; controls were the other 5475 decedents. Case versus control relative risks (RRs; calculated as odds ratios by confounder-adjusted logistic regression) were calculated in ever-drinkers, defining the reference category by two criteria: usual weekly consumption always less than 0.5 half-litre bottles of vodka (or equivalent in total alcohol content) and maximum consumption of spirits in 1 day always less than 0.5 half-litre bottles. Other ever-drinkers were classified by usual weekly consumption into three categories: less than one, one to less than three, and three or more (mean 5.4 [SD 1.4]) bottles of vodka or equivalent. Findings In men, the three causes accounting for the most alcohol-associated deaths were accidents and violence (RR 5.94, 95% CI 5.35-6.59, in the highest consumption category), alcohol poisoning (21.68, 17.94-26.20), and acute ischaemic heart disease other than myocardial infarction (3.04, 2.73-3.39), which includes some misclassified alcohol poisoning. There were significant excesses of upper aerodigestive tract cancer (3.48, 2.84-4.27) and liver cancer (2.11, 1.64-2.70). Another five disease groups had RRs of more than 3.00 in the highest alcohol category: tuberculosis (4.14, 3.44-4.98), pneumonia (3.29, 2.83-3.83), liver disease (6.21, 5.16-7.47), pancreatic disease (6.69, 4.98-9.00), and ill-specified conditions (7.74, 6.48-9.25). Although drinking was less common in women, the RRs associated with it were generally more extreme. After correction for reporting errors, alcohol-associated excesses accounted for 52% of all study deaths at ages 15-54 years (men 8182 [59%] of 13968, women 1565 [33%] of 4751) and 18% of those at 55-74 years (men 3944 [22%] of 17 536, women 1493 [12%] of 12 302). Allowance for under-representation of extreme drinkers would further increase alcohol-associated proportions. Large fluctuations in mortality from these ten strongly alcohol-associated causes were the main determinants of recent fluctuations in overall mortality in the study region and in Russia as a whole. Interpretation Alcohol-attributable mortality varies by year; in several recent years, alcohol was a cause of more than half of all Russian deaths at ages 15-54 years. Alcohol accounts for most of the large fluctuations in Russian mortality, and alcohol and tobacco account for the large difference in adult mortality between Russia and western Europe. Funding UK Medical Research Council, Cancer Research UK, British Heart Foundation, International Agency for Research on Cancer, and European Commission Directorate-General for Research.	[Zaridze, David; Boroda, Alex] Russian Canc Res Ctr, Moscow, Russia; [Brennan, Paul; Boffetta, Paolo] Int Agcy Res Canc, F-69372 Lyon, France; [Boreham, Jillian; Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Boreham, Jillian; Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Karpov, Rostislav; Konobeevskaya, Irina] Tomsk Res Ctr, Inst Cardiol, Tomsk, Russia; [Lazarev, Alexander; Igitov, Vladimir; Terechova, Tatiana] Russian Canc Res Ctr, Altai Branch, Barnaul, Russia	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; University of Oxford; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk	Zaridze, D (corresponding author), NN Blokhin Russian Canc Res Ctr, Dept Epidemiol & Prevent, Kashirskoye Shosse 24, Moscow 115478, Russia.	dgzaridze@crc.umos.ru; secretary@ctsu.ox.ac.uk	Zaridze, David/K-5605-2013; Boroda, Alexander/K-5129-2013; Konobeevskaya, Irina/J-4519-2017; Karpov, Rostislav S./F-5406-2014; Boffetta, Paolo/AAI-7767-2021	Konobeevskaya, Irina/0000-0002-4843-6642; Karpov, Rostislav S./0000-0002-7011-4316; Boffetta, Paolo/0000-0002-3811-2791; Karpov, Rostislav S./0000-0001-8578-6636; Boroda, Alexander/0000-0002-4196-6042	UK Medical Research Council; Cancer Research UK; British Heart Foundation; IARC collaborative research agreements [GEE/07/05, GEP/08/07]; EC D-G [ICA2-1999-10139, ICA2-CT-200110002]; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); IARC collaborative research agreements; EC D-G; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by CTSU core support from the UK Medical Research Council, Cancer Research UK, and British Heart Foundation, IARC collaborative research agreements (GEE/07/05 & GEP/08/07), and EC D-G for Research (grants ICA2-1999-10139 & ICA2-CT-200110002). We thank the field workers for their help and the interviewees for their cooperation.	ALLEN T, 2009, J NATL CANCER I, V101, P282; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x; IARC, 1988, IARC MON EV CARC RIS, V44; Kristiansen L, 2008, AM J EPIDEMIOL, V168, P932, DOI 10.1093/aje/kwn222; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Nemtsov AV, 2000, DRUG ALCOHOL DEPEN, V58, P133, DOI 10.1016/S0376-8716(99)00069-1; NICKOLSON A, 2005, B WORLD HEALTH ORGAN, V83, P812; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, DEATHS SMOKING; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2009, INT J EPIDEMIOL, V38, P154, DOI 10.1093/ije/dyn209; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; SHESTOV DB, 1993, CIRCULATION, V88, P846, DOI 10.1161/01.CIR.88.3.846; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov V, 2004, DEMRES, V2, P71; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; UN Population Division, 2005, WORLD POP PROSP; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; World Health Organization, 2007, WHO STAT INF SYST WH; World Health Organization, 1992, INT CLASS DIS REL HL; ZARIDZE D, 1986, IARC SCI PUBLICATION, V74; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	34	219	240	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2201	2214		10.1016/S0140-6736(09)61034-5	http://dx.doi.org/10.1016/S0140-6736(09)61034-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560602	Green Published, Bronze			2022-12-24	WOS:000267444500032
J	Deng, YB; Guo, XL; Ferguson, DO; Chang, S				Deng, Yibin; Guo, Xiaolan; Ferguson, David O.; Chang, Sandy			Multiple roles for MRE11 at uncapped telomeres	NATURE			English	Article							DOUBLE-STRAND BREAK; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; ATM ACTIVATION; COMPLEX; REPAIR; TRF2; POT1	Progressive telomere attrition or uncapping of the shelterin complex elicits a DNA damage response as a result of a cell's inability to distinguish dysfunctional telomeric ends from DNA double-strand breaks(1). Telomere deprotection activates both ataxia telangiectasia mutated (ATM) and telangiectasia and Rad3-related (ATR) kinase-dependent DNA damage response pathways, and promotes efficient non-homologous end-joining (NHEJ) of dysfunctional telomeres(2-5). The mammalian MRE11-RAD50-NBS1 (MRN; NBS1 is also known as NBN) complex interacts with ATM to sense chromosomal double-strand breaks and coordinate global DNA damage responses(6,7). Although the MRN complex accumulates at dysfunctional telomeres, it is not known whether mammalian MRN promotes repair at these sites. Here we address this question by using mouse alleles that either inactivate the entire MRN complex or eliminate only the nuclease activities of MRE11 (ref. 8). We show that cells lacking MRN do not activate ATM when telomeric repeat binding factor 2 (TRF2) is removed from telomeres, and ligase 4 (LIG4)-dependent chromosome end-to-end fusions are markedly reduced. Residual chromatid fusions involve only telomeres generated by leading strand synthesis. Notably, although cells deficient for MRE11 nuclease activity efficiently activate ATM and recruit 53BP1 (also known as TP53BP1) to deprotected telomeres, the 3' telomeric overhang persists to prevent NHEJ-mediated chromosomal fusions. Removal of shelterin proteins that protect the 3' overhang in the setting of MRE11 nuclease deficiency restores LIG4-dependent chromosome fusions. Our data indicate a critical role for the MRN complex in sensing dysfunctional telomeres, and show that in the absence of TRF2, MRE11 nuclease activity removes the 3' telomeric overhang to promote chromosome fusions. MRE11 can also protect newly replicated leading strand telomeres from NHEJ by promoting 5' strand resection to generate POT1a-TPP1-bound 3' overhangs.	[Deng, Yibin; Guo, Xiaolan; Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Guo, Xiaolan] N Sichuan Med Coll, Inst Rheumatol & Immunol, Nanchong 637000, Sichuan, Peoples R China; [Ferguson, David O.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; North Sichuan Medical University; University of Michigan System; University of Michigan	Chang, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Box 1010,1515 Holcombe Blvd, Houston, TX 77030 USA.	schang@mdanderson.org		Deng, Yibin/0000-0001-5711-3565	National Institute on Aging (NIA) [RO1 AG028888]; National Cancer Institute (NCI) [RO1 CA129037]; Welch Foundation; Susan G. Koman Race for the Cure Foundation; Abraham and Phyllis Katz Foundation; Michael Kadoorie Cancer Genetic Research Program; NCI Howard Temin Award [K01CA124461]; NATIONAL CANCER INSTITUTE [R01CA129037, P30CA046592, K01CA124461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028888] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Susan G. Koman Race for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Abraham and Phyllis Katz Foundation; Michael Kadoorie Cancer Genetic Research Program; NCI Howard Temin Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to M. Zhao, Z. Lu, P. Iyengar and J. Buis for technical help. Both J. Karlseder and P. Carpenter are thanked for providing antibodies. S. C. acknowledges financial support from the National Institute on Aging (NIA) (RO1 AG028888), the National Cancer Institute (NCI) (RO1 CA129037), the Welch Foundation, the Susan G. Koman Race for the Cure Foundation, the Abraham and Phyllis Katz Foundation and the Michael Kadoorie Cancer Genetic Research Program. Y. D. was supported by an NCI Howard Temin Award (K01CA124461).	Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DINKELMANN M, NATURE STRU IN PRESS; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	153	160	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					914	U157		10.1038/nature08196	http://dx.doi.org/10.1038/nature08196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633651	Green Accepted			2022-12-24	WOS:000268938300043
J	Willems, PA				Willems, Paul A.			The Biofuels Landscape Through the Lens of Industrial Chemistry	SCIENCE			English	Editorial Material								Replacing petroleum feedstock with biomass in the production of fuels and value-added chemicals carries considerable appeal. As in industrial chemistry more broadly, high-throughput experimentation has greatly facilitated innovation in small-scale exploration of biomass production and processing. Yet biomass is hard to transport, potentially hindering the integration of manufacturing-scale processes. Moreover, the path from laboratory breakthrough to commercial production remains as tortuous as ever.	Univ Calif Berkeley, Energy Biosci Inst, Calvin Lab 326, BP Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Willems, PA (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Calvin Lab 326, BP Grp, MC 5230, Berkeley, CA 94720 USA.								0	31	31	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					707	708		10.1126/science.1175502	http://dx.doi.org/10.1126/science.1175502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661419				2022-12-24	WOS:000268723700037
J	Palioura, S; Sherrer, RL; Steitz, TA; Soll, D; Simonovic, M				Palioura, Sotiria; Sherrer, R. Lynn; Steitz, Thomas A.; Soell, Dieter; Simonovic, Miljan			The Human SepSecS-tRNA(Sec) Complex Reveals the Mechanism of Selenocysteine Formation	SCIENCE			English	Article							TRANSFER-RNA; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; SYNTHASE; ARCHAEA	Selenocysteine is the only genetically encoded amino acid in humans whose biosynthesis occurs on its cognate transfer RNA (tRNA). O-Phosphoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS) catalyzes the final step of selenocysteine formation by a poorly understood tRNA-dependent mechanism. The crystal structure of human tRNA(Sec) in complex with SepSecS, phosphoserine, and thiophosphate, together with in vivo and in vitro enzyme assays, supports a pyridoxal phosphate-dependent mechanism of Sec-tRNA(Sec) formation. Two tRNA(Sec) molecules, with a fold distinct from other canonical tRNAs, bind to each SepSecS tetramer through their 13-base pair acceptor-T Psi C arm (where Psi indicates pseudouridine). The tRNA binding is likely to induce a conformational change in the enzyme's active site that allows a phosphoserine covalently attached to tRNA(Sec), but not free phosphoserine, to be oriented properly for the reaction to occur.	[Palioura, Sotiria; Sherrer, R. Lynn; Steitz, Thomas A.; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.; Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; msimon5@uic.edu	Steitz, Thomas A./C-6559-2009	Simonovic, Miljan/0000-0002-1576-2222; Sherrer, Lynn/0000-0001-9771-9035	DOE; NIGMS; HHMI, Yale University; Yale University School of Medicine MD/PhD Program; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI, Yale University(Howard Hughes Medical Institute); Yale University School of Medicine MD/PhD Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from DOE (to D.S.) and NIGMS (to T.A.S. and D.S.). In the initial phase of this study M.S. was supported by HHMI at Yale University. S.P. holds a fellowship of the Yale University School of Medicine MD/PhD Program. R.L.S. was supported by a Ruth L. Kirschstein National Research Service Award. Authors contributions, S.P. designed the research, collected and analyzed the data, and wrote the manuscript, R.L.S. did research and read the manuscript, T.A.S. designed the research and wrote the manuscript, D.S. designed the research and wrote the manuscript, M.S. designed the research, collected and analyzed the data, and wrote the manuscript.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOCK A, 2005, AMINOACYL TRNA SYNTH, P320; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Herkel Johannes, 2007, Hepatology, V46, P275, DOI 10.1002/hep.21807; Ioudovitch A, 1998, RNA, V4, P365; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; STURCHLER C, 1993, NUCLEIC ACIDS RES, V21, P1073, DOI 10.1093/nar/21.5.1073; Su D, 2009, IUBMB LIFE, V61, P35, DOI 10.1002/iub.136; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	22	111	116	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					321	325		10.1126/science.1173755	http://dx.doi.org/10.1126/science.1173755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608919	Green Accepted			2022-12-24	WOS:000268036600046
J	Gura, T				Gura, Trisha			Driving Biofuels from Field to Fuel Tank	CELL			English	Editorial Material								Rising oil prices, fears of global warming, and instability in oil-producing countries have ignited the rush to produce biofuels from plants. The science is progressing rapidly, driven by favorable policies and generous financing, but many hurdles remain before cars and trucks run on "gasohol" or "grassoline."											0	6	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					9	12		10.1016/j.cell.2009.06.038	http://dx.doi.org/10.1016/j.cell.2009.06.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596227	Bronze			2022-12-24	WOS:000267848600006
J	Li, DH; Morris, JS; Liu, J; Hassan, MM; Day, RS; Bondy, ML; Abbruzzese, JL				Li, Donghui; Morris, Jeffrey S.; Liu, Jun; Hassan, Manal M.; Day, R. Sue; Bondy, Melissa L.; Abbruzzese, James L.			Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; ANTHROPOMETRIC FACTORS; OBESITY; POPULATION; OVERWEIGHT; ADIPOSITY; ADULTS; METAANALYSIS; ASSOCIATION; PREVALENCE	Context Obesity has been implicated as a risk factor for pancreatic cancer. Objective To demonstrate the association of excess body weight across an age cohort and the risk, age of onset, and overall survival of patients with pancreatic cancer. Design, Setting, and Participants A case-control study of 841 patients with pancreatic adenocarcinoma and 754 healthy individuals frequency matched by age, race, and sex. The study was conducted at a university cancer center in the United States from 2004 to 2008. Height and body weight histories were collected by personal interview starting at ages 14 to 19 years and over 10-year intervals progressing to the year prior to recruitment in the study. Main Outcome Measures The associations between patients' body mass index (BMI) and risk of pancreatic cancer, age at onset, and overall survival were examined by unconditional logistic regression, linear regression, and Cox proportional hazard regression models, respectively. Results Individuals who were overweight (a BMI of 25-29.9) from the ages of 14 to 39 years (highest odds ratio [OR], 1.67; 95% confidence interval [CI], 1.20-2.34) or obese (a BMI >= 30) from the ages of 20 to 49 years (highest OR, 2.58; 95% CI, 1.70-3.90) had an associated increased risk of pancreatic cancer, independent of diabetes status. The association was stronger in men (adjusted OR, 1.80; 95% CI, 1.45-2.23) by mean BMI from the ages of 14 to 59 years than in women (adjusted OR, 1.32; 95% CI, 1.02-1.70) and in ever smokers (adjusted OR, 1.75; 95% CI, 1.37-2.22) than in never smokers (adjusted OR, 1.46; 95% CI, 1.16-1.84). The population-attributable risk percentage of pancreatic cancer based on the mean BMI from the ages of 14 to 59 years was 10.3% for never smokers and 21.3% for ever smokers. Individuals who were overweight or obese from the ages of 20 to 49 years had an earlier onset of pancreatic cancer by 2 to 6 years (median age of onset was 64 years for patients with normal weight, 61 years for overweight patients [P = .02], and 59 years for obese patients [P < .001]). Compared with those with normal body weight and after adjusting for all clinical factors, individuals who were overweight or obese from the ages of 30 to 79 years or in the year prior to recruitment had reduced overall survival of pancreatic cancer regardless of disease stage and tumor resection status (overweight patients: hazard ratio, 1.26 [95% CI, 0.94-1.69], P = .04; obese patients: hazard ratio, 1.86 [95% CI, 1.35-2.56], P < .001). Conclusions Overweight or obesity during early adulthood was associated with a greater risk of pancreatic cancer and a younger age of disease onset. Obesity at an older age was associated with a lower overall survival in patients with pancreatic cancer. JAMA. 2009; 301(24):2553-2562	[Li, Donghui] Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Bondy, Melissa L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Morris, Jeffrey S.; Liu, Jun] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Day, R. Sue] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Li, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dli@mdanderson.org			National Institutes of Health [CA98380, CA101936]; M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA098380, P20CA101936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: This study was supported by National Institutes of Health grants CA98380 and CA101936 (SPORE P20) and a multidisciplinary research program grant from M. D. Anderson Cancer Center.	BEINE J, SOCIAL SECURITY DEAT; Berkey CS, 1998, OBES RES, V6, P187, DOI 10.1002/j.1550-8528.1998.tb00336.x; Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; de Gonzalez AB, 2006, CANCER EPIDEM BIOMAR, V15, P879, DOI 10.1158/1055-9965.EPI-05-0800; Eberle CA, 2005, CANCER CAUSE CONTROL, V16, P1235, DOI 10.1007/s10552-005-0354-y; Efstathiou JA, 2007, CANCER-AM CANCER SOC, V110, P2691, DOI 10.1002/cncr.23093; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleming JB, 2009, ARCH SURG-CHICAGO, V144, P216, DOI 10.1001/archsurg.2008.580; Fryzek JP, 2005, AM J EPIDEMIOL, V162, P222, DOI 10.1093/aje/kwi183; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greene FL, 2002, AJCC CANC STAGING MA, P157, DOI DOI 10.1007/978-1-4757-3656-4_18; Hanley AJG, 2001, INT J CANCER, V94, P140, DOI 10.1002/ijc.1446; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; James TA, 2004, CANCER-AM CANCER SOC, V101, P2722, DOI 10.1002/cncr.20700; Larsson SC, 2005, BRIT J CANCER, V93, P1310, DOI 10.1038/sj.bjc.6602868; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Lin YS, 2007, INT J CANCER, V120, P2665, DOI 10.1002/ijc.22614; McWilliams RR, 2006, CLIN GASTROENTEROL H, V4, P1143, DOI 10.1016/j.cgh.2006.05.029; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P2678, DOI 10.1158/1055-9965.EPI-05-0428; Nothlings U, 2007, CANCER CAUSE CONTROL, V18, P165, DOI 10.1007/s10552-006-0100-0; Noun R, 2008, J PANCREAS, V9, P468; Park SM, 2007, J CLIN ONCOL, V25, P4835, DOI 10.1200/JCO.2006.10.3416; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; SMITH DE, 1994, JAMA-J AM MED ASSOC, V271, P1747, DOI 10.1001/jama.271.22.1747; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stolzenberg-Solomon RZ, 2008, AM J EPIDEMIOL, V167, P586, DOI 10.1093/aje/kwm361; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593	39	299	314	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2553	2562		10.1001/jama.2009.886	http://dx.doi.org/10.1001/jama.2009.886			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549972	Bronze, Green Accepted			2022-12-24	WOS:000267266500020
J	Coombes, R				Coombes, Rebecca			Public Health Vaccine disputes	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEASLES					rcoombes@bmjgroup.com						Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; [Anonymous], 2009, NY TIMES        0113; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Grigg M. A., 2008, Morbidity and Mortality Weekly Report, V57, P893; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; 2008, JAMA, V299, P1660	9	7	7	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2009	338								b2435	10.1136/bmj.b2435	http://dx.doi.org/10.1136/bmj.b2435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MK	19546136				2022-12-24	WOS:000267436100011
J	Severinghaus, JP; Beaudette, R; Headly, MA; Taylor, K; Brook, EJ				Severinghaus, Jeffrey P.; Beaudette, Ross; Headly, Melissa A.; Taylor, Kendrick; Brook, Edward J.			Oxygen-18 of O-2 Records the Impact of Abrupt Climate Change on the Terrestrial Biosphere	SCIENCE			English	Article							MILLENNIAL-SCALE; ASIAN MONSOON; ISOTOPIC COMPOSITION; ATMOSPHERIC OXYGEN; HIGH-RESOLUTION; GREENLAND; ANTARCTICA; FRACTIONATION; HOLOCENE; OCEAN	Photosynthesis and respiration occur widely on Earth's surface, and the O-18/O-16 ratio of the oxygen produced and consumed varies with climatic conditions. As a consequence, the history of climate is reflected in the deviation of the O-18/O-16 of air (delta O-18(atm)) from seawater delta O-18 (known as the Dole effect). We report variations in delta O-18(atm) over the past 60,000 years related to Heinrich and Dansgaard-Oeschger events, two modes of abrupt climate change observed during the last ice age. Correlations with cave records support the hypothesis that the Dole effect is primarily governed by the strength of the Asian and North African monsoons and confirm that widespread changes in low-latitude terrestrial rainfall accompanied abrupt climate change. The rapid delta O-18(atm) changes can also be used to synchronize ice records by providing global time markers.	[Severinghaus, Jeffrey P.; Beaudette, Ross; Headly, Melissa A.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Taylor, Kendrick] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Brook, Edward J.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Oregon State University	Severinghaus, JP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA.	jseveringhaus@ucsd.edu	Taylor, Kendrick/A-3469-2016; Brook, Edward/AAB-7807-2021	Taylor, Kendrick/0000-0001-8535-1261; Severinghaus, Jeffrey/0000-0001-8883-3119	NSF [NSF-OPP 04-40975, NSF-OPP 01-26057, NSF-OPP 95-26421]; Gary Comer Science and Education Foundation	NSF(National Science Foundation (NSF)); Gary Comer Science and Education Foundation	We thank B. Luz, L. Edwards, R. Keeling, M. Bender, A. Landais, K. Kawamura, C. Wunsch, G. Farquhar, and W. Broecker for helpful conversations. B. Cornuelle did the Fourier-series curve fitting. M. Henkart analyzed the tank of air from 1976 to test for anthropogenic change in the Dole effect. We thank J. Rhoades and the staff of the National Ice Core Laboratory for help in sampling the Siple Dome ice core. This work was supported by NSF-OPP 04-40975 (J.P.S), NSF-OPP 01-26057 (E.J.B), and the Gary Comer Science and Education Foundation, and recovery of the Siple Dome ice core was supported by NSF-OPP 95-26421 (K.T.).	Alley RB, 1999, GEOPH MONOG SERIES, V112, P385; Angert A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002056; Barkan E, 2005, RAPID COMMUN MASS SP, V19, P3737, DOI 10.1002/rcm.2250; BARKAN E, 2009, P GOLDSCHM 2009 DAV; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; Bender ML, 1999, GEOPH MONOG SERIES, V112, P149; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Brook EJ, 2005, QUATERNARY SCI REV, V24, P1333, DOI 10.1016/j.quascirev.2005.02.002; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Campen RK, 2003, GEOLOGY, V31, P231, DOI 10.1130/0091-7613(2003)031<0231:EOMCMW>2.0.CO;2; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; CHIANG JCH, 2008, GEOPHYS RES LETT, V35, DOI DOI 10.1029/2008GL033292; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; DENTON GH, 2006, PAGES NEWS, V14, P1416; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Farquhar GD, 2007, PLANT PHYSIOL, V143, P11, DOI 10.1104/pp.106.093278; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Hendricks MB, 2004, DEEP-SEA RES PT I, V51, P1541, DOI 10.1016/j.dsr.2004.06.006; Landais A, 2007, EARTH PLANET SC LETT, V258, P101, DOI 10.1016/j.epsl.2007.03.027; Malaize B, 1999, J GEOPHYS RES-ATMOS, V104, P14199, DOI 10.1029/1999JD900116; Masson V, 2000, GEOPHYS RES LETT, V27, P1747, DOI 10.1029/1999GL006070; Melieres MA, 1997, GEOPHYS RES LETT, V24, P1235, DOI 10.1029/97GL01025; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Petrenko VV, 2006, QUATERNARY SCI REV, V25, P865, DOI 10.1016/j.quascirev.2005.09.005; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; SOWERS T, 1989, J GEOPHYS RES-ATMOS, V94, P5137, DOI 10.1029/JD094iD04p05137; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wunsch C, 2003, QUATERNARY SCI REV, V22, P1631, DOI 10.1016/S0277-3791(03)00152-5	36	112	114	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1431	1434		10.1126/science.1169473	http://dx.doi.org/10.1126/science.1169473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520957				2022-12-24	WOS:000266878700042
J	Sun, YG; Zhao, ZQ; Meng, XL; Yin, J; Liu, XY; Chen, ZF				Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng			Cellular Basis of Itch Sensation	SCIENCE			English	Article							SPINOTHALAMIC TRACT NEURONS; SUBSTANCE-P RECEPTOR; NEURAL PATHWAY; SPINAL-CORD; LAMINAE-I; PRURITUS; MICE; INHIBITION; HISTAMINE; AGENTS	Itch and pain are two distinct sensations. Although our previous study suggested that gastrin-releasing peptide receptor (GRPR) is an itch-specific gene in the spinal cord, a long-standing question of whether there are separate neuronal pathways for itch and pain remains unsettled. We selectively ablated lamina I neurons expressing GRPR in the spinal cord of mice. These mice showed profound scratching deficits in response to all of the itching (pruritogenic) stimuli tested, irrespective of their histamine dependence. In contrast, pain behaviors were unaffected. Our data also suggest that GRPR(+) neurons are different from the spinothalamic tract neurons that have been the focus of the debate. Together, the present study suggests that GRPR(+) neurons constitute a long-sought labeled line for itch sensation in the spinal cord.	[Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr, St Louis, MO 63110 USA; [Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, Pain Ctr, St Louis, MO 63110 USA; [Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, Pain Ctr, St Louis, MO 63110 USA; [Meng, Xiu-Li] Peking Univ, Hosp 3, Dept Anesthesiol, Beijing 100191, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peking University	Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr, St Louis, MO 63110 USA.	chenz@wustl.edu	LIU, XIANYU/B-8111-2014	Liu, Xianyu/0000-0001-6089-8826	NIH [P30 NS057105]; Washington University Pain Center Animal Behavior Core; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS046036, P01NS049048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Pain Center Animal Behavior Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Y. Kim and S. Y. Kim for technical help, J. Battey for GRPR mutant mice, and R. LaMotte for comments. The work was supported by a NIH grant to Z. F. C and by the Washington University Pain Center Animal Behavior Core and NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 NS057105 to Washington University. The work presented in this report is the subject of a pending patent filed by Washington University in St. Louis.	Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Bickford RG, 1938, CLIN SCI, V3, P337; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Hyndman OR, 1943, ARCH NEURO PSYCHIATR, V50, P129, DOI 10.1001/archneurpsyc.1943.02290200029002; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Rothman S, 1941, PHYSIOL REV, V21, P357, DOI 10.1152/physrev.1941.21.2.357; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; SHELLEY WB, 1957, ARCH DERMATOL, V76, P296, DOI 10.1001/archderm.1957.01550210020004; Simone DA, 2004, J NEUROPHYSIOL, V91, P213, DOI 10.1152/jn.00527.2003; SOWUNMI A, 1989, LANCET, V2, P213; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Tuckett R. P, 1994, ITCH MECH MANAGEMENT, P1; VANDERSTEEN PHM, 1991, J AM ACAD DERMATOL, V24, P253, DOI 10.1016/0190-9622(91)70037-3; von Frey M., 1922, ARCH NEERLAND PHYSL, V7, P142; Wahlgren Carl-Fredrik, 1999, Journal of Dermatology (Tokyo), V26, P770	28	408	424	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1531	1534		10.1126/science.1174868	http://dx.doi.org/10.1126/science.1174868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19661382	Green Accepted			2022-12-24	WOS:000269887900036
J	Fekairi, S; Scaglione, S; Chahwan, C; Taylor, ER; Tissier, A; Coulon, S; Dong, MQ; Ruse, C; Yates, JR; Russell, P; Fuchs, RP; McGowan, CH; Gaillard, PHL				Fekairi, Samira; Scaglione, Sarah; Chahwan, Charly; Taylor, Ewan R.; Tissier, Agnes; Coulon, Stephane; Dong, Meng-Qiu; Ruse, Cristian; Yates, John R., III; Russell, Paul; Fuchs, Robert P.; McGowan, Clare H.; Gaillard, Pierre-Henri L.			Human SLX4 Is a Holliday Junction Resolvase Subunit that Binds Multiple DNA Repair/Recombination Endonucleases	CELL			English	Article							REPLICATION FORK PROGRESSION; PROMOTES REPLICATION; UBIQUITIN LIGASE; RIBOSOMAL DNA; REPAIR GENE; PROTEIN; RECOMBINATION; RESOLUTION; DAMAGE; MUS81-EME1	Structure-specific endonucleases resolve DNA secondary structures generated during DNA repair and recombination. The yeast 50 flap endonuclease Slx1-Slx4 has received particular attention with the finding that Slx4 has Slx1-independent key functions in genome maintenance. Although Slx1 is a highly conserved protein in eukaryotes, no orthologs of Slx4 were reported other than in fungi. Here we report the identification of Slx4 orthologs in metazoa, including fly MUS312, essential for meiotic recombination, and human BTBD12, an ATM/ATR checkpoint kinase substrate. Human SLX1-SLX4 displays robust Holliday junction resolvase activity in addition to 50 flap endonuclease activity. Depletion of SLX1 and SLX4 results in 53BP1 foci accumulation and H2AX phosphorylation as well as cellular hypersensitivity to MMS. Furthermore, we show that SLX4 binds the XPF ERCC4 and MUS81 subunits of the XPF-ERCC1 and MUS81-EME1 endonucleases and is required for DNA interstrand crosslink repair. We propose that SLX4 acts as a docking platform for multiple structure-specific endonucleases.	[Fekairi, Samira; Scaglione, Sarah; Tissier, Agnes; Coulon, Stephane; Fuchs, Robert P.; Gaillard, Pierre-Henri L.] Conventionne Univ Aix Marseille 2, Genome Instabil & Carcinogenesis UPR3081, CNRS, IGC, F-13402 Marseille, France; [Chahwan, Charly; Taylor, Ewan R.; Russell, Paul; McGowan, Clare H.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dong, Meng-Qiu; Ruse, Cristian; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Russell, Paul; McGowan, Clare H.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Gaillard, PHL (corresponding author), Conventionne Univ Aix Marseille 2, Genome Instabil & Carcinogenesis UPR3081, CNRS, IGC, IMM 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	gaillard@ifr88.cnrs-mrs.fr	Ruse, Cristian/A-4609-2011; gaillard, pierre-henri/AAC-6004-2020; Coulon, Stéphane/T-8451-2017; Tissier, Agnes/I-4850-2018	Ruse, Cristian/0000-0001-8237-6308; gaillard, pierre-henri/0000-0003-0781-0826; Coulon, Stéphane/0000-0001-8090-914X; TISSIER, Agnes/0000-0002-5676-8719	ATIP-CNRS; Marie Curie [IRG MIRG-CT-2006-046581]; Association pour la Recherche sur le Cancer [ARC-SF1052]; NIH [GM59447, CA77325, P41 RR011823]; NATIONAL CANCER INSTITUTE [R01CA077325] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059447] Funding Source: NIH RePORTER	ATIP-CNRS(Centre National de la Recherche Scientifique (CNRS)); Marie Curie(European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all members of the IGC department as well as Angelos Constantinou for encouragement and stimulating discussions. We thank Mauro Modesti, Genevieve Almouzni, and Michael N. Boddy for critical reading of the manuscript, Benoit Di Martino for technical help, Denise Aragnol and Laurence Roder for MUS312 cDNA, and Rick Wood for providing rXPF-ERCC1. This work was primarily funded by an ATIP-CNRS grant, Marie Curie IRG MIRG-CT-2006-046581, and Association pour la Recherche sur le Cancer grant ARC-SF1052 that were awarded to P.-H. L. G. as well as by NIH grants GM59447 and CA77325 awarded to P. R., and NIH P41 RR011823 awarded to J.R.Y. III. We thank Wade Harper, Jeff Sekelsky, John Rouse, and Monica Colaiacovo for communicating their results prior to publication.	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Brookman KW, 1996, MOL CELL BIOL, V16, P6553; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Coulon S, 2006, MOL BIOL CELL, V17, P2081, DOI 10.1091/mbc.E05-11-1006; Coulon S, 2004, MOL BIOL CELL, V15, P71, DOI 10.1091/mbc.E03-08-0586; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kaliraman V, 2002, CURR GENET, V41, P389, DOI 10.1007/s00294-002-0319-6; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lewis SM, 2006, DNA REPAIR, V5, P1146, DOI 10.1016/j.dnarep.2006.05.014; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Lyndaker AM, 2008, GENETICS, V179, P1807, DOI 10.1534/genetics.108.090654; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Mullen JR, 2001, GENETICS, V157, P103; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Symington LS, 2008, MOL CELL, V32, P603, DOI 10.1016/j.molcel.2008.11.011; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Vazquez MV, 2008, DNA REPAIR, V7, P1693, DOI 10.1016/j.dnarep.2008.06.014; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	62	314	326	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					78	89		10.1016/j.cell.2009.06.029	http://dx.doi.org/10.1016/j.cell.2009.06.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596236	Bronze, Green Accepted			2022-12-24	WOS:000267848600016
J	Ladurner, AG				Ladurner, Andreas G.			Chromatin Places Metabolism Center Stage	CELL			English	Editorial Material							HISTONE ACETYLATION; SYNTHETASE	Dynamic changes in histone and transcription factor acetylation modulate gene expression. A study in Science (Wellen et al., 2009) reports that changes in glucose metabolism alter the availability of acetyl-CoA, the essential cofactor for protein acetylation. These findings reveal a direct connection between central metabolism and mammalian gene expression.	[Ladurner, Andreas G.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Ladurner, Andreas G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ladurner, AG (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	ladurner@embl.de		Ladurner, Andreas/0000-0003-3835-232X				Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	10	14	15	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					18	20		10.1016/j.cell.2009.06.025	http://dx.doi.org/10.1016/j.cell.2009.06.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596230	Bronze			2022-12-24	WOS:000267848600009
J	Lopez-Aranda, MF; Lopez-Tellez, JF; Navarro-Lobato, I; Masmudi-Martin, M; Gutierrez, A; Khan, ZU				Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Navarro-Lobato, Irene; Masmudi-Martin, Mariam; Gutierrez, Antonia; Khan, Zafar U.			Role of Layer 6 of V2 Visual Cortex in Object-Recognition Memory	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; AREA V2; MACAQUE MONKEYS; PERCEPTION; RGS14; PROTEINS; DYNAMICS; COMPLEX; SYSTEM; BRAIN	Cellular responses in the V2 secondary visual cortex to simple as well as complex visual stimuli have been well studied. However, the role of area V2 in visual memory remains unexplored. We found that layer 6 neurons of V2 are crucial for the processing of object-recognition memory (ORM). Using the protein regulator of G protein signaling-14 (RGS-14) as a tool, we found that the expression of this protein into layer 6 neurons of rat-brain area V2 promoted the conversion of a normal short-term ORM that normally lasts for 45 minutes into long-term memory detectable even after many months. Furthermore, elimination of the same-layer neurons by means of injection of a selective cytotoxin resulted in the complete loss of normal as well as protein-mediated enhanced ORM.	[Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Navarro-Lobato, Irene; Masmudi-Martin, Mariam; Khan, Zafar U.] Univ Malaga, Neurobiol Lab, Ctr Invest Med Sanitarias, E-29071 Malaga, Spain; [Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Khan, Zafar U.] Univ Malaga, Dept Med, Fac Med, E-29071 Malaga, Spain; [Gutierrez, Antonia] Univ Malaga, Fac Sci, Dept Cell Biol, E-29071 Malaga, Spain; [Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Gutierrez, Antonia; Khan, Zafar U.] Inst Hlth Carlos III, CIBERNED, Madrid, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; CIBERNED	Khan, ZU (corresponding author), Univ Malaga, Neurobiol Lab, Ctr Invest Med Sanitarias, Campus Teatinos S-N, E-29071 Malaga, Spain.	zkhan@uma.es	Al-Masmudi Martín, Mariam/B-1119-2016; KHAN, Zafaruddin/J-6217-2012; López-Aranda, Manuel F./GNM-7102-2022; Navarro Lobato, Irene/A-9105-2016	Al-Masmudi Martín, Mariam/0000-0001-5005-9199; KHAN, Zafaruddin/0000-0003-0742-399X; López-Aranda, Manuel F./0000-0001-9063-0740; Navarro Lobato, Irene/0000-0002-7866-3192; Gutierrez Perez, Antonia/0000-0002-6264-6152; Lopez-Tellez, Juan Felix/0000-0003-4115-3380	Ministerio de Ciencia e Innovacion [BFU 06-0306]; Junta de Andalucia [CTS 586/07, FIS PI060556]; CIBERNED	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); CIBERNED(Instituto de Salud Carlos III)	This work was supported financially by Ministerio de Ciencia e Innovacion grant BFU 06-0306 and Junta de Andalucia grant CTS 586/07 to Z.U.K. and FIS PI060556 grant to A.G. M.F.L. is the recipient of a CIBERNED contract. Application for the patent on RGS-14 protein has already been filed, and issue of patent is pending.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 2005, CURR OPIN NEUROBIOL, V15, P730, DOI 10.1016/j.conb.2005.10.014; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Gattass R, 1997, CEREB CORTEX, V7, P110, DOI 10.1093/cercor/7.2.110; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; LEBIHAN D, 1993, P NATL ACAD SCI USA, V90, P11802, DOI 10.1073/pnas.90.24.11802; Lopez-Aranda MF, 2006, EUR J NEUROSCI, V23, P2971, DOI 10.1111/j.1460-9568.2006.04838.x; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nolan BC, 2005, BEHAV NEUROSCI, V119, P190, DOI 10.1037/0735-7044.119.1.190; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stepniewska I, 1996, J COMP NEUROL, V371, P129; Traissard N, 2007, NEUROPSYCHOPHARMACOL, V32, P851, DOI 10.1038/sj.npp.1301116; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200	28	54	60	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					87	89		10.1126/science.1170869	http://dx.doi.org/10.1126/science.1170869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574389				2022-12-24	WOS:000267594000041
J	Inomata, K; Aoto, T; Binh, NT; Okamoto, N; Tanimura, S; Wakayama, T; Iseki, S; Hara, E; Masunaga, T; Shimizu, H; Nishimura, EK				Inomata, Ken; Aoto, Takahiro; Binh, Nguyen Thanh; Okamoto, Natsuko; Tanimura, Shintaro; Wakayama, Tomohiko; Iseki, Shoichi; Hara, Eiji; Masunaga, Takuji; Shimizu, Hiroshi; Nishimura, Emi K.			Genotoxic Stress Abrogates Renewal of Melanocyte Stem Cells by Triggering Their Differentiation	CELL			English	Article							DNA-DAMAGE; IONIZING-RADIATION; CELLULAR SENESCENCE; ATAXIA-TELANGIECTASIA; TUMOR SUPPRESSION; MICE DEFICIENT; CYCLE ARREST; ATM; MOUSE; PHENOTYPES	Somatic stem cell depletion due to the accumulation of DNA damage has been implicated in the appearance of aging-related phenotypes. Hair graying, a typical sign of aging in mammals, is caused by the incomplete maintenance of melanocyte stem cells (MSCs) with age. Here, we report that irreparable DNA damage, as caused by ionizing radiation, abrogates renewal of MSCs in mice. Surprisingly, the DNA-damage response triggers MSC differentiation into mature melanocytes in the niche, rather than inducing their apoptosis or senescence. The resulting MSC depletion leads to irreversible hair graying. Furthermore, deficiency of Ataxia-telangiectasia mutated (ATM), a central transducer kinase of the DNA-damage response, sensitizes MSCs to ectopic differentiation, demonstrating that the kinase protects MSCs from their premature differentiation by functioning as a "stemness checkpoint'' to maintain the stem cell quality and quantity.	[Inomata, Ken; Aoto, Takahiro; Binh, Nguyen Thanh; Okamoto, Natsuko; Tanimura, Shintaro; Nishimura, Emi K.] Kanazawa Univ, Div Stem Cell Med, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Inomata, Ken; Masunaga, Takuji] KOSE Corp, Fundamental Res Labs, Itabashi Ku, Tokyo 1740051, Japan; [Inomata, Ken; Tanimura, Shintaro; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Aoto, Takahiro; Nishimura, Emi K.] Tokyo Med & Dent Univ, Dept Stem Cell Biol, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Okamoto, Natsuko] Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Dept Histol & Embryol, Grad Sch Med Sci, Kanazawa, Ishikawa 9200934, Japan; [Hara, Eiji] Japanese Fdn Canc Res, Div Canc Biol, Inst Canc, Koto Ku, Tokyo 1358550, Japan	Kanazawa University; Hokkaido University; Tokyo Medical & Dental University (TMDU); Kyoto University; Kanazawa University; Japanese Foundation for Cancer Research	Nishimura, EK (corresponding author), Kanazawa Univ, Div Stem Cell Med, Ctr Canc & Stem Cell Res, Canc Res Inst, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan.	nishscm@tmd.ac.jp	Shimizu, Hiroshi/A-5193-2012	Inomata, Ken/0000-0002-3556-1380	Japanese Ministry of Education, Culture, Sports, Science and Technology [17689033, 19390293, 20012017]; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation	We thank Dr. Ian Jackson for the Dct-lacZ transgenic mice; Dr. Peter McKinnon and Dr. Atsushi Hirao for the ATM-deficient mice; Dr. Jan Hoeijmaker for the TTD mice; Dr. Vincent Hearing for antibodies; Dr. Naoko Ohtani, Dr. Kimi Yamakoshi, Dr. Keiyo Takubo, and Dr. Toshio Suda for immunostaining information; Ms. Lica Ishida, Ms. Misa Suzuki, Ms. Yuika Osaki, and Ms. Noriko Ikeda for technical assistance; Mr. Hideki Nakamura for mouse importation; and Dr. Richard Wong and Dr. Hiroyuki Nishimura for critical reading of the manuscript. The research was funded by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (17689033, 19390293, 20012017), Uehara Memorial Foundation, and Kato Memorial Bioscience Foundation to E. K. N.	ARGYRIS TS, 1960, ANAT REC, V136, P445, DOI 10.1002/ar.1091360403; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Bennett DC, 2002, PIGM CELL RES, V15, P242, DOI 10.1034/j.1600-0749.2002.02036.x; Boder E, 1970, Psychiatr Neurol Med Psychol Beih, V13-14, P8; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Coolidge WD, 1925, SCIENCE, V62, P441, DOI 10.1126/science.62.1611.441; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Ha LN, 2008, CELL CYCLE, V7, P1944, DOI 10.4161/cc.7.13.6230; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hirobe T, 2007, EUR J CELL BIOL, V86, P315, DOI 10.1016/j.ejcb.2007.03.007; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; Meng AM, 2003, CANCER RES, V63, P5414; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; POTTEN CS, 1970, J INVEST DERMATOL, V55, P410, DOI 10.1111/1523-1747.ep12260552; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2008, MECH AGEING DEV, V129, P460, DOI 10.1016/j.mad.2008.03.009; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; van Heemst D, 2007, EUR J CANCER, V43, P2144, DOI 10.1016/j.ejca.2007.07.011; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200	59	249	257	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1088	1099		10.1016/j.cell.2009.03.037	http://dx.doi.org/10.1016/j.cell.2009.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524511	Bronze, Green Submitted			2022-12-24	WOS:000266916400020
J	Silva, JM; Ezhkova, E; Silva, J; Heart, S; Castillo, M; Campos, Y; Castro, V; Bonilla, F; Cordon-Cardo, C; Muthuswamy, SK; Powers, S; Fuchs, E; Hannon, GJ				Silva, Jose M.; Ezhkova, Elena; Silva, Javier; Heart, Stephen; Castillo, Mireia; Campos, Yolanda; Castro, Veronica; Bonilla, Felix; Cordon-Cardo, Carlos; Muthuswamy, Senthil K.; Powers, Scott; Fuchs, Elaine; Hannon, Gregory J.			Cyfip1 Is a Putative Invasion Suppressor in Epithelial Cancers	CELL			English	Article							MENTAL-RETARDATION PROTEIN; NF-KAPPA-B; CELL MIGRATION; ACTIN; ADHESION; PROLIFERATION; PLASTICITY; MEMBRANE; DYNAMICS; CATENIN	Identification of bona fide tumor suppressors is often challenging because of the large number of genetic alterations present in most human cancers. To evaluate candidate genes present within chromosomal regions recurrently deleted in human cancers, we coupled high-resolution genomic analysis with a two-stage genetic study using RNA interference (RNAi). We found that Cyfip1, a subunit of the WAVE complex, which regulates cytoskeletal dynamics, is commonly deleted in human epithelial cancers. Reduced expression of CYFIP1 is commonly observed during invasion of epithelial tumors and is associated with poor prognosis in this setting. Silencing of Cyfip1 disturbed normal epithelial morphogenesis in vitro and cooperated with oncogenic Ras to produce invasive carcinomas in vivo. Mechanistically, we have linked alterations in WAVE-regulated actin dynamics with impaired cell-cell adhesion and cell-ECM interactions. Thus, we propose Cyfip1 as an invasion suppressor gene.	[Silva, Jose M.; Heart, Stephen; Castro, Veronica; Muthuswamy, Senthil K.; Powers, Scott; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Ezhkova, Elena; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Silva, Javier; Bonilla, Felix] Puerta Hierro Hosp, Genet Oncol Dept, Madrid 28035, Spain; [Castillo, Mireia; Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Campos, Yolanda] Virgen Salud Hosp, Dept Pathol, Toledo 45004, Spain	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University; Hospital Puerta de Hierro-Majadahonda; Columbia University	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Castillo-Martin, Mireia/H-6152-2013; Campos-MArtín, Yolanda/R-2630-2017; Muthuswamy, Senthil K/AGY-2834-2022; Fuchs, Elaine/G-1565-2016; Hannon, Gregory/AAB-3568-2019	Campos-MArtín, Yolanda/0000-0001-9686-7036; Muthuswamy, Senthil K/0000-0001-6564-9634; Powers, Scott/0000-0003-2769-1932; Ezhkova, Elena/0000-0003-4154-1615; Castillo-Martin, Mireia/0000-0001-8926-6013	NCI [54010101-5411]; New York Stem Cell Institute; N.I.H [R01-AR27883]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York Stem Cell Institute; N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are especially thankful to Victoria Aranda (CSHL) for help with the 3D model, to Alberto Munoz (Instituto de Investigaciones Biomedicas "Alberto Sols'') for providing the Snail expression vector, and to Geraldine Guasch (Rockefeller University) for providing tissue sections of HRas/TGF-b R-II-KO mouse tumors. We also thank June Racelis for help with in situ hybridizations and Nicole Stokes for assistance with skin chamber grafting. We thank Ken Chang and Edie Davis for comments on the manuscript and for helpful discussion. This work was partially supported by the NCI with the K99/R00 project # 54010101-5411 (J. M. S.). G. J. H. and E. F. are Investigators of the Howard Hughes Medical Institute and E. E. is a Life Sciences Foundation Postdoctoral Fellow supported by the New York Stem Cell Institute. This work was supported by grants from the N.I.H (G. J. H. and E. F. R01-AR27883) and by a kind gift from Kathryn W. Davis (G. J. H.).	Azzoli CG, 1998, MOL CARCINOGEN, V21, P50, DOI 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hempen PM, 2003, CANCER RES, V63, P994; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WEINBERG WC, 1991, CARCINOGENESIS, V12, P1119, DOI 10.1093/carcin/12.6.1119; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	58	64	68	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1047	1061		10.1016/j.cell.2009.04.013	http://dx.doi.org/10.1016/j.cell.2009.04.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524508	Green Accepted, Bronze			2022-12-24	WOS:000266916400017
J	Xu, XLL; Fang, YQ; Lee, TC; Forrest, D; Gregory-Evans, C; Almeida, D; Liu, AH; Jhanwar, SC; Abramson, DH; Cobrinik, D				Xu, Xiaoliang L.; Fang, Yuqiang; Lee, Thomas C.; Forrest, Douglas; Gregory-Evans, Cheryl; Almeida, Dena; Liu, Aihong; Jhanwar, Suresh C.; Abramson, David H.; Cobrinik, David			Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling	CELL			English	Article							THYROID-HORMONE RECEPTOR; GENOMIC INSTABILITY; RETINAL DEVELOPMENT; CELL; EXPRESSION; RB; MOUSE; GENE; P53; PROGRESSION	Retinoblastomas result from the inactivation of the RB1 gene and the loss of Rb protein, yet the cell type in which Rb suppresses retinoblastoma and the circuitry that underlies the need for Rb are undefined. Here, we show that retinoblastoma cells express markers of postmitotic cone precursors but not markers of other retinal cell types. We also demonstrate that human cone precursors prominently express MDM2 and N-Myc, that retinoblastoma cells require both of these proteins for proliferation and survival, and that MDM2 is needed to suppress ARF-induced apoptosis in cultured retinoblastoma cells. Interestingly, retinoblastoma cell MDM2 expression was regulated by the cone-specific RXR gamma transcription factor and a human-specific RXR gamma consensus binding site, and proliferation required RXR gamma, as well as the cone-specific thyroid hormone receptor-beta 2. These findings provide support for a cone precursor origin of retinoblastoma and suggest that human cone-specific signaling circuitry sensitizes to the oncogenic effects of RB1 mutations.	[Xu, Xiaoliang L.; Almeida, Dena; Liu, Aihong; Cobrinik, David] Weill Cornell Med Coll, Dyson Vis Res Inst, New York, NY 10021 USA; [Xu, Xiaoliang L.; Almeida, Dena; Liu, Aihong; Abramson, David H.; Cobrinik, David] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY 10021 USA; [Xu, Xiaoliang L.; Fang, Yuqiang; Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lee, Thomas C.] Childrens Hosp Los Angeles, Vis Ctr, Los Angeles, CA 90027 USA; [Forrest, Douglas] NIDDK, NIH, Bethesda, MD 20892 USA; [Gregory-Evans, Cheryl] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London SW7 2AZ, England; [Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA	Cornell University; Dyson; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Children's Hospital Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Imperial College London; Memorial Sloan Kettering Cancer Center	Cobrinik, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	cobrinid@mskcc.org	Gregory-Evans, Cheryl Y/G-9550-2011		Starr Foundation Tri-Institutional Stem Cell Initiative; Research to Prevent Blindness; Fund for Ophthalmic Knowledge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047036] Funding Source: NIH RePORTER	Starr Foundation Tri-Institutional Stem Cell Initiative; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fund for Ophthalmic Knowledge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Nathans and A. Swaroop for antibodies, H. te Riele for mou tumors, J. Blaydes for plasmids, M. Pappas for compiling Table S1, and A. Koff for facilitating the completion of this study. This work was supported by the Starr Foundation Tri-Institutional Stem Cell Initiative, Research to Prevent Blindness, and the Fund for Ophthalmic Knowledge.	Abramson DH, 1996, RETINA-J RET VIT DIS, V16, P232, DOI 10.1097/00006982-199616030-00009; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; BOGENMANN E, 1988, SCIENCE, V240, P76, DOI 10.1126/science.2451289; Bremner R, 2009, CELL, V137, P992, DOI 10.1016/j.cell.2009.05.034; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Cornish EE, 2004, EXP EYE RES, V78, P1143, DOI 10.1016/j.exer.2004.01.004; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Danko CG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-407; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; DOWHAN DH, 1994, ENDOCRINOLOGY, V135, P2595, DOI 10.1210/en.135.6.2595; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gallie BL, 1999, CANCER RES, V59, p1731S; GONZALEZFERNANDEZ F, 1992, AM J PATHOL, V141, P363; Hendrickson A, 2006, RETINAL DEVELOPMENT, P126, DOI 10.1017/CBO9780511541629.009; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kleinerman RA, 2005, J CLIN ONCOL, V23, P2272, DOI 10.1200/JCO.2005.05.054; Kondo Y, 1997, EXP CELL RES, V236, P51, DOI 10.1006/excr.1997.3693; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; MAATKIEVIT JA, 1993, PRENATAL DIAG, V13, P377, DOI 10.1002/pd.1970130510; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; MUNIER FL, 1994, OPHTHALMIC GENET, V15, P101, DOI 10.3109/13816819409057835; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P791, DOI 10.1001/archopht.1995.01100060117046; Pacal M, 2006, CURR MOL MED, V6, P759; Rich KA, 1997, J COMP NEUROL, V388, P47; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; RODRIGUES MM, 1992, CURR EYE RES, V11, P425, DOI 10.3109/02713689209001796; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Spencer C, 2005, GENE EXPR PATTERNS, V5, P687, DOI 10.1016/j.modgep.2005.02.003; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; VIRTANEN I, 1988, LAB INVEST, V59, P649; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELLER CARL V., 1937, AMER JOUR CANCER, V30, P39	56	156	168	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1018	1031		10.1016/j.cell.2009.03.051	http://dx.doi.org/10.1016/j.cell.2009.03.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524506	Bronze, Green Accepted			2022-12-24	WOS:000266916400015
J	Liu, YC; Weinberg, MS; Ortega, LS; Painter, JA; Maloney, SA				Liu, Yecai; Weinberg, Michelle S.; Ortega, Luis S.; Painter, John A.; Maloney, Susan A.			Overseas Screening for Tuberculosis in US-Bound Immigrants and Refugees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; UNITED-STATES; INFECTIOUS TUBERCULOSIS; CONTACT INVESTIGATIONS; CALIFORNIA; COUNTY; OUTCOMES; TRENDS	BACKGROUND In 2007, a total of 57.8% of the 13,293 new cases of tuberculosis in the United States were diagnosed in foreign-born persons, and the tuberculosis rate among foreign-born persons was 9.8 times as high as that among U.S.-born persons (20.6 vs. 2.1 cases per 100,000 population). Annual arrivals of approximately 400,000 immigrants and 50,000 to 70,000 refugees from overseas are likely to contribute substantially to the tuberculosis burden among foreign-born persons in the United States. METHODS The Centers for Disease Control and Prevention (CDC) collects information on overseas screening for tuberculosis among U. S.- bound immigrants and refugees, along with follow-up evaluation after their arrival in the United States. We analyzed screening and follow-up data from the CDC to study the epidemiology of tuberculosis in these populations. RESULTS From 1999 through 2005, a total of 26,075 smear-negative cases of tuberculosis (i.e., cases in which a chest radiograph was suggestive of active tuberculosis but sputum smears were negative for acid-fast bacilli on 3 consecutive days) and 22,716 cases of inactive tuberculosis (i.e., cases in which a chest radiograph was suggestive of tuberculosis that was no longer clinically active) were diagnosed by overseas medical screening of 2,714,223 U. S.- bound immigrants, representing prevalences of 961 cases per 100,000 persons (95% confidence interval [CI], 949 to 973) and 837 cases per 100,000 persons (95% CI, 826 to 848), respectively. Among 378,506 U.S.bound refugees, smear-negative tuberculosis was diagnosed in 3923 and inactive tuberculosis in 10,743, representing prevalences of 1036 cases per 100,000 persons (95% CI, 1004 to 1068) and 2838 cases per 100,000 persons (95% CI, 2785 to 2891), respectively. Active pulmonary tuberculosis was diagnosed in the United States in 7.0% of immigrants and refugees with an overseas diagnosis of smear-negative tuberculosis and in 1.6% of those with an overseas diagnosis of inactive tuberculosis. CONCLUSIONS Overseas screening for tuberculosis with follow-up evaluation after arrival in the United States is a high-yield intervention for identifying tuberculosis in U. S.- bound immigrants and refugees and could reduce the number of tuberculosis cases among foreign-born persons in the United States.	[Liu, Yecai; Weinberg, Michelle S.; Ortega, Luis S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Maloney, Susan A.] CDC Collaborat, Thailand Minist Publ Hlth US, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 1600 Clifton Rd,MS E03, Atlanta, GA 30333 USA.	yliu@cdc.gov						[Anonymous], 2007, TECHN INSTR TUB SCRE; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Catlos EK, 1998, AM J RESP CRIT CARE, V158, P1037, DOI 10.1164/ajrccm.158.4.9801024; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DeRiemer K, 1998, ARCH INTERN MED, V158, P753, DOI 10.1001/archinte.158.7.753; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; *OFF IMM SERV, 2007, YB IMM STAT 2006; Pratt R., 2008, Morbidity and Mortality Weekly Report, V57, P281; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Sprinson JE, 2003, INT J TUBERC LUNG D, V7, pS363; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Thorpe LE, 2004, NEW ENGL J MED, V350, P2105, DOI 10.1056/NEJM200405133502023; Wells CD, 1997, AM J RESP CRIT CARE, V156, P573, DOI 10.1164/ajrccm.156.2.9611101; WHO, 2007, WHOHTMTB2007376; Zuber PLF, 1996, TUBERCLE LUNG DIS, V77, P524, DOI 10.1016/S0962-8479(96)90050-7; Zuber PLF, 1996, AM J RESP CRIT CARE, V154, P151, DOI 10.1164/ajrccm.154.1.8680671; 2008, MMWR MORB MORTAL WKL, V57, P292; 1995, MMWR MORB MORTAL WKL, V44, P703	28	94	94	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2406	2415		10.1056/NEJMoa0809497	http://dx.doi.org/10.1056/NEJMoa0809497			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494216	Bronze			2022-12-24	WOS:000266590500006
J	Pernia-Andrade, AJ; Kato, A; Witschi, R; Nyilas, R; Katona, I; Freund, TF; Watanabe, M; Filitz, J; Koppert, W; Schuttler, J; Ji, GC; Neugebauer, V; Marsicano, G; Lutz, B; Vanegas, H; Zeilhofer, HU				Pernia-Andrade, Alejandro J.; Kato, Ako; Witschi, Robert; Nyilas, Rita; Katona, Istvan; Freund, Tamas F.; Watanabe, Masahiko; Filitz, Joerg; Koppert, Wolfgang; Schuettler, Juergen; Ji, Guangchen; Neugebauer, Volker; Marsicano, Giovanni; Lutz, Beat; Vanegas, Horacio; Zeilhofer, Hanns Ulrich			Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber-Induced Heterosynaptic Pain Sensitization	SCIENCE			English	Article							EVOKED ALLODYNIA; NEURONS; SYSTEM; DISINHIBITION; TARGET	Diminished synaptic inhibition in the spinal dorsal horn is a major contributor to chronic pain. Pathways that reduce synaptic inhibition in inflammatory and neuropathic pain states have been identified, but central hyperalgesia and diminished dorsal horn synaptic inhibition also occur in the absence of inflammation or neuropathy, solely triggered by intense nociceptive (C-fiber) input to the spinal dorsal horn. We found that endocannabinoids, produced upon strong nociceptive stimulation, activated type 1 cannabinoid (CB1) receptors on inhibitory dorsal horn neurons to reduce the synaptic release of gamma-aminobutyric acid and glycine and thus rendered nociceptive neurons excitable by nonpainful stimuli. Our results suggest that spinal endocannabinoids and CB1 receptors on inhibitory dorsal horn interneurons act as mediators of heterosynaptic pain sensitization and play an unexpected role in dorsal horn pain-controlling circuits.	[Pernia-Andrade, Alejandro J.; Kato, Ako; Witschi, Robert; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Nyilas, Rita; Katona, Istvan; Freund, Tamas F.] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Filitz, Joerg; Koppert, Wolfgang; Schuettler, Juergen] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Ji, Guangchen; Neugebauer, Volker] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Marsicano, Giovanni] Ctr Rech, INSERM Francois Magendie, U862, F-33077 Bordeaux, France; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; [Vanegas, Horacio] Inst Venezolano Invest Cient, Caracas 1020A, Venezuela; [Kato, Ako; Witschi, Robert; Vanegas, Horacio; Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University; University of Erlangen Nuremberg; University of Texas System; University of Texas Medical Branch Galveston; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johannes Gutenberg University of Mainz; Venezuelan Institute Science Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zeilhofer, HU (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	zeilhofer@pharma.uzh.ch	Watanabe, Masahiko/S-3614-2019; Lutz, Beat/AAG-4538-2022; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; WATANABE, Masahiko/A-4055-2012; Zeilhofer, Hanns Ulrich/A-4600-2008; Katona, Istvan/D-9729-2011	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Katona, Istvan/0000-0003-2808-3330; Nyilas, Rita/0000-0002-9634-9535; Marsicano, Giovanni/0000-0003-3804-1951; Schuttler, Jurgen/0000-0001-5088-2169	Schweizerischer National Fonds [3100A0-116064/1]; Deutsche Forschungsgemeinschaft [KO 1878/2-2, ZE 377/8-2]; NIH [NS38261, NS11255]; European Union [LSHM-CT-2004-005166]; OTKA [F046407]; ETT [561/2006]; German DAAD; Venezuelan FONACIT; Janos Bolyai scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011255, R01NS038261] Funding Source: NIH RePORTER	Schweizerischer National Fonds(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT; German DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Venezuelan FONACIT; Janos Bolyai scholarship(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by grants from the Schweizerischer National Fonds to H.U.Z. (3100A0-116064/1), from the Deutsche Forschungsgemeinschaft to W.K. (KO 1878/2-2) and H.U.Z. (ZE 377/8-2), from NIH (NS38261 and NS11255) to V.N., from the European Union (LSHM-CT-2004-005166) to T.F.F., and from the OTKA (F046407) and ETT (561/2006) to I.K. A.J.P.A. was supported partly by scholarships from the German DAAD and the Venezuelan FONACIT for graduate study at IVIC. I.K. was supported by a Janos Bolyai scholarship. The authors thank R. Kuner and C. V. Wright for providing sns-cre and ptf1a-cre mice, respectively, J.-M. Fritschy, H. Handwerker, H. Mohler, and M. Schmelz for critical reading of the manuscript, T. Muller for very valuable suggestions, and I. Camenisch and L. Scheurer for genotyping of the mice.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Farquhar-Smith WP, 2000, MOL CELL NEUROSCI, V15, P510, DOI 10.1006/mcne.2000.0844; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Jennings EA, 2001, J PHYSIOL-LONDON, V534, P805, DOI 10.1111/j.1469-7793.2001.00805.x; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272, DOI 10.1152/jn.1999.82.1.272; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Treede R D, 2000, Prog Brain Res, V129, P331; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	24	140	144	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					760	764		10.1126/science.1171870	http://dx.doi.org/10.1126/science.1171870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661434	Green Accepted			2022-12-24	WOS:000268723700053
J	Watts, G				Watts, Geoff			Pandemic flu A/H1N1 influenza virus: the basics	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Gallaher WR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-51; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032	3	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2009	339								b3046	10.1136/bmj.b3046	http://dx.doi.org/10.1136/bmj.b3046			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633037				2022-12-24	WOS:000268352100005
J	Forman, JP; Stampfer, MJ; Curhan, GC				Forman, John P.; Stampfer, Meir J.; Curhan, Gary C.			Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MODERATE ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; ANALGESIC USE; FOLLOW-UP; FREQUENCY; REPRODUCIBILITY; VALIDITY; PREVENTION	Context Hypertension is an important preventable risk factor for death among women. While several modifiable risk factors have been identified, their combined risk and distribution in the population have not been assessed. Objective To estimate the hypothetical fraction of hypertension incidence associated with dietary and lifestyle factors in women. Design, Setting, and Participants Prospective cohort study of 83 882 adult women aged 27 to 44 years in the second Nurses' Health Study who did not have hypertension, cardiovascular disease, diabetes, or cancer in 1991, and who had normal reported blood pressure (defined as systolic blood pressure of <= 120 mm Hg and diastolic blood pressure of <= 80 mm Hg), with follow-up for incident hypertension for 14 years through 2005. Six modifiable lifestyle and dietary factors for hypertension were identified. The 6 low-risk factors for hypertension were a body mass index (BMI) of less than 25, a daily mean of 30 minutes of vigorous exercise, a high score on the Dietary Approaches to Stop Hypertension (DASH) diet based on responses to a food frequency questionnaire, modest alcohol intake up to 10 g/d, use of nonnarcotic analgesics less than once per week, and intake of 400 mu g/d or more of supplemental folic acid. The association between combinations of 3 (normal BMI, daily vigorous exercise, and DASH-style diet), 4 (3 low-risk factors plus modest alcohol intake), 5 (4 low-risk factors plus avoidance of nonnarcotic analgesics), and 6 (folic acid supplementation >= 400 mu g/d) low-risk factors and the risk of developing hypertension was analyzed. Main Outcome Measures Adjusted hazard ratios for incident self-reported hypertension and population attributable risks (PARs). Results A total of 12 319 incident cases of hypertension were reported. All 6 modifiable risk factors were independently associated with the risk of developing hypertension during follow-up after also adjusting for age, race, family history of hypertension, smoking status, and use of oral contraceptives. For women who had all 6 low-risk factors (0.3% of the population), the hazard ratio for incident hypertension was 0.22 (95% confidence interval [CI], 0.10-0.51); the hypothetical PAR was 78% (95% CI, 49%-90%) for women who lacked these low-risk factors. The corresponding hypothetical absolute incidence rate difference (ARD) was 8.37 cases per 1000 person-years. The PARs were 72% (95% CI, 57%-82%; ARD, 7.76 cases per 1000 person-years) for 5 low-risk factors (0.8% of the population), 58% (95% CI, 46%-67%; ARD, 6.28 cases per 1000 person-years) for 4 low-risk factors (1.6% of the population), and 53% (95% CI, 45%-60%; ARD, 6.02 cases per 1000 person-years) for 3 low-risk factors (3.1% of the population). Body mass index alone was the most powerful predictor of hypertension, with a BMI of 25 or greater having an adjusted PAR of 40% (95% CI, 38%-41%) compared with a BMI of less than 25. Conclusions Adherence to low-risk dietary and lifestyle factors was associated with a significantly lower incidence of self-reported hypertension. Adopting low-risk dietary and lifestyle factors has the potential to prevent a large proportion of new-onset hypertension occurring among young women. JAMA. 2009;302(4):401-411	[Forman, John P.; Stampfer, Meir J.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Forman, John P.; Curhan, Gary C.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Forman, JP (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave,3rd Floor, Boston, MA 02115 USA.	jforman@partners.org			American Heart Association [0535401T]; National Institutes of Health [HL079929-01A2, CA50385]; NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079929] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by American Heart Association grant 0535401T and National Institutes of Health grants HL079929-01A2 and CA50385.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; [Anonymous], 1996, JAMA, V276, P241; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; CHALMERS JP, 1984, CLIN EXP HYPERTENS A, V6, P1077, DOI 10.3109/10641968409039582; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Dauchet L, 2007, AM J CLIN NUTR, V85, P1650, DOI 10.1093/ajcn/85.6.1650; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Forman JP, 2007, ARCH INTERN MED, V167, P394, DOI 10.1001/archinte.167.4.394; Forman JP, 2005, HYPERTENSION, V46, P500, DOI 10.1161/01.HYP.0000177437.07240.70; Forman JP, 2005, JAMA-J AM MED ASSOC, V293, P320, DOI 10.1001/jama.293.3.320; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gelber RP, 2007, AM J HYPERTENS, V20, P370, DOI 10.1016/j.amjhyper.2006.10.011; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Gu DF, 2007, J HYPERTENS, V25, P517, DOI 10.1097/HJH.0b013e328013e7f4; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; Mangoni AA, 2002, J INTERN MED, V252, P497, DOI 10.1046/j.1365-2796.2002.01059.x; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Parker ED, 2007, AM J PUBLIC HEALTH, V97, P703, DOI 10.2105/AJPH.2004.055889; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira MA, 1999, PREV MED, V28, P304, DOI 10.1006/pmed.1998.0431; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schulze MB, 2003, AM J EPIDEMIOL, V158, P365, DOI 10.1093/aje/kwg156; SELBY JV, 1989, AM J EPIDEMIOL, V129, P43, DOI 10.1093/oxfordjournals.aje.a115123; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Thadhani R, 2002, ARCH INTERN MED, V162, P569, DOI 10.1001/archinte.162.5.569; van Dijk RAJM, 2001, ARTERIOSCL THROM VAS, V21, P2072, DOI 10.1161/hq1201.100223; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WITTEMAN JCM, 1990, AM J CARDIOL, V65, P633, DOI 10.1016/0002-9149(90)91043-6; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	44	316	338	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					401	411		10.1001/jama.2009.1060	http://dx.doi.org/10.1001/jama.2009.1060			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622819	Green Accepted			2022-12-24	WOS:000268139200023
J	Pfau, T; Spence, A; Starke, S; Ferrari, M; Wilson, A				Pfau, Thilo; Spence, Andrew; Starke, Sandra; Ferrari, Marta; Wilson, Alan			Modern Riding Style Improves Horse Racing Times	SCIENCE			English	Article							COST; LOCOMOTION; FORCE		[Pfau, Thilo; Spence, Andrew; Starke, Sandra; Ferrari, Marta; Wilson, Alan] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Pfau, T (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	tpfau@rvc.ac.uk		Starke, Sandra/0000-0002-1434-7094; Wilson, Alan/0000-0001-9914-3455	Horserace Betting Levy Board; Bremer Ausbildungs Partnerschaft; UK Biotechnology and Biological Sciences Research Council; Royal Society; EPSRC [EP/D07682X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [S20242] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500137/1, EP/D07682X/1] Funding Source: researchfish	Horserace Betting Levy Board; Bremer Ausbildungs Partnerschaft; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. J. Hobbs for the horses; T. Cox, the Cox Library, and T. Stanhope, Equine Action Images, for photographs; the Horserace Betting Levy Board for funding (T.P., A.S., and M.F.); and the Bremer Ausbildungs Partnerschaft (international LEONARDO program) for funding (S.S.). The UK Biotechnology and Biological Sciences Research Council funded the technology development. A.W. holds a Royal Society Wolfson Research Merit award. A.W. and T.P. have filed a patent application on monitoring of horses and jockeys during racing with methods similar to those described here.	Chang YH, 1999, J APPL PHYSIOL, V86, P1657, DOI 10.1152/jappl.1999.86.5.1657; Minetti AE, 1999, J EXP BIOL, V202, P2329; MORDIN N, 2002, WINNING THINKING DEF, P91; ORCHAND V, 1954, DERBY STAKES; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Schamhardt H.C., 1991, EQUINE EXERCISE PHYS, V3, P120; TAYLOR CR, 1980, J EXP BIOL, V86, P9; TROWBRIDGE EA, 1995, EUR J APPL PHYSIOL O, V70, P66, DOI 10.1007/BF00601810; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a	10	57	57	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					289	289		10.1126/science.1174605	http://dx.doi.org/10.1126/science.1174605			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608909	Green Published			2022-12-24	WOS:000268036600036
J	[Anonymous]				[Anonymous]			Nowhere to hide	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					307	307		10.1038/460307b	http://dx.doi.org/10.1038/460307b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470MO	19606096	Bronze			2022-12-24	WOS:000267979000002
J	Singh, I; Rose, N				Singh, Ilina; Rose, Nikolas			Biomarkers in psychiatry	NATURE			English	Article							MENTAL-ILLNESS; PREVENTION; GENOTYPE; DISORDER; MEDICINE; GENETICS; GENOME; GENES; RISK; RACE		[Singh, Ilina; Rose, Nikolas] London Sch Econ, BIOS Ctr, London WC2A 2AE, England	University of London; London School Economics & Political Science	Singh, I (corresponding author), London Sch Econ, BIOS Ctr, Houghton St, London WC2A 2AE, England.	i.a.singh@lse.ac.uk	Rose, Nikolas S/D-1918-2010; Rose, Nikolas/A-4229-2013	Singh, Ilina/0000-0003-4497-3587; Rose, Nikolas/0000-0003-4007-5077	ESRC [ES/E020585/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020585/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Beauchaine TP, 2008, DEV PSYCHOPATHOL, V20, P745, DOI 10.1017/S0954579408000369; Beauchaine TP, 2009, BIOMARK MED, V3, P1, DOI 10.2217/17520363.3.1.1; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; BRUNNER HG, 2007, CIBA F SYMP, V194, P155; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Foster MW, 2006, J MED ETHICS, V32, P635, DOI 10.1136/jme.2005.013532; Foster MW, 2008, PERS MED, V5, P399, DOI 10.2217/17410541.5.4.399; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GOSWAMI U, 2005, PSYCHOL ED REV, V29, P2; Green MJ, 2003, ANN INTERN MED, V138, P571, DOI 10.7326/0003-4819-138-7-200304010-00013; HOLTZMAN P, 2000, BRAIN RES REV, V31, P350; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; HUNICHE L, 2001, OUTLINES CRIT SOC ST, V3, P35; Kirkwood TB., 2008, FORESIGHT MENTAL CAP; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Lock M, 2005, CURR ANTHROPOL, V46, pS47, DOI 10.1086/432452; Lock M, 2006, PUBLIC UNDERST SCI, V15, P277, DOI 10.1177/0963662506059259; MARONEY TA, 2009, GRUT I ANN C SQUAW V; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; Parens Erik, 2008, Child Adolesc Psychiatry Ment Health, V2, P5, DOI 10.1186/1753-2000-2-5; Phelan J, 2006, AM J MED GENET B, V141B, P688; Phelan JC, 2002, TRENDS NEUROSCI, V25, P430, DOI 10.1016/S0166-2236(02)02209-9; Prainsack B, 2008, NATURE, V456, P34, DOI 10.1038/456034a; Romeo R, 2006, BRIT J PSYCHIAT, V188, P547, DOI 10.1192/bjp.bp.104.007625; Rose N, 2008, BIOSOCIETIES, V3, P423, DOI 10.1017/S1745855208006339; Schick A, 2005, AM J BIOETHICS, V5, P36, DOI 10.1080/15265160590960410; SCHICK A, 2005, AM J BIOETHICS, V5, pW3; Seyffert M, 2005, CURR PEDIATR REV, V1, P17, DOI 10.2174/1573396052953453; Silverman C, 2008, BIOSOCIETIES, V3, P325, DOI 10.1017/S1745855208006236; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Zito JM, 2007, J CHILD ADOL PSYCHOP, V17, P195, DOI 10.1089/cap.2007.0006	41	219	223	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					202	207		10.1038/460202a	http://dx.doi.org/10.1038/460202a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587761				2022-12-24	WOS:000267761000030
J	Wang, JH; Gostissa, M; Yan, CT; Goff, P; Hickernell, T; Hansen, E; Difilippantonio, S; Wesemann, DR; Zarrin, AA; Rajewsky, K; Nussenzweig, A; Alt, FW				Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Difilippantonio, Simone; Wesemann, Duane R.; Zarrin, Ali A.; Rajewsky, Klaus; Nussenzweig, Andre; Alt, Frederick W.			Mechanisms promoting translocations in editing and switching peripheral B cells	NATURE			English	Article							END-JOINING PATHWAY; CHROMOSOMAL TRANSLOCATIONS; V(D)J RECOMBINATION; RECEPTOR REVISION; BONE-MARROW; DNA BREAKS; LYMPHOCYTE DEVELOPMENT; GENE-REGULATION; AID; EXPRESSION	Variable, diversity and joining gene segment (V(D) J) recombination assembles immunoglobulin heavy or light chain (IgH or IgL) variable region exons in developing bone marrow B cells, whereas class switch recombination (CSR) exchanges IgH constant region exons in peripheral B cells. Both processes use directed DNA double-strand breaks (DSBs) repaired by non-homologous end-joining (NHEJ). Errors in either V(D) J recombination or CSR can initiate chromosomal translocations, including oncogenic IgH locus (Igh) to c-myc (also known as Myc) translocations of peripheral B cell lymphomas. Collaboration between these processes has also been proposed to initiate translocations. However, the occurrence of V(D) J recombination in peripheral B cells is controversial. Here we show that activated NHEJ-deficient splenic B cells accumulate V(D) J-recombination-associated breaks at the lambda IgL locus (Igl), as well as CSR-associated Igh breaks, often in the same cell. Moreover, Igl and Igh breaks are frequently joined to form translocations, a phenomenon associated with specific Igh-Igl co-localization. Igh and c-myc also co-localize in these cells; correspondingly, the introduction of frequent c-myc DSBs robustly promotes Igh-c-myc translocations. Our studies show peripheral B cells that attempt secondary V(D) J recombination, and determine a role for mechanistic factors in promoting recurrent translocations in tumours.	[Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Rajewsky, Klaus; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Difilippantonio, Simone; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Wang, Jing Hong/M-7813-2015; Hickernell, Thomas R/ABG-2642-2021	Wang, Jing Hong/0000-0003-4343-2527; Hickernell, Thomas R/0000-0003-0897-8487; Goff, Peter/0000-0002-3488-4997; Rajewsky, Klaus/0000-0002-6633-6370; Wesemann, Duane/0000-0002-6690-944X	National Insitutes of Health (NIH) [5P01CA92625]; Leukemia and Lymphoma Society of America (LLS) SCORE; NCI; NATIONAL CANCER INSTITUTE [P01CA092625, T32CA009382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077595, R37AI077595] Funding Source: NIH RePORTER	National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCORE(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Alt laboratory members for discussions, and Y. L. Chen, J. M. Bianco and M. Moghimi for technical assistance. This work was supported by the National Insitutes of Health (NIH) grant 5P01CA92625 and a Leukemia and Lymphoma Society of America (LLS) SCORE grant to F. W. A. and K. R. M. G. is and J. H. W. was a Special Fellow of the LLS. J. H. W. and D. R. W. are supported by an NIH training grant and C. T. Y. was supported by an NCI training grant. A. N. is supported by the Intramural Research program of the NIH, NCI, Center for Cancer Research. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Goossens T, 2001, EUR J IMMUNOL, V31, P3638, DOI 10.1002/1521-4141(200112)31:12<3638::AID-IMMU3638>3.0.CO;2-G; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lahvis GP, 1997, J IMMUNOL, V159, P1783; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; PLESSIS A, 1992, GENETICS, V130, P451; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Roth DB, 2002, MOL CELL, V10, P1, DOI 10.1016/S1097-2765(02)00573-7; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Seagal J, 2002, CLIN IMMUNOL, V105, P1, DOI 10.1006/clim.2002.5290; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	50	101	103	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					231	U94		10.1038/nature08159	http://dx.doi.org/10.1038/nature08159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587764	Green Accepted			2022-12-24	WOS:000267761000035
J	Moustafa, A; Beszteri, B; Maier, UG; Bowler, C; Valentin, K; Bhattacharya, D				Moustafa, Ahmed; Beszteri, Bank; Maier, Uwe G.; Bowler, Chris; Valentin, Klaus; Bhattacharya, Debashish			Genomic Footprints of a Cryptic Plastid Endosymbiosis in Diatoms	SCIENCE			English	Article							NUCLEAR GENOMES; PHYLOGENY; REVEALS; GENES; CYANOBACTERIAL; ORIGINS; ENZYMES; PROTEIN; ALGAE	Diatoms and other chromalveolates are among the dominant phytoplankters in the world's oceans. Endosymbiosis was essential to the success of chromalveolates, and it appears that the ancestral plastid in this group had a red algal origin via an ancient secondary endosymbiosis. However, recent analyses have turned up a handful of nuclear genes in chromalveolates that are of green algal derivation. Using a genome-wide approach to estimate the "green" contribution to diatoms, we identified >1700 green gene transfers, constituting 16% of the diatom nuclear coding potential. These genes were probably introduced into diatoms and other chromalveolates from a cryptic endosymbiont related to prasinophyte-like green algae. Chromalveolates appear to have recruited genes from the two major existing algal groups to forge a highly successful, species-rich protist lineage.	[Moustafa, Ahmed; Bhattacharya, Debashish] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Beszteri, Bank; Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Maier, Uwe G.] Univ Marburg, Marburg, Germany; [Bowler, Chris] Ecole Normale Super, Dept Biol, CNRS, UMR8186, F-75005 Paris, France; [Bowler, Chris] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Bhattacharya, Debashish] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; [Bhattacharya, Debashish] Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA	University of Iowa; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; University of Iowa; University of Iowa	Bhattacharya, D (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	debashi-bhattacharya@uiowa.edu	Moustafa, Ahmed/AAZ-3991-2020; Beszteri, Bank M/D-1961-2010; Valentin, Klaus/G-5862-2014; Bowler, Chris/AAC-6256-2019; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Beszteri, Bank M/0000-0002-6852-1588; Valentin, Klaus/0000-0001-7401-9423; Moustafa, Ahmed/0000-0002-0111-3555; Bowler, Chris/0000-0003-3835-6187	NSF; NIH [EF 04-31117, R01ES013679]; Institutional National Research Service Award [T 32 GM98629]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DB was supported by grants from NSF and NIH EF 04-31117 and R01ES013679, respectively. AM was supported by an Institutional National Research Service Award T 32 GM98629 from NIH. UGM thanks the Deutsche Forschungsgemeinschaft grant SFB-TR1 for support. We thank T Mock for providing tiling array generated diatom transcripts and JE DeReus at the High Performance Computing Facility at the University of Iowa for technical support.	Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Falkowski P, 2007, EVOLUTION PRIMARY PR; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; HAUBER MM, 1994, BOT ACTA, V107, P383; Ishida K, 2002, P NATL ACAD SCI USA, V99, P9294, DOI 10.1073/pnas.142091799; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; STEINKOTTER J, 1994, J PHYCOL, V30, P340, DOI 10.1111/j.0022-3646.1994.00340.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Thierstein HR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P455; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	24	298	307	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1724	1726		10.1126/science.1172983	http://dx.doi.org/10.1126/science.1172983			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556510	Green Published			2022-12-24	WOS:000267338200044
J	Pichevin, LE; Reynolds, BC; Ganeshram, RS; Cacho, I; Pena, L; Keefe, K; Ellam, RM				Pichevin, L. E.; Reynolds, B. C.; Ganeshram, R. S.; Cacho, I.; Pena, L.; Keefe, K.; Ellam, R. M.			Enhanced carbon pump inferred from relaxation of nutrient limitation in the glacial ocean	NATURE			English	Article							EASTERN EQUATORIAL PACIFIC; ICP-MS; FLUX; FRACTIONATION; TEMPERATURE; NITROGEN; RATIOS; OPAL	The modern Eastern Equatorial Pacific (EEP) Ocean is a large oceanic source of carbon to the atmosphere(1). Primary productivity over large areas of the EEP is limited by silicic acid and iron availability, and because of this constraint the organic carbon export to the deep ocean is unable to compensate for the outgassing of carbon dioxide that occurs through upwelling of deep waters. It has been suggested that the delivery of dust-borne iron to the glacial ocean(2,3) could have increased primary productivity and enhanced deep-sea carbon export in this region, lowering atmospheric carbon dioxide concentrations during glacial periods. Such a role for the EEP is supported by higher organic carbon burial rates documented in underlying glacial sediments(4,5), but lower opal accumulation rates cast doubts on the importance of the EEP as an oceanic region for significant glacial carbon dioxide drawdown(6,7). Here we present a new silicon isotope record that suggests the paradoxical decline in opal accumulation rate in the glacial EEP results from a decrease in the silicon to carbon uptake ratio of diatoms under conditions of increased iron availability from enhanced dust input. Consequently, our study supports the idea of an invigorated biological pump in this region during the last glacial period that could have contributed to glacial carbon dioxide drawdown. Additionally, using evidence from silicon and nitrogen isotope changes, we infer that, in contrast to the modern situation, the biological productivity in this region is not constrained by the availability of iron, silicon and nitrogen during the glacial period. We hypothesize that an invigorated biological carbon dioxide pump constrained perhaps only by phosphorus limitation was a more common occurrence in low-latitude areas of the glacial ocean.	[Pichevin, L. E.; Ganeshram, R. S.] Univ Edinburgh, Grant Inst, Sch Geosci, Edinburgh EH10 3JW, Midlothian, Scotland; [Reynolds, B. C.] ETH, IGMR, CH-8092 Zurich, Switzerland; [Cacho, I.; Pena, L.] Univ Barcelona, Fac Geol, GRC Geociencies Marines, E-08028 Barcelona, Spain; [Keefe, K.; Ellam, R. M.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland	University of Edinburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Barcelona; Scottish Universities Research & Reactor Center	Pichevin, LE (corresponding author), Univ Edinburgh, Grant Inst, Sch Geosci, W Main Rd, Edinburgh EH10 3JW, Midlothian, Scotland.	laetitia.pichevin@ed.ac.uk	Cacho, Isabel/H-4402-2013; Pena, Leopoldo/B-8140-2013; Pena, Leopoldo/A-7085-2015; Cacho, Isabel/AAX-2610-2021; Ellam, Rob M/B-7878-2009	Cacho, Isabel/0000-0002-6512-0770; Pena, Leopoldo/0000-0001-6414-6293; Pena, Leopoldo/0000-0001-6414-6293; Cacho, Isabel/0000-0002-6512-0770; Ellam, Rob M/0000-0001-8159-4864; Pichevin, Laetitia/0000-0003-2685-6926	Scottish Alliance for Geoscience Environment Society (SAGES); Natural Environment Research Council ( NERC) through a Standard NERC; Marie Curie Intra-European fellowship; ROMIAT; GRACCIE-CONSOLIDER; NERC [NE/E017738/1] Funding Source: UKRI; Natural Environment Research Council [NE/E017738/1] Funding Source: researchfish	Scottish Alliance for Geoscience Environment Society (SAGES); Natural Environment Research Council ( NERC) through a Standard NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie Intra-European fellowship(European Commission); ROMIAT; GRACCIE-CONSOLIDER; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Francois, S. Kienast, W. Geibert, E. Galbraith and G. Leduc for discussions. Funding for this project was provided by the Scottish Alliance for Geoscience Environment Society ( SAGES), the Natural Environment Research Council ( NERC) through a Standard NERC grant ( to R. S. G. and L. E. P.) and a Marie Curie Intra-European fellowship ( to L. E. P.). I. C. and L. P. acknowledge funding from the ROMIAT and GRACCIE-CONSOLIDER projects.	Altabet MA, 2001, LIMNOL OCEANOGR, V46, P368, DOI 10.4319/lo.2001.46.2.0368; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Beucher CP, 2008, GEOCHIM COSMOCHIM AC, V72, P3063, DOI 10.1016/j.gca.2008.04.021; Beucher CP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002746; Bradtmiller LI, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001282; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Ellam RM, 2007, J ANAL ATOM SPECTROM, V22, P147, DOI 10.1039/b612231k; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 2002, NATURE, V415, P156, DOI 10.1038/415156a; Georg RB, 2006, CHEM GEOL, V235, P95, DOI 10.1016/j.chemgeo.2006.06.006; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Kienast SS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026651; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lisitzin A. P., 1971, MICROPALAEONTOLOGY O, P173; Loubere P, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001367; LYLE M, 1988, NATURE, V335, P529, DOI 10.1038/335529a0; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McGee D, 2007, EARTH PLANET SC LETT, V257, P215, DOI 10.1016/j.epsl.2007.02.033; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moore JK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002762; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Morley DW, 2004, J PALEOLIMNOL, V31, P391, DOI 10.1023/B:JOPL.0000021854.70714.6b; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; PEDERSEN TF, 1983, GEOLOGY, V11, P16, DOI 10.1130/0091-7613(1983)11<16:IPITEE>2.0.CO;2; Pena LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001620; Reynolds BC, 2006, EARTH PLANET SC LETT, V244, P431, DOI 10.1016/j.epsl.2006.02.002; Reynolds BC, 2006, J ANAL ATOM SPECTROM, V21, P266, DOI 10.1039/b515908c; Richaud M, 2007, DEEP-SEA RES PT II, V54, P762, DOI 10.1016/j.dsr2.2007.01.012; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Toggweiler JR, 1995, DAHL WS ENV, V18, P337; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595	36	77	79	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1114	U98		10.1038/nature08101	http://dx.doi.org/10.1038/nature08101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553996	Green Accepted			2022-12-24	WOS:000267636700040
J	Fang, YL; Jayaram, H; Shane, T; Kolmakova-Partensky, L; Wu, F; Williams, C; Xiong, Y; Miller, C				Fang, Yiling; Jayaram, Hariharan; Shane, Tania; Kolmakova-Partensky, Ludmila; Wu, Fang; Williams, Carole; Xiong, Yong; Miller, Christopher			Structure of a prokaryotic virtual proton pump at 3.2 angstrom resolution	NATURE			English	Article							EXTREME ACID RESISTANCE; ESCHERICHIA-COLI; TRANSPORTER SUPERFAMILY; AGMATINE ANTIPORTER; CRYSTAL-STRUCTURE; RECOGNITION SITE; APC SUPERFAMILY; MOLECULAR-BASIS; ARGININE; MECHANISM	To reach the mammalian gut, enteric bacteria must pass through the stomach. Many such organisms survive exposure to the harsh gastric environment (pH 1.5-4) by mounting extreme acid-resistance responses, one of which, the arginine-dependent system of Escherichia coli, has been studied at levels of cellular physiology, molecular genetics and protein biochemistry(1-7). This multiprotein system keeps the cytoplasm above pH 5 during acid challenge by continually pumping protons out of the cell using the free energy of arginine decarboxylation. At the heart of the process is a 'virtual proton pump' 8 in the inner membrane, called AdiC(3,4), that imports L-arginine from the gastric juice and exports its decarboxylation product agmatine. AdiC belongs to the APC superfamily of membrane proteins(6,7,9), which transports amino acids, polyamines and organic cations in a multitude of biological roles, including delivery of arginine for nitric oxide synthesis(10), facilitation of insulin release from pancreatic beta-cells(11), and, when inappropriately over-expressed, provisioning of certain fast-growing neoplastic cells with amino acids(12,13). High-resolution structures and detailed transport mechanisms of APC transporters are currently unknown. Here we describe a crystal structure of AdiC at 3.2 angstrom resolution. The protein is captured in an outward-open, substrate-free conformation with transmembrane architecture remarkably similar to that seen in four other families of apparently unrelated transport proteins.	[Fang, Yiling; Jayaram, Hariharan; Shane, Tania; Kolmakova-Partensky, Ludmila; Wu, Fang; Williams, Carole; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; [Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Brandeis University; Howard Hughes Medical Institute; Yale University	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu			NIH [T32 NS 07292]; Advanced Photon Source [GM-CAT, 23-ID]; Advanced Light Source [8.2.1, 8.2.2]; National Synchrotron Light Source [X-25, X-29A]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089688, R01GM031768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Photon Source; Advanced Light Source; National Synchrotron Light Source; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Y. F. was supported by NIH grant T32 NS 07292. We appreciate the support of the beamline scientists at the Advanced Photon Source (GM-CAT, 23-ID), Advanced Light Source (8.2.1, 8.2.2) and National Synchrotron Light Source (X-25, X-29A). We are also grateful to J. Berry for help in hybridoma sequencing, B. Bowman for crystallographic advice, E. Gouaux for sharing information about an APC homologue, and P. DeWeer, D. P. Krummel, H. H. Lim, K. Piasta and J. Robertson for suggestions on the manuscript.	Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; MALONEY PC, 1994, CURR OPIN CELL BIOL, V6, P571, DOI 10.1016/0955-0674(94)90079-5; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Smith PA, 1997, J PHYSIOL-LONDON, V499, P625, DOI 10.1113/jphysiol.1997.sp021955; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8	31	182	183	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1040	1043		10.1038/nature08201	http://dx.doi.org/10.1038/nature08201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19578361	Green Accepted			2022-12-24	WOS:000269085500040
J	Karlsson, J; Bystrom, P; Ask, J; Ask, P; Persson, L; Jansson, M				Karlsson, Jan; Bystrom, Par; Ask, Jenny; Ask, Per; Persson, Lennart; Jansson, Mats			Light limitation of nutrient-poor lake ecosystems	NATURE			English	Article							DISSOLVED ORGANIC-CARBON; CLEAR-WATER LAKES; PHOSPHORUS LIMITATION; FOOD WEBS; BIOMASS; EUTROPHICATION; IMPACT; EXPORT	Productivity denotes the rate of biomass synthesis in ecosystems and is a fundamental characteristic that frames ecosystem function and management. Limitation of productivity by nutrient availability is an established paradigm for lake ecosystems(1-3). Here, we assess the relevance of this paradigm for a majority of the world's small, nutrient-poor lakes, with different concentrations of coloured organic matter(4,5). By comparing small unproductive lakes along a water colour gradient, we show that coloured terrestrial organic matter controls the key process for new biomass synthesis (the benthic primary production) through its effects on light attenuation. We also show that this translates into effects on production and biomass of higher trophic levels (benthic invertebrates and fish). These results are inconsistent with the idea that nutrient supply primarily controls lake productivity, and we propose that a large share of the world's unproductive lakes, within natural variations of organic carbon and nutrient input, are limited by light and not by nutrients. We anticipate that our result will have implications for understanding lake ecosystem function and responses to environmental change. Catchment export of coloured organic matter is sensitive to short-term natural variability and long-term, large-scale changes, driven by climate and different anthropogenic influences(6,7). Consequently, changes in terrestrial carbon cycling will have pronounced effects on most lake ecosystems by mediating changes in light climate and productivity of lakes.	[Karlsson, Jan] Umea Univ, Dept Ecol & Environm Sci, CIRC, SE-98107 Abisko, Sweden; [Bystrom, Par; Ask, Jenny; Ask, Per; Persson, Lennart; Jansson, Mats] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden	Umea University; Umea University	Karlsson, J (corresponding author), Umea Univ, Dept Ecol & Environm Sci, CIRC, Box 62, SE-98107 Abisko, Sweden.	Jan.Karlsson@emg.umu.se	Persson, Lennart/B-2885-2012; Ask, Jenny/AGL-6833-2022	Ask, Jenny/0000-0003-2156-4908	Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas)	The study was part of the research environment LEREC (Lake Ecosystem Response to Environmental Change), financially supported by Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning). We thank the Abisko Scientific Research Station, the Swedish Meteorological and Hydrological Institute and the Umea Marine Sciences Centre for providing PAR data, M. Morth and J. Johansson for chemical analysis and C. Hein for language editing.	Ask J, 2009, ECOLOGY, V90, P1923, DOI 10.1890/07-1855.1; Blenckner T, 2004, BOREAL ENVIRON RES, V9, P371; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Carpenter SR, 1998, LIMNOL OCEANOGR, V43, P73, DOI 10.4319/lo.1998.43.1.0073; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; ELORANTA P, 1978, Holarctic Ecology, V1, P362; HANSON JM, 1982, CAN J FISH AQUAT SCI, V39, P257, DOI 10.1139/f82-036; HANSSON LA, 1992, LIMNOL OCEANOGR, V37, P322, DOI 10.4319/lo.1992.37.2.0322; HOPE D, 1994, ENVIRON POLLUT, V84, P301, DOI 10.1016/0269-7491(94)90142-2; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Karlsson J, 2005, LIMNOL OCEANOGR, V50, P538, DOI 10.4319/lo.2005.50.2.0538; Karlsson J, 2003, LIMNOL OCEANOGR, V48, P269, DOI 10.4319/lo.2003.48.1.0269; Karlsson J, 2002, ECOLOGY, V83, P2902, DOI 10.1890/0012-9658(2002)083[2902:SRBPPA]2.0.CO;2; McCauley E., 1984, IBP HDB, P228; McQuarrie A. D, 1998, REGRESSION TIME SERI; MEILI M, 1992, HYDROBIOLOGIA, V229, P23, DOI 10.1007/BF00006988; Mulholland P.J., 2003, AQUATIC ECOSYSTEMS I, P139, DOI [10.1016/B978-012256371-3/50007-X, 10.1016/b978-012256371-3/50007-x]; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; SVARDSON G, 1976, 56 I FRESHW RES, P144; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2	30	523	534	20	470	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 23	2009	460	7254					506	U80		10.1038/nature08179	http://dx.doi.org/10.1038/nature08179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626113				2022-12-24	WOS:000268257000037
J	Thompson, DM; Parker, R				Thompson, Debrah M.; Parker, Roy			Stressing Out over tRNA Cleavage	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CELL-PROLIFERATION; OXIDATIVE STRESS; ANGIOGENIN; RIBONUCLEASE; APOPTOSIS; TUMOR; EXPRESSION; STARVATION	A conserved response to stress involves endonucleolytic cleavage of cytoplasmic transfer RNAs (tRNAs) by ribonucleases that are normally secreted or sequestered. Ribonuclease activation or release is an intriguing new aspect of cellular stress responses, with a potential impact on translation, apoptosis, cancer, and disease progression.	[Thompson, Debrah M.; Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Acquati F, 2005, INT J ONCOL, V26, P1159; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; ARDELT W, 1991, J BIOL CHEM, V266, P245; BOREK E, 1977, CANCER RES, V37, P3362; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Iordanov MS, 2000, CANCER RES, V60, P1983; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; LEVITZ R, 1990, EMBO J, V9, P1383, DOI 10.1002/j.1460-2075.1990.tb08253.x; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Smirnoff P, 2006, CANCER-AM CANCER SOC, V107, P2760, DOI 10.1002/cncr.22327; SPEER J, 1979, CANCER, V44, P2120, DOI 10.1002/1097-0142(197912)44:6<2120::AID-CNCR2820440623>3.0.CO;2-6; STCLAIR DK, 1988, BIOCHEMISTRY-US, V27, P7263, DOI 10.1021/bi00419a013; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	40	296	310	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					215	219		10.1016/j.cell.2009.07.001	http://dx.doi.org/10.1016/j.cell.2009.07.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632169	Bronze			2022-12-24	WOS:000268277000001
J	Djousse, L; Driver, JA; Gaziano, JM				Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael			Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; DIETARY LINOLENIC ACID; UNITED-STATES; PHYSICIANS HEALTH; CARDIOVASCULAR HEALTH; ALCOHOL-CONSUMPTION; PRIMARY PREVENTION; NATIONAL-HEART; BLOOD-PRESSURE; TRENDS	Context The lifetime risk of heart failure at age 40 years is approximately 1 in 5 in the general population; however, little is known about the association between modifiable lifestyle factors and the remaining lifetime risk of heart failure. Objective To examine the association between modifiable lifestyle factors and the lifetime risk of heart failure in a large cohort of men. Design, Setting, and Participants Prospective cohort study using data from 20 900 men (mean age at baseline, 53.6 years) from the Physicians' Health Study I (19822008) who were apparently healthy at baseline. Six modifiable lifestyle factors were assessed: body weight, smoking, exercise, alcohol intake, consumption of breakfast cereals, and consumption of fruits and vegetables. Main Outcome Measure Lifetime risk of heart failure. Results During a mean follow-up of 22.4 years, 1200 men developed heart failure. Overall, the lifetime risk of heart failure was 13.8% (95% confidence interval [CI], 12.9%-14.7%) at age 40 years. Lifetime risk remained constant in men who survived free of heart failure through age 70 years and reached 10.6% (95% CI, 9.4%-11.7%) at age 80 years. Lifetime risk of heart failure was higher in men with hypertension than in those without hypertension. Healthy lifestyle habits (normal body weight, not smoking, regular exercise, moderate alcohol intake, consumption of breakfast cereals, and consumption of fruits and vegetables) were individually and jointly associated with a lower lifetime risk of heart failure, with the highest risk in men adhering to none of the 6 lifestyle factors (21.2%; 95% CI, 16.8%-25.6%) and the lowest risk in men adhering to 4 or more desirable factors (10.1%; 95% CI, 7.9%-12.3%). Conclusion In this cohort of apparently healthy men, adherence to healthy lifestyle factors is associated with a lower lifetime risk of heart failure. JAMA. 2009;302(4):394-400	[Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Boston, MA 02120 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] MAVERIC, Boston, MA USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Res Ctr GRECC, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center	Djousse, L (corresponding author), Brigham & Womens Hosp, Div Aging, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	ldjousse@rics.bwh.harvard.edu	Djousse, Luc/F-5033-2017	Djousse, Luc/0000-0002-9902-3047	National Cancer Institute [CA-34944, CA-40360, CA097193]; National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-26490, HL-34595]; NATIONAL CANCER INSTITUTE [R01CA040360, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Physicians' Health Study (PHS) is supported by grants CA-34944, CA-40360, and CA097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Djousse L, 2005, CIRCULATION, V111, P2921, DOI 10.1161/CIRCULATIONAHA.104.489534; Djousse L, 2001, AM J CLIN NUTR, V74, P612; Djousse L, 2007, CURR CARDIOVASC RISK, V1, P330, DOI 10.1007/s12170-007-0053-1; Djousse L, 2007, AM HEART J, V154, P855, DOI 10.1016/j.ahj.2007.07.004; Djousse L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; GARG R, 1993, J AM COLL CARDIOL  S, V22, P3; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; Goldberg RJ, 2005, AM J MED, V118, P728, DOI 10.1016/j.amjmed.2005.04.013; Goldberg RJ, 2005, AM J CARDIOL, V95, P1324, DOI 10.1016/j.amjcard.2005.01.076; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; HO KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kochar J, 2007, OBESITY, V15, P3039, DOI 10.1038/oby.2007.362; Koelling TM, 2004, AM HEART J, V147, P74, DOI 10.1016/j.ahj.2003.07.021; Lazarevic AM, 2000, J AM COLL CARDIOL, V35, P1599, DOI 10.1016/S0735-1097(00)00565-9; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Massie BM, 1997, AM HEART J, V133, P703, DOI 10.1016/S0002-8703(97)70173-X; Moore LL, 2005, EPIDEMIOLOGY, V16, P4, DOI 10.1097/01.ede.0000147106.32027.3e; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Piano MR, 2002, CHEST, V121, P1638, DOI 10.1378/chest.121.5.1638; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Shahar E, 2004, J CARD FAIL, V10, P374, DOI 10.1016/j.cardfail.2004.02.003; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	46	285	297	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					394	400		10.1001/jama.2009.1062	http://dx.doi.org/10.1001/jama.2009.1062			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622818	Green Accepted, Bronze			2022-12-24	WOS:000268139200022
J	Zhou, Y; Zheng, HJ; Chen, YY; Zhang, L; Wang, K; Guo, J; Huang, Z; Zhang, B; Huang, W; Jin, K; Dou, TH; Hasegawa, M; Wang, L; Zhang, Y; Zhou, J; Tao, L; Cao, ZW; Li, YX; Vinar, T; Brejova, B; Brown, D; Li, M; Miller, DJ; Blair, D; Zhong, Y; Chen, Z; Hu, W; Wang, ZQ; Zhang, QH; Song, HD; Chen, SJ; Xu, XN; Xu, B; Ju, C; Huang, YC; Brindley, PJ; McManus, DP; Feng, Z; Han, ZG; Lu, G; Ren, SX; Wang, YZ; Gu, WY; Kang, H; Chen, J; Chen, XY; Chen, ST; Wang, LJ; Yan, J; Wang, BY; Lv, XY; Jin, L; Wang, BF; Pu, SY; Zhang, XL; Zhang, W; Hu, QP; Zhu, GF; Wang, J; Yu, J; Wang, J; Yang, HM; Ning, ZM; Beriman, M; Wei, CL; Ruan, YJ; Zhao, GP; Wang, SY; Liu, F; Wang, ZQ; Zheng, HJ; Zhang, QH; Wang, SY; Han, ZG				Zhou, Yan; Zheng, Huajun; Chen, Yangyi; Zhang, Lei; Wang, Kai; Guo, Jing; Huang, Zhen; Zhang, Bo; Huang, Wei; Jin, Ke; Dou, Tonghai; Hasegawa, Masami; Wang, Li; Zhang, Yuan; Zhou, Jie; Tao, Lin; Cao, Zhiwei; Li, Yixue; Vinar, Tomas; Brejova, Brona; Brown, Dan; Li, Ming; Miller, David J.; Blair, David; Zhong, Yang; Chen, Zhu; Hu, Wei; Wang, Zhi-Qin; Zhang, Qin-Hua; Song, Huai-Dong; Chen, Saijuan; Xu, Xuenian; Xu, Bin; Ju, Chuan; Huang, Yucheng; Brindley, Paul J.; McManus, Donald P.; Feng, Zheng; Han, Ze-Guang; Lu, Gang; Ren, Shuangxi; Wang, Yuezhu; Gu, Wenyi; Kang, Hui; Chen, Jie; Chen, Xiaoyun; Chen, Shuting; Wang, Lijun; Yan, Jie; Wang, Biyun; Lv, Xinyan; Jin, Lei; Wang, Bofei; Pu, Shiyin; Zhang, Xianglin; Zhang, Wei; Hu, Qiuping; Zhu, Genfeng; Wang, Jun; Yu, Jun; Wang, Jian; Yang, Huanming; Ning, Zemin; Beriman, Matthew; Wei, Chia-Lin; Ruan, Yijun; Zhao, Guoping; Wang, Shengyue; Liu, Feng; Wang, Zhi-Qin; Zheng, Huajun; Zhang, Qin-hua; Wang, Shengyue; Han, Ze-Guang		Schistosoma Japonicum Genome Seque	The Schistosoma japonicum genome reveals features of host-parasite interplay	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SNP MAP; IDENTIFICATION; CLONING; MANSONI; LOCALIZATION; EVOLUTIONARY; ECDYSTEROIDS; METAANALYSIS; SENSITIVITY	Schistosoma japonicum is a parasitic flatworm that causes human schistosomiasis, which is a significant cause of morbidity in China and the Philippines. Here we present a draft genomic sequence for the worm. The genome provides a global insight into the molecular architecture and host interaction of this complex metazoan pathogen, revealing that it can exploit host nutrients, neuroendocrine hormones and signalling pathways for growth, development and maturation. Having a complex nervous system and a well-developed sensory system, S. japonicum can accept stimulation of the corresponding ligands as a physiological response to different environments, such as fresh water or the tissues of its intermediate and mammalian hosts. Numerous proteases, including cercarial elastase, are implicated in mammalian skin penetration and haemoglobin degradation. The genomic information will serve as a valuable platform to facilitate development of new interventions for schistosomiasis control.	[Zhou, Yan; Zheng, Huajun; Chen, Yangyi; Zhang, Lei; Wang, Kai; Guo, Jing; Huang, Zhen; Zhang, Bo; Huang, Wei; Chen, Zhu; Wang, Zhi-Qin; Han, Ze-Guang; Lu, Gang; Ren, Shuangxi; Wang, Yuezhu; Gu, Wenyi; Kang, Hui; Chen, Jie; Chen, Xiaoyun; Chen, Shuting; Wang, Lijun; Yan, Jie; Wang, Biyun; Lv, Xinyan; Jin, Lei; Wang, Bofei; Pu, Shiyin; Zhang, Xianglin; Zhang, Wei; Hu, Qiuping; Zhu, Genfeng; Zhao, Guoping; Wang, Shengyue; Liu, Feng; Wang, Zhi-Qin; Zheng, Huajun; Wang, Shengyue; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Zhou, Yan; Zheng, Huajun; Jin, Ke; Dou, Tonghai; Hasegawa, Masami; Wang, Li; Zhang, Yuan; Zhou, Jie; Zhong, Yang; Zhao, Guoping; Liu, Feng; Zheng, Huajun] Fudan Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Li; Tao, Lin; Cao, Zhiwei; Li, Yixue; Zhong, Yang] Shanghai Ctr Bioinformat Technol, Shanghai 200235, Peoples R China; [Vinar, Tomas; Brejova, Brona; Brown, Dan; Li, Ming] Univ Waterloo, Cheriton Sch Comp Sci, Waterloo, ON N2L 3G1, Canada; [Miller, David J.; Blair, David] James Cook Univ, Sch Trop Biol, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Chen, Zhu; Song, Huai-Dong; Chen, Saijuan; Lu, Gang] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Chen, Zhu; Song, Huai-Dong; Chen, Saijuan; Lu, Gang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Hu, Wei; Xu, Xuenian; Xu, Bin; Ju, Chuan; Huang, Yucheng; Feng, Zheng] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Zhang, Qin-Hua; Zhang, Qin-hua] Shanghai Ctr Biochip Engn, Shanghai 201203, Peoples R China; [Brindley, Paul J.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [McManus, Donald P.] Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld 4006, Australia; [Wang, Jun; Yu, Jun; Wang, Jian; Yang, Huanming] Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China; [Ning, Zemin; Beriman, Matthew; Zhao, Guoping] Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Hinxton CB10 1SA, England; [Wei, Chia-Lin; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Fudan University; Chinese Academy of Sciences; University of Waterloo; James Cook University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; George Washington University; QIMR Berghofer Medical Research Institute; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Wellcome Trust Sanger Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, Y (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, 250 Bi Bo Rd, Shanghai 201203, Peoples R China.		McManus, Donald P./G-2678-2013; Blair, David/G-6052-2011; Zheng, Huajun/AAN-4973-2020; Wang, Jun/A-7261-2013; Vinar, Tomas/I-3695-2014; HU, Wei/F-1004-2012; McManus, Don/AAC-5394-2020; 郑, 征/C-8514-2011; Brejova, Brona/I-3718-2014; Song, Huai-Dong/G-8961-2011; Blair, David/O-2786-2019; Ning, Zemin/D-2411-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Blair, David/0000-0002-4658-3251; Vinar, Tomas/0000-0003-3898-3447; McManus, Don/0000-0001-6443-1449; Brejova, Brona/0000-0002-9483-1766; Blair, David/0000-0002-4658-3251; Wang, Jun/0000-0002-8540-8931; Zhao, Guo-Ping/0000-0002-7621-6620; Brown, Dan/0000-0002-5205-5762; Ning, Zemin/0000-0003-4359-776X; Zhang, Bo/0000-0001-8890-8416; Tao, Lin/0000-0001-7494-4758; Wang, Jun/0000-0002-2113-5874; Han, Ze-Guang/0000-0002-1018-1752; WANG, kai/0000-0002-6194-0480; Brindley, Paul J./0000-0003-1765-0002	Chinese National High-Tech Program [2004AA2Z1010, 2006AA02Z335, 2006AA02Z318, 2007AA02Z153]; Chinese National Key Project for Basic Research [2006CB708510, 2007CB513100]; Chinese Academy of Sciences; Shanghai Municipal Commission for Science and Technology [04DZ14010, 055407031, 06JC14059, 07QA14043, 07DZ22915]; National Natural Science Foundation of China; US National Institute of Allergy and Infectious Diseases [AI39461]; National Science and Engineering Research Council of Canada [OGP0046506]; National Health and Medical Research Council of Australia; Wellcome Trust, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI039461] Funding Source: NIH RePORTER	Chinese National High-Tech Program(National High Technology Research and Development Program of China); Chinese National Key Project for Basic Research; Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was mainly supported by the Chinese National High-Tech Program (863 Program) (2004AA2Z1010, 2006AA02Z335, 2006AA02Z318, 2007AA02Z153), the Chinese National Key Project for Basic Research (973 Project) (2006CB708510, 2007CB513100), the Chinese Academy of Sciences, the Shanghai Municipal Commission for Science and Technology (04DZ14010, 055407031, 06JC14059, 07QA14043, 07DZ22915), and the National Natural Science Foundation of China. Support from the US National Institute of Allergy and Infectious Diseases (award number AI39461), the National Science and Engineering Research Council of Canada (OGP0046506), a International Collaborative Research Grants award from the National Health and Medical Research Council of Australia, and the Wellcome Trust, UK, is also gratefully acknowledged. The Shanghai Supercomputer Center kindly provided computational facilities for some of the data analysis. The authors wish to thank P. De Jong and his colleagues for the BAC libraries construction of S. japonicum and N. M. El-Sayed for his contribution on the collaboration between the S. japonicum and S. mansoni sequencing consortia.	Abouel-Nour M. F., 2005, Journal of the Egyptian Society of Parasitology, V35, P147; Adamson P B, 1976, Med Hist, V20, P176; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BASCH PF, 1986, COMP BIOCHEM PHYS A, V83, P199, DOI 10.1016/0300-9629(86)90108-8; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergquist R, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000244; BERRIMAN M, NATURE IN PRESS, DOI DOI 10.1038/NATURE08160; Brejova B, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp052; COHEN LM, 1980, J PARASITOL, V66, P362, DOI 10.2307/3280843; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Dvorak J, 2005, INT J PARASITOL, V35, P895, DOI 10.1016/j.ijpara.2005.02.018; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FOSTER JM, 1992, TROP MED PARASITOL, V43, P239; Gamulin V, 2000, BIOL J LINN SOC, V71, P821, DOI [10.1111/j.1095-8312.2000.tb01293.x, 10.1006/bijl.2000.0476]; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grosjean Y, 2003, J NEUROBIOL, V55, P1, DOI 10.1002/neu.10208; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766; Hillyer GV, 2005, J HELMINTHOL, V79, P241, DOI 10.1079/JOH2005304; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Hoffmann KF, 2001, MOL BIOCHEM PARASIT, V112, P113, DOI 10.1016/S0166-6851(00)00352-2; Holmes SP, 2003, INSECT MOL BIOL, V12, P27, DOI 10.1046/j.1365-2583.2003.00384.x; Hu W, 2004, TRENDS MOL MED, V10, P217, DOI 10.1016/j.molmed.2004.03.002; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Koehler JW, 2007, MEM I OSWALDO CRUZ, V102, P83, DOI 10.1590/S0074-02762007000100014; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; Mone H, 2004, ADV PARASIT, V57, P89, DOI 10.1016/S0065-308X(04)57002-1; Mousley A, 2005, PARASITOLOGY, V131, pS143, DOI 10.1007/S0031182005008553; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; NEWPORT GR, 1988, J BIOL CHEM, V263, P13179; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Robert D, 2002, J INSECT PHYSIOL, V48, P189, DOI 10.1016/S0022-1910(01)00163-9; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Scholler S, 2005, BIOCHEM BIOPH RES CO, V327, P29, DOI 10.1016/j.bbrc.2004.11.139; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; SMART D, 1995, PARASITOLOGY, V110, P87, DOI 10.1017/S0031182000081087; SMART D, 1994, J COMP NEUROL, V347, P426, DOI 10.1002/cne.903470308; Sobreira TJP, 2006, BIOINFORMATICS, V22, P361, DOI 10.1093/bioinformatics/bti809; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STRICKLIN SL, 2005, WORMBOOK, V25, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; XU YZ, 1990, EXP PARASITOL, V70, P124, DOI 10.1016/0014-4894(90)90093-R; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	69	518	543	5	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					345	U56		10.1038/nature08140	http://dx.doi.org/10.1038/nature08140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606140	hybrid, Green Accepted			2022-12-24	WOS:000267979000028
J	Kagansky, A; Folco, HD; Almeida, R; Pidoux, AL; Boukaba, A; Simmer, F; Urano, T; Hamilton, GL; Allshire, RC				Kagansky, Alexander; Folco, Hernan Diego; Almeida, Ricardo; Pidoux, Alison L.; Boukaba, Abdelhalim; Simmer, Femke; Urano, Takeshi; Hamilton, Georgina L.; Allshire, Robin C.			Synthetic Heterochromatin Bypasses RNAi and Centromeric Repeats to Establish Functional Centromeres	SCIENCE			English	Article							FISSION YEAST; CHROMATIN; RECRUITMENT; REQUIREMENT; DISTINCT; PROTEIN	In the central domain of fission yeast centromeres, the kinetochore is assembled on CENP-A(Cnp1) nucleosomes. Normally, small interfering RNAs generated from flanking outer repeat transcripts direct histone H3 lysine 9 methyltransferase Clr4 to homologous loci to form heterochromatin. Outer repeats, RNA interference (RNAi), and centromeric heterochromatin are required to establish CENP-AC(np1) chromatin. We demonstrated that tethering Clr4 via DNA-binding sites at euchromatic loci induces heterochromatin assembly, with or without active RNAi. This synthetic heterochromatin completely substitutes for outer repeats on plasmid-based minichromosomes, promoting de novo CENP-A(Cnp1) and kinetochore assembly, to allow their mitotic segregation, even with RNAi inactive. Thus, the role of outer repeats in centromere establishment is simply the provision of RNAi substrates to direct heterochromatin formation; H3K9 methylation-dependent heterochromatin is alone sufficient to form functional centromeres.	[Kagansky, Alexander; Folco, Hernan Diego; Almeida, Ricardo; Pidoux, Alison L.; Boukaba, Abdelhalim; Simmer, Femke; Hamilton, Georgina L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6938501, Japan	University of Edinburgh; Shimane University	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Kagansky, Alexander/B-3137-2011; Simmer, Femke/N-2150-2015	Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625; Urano, Takeshi/0000-0003-3383-3554	European Molecular Biology Organization Long Term Fellowship; Medical Research Council [G0301153]; Wellcome Trust Programme [065061/Z]; MRC [G0301153] Funding Source: UKRI	European Molecular Biology Organization Long Term Fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the following colleagues for strains and reagents, M. Baum, L. Clarke, K. Scott, J. Partridge, J. Ma, S. Grewal, D. Moazed, K. Takahashi, M. Yanagida, and S. A. White. This research was supported by a European Molecular Biology Organization Long Term Fellowship (to F.S.), a Medical Research Council Strategic Grant (G0301153 to R.C.A.), and a Wellcome Trust Programme grant (065061/Z to R.C.A.). R.C.A. is a Wellcome Trust Principal Research Fellow.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	16	122	123	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1716	1719		10.1126/science.1172026	http://dx.doi.org/10.1126/science.1172026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556509	Green Accepted			2022-12-24	WOS:000267338200042
J	de Koning-Ward, TF; Gilson, PR; Boddey, JA; Rug, M; Smith, BJ; Papenfuss, AT; Sanders, PR; Lundie, RJ; Maier, AG; Cowman, AF; Crabb, BS				de Koning-Ward, Tania F.; Gilson, Paul R.; Boddey, Justin A.; Rug, Melanie; Smith, Brian J.; Papenfuss, Anthony T.; Sanders, Paul R.; Lundie, Rachel J.; Maier, Alexander G.; Cowman, Alan F.; Crabb, Brendan S.			A newly discovered protein export machine in malaria parasites	NATURE			English	Article							PLASMODIUM-FALCIPARUM; TARGETING SIGNAL; BINDING PROTEIN; VIRULENCE; SURFACE; TRAFFICKING; COMPLEXES; INVASION; ANTIGEN; CYTOADHERENCE	Several hundred malaria parasite proteins are exported beyond an encasing vacuole and into the cytosol of the host erythrocyte, a process that is central to the virulence and viability of the causative Plasmodium species. The trafficking machinery responsible for this export is unknown. Here we identify in Plasmodium falciparum a translocon of exported proteins (PTEX), which is located in the vacuole membrane. The PTEX complex is ATP-powered, and comprises heat shock protein 101 (HSP101; a ClpA/B-like ATPase from the AAA+ superfamily, of a type commonly associated with protein translocons), a novel protein termed PTEX150 and a known parasite protein, exported protein 2 (EXP2). EXP2 is the potential channel, as it is the membrane-associated component of the core PTEX complex. Two other proteins, a new protein PTEX88 and thioredoxin 2 (TRX2), were also identified as PTEX components. As a common portal for numerous crucial processes, this translocon offers a new avenue for therapeutic intervention.	[de Koning-Ward, Tania F.; Gilson, Paul R.; Boddey, Justin A.; Rug, Melanie; Smith, Brian J.; Papenfuss, Anthony T.; Sanders, Paul R.; Lundie, Rachel J.; Maier, Alexander G.; Cowman, Alan F.; Crabb, Brendan S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds, Vic 3217, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia	Walter & Eliza Hall Institute; Deakin University; Burnet Institute	Crabb, BS (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	crabb@burnet.edu.au	Smith, Brian J/F-8282-2011; de Koning-Ward, Tania F/N-3572-2017; Crabb, Brendan/F-5287-2013; Rug, Melanie/A-9504-2011; Cowman, Alan F/C-7642-2013; Rug, Melanie/B-5417-2015; Papenfuss, Anthony T/C-6297-2008; Maier, Alex G/A-6499-2009	Smith, Brian J/0000-0003-0498-1910; de Koning-Ward, Tania F/0000-0001-5810-8063; Cowman, Alan F/0000-0001-5145-9004; Papenfuss, Anthony T/0000-0002-1102-8506; Maier, Alex G/0000-0001-7369-1058; Boddey, Justin/0000-0001-7322-2040	NHMRC IRIISS [361646, 361637]; NIH [RO1 AI44008]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER	NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Australian Red Cross Blood Bank for the provision of human blood and serum. We thank J. McBride, A. Lupas, A. Diemand, M. T. O'Neill, M. Brown, P. Cannon, S. Charnaud, R. Moritz, S. Haase, R. Waller, G. McFadden, G. Cantin and J. Yates for provision of reagents and/or other assistance with some aspects of this study. We are especially grateful to S. Muller for sharing unpublished images and data. This work was supported by NHMRC, by a grant from the NIH (RO1 AI44008) and by infrastructure support from NHMRC IRIISS (361646 and 361637) and Victorian State Government OIS grants. J. A. B. is an NHMRC Peter Doherty postdoctoral fellow, A. G. M. is an ARC Research fellow and A. F. C. is an International Research Scholar of the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fischer K, 1998, MOL BIOCHEM PARASIT, V92, P47, DOI 10.1016/S0166-6851(97)00224-7; Freyer B, 1998, PARASITOL RES, V84, P583, DOI 10.1007/s004360050453; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutensohn M, 2006, J PLANT PHYSIOL, V163, P333, DOI 10.1016/j.jplph.2005.11.009; HALL R, 1983, MOL BIOCHEM PARASIT, V7, P247, DOI 10.1016/0166-6851(83)90025-7; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	45	325	330	1	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					945	U66		10.1038/nature08104	http://dx.doi.org/10.1038/nature08104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536257	Green Accepted			2022-12-24	WOS:000267063500034
J	Rehm, J; Mathers, C; Popova, S; Thavorncharoensap, M; Teerawattananon, Y; Patra, J				Rehm, Juergen; Mathers, Colin; Popova, Svetlana; Thavorncharoensap, Montarat; Teerawattananon, Yot; Patra, Jayadeep			Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders	LANCET			English	Article							RISK-FACTORS; DRINKING; CONSUMPTION; POPULATION; NUTRITION; PATTERNS; TOBACCO; DRUGS	Alcohol consumption has been identified as an important risk factor for chronic disease and injury. in the first paper in this Series, we quantify the burden of mortality and disease attributable to alcohol, both globally and for ten large countries. We assess alcohol exposure and prevalence of alcohol-use disorders on the basis of reviews of published work. After identification of other major disease categories causally linked to alcohol, we estimate attributable fractions by sex, age, and WHO region. Additionally, we compare social costs of alcohol in selected countries. The net effect of alcohol consumption on health is detrimental, with an estimated 3.8% of all global deaths and 4.6% of global disability-adjusted life-years attributable to alcohol. Disease burden is closely related to average volume of alcohol consumption, and, for every unit of exposure, is strongest in poor people and in those who are marginalised from society. The costs associated with alcohol amount to more than 1% of the gross national product in high-income and middle-income countries, with the costs of social harm constituting a major proportion in addition to health costs. Overall, we conclude that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased.	[Rehm, Juergen; Popova, Svetlana; Patra, Jayadeep] Ctr Addict & Mental Hlth, Publ Hlth & Regulatory Policies, Toronto, ON M5S 2S1, Canada; [Rehm, Juergen; Popova, Svetlana] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] WHO, Collaborat Ctr Subst Abuse, Zurich, Switzerland; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, Klin Psychol & Psychotherapie, Dresden, Germany; [Mathers, Colin] WHO, Dept Hlth Stat, CH-1211 Geneva, Switzerland; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Thavorncharoensap, Montarat; Teerawattananon, Yot] Minist Publ Hlth, Nonthaburi, Thailand; [Thavorncharoensap, Montarat] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; World Health Organization; Technische Universitat Dresden; World Health Organization; University of Toronto; Ministry of Public Health - Thailand; Mahidol University	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Publ Hlth & Regulatory Policies, 33 Russell St,Room 2035B, Toronto, ON M5S 2S1, Canada.	jtrehm@aol.com	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012; Rao, Rahul/P-7158-2014	Rehm, Jürgen/0000-0001-5665-0385; Teerawattananon, Yot/0000-0003-2217-2930; Mathers, Colin/0000-0002-0617-6731	WHO; Swiss Federal Office of Public Health; Centre for Addiction and Mental Health, Toronto, Canada	WHO(World Health Organization); Swiss Federal Office of Public Health; Centre for Addiction and Mental Health, Toronto, Canada	The comparative risk assessments for alcohol for 2000 and 2002 underlying this study have been Supported by WHO and by the Swiss Federal Office of Public Health to the first author. The specific work for this study has been supported by the Centre for Addiction and Mental Health, Toronto, Canada. We thank Robert Beaglehole for his sustained support and comments throughout the whole process of preparing the paper; Sally Casswell, Fotis Kanteres, Dan Chisholm, Peter Anderson, and Robin Room for their detailed comments during various stages of the preparation of the paper; and six anonymous reviewers for their very helpful and constructive comments in the review process.	ANDERSEN P, 2006, ALCOHOL EUROPE; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Babor Thomas F., 2003, ALCOHOL ORDINARY COM; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Begg S., 2007, BURDEN DIS INJURY AU; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chung Woo-Jin, 2006, J Prev Med Public Health, V39, P21; Collins D., 2002, COUNTING COST ESTIMA; COLLINS D, 1996, SOCIAL COSTS DRUG AB; DELVIN NJ, 1997, ADDICTION, V92, P1491; English D.R., 1995, QUANTIFICATION DRUG; Ezzati M, 2004, COMP QUANTIFICATION; Fenoglio P, 2003, EUR ADDICT RES, V9, P18, DOI 10.1159/000067730; Frentzel-Beyme R, 2001, INT J HYG ENVIR HEAL, V204, P81, DOI 10.1078/1438-4639-00077; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Hanson D. J., 1995, PREVENTING ALCOHOL A; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Harwood H., 1998, NIH PUBLICATION; International Monetary Fund, WORLD EC OUTL DAT 20; Johansson P., 2006, SOCIAL COSTS ALCOHOL; KEHOE T, 2007, GLOBAL BURDEN ALCOHO; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mathers C, 2003, GLOBAL BURDEN ALCOHO; MEZEY E, 1991, SEMIN LIVER DIS, V11, P340, DOI 10.1055/s-2008-1040451; Mill J. S., 1967, SYSTEM LOGIC RATIOCI; Murray, 2002, SUMMARY MEASURES POP, P205; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Prasad R, 2009, LANCET, V373, P17, DOI 10.1016/S0140-6736(08)61939-X; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; REHM J, 1995, ADDICTION, V90, P471, DOI 10.1046/j.1360-0443.1995.9044712.x; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J., 2006, COSTS SUBSTANCE ABUS; REHM J, 2008, INT ENCY PUBLIC HLTH, P135; REHM J, INT J METHO IN PRESS; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J., 2006, ALCOHOL CONSUMPTION; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2007, J STUD ALCOHOL DRUGS, V68, P886, DOI 10.15288/jsad.2007.68.886; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rumpf HJ, 2002, ALCOHOL ALCOHOLISM, V37, P261, DOI 10.1093/alcalc/37.3.261; Rush B., 1785, INQUIRY EFFECTS ARDE; SCHMIDT LA, PRIORITY PU IN PRESS; Single E., 2003, INT GUIDELINES ESTIM, V2nd ed.; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P39; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; THAVORNCHAROENS.M, 2008, EC COSTS ALC CONS TH; The United Nations Population Division, 2007, WORLD POP PROSP 2006; Ustun TB., 2003, HLTH SYSTEMS PERFORM; Varney SJ, 2002, PHARMACOECONOMICS, V20, P891, DOI 10.2165/00019053-200220130-00003; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2006, 2 WHO EXP COMM PROBL; *WHO REG OFFF S E, 2006, PUBL HLTH PROBL CAUS; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2007, INT CLASS DIS REL HL; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	65	2293	2350	8	326	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2223	2233		10.1016/S0140-6736(09)60746-7	http://dx.doi.org/10.1016/S0140-6736(09)60746-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560604				2022-12-24	WOS:000267444500035
J	Friedland, AE; Lu, TK; Wang, X; Shi, D; Church, G; Collins, JJ				Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Church, George; Collins, James J.			Synthetic Gene Networks That Count	SCIENCE			English	Article							MAMMALIAN-CELLS; DIRECTED EVOLUTION; ESCHERICHIA-COLI; EXPRESSION; SWITCH; RIBOREGULATORS; BACTERIOPHAGE; RECOMBINASE; OSCILLATOR; PATTERN	Synthetic gene networks can be constructed to emulate digital circuits and devices, giving one the ability to program and design cells with some of the principles of modern computing, such as counting. A cellular counter would enable complex synthetic programming and a variety of biotechnology applications. Here, we report two complementary synthetic genetic counters in Escherichia coli that can count up to three induction events: the first, a riboregulated transcriptional cascade, and the second, a recombinase-based cascade of memory units. These modular devices permit counting of varied user-defined inputs over a range of frequencies and can be expanded to count higher numbers.	[Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Lu, Timothy K.; Church, George] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA.	jcollins@bu.edu	Lu, Timothy/G-4267-2012; Wang, Xiao/A-8414-2008	Wang, Xiao/0000-0002-4056-0155; Lu, Timothy/0000-0002-3918-8923; church, george/0000-0001-6232-9969	NIH Directors Pioneer Award Program; NSF Frontiers in Integrative Biological Research program; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH Directors Pioneer Award Program; NSF Frontiers in Integrative Biological Research program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH Directors Pioneer Award Program, the NSF Frontiers in Integrative Biological Research program, and the Howard Hughes Medical Institute. Authors contributions are in supporting online materials	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Ray A, 1999, MOL CELL BIOL, V19, P31; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	28	415	453	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1199	1202		10.1126/science.1172005	http://dx.doi.org/10.1126/science.1172005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478183	Green Accepted			2022-12-24	WOS:000266410100046
J	Shah, AS; Ben-Shahar, Y; Moninger, TO; Kline, JN; Welsh, MJ				Shah, Alok S.; Ben-Shahar, Yehuda; Moninger, Thomas O.; Kline, Joel N.; Welsh, Michael J.			Motile Cilia of Human Airway Epithelia Are Chemosensory	SCIENCE			English	Article							CELLS; MUTATION; DEFECTS	Cilia are microscopic projections that extend from eukaryotic cells. There are two general types of cilia; primary cilia serve as sensory organelles, whereas motile cilia exert mechanical force. The motile cilia emerging from human airway epithelial cells propel harmful inhaled material out of the lung. We found that these cells express sensory bitter taste receptors, which localized on motile cilia. Bitter compounds increased the intracellular calcium ion concentration and stimulated ciliary beat frequency. Thus, airway epithelia contain a cell-autonomous system in which motile cilia both sense noxious substances entering airways and initiate a defensive mechanical mechanism to eliminate the offending compound. Hence, like primary cilia, classical motile cilia also contain sensors to detect the external environment.	[Shah, Alok S.; Ben-Shahar, Yehuda; Moninger, Thomas O.; Kline, Joel N.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Ben-Shahar, Yehuda; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		kline, joel/0000-0002-5523-8855; Welsh, Michael/0000-0002-1646-6206	National Heart, Lung, and Blood Institute [HL51670]; Cystic Fibrosis Foundation [R458-CR02, ENGLH9850]; National Institute of Diabetes and Digestive and Kidney Disease [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759, R01DK051315] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Yin for assistance and discussions and P. Karp, T. Nesselhauf, P. Hughes, and the In Vitro Models and Cell Culture Core [supported in part by the National Heart, Lung, and Blood Institute (HL51670), Cystic Fibrosis Foundation (R458-CR02 and ENGLH9850), and the National Institute of Diabetes and Digestive and Kidney Disease (DK54759)] for assistance. Y.B.-S. was an Associate and M.J.W. is an Investigator of the Howard Hughes Medical Institute.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; BOITANO S, 1994, J CELL SCI, V107, P3037; Braiman A, 2008, RESP PHYSIOL NEUROBI, V163, P202, DOI 10.1016/j.resp.2008.05.010; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Horvath G, 2008, CELL MOTIL CYTOSKEL, V65, P469, DOI 10.1002/cm.20273; Iomini C, 2006, CURR BIOL, V16, P1147, DOI 10.1016/j.cub.2006.04.035; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Merigo F, 2005, CELL TISSUE RES, V319, P211, DOI 10.1007/s00441-004-1007-2; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SISSON JH, 1994, AM J RESP CRIT CARE, V149, P205, DOI 10.1164/ajrccm.149.1.8111584; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005	30	480	496	5	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1131	1134		10.1126/science.1173869	http://dx.doi.org/10.1126/science.1173869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628819	Green Accepted			2022-12-24	WOS:000269382300042
J	Maji, SK; Perrin, MH; Sawaya, MR; Jessberger, S; Vadodaria, K; Rissman, RA; Singru, PS; Nilsson, KPR; Simon, R; Schubert, D; Eisenberg, D; Rivier, J; Sawchenko, P; Vale, W; Riek, R				Maji, Samir K.; Perrin, Marilyn H.; Sawaya, Michael R.; Jessberger, Sebastian; Vadodaria, Krishna; Rissman, Robert A.; Singru, Praful S.; Nilsson, K. Peter R.; Simon, Rozalyn; Schubert, David; Eisenberg, David; Rivier, Jean; Sawchenko, Paul; Vale, Wylie; Riek, Roland			Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules	SCIENCE			English	Article							MOLECULAR-ORGANIZATION; PROLACTIN GRANULES; PROTEIN; BIOGENESIS; GLYCOSAMINOGLYCANS; SYNUCLEIN; PATHWAYS; FIBRILS; HEPARIN; ATT-20	Amyloids are highly organized cross-beta-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. However, amyloids may also have a normal biological function, as demonstrated by fungal prions, which are involved in prion replication, and the amyloid protein Pmel17, which is involved in mammalian skin pigmentation. We found that peptide and protein hormones in secretory granules of the endocrine system are stored in an amyloid-like cross-beta-sheet-rich conformation. Thus, functional amyloids in the pituitary and other organs can contribute to normal cell and tissue physiology.	[Maji, Samir K.; Riek, Roland] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Perrin, Marilyn H.; Rivier, Jean; Sawchenko, Paul; Vale, Wylie] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Jessberger, Sebastian; Vadodaria, Krishna] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Rissman, Robert A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Singru, Praful S.] Tufts Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02111 USA; [Nilsson, K. Peter R.; Simon, Rozalyn] Linkoping Univ, IFM, Dept Chem, SE-58183 Linkoping, Sweden; [Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Diego; Tufts Medical Center; Linkoping University; Salk Institute	Riek, R (corresponding author), ETH, Phys Chem Lab, Wolfgang Paulistr 10, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Maji, Samir K. K./B-9640-2019; Vadodaria, Krishna C./H-1711-2017; Jessberger, Sebastian/AAJ-4032-2020	Maji, Samir K. K./0000-0002-9110-1565; Vadodaria, Krishna C./0000-0002-3455-0209; Riek, Roland/0000-0002-6333-066X; Jessberger, Sebastian/0000-0002-0056-8275	Swiss National Foundation; Clayton Medical Research Foundation Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [PO1 DK026741-29]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Clayton Medical Research Foundation Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Swiss National Foundation, Clayton Medical Research Foundation Inc., and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant PO1 DK026741-29	Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Arvan P, 2002, CURR OPIN CELL BIOL, V14, P448, DOI 10.1016/S0955-0674(02)00344-7; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; CARLSON SS, 1983, J BIOL CHEM, V258, P1082; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dannies PS, 2001, MOL CELL ENDOCRINOL, V177, P87, DOI 10.1016/S0303-7207(01)00437-3; FARQUHAR MG, 1971, SUBCELLULAR ORG FUNC, P79; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; GIANNATTASIO G, 1975, J CELL BIOL, V64, P246, DOI 10.1083/jcb.64.1.246; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GUMBINER B, 1981, P NATL ACAD SCI-BIOL, V78, P318, DOI 10.1073/pnas.78.1.318; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Keeler C, 2004, J MOL NEUROSCI, V22, P43, DOI 10.1385/JMN:22:1-2:43; KELLY RB, 1987, NATURE, V326, P14, DOI 10.1038/326014a0; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Liu YB, 1998, J NEUROCHEM, V71, P2322; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; MILLER F, 1966, J CELL BIOL, V31, P349, DOI 10.1083/jcb.31.2.349; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; MOORE HP, 1983, NATURE, V302, P434, DOI 10.1038/302434a0; Onoue S, 2004, PHARM RES, V21, P1274, DOI 10.1023/B:PHAM.0000033016.36825.2c; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; ROSA P, 1983, EUR J CELL BIOL, V31, P94; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yonemoto IT, 2008, BIOCHEMISTRY-US, V47, P9900, DOI 10.1021/bi800828u; ZANINI A, 1980, J CELL BIOL, V86, P260, DOI 10.1083/jcb.86.1.260	37	720	736	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					328	332		10.1126/science.1173155	http://dx.doi.org/10.1126/science.1173155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19541956	Green Accepted			2022-12-24	WOS:000268036600048
J	Park, JI; Venteicher, AS; Hong, JY; Choi, J; Jun, S; Shkreli, M; Chang, W; Meng, ZJ; Cheung, P; Ji, H; McLaughlin, M; Veenstra, TD; Nusse, R; McCrea, PD; Artandi, SE				Park, Jae-Il; Venteicher, Andrew S.; Hong, Ji Yeon; Choi, Jinkuk; Jun, Sohee; Shkreli, Marina; Chang, Woody; Meng, Zhaojing; Cheung, Peggie; Ji, Hong; McLaughlin, Margaret; Veenstra, Timothy D.; Nusse, Roel; McCrea, Pierre D.; Artandi, Steven E.			Telomerase modulates Wnt signalling by association with target gene chromatin	NATURE			English	Article							BETA-CATENIN; REVERSE-TRANSCRIPTASE; ANTEROPOSTERIOR AXIS; TRANSIENT ACTIVATION; GROWTH; PROLIFERATION; EXPRESSION; OVEREXPRESSION; DYSFUNCTION; REGULATORS	Stem cells are controlled, in part, by genetic pathways frequently dysregulated during human tumorigenesis. Either stimulation of Wnt/beta-catenin signalling or overexpression of telomerase is sufficient to activate quiescent epidermal stem cells in vivo, although the mechanisms by which telomerase exerts these effects are not understood. Here we show that telomerase directly modulates Wnt/beta-catenin signalling by serving as a cofactor in a beta-catenin transcriptional complex. The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (also called SMARCA4), a SWI/SNF-related chromatin remodelling protein, and activates Wnt-dependent reporters in cultured cells and in vivo. TERT serves an essential role in formation of the anterior-posterior axis in Xenopus laevis embryos, and this defect in Wnt signalling manifests as homeotic transformations in the vertebrae of Tert(-/-) mice. Chromatin immunoprecipitation of the endogenous TERT protein from mouse gastrointestinal tract shows that TERT physically occupies gene promoters of Wnt-dependent genes. These data reveal an unanticipated role for telomerase as a transcriptional modulator of the Wnt/beta-catenin signalling pathway.	[Park, Jae-Il; Venteicher, Andrew S.; Choi, Jinkuk; Jun, Sohee; Shkreli, Marina; Chang, Woody; Cheung, Peggie; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Choi, Jinkuk; Artandi, Steven E.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Hong, Ji Yeon; Ji, Hong; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [McLaughlin, Margaret] MIT, Koch Inst Integrat Canc Biol, Cambridge, MA 02139 USA; [McLaughlin, Margaret] MIT, Dept Biol, Cambridge, MA 02139 USA; [Nusse, Roel] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	park, jaeil/AAS-5894-2021; Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; PARK, JAE-IL/0000-0002-0737-2654; Choi, Jinkuk/0000-0002-2449-8291	Stanford Comprehensive Cancer Center Fellowship; NCI [CA111691, CA125453]; California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [P30CA124435, R01CA125453, R01CA111691] Funding Source: NIH RePORTER	Stanford Comprehensive Cancer Center Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Chu of the Stanford Comparative Medicine Histology Research Core Laboratory for technical assistance. Wethank F. Ishikawa for Xenopus TERT plasmid, G. Crabtree for antibodies and plasmids, T. Jacks for ROSACreER T2 mice, and K. Park for constructive comments. J.-I. P. was supported by a Stanford Comprehensive Cancer Center Fellowship. This work was supported by NCI grants CA111691 and CA125453 and by a grant from the California Breast Cancer Research Program to S. E. A.	Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Rajaraman S, 2007, P NATL ACAD SCI USA, V104, P17747, DOI 10.1073/pnas.0706485104; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	50	482	506	0	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					66	U77		10.1038/nature08137	http://dx.doi.org/10.1038/nature08137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571879	Green Accepted			2022-12-24	WOS:000267545200030
J	Aksentijevich, I; Masters, SL; Ferguson, PJ; Dancey, P; Frenkel, J; van Royen-Kerkhoff, A; Laxer, R; Tedgard, U; Cowen, EW; Pham, TH; Booty, M; Estes, JD; Sandler, NG; Plass, N; Stone, DL; Turner, ML; Hill, S; Butman, JA; Schneider, R; Babyn, P; El-Shanti, HI; Pope, E; Barron, K; Bing, XY; Laurence, A; Lee, CCR; Chapelle, D; Clarke, GI; Ohson, K; Nicholson, M; Gadina, M; Yang, B; Korman, BD; Gregersen, PK; van Hagen, PM; Hak, AE; Huizing, M; Rahman, P; Douek, DC; Remmers, EF; Kastner, DL; Goldbach-Mansky, R				Aksentijevich, Ivona; Masters, Seth L.; Ferguson, Polly J.; Dancey, Paul; Frenkel, Joost; van Royen-Kerkhoff, Annet; Laxer, Ron; Tedgard, Ulf; Cowen, Edward W.; Pham, Tuyet-Hang; Booty, Matthew; Estes, Jacob D.; Sandler, Netanya G.; Plass, Nicole; Stone, Deborah L.; Turner, Maria L.; Hill, Suvimol; Butman, John A.; Schneider, Rayfel; Babyn, Paul; El-Shanti, Hatem I.; Pope, Elena; Barron, Karyl; Bing, Xinyu; Laurence, Arian; Lee, Chyi-Chia R.; Chapelle, Dawn; Clarke, Gillian I.; Ohson, Kamal; Nicholson, Marc; Gadina, Massimo; Yang, Barbara; Korman, Benjamin D.; Gregersen, Peter K.; van Hagen, P. Martin; Hak, A. Elisabeth; Huizing, Marjan; Rahman, Proton; Douek, Daniel C.; Remmers, Elaine F.; Kastner, Daniel L.; Goldbach-Mansky, Raphaela			An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFANTILE CORTICAL HYPEROSTOSIS; GENE-CLUSTER; ASSOCIATION; MUTATIONS; FAMILY; CIAS1; INFLAMMASOME; SECRETION; ARTHRITIS; CELLS	BACKGROUND Autoinflammatory diseases manifest inflammation without evidence of infection, high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations of IL1RN, which encodes the interleukin-1-receptor antagonist, with prominent involvement of skin and bone. METHODS We studied nine children from six families who had neonatal onset of sterile multifocal osteomyelitis, periostitis, and pustulosis. Response to empirical treatment with the recombinant interleukin-1-receptor antagonist anakinra in the first patient prompted us to test for the presence of mutations and changes in proteins and their function in interleukin-1-pathway genes including IL1RN. RESULTS We identified homozygous mutations of IL1RN in nine affected children, from one family from Newfoundland, Canada, three families from the Netherlands, and one consanguineous family from Lebanon. A nonconsanguineous patient from Puerto Rico was homozygous for a genomic deletion that includes IL1RN and five other interleukin-1-family members. At least three of the mutations are founder mutations; heterozygous carriers were asymptomatic, with no cytokine abnormalities in vitro. The IL1RN mutations resulted in a truncated protein that is not secreted, thereby rendering cells hyperresponsive to interleukin-1 beta stimulation. Patients treated with anakinra responded rapidly. CONCLUSIONS We propose the term deficiency of the interleukin-1-receptor antagonist, or DIRA, to denote this autosomal recessive autoinflammatory disease caused by mutations affecting IL1RN. The absence of interleukin-1-receptor antagonist allows unopposed action of interleukin-1, resulting in life-threatening systemic inflammation with skin and bone involvement. (ClinicalTrials.gov number, NCT00059748.)	[Aksentijevich, Ivona; Masters, Seth L.; Pham, Tuyet-Hang; Booty, Matthew; Plass, Nicole; Stone, Deborah L.; Laurence, Arian; Chapelle, Dawn; Gadina, Massimo; Yang, Barbara; Korman, Benjamin D.; Remmers, Elaine F.; Kastner, Daniel L.; Goldbach-Mansky, Raphaela] NIAMSD, Bethesda, MD 20892 USA; [Cowen, Edward W.; Estes, Jacob D.; Turner, Maria L.; Lee, Chyi-Chia R.] NCI, Bethesda, MD 20892 USA; [Sandler, Netanya G.; Douek, Daniel C.] Vaccine Res Ctr, Bethesda, MD USA; [Barron, Karyl] NIAID, Bethesda, MD 20892 USA; [Hill, Suvimol; Butman, John A.] Ctr Clin, Bethesda, MD USA; [Huizing, Marjan] NHGRI, Bethesda, MD 20892 USA; [Ferguson, Polly J.; Bing, Xinyu] Univ Iowa, Iowa City, IA USA; [Dancey, Paul; Clarke, Gillian I.; Ohson, Kamal; Nicholson, Marc; Rahman, Proton] Mem Univ Newfoundland, St John, NF, Canada; [Frenkel, Joost; van Royen-Kerkhoff, Annet] Univ Utrecht, Utrecht, Netherlands; [Laxer, Ron; Schneider, Rayfel; Babyn, Paul; Pope, Elena] Univ Toronto, Toronto, ON, Canada; [Tedgard, Ulf] Lund Univ, Malmo, Sweden; [El-Shanti, Hatem I.] Shafallah Med Genet Ctr, Doha, Qatar; [Gregersen, Peter K.] Feinstein Inst, Manhasset, NY USA; [van Hagen, P. Martin; Hak, A. Elisabeth] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Iowa; Memorial University Newfoundland; Utrecht University; University of Toronto; Lund University; Al Shafallah Center; Northwell Health; Erasmus University Rotterdam; Erasmus MC	Goldbach-Mansky, R (corresponding author), Bldg 10,Rm 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Goldbach-Mansky, Raphaela/N-5917-2017; Laurence, Arian/A-8770-2009; El-Shanti, Hatem/O-5990-2014; Booty, Matthew G/G-9536-2012; Butman, John/J-2780-2013; Lee, Chyi-Chia Richard/AAO-1149-2020; Lee, Chyi-Chia R/I-1938-2013; Gadina, Massimo/R-4195-2019; Aksentijevich, Ivona/AAF-1335-2019; Butman, John A/A-2694-2008; EL-SHANTI, HATEM/Q-4932-2016; Masters, Seth L/N-2886-2013; Tedgård, Ulf/K-8699-2018; Tedgård, Ulf/K-3852-2019; Huizing, Marjan/AAR-8860-2020; Laurence, Arian/H-5534-2019	Laurence, Arian/0000-0003-0942-8292; El-Shanti, Hatem/0000-0001-6230-8316; Butman, John/0000-0002-1547-9195; Lee, Chyi-Chia R/0000-0002-5306-7781; EL-SHANTI, HATEM/0000-0001-6230-8316; Masters, Seth L/0000-0003-4763-576X; Tedgård, Ulf/0000-0003-3266-252X; Laurence, Arian/0000-0003-0942-8292; Remmers, Elaine F/0000-0002-9522-1249; Yang, Barbara/0000-0001-5018-095X; Booty, Matthew/0000-0002-0835-3439; Utay, Netanya/0000-0002-6407-8670; Korman, Benjamin/0000-0002-4873-2628	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH); NIAMS; Children's Miracle Network; Peregrine Charities; Hoffmann-La Roche; Amgen; NIH Clinical Research Training Program; Foundation for the NIH; Pfizer; Roche Pharmaceuticals; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041169, ZIAAR041083, ZICAR041181, ZIAAR041138] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Children's Miracle Network; Peregrine Charities; Hoffmann-La Roche(Hoffmann-La Roche); Amgen(Amgen); NIH Clinical Research Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH; Pfizer(Pfizer); Roche Pharmaceuticals(Roche Holding); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Human Genome Research Institute (NHGRI).; Dr. Ferguson reports receiving grant support from the National Institutes of Health (NIH) and NIAMS, the Children's Miracle Network, and the Peregrine Charities; Dr. Schneider, consulting and lecture fees and a grant support from Hoffmann-La Roche and grant support from Amgen, the company that makes anakinra; and Dr. Korman, grant support from the NIH Clinical Research Training Program, a public - private partnership between the Foundation for the NIH and Pfizer. Dr. Gregersen reports receiving consulting fees from Roche Pharmaceuticals and holding stock options in Amgen, Illumina, and Genentech. No other potential conflict of interest relevant to this article was reported.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1997, CELL, V90, P797; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bernot A, 1997, NAT GENET, V17, P25; Botsios C, 2008, ANN INTERN MED, V149, P284, DOI 10.7326/0003-4819-149-4-200808190-00018; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hacham M, 2000, ADV EXP MED BIOL, V479, P185; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; IVKER RA, 1993, PEDIATR DERMATOL, V10, P277, DOI 10.1111/j.1525-1470.1993.tb00376.x; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; LEUNG VC, 1985, J PEDIATR ORTHOPED, V5, P354, DOI 10.1097/01241398-198505000-00020; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Meulenbelt I, 2004, ARTHRITIS RHEUM, V50, P1179, DOI 10.1002/art.20121; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Schilling F, 2003, Z RHEUMATOL, V62, P527, DOI 10.1007/s00393-003-0526-7; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Timms AE, 2004, AM J HUM GENET, V75, P587, DOI 10.1086/424695; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Vitoratos N, 2007, J ENDOCRINOL INVEST, V30, P35, DOI 10.1007/BF03347393; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961	34	628	650	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2426	2437		10.1056/NEJMoa0807865	http://dx.doi.org/10.1056/NEJMoa0807865			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494218	Green Accepted			2022-12-24	WOS:000266590500008
J	Enard, W; Gehre, S; Hammerschmidt, K; Holter, SM; Blass, T; Somel, M; Bruckner, MK; Schreiweis, C; Winter, C; Sohr, R; Becker, L; Wiebe, V; Nickel, B; Giger, T; Muller, U; Groszer, M; Adler, T; Aguilar, A; Bolle, I; Calzada-Wack, J; Dalke, C; Ehrhardt, N; Favor, J; Fuchs, H; Gailus-Durner, V; Hans, W; Holzlwimmer, G; Javaheri, A; Kalaydjiev, S; Kallnik, M; Kling, E; Kunder, S; Mossbrugger, I; Naton, B; Racz, I; Rathkolb, B; Rozman, J; Schrewe, A; Busch, DH; Graw, J; Ivandic, B; Klingenspor, M; Klopstock, T; Ollert, M; Quintanilla-Martinez, L; Schulz, H; Wolf, E; Wurst, W; Zimmer, A; Fisher, SE; Morgenstern, R; Arendt, T; de Angelis, MH; Fischer, J; Schwarz, J; Paabo, S				Enard, Wolfgang; Gehre, Sabine; Hammerschmidt, Kurt; Hoelter, Sabine M.; Blass, Torsten; Somel, Mehmet; Brueckner, Martina K.; Schreiweis, Christiane; Winter, Christine; Sohr, Reinhard; Becker, Lore; Wiebe, Victor; Nickel, Birgit; Giger, Thomas; Mueller, Uwe; Groszer, Matthias; Adler, Thure; Aguilar, Antonio; Bolle, Ines; Calzada-Wack, Julia; Dalke, Claudia; Ehrhardt, Nicole; Favor, Jack; Fuchs, Helmut; Gailus-Durner, Valerie; Hans, Wolfgang; Hoelzlwimmer, Gabriele; Javaheri, Anahita; Kalaydjiev, Svetoslav; Kallnik, Magdalena; Kling, Eva; Kunder, Sandra; Mossbrugger, Ilona; Naton, Beatrix; Racz, Ildiko; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Busch, Dirk H.; Graw, Jochen; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Ollert, Markus; Quintanilla-Martinez, Leticia; Schulz, Holger; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Fisher, Simon E.; Morgenstern, Rudolf; Arendt, Thomas; de Angelis, Martin Hrabe; Fischer, Julia; Schwarz, Johannes; Paeaebo, Svante			A Humanized Version of Foxp2 Affects Cortico-Basal Ganglia Circuits in Mice	CELL			English	Article							INHERITED SPEECH; LANGUAGE DISORDER; ULTRASONIC VOCALIZATION; SYNAPTIC PLASTICITY; BRAIN-DEVELOPMENT; GENE; EVOLUTION; EXPRESSION; BEHAVIOR; IDENTIFICATION	It has been proposed that two amino acid substitutions in the transcription factor FOXP2 have been positively selected during human evolution due to effects on aspects of speech and language. Here, we introduce these substitutions into the endogenous Foxp2 gene of mice. Although these mice are generally healthy, they have qualitatively different ultrasonic vocalizations, decreased exploratory behavior and decreased dopamine concentrations in the brain suggesting that the humanized Foxp2 allele affects basal ganglia. In the striatum, a part of the basal ganglia affected in humans with a speech deficit due to a nonfunctional FOXP2 allele, we find that medium spiny neurons have increased dendrite lengths and increased synaptic plasticity. Since mice carrying one nonfunctional Foxp2 allele show opposite effects, this suggests that alterations in cortico-basal ganglia circuits might have been important for the evolution of speech and language in humans. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Enard, Wolfgang; Gehre, Sabine; Blass, Torsten; Somel, Mehmet; Schreiweis, Christiane; Wiebe, Victor; Nickel, Birgit; Giger, Thomas; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Dept Cognit Ethol, D-37077 Gottingen, Germany; [Hoelter, Sabine M.; Dalke, Claudia; Kallnik, Magdalena; Graw, Jochen; Wurst, Wolfgang] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Munich, Germany; [Brueckner, Martina K.; Arendt, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Neuroanat, D-04109 Leipzig, Germany; [Winter, Christine] Univ Med Berlin, Charite Campus Mitte, Dept Psychiat & Psychotherapy, Berlin, Germany; [Sohr, Reinhard; Morgenstern, Rudolf] Univ Med Berlin, Charite Campus Mitte, Inst Pharmacol & Toxicol, Berlin, Germany; [Becker, Lore; Kling, Eva; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Becker, Lore; Adler, Thure; Ehrhardt, Nicole; Fuchs, Helmut; Gailus-Durner, Valerie; Hans, Wolfgang; Javaheri, Anahita; Kling, Eva; Naton, Beatrix; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Munich, Germany; [Mueller, Uwe] Univ Leipzig, Inst Immunol, BBZ, D-04103 Leipzig, Germany; [Groszer, Matthias; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Adler, Thure; Kalaydjiev, Svetoslav; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Aguilar, Antonio; Javaheri, Anahita; Ollert, Markus] Tech Univ Munich, Dept Dermatol & Allergy, Div Environm Dermatol & Allergy TUM HMGU, D-80802 Munich, Germany; [Bolle, Ines; Schulz, Holger] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, D-85764 Munich, Germany; [Calzada-Wack, Julia; Hoelzlwimmer, Gabriele; Kunder, Sandra; Mossbrugger, Ilona; Quintanilla-Martinez, Leticia] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Munich, Germany; [Ehrhardt, Nicole] Univ Marburg, Fac Biol, D-35032 Marburg, Germany; [Favor, Jack] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Life & Brain Ctr, Dept Mol Psychiat, D-53105 Bonn, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Schrewe, Anja; Ivandic, Boris] Heidelberg Univ, Dept Med 3, Div Cardiol, D-69120 Heidelberg, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany; [Rozman, Jan; Klingenspor, Martin] Res Ctr Nutr & Food Sci, ZIEL, D-85350 Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-85350 Freising Weihenstephan, Germany; [Schwarz, Johannes] Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany; [Schwarz, Johannes] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	Max Planck Society; Deutsches Primatenzentrum (DPZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; University of Oxford; Wellcome Centre for Human Genetics; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Max Planck Society; Technical University of Munich; Leipzig University; California Institute of Technology	Enard, W (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	enard@eva.mpg.de	Dalke, Claudia/D-5913-2015; Fischer, Julia/B-6674-2008; Zimmer, Andreas/B-8357-2009; Klingenspor, Martin/D-6930-2011; Arendt, Thomas/C-8747-2012; Enard, Wolfgang/K-3483-2014; Graw, Jochen/D-9336-2013; Rathkolb, Birgit/F-7041-2013; Klingenspor, Martin/K-5033-2019; Rozman, Jan/A-2540-2010; Naton, Beatrix/B-5392-2013; Fuchs, Helmut/M-7347-2014; Fisher, Simon E./E-9130-2012; Somel, Mehmet/B-1471-2016; Becker, Lore/AAJ-1203-2020; Hölter, Sabine M./N-5868-2014; Brückner, Martina . K./A-5201-2017; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014; Schulz, Holger/J-5643-2015; Becker, Lore/E-3717-2010; Racz, I./C-3074-2009	Dalke, Claudia/0000-0002-8040-4464; Fischer, Julia/0000-0002-5807-0074; Klingenspor, Martin/0000-0002-4502-6664; Rozman, Jan/0000-0002-8035-8904; Naton, Beatrix/0000-0002-9453-8877; Fuchs, Helmut/0000-0002-5143-2677; Fisher, Simon E./0000-0002-3132-1996; Becker, Lore/0000-0002-6890-4984; Hölter, Sabine M./0000-0003-4878-5241; de Angelis, Martin Hrabe/0000-0002-7898-2353; Schulz, Holger/0000-0002-1157-200X; Racz, I./0000-0002-1549-3616; Somel, Mehmet/0000-0002-3138-1307; Calzada, Julia/0000-0003-0816-9305; Ollert, Markus W./0000-0002-8055-0103; Graw, Jochen/0000-0003-0298-9660; Arendt, Thomas/0000-0003-4553-1625; Groszer, Matthias/0000-0002-6209-305X; Wolf, Eckhard/0000-0002-0430-9510; Muller, Uwe/0000-0003-1502-9271; Wurst, Wolfgang/0000-0003-4422-7410; Schreiweis, Christiane/0000-0002-8523-9445	Bundesministerium fur Bildung und Forschung [01GS0850, 01GS0851, 01GS0852, 01GS0869, 01GS0853, 01GS0854, 01GS0868]; EU grant [LSHG-2006-037188]; Deutsche Forschungsgemeinschaft; Saxonian Staatsministerium fur Wissenschaft und Kunst; Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig; Royal Society; Max Planck Society	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU grant(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Saxonian Staatsministerium fur Wissenschaft und Kunst; Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig; Royal Society(Royal Society of London); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to Ozgene Inc. for generating mice; to Uta Zirkler ( MPI- EVA) for animal care; to Reinhard Seeliger and the German Mouse Clinic technician team ( Maria Kugler, Tamara Halex, Claudia Zeller, Sandra Schadler, Regina Kneuttinger, Bettina Sperling, Elfi Holupirek, Susanne Wittich, Elisabeth Schwarz, Miriam Backs, Eleonore Samson, Christine Fuhrmann-Franz, and Kerstin Kutzner) and the animal caretaker team for expert technical help; to Eunjong Park (MPI-EVA, Neurology Leipzig) for assistance in neuronal cell culture; to Sven-Holger Puppel and Sabrina Reimers ( MPI-EVA) for assistance in generating expression data; and to Christine Green ( MPI-EVA) for comments on the manuscript. This work was supported by NGFN plus grants from the Bundesministerium fur Bildung und Forschung ( 01GS0850 ( I. B., C. C.- W., C. D., J. F., H. F., V. G.- D., W. H., G. H., M. K., S. K., I. M., B., N., J. G., L. Q.- M., H. S., W. W., and M. H. A), 01GS0851 ( L. B., B. R. C. M., E. K., E. W. and Th. K.), 01GS0852 ( T. A., S. K., and D. B.), 01GS0869 ( N. E., J. R., and M. K.), 01GS0853 ( I. R. and A. Z.), 01GS0854 ( A. S. and B. I.), 01GS0868 ( A. A., A. J., and M. O.), by an EU grant ( EUMODIC LSHG-2006-037188, German Mouse Clinic), grants from the Deutsche Forschungsgemeinschaft ( S. G. and J. S., M. K. B. and T. A., Heisenberg grant to J. F.), the Saxonian Staatsministerium fur Wissenschaft und Kunst ( M. K. B. and T. A.), the Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig ( TP C27 to S. G. and J. S.), the Royal Society ( research fellowship to S. E. F.), and the Max Planck Society ( W. E. and S. P.).	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Berretta N, 2008, PROG NEUROBIOL, V84, P343, DOI 10.1016/j.pneurobio.2007.12.004; Campbell P, 2009, J COMP NEUROL, V512, P84, DOI 10.1002/cne.21881; Cox RD, 2003, CURR OPIN GENET DEV, V13, P278, DOI 10.1016/S0959-437X(03)00051-0; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; FUCHS H, 2006, PHENOTYPING LAB MOUS, P35; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; LIEBERMAN P, 2006, EVOLUTIONARY BIOL LA; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; ROBERTS LH, 1975, J ZOOL, V175, P243, DOI 10.1111/j.1469-7998.1975.tb01399.x; Scharff C, 2005, CURR OPIN NEUROBIOL, V15, P694, DOI 10.1016/j.conb.2005.10.004; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Teichmann M, 2008, BRAIN, V131, P1046, DOI 10.1093/brain/awn036; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Wijchers PJEC, 2006, BRAIN RES, V1068, P23, DOI 10.1016/j.brainres.2005.11.022; Zhang JZ, 2002, GENETICS, V162, P1825	65	343	350	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					961	971		10.1016/j.cell.2009.03.041	http://dx.doi.org/10.1016/j.cell.2009.03.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490899	Bronze, Green Submitted			2022-12-24	WOS:000266454800025
J	Li, JB; Levanon, EY; Yoon, JK; Aach, J; Xie, B; LeProust, E; Zhang, K; Gao, Y; Church, GM				Li, Jin Billy; Levanon, Erez Y.; Yoon, Jung-Ki; Aach, John; Xie, Bin; LeProust, Emily; Zhang, Kun; Gao, Yuan; Church, George M.			Genome-Wide Identification of Human RNA Editing Sites by Parallel DNA Capturing and Sequencing	SCIENCE			English	Article							ADENOSINE DEAMINASES; HUMAN TRANSCRIPTOME; ENZYME ADAR2; MICE; DEFICIENT; LETHALITY; CHANNELS; TARGETS; BRAIN	Adenosine-to-inosine (A-to-I) RNA editing leads to transcriptome diversity and is important for normal brain function. To date, only a handful of functional sites have been identified in mammals. We developed an unbiased assay to screen more than 36,000 computationally predicted nonrepetitive A-to-I sites using massively parallel target capture and DNA sequencing. A comprehensive set of several hundred human RNA editing sites was detected by comparing genomic DNA with RNAs from seven tissues of a single individual. Specificity of our profiling was supported by observations of enrichment with known features of targets of adenosine deaminases acting on RNA (ADAR) and validation by means of capillary sequencing. This efficient approach greatly expands the repertoire of RNA editing targets and can be applied to studies involving RNA editing-related human diseases.	[Li, Jin Billy; Levanon, Erez Y.; Yoon, Jung-Ki; Aach, John; Zhang, Kun; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Xie, Bin; Gao, Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [LeProust, Emily] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA	Harvard University; Harvard Medical School; Virginia Commonwealth University; Agilent Technologies; Virginia Commonwealth University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.		Zhang, Kun/ABE-6349-2020; Yoon, Jung-Ki/S-6948-2017; Gao, Yuan/E-1706-2011; Levanon, Erez Y/A-8128-2012	Zhang, Kun/0000-0002-7596-5224; Levanon, Erez Y/0000-0002-3641-4198; church, george/0000-0001-6232-9969	National Human Genome Research Institute Centers of Excellence in Genomic Science	National Human Genome Research Institute Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Emeson, M. P. Ball, and F. Isaacs for critical reading of the manuscript; P. Wang and Z. Liu (BioChain Institute) for helping collect human samples; M. Higuchi and P. Seeburg for providing ADAR2 mouse brain cDNA; Harvard Biopolymers Facility for help with Illumina sequencing; and A. Ahlford, H. Ebling, and J. Santosuosso for assistance with Sanger sequencing. E.Y.L. was supported by the Machiah foundation. Funding came from National Human Genome Research Institute Centers of Excellence in Genomic Science grant to G.M.C. The Illumina sequencing data are deposited at the National Center for Biotechnology Information Short Read Archive under accession number SRA008181.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Gommans WM, 2008, RNA, V14, P2074, DOI 10.1261/rna.816908; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Maas Stefan, 2006, RNA Biol, V3, P1; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tian N, 2008, RNA, V14, P211, DOI 10.1261/rna.797108	25	405	427	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1210	1213		10.1126/science.1170995	http://dx.doi.org/10.1126/science.1170995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478186				2022-12-24	WOS:000266410100049
J	Perez, JC; Groisman, EA				Perez, J. Christian; Groisman, Eduardo A.			Evolution of Transcriptional Regulatory Circuits in Bacteria	CELL			English	Review							COMPLETE GENOME SEQUENCE; LATERAL GENE-TRANSFER; FACTOR-BINDING SITES; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; YERSINIA-PESTIS; NETWORK MOTIFS; VIBRIO-CHOLERAE; RNA-POLYMERASE; FEEDBACK LOOP	Related organisms typically respond to a given cue by altering the level or activity of orthologous transcription factors, which, paradoxically, often regulate expression of distinct gene sets. Although promoter rewiring of shared genes is primarily responsible for regulatory differences among related eukaryotic species, in bacteria, species-specific genes are often controlled by ancestral transcription factors, and regulatory circuit evolution has been further shaped by horizontal gene transfer. Modifications in transcription factors and in promoter structure also contribute to divergence in bacterial regulatory circuits.	[Perez, J. Christian; Groisman, Eduardo A.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu		Perez, J. Christian/0000-0001-5790-1481	National Institutes of Health [49561, 42236]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Schroer for help with the figures. Our research on bacterial regulatory circuits is supported, in part, by grants 49561 and 42236 from the National Institutes of Health. E. A. G. is a Howard Hughes Medical Institute investigator.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Balaji S, 2007, BIOESSAYS, V29, P625, DOI 10.1002/bies.20600; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Cabeza ML, 2007, J BACTERIOL, V189, P7335, DOI 10.1128/JB.00801-07; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Davidson E.H., 2006, REGULATORY GENOME; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Harrison-McMonagle P, 1999, J MOL BIOL, V285, P555, DOI 10.1006/jmbi.1998.2375; Hershberg R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r62; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jeon J, 2008, J BACTERIOL, V190, P7326, DOI 10.1128/JB.00903-08; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Krukonis ES, 2003, MOL CELL, V12, P157, DOI 10.1016/S1097-2765(03)00222-3; Lintner RE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-60; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Lozada-Chavez I, 2008, J MOL BIOL, V379, P627, DOI 10.1016/j.jmb.2008.04.008; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Martinez-Antonio A, 2006, TRENDS MICROBIOL, V14, P22, DOI 10.1016/j.tim.2005.11.002; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mitrophanov AY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000233; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Quinones M, 2006, J BIOL CHEM, V281, P39407, DOI 10.1074/jbc.M609694200; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ruiz N, 2001, J BACTERIOL, V183, P5974, DOI 10.1128/JB.183.20.5974-5981.2001; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Winfield MD, 2005, J BIOL CHEM, V280, P14765, DOI 10.1074/jbc.M413900200; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	93	118	119	3	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					233	244		10.1016/j.cell.2009.07.002	http://dx.doi.org/10.1016/j.cell.2009.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632175	Green Accepted, Bronze			2022-12-24	WOS:000268277000007
J	Maladen, RD; Ding, Y; Li, C; Goldman, DI				Maladen, Ryan D.; Ding, Yang; Li, Chen; Goldman, Daniel I.			Undulatory Swimming in Sand: Subsurface Locomotion of the Sandfish Lizard	SCIENCE			English	Article								The desert-dwelling sandfish (Scincus scincus) moves within dry sand, a material that displays solid and fluidlike behavior. High-speed x-ray imaging shows that below the surface, the lizard no longer uses limbs for propulsion but generates thrust to overcome drag by propagating an undulatory traveling wave down the body. Although viscous hydrodynamics can predict swimming speed in fluids such as water, an equivalent theory for granular drag is not available. To predict sandfish swimming speed, we developed an empirical model by measuring granular drag force on a small cylinder oriented at different angles relative to the displacement direction and summing these forces over the animal movement profile. The agreement between model and experiment implies that the noninertial swimming occurs in a frictional fluid.	[Maladen, Ryan D.; Goldman, Daniel I.] Georgia Inst Technol, Interdisciplinary Bioengn Program, Atlanta, GA 30332 USA; [Ding, Yang; Li, Chen; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Goldman, DI (corresponding author), Georgia Inst Technol, Interdisciplinary Bioengn Program, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu	Li, Chen/A-4003-2013; Ding, Yang/A-9885-2013; Ding, Yang/A-9885-2013	Li, Chen/0000-0001-7516-3646; Ding, Yang/0000-0002-8252-2421; Ding, Yang/0000-0001-8161-2743	NSF [PHY-0749991]; Burroughs Wellcome Fund	NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by NSF Physics of Living Systems grant PHY-0749991 and the Burroughs Wellcome Fund. We thank R. Full and T. Papenfuss for helpful discussion. We thank S. Steinmetz and N. Gravish for experimental assistance and P. Umbanhowar for discussion of the drag model and careful reading of the manuscript.	Albert I, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061303; Albert R, 1999, PHYS REV LETT, V82, P205, DOI 10.1103/PhysRevLett.82.205; Alexander RM., 2003, PRINCIPLES ANIMAL LO; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Baumgartner W, 2007, J BIONIC ENG, V4, P1, DOI 10.1016/S1672-6529(07)60006-7; Baumgartner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003309; Biewener AA, 1999, J EXP BIOL, V202, P3387; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DICKINSON WW, 1994, J SEDIMENT RES A, V64, P226; Dorgan KM, 2005, NATURE, V433, P475, DOI 10.1038/433475a; Ezcurra E., 2006, GLOBAL DESERTS OUTLO; GANS C, 1975, AM ZOOL, V15, P455; GRAY J, 1964, J EXP BIOL, V41, P135; Jaeger HM, 1996, PHYS TODAY, V49, P32, DOI 10.1063/1.881494; Korta J, 2007, J EXP BIOL, V210, P2383, DOI 10.1242/jeb.004572; Lauder GV, 2002, NEWS PHYSIOL SCI, V17, P235, DOI 10.1152/nips.01398.2002; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moon BR, 1998, J EXP BIOL, V201, P2669; Nedderman R. M., 1992, STAT KINEMATICS GRAN; Schofield A.N., 1968, CRITICAL STATE SOIL; TRUEMAN ER, 1970, J EXP BIOL, V53, P701; Vogel S, 1994, LIFE MOVING FLUIDS; White CR, 2001, AUST J ZOOL, V49, P663, DOI 10.1071/ZO00076; WIEGHARDT K, 1975, ANNU REV FLUID MECH, V7, P89, DOI 10.1146/annurev.fl.07.010175.000513	26	263	267	11	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					314	318		10.1126/science.1172490	http://dx.doi.org/10.1126/science.1172490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608917				2022-12-24	WOS:000268036600044
J	Tabor, JJ; Salis, HM; Simpson, ZB; Chevalier, AA; Levskaya, A; Marcotte, EM; Voigt, CA; Ellington, AD				Tabor, Jeffrey J.; Salis, Howard M.; Simpson, Zachary Booth; Chevalier, Aaron A.; Levskaya, Anselm; Marcotte, Edward M.; Voigt, Christopher A.; Ellington, Andrew D.			A Synthetic Genetic Edge Detection Program	CELL			English	Article							MYCOPLASMA-GENITALIUM GENOME; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; BACTERIOPHAGE-LAMBDA; DIRECTED EVOLUTION; CHEMICAL-SYNTHESIS; PATTERN-FORMATION; TOGGLE SWITCH; EXPRESSION; NETWORKS	Edge detection is a signal processing algorithm common in artificial intelligence and image recognition programs. We have constructed a genetically encoded edge detection algorithm that programs an isogenic community of E. coli to sense an image of light, communicate to identify the light-dark edges, and visually present the result of the computation. The algorithm is implemented using multiple genetic circuits. An engineered light sensor enables cells to distinguish between light and dark regions. In the dark, cells produce a diffusible chemical signal that diffuses into light regions. Genetic logic gates are used so that only cells that sense light and the diffusible signal produce a positive output. A mathematical model constructed from first principles and parameterized with experimental measurements of the component circuits predicts the performance of the complete program. Quantitatively accurate models will facilitate the engineering of more complex biological behaviors and inform bottom-up studies of natural genetic regulatory networks.	[Tabor, Jeffrey J.; Salis, Howard M.; Levskaya, Anselm; Voigt, Christopher A.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94158 USA; [Simpson, Zachary Booth; Chevalier, Aaron A.; Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Simpson, Zachary Booth; Chevalier, Aaron A.; Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Voigt, CA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94158 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008; Salis, Howard M/A-2495-2008	Tabor, Jeffrey/0000-0001-7316-0361; Salis, Howard/0000-0003-0411-4390; Marcotte, Edward/0000-0001-8808-180X	National Science Foundation (SynBERC) [NSF-BES0547637,]; Office of Naval Research; Pew and Packard Foundations; Kirschstein National Research Service Award;  [NIH EY016546];  [NIH AI067699];  [NIH R01GM077040]; NATIONAL EYE INSTITUTE [PN1EY016546, PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067699, R01AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067779, F32GM082106, R01GM076536, R01GM077040] Funding Source: NIH RePORTER	National Science Foundation (SynBERC)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Pew and Packard Foundations; Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. A. Davidson, L. A. Lavery, M. Levy, K. McGary, and A. Scouras for helpful discussions; A. Nishimura for the JW3367 E. coli strain; and L. A. Lavery, C. Conboy, and D. Endy for assistance with Biobrick construction. This work was supported by the National Science Foundation (SynBERC), NSF-BES0547637, NIH EY016546, NIH AI067699, NIH R01GM077040, Office of Naval Research, and the Pew and Packard Foundations. J.J.T. is supported by a Kirschstein National Research Service Award.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; CHAN L, 2005, MOL SYST BIOL, V26, P787; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Endy D, 2008, SCIENCE, V319, P1196, DOI 10.1126/science.1155749; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Flagan S, 2003, APPL ENVIRON MICROB, V69, P909, DOI 10.1128/AEM.69.2.909-916.2003; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; Kim JH, 2001, EXP MOL MED, V33, P83, DOI 10.1038/emm.2001.15; Kim PM, 2003, GENOME RES, V13, P2391, DOI 10.1101/gr.1207003; Knight T, 2002, IDEMPOTENT VECTOR DE; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7817, DOI 10.1021/bi00245a022; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Materna SC, 2007, CURR OPIN BIOTECH, V18, P351, DOI 10.1016/j.copbio.2007.07.008; MATURANA HUMBERTO R., 1963, SCIENCE, V142, P977, DOI 10.1126/science.142.3594.977; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rackham O, 2005, J AM CHEM SOC, V127, P17584, DOI 10.1021/ja055338d; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; SUEL M, 2000, PRACTICAL ALGORITHMS; Tabor JJ, 2008, MOL BIOSYST, V4, P754, DOI 10.1039/b801245h; Tabor JJ, 2009, SYSTEMS BIOLOGY AND BIOTECHNOLOGY OF ESCHERICHIA COLI, P401, DOI 10.1007/978-1-4020-9394-4_19; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; WEISS R, 2001, LECT NOTES COMPUTER, P1; WEISS R, 1999, DIMACS WORKSH EV COM, V1, P1; Weiss R, 2001, CELLULAR COMPUTATION; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	73	339	358	5	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1272	1281		10.1016/j.cell.2009.04.048	http://dx.doi.org/10.1016/j.cell.2009.04.048			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563759	Green Accepted, Bronze			2022-12-24	WOS:000267373400020
J	Veatch, JR; McMurray, MA; Nelson, ZW; Gottschling, DE				Veatch, Joshua R.; McMurray, Michael A.; Nelson, Zara W.; Gottschling, Daniel E.			Mitochondrial Dysfunction Leads to Nuclear Genome Instability via an Iron-Sulfur Cluster Defect	CELL			English	Article							OXIDATIVE DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; BUDDING YEAST; CYTOCHROME-C; EXPRESSION; PHENOTYPE; MEMBRANE; IMPORT; GENES	Mutations and deletions in the mitochondrial genome (mtDNA), as well as instability of the nuclear genome, are involved in multiple human diseases. Here, we report that in Saccharomyces cerevisiae, loss of mtDNA leads to nuclear genome instability, through a process of cell-cycle arrest and selection we define as a cellular crisis. This crisis is not mediated by the absence of respiration, but instead correlates with a reduction in the mitochondrial membrane potential. Analysis of cells undergoing this crisis identified a defect in iron-sulfur cluster (ISC) biogenesis, which requires normal mitochondrial function. We found that downregulation of nonmitochondrial ISC protein biogenesis was sufficient to cause increased genomic instability in cells with intact mitochondrial function. These results suggest mitochondrial dysfunction stimulates nuclear genome instability by inhibiting the production of ISC-containing protein(s), which are required for maintenance of nuclear genome integrity. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Veatch, Joshua R.; McMurray, Michael A.; Nelson, Zara W.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Veatch, Joshua R.; McMurray, Michael A.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	dgottsch@fhcrc.org			Aging Training [T32 AG00057]; ARCS foundation; FHCRC; National Institutes of Health [AG023779, GM43893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023779, R37AG023779, T32AG000057] Funding Source: NIH RePORTER	Aging Training; ARCS foundation; FHCRC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Foury, P. Thorsness, J. Pinkham, R. Lill, R. Tsien, and the Yeast Resource Center for reagents. We thank R. Lill and P. Thorsness for experimental advice; J. Vazquez for help with microscopy; and J. Delrow and R. Basom for help with expression array analysis. Thanks to members of the Gottschling lab for critical reading of this manuscript. This work was supported by fellowships to J. R. V. from a Genetic Approaches to Aging Training Grant (T32 AG00057) and the ARCS foundation, and FHCRC pilot project and National Institutes of Health grants (AG023779 and GM43893) to D. E. G.	Alseth I, 1999, MOL CELL BIOL, V19, P3779; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brown MA, 1997, ADV GENET, V36, P45, DOI 10.1016/S0065-2660(08)60307-7; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Church C, 1998, J EXP BIOL, V201, P1729; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; Dagsgaard C, 2001, J BIOL CHEM, V276, P7593, DOI 10.1074/jbc.M009180200; DERISI JL, 1997, ANN MED, V37, P222; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Dunn CD, 2003, GENETICS, V165, P35; DUPONT CH, 1985, BIOCHEM BIOPH RES CO, V132, P1116, DOI 10.1016/0006-291X(85)91922-9; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0; EPHRUSSI B, 1949, ANN I PASTEUR PARIS, V76, P419; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; FLURY F, 1976, GENETICS, V83, P645; FOURY F, 1989, J BIOL CHEM, V264, P20552; Francis BR, 2007, J BIOENERG BIOMEMBR, V39, P127, DOI 10.1007/s10863-007-9071-4; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GASSER SM, 1983, J BIOL CHEM, V258, P3427; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; JAMES AP, 1958, GENETICS, V43, P317; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KOERNER TJ, 1985, J BIOL CHEM, V260, P5871; Kominsky DJ, 2002, GENETICS, V162, P1595; KOTYLAK Z, 1977, MITOCHONDRIA 1977, P83; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; NAGLEY P, 1970, BIOCHEM BIOPH RES CO, V39, P989, DOI 10.1016/0006-291X(70)90422-5; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stevens B., 1981, MOL BIOL YEAST SACCH, V11, P471; Swayne TC, 2007, METHOD CELL BIOL, V80, P591, DOI 10.1016/S0091-679X(06)80029-4; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200	71	290	298	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1247	1258		10.1016/j.cell.2009.04.014	http://dx.doi.org/10.1016/j.cell.2009.04.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563757	Green Accepted, Bronze			2022-12-24	WOS:000267373400018
J	Cordes, KR; Sheehy, NT; White, MP; Berry, EC; Morton, SU; Muth, AN; Lee, TH; Miano, JM; Ivey, KN; Srivastava, D				Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Lee, Ting-Hein; Miano, Joseph M.; Ivey, Kathryn N.; Srivastava, Deepak			miR-145 and miR-143 regulate smooth muscle cell fate and plasticity	NATURE			English	Article							SERUM RESPONSE FACTOR; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; PROGENITOR CELLS; VASCULAR INJURY; MICRORNA; DIFFERENTIATION; MYOCARDIN; ACTIVATION; PROLIFERATION	MicroRNAs (miRNAs) are regulators of myriad cellular events, but evidence for a single miRNA that can efficiently differentiate multipotent stem cells into a specific lineage or regulate direct reprogramming of cells into an alternative cell fate has been elusive. Here we show that miR-145 and miR-143 are co-transcribed in multipotent murine cardiac progenitors before becoming localized to smooth muscle cells, including neural crest stem-cell-derived vascular smooth muscle cells. miR-145 and miR-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated in injured or atherosclerotic vessels containing proliferating, less differentiated smooth muscle cells. miR-145 was necessary for myocardin-induced reprogramming of adult fibroblasts into smooth muscle cells and sufficient to induce differentiation of multipotent neural crest stem cells into vascular smooth muscle. Furthermore, miR-145 and miR-143 cooperatively targeted a network of transcription factors, including Klf4 (Kruppel-like factor 4), myocardin and Elk-1 (ELK1, member of ETS oncogene family), to promote differentiation and repress proliferation of smooth muscle cells. These findings demonstrate that miR-145 can direct the smooth muscle fate and that miR-145 and miR-143 function to regulate the quiescent versus proliferative phenotype of smooth muscle cells.	[Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94543 USA; [Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Lee, Ting-Hein; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Rochester	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	; Miano, Joseph/L-5634-2018	Metzler, Kimberly/0000-0002-9043-3357; Morton, Sarah/0000-0002-7816-2646; Miano, Joseph/0000-0001-7522-3207	NHLBI/NIH [HL62572, HL091168]; California Institute for Regenerative Medicine (CIRM); NIH/NCRR [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Blelloch for DGCR8-null EBs; R. J. Schwartz for SRF-null ES cells; I. Charo and N. Saederup for RNA from atherosclerotic tissue; J. Maurer for JoMa neural crest cell line; L. Qian and Y. Huang for providing mouse cardiac infarct RNA; C. Tsou for help with calcium flux assays; E. N. Olson for the myocardin expression plasmid; P. Swinton for generation of transgenic mice; J. Fish and C. Miller for histopathology support; S. Ordway and G. Howard for scientific editing; B. Taylor for manuscript preparation. We also thank members of the Srivastava laboratory for discussions. J. M. M. was supported by HL62572 and HL091168 from NHLBI/NIH. D. S. was supported by grants from the NHLBI/NIH and the California Institute for Regenerative Medicine (CIRM) and was an Established Investigator of the American Heart Association. This work was also supported by NIH/NCRR grant C06 RR018928 to the Gladstone Institutes.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Mishra-Gorur K, 2002, AM J PATHOL, V161, P1893, DOI 10.1016/S0002-9440(10)64465-3; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamamoto M, 1998, EXP CELL RES, V240, P349, DOI 10.1006/excr.1998.3999; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	1214	1326	8	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					705	U80		10.1038/nature08195	http://dx.doi.org/10.1038/nature08195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19578358	Green Accepted, Green Submitted			2022-12-24	WOS:000268670300031
J	Honnappa, S; Gouveia, SM; Weisbrich, A; Damberger, FF; Bhavesh, NS; Jawhari, H; Grigoriev, I; van Rijssel, FJA; Buey, RM; Lawera, A; Jelesarov, I; Winkler, FK; Wuthrich, K; Akhmanova, A; Steinmetz, MO				Honnappa, Srinivas; Gouveia, Susana Montenegro; Weisbrich, Anke; Damberger, Fred F.; Bhavesh, Neel S.; Jawhari, Hatim; Grigoriev, Ilya; van Rijssel, Frederik J. A.; Buey, Ruben M.; Lawera, Aleksandra; Jelesarov, Ilian; Winkler, Fritz K.; Wuethrich, Kurt; Akhmanova, Anna; Steinmetz, Michel O.			An EB1-Binding Motif Acts as a Microtubule Tip Localization Signal	CELL			English	Article							PLUS-END-TRACKING; CAP-GLY DOMAINS; NMR-SPECTROSCOPY; IN-VITRO; PROTEIN; EB1; DYNAMICS; MCAK; RECOGNITION; NETWORKS	Microtubules are filamentous polymers essential for cell viability. Microtubule plus-end tracking proteins (+TIPs) associate with growing microtubule plus ends and control microtubule dynamics and interactions with different cellular structures during cell division, migration, and morphogenesis. EB1 and its homologs are highly conserved proteins that play an important role in the targeting of +TIPs to microtubule ends, but the underlying molecular mechanism remains elusive. By using live cell experiments and in vitro reconstitution assays, we demonstrate that a short polypeptide motif, Ser-x-Ile-Pro (SxIP), is used by numerous +TIPs, including the tumor suppressor APC, the transmembrane protein STIM1, and the kinesin MCAK, for localization to microtubule tips in an EB1-dependent manner. Structural and biochemical data reveal the molecular basis of the EB1-SxIP interaction and explain its negative regulation by phosphorylation. Our findings establish a general "microtubule tip localization signal'' (MtLS) and delineate a unifying mechanism for this subcellular protein targeting process.	[Gouveia, Susana Montenegro; Grigoriev, Ilya; van Rijssel, Frederik J. A.; Lawera, Aleksandra; Akhmanova, Anna] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Honnappa, Srinivas; Weisbrich, Anke; Jawhari, Hatim; Buey, Ruben M.; Winkler, Fritz K.; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Damberger, Fred F.; Bhavesh, Neel S.; Wuethrich, Kurt] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Jelesarov, Ilian] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Wuethrich, Kurt] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Scripps Research Institute; Scripps Research Institute	Akhmanova, A (corresponding author), Erasmus MC, Dept Cell Biol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.akhmanova@erasmusmc.nl; michel.steinmetz@psi.ch	Martinez-Buey, Ruben/K-4296-2014; Bhavesh, Neel Sarovar/F-3127-2015; Akhmanova, Anna S/B-8896-2011; Steinmetz, Michel O/AAA-3349-2022; Damberger, Fred F/A-8938-2011	Martinez-Buey, Ruben/0000-0003-1263-0221; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Akhmanova, Anna S/0000-0002-9048-8614; Steinmetz, Michel O/0000-0001-6157-3687; Damberger, Fred F/0000-0002-8457-3409; gouveia, susana/0000-0003-1220-410X	Swiss National Science Foundation; Netherlands Organization for Scientific Research; Fundacao para a Ciencia e a Tecnologia; FEBS; ETH Zurich through the NCCR ""Structural Biology''	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEBS; ETH Zurich through the NCCR ""Structural Biology''(ETH Zurich)	We are indebted to A. Blanc, D. Desbouis, and C. Muller for excellent technical assistance, to N. Olieric for cloning of human MCAK, to A. Mussachio for critical reading and comments on the manuscript, and to R. Lewis, D. Compton, and L. Wordeman for the generous gift of materials. X-ray data were collected at beamline X06SA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). This work was supported by the Swiss National Science Foundation (to M.O.S.), by the Netherlands Organization for Scientific Research (to A. A.), by Fundacao para a Ciencia e a Tecnologia fellowship (to S. M. G.), by a FEBS fellowship to R. M. B., and by the Swiss National Science Foundation and the ETH Zurich through the NCCR ""Structural Biology'' (to I. J., F. K. W., and K. W.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Keller R., 2004, COMPUTER AIDED RESON, V1; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	38	456	472	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					366	376		10.1016/j.cell.2009.04.065	http://dx.doi.org/10.1016/j.cell.2009.04.065			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632184	Green Accepted, Bronze			2022-12-24	WOS:000268277000017
J	Curran, SP; Wu, XY; Riedel, CG; Ruvkun, G				Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary			A soma-to-germline transformation in long-lived Caenorhabditis elegans mutants	NATURE			English	Article							LIFE-SPAN; RNA INTERFERENCE; GENE-EXPRESSION; FACTOR SKN-1; DNA-DAMAGE; DAF-16; IDENTIFICATION; LONGEVITY; CHROMATIN; TARGETS	Unlike the soma, which ages during the lifespan of multicellular organisms, the germ line traces an essentially immortal lineage. Genomic instability in somatic cells increases with age, and this decline in somatic maintenance might be regulated to facilitate resource reallocation towards reproduction at the expense of cellular senescence. Here we show that Caenorhabditis elegans mutants with increased longevity exhibit a soma-to-germline transformation of gene expression programs normally limited to the germ line. Decreased insulin-like signalling causes the somatic misexpression of the germline-limited pie-1 and pgl family of genes in intestinal and ectodermal tissues. The forkhead boxO1A (FOXO) transcription factor DAF-16, the major transcriptional effector of insulin-like signalling, regulates pie-1 expression by directly binding to the pie-1 promoter. The somatic tissues of insulin-like mutants are more germline-like and protected from genotoxic stress. Gene inactivation of components of the cytosolic chaperonin complex that induce increased longevity also causes somatic misexpression of PGL-1. These results indicate that the acquisition of germline characteristics by the somatic cells of C. elegans mutants with increased longevity contributes to their increased health and survival.	[Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Riedel, Christian/0000-0002-3689-8022	National Institutes of Health; National Institute on Aging [F32-AG026207, R01-AG016636]; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE ON AGING [F32AG026207, R00AG032308, R01AG016636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank A. Conery, H. Gabel, J. Melo, E. O'Rourke, D. Simon, A. Soukas and M. Wang for reagents, discussion and reading of the manuscript; G. Seydoux and members of the Ruvkun, Ausubel and Kaplan laboratories for discussion; S. Strome for the pie-1p::gfp::pgl-1 strain and C. Mello for monoclonal antisera against PGL-1, S. S. Lee, S. Ercan and the Kingston laboratory for technical advice on ChIP. This work was supported by grants from the National Institutes of Health and the National Institute on Aging F32-AG026207 to S. P. C. and R01-AG016636 to G. R. and the European Molecular Biology Organization and the Human Frontier Science Program to C. G. R.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BRENNER S, 1974, GENETICS, V77, P71; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Houthoofd Koen, 2007, V35, P98; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kim SH, 2007, J CELL BIOL, V179, P41, DOI 10.1083/jcb.200705182; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; O'Neil Nigel, 2006, WormBook, P1; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang D, 2004, COLD SPRING HARB SYM, V69, P429, DOI 10.1101/sqb.2004.69.429; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	49	87	108	2	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1079	U60		10.1038/nature08106	http://dx.doi.org/10.1038/nature08106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19506556	Green Accepted			2022-12-24	WOS:000267636700033
J	Gu, LC; Wang, B; Kulkarni, A; Geders, TW; Grindberg, RV; Gerwick, L; Hakansson, K; Wipf, P; Smith, JL; Gerwick, WH; Sherman, DH				Gu, Liangcai; Wang, Bo; Kulkarni, Amol; Geders, Todd W.; Grindberg, Rashel V.; Gerwick, Lena; Hakansson, Kristina; Wipf, Peter; Smith, Janet L.; Gerwick, William H.; Sherman, David H.			Metamorphic enzyme assembly in polyketide diversification	NATURE			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; BIOSYNTHETIC GENE-CLUSTER; PEPTIDE SYNTHETASE; BARBAMIDE BIOSYNTHESIS; BACTERIAL SYMBIONT; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; NATURAL-PRODUCT; CURACIN-A	Natural product chemical diversity is fuelled by the emergence and ongoing evolution of biosynthetic pathways in secondary metabolism(1). However, co-evolution of enzymes for metabolic diversification is not well understood, especially at the biochemical level. Here, two parallel assemblies with an extraordinarily high sequence identity from Lyngbya majuscula forma beta-branched cyclopropane in the curacin A pathway (Cur), and a vinyl chloride group in the jamaicamide pathway (Jam). The components include a halogenase, a 3-hydroxy-3-methylglutaryl enzyme cassette for polyketide beta-branching, and an enoyl reductase domain. The halogenase from CurA, and the dehydratases (ECH(1)s), decarboxylases (ECH(2)s) and enoyl reductase domains from both Cur and Jam, were assessed biochemically to determine the mechanisms of cyclopropane and vinyl chloride formation. Unexpectedly, the polyketide beta-branching pathway was modified by introduction of a gamma-chlorination step on (S)-3-hydroxy-3-methylglutaryl mediated by Cur halogenase, a non-haem Fe(II), alpha-ketoglutarate-dependent enzyme(2). In a divergent scheme, Cur ECH2 was found to catalyse formation of the alpha,beta enoyl thioester, whereas Jam ECH2 formed a vinyl chloride moiety by selectively generating the corresponding beta, gamma enoyl thioester of the 3-methyl-4-chloroglutaconyl decarboxylation product. Finally, the enoyl reductase domain of CurF specifically catalysed an unprecedented cyclopropanation on the chlorinated product of Cur ECH2 instead of the canonical alpha,beta C=C saturation reaction. Thus, the combination of chlorination and polyketide beta-branching, coupled with mechanistic diversification of ECH2 and enoyl reductase, leads to the formation of cyclopropane and vinyl chloride moieties. These results reveal a parallel interplay of evolutionary events in multienzyme systems leading to functional group diversity in secondary metabolites.	[Gu, Liangcai; Geders, Todd W.; Smith, Janet L.; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gu, Liangcai; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Wang, Bo; Hakansson, Kristina; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kulkarni, Amol; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kulkarni, Amol; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA 15260 USA; [Grindberg, Rashel V.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Grindberg, Rashel V.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	davidhs@umich.edu	Hakansson, Kristina/G-9428-2016; Gu, Liangcai/E-4600-2010; Gu, Liangcai/U-6908-2019; Wipf, Peter/AAG-1771-2021	Hakansson, Kristina/0000-0003-1926-0542; Wipf, Peter/0000-0001-7693-5863	National Institutes of Health; Eli Lilly Co.; Rackham Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Co.(Eli Lilly); Rackham Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. T. Walsh and C. T. Calderone for ACP constructs; S. M. Chernyak, H. Liu and J. Byun for mass spectrometry assistance; P. C. Lopez for NMR assistance; T. M. Ramsey for chiral cyclopronanecarboxylic acid; and D. L. Akey for discussions. This work was supported by grants from the National Institutes of Health ( to D. H. S. and J. L. S.), a graduate fellowship from Eli Lilly & Co. and a Rackham Predoctoral Fellowship ( to L. G.).	Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Kelly WL, 2007, BIOCHEMISTRY-US, V46, P359, DOI 10.1021/bi061930j; KOPKA J, 1995, ANAL BIOCHEM, V224, P51, DOI 10.1006/abio.1995.1007; Neumann CS, 2008, J AM CHEM SOC, V130, P14022, DOI 10.1021/ja8064667; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62	29	137	142	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					731	735		10.1038/nature07870	http://dx.doi.org/10.1038/nature07870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494914	Green Accepted			2022-12-24	WOS:000266608600050
J	Saikrishnan, K; Powell, B; Cook, NJ; Webb, MR; Wigley, DB				Saikrishnan, Kayarat; Powell, Benjamin; Cook, Nicola J.; Webb, Martin R.; Wigley, Dale B.			Mechanistic Basis of 5 '-3 ' Translocation in SF1B Helicases	CELL			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURES; PCRA HELICASE; SH3 DOMAINS; INORGANIC-PHOSPHATE; STRUCTURAL BASIS; RNA HELICASE; PROTEIN; GENE; REVEALS	Superfamily 1B (SF1B) helicases translocate in a 5'-3' direction and are required for a range of cellular activities across all domains of life. However, structural analyses to date have focused on how SF1A helicases achieve 3'-5' movement along nucleic acids. We present crystal structures of the complex between the SF1B helicase RecD2 from Deinococcus radiodurans and ssDNA in the presence and absence of an ATP analog. These snapshots of the reaction pathway reveal a nucleotide binding-induced conformational change of the two motor domains that is broadly reminiscent of changes observed in other SF1 and SF2 helicases. Together with biochemical data, the structures point to a step size for translocation of one base per ATP hydrolyzed. Moreover, the structures also reveal a mechanism for nucleic acid translocation in the 5'-3' direction by SF1B helicases that is surprisingly different from that of 3'-5' translocation by SF1A enzymes, and explains the molecular basis of directionality.	[Saikrishnan, Kayarat; Cook, Nicola J.; Wigley, Dale B.] London Res Inst, Clare Hall Labs, Canc Res UK, Potters Bar EN6 3LD, Herts, England; [Powell, Benjamin; Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England	Cancer Research UK; MRC National Institute for Medical Research	Wigley, DB (corresponding author), London Res Inst, Clare Hall Labs, Canc Res UK, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	dale.wigley@cancer.org.uk		Webb, Martin/0000-0002-0134-9621	Cancer Research UK; Medical Research Council; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank EMBO for a fellowship ( K. S.) and J. Yeeles for the gift of E. coli SSB. The work was funded by Cancer Research UK ( D. B. W.) and the Medical Research Council ( B. P. and M. R. W.).	ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KRELL H, 1979, EUR J BIOCHEM, V93, P387, DOI 10.1111/j.1432-1033.1979.tb12835.x; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Martinez-Senac MM, 2005, BIOCHEMISTRY-US, V44, P16967, DOI 10.1021/bi0512851; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SAHA A, 2006, EMBO J, V27, P2222; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Servinsky MD, 2007, J BACTERIOL, V189, P5101, DOI 10.1128/JB.00409-07; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sistla S, 2004, CRIT REV BIOCHEM MOL, V39, P1, DOI 10.1080/10409230490440532; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Webb Martin R., 2003, P131; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zarrinpar A., 2003, SCI STKE, V2003, DOI [10.1126/stke.2003.179.re8, DOI 10.1126/STKE.2003.179.RE8]	57	99	103	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					849	859		10.1016/j.cell.2009.03.036	http://dx.doi.org/10.1016/j.cell.2009.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490894	Bronze			2022-12-24	WOS:000266454800016
J	Vinces, MD; Legendre, M; Caldara, M; Hagihara, M; Verstrepen, KJ				Vinces, Marcelo D.; Legendre, Matthieu; Caldara, Marina; Hagihara, Masaki; Verstrepen, Kevin J.			Unstable Tandem Repeats in Promoters Confer Transcriptional Evolvability	SCIENCE			English	Article							GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME POSITIONS; GENOME; VARIABILITY; EVOLUTION; YEAST	Relative to most regions of the genome, tandemly repeated DNA sequences display a greater propensity to mutate. A search for tandem repeats in the Saccharomyces cerevisiae genome revealed that the nucleosome-free region directly upstream of genes (the promoter region) is enriched in repeats. As many as 25% of all gene promoters contain tandem repeat sequences. Genes driven by these repeat-containing promoters show significantly higher rates of transcriptional divergence. Variations in repeat length result in changes in expression and local nucleosome positioning. Tandem repeats are variable elements in promoters that may facilitate evolutionary tuning of gene expression by affecting local chromatin structure.	[Vinces, Marcelo D.; Legendre, Matthieu; Caldara, Marina; Verstrepen, Kevin J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Vinces, Marcelo D.; Verstrepen, Kevin J.] Katholieke Univ Leuven, Flanders Inst Biotechnol VIB, Lab Syst Biol, B-3001 Heverlee, Belgium; [Vinces, Marcelo D.; Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG, Genet & Genom Grp, B-3001 Heverlee, Belgium; [Legendre, Matthieu] Univ Mediterranee Parc Sci Luminy, CNRS, UPR 2589, Struct & Genom Informat Lab,IFR 88, FR-13288 Marseille, France; [Hagihara, Masaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan	Harvard University; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Osaka University	Verstrepen, KJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 52 Oxford St, Cambridge, MA 02138 USA.	Kevin.Verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021	Verstrepen, Kevin/0000-0002-3077-6219; Legendre, Matthieu/0000-0002-8413-2910	NIH National Institute for General Medical Studies [P50GM068763]; Human Frontier Science Program (HFSP) award [RGY79/2007]; Flemish Institute for Biotechnology (VIB); Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH National Institute for General Medical Studies; Human Frontier Science Program (HFSP) award(Human Frontier Science Program); Flemish Institute for Biotechnology (VIB); Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Calderon, B. (Sze Ham) Chan, and B. Breaux for their contributions; B. Stern, E. OShea, A. Murray, A. Rowat, and A. New for critique of the manuscript; and the anonymous reviewers for their useful suggestions. Research in the lab of K.J.V. is supported by NIH National Institute for General Medical Studies grant P50GM068763, Human Frontier Science Program (HFSP) award RGY79/2007, the Flemish Institute for Biotechnology (VIB), and the Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program. M.D.V. acknowledges the Ford Foundation and the Belgian American Education Foundation.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; King DG, 1997, ENDEAVOUR, V21, P36, DOI 10.1016/S0160-9327(97)01005-3; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Pennisi E, 2008, SCIENCE, V321, P760, DOI 10.1126/science.321.5890.760; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Streelman JT, 2002, PHYSIOL GENOMICS, V9, P1, DOI 10.1152/physiolgenomics.00105.2001; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	25	244	253	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1213	1216		10.1126/science.1170097	http://dx.doi.org/10.1126/science.1170097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478187	Green Accepted, Green Published			2022-12-24	WOS:000266410100050
J	Hargreaves, DC; Horng, T; Medzhitov, R				Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan			Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation	CELL			English	Article							RNA-POLYMERASE-II; NF-KAPPA-B; BROMODOMAIN PROTEIN BRD4; P-TEFB; CHROMATIN MODIFICATIONS; ACETYLATION CODE; ACTIVATION; DROSOPHILA; GENOME; CELLS	Most inducible transcriptional programs consist of primary and secondary response genes (PRGs and SRGs) that differ in their kinetics of expression and in their requirements for new protein synthesis and chromatin remodeling. Here we show that many PRGs, in contrast to SRGs, have preassembled RNA polymerase II (Pol II) and positive histone modifications at their promoters in the basal state. Pol II at PRGs generates low levels of full-length unspliced transcripts but fails to make mature, protein-coding transcripts in the absence of stimulation. Induction of PRGs is controlled at the level of transcriptional elongation and mRNA processing, through the signal-dependent recruitment of P-TEFb. P-TEFb is in turn recruited by the bromodomain-containing protein Brd4, which detects H4K5/8/12Ac inducibly acquired at PRG promoters. Our findings suggest that the permissive structure of PRGs both stipulates their unique regulation in the basal state by corepressor complexes and enables their rapid induction in multiple cell types.	[Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Horng, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	thorng@hsph.harvard.edu; ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute; NIH [AI046688-08, U01 AI061360]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R37AI046688, U01AI061360] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. Klaus Rajewsky for NEMOflox/flox cells, Dr. Steven Smale for discussions and communication of unpublished results, and Drs. Tian Chi, David Schatz, and Sankar Ghosh for helpful discussions and suggestions. This work was supported by the Howard Hughes Medical Institute and grants from the NIH (AI046688-08 and U01 AI061360).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; KODAMA T, 2008, TIME COURSE GENE EXP; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lis JT, 2000, GENE DEV, V14, P792; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nishiyama A, 2008, FEBS LETT, V582, P1501, DOI 10.1016/j.febslet.2008.03.044; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sharma M, 2007, J BIOL CHEM, V282, P20887, DOI 10.1074/jbc.M701420200; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	47	491	515	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					129	145		10.1016/j.cell.2009.05.047	http://dx.doi.org/10.1016/j.cell.2009.05.047			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596240	Bronze, Green Accepted			2022-12-24	WOS:000267848600020
J	Mitchell, A; Romano, GH; Groisman, B; Yona, A; Dekel, E; Kupiec, M; Dahan, O; Pilpel, Y				Mitchell, Amir; Romano, Gal H.; Groisman, Bella; Yona, Avihu; Dekel, Erez; Kupiec, Martin; Dahan, Orna; Pilpel, Yitzhak			Adaptive prediction of environmental changes by microorganisms	NATURE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; FLUCTUATING ENVIRONMENTS; GENE-EXPRESSION; STRESS-RESPONSE; YEAST; GENOME; RESISTANCE; EVOLUTION; GROWTH	Natural habitats of some microorganisms may fluctuate erratically, whereas others, which are more predictable, offer the opportunity to prepare in advance for the next environmental change. In analogy to classical Pavlovian conditioning, microorganisms may have evolved to anticipate environmental stimuli by adapting to their temporal order of appearance. Here we present evidence for environmental change anticipation in two model microorganisms, Escherichia coli and Saccharomyces cerevisiae. We show that anticipation is an adaptive trait, because pre-exposure to the stimulus that typically appears early in the ecology improves the organism's fitness when encountered with a second stimulus. Additionally, we observe loss of the conditioned response in E. coli strains that were repeatedly exposed in a laboratory evolution experiment only to the first stimulus. Focusing on the molecular level reveals that the natural temporal order of stimuli is embedded in the wiring of the regulatory network-early stimuli pre-induce genes that would be needed for later ones, yet later stimuli only induce genes needed to cope with them. Our work indicates that environmental anticipation is an adaptive trait that was repeatedly selected for during evolution and thus may be ubiquitous in biology.	[Mitchell, Amir; Groisman, Bella; Yona, Avihu; Dahan, Orna; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Romano, Gal H.; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Dekel, Erez] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Pilpel, Yitzhak] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Weizmann Institute of Science; Tel Aviv University; Weizmann Institute of Science; Harvard University; Harvard Medical School	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il	Mitchell, Amir/AAS-1148-2020	Mitchell, Amir/0000-0001-9376-3987; Yona, Avihu H./0000-0002-3923-4897	Tauber Foundation; Minerva Foundation; Israel Science Foundation; European Research Council; Ben May Foundation; Israeli Ministry of Science and Technology	Tauber Foundation; Minerva Foundation; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Ben May Foundation; Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	We thank S. Trattner-Frenkel and Z. Bloom for their help and support in the yeast microarray experiments. We thank members of the Pilpel laboratory for many discussions. We thank E. Schneidman, E. Ben-Jacob, M. Springer, A. Tanay, U. Alon and D. Cavalieri for discussions and advice. We thank U. Alon for providing the promoter-GFP fused plasmids. We thank the Tauber Foundation, the Minerva Foundation, the Israel Science Foundation 'Bikura program', the European Research Council 'Ideas Program' and the Ben May Foundation for grant support. M. K. was supported from grants from the Israel Science Foundation and the Israeli Ministry of Science and Technology.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bauer F. F., 2000, South African Journal of Enology and Viticulture, V21, P27; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Braun E, 2004, PHYS BIOL, V1, P67, DOI 10.1088/1478-3967/1/2/003; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Johnston M., 1992, MOL CELLULAR BIOL YE, P193; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maris AF, 2001, CURR GENET, V39, P137, DOI 10.1007/s002940100194; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; SABLAYROLLES JM, 1993, AM J ENOL VITICULT, V44, P127; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Savageau MA, 1998, GENETICS, V149, P1677; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	29	352	365	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					220	U80		10.1038/nature08112	http://dx.doi.org/10.1038/nature08112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19536156				2022-12-24	WOS:000267761000033
J	Wang, D; Bushnell, DA; Huang, XH; Westover, KD; Levitt, M; Kornberg, RD				Wang, Dong; Bushnell, David A.; Huang, Xuhui; Westover, Kenneth D.; Levitt, Michael; Kornberg, Roger D.			Structural Basis of Transcription: Backtracked RNA Polymerase II at 3.4 Angstrom Resolution	SCIENCE			English	Article							ELONGATION-FACTOR TFIIS; IN-VIVO; TERNARY COMPLEXES; ALPHA-AMANITIN; ACTIVE-CENTER; TRIGGER LOOP; FACTOR-SII; FACTOR S; CLEAVAGE; FIDELITY	Transcribing RNA polymerases oscillate between three stable states, two of which, pre- and posttranslocated, were previously subjected to x-ray crystal structure determination. We report here the crystal structure of RNA polymerase II in the third state, the reverse translocated, or "backtracked" state. The defining feature of the backtracked structure is a binding site for the first backtracked nucleotide. This binding site is occupied in case of nucleotide misincorporation in the RNA or damage to the DNA, and is termed the "P" site because it supports proofreading. The predominant mechanism of proofreading is the excision of a dinucleotide in the presence of the elongation factor SII (TFIIS). Structure determination of a cocrystal with TFIIS reveals a rearrangement whereby cleavage of the RNA may take place.	[Wang, Dong; Bushnell, David A.; Huang, Xuhui; Westover, Kenneth D.; Levitt, Michael; Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Westover, Ken/AAZ-1795-2020; Huang, Xuhui/ABE-3207-2021; Levitt, Michael/E-4582-2012; Wang, Dong/C-8943-2012	Westover, Ken/0000-0003-3653-5923; Huang, Xuhui/0000-0002-7119-9358; Levitt, Michael/0000-0002-8414-7397; 	NIH [GM049985, GM036559, GM041455]; Leukemia and Lymphoma Society; NIH Pathway to Independence Award [K99 GM085136]; NIH Roadmap for Medical Research Grant [U54 GM072970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM085136, R01GM049985, R37GM041455, U54GM072970, R37GM036659, R01GM036659, R01GM041455, R00GM085136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM049985 and GM036559 to R.D.K. D.W. was supported by a special fellow award from the Leukemia and Lymphoma Society and the NIH Pathway to Independence Award (K99 GM085136). X.H. and M.L. were supported by NIH Roadmap for Medical Research Grant U54 GM072970 and NIH grant GM041455. Portions of the research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. Portions of this research were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the DOE, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the DOE, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences. We thank C. D. Kaplan for providing TFIIS E291H mutant for structural studies. PDB accession codes: 13-nt oligomer backtracked pol II, 3GTJ; 18-nt oligomer backtracked pol II, 3GTK; 12-nt oligomer backtracked pol II, 3GTG; and 13-nt oligomer backtracked pol II with TFIIS, 3GTM.	Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; GU WG, 1993, J BIOL CHEM, V268, P25604; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1993, CELL MOL BIOL RES, V39, P331; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shimoaraiso M, 1997, J BIOL CHEM, V272, P26550, DOI 10.1074/jbc.272.42.26550; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 1999, EMBO J, V18, P5052, DOI 10.1093/emboj/18.18.5052; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	50	177	179	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1203	1206		10.1126/science.1168729	http://dx.doi.org/10.1126/science.1168729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478184	Green Accepted			2022-12-24	WOS:000266410100047
J	Dimas, AS; Deutsch, S; Stranger, BE; Montgomery, SB; Borel, C; Attar-Cohen, H; Ingle, C; Beazley, C; Arcelus, MG; Sekowska, M; Gagnebin, M; Nisbett, J; Deloukas, P; Dermitzakis, ET; Antonarakis, SE				Dimas, Antigone S.; Deutsch, Samuel; Stranger, Barbara E.; Montgomery, Stephen B.; Borel, Christelle; Attar-Cohen, Homa; Ingle, Catherine; Beazley, Claude; Arcelus, Maria Gutierrez; Sekowska, Magdalena; Gagnebin, Marilyne; Nisbett, James; Deloukas, Panos; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Common Regulatory Variation Impacts Gene Expression in a Cell Type-Dependent Manner	SCIENCE			English	Article							HUMAN GENOME; MOUSE; ASSOCIATION; DISEASE	Studies correlating genetic variation to gene expression facilitate the interpretation of common human phenotypes and disease. As functional variants may be operating in a tissue-dependent manner, we performed gene expression profiling and association with genetic variants (single-nucleotide polymorphisms) on three cell types of 75 individuals. We detected cell type-specific genetic effects, with 69 to 80% of regulatory variants operating in a cell type-specific manner, and identified multiple expressive quantitative trait loci (eQTLs) per gene, unique or shared among cell types and positively correlated with the number of transcripts per gene. Cell type-specific eQTLs were found at larger distances from genes and at lower effect size, similar to known enhancers. These data suggest that the complete regulatory variant repertoire can only be uncovered in the context of cell-type specificity.	[Deutsch, Samuel; Borel, Christelle; Attar-Cohen, Homa; Gagnebin, Marilyne; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dimas, Antigone S.; Stranger, Barbara E.; Montgomery, Stephen B.; Ingle, Catherine; Beazley, Claude; Arcelus, Maria Gutierrez; Sekowska, Magdalena; Nisbett, James; Deloukas, Panos; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Stranger, Barbara E.] Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA; [Stranger, Barbara E.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Geneva; Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; stylianos.antonarakis@unige.ch	borel, christelle/AAC-9645-2019; Deloukas, Panos/B-2922-2013; Dermitzakis, Emmanouil/B-7687-2013; Antonarakis, Stylianos E/N-8866-2014	Deloukas, Panos/0000-0001-9251-070X; Antonarakis, Stylianos E/0000-0001-8907-5823; Montgomery, Stephen/0000-0002-5200-3903; Stranger, Barbara/0000-0001-9021-7331; Deutsch, Samuel/0000-0001-9456-7101	Wellcome Trust; NIH; Infectigen Foundation; Swiss National Science Foundation; AnEUploidy EU	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectigen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AnEUploidy EU	We thank N. Hammond for technical help. We acknowledge financial support from the Wellcome Trust and NIH to E. T. D. and Infectigen Foundation, Swiss National Science Foundation and AnEUploidy EU to S. E. A. Gene expression data are deposited in NCBI's Gene Expression Omnibus under accession number GSE17080.	ADAMS MD, 1995, NATURE, V377, P3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Cotsapas CJ, 2006, MAMM GENOME, V17, P490, DOI 10.1007/s00335-005-0186-9; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070	27	576	585	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1246	1250		10.1126/science.1174148	http://dx.doi.org/10.1126/science.1174148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19644074	Green Accepted			2022-12-24	WOS:000269523200038
J	Larkum, ME; Nevian, T; Sandler, M; Polsky, A; Schiller, J				Larkum, Matthew E.; Nevian, Thomas; Sandler, Maya; Polsky, Alon; Schiller, Jackie			Synaptic Integration in Tuft Dendrites of Layer 5 Pyramidal Neurons: A New Unifying Principle	SCIENCE			English	Article							DISTAL APICAL DENDRITES; ACTION-POTENTIALS; BASAL DENDRITES; VISUAL-CORTEX; IN-VIVO; CELLS; RAT; CONNECTIONS; MORPHOLOGY; INITIATION	Tuft dendrites are the main target for feedback inputs innervating neocortical layer 5 pyramidal neurons, but their properties remain obscure. We report the existence of N-methyl-D-aspartate (NMDA) spikes in the fine distal tuft dendrites that otherwise did not support the initiation of calcium spikes. Both direct measurements and computer simulations showed that NMDA spikes are the dominant mechanism by which distal synaptic input leads to firing of the neuron and provide the substrate for complex parallel processing of top-down input arriving at the tuft. These data lead to a new unifying view of integration in pyramidal neurons in which all fine dendrites, basal and tuft, integrate inputs locally through the recruitment of NMDA receptor channels relative to the fixed apical calcium and axosomatic sodium integration points.	[Larkum, Matthew E.; Nevian, Thomas] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Sandler, Maya; Polsky, Alon; Schiller, Jackie] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel; [Sandler, Maya; Polsky, Alon; Schiller, Jackie] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	University of Bern; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Larkum, ME (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	matthew.larkum@gmail.com; jackie@tx.technion.ac.il		Sandler, Maya/0000-0002-6094-7517; Larkum, Matthew/0000-0001-9799-2656; Nevian, Thomas/0000-0001-9804-608X	NIH; Israel Science Foundation; Rappaport Foundation; Swiss National Science Foundation [PP0033-119159, 3100A0-118395]; SystemsX.ch	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Rappaport Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This study was supported by NIH, the Israel Science Foundation, and the Rappaport Foundation ( J.S.); by the Swiss National Science Foundation (M.L., grant PP0033-119159; T.N., grant 3100A0-118395); and by SystemsX.ch (M.L., Neurochoice). The authors declare that they have no competing financial interests.	Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Jones EG, 1999, CEREB CORTEX, V13, P139; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Milojkovic BA, 2005, J MEMBRANE BIOL, V208, P155, DOI 10.1007/s00232-005-0827-7; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Spruston N, 2004, NAT NEUROSCI, V7, P567, DOI 10.1038/nn0604-567; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	31	414	420	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					756	760		10.1126/science.1171958	http://dx.doi.org/10.1126/science.1171958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661433				2022-12-24	WOS:000268723700052
J	Malmstrom, J; Beck, M; Schmidt, A; Lange, V; Deutsch, EW; Aebersold, R				Malmstroem, Johan; Beck, Martin; Schmidt, Alexander; Lange, Vinzenz; Deutsch, Eric W.; Aebersold, Ruedi			Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans	NATURE			English	Article							TANDEM MASS-SPECTROMETRY; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; ABSOLUTE QUANTIFICATION; SALMONELLA-TYPHIMURIUM; TOMOGRAPHY; EXPRESSION; PEPTIDES; COMPLEX; MS	Mass-spectrometry-based methods for relative proteome quantification have broadly affected life science research. However, important research directions, particularly those involving mathematical modelling and simulation of biological processes, also critically depend on absolutely quantitative data-that is, knowledge of the concentration of the expressed proteins as a function of cellular state. Until now, absolute protein concentration measurements of a considerable fraction of the proteome (73%) have only been derived from genetically altered Saccharomyces cerevisiae cells(1), a technique that is not directly portable from yeast to other species. Here we present a mass-spectrometry-based strategy to determine the absolute quantity, that is, the average number of protein copies per cell in a cell population, for a large fraction of the proteome in genetically unperturbed cells. Applying the technology to the human pathogen Leptospira interrogans, a spirochete responsible for leptospirosis(2), we generated an absolute protein abundance scale for 83% of the mass-spectrometry-detectable proteome, from cells at different states. Taking advantage of the unique cellular dimensions of L. interrogans, we used cryo-electron tomography morphological measurements to verify, at the single-cell level, the average absolute abundance values of selected proteins determined by mass spectrometry on a population of cells. Because the strategy is relatively fast and applicable to any cell type, we expect that it will become a cornerstone of quantitative biology and systems biology.	[Malmstroem, Johan; Beck, Martin; Schmidt, Alexander; Lange, Vinzenz; Aebersold, Ruedi] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Schmidt, Alexander; Lange, Vinzenz; Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Deutsch, Eric W.; Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich	Aebersold, R (corresponding author), ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch	Beck, Martin/B-5589-2011; Schmidt, Alexander/C-5122-2009; Malmström, Johan A/B-7660-2009; Lange, Vinzenz/I-1077-2019; Schmidt, Alexander/D-6426-2011; Deutsch, Eric/AAF-5912-2020	Beck, Martin/0000-0002-7397-1321; Malmström, Johan A/0000-0002-2889-7169; Lange, Vinzenz/0000-0002-6442-9573; Schmidt, Alexander/0000-0002-3149-2381; Deutsch, Eric/0000-0001-8732-0928	ETH Zurich; Swiss National Science Foundation [31000-10767]; National Heart, Lung and Blood Institute; National Institutes of Health [N01-HV-28179]; ERC; Swedish Society for Medical Research; European Molecular Biology Organization; Marie Curie fellowship of the European Commission; Competence Center for Systems Physiology and Metabolic Diseases; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Swedish Society for Medical Research; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie fellowship of the European Commission(European Commission); Competence Center for Systems Physiology and Metabolic Diseases; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project has been funded in part by ETH Zurich, the Swiss National Science Foundation (grant 31000-10767), federal funds from the National Heart, Lung and Blood Institute, the National Institutes of Health (contract no. N01-HV-28179), SystemsX. ch, the Swiss initiative for systems biology, in part by the PROSPECTS (proteomics in time and space) European network of excellence, and with funds from the ERC project Proteomics V3.0' for R. A. J. M. was supported by a fellowship from the Swedish Society for Medical Research (SSMF), M. B. was supported by a long-term fellowship of the European Molecular Biology Organization and a Marie Curie fellowship of the European Commission, A. S. and V. L. were supported by the Competence Center for Systems Physiology and Metabolic Diseases. We thank O. Medalia and the electron microscopy facility of ETH Zurich (EMEZ) for support, and D. A. Haake for critical reading of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Briegel A, 2008, MOL MICROBIOL, V69, P30, DOI 10.1111/j.1365-2958.2008.06219.x; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Heller M, 2005, J PROTEOME RES, V4, P2273, DOI 10.1021/pr050193v; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; SHALIT I, 1989, ANTIMICROB AGENTS CH, V33, P788, DOI 10.1128/AAC.33.5.788; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SOSINSKY GE, 1992, P NATL ACAD SCI USA, V89, P4801, DOI 10.1073/pnas.89.11.4801; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150	33	335	338	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					762	U112		10.1038/nature08184	http://dx.doi.org/10.1038/nature08184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19606093	Green Accepted			2022-12-24	WOS:000268670300044
J	Ozgul, A; Tuljapurkar, S; Benton, TG; Pemberton, JM; Clutton-Brock, TH; Coulson, T				Ozgul, Arpat; Tuljapurkar, Shripad; Benton, Tim G.; Pemberton, Josephine M.; Clutton-Brock, Tim H.; Coulson, Tim			The Dynamics of Phenotypic Change and the Shrinking Sheep of St. Kilda	SCIENCE			English	Article							CLIMATE-CHANGE; BODY-SIZE; QUANTITATIVE TRAIT; NATURAL-SELECTION; RAPID EVOLUTION; POPULATION; ENVIRONMENT; RESPONSES; GROWTH; TRENDS	Environmental change, including climate change, can cause rapid phenotypic change via both ecological and evolutionary processes. Because ecological and evolutionary dynamics are intimately linked, a major challenge is to identify their relative roles. We exactly decomposed the change in mean body weight in a free-living population of Soay sheep into all the processes that contribute to change. Ecological processes contribute most, with selection-the underpinning of adaptive evolution-explaining little of the observed phenotypic trend. Our results enable us to explain why selection has so little effect even though weight is heritable, and why environmental change has caused a decline in the body size of Soay sheep.	[Ozgul, Arpat; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Benton, Tim G.] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Imperial College London; Stanford University; University of Leeds; University of Edinburgh; University of Cambridge	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Coulson, Tim/AAL-8148-2021; Benton, Tim G/C-6493-2009; Pemberton, Josephine M/F-3100-2010; Ozgul, Arpat/K-2032-2012	Coulson, Tim/0000-0001-9371-9003; Benton, Tim G/0000-0002-7448-1973; Ozgul, Arpat/0000-0001-7477-2642; Tuljapurkar, Shripad/0000-0001-5549-4245	Natural Environment Research Council [NE/E015921/1]; National Institute of Aging [P01/AG/22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; Natural Environment Research Council [NER/A/S/2003/00461] Funding Source: researchfish; NERC [NE/E015921/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/E015921/1 and National Institute of Aging grant P01/AG/22500.	Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2008, AM NAT, V172, P599, DOI 10.1086/591693; Falconer D.S., 1960, INTRO QUANTITATIVE G, P1, DOI [10.2307/2985722, DOI 10.2307/2985722]; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gratten J, 2008, SCIENCE, V319, P318, DOI 10.1126/science.1151182; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Heywood JS, 2005, EVOLUTION, V59, P2287, DOI 10.1111/j.0014-3820.2005.tb00939.x; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kruuk LEB, 2003, TRENDS ECOL EVOL, V18, P207, DOI 10.1016/S0169-5347(03)00073-9; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z	25	227	231	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					464	467		10.1126/science.1173668	http://dx.doi.org/10.1126/science.1173668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574350	Green Accepted			2022-12-24	WOS:000268255100053
J	Wang, QB; Li, W; Zhang, Y; Yuan, X; Xu, KX; Yu, JD; Chen, Z; Beroukhim, R; Wang, HY; Lupien, M; Wu, T; Regan, MM; Meyer, CA; Carroll, JS; Manrai, AK; Janne, OA; Balk, SP; Mehra, R; Han, B; Chinnaiyan, AM; Rubin, MA; True, L; Fiorentino, M; Fiore, C; Loda, M; Kantoff, PW; Liu, XS; Brown, M				Wang, Qianben; Li, Wei; Zhang, Yong; Yuan, Xin; Xu, Kexin; Yu, Jindan; Chen, Zhong; Beroukhim, Rameen; Wang, Hongyun; Lupien, Mathieu; Wu, Tao; Regan, Meredith M.; Meyer, Clifford A.; Carroll, Jason S.; Manrai, Arjun Kumar; Janne, Olli A.; Balk, Steven P.; Mehra, Rohit; Han, Bo; Chinnaiyan, Arul M.; Rubin, Mark A.; True, Lawrence; Fiorentino, Michelangelo; Fiore, Christopher; Loda, Massimo; Kantoff, Philip W.; Liu, X. Shirley; Brown, Myles			Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer	CELL			English	Article							KALLIKREIN 2; HUMAN GENOME; HISTONE H3; CHIP-CHIP; CYCLIN-A; COMPLEX; PROGRESSION; EXPRESSION; SIGNATURES; MODEL	The evolution of prostate cancer from an androgen-dependent state to one that is androgen-independent marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in androgen-independent cancers is poorly understood. We have defined the direct AR-dependent target genes in both androgen-dependent and -independent cancer cells by generating AR-dependent gene expression profiles and AR cistromes. In contrast to what is found in androgen-dependent cells, AR selectively upregulates M-phase cell-cycle genes in androgen-independent cells, including UBE2C, a gene that inactivates the M-phase checkpoint. We find that epigenetic marks at the UBE2C enhancer, notably histone H3K4 methylation and FoxA1 transcription factor binding, are present in androgen-independent cells and direct AR-enhancer binding and UBE2C activation. Thus, the role of AR in androgen-independent cancer cells is not to direct the androgen-dependent gene expression program without androgen, but rather to execute a distinct program resulting in androgen-independent growth.	[Wang, Qianben; Xu, Kexin; Beroukhim, Rameen; Lupien, Mathieu; Fiorentino, Michelangelo; Fiore, Christopher; Loda, Massimo; Kantoff, Philip W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Tao] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wang, Qianben; Chen, Zhong] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wang, Qianben; Chen, Zhong] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Yong; Regan, Meredith M.; Meyer, Clifford A.; Manrai, Arjun Kumar; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Zhang, Yong; Regan, Meredith M.; Meyer, Clifford A.; Manrai, Arjun Kumar; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Yuan, Xin; Wang, Hongyun; Balk, Steven P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02215 USA; [Yu, Jindan; Mehra, Rohit; Han, Bo; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Beroukhim, Rameen] Harvard & MIT, Broad Inst, Cambridge, MA 02139 USA; [Carroll, Jason S.] Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Janne, Olli A.] Univ Helsinki, Inst Biomed Physiol, Biomedicum, FI-00014 Helsinki, Finland; [Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [True, Lawrence] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Helsinki; Cornell University; University of Washington; University of Washington Seattle	Wang, QB (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	qianben.wang@osumc.edu; xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Thomson, Axel/A-7893-2013; Wang, Qianben/E-4267-2011; Brown, Myles/B-6906-2008; Fiorentino, Michelangelo/AAB-8056-2022; Li, Wei/A-8544-2009; Wu, Tao/C-7533-2013; Zhang, Yong/B-4838-2011; Chen, Zhong/E-2776-2018; Brown, Myles/AAX-5332-2021	Zhang, Yong/0000-0001-6316-2734; Chen, Zhong/0000-0002-9644-1737; Brown, Myles/0000-0002-8213-1658; Lupien, Mathieu/0000-0003-0929-9478; Manrai, Arjun/0000-0001-9657-9800; Li, Wei/0000-0001-9931-5990; Rubin, Mark/0000-0002-8321-9950; Carroll, Jason/0000-0003-3643-0080; Kantoff, Philip/0000-0001-7275-0597; Fiore, Christopher/0000-0003-3151-3354	National Institutes of Health [P50 CA090381, K99 CA126160, R01 HG004069, K99 CA129565]; The Prostate Cancer Foundation; Department of Defense [W81XWH-07-1-0037, PC080665]; NATIONAL CANCER INSTITUTE [K99CA126160, P50CA090381, K99CA129565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Prostate Cancer Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health (P50 CA090381 to M. B., K99 CA126160 to Q. W., and R01 HG004069 to X. S. L., and K99 CA129565 to J.Y., The Prostate Cancer Foundation (to M. B), and Department of Defense (W81XWH-07-1-0037 to X. S. L., and PC080665 to J.Y.). We thank Drs. Roland Schule for providing KDM1 constructs; and Michael Rape for UBE2C constructs. We also thank Drs. James DeCaprio, Gustavo Leone, Tim Huang, Yun Li, and Shengjun Ren for helpful discussions; and Dr. Chunpeng Zhang and Anna Rorick for technical assistance.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Comstock CES, 2007, CELL CYCLE, V6, P1307, DOI 10.4161/cc.6.11.4353; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GROUP PCT, 2000, LANCET, V355, P1491; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lin J, 2006, NEOPLASIA, V8, P1062, DOI 10.1593/neo.05832; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thalmann GN, 2000, PROSTATE, V44, P91; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yu DC, 1999, CANCER RES, V59, P1498	48	676	695	3	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					245	256		10.1016/j.cell.2009.04.056	http://dx.doi.org/10.1016/j.cell.2009.04.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632176	Green Accepted, Bronze			2022-12-24	WOS:000268277000008
J	Garske, T; Legrand, J; Donnelly, CA; Ward, H; Cauchemez, S; Fraser, C; Ferguson, NM; Ghani, AC				Garske, Tini; Legrand, Judith; Donnelly, Christl A.; Ward, Helen; Cauchemez, Simon; Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.			Assessing the severity of the novel influenza A/H1N1 pandemic	BRITISH MEDICAL JOURNAL			English	Article							ACUTE-RESPIRATORY-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; CASE-FATALITY RATIO; VIRUS-INFECTIONS; EFFICACY; SAFETY; OSELTAMIVIR; ZANAMIVIR; DISEASE; TIME		[Garske, Tini; Legrand, Judith; Donnelly, Christl A.; Ward, Helen; Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England	Imperial College London	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009; Fraser, Christophe/A-8109-2008; Ferguson, Neil/B-8578-2008; Ward, Helen/A-1836-2009	Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Ward, Helen/0000-0001-8238-5036; Ghani, Azra/0000-0002-0007-4910; Donnelly, Christl/0000-0002-0195-2463	Medical Research Council Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Armitage P., 2002, STAT METHODS MED RES; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *EUR CTR DIS PREV, ECDC SIT REP INFL A; FRASER C, 2009, SCIENCE, V117, P60; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Gigli A, 2000, STAT MED, V19, P175, DOI 10.1002/(SICI)1097-0258(20000130)19:2&lt;175::AID-SIM299&gt;3.0.CO;2-S; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Health Protection Agency, 2009, HPA WEEKL NAT INFL R; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; MAINES TR, 2009, SCIENCE, V117, P723; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; *PAN AM HLTH ORG, 2009, UPD INFL A H1N1 REG; PEREZPADILLA R, 2009, N ENGL J MED; *PUBL HLTH AG CAN, PAND H1N1 2009 OUTBR; Secretaria de Salud de Mexico, SIT ACT EP; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; *US CDCP, 2009, KEY FACTS SEAS INFL; *US CDCP, 2009, NAT LIN INFL A H1N1; *US CDCP, H1N1 FLU; *WHO, SIT UPD INFL A H1N1; Yip PSF, 2005, AM J EPIDEMIOL, V161, P700, DOI 10.1093/aje/kwi088; Yip PSF, 2005, J R STAT SOC A STAT, V168, P233, DOI 10.1111/j.1467-985X.2004.00345.x; 2003, NY TIMES        0422	26	161	165	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 14	2009	339								b2840	10.1136/bmj.b2840	http://dx.doi.org/10.1136/bmj.b2840			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602714				2022-12-24	WOS:000268104900008
J	Clelland, CD; Choi, M; Romberg, C; Clemenson, GD; Fragniere, A; Tyers, P; Jessberger, S; Saksida, LM; Barker, RA; Gage, FH; Bussey, TJ				Clelland, C. D.; Choi, M.; Romberg, C.; Clemenson, G. D., Jr.; Fragniere, A.; Tyers, P.; Jessberger, S.; Saksida, L. M.; Barker, R. A.; Gage, F. H.; Bussey, T. J.			A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation	SCIENCE			English	Article							DENTATE GYRUS; MEMORY; CA3; MICE; ENSEMBLES; CELLS; TASK; RATS; BORN	The dentate gyrus (DG) of the mammalian hippocampus is hypothesized to mediate pattern separation-the formation of distinct and orthogonal representations of mnemonic information-and also undergoes neurogenesis throughout life. How neurogenesis contributes to hippocampal function is largely unknown. Using adult mice in which hippocampal neurogenesis was ablated, we found specific impairments in spatial discrimination with two behavioral assays: (i) a spatial navigation radial arm maze task and (ii) a spatial, but non-navigable, task in the mouse touch screen. Mice with ablated neurogenesis were impaired when stimuli were presented with little spatial separation, but not when stimuli were more widely separated in space. Thus, newborn neurons may be necessary for normal pattern separation function in the DG of adult mice.	[Clelland, C. D.; Clemenson, G. D., Jr.; Gage, F. H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Clelland, C. D.; Choi, M.; Fragniere, A.; Tyers, P.; Barker, R. A.] Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England; [Romberg, C.; Saksida, L. M.; Bussey, T. J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Jessberger, S.] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Saksida, L. M.; Bussey, T. J.] Univ Cambridge, MRC, Cambridge CB2 3EB, England; [Saksida, L. M.; Bussey, T. J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Barker, R. A.] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England	Salk Institute; University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; tjb1000@cam.ac.uk	Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016; Jessberger, Sebastian/AAJ-4032-2020; Clelland, Claire/AAZ-6038-2021; Choi, Minee/AAL-4769-2021	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171; Choi, Minee/0000-0001-9414-8214; Clelland, Claire/0000-0002-9112-2278; Jessberger, Sebastian/0000-0002-0056-8275; Romberg-Taylor, Carola/0000-0002-4379-3579; Barker, Roger Alistair/0000-0001-8843-7730	Lookout; Mathers Foundations; Kavli Institute for Brain and Mind; NIH [NS-050217]; Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge; MaxNetAging; NCCR Neural Plasticity and Repair; Marshalls and Jack Kent Cooke Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217] Funding Source: NIH RePORTER; Medical Research Council [G0300723B, G0001354, G0001354B] Funding Source: researchfish	Lookout; Mathers Foundations; Kavli Institute for Brain and Mind; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge(University of Cambridge); MaxNetAging; NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Marshalls and Jack Kent Cooke Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. J. Armstrong and J. B. Aimone for useful input and discussions, M. L. Gage for editorial comments, and J. Simon for assistance with figures. This work was funded in part by James S. McDonnell, Lookout, and Mathers Foundations, the Kavli Institute for Brain and Mind, and NIH (grant NS-050217) (F.H.G.), and also by the NIHR Biomedical Research Centre Award to the University of Cambridge and generous donations from patients and families to the Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge (R.A.B.). This work was also supported in part by MaxNetAging and NCCR Neural Plasticity and Repair Grants (S.J.) and Marshalls and Jack Kent Cooke Foundation scholarships (C.D.C.).	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; BERNSTEIN D, 1985, PHARMACOL BIOCHEM BE, V22, P301, DOI 10.1016/0091-3057(85)90395-8; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilbert PE, 1998, J NEUROSCI, V18, P804; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McTighe SM, 2009, NEUROREPORT, V20, P881, DOI 10.1097/WNR.0b013e32832c5eb2; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	30	1111	1138	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					210	213		10.1126/science.1173215	http://dx.doi.org/10.1126/science.1173215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590004	Green Accepted			2022-12-24	WOS:000267802000050
J	Wender, PA; Miller, BL				Wender, Paul A.; Miller, Benjamin L.			Synthesis at the molecular frontier	NATURE			English	Article							ORGANIC-SYNTHESIS; ORIENTED SYNTHESIS; NATURAL-PRODUCTS; IN-VITRO; DISCOVERY; CHEMISTRY; ANALOGS; IDENTIFICATION; PROSTRATIN; CONVERSION		[Wender, Paul A.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Wender, Paul A.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Miller, Benjamin L.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA	Stanford University; Stanford University; University of Rochester	Wender, PA (corresponding author), Stanford Univ, Dept Chem, 333 Campus Dr, Stanford, CA 94305 USA.	wenderp@stanford.edu; Benjamin_miller@urmc.rochester.edu	Chen, Yao/AAJ-2409-2020	Miller, Benjamin/0000-0003-1647-0122	NCI NIH HHS [R37 CA031845-29, R37 CA031845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chanon M, 1998, SYNTHESIS-STUTTGART, P1559; Chappell D, 2006, ORG BIOMOL CHEM, V4, P4409, DOI 10.1039/b614011b; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Corey EJ., 2007, MOL MED; CORNFORTH JW, 1993, AUST J CHEM, V46, P157, DOI 10.1071/CH9930157; CURRAN DP, 1987, TETRAHEDRON, V43, P5653, DOI 10.1016/S0040-4020(01)87744-9; Das A, 2009, ACCOUNTS CHEM RES, V42, P631, DOI 10.1021/ar8002249; Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; Gareiss PC, 2008, J AM CHEM SOC, V130, P16254, DOI 10.1021/ja804398y; Greenbaum E, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P496, DOI 10.1109/IEDM.2002.1175888; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Horvath IT, 2007, CHEM REV, V107, P2169, DOI 10.1021/cr078380v; Johnson HE, 2008, J NAT PROD, V71, P2041, DOI 10.1021/np800295m; Kingston DGI, 2007, CURR OPIN DRUG DISC, V10, P130; Koshino M, 2008, NAT NANOTECHNOL, V3, P595, DOI 10.1038/nnano.2008.263; Krueger AT, 2009, CHEM BIOL, V16, P242, DOI 10.1016/j.chembiol.2008.12.004; LaVan DA, 2006, P NATL ACAD SCI USA, V103, P5251, DOI 10.1073/pnas.0506694103; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; McNaughton BR, 2007, J AM CHEM SOC, V129, P11306, DOI 10.1021/ja072114h; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicewicz DA, 2008, J AM CHEM SOC, V130, P17281, DOI 10.1021/ja808347q; Nicolaou KC, 2003, TETRAHEDRON, V59, P6683, DOI 10.1016/S0040-4020(03)00943-8; Padwa A, 2007, TETRAHEDRON, V63, P5341, DOI 10.1016/j.tet.2007.03.158; Reed J. W, 2007, WAY SYNTHESIS EVOLUT; REPPE W, 1948, LIEBIGS ANN CHEM, V560, P1; Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Sun MK, 2008, EUR J PHARMACOL, V584, P328, DOI 10.1016/j.ejphar.2008.02.014; Szpilman AM, 2008, ANGEW CHEM INT EDIT, V47, P4339, DOI 10.1002/anie.200800590; Thomas GL, 2008, ANGEW CHEM INT EDIT, V47, P2808, DOI 10.1002/anie.200705415; Tietze L. F., 2006, DOMINO REACTIONS ORG; Towle MJ, 2001, CANCER RES, V61, P1013; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Vilotijevic I, 2007, SCIENCE, V317, P1189, DOI 10.1126/science.1146421; Wender P. A., 1993, ORGANIC SYNTHESIS TH, V2, P27; Wender PA, 2002, PURE APPL CHEM, V74, P25, DOI 10.1351/pac200274010025; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; WENDER PA, 2007, DRUG DISCOVERY RES N, P127; Wender PA, 2008, J AM CHEM SOC, V130, P6658, DOI 10.1021/ja8015632; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Wilson RM, 2006, J ORG CHEM, V71, P8329, DOI 10.1021/jo0610053; Wulff JE, 2007, J AM CHEM SOC, V129, P4898, DOI 10.1021/ja0690971; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l	50	409	414	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 9	2009	460	7252					197	201		10.1038/460197a	http://dx.doi.org/10.1038/460197a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587760	Green Accepted			2022-12-24	WOS:000267761000029
J	Donohoe, ME; Silva, SS; Pinter, SF; Xu, N; Lee, JT				Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.			The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting	NATURE			English	Article							EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; INACTIVATION; TRANSCRIPTION; CHOICE; TSIX; IDENTIFICATION; INITIATION; ACTIVATOR; PROTEIN	Pluripotency of embryonic stem (ES) cells is controlled by defined transcription factors(1,2). During differentiation, mouse ES cells undergo global epigenetic reprogramming, as exemplified by X-chromosome inactivation (XCI) in which one female X chromosome is silenced to achieve gene dosage parity between the sexes(3-5). Somatic XCI is regulated by homologous X-chromosome pairing(6,7) and counting(8-10), and by the random choice of future active and inactive X chromosomes. XCI and cell differentiation are tightly coupled(11), as blocking one process compromises the other(8,12) and dedifferentiation of somatic cells to induced pluripotent stem cells is accompanied by X chromosome reactivation(2). Recent evidence suggests coupling of Xist expression to pluripotency factors occurs(13), but how the two are interconnected remains unknown. Here we show that Oct4 (also known as Pou5f1)(14) lies at the top of the XCI hierarchy, and regulates XCI by triggering X-chromosome pairing and counting. Oct4 directly binds Tsix and Xite, two regulatory noncoding RNA genes of the X-inactivation centre(15,16), and also complexes with XCI trans-factors, Ctcf and Yy1 (ref. 17), through protein-protein interactions. Depletion of Oct4 blocks homologous X-chromosome pairing and results in the inactivation of both X chromosomes in female cells. Thus, we have identified the first trans-factor that regulates counting, and ascribed new functions to Oct4 during X-chromosome reprogramming.	[Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Pinter, Stefan/O-9228-2019	Pinter, Stefan/0000-0003-4750-1403	National Institutes of Health [GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058839, R01GM058839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Stavropoulos and J. Lopilato for their contributions to the early phase of this work. We also thank J. Zhao, J. A. Erwin and J. Ahn for critical reading of the manuscript and all laboratory members for stimulating discussion. This work was funded by a National Institutes of Health grant to J. T. L. (GM58839). J. T. L. is an Investigator of the Howard Hughes Medical Institute.	Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	30	216	222	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					128	U147		10.1038/nature08098	http://dx.doi.org/10.1038/nature08098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19536159	Green Accepted			2022-12-24	WOS:000267545200043
J	Nolen, BJ; Tomasevic, N; Russell, A; Pierce, DW; Jia, Z; McCormick, CD; Hartman, J; Sakowicz, R; Pollard, TD				Nolen, B. J.; Tomasevic, N.; Russell, A.; Pierce, D. W.; Jia, Z.; McCormick, C. D.; Hartman, J.; Sakowicz, R.; Pollard, T. D.			Characterization of two classes of small molecule inhibitors of Arp2/3 complex	NATURE			English	Article							ACTIN-FILAMENT; PROTEIN; CRYSTALLOGRAPHY; POLYMERIZATION; ASSOCIATION; NUCLEATION; WASP; ADP; ATP	Polymerization of actin filaments directed by the actin-related protein (Arp)2/3 complex supports many types of cellular movements(1). However, questions remain regarding the relative contributions of Arp2/3 complex versus other mechanisms of actin filament nucleation to processes such as path finding by neuronal growth cones; this is because of the lack of simple methods to inhibit Arp2/3 complex reversibly in living cells. Here we describe two classes of small molecules that bind to different sites on the Arp2/3 complex and inhibit its ability to nucleate actin filaments. CK-0944636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation. CK-0993548 inserts into the hydrophobic core of Arp3 and alters its conformation. Both classes of compounds inhibit formation of actin filament comet tails by Listeria and podosomes by monocytes. Two inhibitors with different mechanisms of action provide a powerful approach for studying the Arp2/3 complex in living cells.	[Nolen, B. J.; Pollard, T. D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Nolen, B. J.; Pollard, T. D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Nolen, B. J.; McCormick, C. D.; Pollard, T. D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Tomasevic, N.; Russell, A.; Pierce, D. W.; Jia, Z.; Hartman, J.; Sakowicz, R.] Cytokinetics Inc, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Nolen, Brad/0000-0002-0224-9980; Russell, Alan/0000-0001-7545-5008	Cytokinetics, Inc.; NIH [GM-066311]; NSF; Ruth Kirschstein postdoctoral fellowship [GM074374-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074374, P01GM066311] Funding Source: NIH RePORTER	Cytokinetics, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ruth Kirschstein postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Cytokinetics, Inc., NIH research grant GM-066311 ( to T. D. P.), an NSF graduate research fellowship ( C. D. M.) and a Ruth Kirschstein postdoctoral fellowship (GM074374-02 to B. J. N.). We thank L. Belmont, Z. Khurshid, O. Ezizika, J. Lee, S. Leuenroth, Z. Cournia and H. Chen for help with the project.	Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105	24	346	353	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1031	U121		10.1038/nature08231	http://dx.doi.org/10.1038/nature08231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19648907	Green Accepted			2022-12-24	WOS:000269085500038
J	Hodges, C; Bintu, L; Lubkowska, L; Kashlev, M; Bustamante, C				Hodges, Courtney; Bintu, Lacramioara; Lubkowska, Lucyna; Kashlev, Mikhail; Bustamante, Carlos			Nucleosomal Fluctuations Govern the Transcription Dynamics of RNA Polymerase II	SCIENCE			English	Article							C-MYC; IN-VIVO; ELONGATION; GENE; DNA; TEMPLATES; MECHANISM; BARRIER; BLOCK; END	RNA polymerase II (Pol II) must overcome the barriers imposed by nucleosomes during transcription elongation. We have developed an optical tweezers assay to follow individual Pol II complexes as they transcribe nucleosomal DNA. Our results indicate that the nucleosome behaves as a fluctuating barrier that locally increases pause density, slows pause recovery, and reduces the apparent pause-free velocity of Pol II. The polymerase, rather than actively separating DNA from histones, functions instead as a ratchet that rectifies nucleosomal fluctuations. We also obtained direct evidence that transcription through a nucleosome involves transfer of the core histones behind the transcribing polymerase via a transient DNA loop. The interplay between polymerase dynamics and nucleosome fluctuations provides a physical basis for the regulation of eukaryotic transcription.	[Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lubkowska, Lucyna; Kashlev, Mikhail] NCI, Frederick Canc Res & Dev Ctr, NCI Ctr Canc Res, Frederick, MD 21702 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem & Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Hodges, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073	NIH [GM32543]; NATIONAL CANCER INSTITUTE [ZIABC010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, R37GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM32543 (C.B.).	Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; FELLER W, 1971, INTRO PROBABILITY TH, V2, P59; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; PLET A, 1995, ONCOGENE, V10, P319; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Walter W, 2003, J BIOL CHEM, V278, P36148, DOI 10.1074/jbc.M305647200; WIDMER RM, 1984, EMBO J, V3, P1635, DOI 10.1002/j.1460-2075.1984.tb02022.x; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905	25	269	275	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					626	628		10.1126/science.1172926	http://dx.doi.org/10.1126/science.1172926			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644123	Green Accepted			2022-12-24	WOS:000268493000054
J	Zhang, DW; Shao, J; Lin, J; Zhang, N; Lu, BJ; Lin, SC; Dong, MQ; Han, JH				Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lu, Bao-Ju; Lin, Sheng-Cai; Dong, Meng-Qiu; Han, Jiahuai			RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis	SCIENCE			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; KINASE; PATHWAY; CYTOTOXICITY; INHIBITION; INVOLVEMENT; DOMAIN	Necrosis can be induced by stimulating death receptors with tumor necrosis factor (TNF) or other agonists; however, the underlying mechanism differentiating necrosis from apoptosis is largely unknown. We identified the protein kinase receptor-interacting protein 3 (RIP3) as a molecular switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells. RIP3 did not affect RIP1-mediated apoptosis but was required for RIP1-mediated necrosis and the enhancement of necrosis by the caspase inhibitor zVAD. By activating key enzymes of metabolic pathways, RIP3 regulates TNF-induced reactive oxygen species production, which partially accounts for RIP3's ability to promote necrosis. Our data suggest that modulation of energy metabolism in response to death stimuli has an important role in the choice between apoptosis and necrosis.	[Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lin, Sheng-Cai; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China; [Lu, Bao-Ju; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Xiamen University; National Institute of Biological Sciences, Beijing	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	Zhang, Duanwu/AAH-1627-2020; Lin, SC/G-4666-2010; Han, J/G-4671-2010	Zhang, Duanwu/0000-0003-2946-846X; 	NSFC-CIHR [30611120526]; 973 program [2009CB22200]	NSFC-CIHR(Canadian Institutes of Health Research (CIHR)); 973 program(National Basic Research Program of China)	This work was supported by grants NSFC-CIHR 30611120526 and 973 program 2009CB22200.	Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Goossens V, 1996, J BIOL CHEM, V271, P192, DOI 10.1074/jbc.271.1.192; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	23	1345	1428	11	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					332	336		10.1126/science.1172308	http://dx.doi.org/10.1126/science.1172308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19498109				2022-12-24	WOS:000268036600049
J	Harrison, DE; Strong, R; Sharp, ZD; Nelson, JF; Astle, CM; Flurkey, K; Nadon, NL; Wilkinson, JE; Frenkel, K; Carter, CS; Pahor, M; Javors, MA; Fernandez, E; Miller, RA				Harrison, David E.; Strong, Randy; Sharp, Zelton Dave; Nelson, James F.; Astle, Clinton M.; Flurkey, Kevin; Nadon, Nancy L.; Wilkinson, J. Erby; Frenkel, Krystyna; Carter, Christy S.; Pahor, Marco; Javors, Martin A.; Fernandez, Elizabeth; Miller, Richard A.			Rapamycin fed late in life extends lifespan in genetically heterogeneous mice	NATURE			English	Article							TOR; PATHWAY; DESIGN; TARGET; YEAST	Inhibition of the TOR signalling pathway by genetic or pharmacological intervention extends lifespan in invertebrates, including yeast, nematodes and fruitflies(1-5); however, whether inhibition of mTOR signalling can extend lifespan in a mammalian species was unknown. Here we report that rapamycin, an inhibitor of the mTOR pathway, extends median and maximal lifespan of both male and female mice when fed beginning at 600 days of age. On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. The effect was seen at three independent test sites in genetically heterogeneous mice, chosen to avoid genotype-specific effects on disease susceptibility. Disease patterns of rapamycin-treated mice did not differ from those of control mice. In a separate study, rapamycin fed to mice beginning at 270 days of age also increased survival in both males and females, based on an interim analysis conducted near the median survival point. Rapamycin may extend lifespan by postponing death from cancer, by retarding mechanisms of ageing, or both. To our knowledge, these are the first results to demonstrate a role for mTOR signalling in the regulation of mammalian lifespan, as well as pharmacological extension of lifespan in both genders. These findings have implications for further development of interventions targeting mTOR for the treatment and prevention of age-related diseases.	[Harrison, David E.; Astle, Clinton M.; Flurkey, Kevin] Jackson Lab, Bar Harbor, ME 04609 USA; [Strong, Randy; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Strong, Randy; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Res Serv, Dept Pharmacol, San Antonio, TX 78229 USA; [Strong, Randy; Sharp, Zelton Dave; Nelson, James F.; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Sharp, Zelton Dave] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Nadon, Nancy L.] NIA, Div Aging Biol, Bethesda, MD 20892 USA; [Wilkinson, J. Erby] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Frenkel, Krystyna] NYU, Sch Med, New York, NY 10016 USA; [Carter, Christy S.; Pahor, Marco] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Gerontol & Geriatr Winston Salem, Winston Salem, NC 27157 USA; [Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	Jackson Laboratory; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; New York University; Wake Forest University; University of Texas System; University of Texas Health San Antonio; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	david.harrison@jax.org	Longo, Kenneth A/A-5631-2010; Carter, Christy/E-6630-2011; Carter, Christy/A-6828-2011		NIA [AG022303, AG025707, AG022308, AG022307, AG13319]; Department of Veterans Affairs; DoD [W81XWH-07-1-0605]; NATIONAL INSTITUTE ON AGING [P30AG028740, P30AG013319, U01AG022307, U01AG022308, U01AG022303, P30AG025707] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); DoD(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA grants AG022303 (R. A. M.), AG025707 and AG022308 (D. E. H.), AG022307 (R. S.) and AG13319 (J. F. N. and R. S.), and the Department of Veterans Affairs (R. A. M. and R. S.) and DoD W81XWH-07-1-0605 (Z. D. S.). We wish to thank P. J. Krason, P. J. Harrison, E. Adler, V. Diaz, J. Sewald, L. Burmeister, B. Kohler, M. Han, M. Lauderdale and D. Jones for reliable technical assistance, S. Pletcher and A. Galecki for statistical assistance, and H. Warner and S. N. Austad for scientific counsel.	Archer JR, 1996, J GERONTOL A-BIOL, V51, pB448, DOI 10.1093/gerona/51A.6.B448; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Garber K, 2001, J NATL CANCER I, V93, P1517, DOI 10.1093/jnci/93.20.1517; Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Klebanov S, 2001, EXP BIOL MED, V226, P854, DOI 10.1177/153537020122600908; KOHN RR, 1978, PRINCIPLES MAMMALIAN; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Nadon NL, 2008, AGE, V30, P187, DOI 10.1007/s11357-008-9048-1; Olshansky SJ, 2006, SCIENTIST, V20, P28; Petroulakis E, 2007, Br J Cancer, V96 Suppl, pR11; PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; RODERICK TH, 1963, GENETICS, V48, P205; SCHNEIDER EL, 1985, NEW ENGL J MED, V312, P1159, DOI 10.1056/NEJM198505023121805; SCHNEIDER EL, 1998, BROCKELHURSTS TXB GE, P193; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	30	2446	2568	14	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					392	U108		10.1038/nature08221	http://dx.doi.org/10.1038/nature08221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19587680	Green Submitted, Green Accepted			2022-12-24	WOS:000267979000038
J	Beck, LH; Bonegio, RGB; Lambeau, G; Beck, DM; Powell, DW; Cummins, TD; Klein, JB; Salant, DJ				Beck, Laurence H., Jr.; Bonegio, Ramon G. B.; Lambeau, Gerard; Beck, David M.; Powell, David W.; Cummins, Timothy D.; Klein, Jon B.; Salant, David J.			M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEYMANN NEPHRITIS; EXPERIMENTAL GLOMERULONEPHRITIS; 180-KDA RECEPTOR; A(2); FAMILY; EXPRESSION; CLONING; IDENTIFICATION; LOCALIZATION; GLYCOPROTEIN	Background: Idiopathic membranous nephropathy, a common form of the nephrotic syndrome, is an antibody-mediated autoimmune glomerular disease. Serologic diagnosis has been elusive because the target antigen is unknown. Methods: We performed Western blotting of protein extracts from normal human glomeruli with serum samples from patients with idiopathic or secondary membranous nephropathy or other proteinuric or autoimmune diseases and from normal controls. We used mass spectrometry to analyze the reactive protein bands and confirmed the identity and location of the target antigen with a monospecific antibody. Results: Serum samples from 26 of 37 patients (70%) with idiopathic but not secondary membranous nephropathy specifically identified a 185-kD glycoprotein in nonreduced glomerular extract. Mass spectrometry of the reactive protein band detected the M-type phospholipase A(sub 2) receptor (PLA(sub 2)R). Reactive serum specimens recognized recombinant PLA(sub 2)R and bound the same 185-kD glomerular protein as did the monospecific anti-PLA(sub 2)R antibody. Anti-PLA(sub 2)R autoantibodies in serum samples from patients with membranous nephropathy were mainly IgG4, the predominant immunoglobulin subclass in glomerular deposits. PLA(sub 2)R was expressed in podocytes in normal human glomeruli and colocalized with IgG4 in immune deposits in glomeruli of patients with membranous nephropathy. IgG eluted from such deposits in patients with idiopathic membranous nephropathy, but not in those with lupus membranous or IgA nephropathy, recognized PLA(sub 2)R. Conclusions: A majority of patients with idiopathic membranous nephropathy have antibodies against a conformation-dependent epitope in PLA(sub 2)R. PLA(sub 2)R is present in normal podocytes and in immune deposits in patients with idiopathic membranous nephropathy, indicating that PLA(sub 2)R is a major antigen in this disease. N Engl J Med 2009;361:11-21.	[Beck, Laurence H., Jr.; Bonegio, Ramon G. B.; Beck, David M.; Salant, David J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lambeau, Gerard] Univ Nice Sophia Antipolis, Valbonne, France; [Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Powell, David W.; Cummins, Timothy D.; Klein, Jon B.] Univ Louisville, Sch Med, Louisville, KY 40292 USA	Boston University; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Louisville	Salant, DJ (corresponding author), Evans Biomed Res Ctr, Rm 504,650 Albany St, Boston, MA 02118 USA.	djsalant@bu.edu	Klein, Jon/B-9833-2013; Cummins, Timothy D./C-9120-2013; Powell, David W/E-9288-2013; Lambeau, Gerard/GRJ-5624-2022	Bonegio, Ramon/0000-0002-1286-141X; Salant, David/0000-0002-3866-3120; Beck, Laurence/0000-0003-1482-4089; Lambeau, Gerard/0000-0002-9239-518X; Cummins, Timothy/0000-0001-9648-5441	National Institute of Diabetes and Digestive and Kidney Diseases [DK067658, DK30932, DK076743]; Amgen; Halpin Foundation; Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053, K01DK076743, R21DK067658, R01DK030932, R56DK030932] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen(Amgen); Halpin Foundation; Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer(Centre National de la Recherche Scientifique (CNRS)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK067658 and DK30932, to Dr. Salant, and DK076743, to Dr. Powell), Amgen (to Dr. Beck), the Halpin Foundation (to Dr. Beck), Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer (to Dr. Lambeau), and the Department of Veterans Affairs (to Dr. Klein).	ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Beck S, 2006, KIDNEY INT, V70, P1251, DOI 10.1038/sj.ki.5001664; Brandslund I, 1981, Methods Enzymol, V74 Pt C, P551; COUSER WG, 1980, KIDNEY INT, V17, P1, DOI 10.1038/ki.1980.1; COUSER WG, 1978, J CLIN INVEST, V62, P1275, DOI 10.1172/JCI109248; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; HAAS M, 1994, AM J KIDNEY DIS, V23, P358, DOI 10.1016/S0272-6386(12)80997-8; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; MAKKER SP, 1984, LAB INVEST, V50, P287; MAKKER SP, 1989, J IMMUNOL, V142, P3406; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Silliman CC, 2002, AM J PHYSIOL-CELL PH, V283, pC1102, DOI 10.1152/ajpcell.00608.2001; VANDAMME BJC, 1978, LAB INVEST, V38, P502; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	33	1344	1447	10	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					11	21		10.1056/NEJMoa0810457	http://dx.doi.org/10.1056/NEJMoa0810457			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571279	Green Accepted			2022-12-24	WOS:000267533100005
J	Orso, G; Pendin, D; Liu, S; Tosetto, J; Moss, TJ; Faust, JE; Micaroni, M; Egorova, A; Martinuzzi, A; McNew, JA; Daga, A				Orso, Genny; Pendin, Diana; Liu, Song; Tosetto, Jessica; Moss, Tyler J.; Faust, Joseph E.; Micaroni, Massimo; Egorova, Anastasia; Martinuzzi, Andrea; McNew, James A.; Daga, Andrea			Homotypic fusion of ER membranes requires the dynamin-like GTPase Atlastin	NATURE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; DROSOPHILA; PROTEINS; RECONSTITUTION; MORPHOGENESIS; LIPOSOMES; NEURONS	Establishment and maintenance of proper architecture is essential for endoplasmic reticulum (ER) function. Homotypic membrane fusion is required for ER biogenesis and maintenance, and has been shown to depend on GTP hydrolysis. Here we demonstrate that Drosophila Atlastin-the fly homologue of the mammalian GTPase atlastin 1 involved in hereditary spastic paraplegia-localizes on ER membranes and that its loss causes ER fragmentation. Drosophila Atlastin embedded in distinct membranes has the ability to form trans-oligomeric complexes and its overexpression induces enlargement of ER profiles, consistent with excessive fusion of ER membranes. In vitro experiments confirm that Atlastin autonomously drives membrane fusion in a GTP-dependent fashion. In contrast, GTPase-deficient Atlastin is inactive, unable to form trans-oligomeric complexes owing to failure to self-associate, and incapable of promoting fusion in vitro. These results demonstrate that Atlastin mediates membrane tethering and fusion and strongly suggest that it is the GTPase activity that is required for ER homotypic fusion.	[Orso, Genny; Pendin, Diana; Tosetto, Jessica; Martinuzzi, Andrea; Daga, Andrea] Eugenio Medea Sci Inst, I-31015 Conegliano, Italy; [Liu, Song; Moss, Tyler J.; Faust, Joseph E.; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Tosetto, Jessica] Univ Padua, Dept Pharmacol, I-35131 Padua, Italy; [Micaroni, Massimo] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Egorova, Anastasia] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; [Daga, Andrea] Eugenio Medea Sci Inst, Dulbecco Telethon Inst, I-35131 Padua, Italy; [Daga, Andrea] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	IRCCS Eugenio Medea; Rice University; University of Padua; University of Queensland; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Daga, A (corresponding author), Eugenio Medea Sci Inst, I-31015 Conegliano, Italy.	mcnew@rice.edu; daga@unipd.it	daga, andrea/J-1865-2018; Orso, Genny/C-6492-2016; Martinuzzi, Andrea/AAC-3127-2022; McNew, James/ABD-8081-2020; Martinuzzi, Andrea/K-3887-2016; Pendin, Diana/K-7868-2016; McNew, James/AAV-4911-2020; Liu, Song/E-2254-2011	daga, andrea/0000-0001-8935-5489; Orso, Genny/0000-0002-2959-8806; Martinuzzi, Andrea/0000-0002-0319-3579; Pendin, Diana/0000-0003-2827-935X; McNew, James/0000-0001-8459-3664; Faust, Joseph/0000-0002-2183-8529; Moss, Tyler/0000-0001-7140-9987; Micaroni, Massimo/0000-0001-6405-0451	National Institutes of Health [GM71832]; G. Harold and Leila Mathers Charitable Foundation; Telethon-Italy; Italian Ministry of Health and the Foundation Compagnia di San Paolo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Mathers Charitable Foundation; Telethon-Italy(Fondazione Telethon); Italian Ministry of Health and the Foundation Compagnia di San Paolo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lippincott-Schwartz, R. Rikhy, M. Buszczak, M. Ramaswami and J. Kim for providing Drosophila strains, A. Gazziero for generating transgenic lines, and E. Giordano for the provision of the SympUAST vector. We thank M. G. Rossetto for support throughout the duration of the work, N. D'Elia for technical assistance, R. Polishchuck and the Telethon EM core facility, and W. Guo for help with EM analysis of negative stained Drosophila Atlastin proteoliposomes. This work was supported by grants from the National Institutes of Health (GM71832) and the G. Harold and Leila Mathers Charitable Foundation to J. A. M., and from Telethon-Italy, the Italian Ministry of Health and the Foundation Compagnia di San Paolo to A. D.	Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; BRAND AH, 1993, DEVELOPMENT, V118, P401; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Lee Y, 2008, NEUROBIOL AGING, V29, P84, DOI 10.1016/j.neurobiolaging.2006.09.004; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Polishchuk R S, 2001, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0408s11; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakefield S, 2006, CELL MOL LIFE SCI, V63, P2027, DOI 10.1007/s00018-006-6142-3; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	30	320	329	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					978	U58		10.1038/nature08280	http://dx.doi.org/10.1038/nature08280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19633650				2022-12-24	WOS:000269085500027
J	Purcell, SM; Wray, NR; Stone, JL; Visscher, PM; O'Donovan, MC; Sullivan, PF; Sklar, P; Ruderfer, DM; McQuillin, A; Morris, DW; O'Dushlaine, CT; Corvin, A; Holmans, PA; Macgregor, S; Gurling, H; Blackwood, DHR; Craddock, NJ; Gill, M; Hultman, CM; Kirov, GK; Lichtenstein, P; Muir, WJ; Owen, MJ; Pato, CN; Scolnick, EM; St Clair, D; Williams, NM; Georgieva, L; Nikolov, I; Norton, N; Williams, H; Toncheva, D; Milanova, V; Thelander, EF; Sullivan, P; Kenny, E; Quinn, EM; Choudhury, K; Datta, S; Pimm, J; Thirumalai, S; Puri, V; Krasucki, R; Lawrence, J; Quested, D; Bass, N; Crombie, C; Fraser, G; Kuan, SL; Walker, N; McGhee, KA; Pickard, B; Malloy, P; Maclean, AW; Van Beck, M; Pato, MT; Medeiros, H; Middleton, F; Carvalho, C; Morley, C; Fanous, A; Conti, D; Knowles, JA; Ferreira, CP; Macedo, A; Azevedo, MH; Kirby, AN; Ferreira, MAR; Daly, MJ; Chambert, K; Kuruvilla, F; Gabriel, SB; Ardlie, K; Moran, JL				Purcell, Shaun M.; Wray, Naomi R.; Stone, Jennifer L.; Visscher, Peter M.; O'Donovan, Michael C.; Sullivan, Patrick F.; Sklar, Pamela; Ruderfer, Douglas M.; McQuillin, Andrew; Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Holmans, Peter A.; Macgregor, Stuart; Gurling, Hugh; Blackwood, Douglas H. R.; Craddock, Nick J.; Gill, Michael; Hultman, Christina M.; Kirov, George K.; Lichtenstein, Paul; Muir, Walter J.; Owen, Michael J.; Pato, Carlos N.; Scolnick, Edward M.; St Clair, David; Williams, Nigel M.; Georgieva, Lyudmila; Nikolov, Ivan; Norton, N.; Williams, H.; Toncheva, Draga; Milanova, Vihra; Thelander, Emma F.; Sullivan, Patrick; Kenny, Elaine; Quinn, Emma M.; Choudhury, Khalid; Datta, Susmita; Pimm, Jonathan; Thirumalai, Srinivasa; Puri, Vinay; Krasucki, Robert; Lawrence, Jacob; Quested, Digby; Bass, Nicholas; Crombie, Caroline; Fraser, Gillian; Kuan, Soh Leh; Walker, Nicholas; McGhee, Kevin A.; Pickard, Ben; Malloy, Pat; Maclean, Alan W.; Van Beck, Margaret; Pato, Michele T.; Medeiros, Helena; Middleton, Frank; Carvalho, Celia; Morley, Christopher; Fanous, Ayman; Conti, David; Knowles, James A.; Ferreira, Carlos Paz; Macedo, Antonio; Azevedo, M. Helena; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly; Kuruvilla, Finny; Gabriel, Stacey B.; Ardlie, Kristin; Moran, Jennifer L.			Common polygenic variation contributes to risk of schizophrenia and bipolar disorder	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE RARE ALLELES; PSYCHIATRIC-DISORDERS; DISEASE; GENES; LOCI; TWIN	Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%(1,2). We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.	[Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Ferreira, Manuel A. R.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Scolnick, Edward M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Scolnick, Edward M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly; Kuruvilla, Finny; Gabriel, Stacey B.; Ardlie, Kristin; Moran, Jennifer L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wray, Naomi R.; Visscher, Peter M.; Macgregor, Stuart] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [O'Donovan, Michael C.; Holmans, Peter A.; Craddock, Nick J.; Kirov, George K.; Owen, Michael J.; Williams, Nigel M.; Georgieva, Lyudmila; Nikolov, Ivan; Norton, N.; Williams, H.] Cardiff Univ, Sch Med, Dept Psychol Med, MRC Ctr Neuropsychiat Genet & Gen, Cardiff C14 4XN, Wales; [Sullivan, Patrick F.; Sullivan, Patrick] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.; Sullivan, Patrick] Univ N Carolina, Dept Psychiat & Epidemiol, Chapel Hill, NC 27599 USA; [McQuillin, Andrew; Gurling, Hugh; Choudhury, Khalid; Datta, Susmita; Pimm, Jonathan; Puri, Vinay; Krasucki, Robert; Lawrence, Jacob; Bass, Nicholas] UCL, Sch Med, Mol Psychiat Lab, Res Dept Mental Hlth Sci,Windeyer Inst Med Sci, London W1T 4JF, England; [Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Gill, Michael; Kenny, Elaine; Quinn, Emma M.] Univ Dublin Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Gill, Michael; Kenny, Elaine; Quinn, Emma M.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 2, Ireland; [Blackwood, Douglas H. R.; Muir, Walter J.; McGhee, Kevin A.; Pickard, Ben; Malloy, Pat; Maclean, Alan W.; Van Beck, Margaret] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Hultman, Christina M.; Lichtenstein, Paul; Thelander, Emma F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci, SE-75017 Uppsala, Sweden; [Pato, Carlos N.; Pato, Michele T.; Medeiros, Helena; Carvalho, Celia; Fanous, Ayman; Conti, David; Knowles, James A.] Univ So Calif, Ctr Genom Psychiat, Los Angeles, CA 90033 USA; [St Clair, David; Walker, Nicholas] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Crombie, Caroline; Fraser, Gillian] Univ Aberdeen, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Toncheva, Draga] Univ Hosp Maichin Dom, Dept Med Genet, Sofia 1431, Bulgaria; [Milanova, Vihra] Alexander Univ Hosp, Psychiat Clin 1, Dept Psychiat, Sofia 1431, Bulgaria; [Thirumalai, Srinivasa] W Berkshire NHS Trust, Reading RG3 5LR, Berks, England; [Quested, Digby] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Kuan, Soh Leh] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Middleton, Frank; Morley, Christopher] SUNY Syracuse, Upstate Med Univ Syracuse, Syracuse, NY 13210 USA; [Fanous, Ayman] Washington VA Med Ctr, Washington, DC 20422 USA; [Fanous, Ayman] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, Ayman] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Ferreira, Carlos Paz] Dept Psychiat, P-9500310 Sao Miguel, Azores, Portugal; [Macedo, Antonio; Azevedo, M. Helena] Univ Coimbra, Dept Psychiat, P-3004504 Coimbra, Portugal	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; QIMR Berghofer Medical Research Institute; Cardiff University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; UCL Medical School; Trinity College Dublin; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; Karolinska Institutet; Uppsala University; University of Southern California; University of Aberdeen; University of Aberdeen; Medical University Sofia; Medical University Sofia; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Georgetown University; Virginia Commonwealth University; Universidade de Coimbra	Sklar, P (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, 185 Cambridge St, Boston, MA 02114 USA.	shaun@pngu.mgh.harvard.edu; sklar@chgr.mgh.harvard.edu	Macgregor, Stuart/C-6442-2009; Wray, Naomi/C-8639-2015; Holmans, Peter/F-4518-2015; macedo, antónio/AFQ-1571-2022; Fanous, Ayman H/O-1263-2017; Morley, Christopher P./K-1907-2014; macedo, antónio/AFQ-1570-2022; St Clair, David/AAN-2412-2021; anand, amit/A-7222-2009; Morley, Christopher P./W-5037-2019; Gurling, Hugh M/A-5029-2010; Pickard, Benjamin S/K-3923-2014; blackwood, douglas/AIB-8874-2022; O'Donovan, Michael C/P-7005-2018; Barreto Carvalho, Célia/AAY-8962-2021; Ferreira, Manuel A R/D-3609-2013; Ruderfer, Douglas M/M-5795-2016; Daly, Mark J/B-2453-2017; THOMAS, Sean C./B-6089-2008; Morris, Derek/AAW-8343-2021; Williams, Hywel/AAL-2440-2021; Visscher, Peter/ABB-6151-2020; macedo santos, antónio/M-5737-2013; McQuillin, Andrew/C-1623-2008	Macgregor, Stuart/0000-0001-6731-8142; Wray, Naomi/0000-0001-7421-3357; Holmans, Peter/0000-0003-0870-9412; macedo, antónio/0000-0003-2180-2718; Morley, Christopher P./0000-0003-0185-7148; macedo, antónio/0000-0003-2180-2718; Morley, Christopher P./0000-0003-0185-7148; Pickard, Benjamin S/0000-0002-2374-6329; O'Donovan, Michael C/0000-0001-7073-2379; Ferreira, Manuel A R/0000-0001-9059-1825; Ruderfer, Douglas M/0000-0002-2365-386X; Daly, Mark J/0000-0002-0949-8752; THOMAS, Sean C./0000-0002-0686-2483; Morris, Derek/0000-0002-3413-570X; Williams, Hywel/0000-0001-7758-0312; Visscher, Peter/0000-0002-2143-8760; macedo santos, antónio/0000-0003-2180-2718; McQuillin, Andrew/0000-0003-1567-2240; Gill, Michael/0000-0003-0206-5337; Moran, Jennifer/0000-0002-5664-4716; de Oliveira Barreto Coimbra Carvalho, Celia Maria/0000-0003-4453-8139; lichtenstein, paul/0000-0003-3037-5287; Walters, James/0000-0002-6980-4053; Corvin, Aiden/0000-0001-6717-4089; Toncheva, Draga/0000-0002-7451-6363; Quested, Digby/0000-0001-6155-3336; Middleton, Frank/0000-0002-3107-7188; Kirov, George/0000-0002-3427-3950	Stanley Medical Research Institute; Sylvan C. Herman Foundation [MH071681]; Medical Research Council (UK) Programme; National Institutes of Mental Health (USA) [CONTE: 2 P50 MH066392-05A1]; Swedish Council for Working Life and Social Research [FO 184/2000, 2001-2368]; Stanley Medical Research Institute [MH071681, MH077139]; Narsad Young Investigator Award; Australian National Health and Medical Research Council [389892, 442915, 496688, 496674]; Science Foundation Ireland; Health Research Board (Ireland); Wellcome Trust; National Institutes of Mental Health and the Department of Veterans Affairs; Medical Research Council [G0801418, G0500791, G0800509] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, P50MH066392, R01MH080403, R01MH071681, R01MH074027] Funding Source: NIH RePORTER; MRC [G0500791, G0800509, G0801418] Funding Source: UKRI	Stanley Medical Research Institute; Sylvan C. Herman Foundation; Medical Research Council (UK) Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Mental Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stanley Medical Research Institute; Narsad Young Investigator Award(NARSAD); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (Ireland); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Mental Health and the Department of Veterans Affairs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)US Department of Veterans Affairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and families who contributed to these studies. We also thank E. Lander, N. Patterson and members of the Medical and Population Genetics group at the Broad Institute of Harvard and Massachusetts Institute of Technology for valuable discussion, and members of the Broad Biological Samples and Genetic Analysis Platforms for sample management and genotyping. Weparticularly thank D. Levinson and P. Gejman for allowing access to the MGS samples, and J. Shi for analytic support with the MGS samples. The group at the Stanley Center for Psychiatric Research at the Broad Institute was supported by the Stanley Medical Research Institute (E. M. S.), the Sylvan C. Herman Foundation (E. M. S.), and MH071681 (P. S.). The Cardiff University group was supported by a Medical Research Council (UK) Programme grant and the National Institutes of Mental Health (USA) (CONTE: 2 P50 MH066392-05A1). The group at the Karolinska Institutet was supported by the Swedish Council for Working Life and Social Research (FO 184/2000; 2001-2368). The Massachusetts General Hospital group was supported by the Stanley Medical Research Institute (P. S.), MH071681 and MH077139 (P. S.) and a Narsad Young Investigator Award (S. M. P.). The group at the Queensland Institute of Medical Research was supported by the Australian National Health and Medical Research Council (grants 389892, 442915, 496688 and 496674) and thanks S. Gordon for data preparation. The Trinity College Dublin group was supported by Science Foundation Ireland, the Health Research Board (Ireland), the Stanley Medical Research Institute and the Wellcome Trust; Irish controls were supplied by J. McPartlin from the Trinity College Biobank. The work at the University of Aberdeen was partly funded by GlaxoSmithKline and Generation Scotland, Genetics Health Initiative. University College London clinical and control samples were collected with support from the Neuroscience Research Charitable Trust, the Camden and Islington Mental Health and Social Care Trust, East London and City Mental Heath Trust, the West Berkshire NHS Trust, the West London Mental Health Trust, Oxfordshire and Buckinghamshire Mental Health Partnership NHS Trust, South Essex Partnership NHS Foundation Trust, Gloucestershire Partnership NHS Foundation Trust, Mersey Care NHS Trust, Hampshire Partnership NHS Trust and the North East London Mental Health Trust. The collection of the University of Edinburgh cohort was supported by the Wellcome Trust Clinical Research Facility (Edinburgh) and grants from The Wellcome Trust, London and the Chief Scientist Office of the Scottish Government. The group at the University of North Carolina, Chapel Hill, was supported by MH074027, MH077139 and MH080403, the Sylvan C. Herman Foundation (P. F. S.) and the Stanley Medical Research Institute (P. F. S.). The group at the University of Southern California thanks the patients and their families for their collaboration, and acknowledges the support of the National Institutes of Mental Health and the Department of Veterans Affairs.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; FISHER RA, 1918, PHILOS T R SOC EDINB, V399, P433; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; *PSYCH GWAS CONS C, BR J PSYCHI IN PRESS, DOI DOI 10.1192/BJP.BP.108.063156; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	26	3235	3299	10	496	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					748	752		10.1038/nature08185	http://dx.doi.org/10.1038/nature08185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19571811	Green Accepted			2022-12-24	WOS:000268670300041
J	Solon, J; Kaya-Copur, A; Colombelli, J; Brunner, D				Solon, Jerome; Kaya-Copur, Aynur; Colombelli, Julien; Brunner, Damian			Pulsed Forces Timed by a Ratchet-like Mechanism Drive Directed Tissue Movement during Dorsal Closure	CELL			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DROSOPHILA EMBRYOGENESIS; SHAPE OSCILLATIONS; TERMINAL KINASE; DISTINCT ROLES; MORPHOGENESIS; JUN; CELLS; NANOSURGERY; AMNIOSEROSA	Dorsal closure is a tissue-modeling process in the developing Drosophila embryo during which an epidermal opening is closed. It begins with the appearance of a supracellular actin cable that surrounds the opening and provides a contractile force. Amnioserosa cells that fill the opening produce an additional critical force pulling on the surrounding epidermal tissue. We show that this force is not gradual but pulsed and occurs long before dorsal closure starts. Quantitative analysis, combined with laser cutting experiments and simulations, reveals that tension-based dynamics and cell coupling control the force pulses. These constitutively pull the surrounding epidermal tissue dorsally, but the displacement is initially transient. It is translated into dorsal-ward movement only with the help of the actin cable, which acts like a ratchet, counteracting ventral-ward epidermis relaxation after force pulses. Our work uncovers a sophisticated mechanism of cooperative force generation between two major forces driving morphogenesis.	[Solon, Jerome; Kaya-Copur, Aynur; Brunner, Damian] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Colombelli, Julien] Inst Biomed Res, Barcelona 08028, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Brunner, D (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	damian.brunner@embl.de	Solon, Jerome/H-2039-2015; Brunner, Damian/F-2024-2011	Solon, jerome/0000-0001-9967-9794; Kaya Copur, Aynur/0000-0002-3161-9442; Brunner, Damian/0000-0001-5250-492X; Colombelli, Julien/0000-0002-2784-4276	HFSP [RGP11/2005]	HFSP(Human Frontier Science Program)	We thank Ferenc Jankovics, Lars Hufnagel, Francois Nedelec, Darren Gilmour, Philippe Girard, Chaitanya Athale, Sonia Ferreira Furtado, and Nadia Dube for discussion and/or for critical reading of the manuscript. We are grateful to the EMBL ALMF team for providing help with the microscopy. We also like to thank Juan Riesgo-Escovar for fly strains. A. K. was supported by HFSP research grant RGP11/2005 and J.S. by a BioMS postdoctoral grant.	Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Colombelli J, 2005, TRAFFIC, V6, P1093, DOI 10.1111/j.1600-0854.2005.00334.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Marygold SJ, 2003, MECH DEVELOP, V120, P157, DOI 10.1016/S0925-4773(02)00439-2; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Peralta XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015004; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Sluss HK, 1997, J CELL BIOCHEM, V67, P1; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	38	373	376	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1331	1342		10.1016/j.cell.2009.03.050	http://dx.doi.org/10.1016/j.cell.2009.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563762	Bronze			2022-12-24	WOS:000267373400025
J	Shah, SP; Kobel, M; Senz, J; Morin, RD; Clarke, BA; Wiegand, KC; Leung, G; Zayed, A; Mehl, E; Kalloger, SE; Sun, M; Giuliany, R; Yorida, E; Jones, S; Varhol, R; Swenerton, KD; Miller, D; Clement, PB; Crane, C; Madore, J; Provencher, D; Leung, P; DeFazio, A; Khattra, J; Turashvili, G; Zhao, YJ; Zeng, T; Glover, JNM; Vanderhyden, B; Zhao, CQ; Parkinson, CA; Jimenez-Linan, M; Bowtell, DDL; Mes-Masson, AM; Brenton, JD; Aparicio, SA; Boyd, N; Hirst, M; Gilks, CB; Marra, M; Huntsman, DG				Shah, Sohrab P.; Koebel, Martin; Senz, Janine; Morin, Ryan D.; Clarke, Blaise A.; Wiegand, Kimberly C.; Leung, Gillian; Zayed, Abdalnasser; Mehl, Erika; Kalloger, Steve E.; Sun, Mark; Giuliany, Ryan; Yorida, Erika; Jones, Steven; Varhol, Richard; Swenerton, Kenneth D.; Miller, Dianne; Clement, Philip B.; Crane, Colleen; Madore, Jason; Provencher, Diane; Leung, Peter; DeFazio, Anna; Khattra, Jaswinder; Turashvili, Gulisa; Zhao, Yongjun; Zeng, Thomas; Glover, J. N. Mark; Vanderhyden, Barbara; Zhao, Chengquan; Parkinson, Christine A.; Jimenez-Linan, Mercedes; Bowtell, David D. L.; Mes-Masson, Anne-Marie; Brenton, James D.; Aparicio, Samuel A.; Boyd, Niki; Hirst, Martin; Gilks, C. Blake; Marra, Marco; Huntsman, David G.			Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXL2; CORD-STROMAL TUMORS; GENOME; GENE; P53; IDENTIFICATION; EXPRESSION; BREAST	Background Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian sex cord-stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, their histopathological diagnosis can be challenging, and there is no curative treatment beyond surgery. Methods We analyzed four adult-type GCTs using whole-transcriptome paired-end RNA sequencing. We identified putative GCT-specific mutations that were present in at least three of these samples but were absent from the transcriptomes of 11 epithelial ovarian tumors, published human genomes, and databases of single-nucleotide polymorphisms. We confirmed these variants by direct sequencing of complementary DNA and genomic DNA. We then analyzed additional tumors and matched normal genomic DNA, using a combination of direct sequencing, analyses of restriction-fragment-length polymorphisms, and TaqMan assays. Results All four index GCTs had a missense point mutation, 402C -> G (C134W), in FOXL2, a gene encoding a transcription factor known to be critical for granulosa-cell development. The FOXL2 mutation was present in 86 of 89 additional adult-type GCTs (97%), in 3 of 14 thecomas (21%), and in 1 of 10 juvenile-type GCTs (10%). The mutation was absent in 49 SCSTs of other types and in 329 unrelated ovarian or breast tumors. Conclusions Whole-transcriptome sequencing of four GCTs identified a single, recurrent somatic mutation (402C -> G) in FOXL2 that was present in almost all morphologically identified adult-type GCTs. Mutant FOXL2 is a potential driver in the pathogenesis of adult-type GCTs.	[Shah, Sohrab P.; Senz, Janine; Wiegand, Kimberly C.; Leung, Gillian; Zayed, Abdalnasser; Kalloger, Steve E.; Sun, Mark; Giuliany, Ryan; Yorida, Erika; Boyd, Niki; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Koebel, Martin; Mehl, Erika; Clement, Philip B.; Gilks, C. Blake; Huntsman, David G.] British Columbia Canc Agcy, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada; [Morin, Ryan D.; Jones, Steven; Varhol, Richard; Zhao, Yongjun; Zeng, Thomas; Hirst, Martin; Marra, Marco] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Swenerton, Kenneth D.] British Columbia Canc Agcy, Cheryl Brown Ovarian Canc Outcomes Unit, Vancouver, BC V5Z 4E6, Canada; [Miller, Dianne] British Columbia Canc Agcy, Dept Gynecol, Vancouver, BC V5Z 4E6, Canada; [Khattra, Jaswinder; Turashvili, Gulisa; Aparicio, Samuel A.] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 4E6, Canada; [Koebel, Martin; Mehl, Erika; Miller, Dianne; Clement, Philip B.; Gilks, C. Blake; Huntsman, David G.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Koebel, Martin; Mehl, Erika; Clement, Philip B.; Leung, Peter; Gilks, C. Blake; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Clarke, Blaise A.] Univ Toronto, Dept Pathol, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Toronto, ON, Canada; [Crane, Colleen] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Vanderhyden, Barbara] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Madore, Jason; Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [DeFazio, Anna; Bowtell, David D. L.] Univ Sydney, Westmead Hosp, Dept Gynaecol Oncol, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [DeFazio, Anna; Bowtell, David D. L.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Bowtell, David D. L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D. L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Bowtell, David D. L.] Victorian Cerv Cytol Registry, Melbourne, Vic, Australia; [Zhao, Chengquan] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Parkinson, Christine A.; Jimenez-Linan, Mercedes; Brenton, James D.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Funct Genom Ovarian Canc Lab, Cambridge, England	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; University of Ottawa; Universite de Montreal; University of Alberta; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cancer Research UK; CRUK Cambridge Institute	Huntsman, DG (corresponding author), British Columbia Canc Agcy, Ctr Translat & Appl Genom, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	dhuntsma@bccancer.bc.ca	Jones, Steven J/C-3621-2009; Hirst, Martin/B-7684-2016; Köbel, Martin/A-7373-2011; Turashvili, Gulisa/A-6056-2008; DeFazio, Anna/O-2385-2019; Marra, Marco A/B-5987-2008; Hirst, Martin/C-3619-2009; Huntsman, David/ABE-6082-2020; Bowtell, David/H-1007-2016; Morin, Ryan/AAE-7824-2019; Brenton, James D/B-3174-2008; deFazio, Anna/D-3939-2013	Jones, Steven J/0000-0003-3394-2208; DeFazio, Anna/0000-0003-0057-4744; Marra, Marco A/0000-0001-7146-7175; Bowtell, David/0000-0001-9089-7525; Morin, Ryan/0000-0003-2932-7800; Brenton, James D/0000-0002-5738-6683; deFazio, Anna/0000-0003-0057-4744; Kobel, Martin/0000-0002-6615-2037; Clarke, Blaise/0000-0002-2585-8391; Aparicio, Samuel/0000-0002-0487-9599; Madore, Jason/0000-0002-3499-474X; Leung, Peter/0000-0003-3152-3800; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Turashvili, Gulisa/0000-0001-6125-5865	British Columbia Cancer Foundation; Vancouver General Hospital Foundation; Genome Canada; Michael Smith Foundation for Health Research; Eli Lilly Canada; Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology; Sanofi-Aventis; OvCaRe and Ovarian Cancer Canada; Fonds de la Recherche en Sante du Quebec (Montreal); Ovarian Cancer Canada (Ottawa); Australian National Health and Medical Research Council; Cancer Research UK; University of Cambridge, Hutchinson Whampoa; Experimental Cancer Medicine Centre; National Institute for Health Research's Cambridge Biomedical Research Centre; U. S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia	British Columbia Cancer Foundation; Vancouver General Hospital Foundation; Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Eli Lilly Canada(Eli Lilly); Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology(Canadian Institutes of Health Research (CIHR)); Sanofi-Aventis(Sanofi-Aventis); OvCaRe and Ovarian Cancer Canada; Fonds de la Recherche en Sante du Quebec (Montreal)(Fonds de la Recherche en Sante du Quebec); Ovarian Cancer Canada (Ottawa); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); University of Cambridge, Hutchinson Whampoa(University of Cambridge); Experimental Cancer Medicine Centre; National Institute for Health Research's Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); U. S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from the British Columbia Cancer Foundation and the Vancouver General Hospital Foundation (to OvCaRe in British Columbia), Genome Canada (to the Genome Sciences Centre), the Michael Smith Foundation for Health Research (to OvCaRe and the Genome Sciences Centre and to Drs. Shah, Marra, and Huntsman), Eli Lilly Canada (to Dr. Kobel), and the Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology (to Dr. Turashvili); nondirected research funds from Sanofi-Aventis (to the Genetic Pathology Evaluation Centre); and funding for a Canada Research Chair in Molecular Oncology (to Dr. Aparicio). The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (Vancouver General Hospital), Fonds de la Recherche en Sante du Quebec (Montreal), and Ovarian Cancer Canada (Ottawa). The Westmead Gynaecological Oncology Tissue Bank is a member of the Australasian Biospecimens Network-Oncology group, which is funded by the Australian National Health and Medical Research Council; by Cancer Research UK, the University of Cambridge, Hutchinson Whampoa, the Experimental Cancer Medicine Centre, and the National Institute for Health Research's Cambridge Biomedical Research Centre; by a grant (DAMD17-01-1-0729) from the U. S. Army Medical Research and Materiel Command; and by grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to the Australian Ovarian Cancer Study. Dr. Kobel reports receiving grant support from Eli Lilly; and Dr. Huntsman, receiving grant support from Sanofi-Aventis and Novartis and being listed as an inventor on a provisional patent application filed by the British Columbia Cancer Agency on the diagnostic use of the FOXL2 402C -> G mutation and its development as a therapeutic target. No other potential conflict of interest relevant to this article was reported. We thank Ying Ng and Katie Chow for performing the array comparative-genomic-hybridization experiments; Krista Marcon for performing the immunohistochemical analysis and preparing tissue sections for DNA extraction; Samuel Leung for establishing the online image archive; Mona Mazgani and Salvador Saldivar for helping in the acquisition of informed consent and specimens for the gynecologic tumor bank at Vancouver General Hospital; Catherine Kennedy for helping in the acquisition of specimens from the Westmead Gynaecological Oncology Tissue Bank; Julie Irving for helping with accessing specimens for the secondary validation; the members of the Australian Ovarian Cancer Study (AOCS) management group: D. Bowtell, G. Chenevix-Trench, A. Green, P. Webb, A. deFazio, and D. Gertig; the AOCS study nurses and research assistants; and all the patients who participated in the AOCS study.	Beysen D, 2004, HUM MUTAT, V24, P189, DOI 10.1002/humu.20079; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colombo N, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1005; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; Dorward AM, 2005, CANCER RES, V65, P1259, DOI 10.1158/0008-5472.CAN-04-2992; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Fletcher C., 1995, DIAGNOSTIC HISTOPATH; FLETCHER JA, 1991, AM J PATHOL, V138, P515; Fuller PJ, 2004, TRENDS ENDOCRIN MET, V15, P122, DOI 10.1016/j.tem.2004.02.005; KAPPES S, 1995, INT J CANCER, V64, P52, DOI 10.1002/ijc.2910640111; King LA, 1996, GYNECOL ONCOL, V61, P227, DOI 10.1006/gyno.1996.0130; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Ligtenberg MJ, 1999, J CLIN ENDOCR METAB, V84, P2233, DOI 10.1210/jc.84.6.2233; Liu FS, 1996, GYNECOL ONCOL, V61, P50, DOI 10.1006/gyno.1996.0095; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; Zhao CQ, 2009, AM J SURG PATHOL, V33, P354, DOI 10.1097/PAS.0b013e318188373d	31	507	535	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2719	2729		10.1056/NEJMoa0902542	http://dx.doi.org/10.1056/NEJMoa0902542			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19516027	Bronze			2022-12-24	WOS:000267286600006
J	Vitousek, PM; Naylor, R; Crews, T; David, MB; Drinkwater, LE; Holland, E; Johnes, PJ; Katzenberger, J; Martinelli, LA; Matson, PA; Nziguheba, G; Ojima, D; Palm, CA; Robertson, GP; Sanchez, PA; Townsend, AR; Zhang, FS				Vitousek, P. M.; Naylor, R.; Crews, T.; David, M. B.; Drinkwater, L. E.; Holland, E.; Johnes, P. J.; Katzenberger, J.; Martinelli, L. A.; Matson, P. A.; Nziguheba, G.; Ojima, D.; Palm, C. A.; Robertson, G. P.; Sanchez, P. A.; Townsend, A. R.; Zhang, F. S.			Nutrient Imbalances in Agricultural Development	SCIENCE			English	Editorial Material							MAIZE PRODUCTIVITY; NITROGEN-CYCLE; MANAGEMENT; PHOSPHORUS; ROTATIONS; SYSTEMS; TRENDS; INPUT; RIVER; SOIL		[Vitousek, P. M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Naylor, R.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Naylor, R.] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Crews, T.] Prescott Coll, Prescott, AZ USA; [David, M. B.] Univ Illinois, Dept Nat Resource & Environm Sci, Urbana, IL 61801 USA; [Drinkwater, L. E.] Cornell Univ, Dept Hort, Ithaca, NY 14853 USA; [Holland, E.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Johnes, P. J.] Univ Reading, Sch Human & Environm Sci, Aquat Environm Res Ctr, Reading RG6 6AB, Berks, England; [Katzenberger, J.] Aspen Global Change Inst, Aspen, CO 81611 USA; [Martinelli, L. A.] Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13416000 Piracicaba, SP, Brazil; [Matson, P. A.] Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA; [Nziguheba, G.; Palm, C. A.; Sanchez, P. A.] Columbia Univ, Earth Inst, Palisades, NY 10027 USA; [Ojima, D.] Heinz Ctr Sci Econ & Environm, Washington, DC 20009 USA; [Robertson, G. P.] Michigan State Univ, Dept Crop & Soil Sci, Hickory Corners, MI 49060 USA; [Townsend, A. R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Townsend, A. R.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Zhang, F. S.] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	Stanford University; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; National Center Atmospheric Research (NCAR) - USA; University of Reading; Universidade de Sao Paulo; Stanford University; Columbia University; Michigan State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; China Agricultural University	Vitousek, PM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	vitousek@stanford.edu	Ojima, Dennis/C-5272-2016; Townsend, Alan/AAE-9602-2019; Zhang, Fusuo/AAV-4517-2021; Robertson, G Philip/H-3885-2011; Martinelli, Luiz Antonio/F-7870-2011; Johnes, Penny/AAV-8395-2021; Johnes, Penny J/D-1381-2009	Robertson, G Philip/0000-0001-9771-9895; Martinelli, Luiz Antonio/0000-0002-7103-7551; Johnes, Penny/0000-0003-1605-6896; Johnes, Penny J/0000-0003-1605-6896; Crews, Timothy/0000-0003-4764-341X; Holland, Elisabeth Ann/0000-0002-3570-621X; Drinkwater, Laurie/0000-0002-0746-6765; Nziguheba, Generose/0000-0003-4227-2242; zhang, fusuo/0000-0001-8971-0129				Beaudoin N, 2005, AGR ECOSYST ENVIRON, V111, P292, DOI 10.1016/j.agee.2005.06.006; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Billen G, 2007, SCI TOTAL ENVIRON, V375, P80, DOI 10.1016/j.scitotenv.2006.12.005; Bunemann EK, 2004, PLANT SOIL, V264, P195, DOI 10.1023/B:PLSO.0000047749.43017.fd; Cherry KA, 2008, SCI TOTAL ENVIRON, V406, P1, DOI 10.1016/j.scitotenv.2008.07.015; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; Egli DB, 2008, AGRON J, V100, pS79, DOI 10.2134/agronj2006.0286c; Erisman JW, 2008, ATMOS ENVIRON, V42, P3209, DOI 10.1016/j.atmosenv.2007.04.004; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Johnes P. J., 2007, Redesigning animal agriculture: the challenge of the 21st Century, P185, DOI 10.1079/9781845932237.0185; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KLOPFENSTEIN TJ, 2002, 21 COUNC AGR SCI TEC; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; McIsaac GF, 2002, J ENVIRON QUAL, V31, P1610, DOI 10.2134/jeq2002.1610; PALM CA, 1997, SPECIAL PUBL SOIL SC, V5, P193; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; Sheldrick WF, 2002, NUTR CYCL AGROECOSYS, V62, P61, DOI 10.1023/A:1015124930280; Tang X, 2008, FIELD CROP RES, V108, P231, DOI 10.1016/j.fcr.2008.05.007; *US EPA, 2007, EPSAB08003; [李秋梅 Li Qiumei], 2002, [植物营养与肥料学报, Plant nutrition and fertitizer science], V8, P152; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	22	868	963	43	734	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1519	1520		10.1126/science.1170261	http://dx.doi.org/10.1126/science.1170261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541981				2022-12-24	WOS:000267130600026
J	West, JA; Viswanathan, SR; Yabuuchi, A; Cunniff, K; Takeuchi, A; Park, IH; Sero, JE; Zhu, H; Perez-Atayde, A; Frazier, AL; Surani, MA; Daley, GQ				West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Sero, Julia E.; Zhu, Hao; Perez-Atayde, Antonio; Frazier, A. Lindsay; Surani, M. Azim; Daley, George Q.			A role for Lin28 in primordial germ-cell development and germ-cell malignancy	NATURE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; TRANSGENIC MICE; DOWN-REGULATION; MOUSE; MICRORNA; LINEAGE; LET-7; SPECIFICATION; METHYLATION	The rarity and inaccessibility of the earliest primordial germ cells (PGCs) in the mouse embryo thwart efforts to investigate molecular mechanisms of germ-cell specification. stella (also called Dppa3) marks the rare founder population of the germ lineage(1,2). Here we differentiate mouse embryonic stem cells carrying a stella transgenic reporter into putative PGCs in vitro. The Stella(+) cells possess a transcriptional profile similar to embryo-derived PGCs, and like their counterparts in vivo, lose imprints in a time-dependent manner. Using inhibitory RNAs to screen candidate genes for effects on the development of Stella(+) cells in vitro, we discovered that Lin28, a negative regulator of let-7 microRNA processing(3-6), is essential for proper PGC development. Furthermore, we show that Blimp1 (also called Prdm1), a let-7 target and a master regulator of PGCspecification(7-9), can rescue the effect of Lin28 deficiency during PGC development, thereby establishing a mechanism of action for Lin28 during PGC specification. Overexpression of Lin28 promotes formation of Stella(+) cells in vitro and PGCs in chimaeric embryos, and is associated with human germ-cell tumours. The differentiation of putative PGCs from embryonic stem cells in vitro recapitulates the early stages of gamete development in vivo, and provides an accessible system for discovering novel genes involved in germ-cell development and malignancy.	[West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Frazier, A. Lindsay; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Frazier, A. Lindsay; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Daley, George Q.] Harvard Univ, Stem Cell Inst, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sero, Julia E.; Perez-Atayde, Antonio] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Frazier, A. Lindsay] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cambridge; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	West, Jason/I-4445-2014; Zhu, Hao/L-5114-2013; Julia, Sero/J-5476-2016; Viswanathan, Srinivas/ABA-6316-2021	West, Jason/0000-0002-7252-8651; Zhu, Hao/0000-0002-8417-9698; Julia, Sero/0000-0002-0299-9212; Viswanathan, Srinivas/0000-0003-1856-3023; Surani, Azim/0000-0002-8640-4318	NIH; Harvard Stem Cell Institute; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; MRC [G0300723, G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B, G0300723] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. W. Lensch for comments on this manuscript; D. K. Gifford, G. Gerber, C. Reeder and J. Baughman for comments and input regarding microarray analysis; G. Losyev for flow cytometry expertise; and S. Winkler of the British Consulate for providing support for collaboration between the Daley and Surani laboratories. This study was supported by grants from the NIH, the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research, and by support from the germ cell program of the Harvard Stem Cell Institute. G. Q. D. is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P2006, DOI 10.1002/cncr.20566; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	40	284	304	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					909	U151		10.1038/nature08210	http://dx.doi.org/10.1038/nature08210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19578360	Green Accepted			2022-12-24	WOS:000268938300042
J	Wang, J; Alexander, P; Wu, LJ; Hammer, R; Cleaver, O; McKnight, SL				Wang, Jian; Alexander, Peter; Wu, Leeju; Hammer, Robert; Cleaver, Ondine; McKnight, Steven L.			Dependence of Mouse Embryonic Stem Cells on Threonine Catabolism	SCIENCE			English	Article							3-DEHYDROGENASE; BIOSYNTHESIS	Measurements of the abundance of common metabolites in cultured embryonic stem (ES) cells revealed an unusual state with respect to one-carbon metabolism. These findings led to the discovery of copious expression of the gene encoding threonine dehydrogenase (TDH) in ES cells. TDH-mediated catabolism of threonine takes place in mitochondria to generate glycine and acetylcoenzyme A (CoA), with glycine facilitating one-carbon metabolism via the glycine cleavage system and acetyl-CoA feeding the tricarboxylic acid cycle. Culture media individually deprived of each of the 20 amino acids were applied to ES cells, leading to the discovery that ES cells are critically dependent on one amino acid-threonine. These observations show that ES cells exist in a high-flux backbone metabolic state comparable to that of rapidly growing bacterial cells.	[Wang, Jian; Alexander, Peter; Wu, Leeju; Hammer, Robert; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Cleaver, Ondine] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Cleaver, Ondine/0000-0003-2454-6641; Hammer, Robert E./0000-0001-5487-7551	NIH; Anonymous donor; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anonymous donor; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by an NIH Directors Pioneer Award, and unrestricted funds provided to S.L.M. by an anonymous donor	Alberts B., 2015, MOL BIOL CELL, V1; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; DALE RA, 1978, BIOCHIM BIOPHYS ACTA, V544, P496, DOI 10.1016/0304-4165(78)90324-0; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; HARDY K, 1989, DEVELOPMENT, V107, P597; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; PHEAR EA, 1957, J AM CHEM SOC, V79, P3737, DOI 10.1021/ja01571a034; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; WARREN L, 1957, J BIOL CHEM, V229, P613; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318	16	255	266	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					435	439		10.1126/science.1173288	http://dx.doi.org/10.1126/science.1173288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19589965	Green Accepted			2022-12-24	WOS:000268255100046
J	Jiang, QF; Karata, K; Woodgate, R; Cox, MM; Goodman, MF				Jiang, Qingfei; Karata, Kiyonobu; Woodgate, Roger; Cox, Michael M.; Goodman, Myron F.			The active form of DNA polymerase V is UmuD ' C-2-RecA-ATP	NATURE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; RECA PROTEIN; UV-MUTAGENESIS; REPLICATION; DEFICIENT; MUTATIONS; REPAIR; UMUC; PURIFICATION	DNA-damage-induced SOS mutations arise when Escherichia coli DNA polymerase (pol) V, activated by a RecA nucleoprotein filament (RecA*), catalyses translesion DNA synthesis. Here we address two longstanding enigmatic aspects of SOS mutagenesis, the molecular composition of mutagenically active pol V and the role of RecA*. We show that RecA* transfers a single RecA-ATP stoichiometrically from its DNA 39-end to free polV (UmuD'C-2) to form an active mutasome (polV Mut) with the composition UmuD'C-2-RecA-ATP. PolV Mut catalyses TLS in the absence of RecA* and deactivates rapidly upon dissociation from DNA. Deactivation occurs more slowly in the absence of DNA synthesis, while retaining RecA-ATP in the complex. Reactivation of polV Mut is triggered by replacement of RecA-ATP from RecA*. Thus, the principal role of RecA* in SOS mutagenesis is to transfer RecA-ATP to pol V, and thus generate active mutasomal complex for translesion synthesis.	[Jiang, Qingfei; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Jiang, Qingfei; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Karata, Kiyonobu; Woodgate, Roger] NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu	JIANG, QINGFEI/K-3492-2012	JIANG, QINGFEI/0000-0002-9072-8032; Woodgate, Roger/0000-0001-5581-4616	National Institutes of Health [ES12259, R37GM21422, GM32335]; NICHD/NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, R37GM021422, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants to M. F. G. (ES12259; R37GM21422) and M. M. C. (GM32335), and funds from the NICHD/NIH Intramural Research Program to K. K. and R. W. The authors thank R. Britt for preparation of the RecA E38KDC17 protein used in this study. MALS data were collected using the USC NanoBiophysics Core Facility, with the aid and cooperation of N. Chelyapov. Wethank J. Bertram for his help in performing the MALS experiment and analysing the data. We thank J. Petruska for his comments.	Becherel OJ, 2002, DNA REPAIR, V1, P703, DOI 10.1016/S1568-7864(02)00106-4; BRIDGES BA, 1984, MOL GEN GENET, V196, P364, DOI 10.1007/BF00328073; Bruck I, 1996, J BIOL CHEM, V271, P10767, DOI 10.1074/jbc.271.18.10767; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; DUTREIX M, 1992, MOL GEN GENET, V232, P489, DOI 10.1007/BF00266254; ECHOLS H, 1990, MUTAT RES, V236, P301, DOI 10.1016/0921-8777(90)90013-U; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P463; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lenne-Samuel N, 2002, EMBO REP, V3, P45, DOI 10.1093/embo-reports/kvf007; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; SWEASY JB, 1990, J BACTERIOL, V172, P3030, DOI 10.1128/jb.172.6.3030-3036.1990; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	25	109	112	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					359	363		10.1038/nature08178	http://dx.doi.org/10.1038/nature08178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606142	Green Accepted			2022-12-24	WOS:000267979000030
J	Peelen, MV; Fei-Fei, L; Kastner, S				Peelen, Marius V.; Fei-Fei, Li; Kastner, Sabine			Neural mechanisms of rapid natural scene categorization in human visual cortex	NATURE			English	Article							FEATURE-BASED ATTENTION; CHANGE-BLINDNESS; TEMPORAL CORTEX; SEARCH; FMRI	The visual system has an extraordinary capability to extract categorical information from complex natural scenes. For example, subjects are able to rapidly detect the presence of object categories such as animals or vehicles in new scenes that are presented very briefly(1,2). This is even true when subjects do not pay attention to the scenes and simultaneously perform an unrelated attentionally demanding task(3), a stark contrast to the capacity limitations predicted by most theories of visual attention(4,5). Here we show a neural basis for rapid natural scene categorization in the visual cortex, using functional magnetic resonance imaging and an object categorization task in which subjects detected the presence of people or cars in briefly presented natural scenes. The multi-voxel pattern of neural activity in the object-selective cortex evoked by the natural scenes contained information about the presence of the target category, even when the scenes were task-irrelevant and presented outside the focus of spatial attention. These findings indicate that the rapid detection of categorical information in natural scenes is mediated by a category-specific biasing mechanism in object-selective cortex that operates in parallel across the visual field, and biases information processing in favour of objects belonging to the target object category.	[Peelen, Marius V.; Fei-Fei, Li; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Peelen, Marius V.; Kastner, Sabine] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA; [Peelen, Marius V.; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Fei-Fei, Li] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University; Princeton University	Peelen, MV (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA.	mpeelen@princeton.edu	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Kastner, Sabine/0000-0002-9742-965X	National Institutes of Health [2RO1 MH64043, 1RO1 EY017699, 2P50 MH-62196]; Microsoft Research New Faculty Fellowship; NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH064043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research New Faculty Fellowship(Microsoft); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Downing, U. Hasson, S. McMains, K. Norman, T. Stein and A. Treisman for suggestions on earlier versions of the manuscript, members of the Kastner laboratory for help with retinotopic mapping, and N. Oosterhof for help with data analysis. This work was supported by grants from the National Institutes of Health (2RO1 MH64043, 1RO1 EY017699, 2P50 MH-62196) to S. K., and a Microsoft Research New Faculty Fellowship and the F. Moss gift to L. F.- F.	Broadbent D.E., 1958, PERCEPTION COMMUNICA; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; FEIFEI L, 2005, VIS COGN, V12, P893, DOI DOI 10.1080/13506280444000571; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MOTTER BC, 1994, J NEUROSCI, V14, P2178; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WALTHER DB, J NEUROSCI IN PRESS; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	25	204	210	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	2009	460	7251					94	U105		10.1038/nature08103	http://dx.doi.org/10.1038/nature08103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19506558	Green Accepted			2022-12-24	WOS:000267545200036
J	Mravec, J; Skupa, P; Bailly, A; Hoyerova, K; Krecek, P; Bielach, A; Petrasek, J; Zhang, J; Gaykova, V; Stierhof, YD; Dobrev, PI; Schwarzerova, K; Rolcik, J; Seifertova, D; Luschnig, C; Benkova, E; Zazimalova, E; Geisler, M; Friml, J				Mravec, Jozef; Skupa, Petr; Bailly, Aurelien; Hoyerova, Klara; Krecek, Pavel; Bielach, Agnieszka; Petrasek, Jan; Zhang, Jing; Gaykova, Vassilena; Stierhof, York-Dieter; Dobrev, Petre I.; Schwarzerova, Katerina; Rolcik, Jakub; Seifertova, Daniela; Luschnig, Christian; Benkova, Eva; Zazimalova, Eva; Geisler, Markus; Friml, Jiri			Subcellular homeostasis of phytohormone auxin is mediated by the ER-localized PIN5 transporter	NATURE			English	Article							BOX PROTEIN TIR1; PLASMA-MEMBRANE; TWISTED DWARF1; ARABIDOPSIS; GRADIENTS; LAND; FLOW	The plant signalling molecule auxin provides positional information in a variety of developmental processes by means of its differential distribution (gradients) within plant tissues(1). Thus, cellular auxin levels often determine the developmental output of auxin signalling. Conceptually, transmembrane transport and metabolic processes regulate the steady-state levels of auxin in any given cell(2,3). In particular, PIN auxin-efflux-carrier-mediated, directional transport between cells is crucial for generating auxin gradients(2,4,5). Here we show that Arabidopsis thaliana PIN5, an atypical member of the PIN gene family, encodes a functional auxin transporter that is required for auxin-mediated development. PIN5 does not have a direct role in cell-to-cell transport but regulates intracellular auxin homeostasis and metabolism. PIN5 localizes, unlike other characterized plasma membrane PIN proteins, to endoplasmic reticulum ( ER), presumably mediating auxin flow from the cytosol to the lumen of the ER. The ER localization of other PIN5-like transporters ( including the moss PIN) indicates that the diversification of PIN protein functions in mediating auxin homeostasis at the ER, and cell-to-cell auxin transport at the plasma membrane, represent an ancient event during the evolution of land plants.	[Mravec, Jozef; Bielach, Agnieszka; Zhang, Jing; Benkova, Eva; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Mravec, Jozef; Bielach, Agnieszka; Zhang, Jing; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Mravec, Jozef; Zhang, Jing; Gaykova, Vassilena; Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Skupa, Petr; Hoyerova, Klara; Krecek, Pavel; Petrasek, Jan; Dobrev, Petre I.; Seifertova, Daniela; Zazimalova, Eva] ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; [Bailly, Aurelien; Geisler, Markus] Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Petrasek, Jan; Schwarzerova, Katerina] Charles Univ Prague, Fac Sci, Dept Plant Physiol, CR-12844 Prague 2, Czech Republic; [Rolcik, Jakub] ASCR, Inst Expt Bot, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Rolcik, Jakub] Palacky Univ, Fac Sci, Olomouc 78371, Czech Republic; [Luschnig, Christian] Univ Nat Resources & Appl Life Sci BOKU, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Friml, Jiri] Masaryk Univ, Fac Sci, Dept Funct Genom & Prote, Brno 62500, Czech Republic	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Eberhard Karls University of Tubingen; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Zurich; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; University of Natural Resources & Life Sciences, Vienna; Masaryk University Brno	Friml, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Petrasek, Jan/C-8240-2009; Hoyerová, Klára/F-6800-2014; Benkova, Eva/E-2910-2012; Petrasek, Jan/AAW-1081-2021; Eva, Zazimalova/G-7432-2014; Schwarzerova, Katerina/D-3989-2009; Hoyerova, Klara/AAF-5519-2020; Geisler, Markus M/B-3921-2012; Dobrev, Petre I./H-2391-2014; Friml, Jiri/D-9511-2012; Skupa, Petr/H-2176-2014; Mravec, Jozef/J-7370-2016	Petrasek, Jan/0000-0002-6719-2735; Hoyerová, Klára/0000-0002-6335-6683; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Schwarzerova, Katerina/0000-0001-5269-9499; Hoyerova, Klara/0000-0002-6335-6683; Geisler, Markus M/0000-0002-6641-5810; Friml, Jiri/0000-0002-8302-7596; Mravec, Jozef/0000-0003-0331-3304; Luschnig, Christian/0000-0003-2099-9280; Skupa, Petr/0000-0001-9878-0639	Volkswagenstiftung; Odysseus programme of the FWO [IAA601630703, KJB600380604]; Ministry of Education, Youth and Sports of the Czech Republic [LC06034, MSM6198959216]; European Research Council starting independent research grant; Novartis Foundation; Swiss National Funds; Forschungskredit of the University of Zurich; Austrian Science Fund	Volkswagenstiftung(Volkswagen); Odysseus programme of the FWO(FWO); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Research Council starting independent research grant(European Research Council (ERC)); Novartis Foundation(Novartis); Swiss National Funds(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; Austrian Science Fund(Austrian Science Fund (FWF))	We thank D. G. Robinson, J. Clarke and NASC for providing material; B. Scheres and H. Hofte for sharing unpublished data, E. Bellinvia, M. Parezova,B. Pesek and V. Vincenzetti for technical help and M. De Cock for critical reading and help with preparing the manuscript. This work was supported by the Volkswagenstiftung ( J. F., J. M., V. G.), the Odysseus programme of the FWO ( J. M., J. Z.), GA ASCR IAA601630703 ( J. F.) and KJB600380604 ( J. P., K. S.), the Ministry of Education, Youth and Sports of the Czech Republic, project number LC06034 ( E. Z., P. S., P. K., K. H., J. P., D. S.) and MSM6198959216 ( J. R.), a European Research Council starting independent research grant to E. B. ( A. Bi.), the Novartis Foundation ( M. G.), the Swiss National Funds ( M. G.), the Forschungskredit of the University of Zurich ( A. Ba.) and the Austrian Science Fund ( C. L).	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brewer PB, 2006, NAT PROTOC, V1, P1462, DOI 10.1038/nprot.2006.226; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Maeshima M, 2008, PFLUG ARCH EUR J PHY, V456, P709, DOI 10.1007/s00424-007-0363-7; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	46	375	408	6	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1136	U127		10.1038/nature08066	http://dx.doi.org/10.1038/nature08066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19506555				2022-12-24	WOS:000267636700045
J	Hsieh, TF; Ibarra, CA; Silva, P; Zemach, A; Eshed-Williams, L; Fischer, RL; Zilberman, D				Hsieh, Tzung-Fu; Ibarra, Christian A.; Silva, Pedro; Zemach, Assaf; Eshed-Williams, Leor; Fischer, Robert L.; Zilberman, Daniel			Genome-Wide Demethylation of Arabidopsis Endosperm	SCIENCE			English	Article							DNA METHYLATION; GENE; DEMETER; DOMAIN; PLANTS; CELLS; MAPS	Parent-of-origin-specific (imprinted) gene expression is regulated in Arabidopsis thaliana endosperm by cytosine demethylation of the maternal genome mediated by the DNA glycosylase DEMETER, but the extent of the methylation changes is not known. Here, we show that virtually the entire endosperm genome is demethylated, coupled with extensive local non-CG hypermethylation of small interfering RNA-targeted sequences. Mutation of DEMETER partially restores endosperm CG methylation to levels found in other tissues, indicating that CG demethylation is specific to maternal sequences. Endosperm demethylation is accompanied by CHH hypermethylation of embryo transposable elements. Our findings demonstrate extensive reconfiguration of the endosperm methylation landscape that likely reinforces transposon silencing in the embryo.	[Hsieh, Tzung-Fu; Ibarra, Christian A.; Silva, Pedro; Zemach, Assaf; Eshed-Williams, Leor; Fischer, Robert L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu; daniel.zilberman@nature.berkeley.edu	Silva, Pedro/H-9497-2012	Silva, Pedro/0000-0002-9889-3075; Eshed Williams, Leor/0000-0002-2766-2608; Zilberman, Daniel/0000-0002-0123-8649; Zemach, Assaf/0000-0003-3282-4445; Hsieh, Tzung-Fu/0000-0001-7584-3721	NIH [GM69415]; fellow of the Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); fellow of the Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Tonkin for performing Illumina sequencing, J. Shin for gene annotation, and S. Henikoff for sharing unpublished data. This work was partially funded by an NIH grant (GM69415) to R.L.F. A.Z. is a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. Sequencing data are deposited in GEO with accession number GSE15922 [NCBI GEO] .	Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Han YZ, 2000, PLANTA, V211, P158, DOI 10.1007/s004250000289; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Munshi Anjana, 2007, Journal of Genetics and Genomics, V34, P93, DOI 10.1016/S1673-8527(07)60010-1; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929	17	474	499	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1451	1454		10.1126/science.1172417	http://dx.doi.org/10.1126/science.1172417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520962	Green Accepted			2022-12-24	WOS:000266878700048
J	Luo, J; Emanuele, MJ; Li, DN; Creighton, CJ; Schlabach, MR; Westbrook, TF; Wong, KK; Elledge, SJ				Luo, Ji; Emanuele, Michael J.; Li, Danan; Creighton, Chad J.; Schlabach, Michael R.; Westbrook, Thomas F.; Wong, Kwok-Kin; Elledge, Stephen J.			A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; SMALL-MOLECULE INHIBITOR; XENOPUS-LAEVIS EGGS; HUMAN CANCER-CELLS; POLO-LIKE KINASE-1; K-RAS; LUNG ADENOCARCINOMA; ACTIVATING MUTATIONS; MITOTIC ENTRY; N-RAS	Oncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understanding of the vulnerabilities of these cancers is lacking. We undertook a genome-wide RNAi screen to identify synthetic lethal interactions with the KRAS oncogene. We discovered a diverse set of proteins whose depletion selectively impaired the viability of Ras mutant cells. Among these we observed a strong enrichment for genes with mitotic functions. We describe a pathway involving the mitotic kinase PLK1, the anaphase-promoting complex/cyclosome, and the proteasome that, when inhibited, results in prometaphase accumulation and the subsequent death of Ras mutant cells. Gene expression analysis indicates that reduced expression of genes in this pathway correlates with increased survival of patients bearing tumors with a Ras transcriptional signature. Our results suggest a previously underappreciated role for Ras in mitotic progression and demonstrate a pharmacologically tractable pathway for the potential treatment of cancers harboring Ras mutations.	[Luo, Ji; Emanuele, Michael J.; Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Howard Hughes Med Inst, Boston, MA 02115 USA; [Luo, Ji; Emanuele, Michael J.; Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Genet, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA 02115 USA; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Dan L Duncan Canc Ctr, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Howard Hughes Med Inst, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		wong, kwok kin/0000-0001-6323-235X	AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research; Damon Runyon Cancer Research Foundation [DRG-1996-08]; NIH [R01 CA122794, R01 AG2400401, P30 CA125123]; DF/HCC Lung Cancer SPORE grant [P50 CA090578]; Susan G. Komen for the Cure Foundation [KG090355]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA122794, ZIABC011304, P30CA125123, P50CA090578] Funding Source: NIH RePORTER	AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DF/HCC Lung Cancer SPORE grant; Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Bert Vogelstein and Victor Velculescu for the DLD-1 and HCT116 cells and Dr. Nathanael Gray and SAI Advantium for help with the synthesis of BI-2536. We thank Matthew Buttarazzi, Nicholas Kwiatkowski, Dror Berel, and Dr. Chandra Miduturu for technical assistance and Drs. Greg Hannon, Nicole Solimini, Tim Mitchison, and Randal King for helpful discussions. J. L. is supported by the AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research. M. J. E. is the Philip O'Bryan Montgomery Jr., MD fellow of the Damon Runyon Cancer Research Foundation (DRG-1996-08). K.-K. W. is supported by NIH grants R01 CA122794 and R01 AG2400401 and the DF/HCC Lung Cancer SPORE grant P50 CA090578. C. J. C. and T. F. W. are supported in part by NIH grant P30 CA125123. T. F. W. is supported by the Susan G. Komen for the Cure Foundation ( KG090355). This work is supported by grants from NIH and DOD to S. J. E., and S. J. E. is an investigator with the Howard Hughes Medical Institute.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bezieau S, 2001, HUM MUTAT, V18, P212, DOI 10.1002/humu.1177; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Li J, 2005, MOL CELL BIOL, V25, P767, DOI 10.1128/MCB.25.2.767-778.2005; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Liu PC, 1996, BLOOD, V88, P2699, DOI 10.1182/blood.V88.7.2699.bloodjournal8872699; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ogata A, 1997, J IMMUNOL, V159, P2212; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rowley M, 2002, ONCOGENE, V21, P8769, DOI 10.1038/sj.onc.1205387; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Whitehurst AW, 2008, MOL CELL BIOL, V28, P3190, DOI 10.1128/MCB.02291-07; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	50	755	776	3	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					835	848		10.1016/j.cell.2009.05.006	http://dx.doi.org/10.1016/j.cell.2009.05.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490893	Green Accepted, Bronze			2022-12-24	WOS:000266454800015
J	Hammoud, SS; Nix, DA; Zhang, HY; Purwar, J; Carrell, DT; Cairns, BR				Hammoud, Saher Sue; Nix, David A.; Zhang, Haiying; Purwar, Jahnvi; Carrell, Douglas T.; Cairns, Bradley R.			Distinctive chromatin in human sperm packages genes for embryo development	NATURE			English	Article							STEM-CELLS; DNA METHYLATION; HISTONE H3; POLYCOMB TARGETS; GENOME; ORGANIZATION; FIBROBLASTS; EXPRESSION; DROSOPHILA; COMPLEX	Because nucleosomes are widely replaced by protamine in mature human sperm, the epigenetic contributions of sperm chromatin to embryo development have been considered highly limited. Here we show that the retained nucleosomes are significantly enriched at loci of developmental importance, including imprinted gene clusters, microRNA clusters, HOX gene clusters, and the promoters of stand-alone developmental transcription and signalling factors. Notably, histone modifications localize to particular developmental loci. Dimethylated lysine 4 on histone H3 (H3K4me2) is enriched at certain developmental promoters, whereas large blocks of H3K4me3 localize to a subset of developmental promoters, regions in HOX clusters, certain noncoding RNAs, and generally to paternally expressed imprinted loci, but not paternally repressed loci. Notably, trimethylated H3K27 (H3K27me3) is significantly enriched at developmental promoters that are repressed in early embryos, including many bivalent (H3K4me3/H3K27me3) promoters in embryonic stem cells. Furthermore, developmental promoters are generally DNA hypomethylated in sperm, but acquire methylation during differentiation. Taken together, epigenetic marking in sperm is extensive, and correlated with developmental regulators.	[Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Surg, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Obstet & Gynecol, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Physiol, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Zhang, Haiying; Purwar, Jahnvi; Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Nix, David A.] Univ Utah, Sch Med, Huntsman Canc Inst, Res Informat & Bioinformat Core Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Carrell, DT (corresponding author), Univ Utah, Sch Med, IVF & Androl Labs, Dept Surg, Salt Lake City, UT 84112 USA.	douglas.carrell@hsc.utah.edu; brad.cairns@hci.utah.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA016056, CA16056, CA24014] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Dudoit S, 2008, BIOMETRICAL J, V50, P716, DOI 10.1002/bimj.200710473; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li SSL, 2006, BIOCHEM BIOPH RES CO, V340, P48, DOI 10.1016/j.bbrc.2005.11.149; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917	39	909	941	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					473	U47		10.1038/nature08162	http://dx.doi.org/10.1038/nature08162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19525931	Green Accepted			2022-12-24	WOS:000268257000030
J	Angell, SY; Silver, LD; Goldstein, GP; Johnson, CM; Deitcher, DR; Frieden, TR; Bassett, MT				Angell, Sonia Y.; Silver, Lynn Dee; Goldstein, Gail P.; Johnson, Christine M.; Deitcher, Deborah R.; Frieden, Thomas R.; Bassett, Mary T.			Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction	ANNALS OF INTERNAL MEDICINE			English	Article							ACID CONTENT; US ADULTS; TRENDS; GUIDELINES; DISEASE; FOOD	Decades after key modifiable risk factors were identified, cardiovascular disease remains the leading cause of preventable death, and only one quarter of persons with high cholesterol levels have attained recommended levels of control. Cholesterol control efforts have focused on consumer education and medical treatment. A powerful, complementary approach is to change the makeup of food, a route the New York City Department of Health and Mental Hygiene took when it restricted artificial trans fat-a contributor to coronary heart disease-in restaurants. The Department first undertook a voluntary campaign, but this effort did not decrease the proportion of restaurants that used artificial trans fat. In December 2006, the Board of Health required that artificial trans fat be phased out of restaurant food. To support implementation, the Department provided technical assistance to restaurants. By November 2008, the restriction was in full effect in all New York City restaurants and estimated restaurant use of artificial trans fat for frying, baking, or cooking or in spreads had decreased from 50% to less than 2%. Preliminary analyses suggest that replacement of artificial trans fat has resulted in products with more healthful fatty acid profiles. For example, in major restaurant chains, total saturated fat plus trans fat in French fries decreased by more than 50%. At 2 years, dozens of national chains had removed artificial trans fat, and 13 jurisdictions, including California, had adopted similar laws. Public health efforts that change food content to make default choices healthier enable consumers to more successfully meet dietary recommendations and reduce their cardiovascular risk.	[Angell, Sonia Y.; Silver, Lynn Dee; Goldstein, Gail P.; Johnson, Christine M.; Deitcher, Deborah R.; Frieden, Thomas R.; Bassett, Mary T.] New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Silver, LD (corresponding author), New York City Hlth Dept, 2 Lafayette St,20th Floor,CN-46, New York, NY 10007 USA.	lsilver@health.nyc.gov		Silver, Lynn/0000-0002-2680-7393; Frieden, Thomas/0000-0002-4759-2256	American Heart Association	American Heart Association(American Heart Association)	By the City of New York. The American Heart Association provided an educational grant to support the Trans Fat Help Center.	Albers MJ, 2008, J AM DIET ASSOC, V108, P367, DOI 10.1016/j.jada.2007.10.045; ALLEN RR, 1996, BAILEYS IND OIL FAT, P213; *AM MED ASS HOUS D, 2006, RED T FAT CONT AM DI; [Anonymous], 2003, DIET NUTR PREV CHRON; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Beran MS, 2008, AM J LIFESTYLE MED, V2, P75, DOI 10.1177/1559827607308805; Brunner EJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub3; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; CARUSO DB, 2008, NYC KEEPS CANNOLI DR; Chrysam M. M., 1996, BAILEYS IND OIL FAT, P65; *CTR CONS FREED, 2007, WHOS WORST NANN 2007; DORFMAN B, 2008, MCDONALDS COOKING OI; Dzisiak D, 2006, AM HEART ASS T FAT C; GARDINER J, 2005, NEW YORK SUN    0811; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; HOFFMAN B, 2005, NEW YORK POST   0811, P2; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Marantz PR, 2008, AM J PREV MED, V34, P234, DOI 10.1016/j.amepre.2007.11.017; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; *NY CIT DEP HLTH M, 2008, NOT AD REP REEN ART; *NY CIT TRANS FAT, 2009, 0 GRAMS T FAT PROD L; Ratnayake WMN, 2009, EUR J CLIN NUTR, V63, P808, DOI 10.1038/ejcn.2008.39; SANTORA M, 2005, NY TIMES        0811, V1; STARK D, 2006, AM HEART ASS T FAT C; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Tarrago-Trani MT, 2006, J AM DIET ASSOC, V106, P867, DOI 10.1016/j.jada.2006.03.010; US Departement Of Health and Human Services, 2005, HYPERCHOLESTEROLEMIA, P1; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; *US FDA, 2006, HIST GRAS LIST SCOGS; Willett W, 2001, EAT DRINK BE HLTH HA; 2006, NEW YORK POST   0928, P26; 2003, FED REG         0711, P41434; 2003, FDA CONSUM, V37, P20	38	79	81	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					129	W33		10.7326/0003-4819-151-2-200907210-00010	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620165				2022-12-24	WOS:000268605300007
J	Galloway, JL; Delgado, I; Ros, MA; Tabin, CJ				Galloway, Jenna L.; Delgado, Irene; Ros, Maria A.; Tabin, Clifford J.			A reevaluation of X-irradiation-induced phocomelia and proximodistal limb patterning	NATURE			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; CHICK LIMB; NITROGEN-MUSTARD; SONIC-HEDGEHOG; FEEDBACK LOOP; THALIDOMIDE; BUD; EXPRESSION; OUTGROWTH	Phocomelia is a devastating, rare congenital limb malformation in which the long bones are shorter than normal, with the upper portion of the limb being most severely affected. In extreme cases, the hands or fingers are attached directly to the shoulder and the most proximal elements (those closest to the shoulder) are entirely missing. This disorder, previously known in both autosomal recessive and sporadic forms, showed a marked increase in incidence in the early 1960s due to the tragic toxicological effects of the drug thalidomide, which had been prescribed as a mild sedative(1,2). This human birth defect is mimicked in developing chick limb buds exposed to X-irradiation(3-5). Both X-irradiation(5) and thalidomide-induced phocomelia(5,6) have been interpreted as patterning defects in the context of the progress zone model, which states that a cell's proximodistal identity is determined by the length of time spent in a distal limb region termed the 'progress zone'(7). Indeed, studies of X-irradiation-induced phocomelia have served as one of the two major experimental lines of evidence supporting the validity of the progress zone model. Here, using a combination of molecular analysis and lineage tracing in chick, we show that X-irradiation-induced phocomelia is fundamentally not a patterning defect, but rather results from a time-dependent loss of skeletal progenitors. Because skeletal condensation proceeds from the shoulder to fingers (in a proximal to distal direction), the proximal elements are differentially affected in limb buds exposed to radiation at early stages. This conclusion changes the framework for considering the effect of thalidomide and other forms of phocomelia, suggesting the possibility that the aetiology lies not in a defect in the patterning process, but rather in progenitor cell survival and differentiation. Moreover, molecular evidence that proximodistal patterning is unaffected after X-irradiation does not support the predictions of the progress zone model.	[Galloway, Jenna L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Delgado, Irene] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain; [Ros, Maria A.] CSIC UC IDICAN, Inst Biomed & Biotecnol Cantabria, Santander 39005, Spain	Harvard University; Harvard Medical School; Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@receptor.med.harvard.edu	Ros, Maria A./K-8160-2014; Delgado, Irene/L-9424-2014	Ros, Maria A./0000-0002-1224-7671; Delgado, Irene/0000-0002-0493-8261	NIH [R37 HD032443]; National Institute of Child Health and Human Development [F32HD057701]; Spanish Ministry of Science and Innovation [BFU2008-00397]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD057701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank J. G. Arozamena and D. Connor for help with the irradiation machine and members of the Tabin-Cepko and Ros laboratories for discussions and ideas. Work in the laboratory of C. J. T. is supported by a grant, R37 HD032443, from the NIH. J. L. G. is supported by grant F32HD057701 from the National Institute of Child Health and Human Development. I. D. and M. A. R. are supported by BFU2008-00397 from the Spanish Ministry of Science and Innovation.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; BIGGERS JD, 1964, NATURE, V202, P152, DOI 10.1038/202152a0; Choudhury A, 2006, SEMIN RADIAT ONCOL, V16, P51, DOI 10.1016/j.semradonc.2005.08.007; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; GOFF RA, 1962, J EXP ZOOL, V151, P177, DOI 10.1002/jez.1401510208; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LENZ W, 1962, LANCET, V1, P45; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mercader N, 2000, DEVELOPMENT, V127, P3961; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; PINOT M, 1970, Annales d'Embryologie et de Morphogenese, V3, P215; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; SALZGEBER B, 1975, DEV GROWTH DIFFER, V17, P295; SALZGEBER B, 1969, J EMBRYOL EXP MORPH, V22, P373; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; TOMS D, 1962, LANCET, V280, P400; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175	30	45	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					400	U119		10.1038/nature08117	http://dx.doi.org/10.1038/nature08117			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553938	Green Submitted, Green Accepted			2022-12-24	WOS:000267979000040
J	Thomas, JA; Simcox, DJ; Clarke, RT				Thomas, J. A.; Simcox, D. J.; Clarke, R. T.			Successful Conservation of a Threatened Maculinea Butterfly	SCIENCE			English	Article							SOCIAL PARASITE; NICHE SELECTION; ANT NESTS; HOST; CRISIS; ARION	Globally threatened butterflies have prompted research-based approaches to insect conservation. Here, we describe the reversal of the decline of Maculinea arion (Large Blue), a charismatic specialist whose larvae parasitize Myrmica ant societies. M. arion larvae were more specialized than had previously been recognized, being adapted to a single host-ant species that inhabits a narrow niche in grassland. Inconspicuous changes in grazing and vegetation structure caused host ants to be replaced by similar but unsuitable congeners, explaining the extinction of European Maculinea populations. Once this problem was identified, UK ecosystems were perturbed appropriately, validating models predicting the recovery and subsequent dynamics of the butterfly and ants at 78 sites. The successful identification and reversal of the problem provide a paradigm for other insect conservation projects.	[Thomas, J. A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Thomas, J. A.; Simcox, D. J.; Clarke, R. T.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Clarke, R. T.] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	University of Oxford; UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University	Thomas, JA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	jeremy.thomas@zoo.ox.ac.uk	Clarke, Ralph T/B-3859-2009; Thomas, Jeremy/A-9619-2013		European Union Macman and Biodiversa (CLIMIT) programs; Natural England; Centre for Ecology and Hydrology; National Trust; Somerset Wildlife Trust; Network Rail; J and F Clark Trust; Butterfly Conservation; Gloucester Wildlife Trust; Millfield School; Defra; World Wildlife Fund; Holland and Barrett; Hydrex; ICI; Natural Environment Research Council [CEH010021] Funding Source: researchfish	European Union Macman and Biodiversa (CLIMIT) programs; Natural England; Centre for Ecology and Hydrology; National Trust; Somerset Wildlife Trust; Network Rail; J and F Clark Trust; Butterfly Conservation; Gloucester Wildlife Trust; Millfield School; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); World Wildlife Fund; Holland and Barrett; Hydrex; ICI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding, experimental sites and other resources were generously provided by the European Union Macman and Biodiversa (CLIMIT) programs, Natural England, Centre for Ecology and Hydrology, the National Trust, the Somerset Wildlife Trust, Network Rail, J and F Clark Trust, Butterfly Conservation, Gloucester Wildlife Trust, Millfield School, Defra, the World Wildlife Fund, Sir Terence Conran, Holland and Barrett, Hydrex, ICI, and R. Mattoni.	CLARKE RT, 2005, STUDIES ECOLOGY CONS, V2, P115; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; Dempster J.P., 1991, CONSERVATION INSECTS, P143; Ehrlich PR, 2004, WINGS CHECKERSPOTS M; Elmes GW, 1998, J INSECT CONSERV, V2, P67, DOI 10.1023/A:1009696823965; ELMES GW, 1992, BIODIVERS CONSERV, V1, P155, DOI 10.1007/BF00695913; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; ERHARDT A, 1985, J APPL ECOL, V22, P849, DOI 10.2307/2403234; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Mouquet N, 2005, ECOL MONOGR, V75, P525, DOI 10.1890/05-0319; NEW TR, 1995, ANNU REV ENTOMOL, V40, P57, DOI 10.1146/annurev.en.40.010195.000421; Schonrogge K, 2006, ECOL LETT, V9, P1032, DOI 10.1111/j.1461-0248.2006.00957.x; SPOONER G. M., 1963, ENTOMOLOGIST, V96, P199; Stewart A.J., 2007, INSECT CONSERVATION; Thomas J., 1980, Oryx, V15, P243; THOMAS J A, 1991, P149; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P471, DOI 10.1098/rspb.2000.1398; THOMAS JA, 1992, OECOLOGIA, V91, P101, DOI 10.1007/BF00317247; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 2004, SCIENCE, V305, P1563; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; Thomas JA, 2002, OECOLOGIA, V132, P531, DOI 10.1007/s00442-002-1002-9; WARREN MJ, COMMUNICATION; Wells S.M., 1983, IUCN INVERTEBRATE RE, P97	26	185	189	3	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					80	83		10.1126/science.1175726	http://dx.doi.org/10.1126/science.1175726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19541953				2022-12-24	WOS:000267594000039
J	He, SD; Wang, L; Miao, L; Wang, T; Du, FH; Zhao, LP; Wang, XD				He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong			Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-alpha	CELL			English	Article							TUMOR-NECROSIS-FACTOR; CYTOCHROME-C; DEATH; RIP; IDENTIFICATION; ACTIVATION; APOPTOSIS; CASPASES; INDUCE; INHIBITION	Smac mimetics induce apoptosis synergistically with TNF-alpha by triggering the formation of a caspase-8-activating complex containing receptor interacting protein kinase-1 (RIPK1). Caspase inhibitors block this form of apoptosis in many types of cells. However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis. A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis. The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction. The kinase activity of RIP3 is essential for necrosis execution. Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex. Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model. These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-alpha family of death-inducing cytokines.	[Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA; [He, Sudan] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [He, Sudan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [He, Sudan; Miao, Lin; Wang, Tao; Zhao, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institute of Biological Sciences, Beijing	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		He, Sudan/0000-0002-0846-1210; Wang, Xiaodong/0000-0001-9885-356X	National Cancer Institute (NCI) [PO1 CA 95471]; Chinese Ministry of Science and Technology [2008AA022318]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express our gratitude to the High-throughput Screening Facility at the University of Texas Southwestern Medical Center for help with siRNA screening. We also thank Yinan Gong, Hui Li, and Cai Zhang for technical assistance and Greg Kunkel for help with setting up siRNA screening and he and Sean Petersen for critical reading of the manuscript. This work is also supported by a grant from the National Cancer Institute (NCI) (PO1 CA 95471) and the National High Technology Projects 863 (2008AA022318) from Chinese Ministry of Science and Technology.	Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; LASTER SM, 1988, J IMMUNOL, V141, P2629; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	35	1542	1631	7	208	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1100	1111		10.1016/j.cell.2009.05.021	http://dx.doi.org/10.1016/j.cell.2009.05.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524512	Bronze			2022-12-24	WOS:000266916400021
J	Dang, WW; Steffen, KK; Perry, R; Dorsey, JA; Johnson, FB; Shilatifard, A; Kaeberlein, M; Kennedy, BK; Berger, SL				Dang, Weiwei; Steffen, Kristan K.; Perry, Rocco; Dorsey, Jean A.; Johnson, F. Brad; Shilatifard, Ali; Kaeberlein, Matt; Kennedy, Brian K.; Berger, Shelley L.			Histone H4 lysine 16 acetylation regulates cellular lifespan	NATURE			English	Article							BLOCK PROTEIN FOB1; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; GENOMIC INSTABILITY; MOTHER CELLS; YEAST; SIR2; REPLICATION; CHROMATIN; SIRTUINS	Cells undergoing developmental processes are characterized by persistent non-genetic alterations in chromatin, termed epigenetic changes, represented by distinct patterns of DNA methylation and histone post-translational modifications. Sirtuins, a group of conserved NAD(+)-dependent deacetylases or ADP-ribosyltransferases, promote longevity in diverse organisms; however, their molecular mechanisms in ageing regulation remain poorly understood. Yeast Sir2, the first member of the family to be found, establishes and maintains chromatin silencing by removing histone H4 lysine 16 acetylation and bringing in other silencing proteins. Here we report an age-associated decrease in Sir2 protein abundance accompanied by an increase in H4 lysine 16 acetylation and loss of histones at specific subtelomeric regions in replicatively old yeast cells, which results in compromised transcriptional silencing at these loci. Antagonizing activities of Sir2 and Sas2, a histone acetyltransferase, regulate the replicative lifespan through histone H4 lysine 16 at subtelomeric regions. This pathway, distinct from existing ageing models for yeast, may represent an evolutionarily conserved function of sirtuins in regulation of replicative ageing by maintenance of intact telomeric chromatin.	[Dang, Weiwei; Perry, Rocco; Dorsey, Jean A.; Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Steffen, Kristan K.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Cell & Mol Biol Grp,Biomed Grad Studies, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; [Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Berger, Shelley L.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	The Wistar Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Stowers Institute for Medical Research; University of Pennsylvania	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	sberger@mail.med.upenn.edu		Berger, Shelley/0000-0001-5398-4400; Kaeberlein, Matt/0000-0002-1311-3421; Dang, Weiwei/0000-0002-6931-4636; Kennedy, Brian/0000-0002-5754-1874	US National Institutes of Health; American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research; NATIONAL CANCER INSTITUTE [R01CA089455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025549] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Louis for providing strains for the telomere silencing assay, and members of the Kennedy and Kaeberlein labs who participated in lifespan-determination studies. This work was funded by US National Institutes of Health grants (S. L. B. and B. K. K.), and an American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research (B. K. K.). M. K. is an Ellison Medical Foundation New Scholar in Aging.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Johzuka K, 2002, GENES CELLS, V7, P99, DOI 10.1046/j.1356-9597.2001.00508.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; Laun P, 2007, NUCLEIC ACIDS RES, V35, P7514, DOI 10.1093/nar/gkm919; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Park PU, 2002, METHOD ENZYMOL, V351, P468; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021	45	442	461	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					802	U2		10.1038/nature08085	http://dx.doi.org/10.1038/nature08085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516333	Green Accepted			2022-12-24	WOS:000267084500030
J	Yun, JY; Rago, C; Cheong, I; Pagliarini, R; Angenendt, P; Rajagopalan, H; Schmidt, K; Willson, JKV; Markowitz, S; Zhou, SB; Diaz, LA; Velculescu, VE; Lengauer, C; Kinzler, KW; Vogelstein, B; Papadopoulos, N				Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Willson, James K. V.; Markowitz, Sandy; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas			Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells	SCIENCE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; POSITRON-EMISSION-TOMOGRAPHY; MESSENGER-RNA; CANCER-CELLS; COLON-CANCER; COLORECTAL CARCINOMAS; MISMATCH-REPAIR; RAS; METABOLISM; TRANSPORT	Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4% of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.	[Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Willson, James K. V.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Markowitz, Sandy] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sandy] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sandy] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Markowitz, Sandy] Howard Hughes Med Inst, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute	Vogelstein, B (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NIH [CA43460, CA62924]; the Johns Hopkins University; Genzyme Molecular Oncology; Novartis; Wyeth; Amgen; Glaxo-Smith-Kline; Horizon; NATIONAL CANCER INSTITUTE [R37CA043460, R01CA043460, P50CA062924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the Johns Hopkins University; Genzyme Molecular Oncology(Sanofi-AventisGenzyme Corporation); Novartis(Novartis); Wyeth(Wyeth); Amgen(Amgen); Glaxo-Smith-Kline(GlaxoSmithKline); Horizon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. He for helpful discussions, W. Yu for help with the microarray experiments, and E. Watson for expert technical assistance. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research and NIH grants CA43460 and CA62924. Under agreements between the Johns Hopkins University, Genzyme Molecular Oncology, Novartis, Wyeth, Amgen, Glaxo-Smith-Kline, and Horizon, J. Y., V. E. V., H. R., R. P., C. L., K. W. K., B. V., and N. P. are entitled to a share of the royalties and licensing fees received by the university on cell lines described in this paper, some of which are the subject of patent applications. The Johns Hopkins University and V. E. V., K. W. K., and B. V. also own stock in Genzyme, which is subject to certain restrictions under university policy. The terms of these arrangements are being managed by the university in accordance with its conflict of interest policies.	Abdel-Nabi H, 1998, RADIOLOGY, V206, P755, DOI 10.1148/radiology.206.3.9494497; Airley R, 2001, CLIN CANCER RES, V7, P928; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Blum R, 2005, CANCER RES, V65, P999; BOS JL, 1989, CANCER RES, V49, P4682; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delbeke D, 1997, J NUCL MED, V38, P1196; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Gu J, 2006, DIGEST DIS SCI, V51, P2198, DOI 10.1007/s10620-006-9428-2; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Noguchi Y, 2000, CANCER LETT, V154, P137, DOI 10.1016/S0304-3835(00)00354-2; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sakashita M, 2001, EUR J CANCER, V37, P204, DOI 10.1016/S0959-8049(00)00371-3; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; van Kouwen MCA, 2005, J CLIN ONCOL, V23, P3713, DOI 10.1200/JCO.2005.02.401; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yasuda S, 2001, J NUCL MED, V42, P989; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JZ, 1999, AM J KIDNEY DIS, V34, P189, DOI 10.1016/S0272-6386(99)70131-9	40	648	671	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1555	1559		10.1126/science.1174229	http://dx.doi.org/10.1126/science.1174229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19661383	Green Accepted			2022-12-24	WOS:000269887900044
J	Polin, M; Tuval, I; Drescher, K; Gollub, JP; Goldstein, RE				Polin, Marco; Tuval, Idan; Drescher, Knut; Gollub, J. P.; Goldstein, Raymond E.			Chlamydomonas Swims with Two "Gears" in a Eukaryotic Version of Run-and-Tumble Locomotion	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; CILIA; MICROPIPETTES; COORDINATION; REINHARDTII; TRANSPORT; FLAGELLA; FLUID; FLOW	The coordination of eukaryotic flagella is essential for many of the most basic processes of life (motility, sensing, and development), yet its emergence and regulation and its connection to locomotion are poorly understood. Previous studies show that the unicellular alga Chlamydomonas, widely regarded as an ideal system in which to study flagellar biology, swims forward by the synchronous action of its two flagella. Using high-speed imaging over long intervals, we found a richer behavior: A cell swimming in the dark stochastically switches between synchronous and asynchronous flagellar beating. Three-dimensional tracking shows that these regimes lead, respectively, to nearly straight swimming and to abrupt large reorientations, which yield a eukaryotic version of the "run-and-tumble" motion of peritrichously flagellated bacteria.	[Polin, Marco; Tuval, Idan; Drescher, Knut; Gollub, J. P.; Goldstein, Raymond E.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Gollub, J. P.] Haverford Coll, Dept Phys, Haverford, PA 19041 USA	University of Cambridge; Haverford College	Goldstein, RE (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Wilberforce Rd, Cambridge CB3 0WA, England.	R.E.Goldstein@damtp.cam.ac.uk	Polin, Marco/H-4202-2011; Tuval, Idan/G-9732-2011; Drescher, Knut/N-6730-2015; Goldstein, Raymond/F-2932-2011	Polin, Marco/0000-0002-0623-3046; Tuval, Idan/0000-0002-6629-0851; Drescher, Knut/0000-0002-7340-2444; Goldstein, Raymond/0000-0003-2645-0598	Marie-Curie Program; Human Frontiers Science Program; Leverhulme Trust; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; U.S. Department of Energy; Schlumberger Chair Fund; BBSRC [BB/F021844/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021844/1] Funding Source: researchfish	Marie-Curie Program(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); U.S. Department of Energy(United States Department of Energy (DOE)); Schlumberger Chair Fund(Schlumberger); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Leptos, T. J. Pedley, C. A. Solari, K. Visscher, A. Nedelcu, D. Page-Croft, T. Parkin, and N. Price and acknowledge support from the Marie-Curie Program (M.P.), the Human Frontiers Science Program (I.T.), the Leverhulme Trust (J.P.G.), the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the U.S. Department of Energy, and the Schlumberger Chair Fund.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Berg H. C., 1983, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Drescher K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3053242; Gueron S, 1999, P NATL ACAD SCI USA, V96, P12240, DOI 10.1073/pnas.96.22.12240; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HEGEMANN P, 1989, CELL MOTIL CYTOSKEL, V14, P501, DOI 10.1002/cm.970140408; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Josef K, 2005, CELL MOTIL CYTOSKEL, V61, P83, DOI 10.1002/cm.20064; Mitchell DR, 2000, J PHYCOL, V36, P261, DOI 10.1046/j.1529-8817.2000.99218.x; Niedermayer T, 2008, CHAOS, V18, DOI 10.1063/1.2956984; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okita N, 2005, J CELL SCI, V118, P529, DOI 10.1242/jcs.01633; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Ruffer U, 1998, CELL MOTIL CYTOSKEL, V41, P297, DOI 10.1002/(SICI)1097-0169(1998)41:4<297::AID-CM3>3.0.CO;2-Y; RUFFER U, 1987, CELL MOTIL CYTOSKEL, V7, P87, DOI 10.1002/cm.970070111; Solari CA, 2006, P NATL ACAD SCI USA, V103, P1353, DOI 10.1073/pnas.0503810103; Vilfan A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058102; Vladimirov VA, 2004, J EXP BIOL, V207, P1203, DOI 10.1242/jeb.00881; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044	25	300	300	9	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					487	490		10.1126/science.1172667	http://dx.doi.org/10.1126/science.1172667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628868				2022-12-24	WOS:000268255100060
J	Sardiello, M; Palmieri, M; di Ronza, A; Medina, DL; Valenza, M; Gennarino, VA; Di Malta, C; Donaudy, F; Embrione, V; Polishchuk, RS; Banfi, S; Parenti, G; Cattaneo, E; Ballabio, A				Sardiello, Marco; Palmieri, Michela; di Ronza, Alberto; Medina, Diego Luis; Valenza, Marta; Gennarino, Vincenzo Alessandro; Di Malta, Chiara; Donaudy, Francesca; Embrione, Valerio; Polishchuk, Roman S.; Banfi, Sandro; Parenti, Giancarlo; Cattaneo, Elena; Ballabio, Andrea			A Gene Network Regulating Lysosomal Biogenesis and Function	SCIENCE			English	Article							CATHEPSIN-D; TRANSCRIPTION; EXPRESSION; BRAIN; MODEL; AMINO; BETA	Lysosomes are organelles central to degradation and recycling processes in animal cells. Whether lysosomal activity is coordinated to respond to cellular needs remains unclear. We found that most lysosomal genes exhibit coordinated transcriptional behavior and are regulated by the transcription factor EB (TFEB). Under aberrant lysosomal storage conditions, TFEB translocated from the cytoplasm to the nucleus, resulting in the activation of its target genes. TFEB overexpression in cultured cells induced lysosomal biogenesis and increased the degradation of complex molecules, such as glycosaminoglycans and the pathogenic protein that causes Huntington's disease. Thus, a genetic program controls lysosomal biogenesis and function, providing a potential therapeutic target to enhance cellular clearing in lysosomal storage disorders and neurodegenerative diseases.	[Sardiello, Marco; Palmieri, Michela; di Ronza, Alberto; Medina, Diego Luis; Gennarino, Vincenzo Alessandro; Di Malta, Chiara; Donaudy, Francesca; Embrione, Valerio; Banfi, Sandro; Parenti, Giancarlo; Ballabio, Andrea] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Valenza, Marta; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Valenza, Marta; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy; [Polishchuk, Roman S.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Telethon Electron Microscopy Core Facil, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Parenti, Giancarlo; Ballabio, Andrea] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Milan; University of Milan; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Naples Federico II	Ballabio, A (corresponding author), Telethon Inst Genet & Med, Via P Castellino 111, I-80131 Naples, Italy.	ballabio@tigem.it	PALMIERI, MICHELA/G-4292-2016; Gennarino, Vincenzo A./H-3306-2019; BALLABIO, Andrea/AAL-2672-2020; Banfi, Sandro/K-3963-2018; Di Malta, Chiara/AAX-6395-2020; Embrione, Valerio/AAB-3897-2019; Medina, Diego/AAC-9622-2020; VALENZA, MARTA/B-7763-2017	PALMIERI, MICHELA/0000-0001-9373-1133; Gennarino, Vincenzo A./0000-0002-3312-6991; BALLABIO, Andrea/0000-0003-1381-4604; Banfi, Sandro/0000-0002-6541-8833; Embrione, Valerio/0000-0003-0184-3862; Medina, Diego/0000-0002-7347-2645; Polishchuk, Roman/0000-0002-7698-1955; parenti, giancarlo/0000-0002-6287-5748; VALENZA, MARTA/0000-0002-7048-9257; CATTANEO, ELENA/0000-0002-0755-4917	European Union [201678]; Italian Ministry of Research [PRIN 2006064337]; Italian Telethon Foundation; National MPS Society USA	European Union(European Commission); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Italian Telethon Foundation(Fondazione Telethon); National MPS Society USA	This work was supported by the European Union, 7th Framework Program "Euclyd-a European Consortium for Lysosomal Storage Diseases" (health F2/2008 grant agreement 201678) and by the Italian Ministry of Research (PRIN 2006064337). The contributions of the Italian Telethon Foundation and of the National MPS Society USA are gratefully acknowledged. The authors have no conflicts of interest. Expression microarray data are available at the Gene Expression Omnibus repository under accession number GSE16267. A patent application on the discovery of a gene network regulating lysosomal biogenesis and function has been filed to the European Patent Office (patent application EP 091527788). A.B. and M.S. are inventors on this patent.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Helip-Wooley A, 2004, EXP CELL RES, V292, P89, DOI 10.1016/j.yexcr.2003.09.003; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; KORNFELD S, 2001, METABOLIC MOL BASES, V2, P3469; LADROR US, 1994, J BIOL CHEM, V269, P18422; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; LUBKE T, 2008, BIOCHIM BIOPHYS ACTA, V1793, P625; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; SAFTIG P, 2003, MED INTELLIGENCE UNI; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIEWECK, 2009, BIOCHEM J, DOI DOI 10.1042/BJ20090567; Settembre C, 2007, P NATL ACAD SCI USA, V104, P4506, DOI 10.1073/pnas.0700382104; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717	28	1500	1536	13	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					473	477		10.1126/science.1174447	http://dx.doi.org/10.1126/science.1174447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19556463				2022-12-24	WOS:000268255100056
J	Sharma, V; Crne, M; Park, JO; Srinivasarao, M				Sharma, Vivek; Crne, Matija; Park, Jung Ok; Srinivasarao, Mohan			Structural Origin of Circularly Polarized Iridescence in Jeweled Beetles	SCIENCE			English	Article							CHOLESTERIC LIQUID-CRYSTALS; GRAIN-BOUNDARY SCARS; SPHERICAL CRYSTALLOGRAPHY; PATTERN-FORMATION; COLOR; BUTTERFLIES; REFLECTION; CUTICLE; LIGHT; MOTHS	The iridescent metallic green beetle, Chrysina gloriosa, which selectively reflects left circularly polarized light, possesses an exoskeleton decorated by hexagonal cells (similar to 10 mu m) that coexist with pentagons and heptagons. The fraction of hexagons decreases with an increase in curvature. In bright field microscopy, each cell contains a bright yellow core, placed in a greenish cell with yellowish border, but the core disappears in dark field. With use of confocal microscopy, we observe that these cells consist of nearly concentric nested arcs that lie on the surface of a shallow cone. We infer that the patterns are structurally and optically analogous to the focal conic domains formed spontaneously on the free surface of a cholesteric liquid crystal. These textures provide the basis for the morphogenesis as well as key insights for emulating the intricate optical response of the exoskeleton of scarab beetles.	[Sharma, Vivek; Park, Jung Ok; Srinivasarao, Mohan] Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA; [Sharma, Vivek; Crne, Matija; Park, Jung Ok; Srinivasarao, Mohan] Georgia Inst Technol, CAROM, Atlanta, GA 30332 USA; [Crne, Matija; Srinivasarao, Mohan] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sharma, V (corresponding author), Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA.		Srinivasarao, Mohan/M-9810-2013; Sharma, Vivek/A-9772-2014; Srinivasarao, Mohan/L-4041-2019; Sharma, Vivek/AAC-9903-2019; Sharma, Vivek/B-3615-2009	Sharma, Vivek/0000-0003-1152-1285; Sharma, Vivek/0000-0003-1152-1285; Sharma, Vivek/0000-0003-1152-1285	NSF [DMR-0706235]	NSF(National Science Foundation (NSF))	M.S. acknowledges support from NSF (DMR-0706235) and useful discussions with L. Tolbert, A. Rey, P. Collings, and H. Ghiradella.	Ball P., 1999, SELF MADE TAPESTRY P; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Belyakov V.A., 1989, OPTICS CHIRAL LIQUID; BERREMAN DW, 1986, PHYS REV LETT, V57, P1737, DOI 10.1103/PhysRevLett.57.1737; Bertheier S., 2007, IRIDESCENCES PHYS CO; BOULIGAND Y, 1983, BIFURCATION THEORY M; Bouligand Y, 2008, CR CHIM, V11, P281, DOI 10.1016/j.crci.2007.10.001; Brink DJ, 2007, J PHYS D APPL PHYS, V40, P2189, DOI 10.1088/0022-3727/40/7/050; BROER DJ, 1995, NATURE, V378, P467, DOI 10.1038/378467a0; CAVENEY S, 1971, PROC R SOC SER B-BIO, V178, P205, DOI 10.1098/rspb.1971.0062; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; De Silva L, 2005, ELECTROMAGNETICS, V25, P391, DOI 10.1080/02726340590957399; DEGENNES PG, 1995, INT SER MONOGR PHYS, V83, P263; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Goldstein DH, 2006, APPL OPTICS, V45, P7944, DOI 10.1364/AO.45.007944; Jewell SA, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/099; Kleman M., 2003, SOFT MATTER PHYS INT; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Lowrey S, 2007, J OPT SOC AM A, V24, P2418, DOI 10.1364/JOSAA.24.002418; Meister R, 1996, PHYS REV E, V54, P3771, DOI 10.1103/PhysRevE.54.3771; Michelson A. A., 1927, STUDIES OPTICS; Nelson DR, 2004, P INT SCH PHYS, V155, P365; Neville A. C., 1993, BIOL FIBROUS COMPOSI; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; OSWALD P, 2005, NEMATIC CHOLESTERIC, P415; PACE A, 1972, SCIENCE, V176, P678, DOI 10.1126/science.176.4035.678; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; RIVERS VZ, 2003, INSECTES TRADITION O, P163; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; STEVENS PS, 1974, PATTERNS NATURE; STJOHN WD, 1995, PHYS REV E, V51, P1191, DOI 10.1103/PhysRevE.51.1191; Thompson D.W., 1961, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vitelli V, 2006, P NATL ACAD SCI USA, V103, P12323, DOI 10.1073/pnas.0602755103; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941	36	431	442	20	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					449	451		10.1126/science.1172051	http://dx.doi.org/10.1126/science.1172051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628862				2022-12-24	WOS:000268255100049
J	Colman, RJ; Anderson, RM; Johnson, SC; Kastman, EK; Kosmatka, KJ; Beasley, TM; Allison, DB; Cruzen, C; Simmons, HA; Kemnitz, JW; Weindruch, R				Colman, Ricki J.; Anderson, Rozalyn M.; Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Beasley, T. Mark; Allison, David B.; Cruzen, Christina; Simmons, Heather A.; Kemnitz, Joseph W.; Weindruch, Richard			Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys	SCIENCE			English	Article							DIETARY RESTRICTION; ADULT MALE; LIFE-SPAN; MACAQUES	Caloric restriction (CR), without malnutrition, delays aging and extends life span in diverse species; however, its effect on resistance to illness and mortality in primates has not been clearly established. We report findings of a 20-year longitudinal adult-onset CR study in rhesus monkeys aimed at filling this critical gap in aging research. In a population of rhesus macaques maintained at the Wisconsin National Primate Research Center, moderate CR lowered the incidence of aging-related deaths. At the time point reported, 50% of control fed animals survived as compared with 80% of the CR animals. Furthermore, CR delayed the onset of age-associated pathologies. Specifically, CR reduced the incidence of diabetes, cancer, cardiovascular disease, and brain atrophy. These data demonstrate that CR slows aging in a primate species.	[Colman, Ricki J.; Anderson, Rozalyn M.; Johnson, Sterling C.; Cruzen, Christina; Simmons, Heather A.; Kemnitz, Joseph W.; Weindruch, Richard] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Kemnitz, Joseph W.; Weindruch, Richard] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Weindruch, Richard] William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Beasley, T. Mark; Allison, David B.] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA; [Kemnitz, Joseph W.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Colman, RJ (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	rcolman@primate.wisc.edu; rhweindr@wisc.edu	Kemnitz, Joseph/HGC-4406-2022; Kastman, Erik/N-6645-2016; Simmons, Heather/U-6081-2019; Kemnitz, Joseph/ABA-4668-2020	Kastman, Erik/0000-0001-7221-9042; Colman, Ricki/0000-0001-9706-0525; Allison, David/0000-0003-3566-9399; Kemnitz, Joseph W/0000-0001-6511-404X	NIH [P01 AG-11915, P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; William S. Middleton Memorial Veterans Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); William S. Middleton Memorial Veterans Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the excellent technical assistance provided by S. Baum, J. Christensen, J. A. Adriansjach, C. E. Armstrong, D. G. McLaren, C. Dizack, D. Shanmuganayagam, J. Root, and the Animal Care, Veterinary and Pathology Staff of the WNPRC. R.W. is a cofounder and member of the board of LifeGen Technologies, a company focused on nutritional genomics, including the impact of dietary interventions on the aging process. This work was supported by NIH grants P01 AG-11915 and P51 RR000167. This research was conducted in part at the WNPRC, which received support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This research was supported in part by facilities and resources at the William S. Middleton Memorial Veterans Hospital.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Anderson Rozalyn M., 2007, V35, P18; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 1998, AGING CLIN EXP RES, V10, P83, DOI 10.1007/BF03339642; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; MCCAY CM, 1989, NUTRITION, V5, P155; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rodriguez NA, 2002, J MED PRIMATOL, V31, P74, DOI 10.1034/j.1600-0684.2002.01001.x; Uno H, 1997, AGE, V20, P1, DOI 10.1007/s11357-997-0001-5; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Weindruch R., 1988, RETARDATION AGING DI; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	19	1541	1591	8	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					201	204		10.1126/science.1173635	http://dx.doi.org/10.1126/science.1173635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590001	Green Accepted			2022-12-24	WOS:000267802000047
J	Pagnussat, GC; Alandete-Saez, M; Bowman, JL; Sundaresan, V				Pagnussat, Gabriela C.; Alandete-Saez, Monica; Bowman, John L.; Sundaresan, Venkatesan			Auxin-Dependent Patterning and Gamete Specification in the Arabidopsis Female Gametophyte	SCIENCE			English	Article							YUCCA FLAVIN MONOOXYGENASES; IDENTIFICATION; EXPRESSION; GRADIENTS; ENDOSPERM; PROTEINS; ORIGIN; GENES	The female reproductive unit of flowering plants, the haploid female gametophyte, is highly reduced relative to other land plants. We show that patterning of the Arabidopsis female gametophyte depends on an asymmetric distribution of the hormone auxin during its syncitial development. Furthermore, this auxin gradient is correlated with location-specific auxin biosynthesis, rather than auxin efflux that directs patterning in the diploid sporophytic tissues comprising the rest of the plant. Manipulation of auxin responses or synthesis induces switching of gametic and nongametic cell identities and specialized nonreproductive cells to exhibit attributes presumptively lost during angiosperm evolution. These findings may account for the unique egg cell specification characteristic of angiosperms and the formation of seeds with single diploid embryos while containing endosperm that can have variable numbers of parental haploid genomes.	[Pagnussat, Gabriela C.; Alandete-Saez, Monica; Bowman, John L.; Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; Monash University; University of California System; University of California Davis	Sundaresan, V (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	sundar@ucdavis.edu	Bowman, John P./ABF-5108-2020	Bowman, John P./0000-0002-4528-9333; Bowman, John/0000-0001-7347-3691; Sundaresan, Venkatesan/0000-0002-4670-0630; Pagnussat, Gabriela/0000-0002-6836-3495	NSF [IOS-0313501, IOS-0745167, IOB-0515435]	NSF(National Science Foundation (NSF))	We thank U. Grossniklaus for providing the cell-specific marker lines used in this study; B. Sheres, J. Friml, and M. Tasaka for providing plants carrying PIN::GFP fusions; Y. Zhao for providing YUC::GUS reporter lines and YUC1 cDNA; N. Dharmasiri for seeds of the tir1afb quadruple mutant; M. Yu and A. Krishnan for technical assistance; and G. Ruvkun, D. Hanahan, members of the Gasser, Bowman, and Sundaresan labs, and three anonymous reviewers for valuable suggestions. Funded by NSF grants IOS-0313501 (V.S.), IOS-0745167 (V.S.), and IOB-0515435 (J.L.B.).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brown R. C., 1992, EMSA B, V22, P48; BROWN RC, 1991, PROTOPLASMA, V165, P155, DOI 10.1007/BF01322286; Brukhin V, 2005, CURR SCI INDIA, V89, P1844; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Christensen CA, 1998, DEV BIOL, V202, P136, DOI 10.1006/dbio.1998.8980; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Friedman WE, 2004, PLANT CELL, V16, pS119, DOI 10.1105/tpc.017277; Friedman WE, 2003, EVOLUTION, V57, P216, DOI 10.1111/j.0014-3820.2003.tb00257.x; Friedman WE, 2008, INT J PLANT SCI, V169, P79, DOI 10.1086/523354; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Frohlich MW, 2007, NATURE, V450, P1184, DOI 10.1038/nature06393; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Moore JM, 1997, COLD SPRING HARB SYM, V62, P35, DOI 10.1101/SQB.1997.062.01.007; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Umulis D, 2008, CURR TOP DEV BIOL, V81, P65, DOI 10.1016/S0070-2153(07)81002-7; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	30	206	226	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1684	1689		10.1126/science.1167324	http://dx.doi.org/10.1126/science.1167324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19498110				2022-12-24	WOS:000267338200032
J	Benedito, R; Roca, C; Sorensen, I; Adams, S; Gossler, A; Fruttiger, M; Adams, RH				Benedito, Rui; Roca, Cristina; Soerensen, Inga; Adams, Susanne; Gossler, Achim; Fruttiger, Marcus; Adams, Ralf H.			The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis	CELL			English	Article							INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; CRE-RECOMBINASE; EXPRESSION; DEFECTS; PATHWAY; DELTA1; PROTEOLYSIS; ACTIVATION; REGULATOR	The Notch pathway is a highly conserved signaling system that controls a diversity of growth, differentiation, and patterning processes. In growing blood vessels, sprouting of endothelial tip cells is inhibited by Notch signaling, which is activated by binding of the Notch receptor to its ligand Delta-like 4 (Dll4). Here, we show that the Notch ligand Jagged1 is a potent proangiogenic regulator in mice that antagonizes Dll4-Notch signaling in cells expressing Fringe family glycosyltransferases. Upon glycosylation of Notch, Dll4-Notch signaling is enhanced, whereas Jagged1 has weak signaling capacity and competes with Dll4. Our findings establish that the equilibrium between two Notch ligands with distinct spatial expression patterns and opposing functional roles regulates angiogenesis, a mechanism that might also apply to other Notch-controlled biological processes.	[Benedito, Rui; Roca, Cristina; Adams, Susanne; Adams, Ralf H.] Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; [Benedito, Rui; Adams, Susanne; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Benedito, Rui; Adams, Susanne; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Soerensen, Inga; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30625 Hannover, Germany; [Fruttiger, Marcus] UCL, Inst Ophthalmol, London EC1V 9EL, England	Cancer Research UK; Max Planck Society; University of Munster; Hannover Medical School; University of London; University College London	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@mpi-muenster.mpg.de	Benedito, Rui/G-8295-2012; Benedito, Rui/AAQ-8096-2020; Adams, Ralf H/AAE-9274-2019	Benedito, Rui/0000-0003-2458-3055; Benedito, Rui/0000-0003-2458-3055; Fruttiger, Marcus/0000-0002-6962-5485	Cancer Research UK; Max Planck Society; University of Muenster; Deutsche Forschungsgemeinschaft; Medical Research Council [G0501711] Funding Source: researchfish; MRC [G0501711] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Benjamin, T. Gridley, and J. Lewis for providing VE-Cadherin-tTA, Lfng, and floxed Jag1 mice; K. Serth and K. Schuster-Gossler for isolating Lfng eyes; and M. Stehling for the FACS isolation of ECs. This study was funded by Cancer Research UK, the Max Planck Society, the University of Muenster, and the Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gustafsson E, 2001, J CELL SCI, V114, P671; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; 2007, DEVELOPMENT, V134, P839	49	729	762	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1124	1135		10.1016/j.cell.2009.03.025	http://dx.doi.org/10.1016/j.cell.2009.03.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524514	Bronze			2022-12-24	WOS:000266916400023
J	Bo, S; Siegert, MJ; Mudd, SM; Sugden, D; Fujita, S; Cui, XB; Jiang, YY; Tang, XY; Li, YS				Bo, Sun; Siegert, Martin J.; Mudd, Simon M.; Sugden, David; Fujita, Shuji; Cui Xiangbin; Jiang Yunyun; Tang Xueyuan; Li Yuansheng			The Gamburtsev mountains and the origin and early evolution of the Antarctic Ice Sheet	NATURE			English	Article							EAST ANTARCTICA; MIOCENE; VALLEY; EXPANSION; HISTORY	Ice-sheet development in Antarctica was a result of significant and rapid global climate change about 34 million years ago(1). Ice-sheet and climate modelling suggest reductions in atmospheric carbon dioxide ( less than three times the pre-industrial level of 280 parts per million by volume) that, in conjunction with the development of the Antarctic Circumpolar Current, led to cooling and glaciation paced by changes in Earth's orbit(2). Based on the present subglacial topography, numerical models point to ice-sheet genesis on mountain massifs of Antarctica, including the Gamburtsev mountains at Dome A, the centre of the present ice sheet(2,3). Our lack of knowledge of the present-day topography of the Gamburtsev mountains(4) means, however, that the nature of early glaciation and subsequent development of a continental-sized ice sheet are uncertain. Here we present radar information about the base of the ice at Dome A, revealing classic Alpine topography with pre-existing river valleys overdeepened by valley glaciers formed when the mean summer surface temperature was around 3 degrees C. This landscape is likely to have developed during the initial phases of Antarctic glaciation. According to Antarctic climate history (estimated from offshore sediment records) the Gamburtsev mountains are probably older than 34 million years and were the main centre for ice-sheet growth. Moreover, the landscape has most probably been preserved beneath the present ice sheet for around 14 million years.	[Bo, Sun; Cui Xiangbin; Jiang Yunyun; Tang Xueyuan; Li Yuansheng] Polar Res Inst China, Shanghai 200136, Peoples R China; [Siegert, Martin J.; Mudd, Simon M.; Sugden, David] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Fujita, Shuji] Natl Inst Polar Res, Res Org Informat & Syst, Itabashi Ku, Tokyo 1738515, Japan	Polar Research Institute of China; University of Edinburgh; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Bo, S (corresponding author), Polar Res Inst China, 451 Jinqiao Rd, Shanghai 200136, Peoples R China.	sunbo@pric.gov.cn; m.j.siegert@ed.ac.uk	Fujita, Shuji/A-7884-2016; Siegert, Martin J/A-3826-2008; Cui, Xiangbin/Y-1551-2019; Mudd, Simon M/F-8521-2010; Siegert, Martin/M-9939-2019	Fujita, Shuji/0000-0003-0127-0777; Siegert, Martin J/0000-0002-0090-4806; Mudd, Simon M/0000-0002-1357-8501; Siegert, Martin/0000-0002-0090-4806	National Natural Science Foundation of China [40476005]; Ministry of Science and Technology of China [2006BAB18B03]; UK Natural Environment Research Council [NE/D003733/1]; NERC [NE/F016646/1, NE/E018254/1] Funding Source: UKRI; Natural Environment Research Council [NE/E018254/1, NE/F016646/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is based upon work supported by the National Natural Science Foundation of China ( 40476005), the International Polar Year programme CHINARE ( Ministry of Science and Technology of China 2006BAB18B03) and the UK Natural Environment Research Council (NE/D003733/1). We thank A. Wright for drawing Fig. 1c.	Abramov O, 2004, INT J REMOTE SENS, V25, P669, DOI 10.1080/01431160310001599006; Amerson BE, 2008, GEOMORPHOLOGY, V93, P537, DOI 10.1016/j.geomorph.2007.04.001; Anderson RS, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000344; Barrett PJ, 2007, SPEC PUBL INT ASS SE, V39, P259; DeConto RM, 2003, PALAEOGEOGR PALAEOCL, V198, P39, DOI 10.1016/S0031-0182(03)00393-6; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Drewry DJ., 1983, ANTARCTICA GLACIOLOG; Ehrmann W, 2005, PALAEOGEOGR PALAEOCL, V229, P187, DOI 10.1016/j.palaeo.2005.06.022; Harwood DM, 2000, ANTARCT SCI, V12, P443; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Jamieson S. S. R., 2007, ANTARCTICA KEYSTONE, P39; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; Lewis AR, 2008, P NATL ACAD SCI USA, V105, P10676, DOI 10.1073/pnas.0802501105; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; Montgomery DR, 2002, GEOLOGY, V30, P1047, DOI 10.1130/0091-7613(2002)030<1047:VFBFAG>2.0.CO;2; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Paterson WSB, 1994, PHYS GLACIERS, P1; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; PERKINS D, 1984, SUBGLACIAL LANDSCAPE; Raine JI., 2001, TERRA ANTARCT, V8, P389; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Summerfield MA, 1999, GEOL SOC SPEC PUBL, V162, P255, DOI 10.1144/GSL.SP.1999.162.01.20; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; WATSON D, 1992, CONTOURING GUIDE ANA, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	118	141	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					690	693		10.1038/nature08024	http://dx.doi.org/10.1038/nature08024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494912				2022-12-24	WOS:000266608600041
J	Wignall, PB; Sun, YD; Bond, DPG; Izon, G; Newton, RJ; Vedrine, S; Widdowson, M; Ali, JR; Lai, XL; Jiang, HS; Cope, H; Bottrell, SH				Wignall, Paul B.; Sun, Yadong; Bond, David P. G.; Izon, Gareth; Newton, Robert J.; Vedrine, Stephanie; Widdowson, Mike; Ali, Jason R.; Lai, Xulong; Jiang, Haishui; Cope, Helen; Bottrell, Simon H.			Volcanism, Mass Extinction, and Carbon Isotope Fluctuations in the Middle Permian of China	SCIENCE			English	Article							LARGE IGNEOUS PROVINCE; SW CHINA; BOUNDARY; RELEASE; SECTION; OXYGEN; GSSP	The 260-million-year-old Emeishan volcanic province of southwest China overlies and is interbedded with Middle Permian carbonates that contain a record of the Guadalupian mass extinction. Sections in the region thus provide an opportunity to directly monitor the relative timing of extinction and volcanism within the same locations. These show that the onset of volcanism was marked by both large phreatomagmatic eruptions and extinctions amongst fusulinacean foraminifers and calcareous algae. The temporal coincidence of these two phenomena supports the idea of a cause-and-effect relationship. The crisis predates the onset of a major negative carbon isotope excursion that points to subsequent severe disturbance of the ocean-atmosphere carbon cycle.	[Wignall, Paul B.; Bond, David P. G.; Newton, Robert J.; Vedrine, Stephanie; Bottrell, Simon H.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Sun, Yadong; Lai, Xulong; Jiang, Haishui] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Izon, Gareth; Widdowson, Mike] Open Univ, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Cope, Helen] Univ Strathclyde, Dept Bioengn, Glasgow G4 0NW, Lanark, Scotland	University of Leeds; China University of Geosciences; Open University - UK; University of Hong Kong; University of Strathclyde	Wignall, PB (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	p.wignall@see.leeds.ac.uk	Izon, Gareth/G-6004-2011; Sun, Yadong/N-6907-2013; Izon, Gareth/AAQ-4033-2020; Bond, David/I-6737-2012; Sun, Yadong/AAG-8781-2019; Newton, Robert/B-2599-2009; Ali, Jason/A-2738-2010	Sun, Yadong/0000-0003-4032-2082; Izon, Gareth/0000-0003-2742-4922; Sun, Yadong/0000-0003-4032-2082; Newton, Robert/0000-0003-0144-6867; Ali, Jason Richard/0000-0002-5214-620X; Lai, Xulong/0000-0002-2837-0885	Natural Environment Research Council [NE/D011558/1]; Natural Science Foundation of China [40872002, 406210022, 40232025]; Chinese State Administration of Foreign Experts Affairs [B08030]; Hong Kong Research Grant Council [HKU700204]; NERC [NE/D011558/1, NE/D011094/1] Funding Source: UKRI; Natural Environment Research Council [NE/D011094/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese State Administration of Foreign Experts Affairs; Hong Kong Research Grant Council(Hong Kong Research Grants Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank for funding the Natural Environment Research Council (grant no. NE/D011558/1), Natural Science Foundation of China (grants nos. 40872002, 406210022, and 40232025), Chinese State Administration of Foreign Experts Affairs (grant B08030), and Hong Kong Research Grant Council (grant no. HKU700204).	Ali JR, 2005, LITHOS, V79, P475, DOI 10.1016/j.lithos.2004.09.013; Courtillot V, 1999, EVOLUTIONARY CATASTR; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; He B, 2006, J GEOL, V114, P117, DOI 10.1086/498103; Jin YG, 2006, EPISODES, V29, P253, DOI 10.18814/epiiugs/2006/v29i4/003; Kaiho K, 2005, PALAEOGEOGR PALAEOCL, V223, P172, DOI 10.1016/j.palaeo.2005.04.013; Keller G, 2008, EARTH PLANET SC LETT, V268, P293, DOI 10.1016/j.epsl.2008.01.015; Lai XL, 2008, PALAEOGEOGR PALAEOCL, V269, P78, DOI 10.1016/j.palaeo.2008.08.005; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; Peate IU, 2008, NAT GEOSCI, V1, P625, DOI 10.1038/ngeo281; Retallack GJ, 2008, J GEOL, V116, P1, DOI 10.1086/524120; Self S, 2008, SCIENCE, V319, P1654, DOI 10.1126/science.1152830; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Wang W, 2004, EARTH PLANET SC LETT, V220, P57, DOI 10.1016/S0012-821X(04)00033-0; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wignall PB, 1998, AM J SCI, V298, P537, DOI 10.2475/ajs.298.7.537; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2	17	248	285	14	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1179	1182		10.1126/science.1171956	http://dx.doi.org/10.1126/science.1171956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478179				2022-12-24	WOS:000266410100040
J	Lubenov, EV; Siapas, AG				Lubenov, Evgueniy V.; Siapas, Athanassios G.			Hippocampal theta oscillations are travelling waves	NATURE			English	Article							MEDIAL ENTORHINAL CORTEX; FREELY-MOVING RAT; SYNAPTIC PLASTICITY; FIELD POTENTIALS; PYRAMIDAL CELLS; STELLATE CELLS; BEHAVING RAT; CA1 NEURONS; LAYER-II; RHYTHM	Theta oscillations clock hippocampal activity during awake behaviour and rapid eye movement (REM) sleep. These oscillations are prominent in the local field potential, and they also reflect the subthreshold membrane potential and strongly modulate the spiking of hippocampal neurons. The prevailing view is that theta oscillations are synchronized throughout the hippocampus, despite the lack of conclusive experimental evidence. In contrast, here we show that in freely behaving rats, theta oscillations in area CA1 are travelling waves that propagate roughly along the septotemporal axis of the hippocampus. Furthermore, we find that spiking in the CA1 pyramidal cell layer is modulated in a consistent travelling wave pattern. Our results demonstrate that theta oscillations pattern hippocampal activity not only in time, but also across anatomical space. The presence of travelling waves indicates that the instantaneous output of the hippocampus is topographically organized and represents a segment, rather than a point, of physical space.	[Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Siapas, AG (corresponding author), CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA.	lubenov@caltech.edu; thanos@caltech.edu			Caltech Information Science and Technology Center for Biological Circuit Design; 21st Century McDonnell Foundation Award; Bren Foundation; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082942] Funding Source: NIH RePORTER	Caltech Information Science and Technology Center for Biological Circuit Design; 21st Century McDonnell Foundation Award; Bren Foundation; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Wierzynski, M. Gu, G. Laurent, E. Schuman and A. Tolias for critical discussions and comments on the manuscript. We also thank the Caltech Brain Imaging Center and D. Procissi for the MRI brain scans. This work was supported by the Caltech Information Science and Technology Center for Biological Circuit Design, a 21st Century McDonnell Foundation Award, the Bren Foundation, and the McKnight Foundation.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; AMARAL DG, 2004, RAT NERVOUS SYSTEM, P443; ARNOLDS DEAT, 1980, ELECTROEN CLIN NEURO, V50, P324, DOI 10.1016/0013-4694(80)90160-1; BLAND BH, 1975, BRAIN RES, V94, P199, DOI 10.1016/0006-8993(75)90057-8; BRAGIN A, 1995, J NEUROSCI, V15, P47; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FOX SE, 1986, EXP BRAIN RES, V62, P495; FUJITA Y, 1964, J NEUROPHYSIOL, V27, P1011, DOI 10.1152/jn.1964.27.6.1011; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GREEN JD, 1960, J NEUROPHYSIOL, V23, P403, DOI 10.1152/jn.1960.23.4.403; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LWS, 1986, BRAIN RES, V367, P323, DOI 10.1016/0006-8993(86)91611-2; LEUNG LWS, 1984, J NEUROPHYSIOL, V52, P1051, DOI 10.1152/jn.1984.52.6.1051; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; MILLER R, 1991, CORTICO HIPPOCAMPAL, P159; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pedemonte M, 1996, EXP BRAIN RES, V112, P41; PETSCHE H, 1960, ELECTROEN CLIN NEURO, V12, P589, DOI 10.1016/0013-4694(60)90101-2; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TRAUB RD, 1991, NEURONAL NETWORKS HI, P119; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Vertes RP, 1997, NEUROSCIENCE, V81, P893; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	50	263	265	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					534	539		10.1038/nature08010	http://dx.doi.org/10.1038/nature08010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19489117	Green Accepted			2022-12-24	WOS:000266370500031
J	Gonzales, EB; Kawate, T; Gouaux, E				Gonzales, Eric B.; Kawate, Toshimitsu; Gouaux, Eric			Pore architecture and ion sites in acid-sensing ion channels and P2X receptors	NATURE			English	Article							STRUCTURAL MOTIF; SODIUM; SELECTIVITY; NEURODEGENERATION; MUTATION; DESENSITIZATION; IDENTIFICATION; SENSITIVITY; PERMEATION; PROTEINS	Acid-sensing ion channels are proton-activated, sodium-selective channels composed of three subunits, and are members of the superfamily of epithelial sodium channels, mechanosensitive and FMRF-amide peptide-gated ion channels. These ubiquitous eukaryotic ion channels have essential roles in biological activities as diverse as sodium homeostasis, taste and pain. Despite their crucial roles in biology and their unusual trimeric subunit stoichiometry, there is little knowledge of the structural and chemical principles underlying their ion channel architecture and ion-binding sites. Here we present the structure of a functional acid-sensing ion channel in a desensitized state at 3 angstrom resolution, the location and composition of the similar to 8 angstrom 'thick' desensitization gate, and the trigonal antiprism coordination of caesium ions bound in the extracellular vestibule. Comparison of the acid-sensing ion channel structure with the ATP-gated P2X(4) receptor reveals similarity in pore architecture and aqueous vestibules, suggesting that there are unanticipated yet common structural and mechanistic principles.	[Gonzales, Eric B.; Kawate, Toshimitsu; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Gonzales, Eric B./0000-0001-8596-9053	National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA); National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083615] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel at beamlines 5.0.2 of the Advanced Light Source. We also thank C. Canessa for chicken ASIC1 DNA, L. Vaskalis for assistance with illustrations, and Gouaux laboratory members for discussion. This work was supported by a National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA) to E. B. G. and the National Institutes of Health (NIH) (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BENOS DJ, 1980, J GEN PHYSIOL, V76, P233, DOI 10.1085/jgp.76.2.233; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HILLE B, 2001, ION CHANNELS EXCITAB, pCH10; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	48	330	339	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					599	U62		10.1038/nature08218	http://dx.doi.org/10.1038/nature08218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641589	Green Accepted			2022-12-24	WOS:000268454300043
J	Chi, SW; Zang, JB; Mele, A; Darnell, RB				Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.			Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps	NATURE			English	Article							SYSTEMATIC IDENTIFICATION; NEURONAL DIFFERENTIATION; TARGET PREDICTIONS; BINDING PROTEINS; CROSS-LINKING; BRAIN; ELEGANS; CELLS; IMMUNOPRECIPITATION; TRANSLATION	MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 628 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.	[Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NIH; Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine; MD-PhD Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine; MD-PhD Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Darnell laboratory for discussion, J. Fak for help with exon arrays, C. Zhang for bioinformatic discussions, and G. Dunn, D. Licatalosi, C. Marney, M. Frias, T. Eom, J. Darnell, M. Yano and C. Zhang for critical review of the manuscript. Wealso thank Z. Mourelatos for supplying the 2A8 antibody and communicating unpublished results; G. Hannon for discussions; and S. Dewell for help with high-throughput sequencing. This work was supported in part by grants from the NIH (R. B. D.), the Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine (S. W. C.) and MD-PhD Program (J. B. Z.). R. B. D. is an Investigator of the Howard Hughes Medical Institute.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; HE L, 2004, NAT REV GENET, V5, P522; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	50	1308	1352	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					479	486		10.1038/nature08170	http://dx.doi.org/10.1038/nature08170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19536157	Green Accepted			2022-12-24	WOS:000268257000031
J	Berriman, M; Haas, BJ; LoVerde, PT; Wilson, RA; Dillon, GP; Cerqueira, GC; Mashiyama, ST; Al-Lazikani, B; Andrade, LF; Ashton, PD; Aslett, MA; Bartholomeu, DC; Blandin, G; Caffrey, CR; Coghlan, A; Coulson, R; Day, TA; Delcher, A; DeMarco, R; Djikeng, A; Eyre, T; Gamble, JA; Ghedin, E; Gu, Y; Hertz-Fowler, C; Hirai, H; Hirai, Y; Houston, R; Ivens, A; Johnston, DA; Lacerda, D; Macedo, CD; McVeigh, P; Ning, ZM; Oliveira, G; Overington, JP; Parkhill, J; Pertea, M; Pierce, RJ; Protasio, AV; Quail, MA; Rajandream, MA; Rogers, J; Sajid, M; Salzberg, SL; Stanke, M; Tivey, AR; White, O; Williams, DL; Wortman, J; Wu, WJ; Zamanian, M; Zerlotini, A; Fraser-Liggett, CM; Barrell, BG; El-Sayed, NM				Berriman, Matthew; Haas, Brian J.; LoVerde, Philip T.; Wilson, R. Alan; Dillon, Gary P.; Cerqueira, Gustavo C.; Mashiyama, Susan T.; Al-Lazikani, Bissan; Andrade, Luiza F.; Ashton, Peter D.; Aslett, Martin A.; Bartholomeu, Daniella C.; Blandin, Gaelle; Caffrey, Conor R.; Coghlan, Avril; Coulson, Richard; Day, Tim A.; Delcher, Art; DeMarco, Ricardo; Djikeng, Appolinaire; Eyre, Tina; Gamble, John A.; Ghedin, Elodie; Gu, Yong; Hertz-Fowler, Christiane; Hirai, Hirohisha; Hirai, Yuriko; Houston, Robin; Ivens, Alasdair; Johnston, David A.; Lacerda, Daniela; Macedo, Camila D.; McVeigh, Paul; Ning, Zemin; Oliveira, Guilherme; Overington, John P.; Parkhill, Julian; Pertea, Mihaela; Pierce, Raymond J.; Protasio, Anna V.; Quail, Michael A.; Rajandream, Marie-Adele; Rogers, Jane; Sajid, Mohammed; Salzberg, Steven L.; Stanke, Mario; Tivey, Adrian R.; White, Owen; Williams, David L.; Wortman, Jennifer; Wu, Wenjie; Zamanian, Mostafa; Zerlotini, Adhemar; Fraser-Liggett, Claire M.; Barrell, Barclay G.; El-Sayed, Najib M.			The genome of the blood fluke Schistosoma mansoni	NATURE			English	Article							HIDDEN MARKOV MODEL; EMBRYONIC-DEVELOPMENT; TRYPANOSOMA-CRUZI; GENE; DATABASE; SEQUENCE; RETROTRANSPOSONS; DIVERSITY; DISCOVERY; ALIGNMENT	Schistosoma mansoni is responsible for the neglected tropical disease schistosomiasis that affects 210 million people in 76 countries. Here we present analysis of the 363 megabase nuclear genome of the blood fluke. It encodes at least 11,809 genes, with an unusual intron size distribution, and new families of micro-exon genes that undergo frequent alternative splicing. As the first sequenced flatworm, and a representative of the Lophotrochozoa, it offers insights into early events in the evolution of the animals, including the development of a body pattern with bilateral symmetry, and the development of tissues into organs. Our analysis has been informed by the need to find new drug targets. The deficits in lipid metabolism that make schistosomes dependent on the host are revealed, and the identification of membrane receptors, ion channels and more than 300 proteases provide new insights into the biology of the life cycle and new targets. Bioinformatics approaches have identified metabolic chokepoints, and a chemogenomic screen has pinpointed schistosome proteins for which existing drugs may be active. The information generated provides an invaluable resource for the research community to develop much needed new control tools for the treatment and eradication of this important and neglected disease.	[Berriman, Matthew; Aslett, Martin A.; Eyre, Tina; Gamble, John A.; Gu, Yong; Hertz-Fowler, Christiane; Houston, Robin; Ivens, Alasdair; Parkhill, Julian; Protasio, Anna V.; Quail, Michael A.; Rajandream, Marie-Adele; Rogers, Jane; Tivey, Adrian R.; Barrell, Barclay G.] Wellcome Trust Sanger Inst, Cambridge CB10 1SD, England; [Coulson, Richard; Overington, John P.] European Bioinformat Inst EMBL, Cambridge CB10 1SD, England; [Haas, Brian J.; Bartholomeu, Daniella C.; Blandin, Gaelle; Djikeng, Appolinaire; Ghedin, Elodie; Lacerda, Daniela; White, Owen; Wortman, Jennifer; Fraser-Liggett, Claire M.; El-Sayed, Najib M.] J Craig Venter Inst, Inst Genom Res, Rockville, MD 20850 USA; [LoVerde, Philip T.; Ashton, Peter D.; Wu, Wenjie] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [LoVerde, Philip T.; Ashton, Peter D.; Wu, Wenjie] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Wilson, R. Alan; Dillon, Gary P.; DeMarco, Ricardo] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Cerqueira, Gustavo C.; Macedo, Camila D.; El-Sayed, Najib M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Cerqueira, Gustavo C.; Delcher, Art; Pertea, Mihaela; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Cerqueira, Gustavo C.; Macedo, Camila D.; Salzberg, Steven L.; El-Sayed, Najib M.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mashiyama, Susan T.; Caffrey, Conor R.; Sajid, Mohammed] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Mashiyama, Susan T.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [Mashiyama, Susan T.] Univ Calif San Francisco, Dept Pharmaceut Chem, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [Al-Lazikani, Bissan; Zerlotini, Adhemar] Inst Canc Res, Haddow Labs, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; [Andrade, Luiza F.; Oliveira, Guilherme] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Coghlan, Avril] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Day, Tim A.; McVeigh, Paul; Zamanian, Mostafa] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [DeMarco, Ricardo] Univ Sao Paulo, Inst Quim, BR-05508 Sao Paulo, Brazil; [DeMarco, Ricardo] Univ Sao Paulo, Inst Fis Sao Carlos, BR-05508 Sao Paulo, Brazil; [Hirai, Hirohisha; Hirai, Yuriko] Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan; [Johnston, David A.] Nat Hist Museum, Biomed Parasitol Div, London SW7 5BD, England; [Pierce, Raymond J.] Univ Lille 2, INSERM, U547, Inst Pasteur Lille,IFR 142, Lille, France; [Stanke, Mario] Univ Gottingen, Inst Mikrobiol & Genet, Abt Bioinformat, D-37077 Gottingen, Germany; [Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); J. Craig Venter Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of York - UK; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research UK; University of London; Institute of Cancer Research - UK; Fundacao Oswaldo Cruz; University College Cork; Iowa State University; Universidade de Sao Paulo; Universidade de Sao Paulo; Kyoto University; Natural History Museum London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Gottingen; Illinois State University	Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	mb4@sanger.ac.uk; elsayed@umd.edu	Salzberg, Steven/Q-6514-2019; DeMarco, Ricardo/A-7773-2008; Cerqueira, Gustavo/AAV-7398-2020; Salzberg, Steven L/F-6162-2011; Al-Lazikani, Bissan/AAG-4723-2022; DoenÃas Tropicais, Inct/K-2308-2013; Protasio, Anna/F-7751-2016; Al-Lazikani, Bissan/AFK-6457-2022; 4, INCT/H-4499-2013; Ghedin, Elodie/Y-5654-2019; Zamanian, Mostafa/B-7993-2013; El-Sayed, Najib M.A./K-7266-2015; Pertea, Mihaela/AAT-2705-2021; Parkhill, Julian/G-4703-2011; Zerlotini, Adhemar/E-6533-2012; Ning, Zemin/D-2411-2013; Overington, John P./E-5764-2010; Wilson, Alan/AAD-5050-2020; Stanke, Mario/P-7876-2019; Inbeqmedi, Inct/I-1929-2013; Protasio, Anna V./AAJ-8991-2020; McVeigh, Paul/AAV-7138-2020; Overington, John P/G-8607-2015; Blandin, Gaelle/N-9745-2013; Quail, michael/ABE-6131-2020; Bartholomeu, Daniella C./J-4714-2015; Berriman, Matthew/A-7618-2011; Oliveira, Guilherme/E-2624-2014	Salzberg, Steven/0000-0002-8859-7432; DeMarco, Ricardo/0000-0001-8944-1301; Cerqueira, Gustavo/0000-0002-7692-3886; Salzberg, Steven L/0000-0002-8859-7432; Protasio, Anna/0000-0003-1723-800X; Ghedin, Elodie/0000-0002-1515-725X; El-Sayed, Najib M.A./0000-0001-7970-3312; Pertea, Mihaela/0000-0003-0762-8637; Parkhill, Julian/0000-0002-7069-5958; Zerlotini, Adhemar/0000-0002-7739-0284; Overington, John P./0000-0002-5859-1064; Stanke, Mario/0000-0001-8696-0384; Protasio, Anna V./0000-0003-1723-800X; McVeigh, Paul/0000-0003-1850-9692; Overington, John P/0000-0002-5859-1064; Blandin, Gaelle/0000-0003-2790-9524; Bartholomeu, Daniella C./0000-0003-0974-7357; Berriman, Matthew/0000-0002-9581-0377; Djikeng, Appolinaire/0000-0001-9271-3419; Ivens, Al/0000-0002-0112-3876; Johnston, David/0000-0001-6703-6014; Day, Tim/0000-0002-9037-6540; Fraser, Claire/0000-0003-1462-2428; Al-Lazikani, Bissan/0000-0003-3367-2519; Oliveira, Guilherme/0000-0003-0054-3438; Wilson, Alan/0000-0002-7210-0321; Pierce, Raymond/0000-0001-9820-8608; Ning, Zemin/0000-0003-4359-776X; Ashton, Peter/0000-0002-7446-5009; Zamanian, Mostafa/0000-0001-9233-1760; Dillon, Gary/0000-0002-7743-5040; Wortman, Jennifer/0000-0002-8713-1227; Hertz-Fowler, Christiane/0000-0002-0729-6479; Coghlan, Avril/0000-0002-2775-5951; Wu, Wenjie/0000-0002-0907-0561	Wellcome Trust [WT085775/Z/08/Z]; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI48828]; Oyama Health Foundation; Japan Society for the Promotion of Science [13557021]; Japan's Ministry of Education, Culture, Sports, Science and Technology; Sandler Foundation; NIH-Fogarty [5D43TW006580, 5D43TW007012-03]; NIH [AI054711-01A2]; PhRMA Foundation; Burroughs Wellcome Fund; United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO); CAPES; FAPESP;  [FAPEMIG REDE-281/05]; FOGARTY INTERNATIONAL CENTER [D43TW006580, D43TW007012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054711, U01AI048828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873, R01GM060595] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oyama Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sandler Foundation; NIH-Fogarty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO)(World Health Organization); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The genome sequencing and annotation work was funded by the Wellcome Trust (grant number WT085775/Z/08/Z) and the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant AI48828 to N. M. E.-S. We thank N. D. Rawlings of the MEROPS database team at the Wellcome Trust Sanger Institute for his help, J. C. Illes for discussions on polarity complexes, and F. Prosdocimi and M. R. D. Sananes for early discussions and analyses in the project. FISH chromosome mappings were partially supported by Oyama Health Foundation (H. H.), Japan Society for the Promotion of Science (13557021) (H. H.), 21st century Centers of Exellence and global Centers of Excellence of Japan's Ministry of Education, Culture, Sports, Science and Technology. Additional support was by The Sandler Foundation (C. R. C. and M. S.), NIH-Fogarty 5D43TW006580 (P. T. L.), NIH-Fogarty 5D43TW007012-03, NIH grant AI054711-01A2 (R. A. W. and G. P. D.), FAPEMIG REDE-281/05 (G. O.), the PhRMA Foundation (Postdoctoral Fellowship in Informatics to S. T. M.), The Burroughs Wellcome Fund (P. T. L.) and the United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO) Special program for research and training in tropical diseases (TDR) (P. T. L.). R. D. was a recipient of CAPES and FAPESP fellowships.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anamika K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-625; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barrett J., 1981, BIOCH PARASITIC HELM; Berriman M, 2004, METH MOL B, V270, P17; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biedler J, 2003, MOL BIOL EVOL, V20, P1811, DOI 10.1093/molbev/msg189; Boyle SN, 2007, DRUG DISCOV TODAY, V12, P717, DOI 10.1016/j.drudis.2007.07.019; Brouwers JFHM, 1997, MOL BIOCHEM PARASIT, V88, P175, DOI 10.1016/S0166-6851(97)00091-1; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Caffrey CR, 2008, EXPERT OPIN DRUG DIS, V3, P173, DOI 10.1517/17460441.3.2.173; CAO M, 1993, MOL BIOCHEM PARASIT, V57, P175, DOI 10.1016/0166-6851(93)90256-W; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DeMarco R, 2005, BIOCHEM BIOPH RES CO, V333, P230, DOI 10.1016/j.bbrc.2005.05.080; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Drew AC, 1999, MOL BIOL EVOL, V16, P1256, DOI 10.1093/oxfordjournals.molbev.a026216; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FLETCHER M, 1981, AM J TROP MED HYG, V30, P406, DOI 10.4269/ajtmh.1981.30.406; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hamdan FF, 2002, MOL BIOCHEM PARASIT, V119, P75, DOI 10.1016/S0166-6851(01)00400-5; Hirai H, 2004, METH MOL B, V270, P379; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Humphries JE, 2004, J BIOL CHEM, V279, P39880, DOI 10.1074/jbc.M405624200; Ieko M, 2006, FRONT BIOSCI-LANDMRK, V11, P232, DOI 10.2741/1794; Jeziorski MC, 2006, INT J PARASITOL, V36, P625, DOI 10.1016/j.ijpara.2006.02.002; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIM E, 1995, PARASITOLOGY, V110, P171, DOI 10.1017/S0031182000063939; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Paslier MC, 2000, GENOMICS, V65, P87, DOI 10.1006/geno.2000.6147; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning Gerard, 2005, WormBook, P1; Morales FC, 2004, MOL BIOCHEM PARASIT, V134, P65, DOI 10.1016/j.molbiopara.2003.10.016; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Nash T, 1998, ANTIMICROB AGENTS CH, V42, P1488, DOI 10.1128/AAC.42.6.1488; Okun I, 2008, ANTI-CANCER AGENT ME, V8, P322, DOI 10.2174/187152008783961914; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salkoff L, 2005, WormBook, P1; Sambon L. W., 1907, J TROP MED HYG, V10, P117; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; SIMPSON AJG, 1982, MOL BIOCHEM PARASIT, V6, P125, DOI 10.1016/0166-6851(82)90070-6; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Volfovsky N, 2003, GENOME RES, V13, P1216, DOI 10.1101/gr.677503; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu WJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-27; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	85	801	832	1	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					352	U65		10.1038/nature08160	http://dx.doi.org/10.1038/nature08160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606141	hybrid, Green Accepted			2022-12-24	WOS:000267979000029
J	Nakatani, J; Tamada, K; Hatanaka, F; Ise, S; Ohta, H; Inoue, K; Tomonaga, S; Watanabe, Y; Chung, YJ; Banerjee, R; Iwamoto, K; Kato, T; Okazawa, M; Yamauchi, K; Tanda, K; Takao, K; Miyakawa, T; Bradley, A; Takumi, T				Nakatani, Jin; Tamada, Kota; Hatanaka, Fumiyuki; Ise, Satoko; Ohta, Hisashi; Inoue, Kiyoshi; Tomonaga, Shozo; Watanabe, Yasuhito; Chung, Yeun Jun; Banerjee, Ruby; Iwamoto, Kazuya; Kato, Tadafumi; Okazawa, Makoto; Yamauchi, Kenta; Tanda, Koichi; Takao, Keizo; Miyakawa, Tsuyoshi; Bradley, Allan; Takumi, Toru			Abnormal Behavior in a Chromosome-Engineered Mouse Model for Human 15q11-13 Duplication Seen in Autism	CELL			English	Article							SOCIAL-INTERACTION; DEVELOPMENTAL NEUROBIOLOGY; SPECTRUM DISORDERS; PROXIMAL 15Q; GENETICS; COMPLEX; BRAIN; MICE; REARRANGEMENTS; DEFICITS	Substantial evidence suggests that chromosomal abnormalities contribute to the risk of autism. The duplication of human chromosome 15q11-13 is known to be the most frequent cytogenetic abnormality in autism. We have modeled this genetic change in mice by using chromosome engineering to generate a 6.3 Mb duplication of the conserved linkage group on mouse chromosome 7. Mice with a paternal duplication display poor social interaction, behavioral inflexibility, abnormal ultrasonic vocalizations, and correlates of anxiety. An increased MBII52 snoRNA within the duplicated region, affecting the serotonin 2c receptor (5-HT2cR), correlates with altered intracellular Ca2+ responses elicited by a 5-HT2cR agonist in neurons of mice with a paternal duplication. This chromosome-engineered mouse model for autism seems to replicate various aspects of human autistic phenotypes and validates the relevance of the human chromosome abnormality. This model will facilitate forward genetics of developmental brain disorders and serve as an invaluable tool for therapeutic development.	[Nakatani, Jin; Tamada, Kota; Hatanaka, Fumiyuki; Inoue, Kiyoshi; Tomonaga, Shozo; Watanabe, Yasuhito; Okazawa, Makoto; Takumi, Toru] Osaka Biosci Inst, Osaka 5650874, Japan; [Tamada, Kota; Watanabe, Yasuhito] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Hatanaka, Fumiyuki; Takumi, Toru] Kyoto Univ, Dept Mol Neurosci, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Ise, Satoko; Ohta, Hisashi] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan; [Chung, Yeun Jun; Banerjee, Ruby; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Iwamoto, Kazuya; Kato, Tadafumi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kato, Tadafumi; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348553, Japan; [Yamauchi, Kenta; Tanda, Koichi; Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Frontier Technol Inst, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med, Inst Comprehens Med Sci, Aichi 4701192, Japan	Kyoto University; Kyoto University; Merck & Company; Novartis; Wellcome Trust Sanger Institute; RIKEN; Hiroshima University; Kyoto University; Fujita Health University	Takumi, T (corresponding author), Osaka Biosci Inst, Osaka 5650874, Japan.	takumi@hiroshima-u.ac.jp	Takao, Keizo/B-9527-2008; Kato, Tadafumi/J-3583-2014; Miyakawa, Tsuyoshi/A-7741-2008; Tomonaga, Shozo/S-3307-2018	Takao, Keizo/0000-0002-4734-3583; Kato, Tadafumi/0000-0001-7856-3952; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Tomonaga, Shozo/0000-0003-0888-1407; Yamauchi, Kenta/0000-0002-7090-3067; Bradley, Allan/0000-0002-2349-8839	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Neuroinformatics Japan Center; Institute for Bioinformatics Research and Development; Core Research for Evolutional Science and Technology; Mitsubishi Foundation; Mother and Child Health Foundation; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Sony Corporation; Nippon Boehringer Ingelheim Co., Ltd; Wellcome Trust	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Neuroinformatics Japan Center; Institute for Bioinformatics Research and Development; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Mother and Child Health Foundation(Mother and Child Health Foundation); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Sony Corporation; Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission)	T. T. acknowledges M. Young for discussions that led to start this project and K. Tanaka, O. Hayaishi, H. Hanafusa, and S. Nakanishi for general support. The authors thank K. Sakimura and M. Abe for their help in the initial stage of this study; N. Nakai, A. Yamamoto, T. Sudo, F. Law, A. Beasley, E. Grau, T. Hamilton, L. Davis, H. Kitson, H. Ogino, and R. Takayama for technical assistance; W. Wang, D. Adams, N. Conte, T. Kishino, T. Manabe, and P. Levitt for valuable comments; and all members of the Takumi laboratory. We also thank K. Nakao and members of Animal Resource Unit, RIKEN Center for Developmental Biology, for breeding of mice. J. N. and S. T. were supported by a Japan Society for the Promotion of Science fellowship. This work was supported in part by a grant from the Grants-in-Aid for Scientific Research on Priority AreasResearch on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology, the Neuroinformatics Japan Center, the Institute for Bioinformatics Research and Development, and Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, and by research grants from the Mitsubishi Foundation, the Mother and Child Health Foundation, the Mitsubishi Pharma Research Foundation, the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, Sony Corporation, Nippon Boehringer Ingelheim Co., Ltd, and the Wellcome Trust.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bolton PF, 2004, PSYCHIAT GENET, V14, P131, DOI 10.1097/00041444-200409000-00002; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Caston J, 1998, EUR J NEUROSCI, V10, P2677, DOI 10.1046/j.1460-9568.1998.t01-1-00272.x; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cook EH, 1997, AM J HUM GENET, V60, P928; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Dykens EM, 2004, MENT RETARD DEV D R, V10, P284, DOI 10.1002/mrdd.20042; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geurts HM, 2009, TRENDS COGN SCI, V13, P74, DOI 10.1016/j.tics.2008.11.006; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Maestrini E, 2000, NEURON, V28, P19, DOI 10.1016/S0896-6273(00)00081-7; Mao R, 2000, GENET MED, V2, P131, DOI 10.1097/00125817-200003000-00003; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Mohandas TK, 1999, AM J MED GENET, V82, P294, DOI 10.1002/(SICI)1096-8628(19990212)82:4<294::AID-AJMG4>3.3.CO;2-L; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Murcia CL, 2005, INT J DEV NEUROSCI, V23, P265, DOI 10.1016/j.ijdevneu.2004.07.001; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; NOIROT E, 1966, ANIM BEHAV, V14, P459, DOI 10.1016/S0003-3472(66)80045-3; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Roberts SE, 2002, HUM GENET, V110, P227, DOI 10.1007/s00439-002-0678-6; Rosenzweig-Lipson S, 2006, BRAIN RES, V1073, P240, DOI 10.1016/j.brainres.2005.12.052; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; van der Weyden L, 2006, ANNU REV GENOM HUM G, V7, P247, DOI 10.1146/annurev.genom.7.080505.115741; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veltman MWM, 2005, J AUTISM DEV DISORD, V35, P117, DOI 10.1007/s10803-004-1039-1; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Whitaker-Azmitia PM, 2005, INT J DEV NEUROSCI, V23, P75, DOI 10.1016/j.ijdevneu.2004.07.022; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Young LJ, 2007, NEURON, V54, P353, DOI 10.1016/j.neuron.2007.04.011; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	60	323	340	4	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1235	1246		10.1016/j.cell.2009.04.024	http://dx.doi.org/10.1016/j.cell.2009.04.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563756	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000267373400017
J	Johnston, RJ; Poholek, AC; DiToro, D; Yusuf, I; Eto, D; Barnett, B; Dent, AL; Craft, J; Crotty, S				Johnston, Robert J.; Poholek, Amanda C.; DiToro, Daniel; Yusuf, Isharat; Eto, Danelle; Barnett, Burton; Dent, Alexander L.; Craft, Joe; Crotty, Shane			Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; GERMINAL-CENTER FORMATION; IMMUNE-RESPONSES; IN-VIVO; B-CELLS; GENE-EXPRESSION; PROVIDE HELP; INFLAMMATION; FOLLICLES; SAP	Effective B cell-mediated immunity and antibody responses often require help from CD4(+) T cells. It is thought that a distinct CD4(+) effector T cell subset, called T follicular helper cells (T-FH), provides this help; however, the molecular requirements for T-FH differentiation are unknown. We found that expression of the transcription factor Bcl6 in CD4(+) T cells is both necessary and sufficient for in vivo T-FH differentiation and T cell help to B cells in mice. In contrast, the transcription factor Blimp-1, an antagonist of Bcl6, inhibits T-FH differentiation and help, thereby preventing B cell germinal center and antibody responses. These findings demonstrate that T-FH cells are required for proper B cell responses in vivo and that Bcl6 and Blimp-1 play central but opposing roles in T-FH differentiation.	[Johnston, Robert J.; DiToro, Daniel; Yusuf, Isharat; Eto, Danelle; Barnett, Burton; Crotty, Shane] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Johnston, Robert J.; Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92037 USA; [Poholek, Amanda C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Yale University; Yale University	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, 9420 Athena Circle, La Jolla, CA 92037 USA.	shane@liai.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	LIAI institutional funds; Pew Scholar Award; Cancer Research Institute; National Institute of Allergy and Infectious Diseases [R01 072543]; NIAID [R01 063107]; Rheuminations Inc.; Arthritis Foundation; Connecticut Chapter of the Lupus Foundation of America; NIH [AR40072, AR44076, P30 AR053495]; UCSD/LIAI; NCBI Gene Expression Omnibus [GSE16697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, R01AI072543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, P30AR053495, R01AR040072, R01AR044076] Funding Source: NIH RePORTER	LIAI institutional funds; Pew Scholar Award; Cancer Research Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rheuminations Inc.; Arthritis Foundation; Connecticut Chapter of the Lupus Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD/LIAI; NCBI Gene Expression Omnibus; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by LIAI institutional funds, a Pew Scholar Award, a Cancer Research Institute Award, and National Institute of Allergy and Infectious Diseases grants R01 072543 and NIAID R01 063107 (S.C.), Rheuminations Inc., the Arthritis Foundation, the Connecticut Chapter of the Lupus Foundation of America, and NIH grants AR40072, AR44076, and P30 AR053495 (J.C.), and fellowships from the UCSD/LIAI Immunology NIH Training Grant (I.Y. and R.J.J.). R.J.J. is a member of the UCSD Biomedical Sciences (BMS) graduate program. Microarray data have been deposited at the NCBI Gene Expression Omnibus (GSE16697).	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; TSIAGBE VK, 1998, BIOL GERMINAL CTR LY, P1; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	39	1097	1151	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1006	1010		10.1126/science.1175870	http://dx.doi.org/10.1126/science.1175870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608860	Green Accepted			2022-12-24	WOS:000269242800049
J	Chakravarthy, MV; Lodhi, IJ; Yin, L; Malapaka, RRV; Xu, HE; Turk, J; Semenkovich, CF				Chakravarthy, Manu V.; Lodhi, Irfan J.; Yin, Li; Malapaka, Raghu R. V.; Xu, H. Eric; Turk, John; Semenkovich, Clay F.			Identification of a Physiologically Relevant Endogenous Ligand for PPAR alpha in Liver	CELL			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; TANDEM MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; FATTY-ACID; BINDING DOMAIN; PHOSPHOLIPIDS; PHOSPHATIDYLCHOLINE; EICOSANOIDS; GAMMA; MICE	The nuclear receptor PPAR alpha is activated by drugs to treat human disorders of lipid metabolism. Its endogenous ligand is unknown. PPAR alpha-dependent gene expression is impaired with inactivation of fatty acid synthase (FAS), suggesting that FAS is involved in generation of a PPAR alpha ligand. Here we demonstrate the FAS-dependent presence of a phospholipid bound to PPAR alpha isolated from mouse liver. Binding was increased under conditions that induce FAS activity and displaced by systemic injection of a PPAR alpha agonist. Mass spectrometry identified the species as 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Knockdown of Cept1, required for phosphatidylcholine synthesis, suppressed PPAR alpha-dependent gene expression. Interaction of 16:0/18:1-GPC with the PPAR alpha ligand-binding domain and coactivator peptide motifs was comparable to PPAR alpha agonists, but interactions with PPAR delta were weak and none were detected with PPAR gamma. Portal vein infusion of 16:0/18:1-GPC induced PPAR alpha-dependent gene expression and decreased hepatic steatosis. These data suggest that 16:0/18:1-GPC is a physiologically relevant endogenous PPAR alpha ligand.	[Chakravarthy, Manu V.; Lodhi, Irfan J.; Yin, Li; Turk, John; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Malapaka, Raghu R. V.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Washington University (WUSTL); Washington University (WUSTL); Van Andel Institute	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021; Malapaka, Raghu/B-6185-2012; Xu, H. Eric/ABD-7487-2021	Chakravarthy, Manu/0000-0002-3699-150X; Semenkovich, Clay/0000-0003-1163-1871; Lodhi, Irfan/0000-0002-6246-9862; Xu, H. Eric/0000-0002-6829-8144	NIH [DK076729, P50 HL083762, R37 DK34388, P41 RR00954, HL089301]; Clinical Nutrition Research Unit [DK56341]; Diabetes Research and Training Center [DK20579]; Betty Van Andel Foundation; American Diabetes Association [1-07-JF-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762, R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, R01DK076729, P30DK056341, P60DK020579, P30DK020579] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit; Diabetes Research and Training Center; Betty Van Andel Foundation; American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK076729, P50 HL083762, R37 DK34388, P41 RR00954, HL089301, the Clinical Nutrition Research Unit (DK56341), the Diabetes Research and Training Center (DK20579), the Jay and Betty Van Andel Foundation, and the American Diabetes Association ( Junior Faculty Award 1-07-JF-12 to M. V. C. and a Mentor-Based Postdoctoral Fellowship Award).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Forman BM, 2005, CELL METAB, V1, P153, DOI 10.1016/j.cmet.2005.02.006; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lee H, 2000, CIRC RES, V87, P516; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nichols JS, 1998, ANAL BIOCHEM, V257, P112, DOI 10.1006/abio.1997.2557; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ridgway ND, 2003, BIOCHEM J, V372, P811, DOI 10.1042/BJ20030252; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Stremmel W, 2007, ANN INTERN MED, V147, P603, DOI 10.7326/0003-4819-147-9-200711060-00004; Strubbe JH, 1999, PHYSIOL BEHAV, V65, P885; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	45	386	401	4	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					476	488		10.1016/j.cell.2009.05.036	http://dx.doi.org/10.1016/j.cell.2009.05.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19646743	Green Accepted, Bronze			2022-12-24	WOS:000268771900013
J	Zhang, C; Wu, B; Beglopoulos, V; Wines-Samuelson, M; Zhang, DW; Dragatsis, I; Sudhof, TC; Shen, J				Zhang, Chen; Wu, Bei; Beglopoulos, Vassilios; Wines-Samuelson, Mary; Zhang, Dawei; Dragatsis, Ioannis; Suedhof, Thomas C.; Shen, Jie			Presenilins are essential for regulating neurotransmitter release	NATURE			English	Article							ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; AMYLOID-BETA; TRANSMITTER RELEASE; CORTICAL-NEURONS; TRANSGENIC MICE; RECEPTOR; MEMORY; INACTIVATION; PROBABILITY	Mutations in the presenilin genes are the main cause of familial Alzheimer's disease. Loss of presenilin activity and/or accumulation of amyloid-beta peptides have been proposed to mediate the pathogenesis of Alzheimer's disease by impairing synaptic function(1-5). However, the precise site and nature of the synaptic dysfunction remain unknown. Here we use a genetic approach to inactivate presenilins conditionally in either presynaptic (CA3) or postsynaptic (CA1) neurons of the hippocampal Schaeffer-collateral pathway. We show that long-term potentiation induced by theta-burst stimulation is decreased after presynaptic but not postsynaptic deletion of presenilins. Moreover, we found that presynaptic but not postsynaptic inactivation of presenilins alters short-term plasticity and synaptic facilitation. The probability of evoked glutamate release, measured with the open-channel NMDA (N-methyl-D-aspartate) receptor antagonist MK-801, is reduced by presynaptic inactivation of presenilins. Notably, depletion of endoplasmic reticulum Ca2+ stores by thapsigargin, or blockade of Ca2+ release from these stores by ryanodine receptor inhibitors, mimics and occludes the effects of presynaptic presenilin inactivation. Collectively, these results indicate a selective role for presenilins in the activity-dependent regulation of neurotransmitter release and long-term potentiation induction by modulation of intracellular Ca2+ release in presynaptic terminals, and further suggest that presynaptic dysfunction might be an early pathogenic event leading to dementia and neurodegeneration in Alzheimer's disease.	[Zhang, Chen; Wu, Bei; Beglopoulos, Vassilios; Wines-Samuelson, Mary; Zhang, Dawei; Shen, Jie] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA; [Zhang, Chen; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Dragatsis, Ioannis] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; University of Tennessee System; University of Tennessee Health Science Center	Shen, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022; Wu, Bei/F-6659-2012		National Institutes of Health [R01NS041783]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank K. Nakazawa and S. Tonegawa for Grik4-Cre transgenic mice, R. Kelleher for discussions and comments, and X. Zou for technical assistance. This work was supported by a grant from the National Institutes of Health (NIH; R01NS041783 to J. S.).	Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Handler M, 2000, DEVELOPMENT, V127, P2593; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lazarov O, 2002, J NEUROSCI, V22, P9785; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845	34	214	221	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					632	U100		10.1038/nature08177	http://dx.doi.org/10.1038/nature08177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641596	Green Submitted, Green Accepted			2022-12-24	WOS:000268454300051
J	Gruber, JJ; Zatechka, DS; Sabin, LR; Yong, J; Lum, JJ; Kong, M; Zong, WX; Zhang, ZX; Lau, CK; Rawlings, J; Cherry, S; Ihle, JN; Dreyfuss, G; Thompson, CB				Gruber, Joshua J.; Zatechka, D. Steven; Sabin, Leah R.; Yong, Jeongsik; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Zhang, Zhenxi; Lau, Chi-Kong; Rawlings, Jason; Cherry, Sara; Ihle, James N.; Dreyfuss, Gideon; Thompson, Craig B.			Ars2 Links the Nuclear Cap-Binding Complex to RNA Interference and Cell Proliferation	CELL			English	Article							MESSENGER-RNA; PROTEOMIC ANALYSIS; PROTEIN; SERRATE; MICRORNAS; MIRNA; EXPORT; GENES	Here we identify a component of the nuclear RNA cap-binding complex (CBC), Ars2, that is important for miRNA biogenesis and critical for cell proliferation. Unlike other components of the CBC, Ars2 expression is linked to the proliferative state of the cell. Deletion of Ars2 is developmentally lethal, and deletion in adult mice led to bone marrow failure whereas parenchymal organs composed of nonproliferating cells were unaffected. Depletion of Ars2 or CBP80 from proliferating cells impaired miRNA-mediated repression and led to alterations in primary miRNA processing in the nucleus. Ars2 depletion also reduced the levels of several miRNAs, including miR-21, let-7, and miR-155, that are implicated in cellular transformation. These findings provide evidence for a role for Ars2 in RNA interference regulation during cell proliferation.	[Gruber, Joshua J.; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Thompson, Craig B.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gruber, Joshua J.; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Zatechka, D. Steven; Rawlings, Jason; Ihle, James N.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Sabin, Leah R.; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Yong, Jeongsik; Zhang, Zhenxi; Lau, Chi-Kong; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; St Jude Children's Research Hospital; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu	Lau, Terrence/ABB-7900-2021; Rawlings, Jason/H-4457-2011; Dreyfuss, Gideon/D-1218-2013	Lau, Terrence/0000-0002-7505-7306; Dreyfuss, Gideon/0000-0001-8129-8774; Sabin, Leah/0000-0003-1757-7415; Lum, Julian/0000-0002-5624-3541; cherry, sara/0000-0003-3956-6610	NIH; A.F.C.R.I; NATIONAL CANCER INSTITUTE [K01CA098092, R01CA099179, R01CA092660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.F.C.R.I; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Zissimos Mourelatos for helpful discussions and providing luciferase reporters. We thank Iain Mattaj for kindly providing CBC antibodies, Ramin Shiekhattar for kindly providing Flag-Dicer and Flag-Drosha plasmids, and Michael Milone for providing a pri-miR-155 plasmid. We thank Jim Alwine, Scott Poethig, and members of the Thompson and Dreyfuss laboratories for discussions and inspiration. J.J.G. and C. B. T. are supported by funds from the NIH and the A.F.C.R.I.	Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kiriakidou M, 2005, METH MOL B, V309, P295; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Oh SW, 2003, GENETICS, V163, P195; OHNO M, 1990, NUCLEIC ACIDS RES, V18, P6989, DOI 10.1093/nar/18.23.6989; Papp I, 2004, PLANT MOL BIOL, V55, P679, DOI 10.1007/s11103-004-1680-2; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rossman TG, 1999, CARCINOGENESIS, V20, P311, DOI 10.1093/carcin/20.2.311; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	38	140	152	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					328	339		10.1016/j.cell.2009.04.046	http://dx.doi.org/10.1016/j.cell.2009.04.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632182	Green Accepted, Bronze			2022-12-24	WOS:000268277000014
J	Schraml, BU; Hildner, K; Ise, W; Lee, WL; Smith, WAE; Solomon, B; Sahota, G; Sim, J; Mukasa, R; Cemerski, S; Hatton, RD; Stormo, GD; Weaver, CT; Russell, JH; Murphy, TL; Murphy, KM				Schraml, Barbara U.; Hildner, Kai; Ise, Wataru; Lee, Wan-Ling; Smith, Whitney A. -E.; Solomon, Ben; Sahota, Gurmukh; Sim, Julia; Mukasa, Ryuta; Cemerski, Saso; Hatton, Robin D.; Stormo, Gary D.; Weaver, Casey T.; Russell, John H.; Murphy, Theresa L.; Murphy, Kenneth M.			The AP-1 transcription factor Batf controls T(H)17 differentiation	NATURE			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; ACTIVATOR PROTEIN-1; CELL-DIFFERENTIATION; NEGATIVE REGULATOR; TRANSGENIC MICE; TH17 CELLS; IN-VITRO; B-ATF; IL-21	Activator protein 1 (AP-1, also known as JUN) transcription factors are dimers of JUN, FOS, MAF and activating transcription factor (ATF) family proteins characterized by basic region and leucine zipper domains(1). Many AP-1 proteins contain defined transcriptional activation domains, but BATF and the closely related BATF3 (refs 2, 3) contain only a basic region and leucine zipper, and are considered to be inhibitors of AP-1 activity(3-8). Here we show that Batf is required for the differentiation of IL17-producing T helper (T(H)17) cells(9). T(H)17 cells comprise a CD4(+) T-cell subset that coordinates inflammatory responses in host defence but is pathogenic in autoimmunity(10-13). Batf(-/-) mice have normal T(H)1 and T(H)2 differentiation, but show a defect in T(H)17 differentiation, and are resistant to experimental autoimmune encephalomyelitis. Batf(-/-) T cells fail to induce known factors required for T(H)17 differentiation, such as ROR gamma t(11) (encoded by Rorc) and the cytokine IL21 (refs 14-17). Neither the addition of IL21 nor the overexpression of ROR gamma t fully restores IL17 production in Batf(-/-) T cells. The Il17 promoter is BATF-responsive, and after T(H)17 differentiation, BATF binds conserved intergenic elements in the Il17a-Il17f locus and to the Il17, Il21 and Il22 (ref. 18) promoters. These results demonstrate that the AP-1 protein BATF has a critical role in T(H)17 differentiation.	[Schraml, Barbara U.; Hildner, Kai; Ise, Wataru; Lee, Wan-Ling; Smith, Whitney A. -E.; Solomon, Ben; Cemerski, Saso; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Ise, Wataru; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Sahota, Gurmukh; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Sim, Julia; Russell, John H.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Mukasa, Ryuta; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850; Solomon, Benjamin/0000-0003-1009-7312; Weaver, Casey/0000-0002-2180-1793; Russell, John/0000-0002-3680-9587; Schraml, Barbara/0000-0002-5801-0151; Hatton, Robin/0000-0002-4797-9899	Howard Hughes Medical Institute; National Institutes of Health [HG00249, GM07200, AI035783, AR049293]; Daiichi-Sankyo Co. Ltd; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783, R21AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR049293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802, T32GM007200] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi-Sankyo Co. Ltd(Daiichi Sankyo Company Limited); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lallone for anti-BATF antibody preparation, and B. Sleckman for Cre-expressing adenovirus. This work was supported by the Howard Hughes Medical Institute (K. M. M.), and grants from the National Institutes of Health HG00249 and training grant GM07200 (G. D. S.), AI035783 (C. T. W.), AR049293 (R. D. H.), and from Daiichi-Sankyo Co. Ltd (C. T. W.).	Betti M, 2006, ANN ONCOL, V17, P235; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bower KE, 2004, ONCOGENE, V23, P8805, DOI 10.1038/sj.onc.1208109; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Thornton TM, 2006, EUR J IMMUNOL, V36, P160, DOI 10.1002/eji.200535215; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Williams KL, 2003, J IMMUNOL, V170, P2417, DOI 10.4049/jimmunol.170.5.2417; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	33	421	441	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					405	U125		10.1038/nature08114	http://dx.doi.org/10.1038/nature08114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19578362	Green Accepted			2022-12-24	WOS:000267979000041
J	Saveanu, L; Carroll, O; Weimershaus, M; Guermonprez, P; Firat, E; Lindo, V; Greer, F; Davoust, J; Kratzer, R; Keller, SR; Niedermann, G; van Endert, P				Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Guermonprez, Pierre; Firat, Elke; Lindo, Vivian; Greer, Fiona; Davoust, Jean; Kratzer, Roland; Keller, Susanna R.; Niedermann, Gabriele; van Endert, Peter			IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation	SCIENCE			English	Article							INSULIN-REGULATED AMINOPEPTIDASE; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; DENDRITIC CELLS; PEPTIDES; CROSSPRESENTATION; GLUT4; MOLECULES; NETWORK; PATHWAY	Major histocompatibility complex (MHC) class I molecules present peptides, produced through cytosolic proteasomal degradation of cellular proteins, to cytotoxic T lymphocytes. In dendritic cells, the peptides can also be derived from internalized antigens through a process known as cross-presentation. The cellular compartments involved in cross-presentation remain poorly defined. We found a role for peptide trimming by insulin-regulated aminopeptidase (IRAP) in cross-presentation. In human dendritic cells, IRAP was localized to a Rab14(+) endosomal storage compartment in which it interacted with MHC class I molecules. IRAP deficiency compromised cross-presentation in vitro and in vivo but did not affect endogenous presentation. We propose the existence of two pathways for proteasome-dependent cross-presentation in which final peptide trimming involves IRAP in endosomes and involves the related aminopeptidases in the endoplasmic reticulum.	[Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Davoust, Jean; Kratzer, Roland; van Endert, Peter] INSERM, U580, F-75015 Paris, France; [Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Davoust, Jean; Kratzer, Roland; van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, F-75015 Paris, France; [Guermonprez, Pierre] INSERM, U653, F-75006 Paris, France; [Guermonprez, Pierre] Inst Curie, Ctr Rech, F-75006 Paris, France; [Firat, Elke; Niedermann, Gabriele] Univ Hosp Freiburg, Clin Radiotherapy, D-79106 Freiburg, Germany; [Lindo, Vivian; Greer, Fiona] M SCAN Ltd, Wokingham RG41 2TZ, Berks, England; [Keller, Susanna R.] Univ Virginia, Dept Internal Med, Div Endocrinol, Charlottesville, VA 22908 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Freiburg; University of Virginia	van Endert, P (corresponding author), INSERM, U580, F-75015 Paris, France.	peter.van-endert@inserm.fr	van Endert, Peter/R-4606-2017; Saveanu, Loredana/K-6821-2017; SAVEANU, Loredana/Q-1241-2019; Guermonprez, Pierre/ABE-7718-2020; Davoust, Jean/ABB-6720-2020	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; Guermonprez, Pierre/0000-0001-5621-2262; Davoust, Jean/0000-0002-3098-7665	European Commission [PROTARVAC]; INSERM fellowships; Deutsche Forschungsgemeinschaft; Medical Faculty of the University of Freiburg	European Commission(European CommissionEuropean Commission Joint Research Centre); INSERM fellowships; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Freiburg	We thank Metabolex Inc. for an anti-IRAP serum, N. Shastri for an anti-ERAP serum, B. Rocha for HY mice, O. Lantz for TAP knockout mice, L. Chatenoud for OT-II mice, B. Fouquet and N. Merzougui for technical help, and A. M. Lennon-Dumesnil for critical reading of the manuscript. Supported by grant PROTARVAC of the European Commission (P.v.E., F.G., G.N.), by INSERM fellowships (O.C., R.K.), and by grants from the Deutsche Forschungsgemeinschaft and from the Medical Faculty of the University of Freiburg (G.N.).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Ramachandra L, 1999, IMMUNOL REV, V168, P217, DOI 10.1111/j.1600-065X.1999.tb01295.x; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Wallis MG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1092, DOI 10.1152/ajpendo.00440.2007; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271	21	181	185	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					213	217		10.1126/science.1172845	http://dx.doi.org/10.1126/science.1172845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19498108	Green Published			2022-12-24	WOS:000267802000051
J	Dong, J; MacAlister, CA; Bergmann, DC				Dong, Juan; MacAlister, Cora A.; Bergmann, Dominique C.			BASL Controls Asymmetric Cell Division in Arabidopsis	CELL			English	Article							STOMATAL DEVELOPMENT; TRANSCRIPTION FACTOR; AUXIN TRANSPORT; PLASMA-MEMBRANE; MAPKK KINASE; DIFFERENTIATION; MORPHOGENESIS; CYTOSKELETON; POLARITY; ELEGANS	Development in multicellular organisms requires the organized generation of differences. A universal mechanism for creating such differences is asymmetric cell division. In plants, as in animals, asymmetric divisions are correlated with the production of cellular diversity and pattern; however, structural constraints imposed by plant cell walls and the absence of homologs of known animal or fungal cell polarity regulators necessitates that plants utilize new molecules and mechanisms to create asymmetries. Here, we identify BASL, a novel regulator of asymmetric divisions in Arabidopsis. In asymmetrically dividing stomatal-lineage cells, BASL accumulates in a polarized crescent at the cell periphery before division, and then localizes differentially to the nucleus and a peripheral crescent in self-renewing cells and their sisters after division. BASL presence at the cell periphery is critical for its function, and we propose that BASL represents a plant-specific solution to the challenge of asymmetric cell division.	[Dong, Juan; MacAlister, Cora A.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596	national Science Foundation [IOS-0544895, IOS-0844521]; Stanford Genome Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	national Science Foundation(National Science Foundation (NSF)); Stanford Genome Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by national Science Foundation grants IOS-0544895 and IOS-0844521 and a Terman award ( to D. C. B.). C. A. M. was supported in part by the Stanford Genome Training Program ( National Human Genome Research Institute). We thank Marcus Heisler ( Caltech) for the gift of PIN1::PIN1-GFP, Jiri Friml (Ghent) for the gift of PIN2::PIN2-GFP, and Zhenbiao Yang (University of California, Riverside) for ROP reagents. We are indebted to Ryan Gutierrez, Sylvie Lalonde, David Ehrhardt, and other members of the Carnegie Institution Department of Plant Biology for expertise and for the use of microscopy facilities and to members of the lab for discussion and comments on the manuscript.	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dhonukshe P, 2005, PROTOPLASMA, V226, P67, DOI 10.1007/s00709-005-0104-8; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; Fleming AJ, 2006, J EXP BOT, V57, P25, DOI 10.1093/jxb/eri268; Fowler JE, 1997, ANNU REV CELL DEV BI, V13, P697, DOI 10.1146/annurev.cellbio.13.1.697; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Mizumoto K, 2007, DEV CELL, V12, P287, DOI 10.1016/j.devcel.2007.01.004; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2003, TRENDS PLANT SCI, V8, P294, DOI 10.1016/S1360-1385(03)00102-X; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; TEN H, 2008, CURR OPIN PLANT BIOL, V11, P34; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	47	194	209	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1320	1330		10.1016/j.cell.2009.04.018	http://dx.doi.org/10.1016/j.cell.2009.04.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19523675	Bronze, Green Accepted			2022-12-24	WOS:000267373400024
J	Jiang, HQ; Patel, PH; Kohlmaier, A; Grenley, MO; McEwen, DG; Edgar, BA				Jiang, Huaqi; Patel, Parthive H.; Kohlmaier, Alexander; Grenley, Marc O.; McEwen, Donald G.; Edgar, Bruce A.			Cytokine/Jak/Stat Signaling Mediates Regeneration and Homeostasis in the Drosophila Midgut	CELL			English	Article							INTESTINAL-STEM-CELLS; COLORECTAL-CANCER; JAK/STAT PATHWAY; HOST-DEFENSE; JNK ACTIVITY; IN-VIVO; ACTIVATION; GROWTH; PROLIFERATION; INFECTION	Cells in intestinal epithelia turn over rapidly due to damage from digestion and toxins produced by the enteric microbiota. Gut homeostasis is maintained by intestinal stem cells (ISCs) that divide to replenish the intestinal epithelium, but little is known about how ISC division and differentiation are coordinated with epithelial cell loss. We show here that when enterocytes (ECs) in the Drosophila midgut are subjected to apoptosis, enteric infection, or JNK-mediated stress signaling, they produce cytokines (Upd, Upd2, and Upd3) that activate Jak/Stat signaling in ISCs, promoting their rapid division. Upd/Jak/Stat activity also promotes progenitor cell differentiation, in part by stimulating Delta/Notch signaling, and is required for differentiation in both normal and regenerating midguts. Hence, cytokine-mediated feedback enables stem cells to replace spent progeny as they are lost, thereby establishing gut homeostasis.	[Jiang, Huaqi; Patel, Parthive H.; Kohlmaier, Alexander; Grenley, Marc O.; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bedgar@fhcrc.org	Patel, Parthive H./ABC-8505-2021	Patel, Parthive/0000-0002-9288-8056	UW/FHCRC Cancer Consortium; National Institutes of Health [R01 GM51186]; American Cancer Society [PF-08-040-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	UW/FHCRC Cancer Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schubiger, C. O'Cane, N. Reich, P. Hagan, D. Montell, G. Baeg, P. O'Farrell, M. Van Doren, E. Bach, K. Choi, S. Hou, H. Sun, K. Smith, VDRC, NIG, and the Bloomington DSC for reagents. We thank C. M. Ulrich for comments on the manuscript. This work was supported by the UW/FHCRC Cancer Consortium and National Institutes of Health grant R01 GM51186 to B. A. E. P. H. P. was an American Cancer Society Fellow (PF- 08-040-01-DDC). A. K. was a Human Frontiers in Science Program Fellow.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Becker C, 2005, CELL CYCLE, V4, P217; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1810, DOI 10.3748/wjg.14.1810; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hakim RS, 2001, IN VITRO CELL DEV-AN, V37, P338; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kanda H, 2004, J BIOCHEM, V136, P1, DOI 10.1093/jb/mvh098; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Loeb MJ, 2001, IN VITRO CELL DEV-AN, V37, P348; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; MCGUIRE SE, 2004, SCI STKE, pPL6; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; MORGAN NS, 1994, J MOL BIOL, V239, P347, DOI 10.1006/jmbi.1994.1376; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Prieto Jesus, 2008, J Hepatol, V48, P380, DOI 10.1016/j.jhep.2007.11.007; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2	44	673	686	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1343	1355		10.1016/j.cell.2009.05.014	http://dx.doi.org/10.1016/j.cell.2009.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563763	Green Accepted, Bronze			2022-12-24	WOS:000267373400026
J	Pornillos, O; Ganser-Pornillos, BK; Kelly, BN; Hua, YZ; Whitby, FG; Stout, CD; Sundquist, WI; Hill, CP; Yeager, M				Pornillos, Owen; Ganser-Pornillos, Barbie K.; Kelly, Brian N.; Hua, Yuanzi; Whitby, Frank G.; Stout, C. David; Sundquist, Wesley I.; Hill, Christopher P.; Yeager, Mark			X-Ray Structures of the Hexameric Building Block of the HIV Capsid	CELL			English	Article							ROUS-SARCOMA-VIRUS; C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; ASSEMBLY PROPERTIES; PEPTIDE INHIBITOR; IN-VITRO; PROTEIN; CORE; HIV-1CA; COMPLEX	The mature capsids of HIV and other retroviruses organize and package the viral genome and its associated enzymes for delivery into host cells. The HIV capsid is a fullerene cone: a variably curved, closed shell composed of approximately 250 hexamers and exactly 12 pentamers of the viral CA protein. We devised methods for isolating soluble, assembly-competent CA hexamers and derived four crystallographically independent models that define the structure of this capsid assembly unit at atomic resolution. A ring of six CA N-terminal domains form an apparently rigid core, surrounded by an outer ring of C-terminal domains. Mobility of the outer ring appears to be an underlying mechanism for generating the variably curved lattice in authentic capsids. Hexamer-stabilizing interfaces are highly hydrated, and this property may be key to the formation of quasi-equivalent interactions within hexamers and pentamers. The structures also clarify the molecular basis for capsid assembly inhibition and should facilitate structure-based drug design strategies.	[Pornillos, Owen; Ganser-Pornillos, Barbie K.; Hua, Yuanzi; Yeager, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kelly, Brian N.; Whitby, Frank G.; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT 84112 USA; [Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yeager, Mark] Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; [Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Scripps Research Institute; Utah System of Higher Education; University of Utah; Scripps Research Institute; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	yeager@scripps.edu			NIH [R01-GM066087, P50-GM082545]; George E. Hewitt Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066087, P50GM082545] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George E. Hewitt Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grants R01-GM066087 (M.Y.) and P50-GM082545 (M.Y., C.P.H., and W.I.S.). B.G.-P. was supported by a postdoctoral fellowship from the George E. Hewitt Foundation for Medical Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Mortuza GB, 2009, J MOL BIOL, V386, P1179, DOI 10.1016/j.jmb.2008.10.066; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	49	391	408	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1282	1292		10.1016/j.cell.2009.04.063	http://dx.doi.org/10.1016/j.cell.2009.04.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19523676	Green Accepted, Bronze			2022-12-24	WOS:000267373400021
J	Celniker, SE; Dillon, LAL; Gerstein, MB; Gunsalus, KC; Henikoff, S; Karpen, GH; Kellis, M; Lai, EC; Lieb, JD; MacAlpine, DM; Micklem, G; Piano, F; Snyder, M; Stein, L; White, KP; Waterston, RH				Celniker, Susan E.; Dillon, Laura A. L.; Gerstein, Mark B.; Gunsalus, Kristin C.; Henikoff, Steven; Karpen, Gary H.; Kellis, Manolis; Lai, Eric C.; Lieb, Jason D.; MacAlpine, David M.; Micklem, Gos; Piano, Fabio; Snyder, Michael; Stein, Lincoln; White, Kevin P.; Waterston, Robert H.		modENCODE Consortium	Unlocking the secrets of the genome	NATURE			English	Article							GENE-EXPRESSION MAP; FUNCTIONAL ELEMENTS; DROSOPHILA; DISCOVERY; IDENTIFICATION; TRANSCRIPTION; EVOLUTION; PROFILES; NETWORKS		[Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA; [Dillon, Laura A. L.] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gunsalus, Kristin C.; Piano, Fabio] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; [Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02140 USA; [Kellis, Manolis] Harvard Univ, Cambridge, MA 02140 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [MacAlpine, David M.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Micklem, Gos] Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06824 USA; [Stein, Lincoln] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11542 USA; [White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [White, Kevin P.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Waterston, Robert H.] Dept Genome Sci, Seattle, WA 98195 USA; [Waterston, Robert H.] Univ Washington, Sch Med, Seattle, WA 98195 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yale University; Yale University; Yale University; New York University; Fred Hutchinson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Cambridge; University of Cambridge; Yale University; Cold Spring Harbor Laboratory; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Washington; University of Washington Seattle	Celniker, SE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA.	celniker@fruitfly.org	Kellis, Manolis/ABE-7385-2020; Brenner, Steven E/A-8729-2008; Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Kellis, Manolis/0000-0001-7113-9630; Brenner, Steven E/0000-0001-7559-6185; Lai, Eric/0000-0002-8432-5851; Gingeras, Thomas/0000-0001-9106-3573; Micklem, Gos/0000-0002-6883-6168; Brown, Christopher/0000-0002-3785-5008; Lieb, Jason/0000-0001-7601-8061; Edsall, Lee Elizabeth/0000-0002-0326-2829; Snyder, Michael/0000-0003-0784-7987; manoharan, arun prasad/0000-0002-7030-7353; Perrimon, Norbert/0000-0001-7542-472X; Riddle, Nicole/0000-0003-1827-9145; Russell, Steven/0000-0003-0546-3031; Henikoff, Steven/0000-0002-7621-8685	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004258, R01HG004037, U01HG004279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG004258-03, R01 HG004037-02, U01 HG004258, U01 HG004279, R01 HG004037] Funding Source: Medline; NIGMS NIH HHS [R01 GM066272] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102	35	596	603	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					927	930		10.1038/459927a	http://dx.doi.org/10.1038/459927a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536255	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-24	WOS:000267063500031
J	Gehring, M; Bubb, KL; Henikoff, S				Gehring, Mary; Bubb, Kerry L.; Henikoff, Steven			Extensive Demethylation of Repetitive Elements During Seed Development Underlies Gene Imprinting	SCIENCE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; ARABIDOPSIS ENDOSPERM; GENOME; THALIANA	DNA methylation is an epigenetic mark associated with transposable element silencing and gene imprinting in flowering plants and mammals. In plants, imprinting occurs in the endosperm, which nourishes the embryo during seed development. We have profiled Arabidopsis DNA methylation genome-wide in the embryo and endosperm and found that large-scale methylation changes accompany endosperm development and endosperm-specific gene expression. Transposable element fragments are extensively demethylated in the endosperm. We discovered new imprinted genes by the identification of candidates associated with regions of reduced endosperm methylation and preferential expression in endosperm relative to other parts of the plant. These data suggest that imprinting in plants evolved from targeted methylation of transposable element insertions near genic regulatory elements followed by positive selection when the resulting expression change was advantageous.	[Gehring, Mary; Bubb, Kerry L.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	HHMI Fellow of the Life Sciences Research Foundation	HHMI Fellow of the Life Sciences Research Foundation(Howard Hughes Medical Institute)	We thank the FHCRC Genomics Shared Resources for performing microarray hybridizations and Illumina sequencing, J. Henikoff for assistance with computational analyses, R. Deal and J. Cooper for comments on the manuscript, and D. Zilberman and R. Fischer for sharing unpublished data. M.G. is a HHMI Fellow of the Life Sciences Research Foundation. Illumina and NimbleGen data are deposited in the Genome Expression Omnibus (GEO) (accession number GSE14570 [NCBI GEO] ).	BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	18	412	441	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1447	1451		10.1126/science.1171609	http://dx.doi.org/10.1126/science.1171609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520961	Green Submitted, Green Accepted			2022-12-24	WOS:000266878700047
J	Dioum, EM; Chen, R; Alexander, MS; Zhang, QY; Hogg, RT; Gerard, RD; Garcia, JA				Dioum, Elhadji M.; Chen, Rui; Alexander, Matthew S.; Zhang, Quiyang; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.			Regulation of Hypoxia-Inducible Factor 2 alpha Signaling by the Stress-Responsive Deacetylase Sirtuin 1	SCIENCE			English	Article							CALORIE RESTRICTION; CELL-SURVIVAL; LIFE-SPAN; SIR2; TRANSCRIPTION; FAMILY; P53; ERYTHROPOIETIN; HOMEOSTASIS; EXPRESSION	To survive in hostile environments, organisms activate stress-responsive transcriptional regulators that coordinately increase production of protective factors. Hypoxia changes cellular metabolism and thus activates redox-sensitive as well as oxygen-dependent signal transducers. We demonstrate that Sirtuin 1 (Sirt1), a redox-sensing deacetylase, selectively stimulates activity of the transcription factor hypoxia-inducible factor 2 alpha (HIF-2 alpha) during hypoxia. The effect of Sirt1 on HIF-2 alpha required direct interaction of the proteins and intact deacetylase activity of Sirt1. Select lysine residues in HIF-2 alpha that are acetylated during hypoxia confer repression of Sirt1 augmentation by small-molecule inhibitors. In cultured cells and mice, decreasing or increasing Sirt1 activity or levels affected expression of the HIF-2 alpha target gene erythropoietin accordingly. Thus, Sirt1 promotes HIF-2 signaling during hypoxia and likely other environmental stresses.	[Dioum, Elhadji M.; Chen, Rui; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Dioum, Elhadji M.; Chen, Rui; Alexander, Matthew S.; Zhang, Quiyang; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Garcia, Joseph/0000-0002-5621-7538; Alexander, Matthew/0000-0001-7406-5171	Amgen; American Heart Association; Department of Veterans Affairs; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	Amgen(Amgen); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge A. Das, N. Wang, and K. Ding for technical assistance. We thank members of the laboratory of F. Alt for generously providing Sirt1 knockout mice, R. Hammer for assistance with mouse husbandry, Y. Li and H. Ball in the University of Texas Southwestern Medical Center Protein Chemistry Technology Center for mass spectrometry, and C. Xing for suggestions for statistical analyses. These studies were supported by funds provided by Amgen, American Heart Association, and Department of Veterans Affairs.	Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; VANNUCCI RC, 1994, BRAIN RES, V653, P141, DOI 10.1016/0006-8993(94)90382-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	38	357	375	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1289	1293		10.1126/science.1169956	http://dx.doi.org/10.1126/science.1169956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498162				2022-12-24	WOS:000266635100035
J	Weis, VM; Allemand, D				Weis, Virginia M.; Allemand, Denis			What Determines Coral Health?	SCIENCE			English	Editorial Material							REEF-BUILDING CORALS; THERMAL-STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; SEA-ANEMONE; MECHANISMS; SYMBIOSIS; PROTEIN; BIOMINERALIZATION; ACIDIFICATION		[Weis, Virginia M.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Allemand, Denis] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Allemand, Denis] Univ Nice Sophia Antipolis, Dept Sci Vie, Nice 2, France	Oregon State University; UDICE-French Research Universities; Universite Cote d'Azur	Weis, VM (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	weisv@science.oregonstate.edu	Weis, Virginia/T-5095-2019	Weis, Virginia/0000-0002-1826-2848				Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2; Chen MC, 2005, BIOCHEM BIOPH RES CO, V338, P1607, DOI 10.1016/j.bbrc.2005.10.133; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; KLEYPAS JA, 2006, NSF NOAA USGS; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Relman DA, 2008, NAT REV MICROBIOL, V6, P721, DOI 10.1038/nrmicro1990; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; TAMBUTTE S, 2007, HDB BIOMINERALIZATIO, V1, P243; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Wood-Charlson EM, 2009, DEV COMP IMMUNOL, V33, P881, DOI 10.1016/j.dci.2009.01.008; Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6	26	61	62	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1153	1155		10.1126/science.1172540	http://dx.doi.org/10.1126/science.1172540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478172				2022-12-24	WOS:000266410100031
J	Ahel, D; Horejsi, Z; Wiechens, N; Polo, SE; Garcia-Wilson, E; Ahel, I; Flynn, H; Skehel, M; West, SC; Jackson, SP; Owen-Hughes, T; Boulton, SJ				Ahel, Dragana; Horejsi, Zuzana; Wiechens, Nicola; Polo, Sophie E.; Garcia-Wilson, Elisa; Ahel, Ivan; Flynn, Helen; Skehel, Mark; West, Stephen C.; Jackson, Stephen P.; Owen-Hughes, Tom; Boulton, Simon J.			Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1	SCIENCE			English	Article							DAMAGE; POLY(ADP-RIBOSYL)ATION; BINDING; POLYNUCLEOSOMES; IDENTIFICATION; RELAXATION; PROTEINS; MOTIFS	Posttranslational modifications play key roles in regulating chromatin plasticity. Although various chromatin-remodeling enzymes have been described that respond to specific histone modifications, little is known about the role of poly[adenosine 5'-diphosphate (ADP)-ribose] in chromatin remodeling. Here, we identify a chromatin-remodeling enzyme, ALC1 (Amplified in Liver Cancer 1, also known as CHD1L), that interacts with poly(ADP-ribose) and catalyzes PARP1-stimulated nucleosome sliding. Our results define ALC1 as a DNA damage-response protein whose role in this process is sustained by its association with known DNA repair factors and its rapid poly(ADP-ribose)-dependent recruitment to DNA damage sites. Furthermore, we show that depletion or overexpression of ALC1 results in sensitivity to DNA-damaging agents. Collectively, these results provide new insights into the mechanisms by which poly(ADP-ribose) regulates DNA repair.	[Ahel, Dragana; Horejsi, Zuzana; Boulton, Simon J.] London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Wiechens, Nicola; Garcia-Wilson, Elisa; Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Polo, Sophie E.; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Polo, Sophie E.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England; [Ahel, Ivan] London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen; Skehel, Mark] London Res Inst, Prot Anal & Prote Lab, S Mimms EN6 3LD, Herts, England	University of Dundee; University of Cambridge; University of Cambridge; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Boulton, SJ (corresponding author), London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	Simon.boulton@cancer.org.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Polo, Sophie/0000-0003-4821-9354; Flynn, Helen/0000-0001-7002-9130; Ahel, Ivan/0000-0002-9446-3756; Owen-Hughes, Tom/0000-0002-0618-8185; West, Stephen/0000-0001-8848-9418; Licenikova Horejsi, Zuzana/0000-0002-9943-1649	Wellcome Trust Senior Fellowship [064414]; UK Biotechnology and Biological Sciences Research Council; Medical Research Council (UK); European Union; European Molecular Biology Organization; Human Frontier Science Program Organization; Louis-Jeantet Foundation	Wellcome Trust Senior Fellowship(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Louis-Jeantet Foundation	Research in the labs of S. J. B., S. P. J., S. C. W., I. A., and M. S. is supported by Cancer Research UK. The lab of T. O.-H. is funded by a Wellcome Trust Senior Fellowship 064414. S. P. J. is also funded by the UK Biotechnology and Biological Sciences Research Council, Medical Research Council (UK), the Wellcome Trust, and the European Union (EU Projects GENICA and DNA Repair). D. A. is supported by the European Molecular Biology Organization. S. E. P. is supported by the Human Frontier Science Program Organization. S. C. W. and I. A. are also funded by the Louis-Jeantet Foundation. The authors declare no conflict of interest.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; FRECHETTE A, 1985, CAN J BIOCHEM CELL B, V63, P764, DOI 10.1139/o85-096; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; KUO MT, 1981, CANCER RES, V41, P2439; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; LEDUC Y, 1986, BIOCHIM BIOPHYS ACTA, V885, P248, DOI 10.1016/0167-4889(86)90239-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LINDAHL T, 1995, PHILOS T ROY SOC B, V347, P57, DOI 10.1098/rstb.1995.0009; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; REALINI CA, 1992, J BIOL CHEM, V267, P18858; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0	23	428	445	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1240	1243		10.1126/science.1177321	http://dx.doi.org/10.1126/science.1177321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19661379	Green Accepted			2022-12-24	WOS:000269523200036
J	Jost, PJ; Grabow, S; Gray, D; McKenzie, MD; Nachbur, U; Huang, DCS; Bouillet, P; Thomas, HE; Borner, C; Silke, J; Strasser, A; Kaufmann, T				Jost, Philipp J.; Grabow, Stephanie; Gray, Daniel; McKenzie, Mark D.; Nachbur, Ueli; Huang, David C. S.; Bouillet, Philippe; Thomas, Helen E.; Borner, Christoph; Silke, John; Strasser, Andreas; Kaufmann, Thomas			XIAP discriminates between type I and type II FAS-induced apoptosis	NATURE			English	Article							ALPHA-DEPENDENT APOPTOSIS; DEFICIENT MICE; IMMUNE-SYSTEM; T-LYMPHOCYTES; CYTOCHROME-C; CELL-DEATH; PROTEIN; SMAC; ACTIVATION; RECEPTOR	FAS (also called APO-1 and CD95) and its physiological ligand, FASL, regulate apoptosis of unwanted or dangerous cells, functioning as a guardian against autoimmunity and cancer development(1-4). Distinct cell types differ in the mechanisms by which the 'death receptor' FAS triggers their apoptosis(1-4). In type I cells, such as lymphocytes, activation of 'effector caspases' by FAS-induced activation of caspase-8 suffices for cell killing, whereas in type II cells, including hepatocytes and pancreatic beta-cells, caspase cascade amplification through caspase-8-mediated activation of the proapoptotic BCL-2 family member BID (BH3 interacting domain death agonist) 5 is essential(6-8). Here we show that loss of XIAP (X-chromosome linked inhibitor of apoptosis protein) 9,10 function by gene targeting or treatment with a second mitochondria-derived activator of caspases (SMAC(11,) also called DIABLO(12); direct IAP-binding protein with low pI) mimetic drug in mice rendered hepatocytes and beta-cells independent of BID for FAS-induced apoptosis. These results show that XIAP is the critical discriminator between type I and type II apoptosis signalling and suggest that IAP inhibitors should be used with caution in cancer patients with underlying liver conditions.	[Jost, Philipp J.; Grabow, Stephanie; Gray, Daniel; Huang, David C. S.; Bouillet, Philippe; Strasser, Andreas; Kaufmann, Thomas] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Grabow, Stephanie; McKenzie, Mark D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [McKenzie, Mark D.; Thomas, Helen E.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Nachbur, Ueli; Silke, John] La Trobe Univ, Inst Biochem, Bundoora, Vic 3086, Australia; [Borner, Christoph] Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; St. Vincent's Institute of Medical Research; La Trobe University	Strasser, A (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	strasser@wehi.edu.au; thomas.kaufmann@pki.unibe.ch	Bouillet, Philippe/E-1241-2013; Jost, Philipp J./S-4962-2016; Silke, John/B-7622-2008; Huang, David C. S./C-7586-2013; Strasser, Andreas/C-7581-2013; Gray, Daniel HD/A-3293-2013	Bouillet, Philippe/0000-0002-9012-6058; Jost, Philipp J./0000-0003-2454-0362; Silke, John/0000-0002-7611-5774; Huang, David C. S./0000-0002-3101-4873; Strasser, Andreas/0000-0002-5020-4891; Gray, Daniel HD/0000-0002-8457-8242; Kaufmann, Thomas/0000-0001-9906-874X; Nachbur, Ueli/0000-0001-5968-2235	NHMRC ( Canberra); NCI [CA 80188, CA 43540]; Leukemia and Lymphoma Society of America [7015]; JDRF/ NHMRC; Cancer Council Victoria; Leukemia Foundation of Australia; Swiss National Science Foundation; Novartis Jubilaeumsstiftung; HepatoSys programme; German Jose Carreras Leukemia Foundation [06/09]; Spemann Graduate School of Biology and Medicine [GSC-4]; Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe;  [257502];  [251608];  [384404]; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	NHMRC ( Canberra)(National Health and Medical Research Council (NHMRC) of Australia); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); JDRF/ NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Jubilaeumsstiftung(Novartis); HepatoSys programme; German Jose Carreras Leukemia Foundation; Spemann Graduate School of Biology and Medicine; Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Vaux, J. Tschopp, S. Cory, J. Adams, S. Nagata and Y. Lazebnik for gifts of mice and reagents, K. Vella, D. Cooper and G. Siciliano for animal care, B. Helbert for genotyping, the Biochemistry Department of the Royal Melbourne Hospital for ALT/AST measurements, C. Young and D. Chau for technical assistance and D. Vaux, M. Van Delft and L. O'Reilly for advice. This work was supported by grants ( programmes 257502 and 251608; project 384404) and fellowships from the NHMRC ( Canberra), NCI ( NIH, CA 80188, CA 43540), Leukemia and Lymphoma Society of America ( SCOR grant 7015), JDRF/ NHMRC, Cancer Council Victoria, Leukemia Foundation of Australia, Swiss National Science Foundation ( T. K. and U. N.), Novartis Jubilaeumsstiftung ( U. N.), HepatoSys programme ( BMBF), German Jose Carreras Leukemia Foundation ( DJCLS R 06/09), Spemann Graduate School of Biology and Medicine ( GSC-4), DFG ( to C. B.) and Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe ( P. J. J.).	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Conte D, 2001, P NATL ACAD SCI USA, V98, P5049, DOI 10.1073/pnas.081547998; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; WAANDERS GA, 1990, INT IMMUNOL, V2, P461, DOI 10.1093/intimm/2.5.461; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	35	319	331	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1035	U128		10.1038/nature08229	http://dx.doi.org/10.1038/nature08229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19626005	Green Accepted			2022-12-24	WOS:000269085500039
J	Buckler, ES; Holland, JB; Bradbury, PJ; Acharya, CB; Brown, PJ; Browne, C; Ersoz, E; Flint-Garcia, S; Garcia, A; Glaubitz, JC; Goodman, MM; Harjes, C; Guill, K; Kroon, DE; Larsson, S; Lepak, NK; Li, HH; Mitchell, SE; Pressoir, G; Peiffer, JA; Rosas, MO; Rocheford, TR; Romay, MC; Romero, S; Salvo, S; Villeda, HS; da Silva, HS; Sun, Q; Tian, F; Upadyayula, N; Ware, D; Yates, H; Yu, JM; Zhang, ZW; Kresovich, S; McMullen, MD				Buckler, Edward S.; Holland, James B.; Bradbury, Peter J.; Acharya, Charlotte B.; Brown, Patrick J.; Browne, Chris; Ersoz, Elhan; Flint-Garcia, Sherry; Garcia, Arturo; Glaubitz, Jeffrey C.; Goodman, Major M.; Harjes, Carlos; Guill, Kate; Kroon, Dallas E.; Larsson, Sara; Lepak, Nicholas K.; Li, Huihui; Mitchell, Sharon E.; Pressoir, Gael; Peiffer, Jason A.; Rosas, Marco Oropeza; Rocheford, Torbert R.; Cinta Romay, M.; Romero, Susan; Salvo, Stella; Sanchez Villeda, Hector; da Silva, H. Sofia; Sun, Qi; Tian, Feng; Upadyayula, Narasimham; Ware, Doreen; Yates, Heather; Yu, Jianming; Zhang, Zhiwu; Kresovich, Stephen; McMullen, Michael D.			The Genetic Architecture of Maize Flowering Time	SCIENCE			English	Article							NATURAL VARIATION; ARTIFICIAL SELECTION; HEADING DATE; CO-ORTHOLOG; RICE; LOCUS; POLYMORPHISM; PHOTOPERIOD; REGULATOR; DIVERSITY	Flowering time is a complex trait that controls adaptation of plants to their local environment in the outcrossing species Zea mays (maize). We dissected variation for flowering time with a set of 5000 recombinant inbred lines (maize Nested Association Mapping population, NAM). Nearly a million plants were assayed in eight environments but showed no evidence for any single large-effect quantitative trait loci (QTLs). Instead, we identified evidence for numerous small-effect QTLs shared among families; however, allelic effects differ across founder lines. We identified no individual QTLs at which allelic effects are determined by geographic origin or large effects for epistasis or environmental interactions. Thus, a simple additive model accurately predicts flowering time for maize, in contrast to the genetic architecture observed in the selfing plant species rice and Arabidopsis.	[Buckler, Edward S.; Holland, James B.; Bradbury, Peter J.; Browne, Chris; Flint-Garcia, Sherry; Garcia, Arturo; Guill, Kate; Lepak, Nicholas K.; Salvo, Stella; Ware, Doreen; McMullen, Michael D.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Buckler, Edward S.; Bradbury, Peter J.; Acharya, Charlotte B.; Brown, Patrick J.; Ersoz, Elhan; Kroon, Dallas E.; Li, Huihui; Mitchell, Sharon E.; Pressoir, Gael; Cinta Romay, M.; Romero, Susan; Tian, Feng; Yates, Heather; Zhang, Zhiwu; Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Buckler, Edward S.; Larsson, Sara; Lepak, Nicholas K.; Peiffer, Jason A.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Holland, James B.; Goodman, Major M.; Rosas, Marco Oropeza; Salvo, Stella] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Browne, Chris; Flint-Garcia, Sherry; Garcia, Arturo; Guill, Kate; Sanchez Villeda, Hector; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Glaubitz, Jeffrey C.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Harjes, Carlos] Monsanto Co, Leesburg, GA 31763 USA; [Li, Huihui] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Li, Huihui] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Rocheford, Torbert R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Rocheford, Torbert R.] Purdue Univ, Dept Agron, Urbana, IL 61801 USA; [Cinta Romay, M.] CSIC, Mision Biol Galicia, Pontevedra 36080, Spain; [Sanchez Villeda, Hector] CIMMYT, INT, Crop Res Lab, Carretera Mex Veracruz 56130, Mexico; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yu, Jianming] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; Monsanto; Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Cornell University; Cold Spring Harbor Laboratory; Kansas State University	Buckler, ES (corresponding author), Cornell Univ, USDA ARS, Ithaca, NY 14853 USA.	esb33@cornell.edu; james_holland@ncsu.edu; sk20@cornell.edu; mcmullenm@missouri.edu	Buckler, Edward/L-7651-2019; Yu, Jianming/Q-6722-2019; Romay, Cinta/ABE-8340-2020; Buckler, Edward/GPS-4932-2022; Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Buckler, Edward/0000-0002-3100-371X; Yu, Jianming/0000-0001-5326-3099; Romay, Cinta/0000-0001-9309-1586; Zhang, Zhiwu/0000-0002-5784-9684; Holland, James/0000-0002-4341-9675; Flint-Garcia, Sherry/0000-0003-4156-5318	U.S. NSF Plant Genome Program; U.S. Department of Agriculture; Spanish Ministry for Education and Science [AP-2004-6033];  [DBI-9872631];  [DBI-0321467];  [DBI-0820619];  [DBI-0604923]	U.S. NSF Plant Genome Program; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Spanish Ministry for Education and Science(Spanish Government); ; ; ; 	This work was supported by U.S. NSF Plant Genome Program DBI 9872631, DBI 0321467, DBI 0820619 to E.S.B., M.M.G. 98,03, J.B.H. 03,08, M.D.M. 03,08, S.K. 03,08, D.W. 03, DBI-0604923 to T.R.R., U.S. Department of Agriculture Agricultural Research Service to E.S.B., J.B.H., M.D.M., and Spanish Ministry for Education and Science AP-2004-6033, fellowship to M.C.R..	Alonso-Blanco C, 1998, GENETICS, V149, P749; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Henry AM, 1997, MOL GEN GENET, V256, P147, DOI 10.1007/s004380050556; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; KULESHOV N. N., 1933, JOUR AMER SOC AGRON, V25, P688; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; LIN YR, 1995, GENETICS, V141, P391; Liu KJ, 2003, GENETICS, V165, P2117; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; McSteen P, 2007, PLANT PHYSIOL, V144, P1000, DOI 10.1104/pp.107.098558; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; YANO M, 2005, P 5 INT RIC GEN S 19, P177	31	940	998	10	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					714	718		10.1126/science.1174276	http://dx.doi.org/10.1126/science.1174276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661422				2022-12-24	WOS:000268723700040
J	Jaiswal, S; Jamieson, CHM; Pang, WW; Park, CY; Chao, MP; Majeti, R; Traver, D; van Rooijen, N; Weissman, IL				Jaiswal, Siddhartha; Jamieson, Catriona H. M.; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Traver, David; van Rooijen, Nico; Weissman, Irving L.			CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis	CELL			English	Article							INTEGRIN-ASSOCIATED PROTEIN; COLONY-STIMULATING FACTOR; MYELOID PROGENITORS; EXPRESSION; MOBILIZATION; BLOOD; ENGRAFTMENT; RECEPTOR; MARKER; MICE	Macrophages clear pathogens and damaged or aged cells from the blood stream via phagocytosis. Cell-surface CD47 interacts with its receptor on macrophages, SIRP alpha, to inhibit phagocytosis of normal, healthy cells. We find that mobilizing cytokines and inflammatory stimuli cause CD47 to be transiently upregulated on mouse hematopoietic stem cells (HSCs) and progenitors just prior to and during their migratory phase, and that the level of CD47 on these cells determines the probability that they are engulfed in vivo. CD47 is also constitutively upregulated on mouse and human myeloid leukemias, and overexpression of CD47 on a myeloid leukemia line increases its pathogenicity by allowing it to evade phagocytosis. We conclude that CD47 upregulation is an important mechanism that provides protection to normal HSCs during inflammation-mediated mobilization, and that leukemic progenitors co-opt this ability in order to evade macrophage killing.	[Jaiswal, Siddhartha; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Stanford, Stanford Canc Ctr,Dept Pathol, Stanford, CA 94305 USA; [Jaiswal, Siddhartha; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Jamieson, Catriona H. M.] Univ Calif San Diego, Moores UCSD Canc Ctr, Stem Cell Res Program, La Jolla, CA 92093 USA; [Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands	Stanford Cancer Institute; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Vrije Universiteit Amsterdam	Jaiswal, S (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Stanford, Stanford Canc Ctr,Dept Pathol, Stanford, CA 94305 USA.	sjaiswal@stanford.edu; irv@stanford.edu	Van Rooijen, Nico/Z-1578-2019	Majeti, Ravindra/0000-0002-5814-0984	National Institutes of Health [5R01CA086017-08, 5R01HL058770-08, 5P01DK053074-08]; Leukemia Society; Ludwig Institute; Smith Family Fund; NATIONAL CANCER INSTITUTE [R01CA086017, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Society; Ludwig Institute; Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in this study was supported in part by National Institutes of Health Grants 5R01CA086017-08, 5R01HL058770-08, and 5P01DK053074-08 awarded to I. L. W., the de Villier award of the Leukemia Society, the Ludwig Institute, and a gift from the Smith Family Fund. The authors would also like to thank Christina Muscat for antibody production, Libuse Jerabek for capable laboratory management, and Eric Brown and Mette Johanssen for providing valuable advice and reagents.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; CLINE MJ, 1977, EXP HEMATOL, V5, P186; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Olsson M, 2007, BIOCHEM BIOPH RES CO, V352, P193, DOI 10.1016/j.bbrc.2006.11.002; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Reinhold MI, 1997, J EXP MED, V185, P1, DOI 10.1084/jem.185.1.1; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uno S, 2007, ONCOL REP, V17, P1189; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	42	962	1042	9	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					271	285		10.1016/j.cell.2009.05.046	http://dx.doi.org/10.1016/j.cell.2009.05.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632178	Bronze, Green Accepted			2022-12-24	WOS:000268277000010
J	Tzur, A; Kafri, R; LeBleu, VS; Lahav, G; Kirschner, MW				Tzur, Amit; Kafri, Ran; LeBleu, Valerie S.; Lahav, Galit; Kirschner, Marc W.			Cell Growth and Size Homeostasis in Proliferating Animal Cells	SCIENCE			English	Article							MOUSE FIBROBLASTS; INTERPHASE GROWTH; ESCHERICHIA-COLI; MAMMALIAN-CELLS; DNA RNA; CYCLE; DIVISION; YEAST; MASS; CONSTANCY	A long-standing question in biology is whether there is an intrinsic mechanism for coordinating growth and the cell cycle in metazoan cells. We examined cell size distributions in populations of lymphoblasts and applied a mathematical analysis to calculate how growth rates vary with both cell size and the cell cycle. Our results show that growth rate is size-dependent throughout the cell cycle. After initial growth suppression, there is a rapid increase in growth rate during the G(1) phase, followed by a period of constant exponential growth. The probability of cell division varies independently with cell size and cell age. We conclude that proliferating mammalian cells have an intrinsic mechanism that maintains cell size.	[Tzur, Amit; Kafri, Ran; Lahav, Galit; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [LeBleu, Valerie S.] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu	LeBleu, Valerie/E-2991-2015		NIH [GM083303, GM026875]; Human Frontier Science Program fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875, R01GM083303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM083303 (G.L.), a Human Frontier Science Program fellowship (R.K.), and NIH grant GM026875.	ANDERSON EC, 1970, BIOPHYS J, V10, P630, DOI 10.1016/S0006-3495(70)86325-1; ANDERSON EC, 1969, BIOPHYS J, V9, P246, DOI 10.1016/S0006-3495(69)86383-6; BELL GI, 1967, BIOPHYS J, V7, P329, DOI 10.1016/S0006-3495(67)86592-5; COLLINS JF, 1962, J GEN MICROBIOL, V28, P15, DOI 10.1099/00221287-28-1-15; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Echave P, 2007, CELL CYCLE, V6, P218, DOI 10.4161/cc.6.2.3744; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; KUBITSCH.HE, 1968, BIOPHYS J, V8, P1401, DOI 10.1016/S0006-3495(68)86562-2; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P613, DOI 10.1128/jb.168.2.613-618.1986; LeBleu VS, 2006, CYTOTECHNOLOGY, V51, P149, DOI 10.1007/s10616-006-9024-5; LOKEN MR, 1984, J CELL PHYSIOL, V118, P22, DOI 10.1002/jcp.1041180106; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; Sveiczer Akos, 2004, Theor Biol Med Model, V1, P12, DOI 10.1186/1742-4682-1-12; TRUCCO E, 1970, Bulletin of Mathematical Biophysics, V32, P459, DOI 10.1007/BF02476765; TRUCCO E, 1970, Bulletin of Mathematical Biophysics, V32, P475, DOI 10.1007/BF02476766; TYSON JJ, 1985, J MATH BIOL, V22, P61, DOI 10.1007/BF00276546; ZETTERBERG A, 1965, EXP CELL RES, V39, P22, DOI 10.1016/0014-4827(65)90003-0	26	280	288	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					167	171		10.1126/science.1174294	http://dx.doi.org/10.1126/science.1174294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589995	Green Accepted			2022-12-24	WOS:000267802000037
J	Ganem, NJ; Godinho, SA; Pellman, D				Ganem, Neil J.; Godinho, Susana A.; Pellman, David			A mechanism linking extra centrosomes to chromosomal instability	NATURE			English	Article							MEROTELIC KINETOCHORE ORIENTATION; CLONAL EVOLUTION; CANCER-CELLS; ANEUPLOIDY; AMPLIFICATION; MITOSIS; NUMBERS	Chromosomal instability (CIN) is a hallmark of many tumours and correlates with the presence of extra centrosomes(1-4). However, a direct mechanistic link between extra centrosomes and CIN has not been established. It has been proposed that extra centrosomes generate CIN by promoting multipolar anaphase, a highly abnormal division that produces three or more aneuploid daughter cells. Here we use long-term live-cell imaging to demonstrate that cells with multiple centrosomes rarely undergo multipolar cell divisions, and the progeny of these divisions are typically inviable. Thus, multipolar divisions cannot explain observed rates of CIN. In contrast, we observe that CIN cells with extra centrosomes routinely undergo bipolar cell divisions, but display a significantly increased frequency of lagging chromosomes during anaphase. To define the mechanism underlying this mitotic defect, we generated cells that differ only in their centrosome number. We demonstrate that extra centrosomes alone are sufficient to promote chromosome missegregation during bipolar cell division. These segregation errors are a consequence of cells passing through a transient 'multipolar spindle intermediate' in which merotelic kinetochore-microtubule attachment errors accumulate before centrosome clustering and anaphase. These findings provide a direct mechanistic link between extra centrosomes and CIN, two common characteristics of solid tumours. We propose that this mechanism may be a common underlying cause of CIN in human cancer.	[Ganem, Neil J.; Godinho, Susana A.; Pellman, David] Harvard Univ, Sch Med,Dept Pediat Oncol, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Pellman, D (corresponding author), Harvard Univ, Sch Med,Dept Pediat Oncol, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Childrens Hosp, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Godinho, Susana/0000-0003-0638-065X; Ganem, Neil/0000-0003-0269-6585	Leukemia and Lymphoma Society; NIH [GM083299]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Compton, R. King, D. Livingston, A. Manning, T. Rapoport, J. Shah, T. Stukenberg and members of the Pellman laboratory for comments and discussion of the manuscript; L. Cameron for setting up the confocal microscope; P. Schow for help with FACS; D. Neuberg for help with statistical analysis; C. King for help with the model figure; J. Iwasa for creating the animations; and L. Moreau and S. Thompson for technical advice on chromosome spreads and FISH analysis. Reagents were provided by D. Compton, S. Gollin, R. King, A. Khodjakov, E. Nigg and G. Wahl. N.J.G. is a fellow of the Leukemia and Lymphoma Society and D. P. is an HHMI Investigator. This work was supported by NIH grant GM083299.	Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; HENEEN WK, 1975, EXP CELL RES, V91, P57, DOI 10.1016/0014-4827(75)90140-8; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Sluder G, 1997, J CELL SCI, V110, P421; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	30	958	986	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					278	U146		10.1038/nature08136	http://dx.doi.org/10.1038/nature08136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19506557	Green Accepted			2022-12-24	WOS:000267761000045
J	Elliott, P; Chambers, JC; Zhang, WH; Clarke, R; Hopewell, JC; Peden, JF; Erdmann, J; Braund, P; Engert, JC; Bennett, D; Coin, L; Ashby, D; Tzoulaki, I; Brown, IJ; Mt-Isa, S; McCarthy, MI; Peltonen, L; Freimer, NB; Farrall, M; Ruokonen, A; Hamsten, A; Lim, N; Froguel, P; Waterworth, DM; Vollenweider, P; Waeber, G; Jarvelin, MR; Mooser, V; Scott, J; Hall, AS; Schunkert, H; Anand, SS; Collins, R; Samani, NJ; Watkins, H; Kooner, JS				Elliott, Paul; Chambers, John C.; Zhang, Weihua; Clarke, Robert; Hopewell, Jemma C.; Peden, John F.; Erdmann, Jeanette; Braund, Peter; Engert, James C.; Bennett, Derrick; Coin, Lachlan; Ashby, Deborah; Tzoulaki, Ioanna; Brown, Ian J.; Mt-Isa, Shahrul; McCarthy, Mark I.; Peltonen, Leena; Freimer, Nelson B.; Farrall, Martin; Ruokonen, Aimo; Hamsten, Anders; Lim, Noha; Froguel, Philippe; Waterworth, Dawn M.; Vollenweider, Peter; Waeber, Gerard; Jarvelin, Marjo-Riitta; Mooser, Vincent; Scott, James; Hall, Alistair S.; Schunkert, Heribert; Anand, Sonia S.; Collins, Rory; Samani, Nilesh J.; Watkins, Hugh; Kooner, Jaspal S.			Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; LOW-GRADE INFLAMMATION; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; CRP GENE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; VASCULAR EVENTS; PREDICTION; MEN	Context Plasma levels of C-reactive protein (CRP) are independently associated with risk of coronary heart disease, but whether CRP is causally associated with coronary heart disease or merely a marker of underlying atherosclerosis is uncertain. Objective To investigate association of genetic loci with CRP levels and risk of coronary heart disease. Design, Setting, and Participants We first carried out a genome-wide association (n = 17 967) and replication study (n = 13 615) to identify genetic loci associated with plasma CRP concentrations. Data collection took place between 1989 and 2008 and genotyping between 2003 and 2008. We carried out a mendelian randomization study of the most closely associated single-nucleotide polymorphism (SNP) in the CRP locus and published data on other CRP variants involving a total of 28 112 cases and 100 823 controls, to investigate the association of CRP variants with coronary heart disease. We compared our finding with that predicted from meta-analysis of observational studies of CRP levels and risk of coronary heart disease. For the other loci associated with CRP levels, we selected the most closely associated SNP for testing against coronary heart disease among 14 365 cases and 32 069 controls. Main Outcome Measure Risk of coronary heart disease. Results Polymorphisms in 5 genetic loci were strongly associated with CRP levels (% difference per minor allele): SNP rs6700896 in LEPR (-14.8%; 95% confidence interval [CI], -17.6% to -12.0%; P = 6.2 x 10(-22)), rs4537545 in IL6R (-11.5%; 95% CI, -14.4% to -8.5%; P = 1.3 x 10(-12)), rs7553007 in the CRP locus (-20.7%; 95% CI, -23.4% to -17.9%; P = 1.3 x 10(-38)), rs1183910 in HNF1A (-13.8%; 95% CI, -16.6% to -10.9%; P = 1.9 x 10(-18)), and rs4420638 in APOE-CI-CII (-21.8%; 95% CI, -25.3% to -18.1%; P = 8.1 x 10(-26)). Association of SNP rs7553007 in the CRP locus with coronary heart disease gave an odds ratio (OR) of 0.98 (95% CI, 0.94 to 1.01) per 20% lower CRP level. Our mendelian randomization study of variants in the CRP locus showed no association with coronary heart disease: OR, 1.00; 95% CI, 0.97 to 1.02; per 20% lower CRP level, compared with OR, 0.94; 95% CI, 0.94 to 0.95; predicted from meta-analysis of the observational studies of CRP levels and coronary heart disease (z score, -3.45; P < .001). SNPs rs6700896 in LEPR (OR, 1.06; 95% CI, 1.02 to 1.09; per minor allele), rs4537545 in IL6R (OR, 0.94; 95% CI, 0.91 to 0.97), and rs4420638 in the APOE-CI-CII cluster (OR, 1.16; 95% CI, 1.12 to 1.21) were all associated with risk of coronary heart disease. Conclusion The lack of concordance between the effect on coronary heart disease risk of CRP genotypes and CRP levels argues against a causal association of CRP with coronary heart disease. JAMA. 2009;302(1):37-48	[Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRCHPA Ctr Environm & Hlth, Dept Epidemiol & Publ Hlth, Fac Med, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welfare, Oulu, Finland; [Clarke, Robert; Hopewell, Jemma C.; Bennett, Derrick; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert; Hopewell, Jemma C.; Bennett, Derrick; Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Inst Hlth Res Biomed Res, Oxford Natl Inst, Oxford, England; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Braund, Peter; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet & Therapeut, Leeds, W Yorkshire, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, D-23538 Lubeck, Germany; [Anand, Sonia S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Vollenweider, Peter; Waeber, Gerard] CHUV Univ Hosp, Dept Med, Lausanne, Switzerland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Hamsten, Anders] Karolinska Inst, Dept Med, Stockholm, Sweden; [Lim, Noha; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA	Imperial College London; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Wellcome Trust Sanger Institute; University of Leicester; McGill University; McGill University; University of Leeds; University of Lubeck; McMaster University; Population Health Research Institute; McMaster University; McMaster University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California Los Angeles; Karolinska Institutet; GlaxoSmithKline	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRCHPA Ctr Environm & Hlth, Dept Epidemiol & Publ Hlth, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.elliott@imperial.ac.uk	Bennett, Derrick/AAH-1220-2022; Colaus, PsyColaus/K-6607-2013; Erdmann, Jeanette/A-4417-2009; Mt-Isa, Shahrul/F-1275-2010; Collins, Rory/ABA-8487-2020; Lim, Noha/ABA-2509-2020; , Bennett/O-7998-2019; zhang, weihua/GXV-1334-2022; Erdmann, Jeanette/P-7513-2014; Bennett, Derrick/AFL-9254-2022; Coin, Lachlan JM/A-9001-2014; Tzoulaki, Ioanna/ABE-6269-2020; Coin, Lachlan/O-4976-2019; Hall, Alistair/K-1953-2019; FROGUEL, Philippe/O-6799-2017; Tzoulaki, Ioanna/C-1381-2008; McCarthy, Mark/M-3763-2015	Bennett, Derrick/0000-0002-9170-8447; Mt-Isa, Shahrul/0000-0002-7163-8402; Erdmann, Jeanette/0000-0002-4486-6231; Bennett, Derrick/0000-0002-9170-8447; Coin, Lachlan JM/0000-0002-4300-455X; Tzoulaki, Ioanna/0000-0002-4275-9328; Coin, Lachlan/0000-0002-4300-455X; FROGUEL, Philippe/0000-0003-2972-0784; Elliott, Paul/0000-0002-7511-5684; Waeber, Gerard/0000-0003-4193-788X; Hopewell, Jemma/0000-0002-3870-8018; Engert, James/0000-0001-8411-4790; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Watkins, Hugh/0000-0002-5287-9016; McCarthy, Mark/0000-0002-4393-0510; Hall, Alistair/0000-0003-0306-7887	INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; European Union [EURODIA LSHM-CT-2006-518153]; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Deutsche Herzstiftung; National Genome Research Network 2 of the German Federal Ministry of Education and Research; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; International Clinical Epidemiology Network (INCLEN); Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud; Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim; Japan, Sankyo Pharmaceutical Co; Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development; Pfizer Philippines Foundation, Inc; Astra Pharmaceuticals Inc; Astra Fund for Clinical Research and Continuing Medical Education; Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa; Warner-Parke-Davis Pharmaceuticals; Aventis; Swedish State under the LUA agreement; Swedish Heart and Lung Foundation; Thailand, Heart Association of Thailand; Thailand Research Fund; British Heart Foundation; Medical Research Council; Cancer Research UK; Tobacco Products Research Trust; Giorgi-Cavaglieri Foundation; Swiss National Science Foundation [3100AO-116323/1]; Universite de Lausanne, Lausanne, Switzerland.; British Heart Foundation [SP/04/002]; National Heart, Lung, and Blood Institute [5R01HL087679-02]; Medical Research Council of the United Kingdom; European Birth Life-Course Study; European Commission [QLG1-CT2000-01643]; Biocenter Oulu of University of Oulu; Academy of Finland; National Institute of Mental Health [1RL1MH083268-01]; EC Sixth Framework Programme [LSHM33 CT-2007-037273]; Wellcome Trust; MRC [G0600331, MC_U137686857, G0801056, G0700931, G0601966] Funding Source: UKRI; Medical Research Council [G0600331, G0801056B, G0700931, MC_U137686857, G0801056, G0601966] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; European Union(European Commission); GlaxoSmithKline(GlaxoSmithKline); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; National Genome Research Network 2 of the German Federal Ministry of Education and Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); International Clinical Epidemiology Network (INCLEN); Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim(Boehringer Ingelheim); Japan, Sankyo Pharmaceutical Co; Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development; Pfizer Philippines Foundation, Inc; Astra Pharmaceuticals Inc; Astra Fund for Clinical Research and Continuing Medical Education; Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warner-Parke-Davis Pharmaceuticals; Aventis(Sanofi-Aventis); Swedish State under the LUA agreement; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Thailand, Heart Association of Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Tobacco Products Research Trust; Giorgi-Cavaglieri Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Universite de Lausanne, Lausanne, Switzerland.; British Heart Foundation(British Heart Foundation); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Birth Life-Course Study; European Commission(European CommissionEuropean Commission Joint Research Centre); Biocenter Oulu of University of Oulu; Academy of Finland(Academy of Finland); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EC Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Data from an Epidemiological Study on the Insulin Resistance syndrome (DESIR) received support from INSERM, CNAMTS, Lilly, Novartis Pharma, Sanofi-Aventis, the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon, and the European Union (P. F.) (Integrated Project EURODIA LSHM-CT-2006-518153 in the Framework Programme 6 [FP06] of the European Community). The Genetic Epidemiology of Metabolic Syndrome (GEMS) study was sponsored in part by GlaxoSmithKline. The German MI Family Study was supported by grants from the Deutsche Forschungsgemeinschaft and the Deutsche Herzstiftung, the National Genome Research Network 2 of the German Federal Ministry of Education and Research, and the Cardiogenics project of the European Union. From the INTERHEART study, Dr Anand holds the Michael G. DeGroot and Heart and Stroke Foundation of Ontario Chair in Population Health and the May Cohen Eli Lilly Endowed Chair in Women's Health Research, McMaster University. The INTERHEART study was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and the International Clinical Epidemiology Network (INCLEN); through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca, Novartis, Sanofi-Aventis, Knoll Pharmaceuticals [now Abbott], Bristol Myers Squibb, and King Pharma); and by various national bodies in different countries as follows: Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud; Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim; Japan, Sankyo Pharmaceutical Co, Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development, Pfizer Philippines Foundation, Inc, Astra Pharmaceuticals Inc and the Astra Fund for Clinical Research and Continuing Medical Education, Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa, Warner-Parke-Davis Pharmaceuticals, Aventis; Sweden, grant from the Swedish State under the LUA agreement, Swedish Heart and Lung Foundation; Thailand, Heart Association of Thailand, Thailand Research Fund. The International Studies of Infarct Survival (ISIS) trials and epidemiological studies were supported by the manufacturers of the study drugs and by the British Heart Foundation, Medical Research Council, Cancer Research UK, Tobacco Products Research Trust of the UK Department of Health Independent Scientific Committee on Smoking and Health, and Oxford NHS Genetic Knowledge Park. The Lausanne Cohort (CoLaus) study received support from the Giorgi-Cavaglieri Foundation (Toby Johnson, Sven Bergmann), the Universite de Lausanne (Jacques S. Beckmann), and grant 3100AO-116323/1 (Sven Bergmann) from the Swiss National Science Foundation (Murielle Bochud). GlaxoSmithKline provided support to build the CoLaus study (Drs Vollenweider and Waeber). Thiswork was supported by GlaxoSmithKline and the Faculty of Biology and Medicine, Universite de Lausanne, Lausanne, Switzerland.; The London Life Siences Population (LOLIPOP) received support from grant SP/04/002 from the British Heart Foundation. The 1966 North Finland Birth Cohort received support from grant 5R01HL087679-02 from the National Heart, Lung, and Blood Institute through the STAMPEED program; the Medical Research Council of the United Kingdom; the European Birth Life-Course Study; contract QLG1-CT2000-01643 from the European Commission "Quality of Life and Management of Living Resources"; the Biocenter Oulu of University of Oulu; the Academy of Finland; and grant 1RL1MH083268-01 from the National Institute of Mental Health. The Precocious Coronary Artery Disease study (PROCARDIS) was funded by the British Heart Foundation, EC Sixth Framework Programme (LSHM33 CT-2007-037273), AstraZeneca AB, and the Knut and Alice Wallenberg Foundation. The Wellcome Trust Case Control Consortium (WTCCC) study received support for recruitment from grants from the British Heart Foundation and the UK Medical Research Council. It also received support from the Wellcome Trust Functional Genomics Initiative in Cardiovascular Genetics. Dr Samani holds a chair funded by the British Heart Foundation.	Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen JH, 2005, J MOL MED, V83, P72, DOI 10.1007/s00109-004-0585-5; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Backer J, 2002, ATHEROSCLEROSIS, V160, P457, DOI 10.1016/S0021-9150(01)00602-5; Erbel R, 2008, ATHEROSCLEROSIS, V197, P662, DOI 10.1016/j.atherosclerosis.2007.02.031; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Gauderman W, QUANTO 1 1 COMPUTER; Hansma AHG, 2005, ANN ONCOL, V16, P1695, DOI 10.1093/annonc/mdi318; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hlatky MA, 2008, NEW ENGL J MED, V359, P2280, DOI 10.1056/NEJMe0808320; Hung J, 2008, HEART LUNG CIRC, V17, P90, DOI 10.1016/j.hlc.2007.07.002; HUNT D, 1992, LANCET, V339, P753; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P3071, DOI 10.1161/01.ATV.19.12.3071; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pepys MB, 2008, NAT CLIN PRACT NEPHR, V4, P234, DOI 10.1038/ncpneph0778; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sakkinen P, 2002, J CLIN EPIDEMIOL, V55, P445, DOI 10.1016/S0895-4356(01)00502-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Verma S, 2005, NAT CLIN PRACT CARD, V2, P29, DOI 10.1038/ncpcardio0074; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wang CH, 2006, INT J HYG ENVIR HEAL, V209, P265, DOI 10.1016/j.ijheh.2005.12.005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Wyszynski DF, 2005, AM J CARDIOL, V95, P194, DOI 10.1016/j.amjcard.2004.08.091; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	72	469	488	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					37	48		10.1001/jama.2009.954	http://dx.doi.org/10.1001/jama.2009.954			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567438	Green Accepted, Bronze			2022-12-24	WOS:000267492800020
J	Diskin, SJ; Hou, CP; Glessner, JT; Attiyeh, EF; Laudenslager, M; Bosse, K; Cole, K; Mosse, YP; Wood, A; Lynch, JE; Pecor, K; Diamond, M; Winter, C; Wang, K; Kim, C; Geiger, EA; McGrady, PW; Blakemore, AIF; London, WB; Shaikh, TH; Bradfield, J; Grant, SFA; Li, HZ; Devoto, M; Rappaport, ER; Hakonarson, H; Maris, JM				Diskin, Sharon J.; Hou, Cuiping; Glessner, Joseph T.; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Wang, Kai; Kim, Cecilia; Geiger, Elizabeth A.; McGrady, Patrick W.; Blakemore, Alexandra I. F.; London, Wendy B.; Shaikh, Tamim H.; Bradfield, Jonathan; Grant, Struan F. A.; Li, Hongzhe; Devoto, Marcella; Rappaport, Eric R.; Hakonarson, Hakon; Maris, John M.			Copy number variation at 1q21.1 associated with neuroblastoma	NATURE			English	Article							PEDIATRIC-ONCOLOGY-GROUP; GENE AMPLIFICATION; GENOME; SCHIZOPHRENIA; EXPRESSION; HYBRIDIZATION; DUPLICATIONS; POLYMORPHISM; PHENOTYPES; CANCER	Common copy number variations (CNVs) represent a significant source of genetic diversity, yet their influence on phenotypic variability, including disease susceptibility, remains poorly understood. To address this problem in human cancer, we performed a genome-wide association study of CNVs in the childhood cancer neuroblastoma, a disease in which single nucleotide polymorphism variations are known to influence susceptibility(1,2). We first genotyped 846 Caucasian neuroblastoma patients and 803 healthy Caucasian controls at similar to 550,000 single nucleotide polymorphisms, and performed a CNV-based test for association. We then replicated significant observations in two independent sample sets comprised of a total of 595 cases and 3,357 controls. Here we describe the identification of a common CNV at chromosome 1q21.1 associated with neuroblastoma in the discovery set, which was confirmed in both replication sets. This CNV was validated by quantitative polymerase chain reaction, fluorescent in situ hybridization and analysis of matched tumour specimens, and was shown to be heritable in an independent set of 713 cancer-free parent offspring trios. We identified a previously unknown transcript within the CNV that showed high sequence similarity to several neuroblastoma breakpoint family (NBPF) genes(3,4) and represents a new member of this gene family (NBPF23). This transcript was preferentially expressed in fetal brain and fetal sympathetic nervous tissues, and the expression level was strictly correlated with CNV state in neuroblastoma cells. These data demonstrate that inherited copy number variation at 1q21.1 is associated with neuroblastoma and implicate a previously unknown neuroblastoma breakpoint family gene in early tumorigenesis of this childhood cancer.	[Diskin, Sharon J.; Hou, Cuiping; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Rappaport, Eric R.; Maris, John M.] Univ Penn, Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Hou, Cuiping; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Rappaport, Eric R.; Maris, John M.] Univ Penn, Sch Med, Ctr Childhood Canc Res, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hou, Cuiping; Glessner, Joseph T.; Wang, Kai; Kim, Cecilia; Bradfield, Jonathan; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Ctr Appl Genom, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Mosse, Yael P.; Shaikh, Tamim H.; Grant, Struan F. A.; Devoto, Marcella; Rappaport, Eric R.; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Geiger, Elizabeth A.; Shaikh, Tamim H.; Grant, Struan F. A.; Devoto, Marcella; Hakonarson, Hakon] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Li, Hongzhe; Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [McGrady, Patrick W.; London, Wendy B.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [McGrady, Patrick W.; London, Wendy B.] Childrens Oncol Grp, Gainesville, FL 32611 USA; [Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; State University System of Florida; University of Florida; Children's Oncology Group (COG); Imperial College London; Sapienza University Rome	Maris, JM (corresponding author), Univ Penn, Sch Med, Div Oncol, Philadelphia, PA 19104 USA.	maris@chop.edu	Rappaport, Eric/GRO-4051-2022; London, Wendy/ABD-4624-2021; Devoto, Marcella/AAP-7595-2021; Blakemore, Alexandra I F/D-2253-2009; London, Wendy Beth/ABA-8948-2021	Blakemore, Alexandra I F/0000-0003-0661-564X; London, Wendy Beth/0000-0003-3571-6538; DEVOTO, MARCELLA/0000-0002-4431-5114; Grant, Struan/0000-0003-2025-5302; Glessner, Joseph/0000-0001-5131-2811	Children's Oncology Group [U10-CA98543]; NIH [T32-HG000046, R01-CA87847, R01-CA124709, GM081519]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute Medical Research Training Fellowship; Center for Applied Genomics; Joseph Stokes Research Institute of the Children's Hospital of Philadelphia; NATIONAL CANCER INSTITUTE [R01CA124709, R00CA151869, R01CA087847, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081519] Funding Source: NIH RePORTER	Children's Oncology Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute Medical Research Training Fellowship(Howard Hughes Medical Institute); Center for Applied Genomics; Joseph Stokes Research Institute of the Children's Hospital of Philadelphia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the Children's Oncology Group (U10-CA98543) for providing neuroblastoma specimens and thank the many children who participated in this study. This work was supported in part by NIH grants T32-HG000046 (S. J. D.), R01-CA87847 (J. M. M.) and R01-CA124709, GM081519 (T. H. S.), the Giulio D'Angio Endowed Chair (J. M. M.), the Alex's Lemonade Stand Foundation (J. M. M.), the Evan Dunbar Foundation (J. M. M.), the Rally Foundation (J. M. M.), Andrew's Army Foundation (J. M. M.), the Abramson Family Cancer Research Institute (J. M. M.), Howard Hughes Medical Institute Medical Research Training Fellowship (K. B.) and the Center for Applied Genomics (H. H.) at the Joseph Stokes Research Institute of the Children's Hospital of Philadelphia.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Meza-Zepeda LA, 2002, ONCOGENE, V21, P2261, DOI 10.1038/sj.onc.1205339; Petroziello J, 2004, ONCOGENE, V23, P7734, DOI 10.1038/sj.onc.1207921; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; van den Bogert AJ, 2008, COMPUT METHOD BIOMEC, V11, P3, DOI 10.1080/10255840701550865; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	31	275	292	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					987	U112		10.1038/nature08035	http://dx.doi.org/10.1038/nature08035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536264	Green Accepted			2022-12-24	WOS:000267063500043
J	Perez-Padilla, R; de la Rosa-Zamboni, D; de Leon, SP; Hernandez, M; Quinones-Falconi, F; Bautista, E; Ramirez-Venegas, A; Rojas-Serrano, J; Ormsby, CE; Corrales, A; Higuera, A; Mondragon, E; Cordova-Villalobos, JA				Perez-Padilla, Rogelio; de la Rosa-Zamboni, Daniela; de Leon, Samuel Ponce; Hernandez, Mauricio; Quinones-Falconi, Francisco; Bautista, Edgar; Ramirez-Venegas, Alejandra; Rojas-Serrano, Jorge; Ormsby, Christopher E.; Corrales, Ariel; Higuera, Anjarath; Mondragon, Edgar; Cordova-Villalobos, Jose Angel		INER Working Grp Influenza	Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AVIAN INFLUENZA; VIRUS-INFECTIONS; H5N1; HUMANS; DISEASE	Background In late March 2009, an outbreak of a respiratory illness later proved to be caused by novel swine-origin influenza A (H1N1) virus (S-OIV) was identified in Mexico. We describe the clinical and epidemiologic characteristics of persons hospitalized for pneumonia at the national tertiary hospital for respiratory illnesses in Mexico City who had laboratory-confirmed S-OIV infection, also known as swine flu. Methods We used retrospective medical chart reviews to collect data on the hospitalized patients. S-OIV infection was confirmed in specimens with the use of a real-time reverse-transcriptase-polymerase-chain-reaction assay. Results From March 24 through April 24, 2009, a total of 18 cases of pneumonia and confirmed S-OIV infection were identified among 98 patients hospitalized for acute respiratory illness at the National Institute of Respiratory Diseases in Mexico City. More than half of the 18 case patients were between 13 and 47 years of age, and only 8 had preexisting medical conditions. For 16 of the 18 patients, this was the first hospitalization for their illness; the other 2 patients were referred from other hospitals. All patients had fever, cough, dyspnea or respiratory distress, increased serum lactate dehydrogenase levels, and bilateral patchy pneumonia. Other common findings were an increased creatine kinase level ( in 62% of patients) and lymphopenia ( in 61%). Twelve patients required mechanical ventilation, and seven died. Within 7 days after contact with the initial case patients, a mild or moderate influenza-like illness developed in 22 health care workers; they were treated with oseltamivir, and none were hospitalized. Conclusions S-OIV infection can cause severe illness, the acute respiratory distress syndrome, and death in previously healthy persons who are young to middle-aged. None of the secondary infections among health care workers were severe.	[Perez-Padilla, Rogelio; de la Rosa-Zamboni, Daniela; Quinones-Falconi, Francisco; Bautista, Edgar; Ramirez-Venegas, Alejandra; Rojas-Serrano, Jorge; Ormsby, Christopher E.; Corrales, Ariel; Higuera, Anjarath; Mondragon, Edgar] Inst Nacl Enfermedades Resp, Mexico City 14080, DF, Mexico; [de Leon, Samuel Ponce] Biol & React Mexico BIRMEX, Mexico City, DF, Mexico; [Hernandez, Mauricio; Cordova-Villalobos, Jose Angel] Secretariat Hlth, Mexico City, DF, Mexico		Perez-Padilla, R (corresponding author), Inst Nacl Enfermedades Resp, Tlalpan 4502, Mexico City 14080, DF, Mexico.	perezpad@gmail.com	Carrillo Montiel, Isabel/GXH-4018-2022; Hernandez, Alher Mauricio/AAX-2227-2021; Rojas-Serrano, Jorge/Q-4206-2018	Hernandez, Alher Mauricio/0000-0003-1132-5794; Zuniga, Joaquin/0000-0002-7143-0281				Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; [Anonymous], 2005, STAT STAT SOFTW REL; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; *DIR GEN ADJ EP, 2009, BROT INFL HUM H1N1 M; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hui DSC, 2008, RESPIROLOGY, V13, pS10, DOI 10.1111/j.1440-1843.2008.01247.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; MURRAY JF, 1989, AM REV RESPIR DIS, V139, P1065; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; *WHO, 2009, CDC PROT REALT RTPCR; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2009, INFL H1N1 UPD 14; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; 2009, MMWR MORB MORTAL WKL, V58, P435; 2009, MMWR MORB MORTAL WKL, V58, P431	20	1005	1134	1	210	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					680	689		10.1056/NEJMoa0904252	http://dx.doi.org/10.1056/NEJMoa0904252			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19564631				2022-12-24	WOS:000268884100008
J	Chiu, YH; MacMillan, JB; Chen, ZJJ				Chiu, Yu-Hsin; MacMillan, John B.; Chen, Zhijian J.			RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; EPSTEIN-BARR VIRUS; HEPATITIS-C VIRUS; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; KAPPA-B; RESPONSES; RECOGNITION; CELLS	Type I interferons (IFNs) are important for antiviral and autoimmune responses. Retinoic acid-induced gene I (RIG-I) and mitochondrial antiviral signaling (MAVS) proteins mediate IFN production in response to cytosolic double-stranded RNA or single-stranded RNA containing 5'-triphosphate (5'-ppp). Cytosolic B form double-stranded DNA, such as poly(dA-dT).poly(dA-dT)[poly(dA-dT)], can also induce IFN-beta, but the underlying mechanism is unknown. Here, we show that the cytosolic poly(dA-dT) DNA is converted into 5'-ppp RNA to induce IFN-beta through the RIG-I pathway. Biochemical purification led to the identification of DNA-dependent RNA polymerase III (Pol-III) as the enzyme responsible for synthesizing 5'-ppp RNA from the poly(dA-dT) template. Inhibition of RNA Pol-III prevents IFN-beta induction by transfection of DNA or infection with DNA viruses. Furthermore, Pol-III inhibition abrogates IFN-beta induction by the intracellular bacterium Legionella pneumophila and promotes the bacterial growth. These results suggest that RNA Pol-III is a cytosolic DNA sensor involved in innate immune responses.	[Chiu, Yu-Hsin; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [MacMillan, John B.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; MacMillan, John/0000-0003-1430-1077	National Institutes of Health; Welch Foundation; Chilton Foundation; Investigator of Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Chilton Foundation; Investigator of Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xiang Chen and Xiao-Dong Li for assistance in preparing BMDM, Hon-Ren Huang ( Harvard University) for technical advice, and Brian Skaug for critical reading of the manuscript. This work was supported by grants from the National Institutes of Health and the Welch Foundation (Z.J.C.) and by the Chilton Foundation (J.M.). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HOWE JG, 1993, MOL CELL BIOL, V13, P2655, DOI 10.1128/MCB.13.5.2655; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	29	847	907	2	110	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 7	2009	138	3					576	591		10.1016/j.cell.2009.06.015	http://dx.doi.org/10.1016/j.cell.2009.06.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19631370	Green Accepted, Bronze			2022-12-24	WOS:000268771900021
J	Gross, T; Rudolf, L; Levin, SA; Dieckmann, U				Gross, Thilo; Rudolf, Lars; Levin, Simon A.; Dieckmann, Ulf			Generalized Models Reveal Stabilizing Factors in Food Webs	SCIENCE			English	Article							LARGE COMPLEX SYSTEM; INTERACTION STRENGTHS; DIVERSITY; WILL	Insights into what stabilizes natural food webs have always been limited by a fundamental dilemma: Studies either need to make unwarranted simplifying assumptions, which undermines their relevance, or only examine few replicates of small food webs, which hampers the robustness of findings. We used generalized modeling to study several billion replicates of food webs with nonlinear interactions and up to 50 species. In this way, first we show that higher variability in link strengths stabilizes food webs only when webs are relatively small, whereas larger webs are instead destabilized. Second, we reveal a new power law describing how food-web stability scales with the number of species and their connectance. Third, we report two universal rules: Food-web stability is enhanced when (i) species at a high trophic level feed on multiple prey species and (ii) species at an intermediate trophic level are fed upon by multiple predator species.	[Gross, Thilo; Rudolf, Lars] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Levin, Simon A.] Princeton Univ, Ctr BioComplex, Princeton, NJ 08540 USA; [Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	Max Planck Society; Princeton University; Princeton University; International Institute for Applied Systems Analysis (IIASA)	Gross, T (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	thilo.gross@physics.org	Gross, Thilo/B-4444-2010; Levin, Simon A/J-1218-2014; Dieckmann, Ulf/E-1424-2011	Gross, Thilo/0000-0002-1356-6690; Levin, Simon A/0000-0002-8216-5639; Dieckmann, Ulf/0000-0001-7089-0393	NSF [DEB-0083566]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; European Commission; European Science Foundation; Austrian Science Fund; Vienna Science and Technology Fund	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund	T.G. and L.R. thank B. Blasius for extensive discussions and insightful comments. S.L. acknowledges the support of NSF (grant DEB-0083566) and the Defense Advanced Research Projects Agency (grant HR0011-05-1-0057). U.D. acknowledges support by the European Commission, the European Science Foundation, the Austrian Science Fund, and the Vienna Science and Technology Fund.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; COHEN JE, 1985, J THEOR BIOL, V113, P153, DOI 10.1016/S0022-5193(85)80081-3; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Gross T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016205; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; KING AW, 1983, AM NAT, V122, P229, DOI 10.1086/284132; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Navarrete SA, 2006, ECOL LETT, V9, P526, DOI 10.1111/j.1461-0248.2006.00899.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Sinha S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.020902; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	22	197	198	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					747	750		10.1126/science.1173536	http://dx.doi.org/10.1126/science.1173536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661430	Green Submitted			2022-12-24	WOS:000268723700049
J	Swirski, FK; Nahrendorf, M; Etzrodt, M; Wildgruber, M; Cortez-Retamozo, V; Panizzi, P; Figueiredo, JL; Kohler, RH; Chudnovskiy, A; Waterman, P; Aikawa, E; Mempel, TR; Libby, P; Weissleder, R; Pittet, MJ				Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Libby, Peter; Weissleder, Ralph; Pittet, Mikael J.			Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites	SCIENCE			English	Article							BLOOD-VESSELS; BONE-MARROW; RECEPTOR; SUBSETS; CCR2; HETEROGENEITY; RECRUITMENT; MACROPHAGES; MIGRATION; ORIGIN	A current paradigm states that monocytes circulate freely and patrol blood vessels but differentiate irreversibly into dendritic cells (DCs) or macrophages upon tissue entry. Here we show that bona fide undifferentiated monocytes reside in the spleen and outnumber their equivalents in circulation. The reservoir monocytes assemble in clusters in the cords of the subcapsular red pulp and are distinct from macrophages and DCs. In response to ischemic myocardial injury, splenic monocytes increase their motility, exit the spleen en masse, accumulate in injured tissue, and participate in wound healing. These observations uncover a role for the spleen as a site for storage and rapid deployment of monocytes and identify splenic monocytes as a resource that the body exploits to regulate inflammation.	[Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Weissleder, Ralph; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Etzrodt, Martin] Univ Lausanne, Fac Biol & Med, CH-1015 Lausanne, Switzerland; [Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Mempel, Thorsten R.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Libby, Peter] Brigham & Womens Hosp, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Lausanne; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	fswirski@mgh.harvard.edu; rweissleder@mgh.harvard.edu; mpittet@mgh.harvard.edu	Etzrodt, Martin/P-3325-2015; Aikawa, Elena/L-6173-2019; Pittet, Mikael/ABD-6300-2021; Panizzi, Peter/A-6072-2019; Swirski, Filip/AAF-1340-2019; Libby, Peter/AAY-6404-2021	Etzrodt, Martin/0000-0003-1928-3904; Panizzi, Peter/0000-0003-0141-8807; Libby, Peter/0000-0002-1502-502X; Swirski, Filip/0000-0002-3163-9152; Aikawa, Elena/0000-0001-7835-2135; /0000-0003-0828-4143; kohler, rainer/0000-0001-6269-6590	NIH [U01 HL080731, P50 CA86355, R24 CA69246, U54 CA126515, P01 A154904, 1R01HL095612]; MGH-Center for Systems Biology; AHA [SDG 0835623D]; NATIONAL CANCER INSTITUTE [P50CA086355, P01CA069246, U54CA126515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095629, U01HL080731, R01HL095612, R00HL094533, R01HL096576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH-Center for Systems Biology; AHA(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants U01 HL080731, P50 CA86355, R24 CA69246, U54 CA126515, and P01 A154904 to RW, MGH Center for Systems Biology to MJP, AHA SDG 0835623D to MN, and NIH grant 1R01HL095612 to FKS. The authors thank U. von Andrian for critical assessment of the manuscript, A. Luster for providing Ccr2 mice, D. Erle, A. Barcak, and C. Eisley for microarray hybridization and data analysis, M. Waring for sorting cells, A. Moseman for helpful discussion and feedback with parabiosis experiments, and A. Newton, C. Siegel, N. Sergeyev, and Y. Iwamoto for technical assistance. MIAME minimum information about a microarray experiment compliant expression data have been deposited under accession no. GSE14850. This work is dedicated to the memory of Marc Henri Pittet.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; DAVIES BN, 1973, PHARMACOL REV, V25, P373; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917	27	1490	1547	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					612	616		10.1126/science.1175202	http://dx.doi.org/10.1126/science.1175202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644120	Green Accepted			2022-12-24	WOS:000268493000051
J	Mosher, RA; Melnyk, CW; Kelly, KA; Dunn, RM; Studholme, DJ; Baulcombe, DC				Mosher, Rebecca A.; Melnyk, Charles W.; Kelly, Krystyna A.; Dunn, Ruth M.; Studholme, David J.; Baulcombe, David C.			Uniparental expression of PolIV-dependent siRNAs in developing endosperm of Arabidopsis	NATURE			English	Article							RNA-POLYMERASE-IV; DNA-METHYLATION; GENE; MEDEA; TRANSPOSONS; MICRORNAS	Most eukaryotes produce small RNA (sRNA) mediators of gene silencing that bind to Argonaute proteins and guide them, by base pairing, to an RNA target. MicroRNAs (miRNAs) that normally target messenger RNAs for degradation or translational arrest are the best-understood class of sRNAs. However, in Arabidopsis thaliana flowers, miRNAs account for only 5% of the sRNA mass and less than 0.1% of the sequence complexity. The remaining sRNAs form a complex population of more than 100,000 different small interfering RNAs (siRNAs) transcribed from thousands of loci(1-5). The biogenesis of most of the siRNAs in Arabidopsis are dependent on RNA polymerase IV (PolIV), a homologue of DNA-dependent RNA polymerase II2,3,6. A subset of these PolIV-dependent (p4)-siRNAs are involved in stress responses, and others are associated with epigenetic modifications to DNA or chromatin; however, the biological role is not known for most of them. Here we show that the predominant phase of p4-siRNA accumulation is initiated in the maternal gametophyte and continues during seed development. Expression of p4-siRNAs in developing endosperm is specifically from maternal chromosomes. Our results provide the first evidence for a link between genomic imprinting and RNA silencing in plants.	[Mosher, Rebecca A.; Melnyk, Charles W.; Kelly, Krystyna A.; Dunn, Ruth M.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Studholme, David J.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk	Mosher, Rebecca/F-4800-2010; Studholme, David/H-6790-2019; Melnyk, Charles W/R-2846-2017	Mosher, Rebecca/0000-0003-2195-0825; Studholme, David/0000-0002-3010-6637; Melnyk, Charles W/0000-0003-3251-800X; Baulcombe, David/0000-0003-0780-6878	Gatsby Charitable Foundation; SIROCCO [LSHG-CT-2006-037900]; National Science Foundation; Commonwealth and NSERC Scholarships; Royal Society Research	Gatsby Charitable Foundation; SIROCCO; National Science Foundation(National Science Foundation (NSF)); Commonwealth and NSERC Scholarships; Royal Society Research(Royal Society of London)	We thank I. Furner for met1-1 seed and A. Davis for photography. This work was supported by the Gatsby Charitable Foundation, the European Union Sixth Framework Programme Integrated Project SIROCCO (grant LSHG-CT-2006-037900), a postdoctoral fellowship from the National Science Foundation (to R. A. M.), and Commonwealth and NSERC Scholarships (to C. W. M.). D. C. B. is funded as a Royal Society Research Professor.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	21	235	243	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					283	U151		10.1038/nature08084	http://dx.doi.org/10.1038/nature08084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19494814				2022-12-24	WOS:000267761000046
J	Patterson, CC; Dahquist, GG; Gyurus, E; Green, A; Soltesz, G				Patterson, Christopher C.; Dahquist, Gisela G.; Gyurus, Eva; Green, Anders; Soltesz, Gyula		EURODIAB Study Grp	Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study	LANCET			English	Article							AGED LESS-THAN-15 YEARS; MISSING LINK; YOUNG-ADULTS; ONSET; MELLITUS; CHILDREN; PERIOD; YORKSHIRE; DISEASE; SWEDEN	Background The incidence of type 1 diabetes in children younger than 15 years is increasing. Prediction of future incidence of this disease will enable adequate fund allocation for delivery of care to be planned. We aimed to establish 15-year incidence trends for childhood type 1 diabetes in European centres, and thereby predict the future burden of childhood diabetes in Europe. Methods 20 population-based EURODIAB registers in 17 countries registered 29311 new cases of type 1 diabetes, diagnosed in children before their 15th birthday during a 15-year period, 1989-2003. Age-specific log linear rates of increase were estimated in five geographical regions, and used in conjunction with published incidence rates and population projections to predict numbers of new cases throughout Europe in 2005, 2010, 2015, and 2020. Findings Ascertainment was better than 90% in most registers. All but two registers showed significant yearly increases in incidence, ranging from 0.6% to 9.3%. The overall annual increase was 3.9% (95% Cl 3.6-4.2), and the increases in the age groups 0-4 years, 5-9 years, and 10-14 years were 5.4% (4.8-6.1), 4.3% (3.8-4.8), and 2.9% (2.5-3.3), respectively. The number of new cases in Europe in 2005 is estimated as 15000, divided between the 0-4 year, 5-9 year, and 10-14 year age-groups in the ratio 24%, 35%, and 41%, respectively. In 2020, the predicted number of new cases is 24400, with a doubling in numbers in children younger than 5 years and a more even distribution across age-groups than at present (29%, 37%, and 34%, respectively). Prevalence under age 15 years is predicted to rise from 94 000 in 2005, to 160 000 in 2020. Interpretation If present trends continue, doubling of new cases of type 1 diabetes in European children younger than 5 years is predicted between 2005 and 2020, and prevalent cases younger than 15 years will rise by 70%. Adequate health-care resources to meet these children's needs should be made available.	[Patterson, Christopher C.] Queens Univ Belfast, Ctr Publ Hlth, Epidemiol Res Grp, Mulhouse Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland; [Dahquist, Gisela G.] Umea Univ, Dept Clin Sci, Umea, Sweden; [Gyurus, Eva; Soltesz, Gyula] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Green, Anders] Univ So Denmark, Inst Publ Hlth, Dept Epidemiol, Odense, Denmark; [Green, Anders] S Odense Univ Hosp, Ctr Natl Clin Database, Odense, Denmark	Queens University Belfast; Umea University; University of Pecs; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Patterson, CC (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Epidemiol Res Grp, Mulhouse Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.patterson@qub.ac.uk	Polanska, Joanna/H-4513-2013; Green, Anders/T-8788-2019; Polanska, Joanna/A-5271-2008	Polanska, Joanna/0000-0001-8004-9864; Green, Anders/0000-0002-5059-3655; Mortensen, Henrik Bindesbol/0000-0001-9231-8363; Svensson, Jannet/0000-0002-9365-0728; Jarosz-Chobot, Przemyslawa/0000-0002-1120-0994; Cardwell, Chris/0000-0002-2689-4335; Albert Goday Arno, Albert/0000-0001-7356-1595; Weets, Ilse/0000-0002-9007-5203; Gorus, Frans/0000-0002-9007-6177; Sjoberg, Lena/0000-0002-5420-5189; Cinek, Ondrej/0000-0002-0526-8714; Battelino, Tadej/0000-0002-0273-4732; Sumnik, Zdenek/0000-0002-6462-6462; de Beaufort, Carine/0000-0003-4310-6799	Czech Ministry of Eduction [MSM 0021620814]; Finnish National Institute for Health and Welfare; German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University; Hungarian Childhood Diabetes Epidemiology Group; Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group; Yorkshire Paediatric Diabetes Specialist Interest Group; Health Quality Information Partnership, Department of Health, England; Swedish Research Council [07531]; European Community [MR4*/029/UK, BMH1-CT92-0043, BMH4-CT96-0577, IC20-CT96-0070]; Diabetes UK; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	Czech Ministry of Eduction; Finnish National Institute for Health and Welfare; German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University; Hungarian Childhood Diabetes Epidemiology Group; Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group; Yorkshire Paediatric Diabetes Specialist Interest Group; Health Quality Information Partnership, Department of Health, England; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Diabetes UK(Diabetes UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank Gerda Brutti, who was administrator for the EURODIAB study group during its first decade, the Austrian Diabetes Incidence Study Group, the Czech Childhood Diabetes Register (supported by Czech Ministry of Eduction grant MSM 0021620814), the Finnish National Institute for Health and Welfare, the German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University, the Hungarian Childhood Diabetes Epidemiology Group, the Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group (register funded by Diabetes UK), the Yorkshire Paediatric Diabetes Specialist Interest Group (register funded by the Health Quality Information Partnership, Department of Health, England), and the Swedish Childhood Diabetes Study Group (register funded by the Swedish Research Council, Project number 07531). The collaboration was supported in part by European Community Concerted Action Program grants (MR4*/029/UK, BMH1-CT92-0043, BMH4-CT96-0577, and IC20-CT96-0070).	Aamodt G, 2007, DIABETES CARE, V30, P884, DOI 10.2337/dc06-1568; [Anonymous], WORLD POPULATION PRO; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bishop YM, 1974, DISCRETE MULTIVARIAT; Bruno G, 2001, DIABETOLOGIA, V44, P22, DOI 10.1007/s001250051575; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Dahlquist G, 2002, DIABETES CARE, V25, P1755; *EUROSTAT, EUROSTAT EST 2005 PO; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Joner G, 2004, DIABETES CARE, V27, P1618, DOI 10.2337/diacare.27.7.1618; Kaufman FR, 2007, PEDIATR DIABETES, V8, P4, DOI 10.1111/j.1399-5448.2007.00327.x; Kyvik KO, 2004, DIABETOLOGIA, V47, P377, DOI 10.1007/s00125-004-1331-9; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; Moltchanova E, 2005, STAT MED, V24, P2989, DOI 10.1002/sim.2166; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Pundziute-Lycka A, 2004, ACTA PAEDIATR, V93, P1519, DOI 10.1080/08035250410026680; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Schober E, 2008, EUR J PEDIATR, V167, P293, DOI 10.1007/s00431-007-0480-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; SOLTESZ G, 2006, DIABETES ATLAS, P153; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; Weets I, 2002, DIABETES CARE, V25, P840, DOI 10.2337/diacare.25.5.840; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548	31	1203	1244	0	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2027	2033		10.1016/S0140-6736(09)60568-7	http://dx.doi.org/10.1016/S0140-6736(09)60568-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19481249				2022-12-24	WOS:000267080100029
J	Lentink, D; Dickson, WB; van Leeuwen, JL; Dickinson, MH				Lentink, D.; Dickson, W. B.; van Leeuwen, J. L.; Dickinson, M. H.			Leading-Edge Vortices Elevate Lift of Autorotating Plant Seeds	SCIENCE			English	Article							LONG-DISTANCE DISPERSAL; LOW REYNOLDS-NUMBERS; REVOLVING WINGS; INSECT FLIGHT; VORTEX; AERODYNAMICS; PERFORMANCE; MECHANISMS; SAMARAS; SWIFTS	As they descend, the autorotating seeds of maples and some other trees generate unexpectedly high lift, but how they attain this elevated performance is unknown. To elucidate the mechanisms responsible, we measured the three-dimensional flow around dynamically scaled models of maple and hornbeam seeds. Our results indicate that these seeds attain high lift by generating a stable leading-edge vortex (LEV) as they descend. The compact LEV, which we verified on real specimens, allows maple seeds to remain in the air more effectively than do a variety of nonautorotating seeds. LEVs also explain the high lift generated by hovering insects, bats, and possibly birds, suggesting that the use of LEVs represents a convergent aerodynamic solution in the evolution of flight performance in both animals and plants.	[Lentink, D.; van Leeuwen, J. L.] Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; [Dickson, W. B.; Dickinson, M. H.] CALTECH, Pasadena, CA 91125 USA	Wageningen University & Research; California Institute of Technology	Lentink, D (corresponding author), Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	david.lentink@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X; Lentink, David/0000-0003-4717-6815	Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO ALW) [817.02.012]; NSF [IBN-0217229]	Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO ALW)(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF))	We thank M. Lino, E. W. Karruppannan, E. Janssen, J. G. M. van den Boogaart, K. M. Leon, and H. Schipper for help with the free flight experiments. We thank G. E. Elsinga, J. R. Usherwood, and G. J. F. van Heijst for valuable comments. Research was funded by Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO-ALW, grant 817.02.012) (to D.L. and J.L.v.L.) and NSF grant IBN-0217229 (to M.H.D.).	AZUMA A, 1987, J THEOR BIOL, V129, P263, DOI 10.1016/S0022-5193(87)80001-2; AZUMA A, 1989, J THEOR BIOL, V138, P23, DOI 10.1016/S0022-5193(89)80176-6; Azuma A., 2006, BIOKINETICS FLYING S; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Burrows FM., 1986, SEED DISPERSAL, P1; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dickson WB, 2004, J EXP BIOL, V207, P4269, DOI 10.1242/jeb.01266; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Hubel T., 2006, THESIS TU DARMSTADT; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; LINO M, 81702012 NWOALW NETH; Lorenz R.D., 2006, SPINNING FLIGHT; LUGT HJ, 1983, ANNU REV FLUID MECH, V15, P123, DOI 10.1146/annurev.fl.15.010183.001011; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; Minami S, 2003, J THEOR BIOL, V225, P1, DOI 10.1016/S0022-5193(03)00216-9; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Niklas KJ, 1992, PLANT BIOMECHANICS; NORBERG RA, 1973, BIOL REV, V48, P561, DOI 10.1111/j.1469-185X.1973.tb01569.x; Poelma C, 2006, EXP FLUIDS, V41, P213, DOI 10.1007/s00348-006-0172-3; SETER D, 1992, T ASME, V59, P1000; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Usherwood JR, 2002, J EXP BIOL, V205, P1547; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Yasuda K, 1997, J THEOR BIOL, V185, P313, DOI 10.1006/jtbi.1996.0299	30	143	149	14	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1438	1440		10.1126/science.1174196	http://dx.doi.org/10.1126/science.1174196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520959				2022-12-24	WOS:000266878700044
J	Brown, AEX; Litvinov, RI; Discher, DE; Purohit, PK; Weisel, JW				Brown, Andre E. X.; Litvinov, Rustem I.; Discher, Dennis E.; Purohit, Prashant K.; Weisel, John W.			Multiscale Mechanics of Fibrin Polymer: Gel Stretching with Protein Unfolding and Loss of Water	SCIENCE			English	Article							NONLINEAR ELASTICITY; X-RAY; FIBERS; MICROSCOPY; NETWORKS; KERATIN; STRESS; CELLS; CLOTS; FINE	Blood clots and thrombi consist primarily of a mesh of branched fibers made of the protein fibrin. We propose a molecular basis for the marked extensibility and negative compressibility of fibrin gels based on the structural and mechanical properties of clots at the network, fiber, and molecular levels. The force required to stretch a clot initially rises linearly and is accompanied by a dramatic decrease in clot volume and a peak in compressibility. These macroscopic transitions are accompanied by fiber alignment and bundling after forced protein unfolding. Constitutive models are developed to integrate observations at spatial scales that span six orders of magnitude and indicate that gel extensibility and expulsion of water are both manifestations of protein unfolding, which is not apparent in other matrix proteins such as collagen.	[Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Brown, Andre E. X.; Discher, Dennis E.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Brown, Andre E. X.; Discher, Dennis E.] Univ Penn, Nano Bio Interface Ctr, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Grad Grp Phys, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Grad Grp Cell Biol & Physiol, Philadelphia, PA 19104 USA; [Purohit, Prashant K.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu	Litvinov, Rustem/E-5291-2011; Brown, Andre/D-6516-2012	Litvinov, Rustem/0000-0003-0643-1496; Brown, Andre/0000-0002-1324-8764; discher, dennis/0000-0001-6163-2229	NIH [HL090774, HL30954, HL62352]; Nano/Bio Interface Center NSF Nanoscale Science and Engineering Center; Natural Sciences and Engineering Research Council of Canada;  [DMR-0425780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL090774, R01HL090774, R01HL030954, R01HL062352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nano/Bio Interface Center NSF Nanoscale Science and Engineering Center; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (grants HL090774 and HL30954 to J.W.W. and grant HL62352 to D.E.D.) and by the Nano/Bio Interface Center through NSF Nanoscale Science and Engineering Center (grant DMR-0425780). A.E.X.B. was supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada.	Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6; Alexander L.E., 1979, XRAY DIFFRACTION MET; Astbury WT, 1934, P R SOC LOND B-CONTA, V114, P314, DOI 10.1098/rspb.1934.0009; Bailey K, 1943, NATURE, V151, P716, DOI 10.1038/151716a0; Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; COLMAN RW, 2005, HEMOSTASIS THROMBOSI; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; GABRIEL DA, 1992, J BIOL CHEM, V267, P24259; Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1; JANMEY PA, 1983, J RHEOL, V27, P135, DOI 10.1122/1.549722; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kang H, 2009, J PHYS CHEM B, V113, P3799, DOI 10.1021/jp807749f; Kharakoz DP, 2000, BIOPHYS J, V79, P511, DOI 10.1016/S0006-3495(00)76313-2; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; MULLER MF, 1984, J MOL BIOL, V174, P369, DOI 10.1016/0022-2836(84)90343-7; Qi HJ, 2006, J ENG MATER-T ASME, V128, P509, DOI 10.1115/1.2345442; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; ROSKA FJ, 1982, BIOPOLYMERS, V21, P1833, DOI 10.1002/bip.360210911; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; STRYER L, 1963, NATURE, V197, P793, DOI 10.1038/197793a0; Treloar L. R. G., 1975, PHYS TODAY, DOI DOI 10.1063/1.3060678; VOTER WA, 1986, BIOPOLYMERS, V25, P2375, DOI 10.1002/bip.360251214; WEISEL JW, 1987, P NATL ACAD SCI USA, V84, P8991, DOI 10.1073/pnas.84.24.8991; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	29	268	273	7	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					741	744		10.1126/science.1172484	http://dx.doi.org/10.1126/science.1172484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661428	Green Accepted			2022-12-24	WOS:000268723700047
J	Chase, MW; Fay, MF				Chase, Mark W.; Fay, Michael F.			Barcoding of Plants and Fungi	SCIENCE			English	Editorial Material							DNA BARCODES		[Chase, Mark W.; Fay, Michael F.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England	Royal Botanic Gardens, Kew	Chase, MW (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England.	m.fay@rbgkew.org.uk	Fay, Michael F/G-4741-2010; 赵, 鹏/B-8401-2009; Fay, Michael/AAU-5861-2021; Chase, Mark W/A-6642-2011	Fay, Michael F/0000-0003-3491-9093; 				Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Thomas C, 2009, SCIENCE, V324, P1632, DOI 10.1126/science.324_1632; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	15	135	157	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					682	683		10.1126/science.1176906	http://dx.doi.org/10.1126/science.1176906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480HF	19644072				2022-12-24	WOS:000268723700023
J	Dietz, H; Douglas, SM; Shih, WM				Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.			Folding DNA into Twisted and Curved Nanoscale Shapes	SCIENCE			English	Article							DOUBLE-CROSSOVER MOLECULES; CONDUCTIVE NANOWIRES; NANOTUBES; NANOSTRUCTURES; OCTAHEDRON; DESIGN	We demonstrate the ability to engineer complex shapes that twist and curve at the nanoscale from DNA. Through programmable self-assembly, strands of DNA are directed to form a custom-shaped bundle of tightly cross-linked double helices, arrayed in parallel to their helical axes. Targeted insertions and deletions of base pairs cause the DNA bundles to develop twist of either handedness or to curve. The degree of curvature could be quantitatively controlled, and a radius of curvature as tight as 6 nanometers was achieved. We also combined multiple curved elements to build several different types of intricate nanostructures, such as a wireframe beach ball or square-toothed gears.	[Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Douglas, Shawn M.; Shih, William M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Shih, WM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	william_shih@dfci.harvard.edu	Douglas, Shawn/GVU-2004-2022	Douglas, Shawn/0000-0001-5398-9041; Dietz, Hendrik/0000-0003-1270-3662	Claudia Adams Barr Program; Wyss Institute for Biologically Inspired Engineering; NIH [1DP2OD004641-01]; Feodor-Lynen Humboldt; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	Claudia Adams Barr Program; Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feodor-Lynen Humboldt; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Claudia Adams Barr Program Investigator, Wyss Institute for Biologically Inspired Engineering, and NIH New Innovator (1DP2OD004641-01) grants to W.M.S. and a Feodor-Lynen Humboldt Fellowship to H.D. H.D., S.M.D., and W.M.S. designed the research for this paper. H.D. developed rules for twisting and bending; H.D. and S.M.D. designed all shapes; H.D. and S.M.D. collected data; H.D. analyzed data; S.M.D. provided caDNAno software support; and H.D., W.M.S., and S.M.D. wrote the manuscript.	BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Lin CX, 2009, NANO LETT, V9, P433, DOI 10.1021/nl803328v; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	27	909	967	20	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					725	730		10.1126/science.1174251	http://dx.doi.org/10.1126/science.1174251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661424	Green Accepted			2022-12-24	WOS:000268723700043
J	Hough, LE; Jung, HT; Kruerke, D; Heberling, MS; Nakata, M; Jones, CD; Chen, D; Link, DR; Zasadzinski, J; Heppke, G; Rabe, JP; Stocker, W; Korblova, E; Walba, DM; Glaser, MA; Clark, NA				Hough, L. E.; Jung, H. T.; Krueerke, D.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Zasadzinski, J.; Heppke, G.; Rabe, J. P.; Stocker, W.; Koerblova, E.; Walba, D. M.; Glaser, M. A.; Clark, N. A.			Helical Nanofilament Phases	SCIENCE			English	Article							SMECTIC LIQUID-CRYSTALS; ACHIRAL MOLECULES; TRANSITION; CHIRALITY; SYSTEMS; MODEL	In the formation of chiral crystals, the tendency for twist in the orientation of neighboring molecules is incompatible with ordering into a lattice: Twist is expelled from planar layers at the expense of local strain. We report the ordered state of a neat material in which a local chiral structure is expressed as twisted layers, a state made possible by spatial limitation of layering to a periodic array of nanoscale filaments. Although made of achiral molecules, the layers in these filaments are twisted and rigorously homochiral-a broken symmetry. The precise structural definition achieved in filament self-assembly enables collective organization into arrays in which an additional broken symmetry-the appearance of macroscopic coherence of the filament twist-produces a liquid crystal phase of helically precessing layers.	[Hough, L. E.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Hough, L. E.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Koerblova, E.; Walba, D. M.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Jung, H. T.] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn BK 21, Taejon 305701, South Korea; [Krueerke, D.; Heppke, G.] Tech Univ Berlin, Inst Inorgan & Analyt Chem, D-10623 Berlin, Germany; [Zasadzinski, J.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Rabe, J. P.; Stocker, W.] Humboldt Univ, Dept Phys, D-10099 Berlin, Germany; [Koerblova, E.; Walba, D. M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Korea Advanced Institute of Science & Technology (KAIST); Technical University of Berlin; University of California System; University of California Santa Barbara; Humboldt University of Berlin; University of Colorado System; University of Colorado Boulder	Hough, LE (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	hough@colorado.edu; noel.clark@colorado.edu	Jung, Hee-Tae/C-1574-2011; Clark, Noel A/AAP-9116-2020; Rabe, Jürgen P./D-1032-2010; Glaser, Matthew/H-2345-2016; Korblova, Eva/AAC-3502-2021; Walba, David/F-7284-2013; Clark, Noel A./E-9011-2010; Chen, Dong/D-3874-2014	Rabe, Jürgen P./0000-0003-0847-6663; Glaser, Matthew/0000-0002-8366-5598; Korblova, Eva/0000-0002-3818-4373; Clark, Noel A./0000-0001-9301-5540; Chen, Dong/0000-0002-8904-9307; HOUGH, LOREN/0000-0002-1104-0126	NSF [DMR 0606528]; NSF Materials Research Science and Engineering Center [DMR 0820579]; Deutsche Forschungsgemeinschaft [Sfb 448]; NIH [HL-51177]; U.S. Department of Energy, Divisions of Materials and Chemical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051177] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Divisions of Materials and Chemical Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NSF grant DMR 0606528 (N.A.C.), NSF Materials Research Science and Engineering Center grant DMR 0820579 (N.A.C.), an NSF Graduate Research Fellowship (L.H.), Deutsche Forschungsgemeinschaft grant Sfb 448 (J.P.R.), and NIH grant HL-51177 (J.Z.). Use of the National Synchrotron Light Source was supported by the U.S. Department of Energy, Divisions of Materials and Chemical Sciences.	Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Annett J.E., 2004, OXFORD MASTER SERIES; Araoka F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137801; BOULIGAND Y, 1984, J PHYS-PARIS, V45, P1899, DOI 10.1051/jphys:0198400450120189900; Choi SW, 2006, ANGEW CHEM INT EDIT, V45, P6503, DOI 10.1002/anie.200601129; Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956; COLLINGS P, 1997, 1 INT WORKSH BANN SH; de Vries AH, 2005, P NATL ACAD SCI USA, V102, P5392, DOI 10.1073/pnas.0408249102; DEGENNES PG, 1972, SOLID STATE COMMUN, V10, P753, DOI 10.1016/0038-1098(72)90186-X; Fernsler J, 2005, P NATL ACAD SCI USA, V102, P14191, DOI 10.1073/pnas.0500664102; Link DR, 1997, SCIENCE, V278, P1924, DOI 10.1126/science.278.5345.1924; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; Niwano H, 2004, J PHYS CHEM B, V108, P14889, DOI 10.1021/jp0311355; Noorduin WL, 2008, J AM CHEM SOC, V130, P1158, DOI 10.1021/ja7106349; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; RENN SR, 1988, PHYS REV A, V38, P2132, DOI 10.1103/PhysRevA.38.2132; Sekine T, 1997, JPN J APPL PHYS 1, V36, P6455, DOI 10.1143/JJAP.36.6455; Sekine T, 1997, J MATER CHEM, V7, P1307, DOI 10.1039/a702026k; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; SPECTOR MS, 2002, MAT CHIRALITY SPECIA, P281; Takezoe H, 2006, JPN J APPL PHYS 1, V45, P597, DOI 10.1143/JJAP.45.597; Thisayukta J, 2001, JPN J APPL PHYS 1, V40, P3277, DOI 10.1143/JJAP.40.3277; Thisayukta J, 2000, J AM CHEM SOC, V122, P7441, DOI 10.1021/ja001370q; Walba DM, 2005, CRYST GROWTH DES, V5, P2091, DOI 10.1021/cg050282k; WEISS RG, 2005, MOL GELS MAT SELF AS	25	249	250	8	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					456	460		10.1126/science.1170027	http://dx.doi.org/10.1126/science.1170027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628864				2022-12-24	WOS:000268255100051
J	Delvaeye, M; Noris, M; De Vriese, A; Esmon, CT; Esmon, NL; Ferrell, G; Del-Favero, J; Plaisance, S; Claes, B; Lambrechts, D; Zoja, C; Remuzzi, G; Conway, EM				Delvaeye, Mieke; Noris, Marina; De Vriese, Astrid; Esmon, Charles T.; Esmon, Naomi L.; Ferrell, Gary; Del-Favero, Jurgen; Plaisance, Stephane; Claes, Bart; Lambrechts, Diether; Zoja, Carla; Remuzzi, Giuseppe; Conway, Edward M.			Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEMBRANE COFACTOR PROTEIN; LECTIN-LIKE DOMAIN; ACTIVATABLE FIBRINOLYSIS INHIBITOR; FACTOR-H; THROMBOTIC MICROANGIOPATHIES; MYOCARDIAL-INFARCTION; COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; GENE MUTATION; INFLAMMATION	Background The hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. The common form of the syndrome is triggered by infection with Shiga toxin-producing bacteria and has a favorable outcome. The less common form of the syndrome, called atypical hemolytic-uremic syndrome, accounts for about 10% of cases, and patients with this form of the syndrome have a poor prognosis. Approximately half of the patients with atypical hemolytic-uremic syndrome have mutations in genes that regulate the complement system. Genetic factors in the remaining cases are unknown. We studied the role of thrombomodulin, an endothelial glycoprotein with anticoagulant, antiinflammatory, and cytoprotective properties, in atypical hemolytic-uremic syndrome. Methods We sequenced the entire thrombomodulin gene (THBD) in 152 patients with atypical hemolytic-uremic syndrome and in 380 controls. Using purified proteins and cell-expression systems, we investigated whether thrombomodulin regulates the complement system, and we characterized the mechanisms. We evaluated the effects of thrombomodulin missense mutations associated with atypical hemolytic uremic syndrome on complement activation by expressing thrombomodulin variants in cultured cells. Results Of 152 patients with atypical hemolytic-uremic syndrome, 7 unrelated patients had six different heterozygous missense THBD mutations. In vitro, thrombomodulin binds to C3b and factor H (CFH) and negatively regulates complement by accelerating factor I-mediated inactivation of C3b in the presence of cofactors, CFH or C4b binding protein. By promoting activation of the plasma procarboxypeptidase B, thrombomodulin also accelerates the inactivation of anaphylatoxins C3a and C5a. Cultured cells expressing thrombomodulin variants associated with atypical hemolytic-uremic syndrome had diminished capacity to inactivate C3b and to activate procarboxypeptidase B and were thus less protected from activated complement. Conclusions Mutations that impair the function of thrombomodulin occur in about 5% of patients with atypical hemolytic-uremic syndrome.	[Delvaeye, Mieke; De Vriese, Astrid; Claes, Bart; Lambrechts, Diether; Conway, Edward M.] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Leuven, Belgium; [Del-Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Grp, B-2610 Antwerp, Belgium; [Plaisance, Stephane] VIB BioInformat Training & Serv Facil, Ghent, Belgium; [Noris, Marina; Zoja, Carla; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis, I-24100 Bergamo, Italy; [Esmon, Charles T.; Esmon, Naomi L.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Esmon, Charles T.; Ferrell, Gary] Howard Hughes Med Inst, Oklahoma City, OK USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Conway, EM (corresponding author), Univ British Columbia, Life Sci Ctr, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	emconway@interchange.ubc.ca	Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012; zoja, carlamaria/ABF-5896-2020; NORIS, MARINA/ABG-2219-2020; Plaisance, Stephane/ABI-6307-2020; Plaisance, Stephane/B-3488-2009; Remuzzi, Giuseppe/V-9766-2017	Lambrechts, Diether/0000-0002-3429-302X; zoja, carlamaria/0000-0003-2507-8894; NORIS, MARINA/0000-0001-7651-5033; Plaisance, Stephane/0000-0002-1651-241X; Plaisance, Stephane/0000-0002-1651-241X; Conway, Edward/0000-0003-0081-0305; Remuzzi, Giuseppe/0000-0002-6194-3446; Del Favero, jurgen/0000-0002-7427-7489	National Institutes of Health [DK71221]; Istituto Superiore della Sanita [526D/9]; Fondazione ART Per La Ricerca Sui Trapianti (Milan); Fonds voor Wetenschappelijk Onderzoek [G.0675.08]; Fondation Leducq in Paris; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istituto Superiore della Sanita; Fondazione ART Per La Ricerca Sui Trapianti (Milan); Fonds voor Wetenschappelijk Onderzoek(FWO); Fondation Leducq in Paris(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the National Institutes of Health (DK71221), Istituto Superiore della Sanita (Project no. 526D/9), Fondazione ART Per La Ricerca Sui Trapianti (Milan) (all to Drs. Noris and Remuzzi), Fonds voor Wetenschappelijk Onderzoek (FWO #G.0675.08, to Dr. Conway), and Fondation Leducq in Paris (to Drs. C. T. Esmon and N. L. Esmon).	BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Buelens K, 2008, CIRC RES, V102, P295, DOI 10.1161/CIRCRESAHA.107.157099; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P743; Esmon C, 2005, NAT MED, V11, P475, DOI 10.1038/nm0505-475; Faioni EM, 2002, BRIT J HAEMATOL, V118, P595, DOI 10.1046/j.1365-2141.2002.03644.x; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Fremeaux-Bacchi V, 2005, J MED GENET, V42, P852, DOI 10.1136/jmg.2005.030783; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GERLITZ B, 1993, BIOCHEM J, V295, P131, DOI 10.1042/bj2950131; Geudens N, 2008, EUR RESPIR J, V32, P862, DOI 10.1183/09031936.00157107; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jokiranta TS, 2007, MOL IMMUNOL, V44, P3889, DOI 10.1016/j.molimm.2007.06.003; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kaare M, 2007, HUM REPROD, V22, P864, DOI 10.1093/humrep/del436; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Kunz G, 2000, BLOOD, V95, P569, DOI 10.1182/blood.V95.2.569; Liszewski MK, 2007, MOL IMMUNOL, V44, P1559, DOI 10.1016/j.molimm.2006.08.024; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Monteferrante G, 2007, MOL IMMUNOL, V44, P1704, DOI 10.1016/j.molimm.2006.08.004; Morigi M, 2001, BLOOD, V98, P1828, DOI 10.1182/blood.V98.6.1828; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Norlund L, 1997, THROMB HAEMOSTASIS, V78, P1164; Ohlin AK, 1999, THROMB HAEMOSTASIS, V81, P338; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Razzaq S, 2006, AM FAM PHYSICIAN, V74, P991; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Sucker C, 2007, NEPHROL DIAL TRANSPL, V22, P1347, DOI 10.1093/ndt/gfl753; Taylor F B Jr, 1994, Prog Clin Biol Res, V388, P175; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; van den Boom Dirk, 2007, Methods Mol Biol, V366, P287; Vercellotti GM, 1998, BLOOD COAGUL FIBRIN, V9, pS3; Villoutreix BO, 1998, J MOL MODEL, V4, P310, DOI 10.1007/s008940050088; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Wu KK, 2001, CIRCULATION, V103, P1386, DOI 10.1161/01.CIR.103.10.1386; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	57	368	394	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					345	357		10.1056/NEJMoa0810739	http://dx.doi.org/10.1056/NEJMoa0810739			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625716	Green Accepted			2022-12-24	WOS:000268184500005
J	Majeti, R; Chao, MP; Alizadeh, AA; Pang, WW; Jaiswal, S; Gibbs, KD; van Rooijen, N; Weissman, IL				Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Gibbs, Kenneth D., Jr.; van Rooijen, Nico; Weissman, Irving L.			CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells	CELL			English	Article							ACUTE MYELOGENOUS LEUKEMIA; SIGNAL-REGULATORY PROTEIN; RECEPTOR-ALPHA CHAIN; MONOCLONAL-ANTIBODY; DENDRITIC CELL; SIRP-ALPHA; NEGATIVE REGULATION; CANCER; PROGENITORS; MARKER	Acute myeloid leukemia (AML) is organized as a cellular hierarchy initiated and maintained by a subset of self-renewing leukemia stem cells (LSC). We hypothesized that increased CD47 expression on human AML LSC contributes to pathogenesis by inhibiting their phagocytosis through the interaction of CD47 with an inhibitory receptor on phagocytes. We found that CD47 was more highly expressed on AML LSC than their normal counterparts, and that increased CD47 expression predicted worse overall survival in three independent cohorts of adult AML patients. Furthermore, blocking monoclonal antibodies directed against CD47 preferentially enabled phagocytosis of AML LSC and inhibited their engraftment in vivo. Finally, treatment of human AML LSC-engrafted mice with anti-CD47 antibody depleted AML and targeted AML LSC. In summary, increased CD47 expression is an independent, poor prognostic factor that can be targeted on human AML stem cells with blocking monoclonal antibodies capable of enabling phagocytosis of LSC.	[Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Div Hematol, Dept Internal Med, Palo Alto, CA 94304 USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Weissman, Irving L.] Stanford Univ, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Weissman, Irving L.] Stanford Univ, Ludwig Ctr Stanford, Palo Alto, CA 94304 USA; [Gibbs, Kenneth D., Jr.] Stanford Univ, Program Immunol, Palo Alto, CA 94304 USA; [Gibbs, Kenneth D., Jr.] Stanford Univ, Baxter Lab Genet Pharmacol, Palo Alto, CA 94304 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Vrije Universiteit Amsterdam	Majeti, R (corresponding author), Stanford Univ, Div Hematol, Dept Internal Med, Palo Alto, CA 94304 USA.	rmajeti@stanford.edu; irv@stanford.edu	Alizadeh, Ash A/C-5594-2009; Van Rooijen, Nico/Z-1578-2019	Alizadeh, Ash A/0000-0002-5153-5625; Majeti, Ravindra/0000-0002-5814-0984; Gibbs, Kenneth/0000-0002-3532-5396	Walter and Idun Y. Berry Foundation; Doctors Cancer Foundation; American Association for Cancer Research; Howard Hughes Medical Institute; American Medical Association Seed Research; Stanford Medical Scholars Research Program; Stanford Medical Scientist Training Program; NIH Interdisciplinary Regenerative Medicine Predoctoral; National Science Foundation Graduate Research; National Institutes of Health [R01CA86017]; Smith Family Fund; NATIONAL CANCER INSTITUTE [R01CA086017, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	Walter and Idun Y. Berry Foundation; Doctors Cancer Foundation; American Association for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Medical Association Seed Research; Stanford Medical Scholars Research Program; Stanford Medical Scientist Training Program; NIH Interdisciplinary Regenerative Medicine Predoctoral; National Science Foundation Graduate Research(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge Libuse Jerabek and Theresa Storm for excellent lab management, Adriane Mosely for animal husbandry, Chrissy Muscat for antibody preparation, Chris Park for histology assistance, and Garry Nolan for support. The authors are grateful to Drs. Jonathan Pollack, Lars Bullinger, Hartmut Dohner, Peter J. M. Valk, Ruud Delwel, and Bob Lowenberg for sharing microarray data as well as the corresponding clinical covariates for AML patients and to Rob Tibshirani for statistical advice. R. M. is supported by grants from the Walter and Idun Y. Berry Foundation, the Doctors Cancer Foundation, and the American Association for Cancer Research. R. M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. P. C. is supported by a Medical Student Training Fellowship from the Howard Hughes Medical Institute, an American Medical Association Seed Research Grant, and the Stanford Medical Scholars Research Program. W. W. P. is supported by the Stanford Medical Scientist Training Program and an NIH Interdisciplinary Regenerative Medicine Predoctoral Fellowship. S. J. is supported by the Stanford Medical Scientist Training Program. K. D. G. is supported by the National Science Foundation Graduate Research Fellowship and Stanford DARE Fellowship. I. L. W. is the Virginia and Daniel Ludwig Professor of Clinical Cancer at Stanford University. I. L. W. is a cofounder and Director of Stem Cells Inc. and cofounded Cellerant, Inc. but holds no stock in the company. I. L. W. is an inventor of U. S. Patent Application 11/528,890 entitled "Methods for Diagnosing and Evaluating Treatment of Blood Disorders.'' I. L. W., S. J., M. P. C., and R. M. have filed U. S. Patent Application Serial No. 12/321,215 entitled "Methods For Manipulating Phagocytosis Mediated by CD47.'' This research is supported by National Institutes of Health grant R01CA86017 to I. L. W. and funding from the Smith Family Fund.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ailles LE, 1997, BLOOD, V90, P2555, DOI 10.1182/blood.V90.7.2555.2555_2555_2564; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bullinger L, 2008, BLOOD, V111, P4490, DOI 10.1182/blood-2007-09-115055; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kikuchi Y, 2004, BIOCHEM BIOPH RES CO, V315, P912, DOI 10.1016/j.bbrc.2004.01.128; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Uno S, 2007, ONCOL REP, V17, P1189; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359	46	1010	1129	6	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					286	299		10.1016/j.cell.2009.05.045	http://dx.doi.org/10.1016/j.cell.2009.05.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632179	Bronze, Green Accepted			2022-12-24	WOS:000268277000011
J	Sowa, ME; Bennett, EJ; Gygi, SP; Harper, JW				Sowa, Mathew E.; Bennett, Eric J.; Gygi, Steven P.; Harper, J. Wade			Defining the Human Deubiquitinating Enzyme Interaction Landscape	CELL			English	Article							ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASE; PROTEIN; COMPLEX; BRCA1; TRANSCRIPTION; DEGRADATION; NUCLEAR	Deubiquitinating enzymes (Dubs) function to remove covalently attached ubiquitin from proteins, thereby controlling substrate activity and/or abundance. For most Dubs, their functions, targets, and regulation are poorly understood. To systematically investigate Dub function, we initiated a global proteomic analysis of Dubs and their associated protein complexes. This was accomplished through the development of a software platform called CompPASS, which uses unbiased metrics to assign confidence measurements to interactions from parallel nonreciprocal proteomic data sets. We identified 774 candidate interacting proteins associated with 75 Dubs. Using Gene Ontology, interactome topology classification, subcellular localization, and functional studies, we link Dubs to diverse processes, including protein turnover, transcription, RNA processing, DNA damage, and endoplasmic reticulum-associated degradation. This work provides the first glimpse into the Dub interaction landscape, places previously unstudied Dubs within putative biological pathways, and identifies previously unknown interactions and protein complexes involved in this increasingly important arm of the ubiquitin-proteasome pathway.	[Sowa, Mathew E.; Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [AG085011, GM054137, GM67945]; Paul Glenn Foundation; Stewart Trust; American Cancer Society; Damon Runyon Cancer Research Foundation [1974-08]; Herb Gordon Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn Foundation; Stewart Trust; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation; Herb Gordon Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marc Vidal (Dana Farber Cancer Institute) for the human ORFeome collection, Xue Li and Wilhem Haas from the Gygi laboratory for assistance with mass spectrometry, Frank Stegmeier and Steve Elledge (Harvard Medical School), Robin Voss and Peter Howley (Harvard Medical School), Vishva Dixit (Genetech), Paul Evans (Imperial College, London), Akio Sugiyama (TOYOBO), and Jennifer Svendsen (Harvard Medical School, Harper laboratory) for plasmids. We also thank John Koe Christianson, Steve Kaiser, and Ron Kopito (Stanford University) for the TCRaGFP cell line and antibodies against Hrd1, Ufd1L, and VAPA. This work was supported by grants from the National Institutes of Health (AG085011, GM054137), the Paul Glenn Foundation, and by the Stewart Trust to J. W. H. S. P. G was supported by GM67945 from the National Institutes of Health. M. E. S. was supported by a postdoctoral fellowship from the American Cancer Society. E. J. B. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG 1974-08) and Herb Gordon Postdoctoral Fellowship.	Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; COHN MA, 2008, J BIOL CHEM IN PRESS; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	44	1108	1155	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					389	403		10.1016/j.cell.2009.04.042	http://dx.doi.org/10.1016/j.cell.2009.04.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19615732	Bronze, Green Accepted			2022-12-24	WOS:000268277000019
J	Caselli, RJ; Dueck, AC; Osborne, D; Sabbagh, MN; Connor, DJ; Ahern, GL; Baxter, LC; Rapcsak, SZ; Shi, J; Woodruff, BK; Locke, DEC; Snyder, CH; Alexander, GE; Rademakers, R; Reiman, EM				Caselli, Richard J.; Dueck, Amylou C.; Osborne, David; Sabbagh, Marwan N.; Connor, Donald J.; Ahern, Geoffrey L.; Baxter, Leslie C.; Rapcsak, Steven Z.; Shi, Jiong; Woodruff, Bryan K.; Locke, Dona E. C.; Snyder, Charlene Hoffman; Alexander, Gene E.; Rademakers, Rosa; Reiman, Eric M.			Longitudinal Modeling of Age-Related Memory Decline and the APOE epsilon 4 Effect	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; E ALLELE EPSILON-4; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; RISK; INDIVIDUALS; POPULATION; DIAGNOSIS; DEMENTIA; CORTEX	Background The APOE epsilon 4 allele is associated with the risk of late-onset Alzheimer's disease. The age at which memory decline diverges among persons who are homozygous for the APOE epsilon 4 allele, those who are heterozygous for the allele, and noncarriers is unknown. Methods Using local advertisements, we recruited cognitively normal subjects between the ages of 21 and 97 years, who were grouped according to their APOE epsilon 4 status. We then followed the subjects with longitudinal neuropsychological testing. Anyone in whom mild cognitive impairment or dementia developed during follow-up was excluded. We compared the rates of decline in predetermined cognitive measures between carriers and noncarriers of the APOE epsilon 4 allele, using a mixed model for longitudinal change with age. Results We analyzed 815 subjects: 317 APOE epsilon 4 carriers (79 who were homozygous for the APOE epsilon 4 allele and 238 who were heterozygous) and 498 noncarriers. Carriers, as compared with noncarriers, were generally younger (mean age, 58.0 vs. 61.4 years; P<0.001) and were followed for a longer period (5.3 vs. 4.7 years, P = 0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in carriers began before the age of 60 years and showed greater acceleration than in noncarriers (P = 0.03), with a possible allele-dose effect (P = 0.008). We observed similar although weaker effects on measures of visuospatial awareness and general mental status. Conclusions Age-related memory decline in APOE epsilon 4 carriers diverges from that of noncarriers before the age of 60 years, despite ongoing normal clinical status.	[Caselli, Richard J.] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ 85259 USA; [Sabbagh, Marwan N.; Connor, Donald J.] Sun Hlth Res Inst, Sun City, AZ USA; [Ahern, Geoffrey L.; Rapcsak, Steven Z.; Alexander, Gene E.; Reiman, Eric M.] Univ Arizona, Tucson, AZ USA; [Baxter, Leslie C.; Shi, Jiong] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Reiman, Eric M.] Translat Genom Res Inst, Phoenix, AZ USA; [Rademakers, Rosa] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic Phoenix; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Arizona; Barrow Neurological Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; Translational Genomics Research Institute; Mayo Clinic	Caselli, RJ (corresponding author), Mayo Clin Arizona, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	caselli.richard@mayo.edu		Locke, Dona/0000-0002-1966-7716; Baxter, Leslie/0000-0002-3971-863X	National Institute on Aging [P30-AG19610, R01-AG031581]; National Institute of Mental Health [R01-MH057899]; Alzheimer's Association [IIRG-98-078]; Arizona Alzheimer's Consortium; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); Arizona Alzheimer's Consortium; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the National Institute on Aging (P30-AG19610 and R01-AG031581), the National Institute of Mental Health (R01-MH057899), the Alzheimer's Association (IIRG-98-078), the Arizona Alzheimer's Consortium, and the State of Arizona.	Alafuzoff I, 2000, ANN NY ACAD SCI, V903, P244, DOI 10.1111/j.1749-6632.2000.tb06374.x; Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Balding DJ, 2004, APPL LONGITUDINAL AN; Baxter LC, 2003, NEUROBIOL AGING, V24, P947, DOI 10.1016/S0197-4580(03)00006-X; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Brickell KL, 2006, ARCH NEUROL-CHICAGO, V63, P1307, DOI 10.1001/archneur.63.9.1307; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; Caselli RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1231, DOI 10.1001/archneurol.2008.1; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Caselli RJ, 2002, J AM GERIATR SOC, V50, P49, DOI 10.1046/j.1532-5415.2002.50007.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Crystal HA, 1996, ARCH NEUROL-CHICAGO, V53, P82, DOI 10.1001/archneur.1996.00550010102023; Ferris SH, 2006, ALZ DIS ASSOC DIS, V20, pS109, DOI 10.1097/01.wad.0000213870.40300.21; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; HIXSON JE, 1990, J LIPID RES, V31, P545; Howieson DB, 2008, J INT NEUROPSYCH SOC, V14, P192, DOI 10.1017/S1355617708080375; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morishima-Kawashima M, 2000, AM J PATHOL, V157, P2093, DOI 10.1016/S0002-9440(10)64847-X; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Petersen, 1999, ARCH NEUROL-CHICAGO, V56, P760; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; PETERSEN RC, 1992, NEUROLOGY, V42, P396, DOI 10.1212/WNL.42.2.396; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rey A, 1964, LEXAMEN CLINIQUE PSY; Salthouse TA, 2003, ALZ DIS ASSOC DIS, V17, P162, DOI 10.1097/00002093-200307000-00008; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P464, DOI 10.1080/13854040590945193; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	41	376	391	4	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					255	263		10.1056/NEJMoa0809437	http://dx.doi.org/10.1056/NEJMoa0809437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19605830	Green Accepted			2022-12-24	WOS:000267976100006
J	Kragl, M; Knapp, D; Nacu, E; Khattak, S; Maden, M; Epperlein, HH; Tanaka, EM				Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Maden, Malcolm; Epperlein, Hans Henning; Tanaka, Elly M.			Cells keep a memory of their tissue origin during axolotl limb regeneration	NATURE			English	Article							CDNA LIBRARIES; BLASTEMA; DEDIFFERENTIATION; DIFFERENTIATION; THYMIDINE; NERVES; STUMP; SKIN	During limb regeneration adult tissue is converted into a zone of undifferentiated progenitors called the blastema that reforms the diverse tissues of the limb. Previous experiments have led to wide acceptance that limb tissues dedifferentiate to form pluripotent cells. Here we have reexamined this question using an integrated GFP transgene to track the major limb tissues during limb regeneration in the salamander Ambystoma mexicanum (the axolotl). Surprisingly, we find that each tissue produces progenitor cells with restricted potential. Therefore, the blastema is a heterogeneous collection of restricted progenitor cells. On the basis of these findings, we further demonstrate that positional identity is a cell-type-specific property of blastema cells, in which cartilage-derived blastema cells harbour positional identity but Schwann-derived cells do not. Our results show that the complex phenomenon of limb regeneration can be achieved without complete dedifferentiation to a pluripotent state, a conclusion with important implications for regenerative medicine.	[Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Tanaka, Elly M.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Epperlein, Hans Henning] Tech Univ Dresden, Fac Med, Inst Anat, D-01307 Dresden, Germany; [Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Maden, Malcolm] Univ Florida, McKnight Brian Inst, Regenerat Project, Gainesville, FL 32611 USA	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; State University System of Florida; University of Florida	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010; Knapp, Dunja/N-2180-2017	Knapp, Dunja/0000-0002-7533-2208; Tanaka, Elly/0000-0003-4240-2158	Volkswagen Foundation [I/78 766]; DFG [SFB655, SPP1109, SPP 1356]; BMBF Biofutures program; Max Planck Institute; Center of Regenerative Therapies; Alexander von Humboldt Foundation	Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); BMBF Biofutures program(Federal Ministry of Education & Research (BMBF)); Max Planck Institute(Foundation CELLEX); Center of Regenerative Therapies; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by grants from the Volkswagen Foundation I/78 766; DFG SFB655, SPP1109, SPP 1356, the BMBF Biofutures program, funds from the Max Planck Institute, and the Center of Regenerative Therapies, Dresden. D. K. was a fellow of the Alexander von Humboldt Foundation. We are grateful to K. Agata, H. Tarui, T. Hayashi and M. Saitou for advice on the single-cell PCR technique. We thank I. Nusslein for assistance on FACS analysis and A. Merseburg for assistance on the nerve rescue experiments. We thank H. Andreas, T. Richter and M. Schuez for technical assistance. We are grateful to L. Rohde, C. Antos, G. Weidinger and A. To ' th for comments on the manuscript.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CARLSON BM, 1974, DEV BIOL, V39, P263, DOI 10.1016/S0012-1606(74)80029-1; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Epperlein HH, 2000, DEVELOPMENT, V127, P2751; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Horstadius S., 1946, Nova Acta Societatis Scientiarum Upsaliensis (4), V13, P1; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; Lheureux E, 1983, Prog Clin Biol Res, V110 Pt A, P455; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; MADEN M, 1982, DEV BIOL, V93, P257, DOI 10.1016/0012-1606(82)90257-3; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; NAMENWIRTH M, 1974, DEV BIOL, V41, P42, DOI 10.1016/0012-1606(74)90281-4; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; ROLLMANDINSMORE C, 1984, DEV BIOL, V106, P275, DOI 10.1016/0012-1606(84)90225-2; SLACK JMW, 1980, J EMBRYOL EXP MORPH, V58, P265; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Thornton CS, 1938, J MORPHOL, V62, P219, DOI 10.1002/jmor.1050620204; UMANSKI E, 1938, B BIOL MED EXP, V6, P141; Wada MR, 2002, DEVELOPMENT, V129, P2987; WALLACE BM, 1973, J EMBRYOL EXP MORPH, V29, P559; WALLACE H, 1972, J EMBRYOL EXP MORPH, V28, P419; Weiss P, 1925, ARCH MIKROSK ANAT EN, V104, P359, DOI 10.1007/BF02254265	41	582	599	14	244	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					60	65		10.1038/nature08152	http://dx.doi.org/10.1038/nature08152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571878				2022-12-24	WOS:000267545200029
J	Niwa, H; Ogawa, K; Shimosato, D; Adachi, K				Niwa, Hitoshi; Ogawa, Kazuya; Shimosato, Daisuke; Adachi, Kenjiro			A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR KLF4; SELF-RENEWAL; NANOG EXPRESSION; DIFFERENTIATION; ACTIVATION; SOX2; IDENTIFICATION; SUFFICIENT; PROMOTER	The cytokine leukaemia inhibitory factor (LIF) integrates signals into mouse embryonic stem (ES) cells to maintain pluripotency. Although the Jak-Stat3 pathway is essential and sufficient to mediate LIF signals(1,2), it is still unclear how these signals are linked to the core circuitry of pluripotency-associated transcription factors, consisting of Oct3/4 (also called Pou5f1), Sox2 and Nanog(3,4). Here we show that two LIF signalling pathways are each connected to the core circuitry via different transcription factors. In mouse ES cells, Klf4 is mainly activated by the Jak-Stat3 pathway and preferentially activates Sox2, whereas Tbx3 is preferentially regulated by the phosphatidylinositol-3-OH kinase-Akt and mitogen-activated protein kinase pathways and predominantly stimulates Nanog. In the absence of LIF, artificial expression of Klf4 or Tbx3 is sufficient to maintain pluripotency while maintaining the expression of Oct3/4. Notably, overexpression of Nanog supports LIF-independent self-renewal of mouse ES cells in the absence of Klf4 and Tbx3 activity. Therefore, Klf4 and Tbx3 are involved in mediating LIF signalling to the core circuitry but are not directly associated with the maintenance of pluripotency, because ES cells keep pluripotency without their expression in the particular context.	[Niwa, Hitoshi; Ogawa, Kazuya; Shimosato, Daisuke; Adachi, Kenjiro] RIKEN Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hitoshi; Shimosato, Daisuke] Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Niwa, Hitoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	RIKEN; Kobe University; Japan Science & Technology Agency (JST)	Niwa, H (corresponding author), RIKEN Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp						Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	640	661	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	2009	460	7251					118	122		10.1038/nature08113	http://dx.doi.org/10.1038/nature08113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571885				2022-12-24	WOS:000267545200041
J	Spoel, SH; Mou, ZL; Tada, Y; Spivey, NW; Genschik, P; Dong, XNA				Spoel, Steven H.; Mou, Zhonglin; Tada, Yasuomi; Spivey, Natalie W.; Genschik, Pascal; Dong, Xinnian			Proteasome-Mediated Turnover of the Transcription Coactivator NPR1 Plays Dual Roles in Regulating Plant Immunity	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DNA-BINDING ACTIVITY; NF-KAPPA-B; SALICYLIC-ACID; GENE-EXPRESSION; PR-1 GENE; DISEASE RESISTANCE; UBIQUITIN-LIGASE; 26S PROTEASOME; IN-VIVO	Systemic acquired resistance (SAR) is a broad-spectrum plant immune response involving profound transcriptional changes that are regulated by the coactivator NPR1. Nuclear translocation of NPR1 is a critical regulatory step, but how the protein is regulated in the nucleus is unknown. Here, we show that turnover of nuclear NPR1 protein plays an important role in modulating transcription of its target genes. In the absence of pathogen challenge, NPR1 is continuously cleared from the nucleus by the proteasome, which restricts its coactivator activity to prevent untimely activation of SAR. Surprisingly, inducers of SAR promote NPR1 phosphorylation at residues Ser11/Ser15, and then facilitate its recruitment to a Cullin3-based ubiquitin ligase. Turnover of phosphorylated NPR1 is required for full induction of target genes and establishment of SAR. These in vivo data demonstrate dual roles for coactivator turnover in both preventing and stimulating gene transcription to regulate plant immunity.	[Spoel, Steven H.; Mou, Zhonglin; Tada, Yasuomi; Spivey, Natalie W.; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Genschik, Pascal] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Duke University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dong, XNA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	xdong@duke.edu	Tada, Yasuomi/M-5041-2014	Tada, Yasuomi/0000-0001-9900-069X; GENSCHIK, Pascal/0000-0002-4107-5071; Spoel, Steven/0000-0003-4340-7591	National Institutes of Health (NIH) [1R01-GM69594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Zhen- Ming Pei for providing the anti-CAS antibodies, Xudong Zhang and Dr. Karolina Pajerowska-Mukhtar for technical assistance, Dr. Yue Xiong for helpful discussions, and Drs. Meng Chen, James Siedow, Tai- ping Sun, and Tso-Pang Yao for critically reading the manuscript. This work was supported by a grant from the National Institutes of Health (NIH) (1R01-GM69594) to X. D.	Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	42	383	405	3	95	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					860	872		10.1016/j.cell.2009.03.038	http://dx.doi.org/10.1016/j.cell.2009.03.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490895	Green Accepted, Bronze			2022-12-24	WOS:000266454800017
J	Castle, PE; Rodriguez, AC; Burk, RD; Herrero, R; Wacholder, S; Alfaro, M; Morales, J; Guillen, D; Sherman, ME; Solomon, D; Schiffman, M				Castle, Philip E.; Cecilia Rodriguez, Ana; Burk, Robert D.; Herrero, Rolando; Wacholder, Sholom; Alfaro, Mario; Morales, Jorge; Guillen, Diego; Sherman, Mark E.; Solomon, Diane; Schiffman, Mark		PEG Grp	Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCIDENCE TRENDS; QUALITY-CONTROL; FOLLOW-UP; WOMEN; HPV; NEOPLASIA; DNA; INFECTION; ADENOCARCINOMA; ABNORMALITIES	Objective To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence of prevalently detected carcinogenic human papillomavirus (HPV). Design Population based cohort study. Setting Guanacaste, Costa Rica. Participants 2282 sexually active women actively followed after enrolment. Main outcome measures Primary end points: three year and five year cumulative incidence of histologically confirmed cervical intraepithelial neoplasia grade II+ (n=70). Cervical specimens collected at each visit tested for more than 40 HPV genotypes. HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, and 82 were considered the primary carcinogenic genotypes. Results Women who tested positive for a carcinogenic HPV at enrolment and after about one year (9-21 months) (positive/positive) had a three year cumulative incidence of cervical intraepithelial neoplasia grade II+ of 17.0% (95% confidence interval 12.1% to 22.0%). Those who tested negative/positive (3.4%, 0.1% to 6.8%), positive/negative (1.2%,-0.2% to 2.5%), and negative/negative (0.5%, 0.1% to 0.9%) were at a significantly lower risk. There was little difference in the cumulative incidence of cervical intraepithelial neoplasia grade II+ between testing positive twice for any carcinogenic HPV genotype (same genotype or different genotypes) v testing positive twice for the same carcinogenic genotype (17.0% v 21.3%, respectively). Short term persistence of HPV 16 strongly predicted cervical intraepithelial neoplasia grade II+, with a three year cumulative incidence of 40.8% (26.4% to 55.1%). Similar patterns were observed for the five year cumulative incidence of grade II+ and for three year and five year cumulative incidence of grade III+. Conclusions Short term persistence of a prevalently detected carcinogenic HPV infection, especially HPV 16, strongly predicts a subsequent diagnosis of cervical intraepithelial neoplasia II+ over the next few years.	[Castle, Philip E.; Wacholder, Sholom; Sherman, Mark E.; Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Solomon, Diane] NCI, Canc Prevent Div, NIH, DHHS, Bethesda, MD 20892 USA; [Cecilia Rodriguez, Ana; Herrero, Rolando; Alfaro, Mario; Morales, Jorge; Guillen, Diego] INCIEN SA Fdn, San Jose, Costa Rica; [Burk, Robert D.] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine	Castle, PE (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA.	castlep@mail.nih.gov	Hildesheim, Allan/B-9760-2015; Castle, Philip/AAP-6395-2020; Schiffman, Mark/B-9766-2015	Hildesheim, Allan/0000-0003-0257-2363; Castle, Philip/0000-0003-1082-6554; 	National Institutes of Health [N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP- 81023, CA78527]; National Cancer Institute; National Institutes of Health, Department of Health and Human Services; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP050535, N01CP021081, N01CP040542, N01CP033061, N01CP081023] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA078527, R01CA078527, ZIACP010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP- 81023, intramural programme, CA78527 to RB). The Guanacaste cohort was partly funded by the intramural research programme of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. ACR was supported by an appointment to the senior fellowship programme at the National Institutes of Health. The programme is administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the National Institutes of Health. The sponsors had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bratti MC, 2004, REV PANAM SALUD PUBL, V15, P75; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Bulk S, 2007, BRIT J CANCER, V96, P1234, DOI 10.1038/sj.bjc.6603693; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Carozzi FM, 2005, AM J CLIN PATHOL, V124, P716, DOI 10.1309/84E5WHJQHK83BGQD; Castle PE, 2004, AM J CLIN PATHOL, V122, P238, DOI 10.1309/BA43HMCAJ26VWQH3; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2008, AM J EPIDEMIOL, V168, P138, DOI 10.1093/aje/kwn037; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; IARC, 2005, IARC HDB CANC PREV; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	31	132	141	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2569	10.1136/bmj.b2569	http://dx.doi.org/10.1136/bmj.b2569			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PG	19638649	Green Published, hybrid			2022-12-24	WOS:000268672800004
J	Kornmann, B; Currie, E; Collins, SR; Schuldiner, M; Nunnari, J; Weissman, JS; Walter, P				Kornmann, Benoit; Currie, Erin; Collins, Sean R.; Schuldiner, Maya; Nunnari, Jodi; Weissman, Jonathan S.; Walter, Peter			An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; BIOSYNTHETIC PATHWAYS; YEAST; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; PROTEINS; PHOSPHATIDYLSERINE; INHERITANCE; MORPHOLOGY	Communication between organelles is an important feature of all eukaryotic cells. To uncover components involved in mitochondria/endoplasmic reticulum (ER) junctions, we screened for mutants that could be complemented by a synthetic protein designed to artificially tether the two organelles. We identified the Mmm1/Mdm10/Mdm12/Mdm34 complex as a molecular tether between ER and mitochondria. The tethering complex was composed of proteins resident of both ER and mitochondria. With the use of genome-wide mapping of genetic interactions, we showed that the components of the tethering complex were functionally connected to phospholipid biosynthesis and calcium-signaling genes. In mutant cells, phospholipid biosynthesis was impaired. The tethering complex localized to discrete foci, suggesting that discrete sites of close apposition between ER and mitochondria facilitate interorganelle calcium and phospholipid exchange.	[Kornmann, Benoit; Currie, Erin; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Collins, Sean R.; Weissman, Jonathan S.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Nunnari, Jodi] Univ Calif Davis, Davis, CA 95616 USA; [Schuldiner, Maya] Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Davis; Weizmann Institute of Science	Kornmann, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	benoit.kornmann@ucsf.edu	Kornmann, Benoît/B-6388-2018; Weisbart, Erin/AAE-5505-2022; Schuldiner, Maya/C-9488-2009	Kornmann, Benoît/0000-0002-6030-8555; Weisbart, Erin/0000-0002-6437-2458; Schuldiner, Maya/0000-0001-9947-115X; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X	NIH; Swiss National Science Foundation; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R01GM062942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH. B.K. is a fellow of the Swiss National Science Foundation; M.S. is supported by a Human Frontiers Science Program Career Development Award; and P.W. and J.S.W. are investigators at the Howard Hughes Medical Institute.	Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; VANCE JE, 1991, J BIOL CHEM, V266, P89; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; [No title captured]	32	864	882	4	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					477	481		10.1126/science.1175088	http://dx.doi.org/10.1126/science.1175088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19556461	Green Accepted			2022-12-24	WOS:000268255100057
J	de Aguiar, MAM; Baranger, M; Baptestini, EM; Kaufman, L; Bar-Yam, Y				de Aguiar, M. A. M.; Baranger, M.; Baptestini, E. M.; Kaufman, L.; Bar-Yam, Y.			Global patterns of speciation and diversity	NATURE			English	Article							ADAPTIVE SPECIATION; SPECIES ABUNDANCE; SPACE	In recent years, strikingly consistent patterns of biodiversity have been identified over space, time, organism type and geographical region(1,2). A neutral theory (assuming no environmental selection or organismal interactions) has been shown to predict many patterns of ecological biodiversity(2,3). This theory is based on a mechanism by which new species arise similarly to point mutations in a population without sexual reproduction. Here we report the simulation of populations with sexual reproduction, mutation and dispersal. We found simulated time dependence of speciation rates, species-area relationships and species abundance distributions consistent with the behaviours found in nature(1-13). From our results, we predict steady speciation rates, more species in one-dimensional environments than two-dimensional environments, three scaling regimes of species-area relationships and lognormal distributions of species abundance with an excess of rare species and a tail that may be approximated by Fisher's logarithmic series. These are consistent with dependences reported for, among others, global birds(4) and flowering plants(5), marine invertebrate fossils(6), ray-finned fishes(7), British birds(8,9) and moths(10), North American songbirds(11), mammal fossils from Kansas(12) and Panamanian shrubs(13). Quantitative comparisons of specific cases are remarkably successful. Our biodiversity results provide additional evidence that species diversity arises without specific physical barriers(6,11,14). This is similar to heavy traffic flows, where traffic jams can form even without accidents or barriers(15).	[de Aguiar, M. A. M.; Baranger, M.; Kaufman, L.; Bar-Yam, Y.] New England Complex Syst Inst, Cambridge, MA 02138 USA; [de Aguiar, M. A. M.; Baptestini, E. M.] Univ Estadual Campinas, BR-13083970 Campinas, SP, Brazil; [Baranger, M.] Univ Arizona, Tucson, AZ 85719 USA; [Kaufman, L.] Boston Univ, Boston, MA 02215 USA	Universidade Estadual de Campinas; University of Arizona; Boston University	Bar-Yam, Y (corresponding author), New England Complex Syst Inst, Cambridge, MA 02138 USA.	yaneer@necsi.edu	de Aguiar, Marcus A M/C-9137-2012; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We acknowledge internal support by the New England Complex Systems Institute. M. A. M. d. A. and E. M. B. acknowledge financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and L. K. from the Marine Management Area Science Program of Conservation International and the Gordon and Betty Moore Foundation.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; DARCY WE, 1987, FLORA PANAMA CHECKLI, V1; Dobzhansky T., 1937; Doebeli M, 2005, EVOLUTION, V59, P691; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gavrilets S, 2005, EVOLUTION, V59, P696; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gibbons D. W., 1993, NEW ATLAS BREEDING B; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREGORY RD, 1994, P ROY SOC B-BIOL SCI, V257, P299, DOI 10.1098/rspb.1994.0129; HIGGS PG, 1991, J PHYS A-MATH GEN, V24, pL985, DOI 10.1088/0305-4470/24/17/005; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Hubbell Stephen P., 2001, V32, pi; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Moyle P. B., 2003, FISHES INTRO ICHTHYO, Vfifth; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1997, SCIENCE, V277, P1622, DOI 10.1126/science.277.5332.1622; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Williams C. B., 1964, PATTERNS BALANCE NAT	30	118	122	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					384	387		10.1038/nature08168	http://dx.doi.org/10.1038/nature08168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606148				2022-12-24	WOS:000267979000036
J	Drdla, R; Gassner, M; Gingl, E; Sandkuhler, J				Drdla, Ruth; Gassner, Matthias; Gingl, Ewald; Sandkuehler, Juergen			Induction of Synaptic Long-Term Potentiation After Opioid Withdrawal	SCIENCE			English	Article							PROTEIN-KINASE-C; INDUCED HYPERALGESIA; MORPHINE-WITHDRAWAL; CELLULAR MECHANISMS; TOLERANCE; NEURONS; ACTIVATION; PAIN; EXCITABILITY; DEPENDENCE	mu-Opioid receptor (MOR) agonists represent the gold standard for the treatment of severe pain but may paradoxically also enhance pain sensitivity, that is, lead to opioid-induced hyperalgesia (OIH). We show that abrupt withdrawal from MOR agonists induces long-term potentiation (LTP) at the first synapse in pain pathways. Induction of opioid withdrawal LTP requires postsynaptic activation of heterotrimeric guanine nucleotide-binding proteins and N-methyl-D-aspartate receptors and a rise of postsynaptic calcium concentrations. In contrast, the acute depression by opioids is induced presynaptically at these synapses. Withdrawal LTP can be prevented by tapered withdrawal and shares pharmacology and signal transduction pathways with OIH. These findings provide a previously unrecognized target to selectively combat pro-nociceptive effects of opioids without compromising opioid analgesia.	[Drdla, Ruth; Gassner, Matthias; Gingl, Ewald; Sandkuehler, Juergen] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, A-1090 Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Spitalgasse 4, A-1090 Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Austrian Science Fund [P18129-B02]	Austrian Science Fund(Austrian Science Fund (FWF))	Supported by grant no. P18129-B02 from the Austrian Science Fund (FWF).	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Brown CH, 2004, STRESS, V7, P97, DOI 10.1080/10253890410001727776; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; FRY JP, 1980, BRIT J PHARMACOL, V68, P585, DOI 10.1111/j.1476-5381.1980.tb14574.x; Gardell LR, 2002, J NEUROSCI, V22, P6747; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jhamandas KH, 1996, J NEUROSCI, V16, P2758; Kieffer BL, 2002, CELL, V108, P587, DOI 10.1016/S0092-8674(02)00666-9; MAO J, 1994, J NEUROSCI, V14, P2301; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Sweitzer SM, 2004, PAIN, V110, P281, DOI 10.1016/j.pain.2004.04.004; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Vera-Portocarrero LP, 2007, PAIN, V129, P35, DOI 10.1016/j.pain.2006.09.033; Wang HY, 2005, NEUROSCIENCE, V135, P247, DOI 10.1016/j.neuroscience.2005.06.003; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; WOOLF CJ, 1981, BRAIN RES, V209, P491, DOI 10.1016/0006-8993(81)90176-1; YAKSH TL, 1986, ANESTHESIOLOGY, V64, P590, DOI 10.1097/00000542-198605000-00008; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	27	149	157	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					207	210		10.1126/science.1171759	http://dx.doi.org/10.1126/science.1171759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590003				2022-12-24	WOS:000267802000049
J	Ramirez-Carrozzi, VR; Braas, D; Bhatt, DM; Cheng, CS; Hong, C; Doty, KR; Black, JC; Hoffmann, A; Carey, M; Smale, ST				Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Cheng, Christine S.; Hong, Christine; Doty, Kevin R.; Black, Joshua C.; Hoffmann, Alexander; Carey, Michael; Smale, Stephen T.			A Unifying Model for the Selective Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling	CELL			English	Article							HUMAN GENOME; DNA INTERACTIONS; BAF COMPLEX; CHROMATIN; PROMOTER; HISTONE; GENE; IDENTIFICATION; ACCESSIBILITY; POLY(DA-DT)	We describe a broad mechanistic framework for the transcriptional induction of mammalian primary response genes by Toll-like receptors and other stimuli. One major class of primary response genes is characterized by CpG-island promoters, which facilitate promiscuous induction from constitutively active chromatin without a requirement for SWI/SNF nucleosome remodeling complexes. The low nucleosome occupancy at promoters in this class can be attributed to the assembly of CpG islands into unstable nucleosomes, which may lead to SWI/SNF independence. Another major class consists of non-CpG-island promoters that assemble into stable nucleosomes, resulting in SWI/SNF dependence and a requirement for transcription factors that promote selective nucleosome remodeling. Some stimuli, including serum and tumor necrosis factor-alpha, exhibit a strong bias toward activation of SWI/SNF-independent CpG-island genes. In contrast, interferon-beta is strongly biased toward SWI/SNF-dependent non-CpG-island genes. By activating a diverse set of transcription factors, Toll-like receptors induce both classes and others for an optimal response to microbial pathogens.	[Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Hong, Christine; Doty, Kevin R.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Hong, Christine; Doty, Kevin R.; Black, Joshua C.; Carey, Michael; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Black, Joshua C.; Carey, Michael] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cheng, Christine S.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu	Black, Joshua/Q-2484-2015	Bhatt, Dev/0000-0003-3616-3701; Black, Joshua/0000-0002-2491-8815; Carey, Michael/0000-0003-3899-6280	Giannini Family Foundation Fellowship; German Academic Exchange Service; Jonsson Cancer Center Foundation Fellowship; NIH [T32AI007126, T32GM07185, R01GM086372, R01CA127279, P50CA092131]; NATIONAL CANCER INSTITUTE [R01CA127279, P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM086372] Funding Source: NIH RePORTER	Giannini Family Foundation Fellowship; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Jonsson Cancer Center Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Genhong Cheng, Diana Hargreaves, Harvey Herschman, Siavash Kurdistani, Ruslan Medzhitov, Amy Weinmann, Jonathan Widom, and Michael Zhang for helpful discussions. V. R. R. C. was supported by a Giannini Family Foundation Fellowship, D. B. by the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD) and a Jonsson Cancer Center Foundation Fellowship, D. M. B. by NIH T32AI007126, K. R. D. by NIH T32GM07185, and S. T. S. by NIH R01GM086372, R01CA127279, and P50CA092131.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Williams LR, 2007, SIGHT SOUND, V17, P93; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	40	428	437	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					114	128		10.1016/j.cell.2009.04.020	http://dx.doi.org/10.1016/j.cell.2009.04.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596239	Green Accepted, Bronze			2022-12-24	WOS:000267848600019
J	Araki, K; Turner, AP; Shaffer, VO; Gangappa, S; Keller, SA; Bachmann, MF; Larsen, CP; Ahmed, R				Araki, Koichi; Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Keller, Susanne A.; Bachmann, Martin F.; Larsen, Christian P.; Ahmed, Rafi			mTOR regulates memory CD8 T-cell differentiation	NATURE			English	Article							SELECTIVE EXPRESSION; DENDRITIC CELLS; VIRAL-INFECTION; EFFECTOR; RECEPTOR; RAPAMYCIN; SUBSETS; HOMEOSTASIS; PATHWAY; TARGET	Memory CD8 T cells are a critical component of protective immunity, and inducing effective memory T-cell responses is a major goal of vaccines against chronic infections and tumours(1-3). Considerable effort has gone into designing vaccine regimens that will increase the magnitude of the memory response, but there has been minimal emphasis on developing strategies to improve the functional qualities of memory T cells(4). Here we show that mTOR (mammalian target of rapamycin(5), also known as FRAP1) is a major regulator of memory CD8 T-cell differentiation, and in contrast to what we expected, the immunosuppressive drug rapamycin has immunostimulatory effects on the generation of memory CD8 T cells. Treatment of mice with rapamycin following acute lymphocytic choriomeningitis virus infection enhanced not only the quantity but also the quality of virus-specific CD8 T cells. Similar effects were seen after immunization of mice with a vaccine based on non-replicating virus-like particles. In addition, rapamycin treatment also enhanced memory T-cell responses in non-human primates following vaccination with modified vaccinia virus Ankara. Rapamycin was effective during both the expansion and contraction phases of the T-cell response; during the expansion phase it increased the number of memory precursors, and during the contraction phase (effector to memory transition) it accelerated the memory T-cell differentiation program. Experiments using RNA interference to inhibit expression of mTOR, raptor (also known as 4932417H02Rik) or FKBP12 (also known as FKBP1A) in antigen-specific CD8 T cells showed that mTOR acts intrinsically through the mTORC1 (mTOR complex 1) pathway to regulate memory T-cell differentiation. Thus these studies identify a molecular pathway regulating memory formation and provide an effective strategy for improving the functional qualities of vaccine-or infection-induced memory T cells.	[Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Larsen, Christian P.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Larsen, Christian P.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Keller, Susanne A.; Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Zurich, Switzerland	Emory University; Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu	Larsen, Christian P./B-6906-2012; Shaffer, Virginia/G-7945-2012	Larsen, Christian P./0000-0001-6573-2649; Araki, Koichi/0000-0003-3478-6315	NIH [AI030048, N01-AI-50025, AI040519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R01AI040519, R37AI030048, R37AI040519, N01AI050025, R01AI073707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. T. Konieczny for technical assistance; D. Garber for providing us with the MVA; R. Amara for help developing rhesus macaque assays; W. Hahn for providing pMKO. 1 GFP vector; and E. Strobert and P. L. Turner for technical assistance. This work was supported by NIH grants AI030048 (to R. A.) and N01-AI-50025 and AI040519 (to C. P. L).	Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	24	1108	1137	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					108	U124		10.1038/nature08155	http://dx.doi.org/10.1038/nature08155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19543266	Green Accepted, Bronze			2022-12-24	WOS:000267545200039
J	Pearce, EL; Walsh, MC; Cejas, PJ; Harms, GM; Shen, H; Wang, LS; Jones, RG; Choi, YW				Pearce, Erika L.; Walsh, Matthew C.; Cejas, Pedro J.; Harms, Gretchen M.; Shen, Hao; Wang, Li-San; Jones, Russell G.; Choi, Yongwon			Enhancing CD8 T-cell memory by modulating fatty acid metabolism	NATURE			English	Article							REGULATES LIPID-METABOLISM; CD8-T-CELL MEMORY; MAMMALIAN TARGET; CD4-T-CELL HELP; CUTTING EDGE; HOMEOSTASIS; ACTIVATION; EXPRESSION; RAPAMYCIN; GROWTH	CD8 T cells, which have a crucial role in immunity to infection and cancer, are maintained in constant numbers, but on antigen stimulation undergo a developmental program characterized by distinct phases encompassing the expansion and then contraction of antigen-specific effector (T-E) populations, followed by the persistence of long-lived memory (T-M) cells(1,2). Although this predictable pattern of CD8 T-cell responses is well established, the underlying cellular mechanisms regulating the transition to T-M cells remain undefined(1,2). Here we show that tumour necrosis factor (TNF) receptor-associated factor 6 (TRAF6), an adaptor protein in the TNF-receptor and interleukin-1R/Toll-like receptor superfamily, regulates CD8 T-M-cell development after infection by modulating fatty acid metabolism. We show that mice with a T-cell-specific deletion of TRAF6 mount robust CD8 T-E-cell responses, but have a profound defect in their ability to generate T-M cells that is characterized by the disappearance of antigen-specific cells in the weeks after primary immunization. Microarray analyses revealed that TRAF6-deficient CD8 T cells exhibit altered expression of genes that regulate fatty acid metabolism. Consistent with this, activated CD8 T cells lacking TRAF6 display defective AMP-activated kinase activation and mitochondrial fatty acid oxidation (FAO) in response to growth factor withdrawal. Administration of the anti-diabetic drug metformin restored FAO and CD8 T-M-cell generation in the absence of TRAF6. This treatment also increased CD8 T-M cells in wild-type mice, and consequently was able to considerably improve the efficacy of an experimental anti-cancer vaccine.	[Pearce, Erika L.; Walsh, Matthew C.; Cejas, Pedro J.; Harms, Gretchen M.; Wang, Li-San; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shen, Hao] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Sch Med, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Jones, Russell G.] McGill Univ, Dept Physiol, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; McGill University	Choi, YW (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Jones, Russell Graham/ABD-5261-2021; shen, hao/HGF-0551-2022; Jones, Russell/AAC-2861-2022	Jones, Russell Graham/0000-0003-2250-4675; 	NIH; CIHR; NCI Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NCI Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Krawczyk, C. King, M. Farrar, Y. Paterson, Z.- K. Pan and E. J. Pearce. This work is supported in part by grants from the NIH (Y. C., H. S.), CIHR (R. G. J.) and an NCI Institutional Training Grant (E. L. P.).	Albert MH, 2005, BLOOD, V105, P1355, DOI 10.1182/blood-2004-08-3305; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karst AM, 2006, CANCER RES, V66, P9221, DOI 10.1158/0008-5472.CAN-05-3633; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	40	1035	1069	5	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					103	U118		10.1038/nature08097	http://dx.doi.org/10.1038/nature08097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19494812	Green Accepted, Bronze			2022-12-24	WOS:000267545200038
J	Scherrer, G; Imamachi, N; Cao, YQ; Contet, C; Mennicken, F; O'Donnell, D; Kieffer, BL; Basbaum, AI				Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Contet, Candice; Mennicken, Francoise; O'Donnell, Dajan; Kieffer, Brigitte L.; Basbaum, Allan I.			Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain	CELL			English	Article							DORSAL-ROOT GANGLIA; MICE LACKING; MORPHINE-TOLERANCE; NEUROPATHIC PAIN; DELTA-AGONISTS; SPINAL-CORD; MU-OPIATE; ANALGESIA; RAT; TRAFFICKING	Delta and mu opioid receptors (DORs and MORs) are inhibitory G protein-coupled receptors that reportedly cooperatively regulate the transmission of pain messages by substance P and TRPV1-expressing pain fibers. Using a DOReGFP reporter mouse we now show that the DOR and MOR are, in fact, expressed by different subsets of primary afferents. The MOR is expressed in peptidergic pain fibers, the DOR in myelinated and nonpeptidergic afferents. Contrary to the prevailing view, we demonstrate that the DOR is trafficked to the cell surface under resting conditions, independently of substance P, and internalized following activation by DOR agonists. Finally, we show that the segregated DOR and MOR distribution is paralleled by a remarkably selective functional contribution of the two receptors to the control of mechanical and heat pain, respectively. These results demonstrate that behaviorally relevant pain modalities can be selectively regulated through the targeting of distinct subsets of primary afferent pain fibers.	[Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Contet, Candice; Kieffer, Brigitte L.] Univ Strasbourg 1, Dept Neurobiol, Inst Genet & Biol Mol & Cellulaire, INSERM,U596,CNRS UMR7104, Illkirch Graffenstaden, France; [Mennicken, Francoise; O'Donnell, Dajan] AstraZeneca R&D, Quebec City, PQ H4S 1Z9, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AstraZeneca	Basbaum, AI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	allan.basbaum@ucsf.edu	Contet, Candice/H-2774-2019	Scherrer, Gregory/0000-0002-1983-5126; Contet, Candice/0000-0002-4459-9540; Imamachi, Noritaka/0000-0002-8972-7665	Fondation pour la Recherche Medicale;  [NS48499];  [NS14627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014627, P01NS048499, R37NS014627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. D. Shields, D. Julius, D. Cavanaugh and J. Braz for helpful discussions, J. E. Maggio, C. J. Evans and D. Julius for providing the SP, MOR and TRP antibodies, J. Pintar for providing tissue from dor null mice and J. Butterworth and D. Hubatsch for providing excellent technical support. This work was supported by NS48499, NS14627 and Fondation pour la Recherche Medicale. DOD and FM are employees of AstraZeneca and declare that they have competing financial interests.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Aicher SA, 2000, J NEUROSCI, V20, P4345; Aicher SA, 2000, J COMP NEUROL, V422, P181, DOI 10.1002/(SICI)1096-9861(20000626)422:2<181::AID-CNE3>3.0.CO;2-G; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; ARVIDSSON U, 1995, J NEUROSCI, V15, P1215; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gallantine EL, 2005, BASIC CLIN PHARMACOL, V97, P39, DOI 10.1111/j.1742-7843.2005.pto_97107.x; Gendron L, 2007, NEUROSCIENCE, V150, P807, DOI 10.1016/j.neuroscience.2007.09.060; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Goody RJ, 2002, BRAIN RES, V945, P9, DOI 10.1016/S0006-8993(02)02452-6; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3081, DOI 10.1073/pnas.74.7.3081; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; Ji RR, 1995, J NEUROSCI, V15, P8156; Jutkiewicz EM, 2004, J PHARMACOL EXP THER, V309, P173, DOI 10.1124/jpet.103.061242; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; LACOSTE A, 2003, DELTA RECEPTOR, P15; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mennicken F, 2003, J COMP NEUROL, V465, P349, DOI 10.1002/cne.10839; MINAMI M, 1995, MOL BRAIN RES, V30, P203, DOI 10.1016/0169-328X(94)00290-U; Morinville A, 2003, J NEUROSCI, V23, P4888; MOSBERG HI, 1983, P NATL ACAD SCI-BIOL, V80, P5871, DOI 10.1073/pnas.80.19.5871; NARITA M, 2003, DELTA RECEPTOR, P331; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; ONOFRIO BM, 1983, LANCET, V1, P1386; OSSIPOV MH, 1995, PAIN, V62, P287, DOI 10.1016/0304-3959(94)00231-3; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; PORRECA F, 1987, J PHARMACOL EXP THER, V241, P393; PORTOGHESE PS, 1990, J MED CHEM, V33, P1547, DOI 10.1021/jm00168a004; Powell KJ, 2003, EUR J NEUROSCI, V18, P1572, DOI 10.1046/j.1460-9568.2003.02887.x; Rozenfeld Raphael, 2007, ScientificWorldJournal, V7, P64; Scherrer G, 2004, EUR J NEUROSCI, V19, P2239, DOI 10.1111/j.0953-816X.2004.03339.x; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sora I, 1997, EUR J PHARMACOL, V324, pR1, DOI 10.1016/S0014-2999(97)10016-4; Sun H, 2001, PAIN, V90, P105, DOI 10.1016/S0304-3959(00)00392-4; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Trafton JA, 2000, J NEUROSCI, V20, P8578; Walwyn W, 2005, MOL PHARMACOL, V68, P1688, DOI 10.1124/mol.105.014829; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005; Zhang X, 1998, NEUROSCIENCE, V82, P1225; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	58	357	364	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1148	1159		10.1016/j.cell.2009.04.019	http://dx.doi.org/10.1016/j.cell.2009.04.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524516	Green Accepted, Bronze			2022-12-24	WOS:000266916400025
J	Zhang, XH; Halvorsen, K; Zhang, CZ; Wong, WP; Springer, TA				Zhang, Xiaohui; Halvorsen, Kenneth; Zhang, Cheng-Zhong; Wong, Wesley P.; Springer, Timothy A.			Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor	SCIENCE			English	Article							FACTOR A2 DOMAIN; VONWILLEBRAND-FACTOR; FACTOR MULTIMERS; SHEAR-STRESS; PLASMA; ADAMTS13; SUBSTRATE; ADHESION; DISEASE; CONFORMATION	Von Willebrand factor (VWF) is secreted as ultralarge multimers that are cleaved in the A2 domain by the metalloprotease ADAMTS13 to give smaller multimers. Cleaved VWF is activated by hydrodynamic forces found in arteriolar bleeding to promote hemostasis, whereas uncleaved VWF is activated at lower, physiologic shear stresses and causes thrombosis. Single-molecule experiments demonstrate that elongational forces in the range experienced by VWF in the vasculature unfold the A2 domain, and only the unfolded A2 domain is cleaved by ADAMTS13. In shear flow, tensile force on a VWF multimer increases with the square of multimer length and is highest at the middle, providing an efficient mechanism for homeostatic regulation of VWF size distribution by force-induced A2 unfolding and cleavage by ADAMTS13, as well as providing a counterbalance for VWF-mediated platelet aggregation.	[Zhang, Xiaohui; Zhang, Cheng-Zhong; Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Halvorsen, Kenneth; Wong, Wesley P.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA; [Zhang, Xiaohui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	wong@rowland.harvard.edu; springer@idi.harvard.edu		Wong, Wesley/0000-0001-7398-546X; Zhang, Xiaohui (Frank)/0000-0002-8778-595X	NIH [HL-48675]; Rowland Junior Fellows; American Heart Association [525918T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowland Junior Fellows; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH HL-48675 (T.A.S.), the Rowland Junior Fellows (W.P.W.), and American Heart Association 525918T (X.Z.). The authors thank C. Bustamante, S. Marqusee, and C. Cecconi for protocols for DNA-protein coupling; J. E. Sadler, D. Schaak, J. Kim, J. Seog, C. Lu, and A. Alexander-Katz for reagents and insightful discussions; and G. Dempsey for work on the early stages of this project.	Alexander-Katz A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138101; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; BATLLE J, 1987, BLOOD, V70, P173; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; EVANS E, HDB SINGLE IN PRESS; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; ODELL JA, 1988, J CHEM PHYS, V88, P4022, DOI 10.1063/1.453855; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; SLAYTER H, 1985, J BIOL CHEM, V260, P8559; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Valiaev A, 2007, J AM CHEM SOC, V129, P6491, DOI 10.1021/ja070147r; vanGenderen PJJ, 1996, BRIT J HAEMATOL, V93, P962, DOI 10.1046/j.1365-2141.1996.d01-1729.x; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; ZHANG Q, 2009, P NATL ACAD SCI US	32	377	387	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1330	1334		10.1126/science.1170905	http://dx.doi.org/10.1126/science.1170905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498171	Green Accepted			2022-12-24	WOS:000266635100047
J	Kaneko, T; Hamazaki, J; Iemura, S; Sasaki, K; Furuyama, K; Natsume, T; Tanaka, K; Murata, S				Kaneko, Takeumi; Hamazaki, Jun; Iemura, Shun-ichiro; Sasaki, Katsuhiro; Furuyama, Kaori; Natsume, Tohru; Tanaka, Keiji; Murata, Shigeo			Assembly Pathway of the Mammalian Proteasome Base Subcomplex Is Mediated by Multiple Specific Chaperones	CELL			English	Article							19S REGULATORY PARTICLE; 26 S-PROTEASOME; DEUBIQUITINATING ENZYME; UBIQUITIN SYSTEM; 20S PROTEASOMES; CDNA CLONING; PROTEIN; DEGRADATION; EXPRESSION; GANKYRIN	The 26S proteasome is an enzymatic complex that degrades ubiquitinated proteins in eukaryotic cells. It is composed of the 20S core particle (CP) and the 19S regulatory particle (RP). The latter is further divided into the lid and base subcomplexes. While the mechanism involved in the assembly of the CP is well investigated, that of the RP is poorly understood. Here, we show that the formation of the mammalian base subcomplex involves three distinct modules, where specific pairs of ATPase subunits are associated with the distinct chaperones p28, S5b, or p27. The process of base formation starts from association of the p28-Rpt3-Rpt6-Rpn14 complex with the S5b-Rpt1-Rpt2-Rpn1 complex, followed by incorporation of the p27-Rpt5-Rpt4 complex and Rpn2, where p28, S5b, and p27 regulate the associations between the modules. These chaperones dissociate before completion of 26S proteasome formation. Our results demonstrate that base assembly is facilitated by multiple proteasome-dedicated chaperones, like CP assembly.	[Kaneko, Takeumi; Hamazaki, Jun; Furuyama, Kaori; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Sasaki, Katsuhiro; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Metropolitan Institute of Medical Science	Murata, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	smurata@mol.f.u-tokyo.ac.jp	Natsume, Tohru/M-7627-2018; Murata, Shigeo/A-1426-2010; hamazaki, jun/AAG-4823-2019	Natsume, Tohru/0000-0002-1510-2582; Murata, Shigeo/0000-0002-3177-3503; hamazaki, jun/0000-0002-7145-3424	Ministry of Education, Science, and Culture of Japan; Takeda Science Foundation; Target Protein Project of MEXT; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan ( MEXT; to S. M. and K. T.), the Takeda Science Foundation ( to S. M. and K. T.), Target Protein Project of MEXT ( to K. T.), and the New Energy and Industrial Technology Development Organization ( to T. N.).	Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vidal-Taboada JM, 2000, BIOCHEM BIOPH RES CO, V272, P156, DOI 10.1006/bbrc.2000.2726; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang ZX, 2001, WORLD J GASTROENTERO, V7, P821, DOI 10.3748/wjg.v7.i6.821; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	44	144	151	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					914	925		10.1016/j.cell.2009.05.008	http://dx.doi.org/10.1016/j.cell.2009.05.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490896	Bronze			2022-12-24	WOS:000266454800021
J	Fabian, AC; Zoghbi, A; Ross, RR; Uttley, P; Gallo, LC; Brandt, WN; Blustin, AJ; Boller, T; Caballero-Garcia, MD; Larsson, J; Miller, JM; Miniutti, G; Ponti, G; Reis, RC; Reynolds, CS; Tanaka, Y; Young, AJ				Fabian, A. C.; Zoghbi, A.; Ross, R. R.; Uttley, P.; Gallo, L. C.; Brandt, W. N.; Blustin, A. J.; Boller, T.; Caballero-Garcia, M. D.; Larsson, J.; Miller, J. M.; Miniutti, G.; Ponti, G.; Reis, R. C.; Reynolds, C. S.; Tanaka, Y.; Young, A. J.			Broad line emission from iron K- and L-shell transitions in the active galaxy 1H 0707-495	NATURE			English	Article							X-RAY VARIABILITY; NARROW-LINE; BLACK-HOLE; SEYFERT-1 GALAXY-1H-0707-495; GALACTIC NUCLEI; REFLECTION; DISK; 1H-0707-495; BINARIES; SPECTRA	Since the 1995 discovery of the broad iron K-line emission from the Seyfert galaxy MCG-6-30-15 (ref. 1), broad iron K lines have been found in emission from several other Seyfert galaxies(2), from accreting stellar-mass black holes(3) and even from accreting neutron stars(4). The iron K line is prominent in the reflection spectrum(5,6) created by the hard-X-ray continuum irradiating dense accreting matter. Relativistic distortion(7) of the line makes it sensitive to the strong gravity and spin of the black hole(8). The accompanying iron L-line emission should be detectable when the iron abundance is high. Here we report the presence of both iron K and iron L emission in the spectrum of the narrow-line Seyfert 1 galaxy(9) 1H 0707-495. The bright iron L emission has enabled us to detect a reverberation lag of about 30 s between the direct X-ray continuum and its reflection from matter falling into the black hole. The observed reverberation timescale is comparable to the light-crossing time of the innermost radii around a supermassive black hole. The combination of spectral and timing data on 1H 0707-495 provides strong evidence that we are witnessing emission from matter within a gravitational radius, or a fraction of a light minute, from the event horizon of a rapidly spinning, massive black hole.	[Fabian, A. C.; Zoghbi, A.; Blustin, A. J.; Caballero-Garcia, M. D.; Larsson, J.; Reis, R. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Ross, R. R.] Coll Holy Cross, Dept Phys, Worcester, MA 01610 USA; [Uttley, P.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Gallo, L. C.] St Marys Univ, Dept Phys & Astron, Halifax, NS B3H 3C3, Canada; [Brandt, W. N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Boller, T.; Tanaka, Y.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Miller, J. M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Miniutti, G.] LAEFF, Ctr Astrobiol CSIC INTA, LAEX, E-28691 Madrid, Spain; [Ponti, G.] Lab APC, UMR 7164, F-75205 Paris, France; [Reynolds, C. S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Reynolds, C. S.] Univ Maryland, Ctr Theory & Computat, College Pk, MD 20742 USA; [Young, A. J.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	University of Cambridge; College of the Holy Cross; University of Southampton; Saint Marys University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Bristol	Fabian, AC (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	acf@ast.cam.ac.uk	Zoghbi, Abderahmen/A-8445-2017; Miniutti, Giovanni/L-2721-2014; Caballero-Garcia, Maria D./D-5659-2017; Boller, Thomas/AAT-8934-2021; Brandt, William N/N-2844-2015	Zoghbi, Abderahmen/0000-0002-0572-9613; Miniutti, Giovanni/0000-0003-0707-4531; Caballero-Garcia, Maria D./0000-0001-7920-4564; Brandt, William N/0000-0002-0167-2453; Young, Andrew/0000-0003-3626-9151; Ponti, Gabriele/0000-0003-0293-3608; /0000-0003-0065-2933; reis, rubens/0000-0002-6618-2412; Reynolds, Christopher/0000-0002-1510-4860; Miller, Jon/0000-0003-2869-7682	ESA; USA (NASA); Algerian Higher Education Ministry; UK Science and Technology Facilities Council (STFC); Spanish Ministerio de Ciencia e Innovacion; French National Research Agency; Science and Technology Facilities Council [ST/G002339/1, PP/D00571X/1, PP/D003636/2] Funding Source: researchfish; STFC [ST/G002339/1, PP/D003636/2] Funding Source: UKRI	ESA(European Space Agency); USA (NASA)(National Aeronautics & Space Administration (NASA)); Algerian Higher Education Ministry; UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); French National Research Agency(French National Research Agency (ANR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A. C. F. thanks the Royal Society for support. This work is based on observations made with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the USA (NASA). A. Z. acknowledges the support of the Algerian Higher Education Ministry and the UK Science and Technology Facilities Council (STFC). C. S. R., W. N. B., G. M., G. P. and R. C. R., and A. J. B. acknowledge support from the US National Science Foundation, NASA, the Spanish Ministerio de Ciencia e Innovacion, the French National Research Agency and the UK STFC for support, respectively.	Arevalo P, 2006, MON NOT R ASTRON SOC, V367, P801, DOI 10.1111/j.1365-2966.2006.09989.x; Bian W, 2003, MON NOT R ASTRON SOC, V343, P164, DOI 10.1046/j.1365-8711.2003.06650.x; Boller T, 2002, MON NOT R ASTRON SOC, V329, pL1, DOI 10.1046/j.1365-8711.2002.05040.x; Brenneman LW, 2006, ASTROPHYS J, V652, P1028, DOI 10.1086/508146; Cackett EM, 2008, ASTROPHYS J, V674, P415, DOI 10.1086/524936; Fabian AC, 2004, MON NOT R ASTRON SOC, V353, P1071, DOI 10.1111/j.1365-2966.2004.08036.x; FABIAN AC, 1989, MON NOT R ASTRON SOC, V238, P729, DOI 10.1093/mnras/238.3.729; Gallo LC, 2004, MON NOT R ASTRON SOC, V353, P1064, DOI 10.1111/j.1365-2966.2004.08248.x; Gallo LC, 2006, MON NOT R ASTRON SOC, V368, P479, DOI 10.1111/j.1365-2966.2006.10137.x; GUILBERT PW, 1988, MON NOT R ASTRON SOC, V233, P475, DOI 10.1093/mnras/233.2.475; LAOR A, 1991, ASTROPHYS J, V376, P90, DOI 10.1086/170257; Miller JM, 2007, ANNU REV ASTRON ASTR, V45, P441, DOI 10.1146/annurev.astro.45.051806.110555; Nandra K, 2007, MON NOT R ASTRON SOC, V382, P194, DOI 10.1111/j.1365-2966.2007.12331.x; OSTERBROCK DE, 1985, ASTROPHYS J, V297, P166, DOI 10.1086/163513; ROSS RR, 1993, MON NOT R ASTRON SOC, V261, P74, DOI 10.1093/mnras/261.1.74; Ross RR, 2005, MON NOT R ASTRON SOC, V358, P211, DOI 10.1111/j.1365-2966.2005.08797.x; Shara MM, 2002, ASTROPHYS J, V571, P830, DOI 10.1086/340062; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; Tanaka Y, 2004, PUBL ASTRON SOC JPN, V56, pL9, DOI 10.1093/pasj/56.3.L9; Uttley P, 2005, MON NOT R ASTRON SOC, V359, P345, DOI 10.1111/j.1365-2966.2005.08886.x	20	405	409	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					540	542		10.1038/nature08007	http://dx.doi.org/10.1038/nature08007			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478778	Green Accepted			2022-12-24	WOS:000266370500032
J	Lepper, C; Conway, SJ; Fan, CM				Lepper, Christoph; Conway, Simon J.; Fan, Chen-Ming			Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements	NATURE			English	Article							MOLECULAR REGULATION; SELF-RENEWAL; STEM-CELLS; PAX7; POPULATION; FATE; CRE; EFFICIENT	Myogenic potential, survival and expansion of mammalian muscle progenitors depend on the myogenic determinants Pax3 and Pax7 embryonically(1), and Pax7 alone perinatally(2-5). Several in vitro studies support the critical role of Pax7 in these functions of adult muscle stem cells(5-8) (satellite cells), but a formal demonstration has been lacking in vivo. Here we show, through the application of inducible Cre/loxP lineage tracing(9) and conditional gene inactivation to the tibialis anterior muscle regeneration paradigm, that, unexpectedly, when Pax7 is inactivated in adult mice, mutant satellite cells are not compromised in muscle regeneration, they can proliferate and reoccupy the sublaminal satellite niche, and they are able to support further regenerative processes. Dual adult inactivation of Pax3 and Pax7 also results in normal muscle regeneration. Multiple time points of gene inactivation reveal that Pax7 is only required up to the juvenile period when progenitor cells make the transition into quiescence. Furthermore, we demonstrate a cell-intrinsic difference between neonatal progenitor and adult satellite cells in their Pax7-dependency. Our finding of an age-dependent change in the genetic requirement for muscle stem cells cautions against inferring adult stem-cell biology from embryonic studies, and has direct implications for the use of stem cells from hosts of different ages in transplantation-based therapy.	[Lepper, Christoph; Fan, Chen-Ming] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Lepper, Christoph] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Carnegie Institution for Science; Johns Hopkins University; Indiana University System; Indiana University Bloomington	Lepper, C (corresponding author), Carnegie Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	lepper@ciwemb.edu; fan@ciwemb.edu			Carnegie Institution; NIH; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	Carnegie Institution; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank E. Dikovskaia and E. Siple for technical assistance and Y. Zheng, A. Spradling, S.-J. Lee and J. J. Weyers for comments on the manuscript. D. Barry and K. R. Wagner taught us muscle injury techniques and sample preparation. The Carnegie Institution, NIH and Riley Children's Foundation provided funding for this work.	Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Bigard AX, 1999, ACTA PHYSIOL SCAND, V165, P185; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Harlow E., 1988, ANTIBODIES LAB MANUA; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hogan B, 1994, MANIPULATING MOUSE E; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Koushik SV, 2002, GENESIS, V32, P114, DOI 10.1002/gene.10051; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Springer Matthew L, 2002, Curr Protoc Hum Genet, VChapter 13, DOI 10.1002/0471142905.hg1304s31; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	30	380	388	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					627	U94		10.1038/nature08209	http://dx.doi.org/10.1038/nature08209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19554048	Green Accepted			2022-12-24	WOS:000268454300050
J	Gao, X; Lu, FR; Zhou, LJ; Dang, SY; Sun, LF; Li, XC; Wang, JW; Shi, YG				Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei; Shi, Yigong			Structure and Mechanism of an Amino Acid Antiporter	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSPORTER SUPERFAMILY; AGMATINE ANTIPORTER; RECOGNITION SITE; MOLECULAR-BASIS; RESISTANCE; PUTRESCINE; EXCRETION; ARGININE	Virulent enteric pathogens such as Escherichia coli strain O157:H7 rely on acid-resistance (AR) systems to survive the acidic environment in the stomach. A major component of AR is an arginine-dependent arginine: agmatine antiporter that expels intracellular protons. Here, we report the crystal structure of AdiC, the arginine: agmatine antiporter from E. coli O157:H7 and a member of the amino acid/polyamine/organocation (APC) superfamily of transporters at 3.6 angstrom resolution. The overall fold is similar to that of several Na+-coupled symporters. AdiC contains 12 transmembrane segments, forms a homodimer, and exists in an outward-facing, open conformation in the crystals. A conserved, acidic pocket opens to the periplasm. Structural and biochemical analysis reveals the essential ligand-binding residues, defines the transport route, and suggests a conserved mechanism for the antiporter activity.	[Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Struct Biol Ctr, Dept Biol Sci & Biotechol, Beijing 100084, Peoples R China; [Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Struct Biol Ctr, Dept Biol Sci & Biotechol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Dang, Shangyu/0000-0001-9141-1865; gao, xiang/0000-0001-6397-5639; Zhou, Lijun/0000-0002-0393-4787; Shi, Yigong/0000-0003-2030-168X; Li, Xiaochun/0000-0002-0177-0803; Lu, Feiran/0000-0002-1757-2895	Ministry of Science and Technology [2009CB918801]; Tsinghua University 985 Phase II; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University 985 Phase II; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	We thank N. Shimizu at the Spring-8 beamline BL41XU and T. Kumasaka and S. Baba at beamline BL38XU for on-site assistance, Q. Liu for screening crystals at MacCHESS (Macromolecular Diffraction at the Cornell High Energy Synchrotron Source), and N. Yan for discussion and comments on the manuscript. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801), Tsinghua University 985 Phase II funds, National Natural Science Foundation, and Beijing Municipal Commissions of Education and Science and Technology. The atomic coordinates have been deposited in the Protein Data Bank with the accession codes 3H5M and 3H6B.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	28	187	189	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1565	1568		10.1126/science.1173654	http://dx.doi.org/10.1126/science.1173654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19478139				2022-12-24	WOS:000267130600045
J	Grice, EA; Kong, HH; Conlan, S; Deming, CB; Davis, J; Young, AC; Bouffard, GG; Blakesley, RW; Murray, PR; Green, ED; Turner, ML; Segre, JA				Grice, Elizabeth A.; Kong, Heidi H.; Conlan, Sean; Deming, Clayton B.; Davis, Joie; Young, Alice C.; Bouffard, Gerard G.; Blakesley, Robert W.; Murray, Patrick R.; Green, Eric D.; Turner, Maria L.; Segre, Julia A.		NISC Comparative Sequencing Progra	Topographical and Temporal Diversity of the Human Skin Microbiome	SCIENCE			English	Article							BACTERIAL BIOTA	Human skin is a large, heterogeneous organ that protects the body from pathogens while sustaining microorganisms that influence human health and disease. Our analysis of 16S ribosomal RNA gene sequences obtained from 20 distinct skin sites of healthy humans revealed that physiologically comparable sites harbor similar bacterial communities. The complexity and stability of the microbial community are dependent on the specific characteristics of the skin site. This topographical and temporal survey provides a baseline for studies that examine the role of bacterial communities in disease states and the microbial interdependencies required to maintain healthy skin.	[Grice, Elizabeth A.; Conlan, Sean; Deming, Clayton B.; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Kong, Heidi H.; Turner, Maria L.] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Davis, Joie] NHGRI, Off Translat Res, Bethesda, MD 20892 USA; [Young, Alice C.; Bouffard, Gerard G.; Blakesley, Robert W.; Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Bouffard, Gerard G.; Blakesley, Robert W.; Green, Eric D.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Murray, Patrick R.] NIH, Clin Microbiol Lab, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Segre, JA (corresponding author), NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov	ravegnini, gloria/K-1330-2016; Conlan, Sean/B-4401-2008; Kong, Heidi H/L-4856-2018	ravegnini, gloria/0000-0002-7774-402X; Conlan, Sean/0000-0001-6848-3465; Kong, Heidi H/0000-0003-4424-064X; Grice, Elizabeth/0000-0003-3939-2200	NIGMS Pharmacology Research Associate Training Fellowship; NHGRI; NCI Center for Cancer Research Intramural Research Programs; NCBI Genome Project [30125]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG000180] Funding Source: NIH RePORTER	NIGMS Pharmacology Research Associate Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI Center for Cancer Research Intramural Research Programs; NCBI Genome Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the volunteers who participated in this study; E. Bassett for assistance with sample collection; members of the Segre laboratory for their underlying contributions; M. Udey, N. Salafsky, and E. Lander for critical reading of the manuscript; and J. Fekecs and D. Leja for graphical assistance. Supported by a NIGMS Pharmacology Research Associate Training Fellowship (E.A.G.) and by the NHGRI and NCI Center for Cancer Research Intramural Research Programs. All sequences are deposited under NCBI Genome Project 30125, GenBank accession numbers GQ000001 to GQ116391.	Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Marples M. J., 1965, ECOLOGY HUMAN SKIN; SCHARSCHMIDT TC, 2009, J INVEST DERMATOL; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521	11	1660	1792	23	511	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1190	1192		10.1126/science.1171700	http://dx.doi.org/10.1126/science.1171700			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478181	Green Accepted			2022-12-24	WOS:000266410100043
J	Shaffer, PL; Goehring, A; Shankaranarayanan, A; Gouaux, E				Shaffer, Paul L.; Goehring, April; Shankaranarayanan, Aruna; Gouaux, Eric			Structure and Mechanism of a Na+-Independent Amino Acid Transporter	SCIENCE			English	Article							LYSINURIC PROTEIN INTOLERANCE; CRYSTAL-STRUCTURE; FAMILY; IDENTIFICATION; SUPERFAMILY; ANTIPORTER; EXPRESSION; GALACTOSE; CYSTINE; SLC7A7	Amino acid, polyamine, and organocation (APC) transporters are secondary transporters that play essential roles in nutrient uptake, neurotransmitter recycling, ionic homeostasis, and regulation of cell volume. Here, we present the crystal structure of apo-ApcT, a proton-coupled broad-specificity amino acid transporter, at 2.35 angstrom resolution. The structure contains 12 transmembrane helices, with the first 10 consisting of an inverted structural repeat of 5 transmembrane helices like the leucine transporter LeuT. The ApcT structure reveals an inward-facing, apo state and an amine moiety of lysine-158 located in a position equivalent to the sodium ion site Na2 of LeuT. We propose that lysine-158 is central to proton-coupled transport and that the amine group serves the same functional role as the Na2 ion in LeuT, thus demonstrating common principles among proton-and sodium-coupled transporters.	[Shaffer, Paul L.; Goehring, April; Shankaranarayanan, Aruna; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	New York Consortium for Membrane Protein Structure, NIH-supported Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, U54GM075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070039] Funding Source: NIH RePORTER	New York Consortium for Membrane Protein Structure, NIH-supported Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the New York Consortium for Membrane Protein Structure, a NIH-supported Protein Structure Initiative (E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. Coordinates and structure factors of the apo ApcT, ApcT-7F11 Fab complex, and ApcT K158A-7F11 Fab complex have been deposited in the Protein DataBank with accession codes 3GIA, 3GI9, and 3GI8, respectively.	BANNAI S, 1980, J BIOL CHEM, V255, P2372; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Cosgriff AJ, 2000, J BACTERIOL, V182, P2207, DOI 10.1128/JB.182.8.2207-2217.2000; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	30	242	243	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					1010	1014		10.1126/science.1176088	http://dx.doi.org/10.1126/science.1176088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608859	Green Accepted			2022-12-24	WOS:000269242800050
J	McMullen, MD; Kresovich, S; Villeda, HS; Bradbury, P; Li, HH; Sun, Q; Flint-Garcia, S; Thornsberry, J; Acharya, C; Bottoms, C; Brown, P; Browne, C; Eller, M; Guill, K; Harjes, C; Kroon, D; Lepak, N; Mitchell, SE; Peterson, B; Pressoir, G; Romero, S; Rosas, MO; Salvo, S; Yates, H; Hanson, M; Jones, E; Smith, S; Glaubitz, JC; Goodman, M; Ware, D; Holland, JB; Buckler, ES				McMullen, Michael D.; Kresovich, Stephen; Villeda, Hector Sanchez; Bradbury, Peter; Li, Huihui; Sun, Qi; Flint-Garcia, Sherry; Thornsberry, Jeffry; Acharya, Charlotte; Bottoms, Christopher; Brown, Patrick; Browne, Chris; Eller, Magen; Guill, Kate; Harjes, Carlos; Kroon, Dallas; Lepak, Nick; Mitchell, Sharon E.; Peterson, Brooke; Pressoir, Gael; Romero, Susan; Rosas, Marco Oropeza; Salvo, Stella; Yates, Heather; Hanson, Mark; Jones, Elizabeth; Smith, Stephen; Glaubitz, Jeffrey C.; Goodman, Major; Ware, Doreen; Holland, James B.; Buckler, Edward S.			Genetic Properties of the Maize Nested Association Mapping Population	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED LINES; LINKAGE; RECOMBINATION; ARCHITECTURE; PATTERNS; MARKERS	Maize genetic diversity has been used to understand the molecular basis of phenotypic variation and to improve agricultural efficiency and sustainability. We crossed 25 diverse inbred maize lines to the B73 reference line, capturing a total of 136,000 recombination events. Variation for recombination frequencies was observed among families, influenced by local (cis) genetic variation. We identified evidence for numerous minor single-locus effects but little two-locus linkage disequilibrium or segregation distortion, which indicated a limited role for genes with large effects and epistatic interactions on fitness. We observed excess residual heterozygosity in pericentromeric regions, which suggested that selection in inbred lines has been less efficient in these regions because of reduced recombination frequency. This implies that pericentromeric regions may contribute disproportionally to heterosis.	[McMullen, Michael D.; Bradbury, Peter; Flint-Garcia, Sherry; Browne, Chris; Eller, Magen; Guill, Kate; Lepak, Nick; Peterson, Brooke; Romero, Susan; Salvo, Stella; Ware, Doreen; Holland, James B.; Buckler, Edward S.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [McMullen, Michael D.; Villeda, Hector Sanchez; Flint-Garcia, Sherry; Bottoms, Christopher] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kresovich, Stephen; Bradbury, Peter; Li, Huihui; Acharya, Charlotte; Brown, Patrick; Harjes, Carlos; Kroon, Dallas; Mitchell, Sharon E.; Pressoir, Gael; Yates, Heather; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Li, Huihui] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Li, Huihui] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [Thornsberry, Jeffry] NW Missouri State Univ, Maryville, MO 64468 USA; [Rosas, Marco Oropeza; Goodman, Major; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Hanson, Mark] Illumina Inc, San Diego, CA 92121 USA; [Jones, Elizabeth; Smith, Stephen] Pioneer HiBred Int Inc, Johnston, IA 50131 USA; [Glaubitz, Jeffrey C.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Cornell University; Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Cornell University; University of North Carolina; North Carolina State University; Illumina; DuPont; University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Cornell University	McMullen, MD (corresponding author), Univ Missouri, USDA ARS, Columbia, MO 65211 USA.	mcmullenm@missouri.edu; sk20@cornell.edu; james_holland@ncsu.edu; esb33@cornell.edu	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Brown, Patrick/E-4085-2012	Buckler, Edward/0000-0002-3100-371X; Brown, Patrick/0000-0001-6857-8608; Flint-Garcia, Sherry/0000-0003-4156-5318; Holland, James/0000-0002-4341-9675	National Science Foundation [DBI0321467]; USDA-ARS	National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Supported by National Science Foundation Award DBI0321467 and by research funds provided by USDA-ARS to M.D.M., E.S.B., and J.B.H.	BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Emerson RA, 1934, GENETICS, V19, P0137; Esch E, 2007, GENETICS, V177, P1851, DOI 10.1534/genetics.107.080622; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Graham GI, 1997, CROP SCI, V37, P1601, DOI 10.2135/cropsci1997.0011183X003700050033x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; LANDER ES, 1989, GENETICS, V121, P185; Liu KJ, 2003, GENETICS, V165, P2117; LONGLEY AE, 1961, GENETICS, V46, P641; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; NASS HG, 1970, CROP SCI, V10, P139, DOI 10.2135/cropsci1970.0011183X001000020004x; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; STUBER CW, 1992, GENETICS, V132, P823; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; WILLIAMS CG, 1995, GENETICS, V141, P1573; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yao H, 2005, GENETICS, V170, P1929, DOI 10.1534/genetics.104.034454; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang M, 2005, GENETICS, V169, P2305, DOI 10.1534/genetics.104.034181	27	690	717	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					737	740		10.1126/science.1174320	http://dx.doi.org/10.1126/science.1174320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661427				2022-12-24	WOS:000268723700046
J	Vago, L; Perna, SK; Zanussi, M; Mazzi, B; Barlassina, C; Stanghellini, MTL; Perrelli, NF; Cosentino, C; Torri, F; Angius, A; Forno, B; Casucci, M; Bernardi, M; Peccatori, J; Corti, C; Bondanza, A; Ferrari, M; Rossini, S; Roncarolo, MG; Bordignon, C; Bonini, C; Ciceri, F; Fleischhauer, K				Vago, Luca; Perna, Serena Kimi; Zanussi, Monica; Mazzi, Benedetta; Barlassina, Cristina; Stanghellini, Maria Teresa Lupo; Perrelli, Nicola Flavio; Cosentino, Cristian; Torri, Federica; Angius, Andrea; Forno, Barbara; Casucci, Monica; Bernardi, Massimo; Peccatori, Jacopo; Corti, Consuelo; Bondanza, Attilio; Ferrari, Maurizio; Rossini, Silvano; Roncarolo, Maria Grazia; Bordignon, Claudio; Bonini, Chiara; Ciceri, Fabio; Fleischhauer, Katharina			Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC TUMOR VARIANTS; RISK ACUTE-LEUKEMIA; HEMATOPOIETIC TRANSPLANTS; UNIPARENTAL DISOMY; DONOR LYMPHOCYTES; DOWN-REGULATION; ANTIGENS; RELAPSE; RECONSTITUTION; ALLOREACTIVITY	Background: Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease. Methods: We identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures. Results: In 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed. Conclusions: After transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse. N Engl J Med 2009;361:478-88.	[Vago, Luca; Perna, Serena Kimi; Stanghellini, Maria Teresa Lupo; Forno, Barbara; Bernardi, Massimo; Peccatori, Jacopo; Corti, Consuelo; Ciceri, Fabio] IRCCS H San Raffaele, Hematol & Bone Marrow Transplantat Unit, Dept Oncol, I-20132 Milan, Italy; [Vago, Luca; Roncarolo, Maria Grazia; Fleischhauer, Katharina] IRCCS H San Raffaele, HSR TIGET, I-20132 Milan, Italy; [Perna, Serena Kimi; Casucci, Monica; Bondanza, Attilio; Bonini, Chiara] IRCCS H San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy; [Mazzi, Benedetta; Rossini, Silvano; Fleischhauer, Katharina] IRCCS H San Raffaele, HLA Tissue Typing Lab, I-20132 Milan, Italy; [Mazzi, Benedetta; Rossini, Silvano; Fleischhauer, Katharina] IRCCS H San Raffaele, Immunohematol & Transfus Med Serv, I-20132 Milan, Italy; [Ferrari, Maurizio; Roncarolo, Maria Grazia; Bordignon, Claudio] Univ Vita Salute San Raffaele, Milan, Italy; [Barlassina, Cristina; Cosentino, Cristian; Torri, Federica] Univ Milan, Dipartimento Sci & Tecnol Biomed, Milan, Italy; [Barlassina, Cristina; Cosentino, Cristian; Torri, Federica] Fdn Filarete, Milan, Italy; [Bordignon, Claudio] MolMed, Milan, Italy; [Angius, Andrea] Shardna Life Sci, Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Ciceri, F (corresponding author), IRCCS H San Raffaele, Hematol & Bone Marrow Transplantat Unit, Dept Oncol, Via Olgettina 60, I-20132 Milan, Italy.	ciceri.fabio@hsr.it	Angius, Andrea/P-9549-2015; Ferrari, Maurizio/D-9107-2013; Casucci, Monica/AAN-4115-2020; Cosentino, Cristian/F-2604-2010; bonini, chiara/I-9202-2012; bernardi, massimo/ABG-4445-2020; Angius, Andrea/B-8966-2015; Peccatori, Iacopo/AAB-7506-2019	Angius, Andrea/0000-0003-2596-6461; Cosentino, Cristian/0000-0002-2784-0048; bernardi, massimo/0000-0002-1334-0851; Peccatori, Iacopo/0000-0003-4639-1716; BONINI, Maria Chiara/0000-0002-0772-1674; Lupo-Stanghellini, Maria Teresa/0000-0003-1382-6939; Angius, Andrea/0000-0001-9372-1162; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Vago, Luca/0000-0003-4247-3175; Barlassina, Cristina/0000-0001-7407-2697; Casucci, Monica/0000-0003-4500-9060	Associazione Italiana per la Ricerca sul Cancro [AIRC 44/2007]; Cariplo Foundation [2007.5486]; Telethon Foundation [GGP08201]; European Commission [FP7-ICT-2007-216088]; Italian Ministry of Health; Italian Ministry of Research and University	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); Telethon Foundation(Fondazione Telethon); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	Supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC 44/2007), the Cariplo Foundation (2007.5486), the Telethon Foundation (GGP08201), the European Commission (FP7-ICT-2007-216088), the Italian Ministry of Health, and the Italian Ministry of Research and University.	Amrolia PJ, 2006, BLOOD, V108, P1797, DOI 10.1182/blood-2006-02-001909; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Burroughs LM, 2008, BIOL BLOOD MARROW TR, V14, P1279, DOI 10.1016/j.bbmt.2008.08.014; Ciceri F, 2008, BLOOD, V112, P3574, DOI 10.1182/blood-2008-02-140095; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Garcia-Lora A, 2001, INT J CANCER, V91, P109, DOI 10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E; Garcia-Lora A, 2003, INT J CANCER, V106, P521, DOI 10.1002/ijc.11241; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Gorletta TA, 2005, GENE CHROMOSOME CANC, V44, P334, DOI 10.1002/gcc.20234; Goulmy E, 2006, HUM IMMUNOL, V67, P433, DOI 10.1016/j.humimm.2006.03.012; Huang XJ, 2008, J CLIN IMMUNOL, V28, P276, DOI 10.1007/s10875-007-9166-z; Kennedy-Nasser AA, 2007, CURR OPIN HEMATOL, V14, P616, DOI 10.1097/MOH.0b013e3282ef615a; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koh LP, 2007, BIOL BLOOD MARROW TR, V13, P1249, DOI 10.1016/j.bbmt.2007.08.003; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Lewalle P, 2004, BLOOD CELL MOL DIS, V33, P256, DOI 10.1016/j.bcmd.2004.08.012; Masuda K, 2007, CANCER SCI, V98, P102, DOI 10.1111/j.1349-7006.2006.00356.x; Mazzi B, 2008, LEUKEMIA, V22, P2119, DOI 10.1038/leu.2008.98; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Raghavan M, 2005, CANCER RES, V65, P375; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Vago L, 2008, BLOOD, V112, P3488, DOI 10.1182/blood-2007-07-103325; van Rood JJ, 2005, SEMIN HEMATOL, V42, P104, DOI 10.1053/j.seminhematol.2005.01.008; Velardi A, 2008, SEMIN IMMUNOPATHOL, V30, P489, DOI 10.1007/s00281-008-0136-1; Zheng P, 1999, CANCER RES, V59, P3461	31	341	350	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					478	488		10.1056/NEJMoa0811036	http://dx.doi.org/10.1056/NEJMoa0811036			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641204				2022-12-24	WOS:000268443900008
J	Yoo, AS; Staahl, BT; Chen, L; Crabtree, GR				Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.			MicroRNA-mediated switching of chromatin-remodelling complexes in neural development	NATURE			English	Article							MAMMALIAN SWI/SNF COMPLEXES; STEM-CELLS; TRANSCRIPTION; GENES; NEURONS; MIR-124; MOUSE; REST; IDENTIFICATION; EMBRYOGENESIS	One of the most distinctive steps in the development of the vertebrate nervous system occurs at mitotic exit when cells lose multi-potency and begin to develop stable connections that will persist for a lifetime(1,2). This transition is accompanied by a switch in ATP-dependent chromatin-remodelling mechanisms that appears to coincide with the final mitotic division of neurons. This switch involves the exchange of the BAF53a (also known as ACTL6a) and BAF45a (PHF10) subunits within Swi/Snf-like neural-progenitor-specific BAF (npBAF) complexes for the homologous BAF53b (ACTL6b) and BAF45b (DPF1) subunits within neuron-specific BAF (nBAF) complexes in post-mitotic neurons. The subunits of the npBAF complex are essential for neural-progenitor proliferation, and mice with reduced dosage for the genes encoding its subunits have defects in neural-tube closure similar to those in human spina bifida(3), one of the most serious congenital birth defects. In contrast, BAF53b and the nBAF complex are essential for an evolutionarily conserved program of post-mitotic neural development and dendritic morphogenesis(4,5). Here we show that this essential transition is mediated by repression of BAF53a by miR-9* and miR-124. We find that BAF53a repression is mediated by sequences in the 3' untranslated region corresponding to the recognition sites for miR-9* and miR-124, which are selectively expressed in post-mitotic neurons. Mutation of these sites led to persistent expression of BAF53a and defective activity-dependent dendritic outgrowth in neurons. In addition, overexpression of miR-9* and miR-124 in neural progenitors caused reduced proliferation. Previous studies have indicated that miR-9* and miR-124 are repressed by the repressor-element-1-silencing transcription factor (REST, also known as NRSF)(6). Indeed, expression of REST in post-mitotic neurons led to derepression of BAF53a, indicating that REST-mediated repression of microRNAs directs the essential switch of chromatin regulatory complexes.	[Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Yoo, Andrew S.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Yoo, Andrew/0000-0002-0304-3247	Helen Hay Whitney Foundation; US National Institutes of Health (NIH) [2 T32 HD007249]; Howard Hughes Medical Institute; NIH [HD55391, AI060037, NS046789]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249, R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. I. Wu and J. Lessard for suggestions. We thank N. Copeland and N. Jenkins for providing us with the reagents for recombineering techniques. A. S. Y. is a fellow of Helen Hay Whitney Foundation. B. T. S. is supported by the Developmental and Neonatal Biology Training Program 2 T32 HD007249 from the US National Institutes of Health (NIH). This work was supported by grants from the Howard Hughes Medical Institute and the NIH, HD55391, AI060037 and NS046789, to G. R. C.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021	32	457	473	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					642	U112		10.1038/nature08139	http://dx.doi.org/10.1038/nature08139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19561591	Green Accepted			2022-12-24	WOS:000268454300053
J	Soshnikova, N; Duboule, D				Soshnikova, Natalia; Duboule, Denis			Epigenetic Temporal Control of Mouse Hox Genes in Vivo	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; POLYCOMB GROUP GENES; COMPLEX; MURINE; ORGANIZATION; EXPRESSION; CLUSTERS; ENHANCER; LOCI	During vertebrate development, the temporal control of Hox gene transcriptional activation follows the genomic order of the genes within the Hox clusters. Although it is recognized that this "Hox clock" serves to coordinate body patterning, the underlying mechanism remains elusive. We have shown that successive Hox gene activation in the mouse embryo is closely associated with a directional transition in chromatin status, as judged by the dynamic progression of transcription-competent modifications: Increases in activation marks correspond to decreases in repressive marks. Furthermore, using a mouse in which a Hox cluster was split into two pieces, we document the necessity to maintain a clustered organization to properly implement this process. These results suggest that chromatin modifications are important parameters in the temporal regulation of this gene family.	[Soshnikova, Natalia; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Duboule, Denis] Fed Inst Technol EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	Denis.Duboule@unige.ch		duboule, denis/0000-0001-9961-2960	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund; National Research Center Frontiers in Genetics; European Union program Crescendo	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center Frontiers in Genetics; European Union program Crescendo	We thank T. Montavon, A. Puglisi, and D. Schubeler for advice; F. Chabaud for cell culture; and P. Descombes and members of the Genomics Platform for their help with tiling arrays. N.S. was supported by a European Molecular Biology Organization long-term fellowship. This work was funded by the University of Geneva, the Federal Institute of Technology in Lausanne, the Swiss National Research Fund, the National Research Center Frontiers in Genetics, and the European Union program Crescendo. Data and analysis are available for download from ArrayExpress (accession E-TABM-677).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SIMON J, 1992, DEVELOPMENT, V114, P493; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126	28	191	196	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1320	1323		10.1126/science.1171468	http://dx.doi.org/10.1126/science.1171468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498168	Green Published			2022-12-24	WOS:000266635100044
J	Muzzey, D; Gomez-Uribe, CA; Mettetal, JT; van Oudenaarden, A				Muzzey, Dale; Gomez-Uribe, Carlos A.; Mettetal, Jerome T.; van Oudenaarden, Alexander			A Systems-Level Analysis of Perfect Adaptation in Yeast Osmoregulation	CELL			English	Article							KINASE SIGNALING SPECIFICITY; GLYCEROL HOG PATHWAY; SACCHAROMYCES-CEREVISIAE; HIGH OSMOLARITY; HYPEROSMOTIC STRESS; OSMOTIC-STRESS; MODEL; ACCUMULATION; ROBUSTNESS; SHOCK	Negative feedback can serve many different cellular functions, including noise reduction in transcriptional networks and the creation of circadian oscillations. However, only one special type of negative feedback ("integral feedback'') ensures perfect adaptation, where steady-state output is independent of steady-state input. Here we quantitatively measure single-cell dynamics in the Saccharomyces cerevisiae hyperosmotic shock network, which regulates membrane turgor pressure. Importantly, we find that the nuclear enrichment of the MAP kinase Hog1 perfectly adapts to changes in external osmolarity, a feature robust to signaling fidelity and operating with very low noise. By monitoring multiple system quantities (e.g., cell volume, Hog1, glycerol) and using varied input waveforms (e.g., steps and ramps), we assess in a minimally invasive manner the network location of the mechanism responsible for perfect adaptation. We conclude that the system contains only one effective integrating mechanism, which requires Hog1 kinase activity and regulates glycerol synthesis but not leakage.	[Muzzey, Dale; Gomez-Uribe, Carlos A.; Mettetal, Jerome T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Gomez-Uribe, Carlos A.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Muzzey, Dale] Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; NIDDK NIH HHS [R90 DK071511-01, R90 DK071511, 5 R90 DK071511-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM068957-06, R01 GM068957-05, R01 GM068957, R01-GM068957, R01 GM068957-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gennemark Peter, 2006, In Silico Biology, V6, P193; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; Sontag ED, 2003, SYST CONTROL LETT, V50, P119, DOI 10.1016/S0167-6911(03)00136-1; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	31	243	245	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					160	171		10.1016/j.cell.2009.04.047	http://dx.doi.org/10.1016/j.cell.2009.04.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596242	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000267848600022
J	Nguyen, DX; Chiang, AC; Zhang, XHF; Kim, JY; Kris, MG; Ladanyi, M; Gerald, WL; Massague, J				Nguyen, Don X.; Chiang, Anne C.; Zhang, Xiang H. -F.; Kim, Juliet Y.; Kris, Mark G.; Ladanyi, Marc; Gerald, William L.; Massague, Joan			WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis	CELL			English	Article							GENE-EXPRESSION; BETA-CATENIN; BRAIN METASTASES; STEM-CELLS; CANCER; WNT; RECURRENCE; ACTIVATION; MUTATIONS; PATHWAY	Metastasis from lung adenocarcinoma can occur swiftly to multiple organs within months of diagnosis. The mechanisms that confer this rapid metastatic capacity to lung tumors are unknown. Activation of the canonical WNT/TCF pathway is identified here as a determinant of metastasis to brain and bone during lung adenocarcinoma progression. Gene expression signatures denoting WNT/TCF activation are associated with relapse to multiple organs in primary lung adenocarcinoma. Metastatic subpopulations isolated from independent lymphnode-derived lung adenocarcinoma cell lines harbor a hyperactive WNT/TCF pathway. Reduction of TCF activity in these cells attenuates their ability to form brain and bone metastases in mice, independently of effects on tumor growth in the lungs. The WNT/TCF target genes HOXB9 and LEF1 are identified as mediators of chemotactic invasion and colony outgrowth. Thus, a distinct WNT/TCF signaling program through LEF1 and HOXB9 enhances the competence of lung adenocarcinoma cells to colonize the bones and the brain. For a video summary of this article, see the Paper Flick file available with the online Supplemental Data.	[Nguyen, Don X.; Zhang, Xiang H. -F.; Kim, Juliet Y.; Massague, Joan] Cornell Univ, Canc Biol & Genet Program, Ithaca, NY 14853 USA; [Chiang, Anne C.; Kris, Mark G.] Cornell Univ, Dept Med, Ithaca, NY 14853 USA; [Ladanyi, Marc; Gerald, William L.] Cornell Univ, Dept Pathol, Ithaca, NY 14853 USA; [Ladanyi, Marc; Gerald, William L.] Cornell Univ, Human Oncol & Pathogenesis Program, Ithaca, NY 14853 USA; [Kris, Mark G.] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Cornell Univ, Canc Biol & Genet Program, Ithaca, NY 14853 USA.	j-massague@ski.mskcc.org	Ladanyi, Marc/AAG-8585-2019	Zhang, Xiang/0000-0002-5674-8670; Kris, Mark/0000-0002-7317-5341; Massague, Joan/0000-0001-9324-8408	Alan and Sandra Gerry Metastasis Research Initiative; National Institutes of Health [P01-129243]; Damon Runyon Cancer Research Foundation; American Society of Clinical Oncology Career Development Award; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA129243] Funding Source: NIH RePORTER	Alan and Sandra Gerry Metastasis Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; American Society of Clinical Oncology Career Development Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express deep gratitude to our late colleague William L. Gerald. We are indebted to H. Varmus, W. Pao, V. Rusch, and members of the Massague laboratory for insightful discussions. We thank A. Heguy for supervising sequencing and mutational analysis. H. Clevers, E. Batlle, R. Moon, W. Pao, and H. Varmus generously provided constructs and cell lines. This work was supported by the Alan and Sandra Gerry Metastasis Research Initiative and National Institutes of Health grant P01-129243 (M. G. K., M. L., W. L. G., and J. M.). D. X. N. was the Bayer postdoctoral fellow of the Damon Runyon Cancer Research Foundation. A. C. C. was supported by an American Society of Clinical Oncology Career Development Award. J. M. is an Investigator of the Howard Hughes Medical Institute.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BOS PD, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08021; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen AM, 2007, CANCER-AM CANCER SOC, V109, P1668, DOI 10.1002/cncr.22565; CHITALE D, 2009, ONCOGENE IN PRESS, DOI DOI 10.1038/ONC.2009.135; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Gaspar Laurie E, 2004, Expert Rev Anticancer Ther, V4, P259, DOI 10.1586/14737140.4.2.259; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Phelps RM, 1996, J CELL BIOCHEM, P32; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; RODENHUIS S, 1988, CANCER RES, V48, P5738; SASAKI Y, 1991, CANCER CHEMOTH PHARM, V27, P263, DOI 10.1007/BF00685110; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thomas AJ, 2000, J NEUROSURG, V93, P927, DOI 10.3171/jns.2000.93.6.0927; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	60	448	474	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					51	62		10.1016/j.cell.2009.04.030	http://dx.doi.org/10.1016/j.cell.2009.04.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19576624	Green Accepted, Bronze			2022-12-24	WOS:000267848600014
J	Sankaran, VG; Xu, J; Ragoczy, T; Ippolito, GC; Walkley, CR; Maika, SD; Fujiwara, Y; Ito, M; Groudine, M; Bender, MA; Tucker, PW; Orkin, SH				Sankaran, Vijay G.; Xu, Jian; Ragoczy, Tobias; Ippolito, Gregory C.; Walkley, Carl R.; Maika, Shanna D.; Fujiwara, Yuko; Ito, Masafumi; Groudine, Mark; Bender, M. A.; Tucker, Philip W.; Orkin, Stuart H.			Developmental and species-divergent globin switching are driven by BCL11A	NATURE			English	Article							YEAST ARTIFICIAL CHROMOSOME; LOCUS-CONTROL REGION; TRANSGENIC MICE; FETAL-HEMOGLOBIN; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; EVO-DEVO; TRANSCRIPTION; CELLS; MOUSE	The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian beta-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human beta-globin locus, consisting of the linked embryonic (epsilon), fetal (gamma) and adult (beta) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human gamma-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human gamma-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human gamma-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of beta-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.	[Sankaran, Vijay G.; Xu, Jian; Walkley, Carl R.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Sankaran, Vijay G.; Xu, Jian; Walkley, Carl R.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xu, Jian; Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ragoczy, Tobias; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ippolito, Gregory C.; Maika, Shanna D.; Tucker, Philip W.] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Ito, Masafumi] Nagoya First Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Groudine, Mark] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Austin; Red Cross Nagoya Daiichi Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Walkley, Carl/AAO-6021-2020; Ippolito, Gregory C./AAR-2930-2021	Walkley, Carl/0000-0002-4784-9031; Ippolito, Gregory C./0000-0002-7565-7002	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); National Cancer Institute; Howard Hughes Medical Institute (HHMI); Leukemia & Lymphoma Society; American Society of Hematology; Helen Hay Whitney Foundation; NCI postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; Helen Hay Whitney Foundation; NCI postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to K. Peterson and H. Fedosyuk for providing beta-locus mice, K. Gaensler for the A20 and A85 strains of b- locus mice, and T. Jacks for providing the K- RasG12D mice. We thank J. Palis and P. Kingsley for providing mouse embryonic globin antibodies, H. Mikkola and B. Van Handel for providing sorted human samples, and R. Byron and A. Telling for technical support. Wethank L. Zon, K. McGrath, P. Kingsley, J. Palis, M. Kowalczyk and T. Menne for advice and discussions. This work was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) (S.H.O. and M. G.) and the National Cancer Institute ( P. W. T.). S. H. O. is an Investigator of the Howard Hughes Medical Institute (HHMI). C. R. W. is a special fellow of the Leukemia & Lymphoma Society. T. R. is supported by a fellowship from the American Society of Hematology. J. X. is an HHMI fellow of the Helen Hay Whitney Foundation. V. G. S. is supported by a Medical Scientist Training Program Award from the NIH and G. C. I. is supported by a NCI postdoctoral fellowship.	Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Choi JW, 2001, INT J HEMATOL, V74, P277, DOI 10.1007/BF02982061; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Harju S, 2005, MOL CELL BIOL, V25, P8765, DOI 10.1128/MCB.25.20.8765-8778.2005; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jasinski M, 2001, BLOOD, V98, P2248, DOI 10.1182/blood.V98.7.2248; Johnson RM, 2006, P NATL ACAD SCI USA, V103, P3186, DOI 10.1073/pnas.0511347103; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; PACE B, 1994, BLOOD, V84, P4344, DOI 10.1182/blood.V84.12.4344.bloodjournal84124344; PAPAYANNOPOULOU T, 1984, SCIENCE, V224, P617, DOI 10.1126/science.6200940; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Sloane-Stanley J, 2006, BRIT J HAEMATOL, V135, P735, DOI 10.1111/j.1365-2141.2006.06354.x; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; WEATHERALL DJ, 1975, NATURE, V257, P710, DOI 10.1038/257710a0; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	38	286	311	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1093	U50		10.1038/nature08243	http://dx.doi.org/10.1038/nature08243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19657335	Green Accepted			2022-12-24	WOS:000269314000030
J	Dias-Ferreira, E; Sousa, JC; Melo, I; Morgado, P; Mesquita, AR; Cerqueira, JJ; Costa, RM; Sousa, N				Dias-Ferreira, Eduardo; Sousa, Joao C.; Melo, Irene; Morgado, Pedro; Mesquita, Ana R.; Cerqueira, Joao J.; Costa, Rui M.; Sousa, Nuno			Chronic Stress Causes Frontostriatal Reorganization and Affects Decision-Making	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; BASAL GANGLIA; CONTINGENCY; STRIATUM; HIPPOCAMPAL; SENSITIVITY; MORPHOLOGY; HABITS; REWARD	The ability to shift between different behavioral strategies is necessary for appropriate decision-making. Here, we show that chronic stress biases decision-making strategies, affecting the ability of stressed animals to perform actions on the basis of their consequences. Using two different operant tasks, we revealed that, in making choices, rats subjected to chronic stress became insensitive to changes in outcome value and resistant to changes in action-outcome contingency. Furthermore, chronic stress caused opposing structural changes in the associative and sensorimotor corticostriatal circuits underlying these different behavioral strategies, with atrophy of medial prefrontal cortex and the associative striatum and hypertrophy of the sensorimotor striatum. These data suggest that the relative advantage of circuits coursing through sensorimotor striatum observed after chronic stress leads to a bias in behavioral strategies toward habit.	[Dias-Ferreira, Eduardo; Costa, Rui M.] NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA; [Dias-Ferreira, Eduardo; Sousa, Joao C.; Melo, Irene; Morgado, Pedro; Mesquita, Ana R.; Cerqueira, Joao J.; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Dias-Ferreira, Eduardo] Univ Coimbra, PhD Programme Expt Biol & Biomed PDBEB, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Costa, Rui M.] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, P-2780901 Oeiras, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Universidade do Minho; Universidade de Coimbra; Fundacao Champalimaud	Costa, RM (corresponding author), NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA.	costarui@mail.nih.gov; njcsousa@ecsaude.uminho.pt	Sousa, Nuno/C-2782-2009; Sousa, Nuno JC/N-9137-2017; Sousa, João C/C-1048-2009; Sousa, João/T-6628-2019; Cerqueira, Joao J/B-4579-2008; Morgado, Pedro/Q-1769-2015	Sousa, Nuno JC/0000-0002-8755-5126; Sousa, João C/0000-0003-3249-0035; Sousa, João/0000-0003-3249-0035; Cerqueira, Joao J/0000-0003-3155-2775; Morgado, Pedro/0000-0003-3880-3258; Costa, Rui M./0000-0003-0495-8374; Mesquita, Ana/0000-0002-9635-2355	Bial Foundation [134/06]; ICV; Division of Intramural Clinical and Basic Research, NIAAA, NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, Z01AA000416] Funding Source: NIH RePORTER	Bial Foundation(Bial Foundation); ICV; Division of Intramural Clinical and Basic Research, NIAAA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Bial Foundation (134/06), the ICV, and the Division of Intramural Clinical and Basic Research, NIAAA, NIH.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Schilman EA, 2008, NEUROSCI LETT, V432, P40, DOI 10.1016/j.neulet.2007.12.024; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Vyas A, 2002, J NEUROSCI, V22, P6810; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	30	572	587	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					621	625		10.1126/science.1171203	http://dx.doi.org/10.1126/science.1171203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644122				2022-12-24	WOS:000268493000053
J	Harris, J				Harris, Jim			Soil Microbial Communities and Restoration Ecology: Facilitators or Followers?	SCIENCE			English	Editorial Material							ABANDONED AGRICULTURAL FIELDS; LAND ABANDONMENT; ECOSYSTEMS; DIVERSITY; PRODUCTIVITY; MANAGEMENT; FORESTS	Microorganisms have critical roles in the functioning of soil in nutrient cycling, structural formation, and plant interactions, both positive and negative. These roles are important in reestablishing function and biodiversity in ecosystem restoration. Measurement of the community indicates the status of the system in relation to restoration targets and the effectiveness of management interventions, and manipulation of the community shows promise in the enhancement of the rate of recovery of degraded systems.	Cranfield Univ, Dept Nat Resources, Cranfield MK43 0AL, Beds, England	Cranfield University	Harris, J (corresponding author), Cranfield Univ, Dept Nat Resources, Cranfield MK43 0AL, Beds, England.		Harris, Jim A/B-2816-2011	Harris, Jim A/0000-0001-9266-4979				Bending GD, 2007, NEW PHYTOL, V174, P707, DOI 10.1111/j.1469-8137.2007.02076.x; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Gros R, 2006, ENVIRON MICROBIOL, V8, P1889, DOI 10.1111/j.1462-2920.2006.01106.x; Harris JA, 2003, EUR J SOIL SCI, V54, P801, DOI 10.1046/j.1351-0754.2003.0559.x; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Heneghan L, 2008, RESTOR ECOL, V16, P608, DOI 10.1111/j.1526-100X.2008.00477.x; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Hodkinson ID, 2002, J ECOL, V90, P569, DOI 10.1046/j.1365-2745.2002.00696.x; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jasper DA, 2007, RESTOR ECOL, V15, pS74, DOI 10.1111/j.1526-100X.2007.00295.x; Kardol P, 2009, RESTOR ECOL, V17, P258, DOI 10.1111/j.1526-100X.2007.00351.x; Kulmatiski A, 2006, RESTOR ECOL, V14, P251, DOI 10.1111/j.1526-100X.2006.00127.x; Mummey DL, 2009, SOIL BIOL BIOCHEM, V41, P1173, DOI 10.1016/j.soilbio.2009.02.027; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Richter BS, 2002, RESTOR ECOL, V10, P607, DOI 10.1046/j.1526-100X.2002.01041.x; Teste FP, 2008, OECOLOGIA, V158, P193, DOI 10.1007/s00442-008-1136-5; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	21	360	398	34	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					573	574		10.1126/science.1172975	http://dx.doi.org/10.1126/science.1172975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644111				2022-12-24	WOS:000268493000039
J	Geurts, AM; Cost, GJ; Freyvert, Y; Zeitler, B; Miller, JC; Choi, VM; Jenkins, SS; Wood, A; Cui, XX; Meng, XD; Vincent, A; Lam, S; Michalkiewicz, M; Schilling, R; Foeckler, J; Kalloway, S; Weiler, H; Menoret, S; Anegon, I; Davis, GD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Jacob, HJ; Buelow, R				Geurts, Aron M.; Cost, Gregory J.; Freyvert, Yevgeniy; Zeitler, Bryan; Miller, Jeffrey C.; Choi, Vivian M.; Jenkins, Shirin S.; Wood, Adam; Cui, Xiaoxia; Meng, Xiangdong; Vincent, Anna; Lam, Stephen; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Foeckler, Jamie; Kalloway, Shawn; Weiler, Hartmut; Menoret, Severine; Anegon, Ignacio; Davis, Gregory D.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Jacob, Howard J.; Buelow, Roland			Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases	SCIENCE			English	Article							PROSPECTS; PROGRESS		[Geurts, Aron M.; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Weiler, Hartmut; Jacob, Howard J.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Geurts, Aron M.; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Weiler, Hartmut; Jacob, Howard J.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Cost, Gregory J.; Freyvert, Yevgeniy; Zeitler, Bryan; Miller, Jeffrey C.; Choi, Vivian M.; Jenkins, Shirin S.; Meng, Xiangdong; Vincent, Anna; Lam, Stephen; Foeckler, Jamie; Kalloway, Shawn; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [Wood, Adam; Cui, Xiaoxia; Davis, Gregory D.] Sigma Aldrich Biotechnol, St Louis, MO 63103 USA; [Menoret, Severine; Anegon, Ignacio] Univ Nantes, CHU Nantes, INSERM, UMR 643, F-44322 Nantes, France; [Jacob, Howard J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Buelow, Roland] Open Monoclonal Technol Inc, Palo Alto, CA 94303 USA	Medical College of Wisconsin; Medical College of Wisconsin; Sangamo Therapeutics, Inc.; Merck KGaA; MilliporeSigma; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Medical College of Wisconsin	Jacob, HJ (corresponding author), Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA.	jacob@mcw.edu; rbuelow@omtinc.net	Anegon, Ignacio/I-7498-2018; Anegon, Ignacio/I-7760-2018	Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653	NIH [5U01HL066579-08, 5P01HL082798-03]; Medical College of Wisconsin; Sigma-Aldrich; American Physiological Society Fellowship in Physiological Genomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066579, P01HL082798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin(General Electric); Sigma-Aldrich; American Physiological Society Fellowship in Physiological Genomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants 5U01HL066579-08 and 5P01HL082798-03, a sponsored research agreement between the Medical College of Wisconsin and Sigma-Aldrich, and the American Physiological Society Fellowship in Physiological Genomics to A.M.G. The authors are filing patents based on the results reported in this paper.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Klug A, 2005, P JPN ACAD B-PHYS, V81, P87, DOI 10.2183/pjab.81.87; Michalkiewicz M, 2007, AM J PHYSIOL-HEART C, V293, pH881, DOI 10.1152/ajpheart.00060.2007; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313	6	695	850	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					433	433		10.1126/science.1172447	http://dx.doi.org/10.1126/science.1172447			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628861	Green Accepted			2022-12-24	WOS:000268255100045
J	Wu, Q; Boyle, MP; Palmiter, RD				Wu, Qi; Boyle, Maureen P.; Palmiter, Richard D.			Loss of GABAergic Signaling by AgRP Neurons to the Parabrachial Nucleus Leads to Starvation	CELL			English	Article							GABA(A) RECEPTOR SUBTYPES; NEUROPEPTIDE-Y; ENERGY-BALANCE; FOOD-INTAKE; BODY-WEIGHT; EXPRESSING NEURONS; NPY/AGRP NEURONS; ARCUATE NUCLEUS; TASTE-AVERSION; AGOUTI	Neurons in the arcuate nucleus that produce AgRP, NPY, and GABA (AgRP neurons) promote feeding. Ablation of AgRP neurons in adult mice results in Fos activation in postsynaptic neurons and starvation. Loss of GABA is implicated in starvation because chronic subcutaneous delivery of bretazenil (a GABA(A) receptor partial agonist) suppresses Fos activation and maintains feeding during ablation of AgRP neurons. Moreover, under these conditions, direct delivery of bretazenil into the parabrachial nucleus (PBN), a direct target of AgRP neurons that also relays gustatory and visceral sensory information, is sufficient to maintain feeding. Conversely, inactivation of GABA biosynthesis in the ARC or blockade of GABAA receptors in the PBN of mice promote anorexia. We suggest that activation of the PBN by AgRP neuron ablation or gastrointestinal malaise inhibits feeding. Chronic delivery of bretazenil during loss of AgRP neurons provides time to establish compensatory mechanisms that eventually allow mice to eat.	[Wu, Qi; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Wu, Qi; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Boyle, Maureen P.] Allen Inst Brain Sci, Seattle, WA 98103 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Allen Institute for Brain Science	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@u.washington.edu			National Institutes of Health [DA024908]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grant DA024908 to R.D.P.	Andre V, 2007, EPILEPSIA, V48, P41, DOI 10.1111/j.1528-1167.2007.01288.x; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Broberger C, 2001, PHYSIOL BEHAV, V74, P669, DOI 10.1016/S0031-9384(01)00611-4; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Chaijale NN, 2008, BRAIN RES, V1240, P111, DOI 10.1016/j.brainres.2008.08.066; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Duke AN, 2006, PSYCHOPHARMACOLOGY, V187, P321, DOI 10.1007/s00213-006-0431-2; Ebenezer IS, 2007, EUR J PHARMACOL, V569, P90, DOI 10.1016/j.ejphar.2007.05.022; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Flier JS, 2006, CELL METAB, V3, P83, DOI 10.1016/j.cmet.2006.01.003; Gerra G, 2002, ADDICT BIOL, V7, P385, DOI 10.1080/1355621021000005973; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Higgs S, 1996, EUR J PHARMACOL, V313, P1, DOI 10.1016/0014-2999(96)00446-3; Horvath TL, 2006, OBESITY, V14, P228; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Lamprecht R, 1995, NEUROREPORT, V7, P289, DOI 10.1097/00001756-199512290-00069; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Paxinos G., 2001, MOUSE BRAIN STEROTAX; PECKNOLD JC, 1993, J PSYCHIAT RES, V27, P155, DOI 10.1016/0022-3956(93)90025-W; Phillips CT, 2008, ENDOCRINOLOGY, V149, P544, DOI 10.1210/en.2007-1153; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Reilly S, 2000, BRAIN RES BULL, V52, P269, DOI 10.1016/S0361-9230(00)00263-X; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Scopinho AA, 2008, BRIT J PHARMACOL, V155, P752, DOI 10.1038/bjp.2008.295; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SWANK MW, 1994, BRAIN RES, V636, P202, DOI 10.1016/0006-8993(94)91018-9; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trifunovic R, 2002, BRAIN RES BULL, V58, P107, DOI 10.1016/S0361-9230(02)00766-9; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Wilson JD, 2003, AM J PHYSIOL-REG I, V285, pR1055, DOI 10.1152/ajpregu.00108.2003; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105	50	316	320	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1225	1234		10.1016/j.cell.2009.04.022	http://dx.doi.org/10.1016/j.cell.2009.04.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563755	Bronze, Green Accepted			2022-12-24	WOS:000267373400016
J	Scott, KL; Kabbarah, O; Liang, MC; Ivanova, E; Anagnostou, V; Wu, J; Dhakal, S; Wu, M; Chen, SJ; Feinberg, T; Huang, J; Saci, A; Widlund, HR; Fisher, DE; Xiao, YH; Rimm, DL; Protopopov, A; Wong, KK; Chin, L				Scott, Kenneth L.; Kabbarah, Omar; Liang, Mei-Chih; Ivanova, Elena; Anagnostou, Valsamo; Wu, Joyce; Dhakal, Sabin; Wu, Min; Chen, Shujuan; Feinberg, Tamar; Huang, Joseph; Saci, Abdel; Widlund, Hans R.; Fisher, David E.; Xiao, Yonghong; Rimm, David L.; Protopopov, Alexei; Wong, Kwok-Kin; Chin, Lynda			GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer	NATURE			English	Article							P70 S6 KINASE; CELL-SIZE; GOLGI; TARGET; GROWTH; TOR; GLYCOSYLTRANSFERASES; PHOSPHORYLATION; LOCALIZATION; PROGRESSION	Genome-wide copy number analyses of human cancers identified a frequent 5p13 amplification in several solid tumour types, including lung (56%), ovarian (38%), breast (32%), prostate (37%) and melanoma ( 32%). Here, using integrative analysis of a genomic profile of the region, we identify a Golgi protein, GOLPH3, as a candidate targeted for amplification. Gain- and loss-of-function studies in vitro and in vivo validated GOLPH3 as a potent oncogene. Physically, GOLPH3 localizes to the trans- Golgi network and interacts with components of the retromer complex, which in yeast has been linked to target of rapamycin ( TOR) signalling. Mechanistically, GOLPH3 regulates cell size, enhances growth-factor-induced mTOR (also known as FRAP1) signalling in human cancer cells, and alters the response to an mTOR inhibitor in vivo. Thus, genomic and genetic, biological, functional and biochemical data in yeast and humans establishes GOLPH3 as a new oncogene that is commonly targeted for amplification in human cancer, and is capable of modulating the response to rapamycin, a cancer drug in clinical use.	[Scott, Kenneth L.; Kabbarah, Omar; Liang, Mei-Chih; Wu, Joyce; Dhakal, Sabin; Wu, Min; Chen, Shujuan; Feinberg, Tamar; Huang, Joseph; Wong, Kwok-Kin; Chin, Lynda] Harvard Univ, Ctr Canc, Dept Med Oncol, Boston, MA 02115 USA; [Ivanova, Elena; Xiao, Yonghong; Protopopov, Alexei; Chin, Lynda] Harvard Univ, Ctr Canc, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Widlund, Hans R.; Fisher, David E.] Harvard Univ, Ctr Canc, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wong, Kwok-Kin] Harvard Univ, Ctr Canc, Ludwig Ctr Dana Farber, Boston, MA 02115 USA; [Anagnostou, Valsamo; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Saci, Abdel] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Widlund, Hans R.; Chin, Lynda] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Chin, L (corresponding author), Harvard Univ, Ctr Canc, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu		Widlund, Hans/0000-0002-7506-2447; wong, kwok kin/0000-0001-6323-235X; Rimm, David/0000-0001-5820-4397; Ivanova, Elena/0000-0002-5069-4974; Liang, Mei-Chih/0000-0002-7389-2455	American Cancer Society [PF-07-039-01-CSM]; National Institutes of Health (NIH) [5-T32-AR07098-31, R01 AG2400401, R01 CA122794, RO-1 CA 114277, RO1 CA93947, P50 CA93683]; Program of Research Excellence (SPORE) grant [P50 CA090578]; NATIONAL CANCER INSTITUTE [R01CA093947, P50CA093683, R01CA114277, P50CA090578, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Research Excellence (SPORE) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. DePinho for critical reading of the manuscript, and L. Cantley, as well as members of the Chin laboratory, for helpful discussion. We thank H. Ying for assistance with confocal microscopy. The rabbit polyclonal antibody against human GOLPH3 was kindly provided by J. J. Bergeron of McGill University. Mouse monoclonal antibody against human GOLPH3, C19, was generated at the Dana-Farber/Harvard Cancer Center Monoclonal Antibody Core Facility. K. L. S. is at present supported by a Postdoctoral Fellowship from the American Cancer Society (PF-07-039-01-CSM), and K. L. S. and O. K. were previously supported by a National Institutes of Health (NIH) Training Grant appointment in the Department of Dermatology at Brigham and Women's Hospital (5-T32-AR07098-31). K.-K. W. was supported by a Program of Research Excellence (SPORE) grant (P50 CA090578) and NIH grants (R01 AG2400401; R01 CA122794). The AQUA immunofluorescence study was supported by a grant from the NIH to D. L. R. (RO-1 CA 114277). This work is primarily supported by grants from the NIH to L. C. (RO1 CA93947; P50 CA93683).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	33	268	299	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1085	U68		10.1038/nature08109	http://dx.doi.org/10.1038/nature08109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553991	Green Accepted			2022-12-24	WOS:000267636700034
J	Smith, GJD; Vijaykrishna, D; Bahl, J; Lycett, SJ; Worobey, M; Pybus, OG; Ma, SK; Cheung, CL; Raghwani, J; Bhatt, S; Peiris, JSM; Guan, Y; Rambaut, A				Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Lycett, Samantha J.; Worobey, Michael; Pybus, Oliver G.; Ma, Siu Kit; Cheung, Chung Lam; Raghwani, Jayna; Bhatt, Samir; Peiris, J. S. Malik; Guan, Yi; Rambaut, Andrew			Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; VIRUS; TRANSMISSION; INFECTION; PIGS	In March and early April 2009, a new swine-origin influenza A (H1N1) virus (S-OIV) emerged in Mexico and the United States(1). During the first few weeks of surveillance, the virus spread worldwide to 30 countries (as of May 11) by human-to-human transmission, causing the World Health Organization to raise its pandemic alert to level 5 of 6. This virus has the potential to develop into the first influenza pandemic of the twenty-first century. Here we use evolutionary analysis to estimate the time-scale of the origins and the early development of the S-OIV epidemic. We show that it was derived from several viruses circulating in swine, and that the initial transmission to humans occurred several months before recognition of the outbreak. A phylogenetic estimate of the gaps in genetic surveillance indicates a long period of unsampled ancestry before the S-OIV outbreak, suggesting that the reassortment of swine lineages may have occurred years before emergence in humans, and that the multiple genetic ancestry of S-OIV is not indicative of an artificial origin. Furthermore, the unsampled history of the epidemic means that the nature and location of the genetically closest swine viruses reveal little about the immediate origin of the epidemic, despite the fact that we included a panel of closely related and previously unpublished swine influenza isolates. Our results highlight the need for systematic surveillance of influenza in swine, and provide evidence that the mixing of new genetic elements in swine can result in the emergence of viruses with pandemic potential in humans(2).	[Lycett, Samantha J.; Raghwani, Jayna; Rambaut, Andrew] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Ma, Siu Kit; Cheung, Chung Lam; Peiris, J. S. Malik; Guan, Yi] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Ma, Siu Kit; Cheung, Chung Lam; Peiris, J. S. Malik; Guan, Yi] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85705 USA; [Pybus, Oliver G.; Bhatt, Samir] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Edinburgh; University of Hong Kong; University of Hong Kong; University of Arizona; University of Oxford	Rambaut, A (corresponding author), Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3JT, Midlothian, Scotland.	yguan@hku.hk; a.rambaut@ed.ac.uk	Bhatt, Samir/ABE-7938-2020; Cheung, Yiu Man/T-2708-2019; Bahl, Justin/A-4728-2011; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Rambaut, Andrew/B-2481-2009; Lycett, Samantha/F-9598-2013; Dhanasekaran, Vijaykrishna/D-1011-2010; Pybus, Oliver G/B-2640-2012	Bahl, Justin/0000-0001-7572-4300; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Rambaut, Andrew/0000-0003-4337-3707; Lycett, Samantha/0000-0003-3159-596X; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Pybus, Oliver G/0000-0002-8797-2667; Guan, Yi/0000-0001-6057-9243; Raghwani, Jayna/0000-0001-8538-4995; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Bhatt, Samir/0000-0002-0891-4611; Smith, Gavin JD/0000-0001-5031-468X	The Royal Society of London; National Institute of Allergy and Infectious Diseases ( NIAID); Biotechnology and Biological Sciences Research Council ( BBSRC); David and Lucile Packard Foundation; Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR); National Institutes of Health [HHSN266200700005C]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR Government [AoE/M-12/06]; BBSRC [BB/E009670/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009670/1] Funding Source: researchfish	The Royal Society of London(Royal Society of London); National Institute of Allergy and Infectious Diseases ( NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council ( BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. C. Holmes for comments and encouragement. We acknowledge support from The Royal Society of London ( A. R. and O. G. P.), the National Institute of Allergy and Infectious Diseases ( NIAID) ( G. J. D. S. and M. W.), the Biotechnology and Biological Sciences Research Council ( BBSRC) ( S. J. L.), and the David and Lucile Packard Foundation ( M. W.). A. R. works as a part of the Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR). This study was supported by the National Institutes of Health ( NIAID contract HHSN266200700005C) and the Area of Excellence Scheme of the University Grants Committee ( grant AoE/M-12/06) of the Hong Kong SAR Government.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; *CDCP, 2009, NOV INFL A VIR INF 2; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; GARTEN RJ, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Jung K, 2007, VET REC, V161, P104, DOI 10.1136/vr.161.3.104; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; SHOPE RICHARD E., 1931, JOUR EXP MED, V54, P349, DOI 10.1084/jem.54.3.349; SHORTRIDGE KF, 1977, SCIENCE, V196, P1454, DOI 10.1126/science.867041; Smith G. J. D., P NATL ACAD IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifonov V, 2009, EUROSURVEILLANCE, V14, P6; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000	29	1513	1624	9	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1122	U107		10.1038/nature08182	http://dx.doi.org/10.1038/nature08182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19516283	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000267636700042
J	Matthews, HD; Gillett, NP; Stott, PA; Zickfeld, K				Matthews, H. Damon; Gillett, Nathan P.; Stott, Peter A.; Zickfeld, Kirsten			The proportionality of global warming to cumulative carbon emissions	NATURE			English	Article							DYNAMICS; MODEL	The global temperature response to increasing atmospheric CO2 is often quantified by metrics such as equilibrium climate sensitivity and transient climate response(1). These approaches, however, do not account for carbon cycle feedbacks and therefore do not fully represent the net response of the Earth system to anthropogenic CO2 emissions. Climate-carbon modelling experiments have shown that: (1) the warming per unit CO2 emitted does not depend on the background CO2 concentration(2); (2) the total allowable emissions for climate stabilization do not depend on the timing of those emissions(3-5); and (3) the temperature response to a pulse of CO2 is approximately constant on timescales of decades to centuries(3,6-8). Here we generalize these results and show that the carbon-climate response (CCR), defined as the ratio of temperature change to cumulative carbon emissions, is approximately independent of both the atmospheric CO2 concentration and its rate of change on these timescales. From observational constraints, we estimate CCR to be in the range 1.0-2.1 degrees C per trillion tonnes of carbon (Tt C) emitted (5th to 95th percentiles), consistent with twenty-first-century CCR values simulated by climate-carbon models. Uncertainty in land-use CO2 emissions and aerosol forcing, however, means that higher observationally constrained values cannot be excluded. The CCR, when evaluated from climate-carbon models under idealized conditions, represents a simple yet robust metric for comparing models, which aggregates both climate feedbacks and carbon cycle feedbacks. CCR is also likely to be a useful concept for climate change mitigation and policy; by combining the uncertainties associated with climate sensitivity, carbon sinks and climate-carbon feedbacks into a single quantity, the CCR allows CO2-induced global mean temperature change to be inferred directly from cumulative carbon emissions.	[Matthews, H. Damon] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada; [Gillett, Nathan P.; Zickfeld, Kirsten] Environm Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8P 5C2, Canada; [Stott, Peter A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Concordia University - Canada; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Met Office - UK; Hadley Centre	Matthews, HD (corresponding author), Concordia Univ, Dept Geog Planning & Environm, 1455 Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	dmatthew@alcor.concordia.ca	Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016; Matthews, Damon/A-8965-2008; /AAD-2430-2020	Stott, Peter/0000-0003-4853-7686; /0000-0003-3625-390X	National Science and Engineering Research Council of Canada; Canadian Foundation for Climate and Atmospheric Sciences Project; DECC; Defra and MoD Integrated Climate Programme; Leverhulme Trust; Climate Change Detection and Attribution Project; NOAA's Office of Global Programs; US Department of Energy	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Climate and Atmospheric Sciences Project; DECC; Defra and MoD Integrated Climate Programme; Leverhulme Trust(Leverhulme Trust); Climate Change Detection and Attribution Project; NOAA's Office of Global Programs(National Oceanic Atmospheric Admin (NOAA) - USA); US Department of Energy(United States Department of Energy (DOE))	We thank A. Weaver, M. Eby, V. Arora, N. Ramankutty, M. Allen, S. Solomon, K. Keller, K. Caldeira and S. Turner for commentary and discussions on this work. We also thank P. Forster for providing radiative forcing time series, and P. Friedlingstein and the C4MIP modelling community for the availability of their model output. H. D. M. acknowledges support from the National Science and Engineering Research Council of Canada, and the Canadian Foundation for Climate and Atmospheric Sciences Project Grants. P. A. S. was supported by the Joint DECC, Defra and MoD Integrated Climate Programme. N. P. G. received support from the Leverhulme Trust. N. P. G. and P. A. S. acknowledge support from the Climate Change Detection and Attribution Project, jointly funded by NOAA's Office of Global Programs and the US Department of Energy.	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; CALDEIRA K, 1993, NATURE, V366, P251, DOI 10.1038/366251a0; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Eby M, 2009, J CLIMATE, V22, P2501, DOI 10.1175/2008JCLI2554.1; European Commission, 2007, LIM GLOB CLIM CHANG; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gregory JM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010405; Houghton R. A, 2008, TRENDS COMPENDIUM DA; Huntingford C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024831; Marland G., 2008, TRENDS COMPENDIUM DA; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2006, TELLUS B, V58, P591, DOI 10.1111/j.1600-0889.2006.00200.x; Matthews HD, 2005, J CLIMATE, V18, P1609, DOI 10.1175/JCLI3359.1; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meissner KJ, 2003, CLIM DYNAM, V21, P515, DOI 10.1007/s00382-003-0352-2; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Shine KP, 2005, CLIMATIC CHANGE, V68, P281, DOI 10.1007/s10584-005-1146-9; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; ZICKFELD K, P NATL ACAD SC UNPUB	24	540	560	18	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					829	U3		10.1038/nature08047	http://dx.doi.org/10.1038/nature08047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516338				2022-12-24	WOS:000267084500036
J	Munster, VJ; de Wit, E; van den Brand, JMA; Herfst, S; Schrauwen, EJA; Bestebroer, TM; van de Vijver, D; Boucher, CA; Koopmans, M; Rimmelzwaan, GF; Kuiken, T; Osterhaus, ADME; Fouchier, RAM				Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets	SCIENCE			English	Article							H5N1 VIRUSES; A VIRUS; HUMANS; VIRULENCE; MAMMALS	The swine-origin A(H1N1) influenza virus that has emerged in humans in early 2009 has raised concerns about pandemic developments. In a ferret pathogenesis and transmission model, the 2009 A(H1N1) influenza virus was found to be more pathogenic than a seasonal A(H1N1) virus, with more extensive virus replication occurring in the respiratory tract. Replication of seasonal A(H1N1) virus was confined to the nasal cavity of ferrets, but the 2009 A(H1N1) influenza virus also replicated in the trachea, bronchi, and bronchioles. Virus shedding was more abundant from the upper respiratory tract for 2009 A(H1N1) influenza virus as compared with seasonal virus, and transmission via aerosol or respiratory droplets was equally efficient. These data suggest that the 2009 A(H1N1) influenza virus has the ability to persist in the human population, potentially with more severe clinical consequences.	[Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; [Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; [Koopmans, Marion] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment	Fouchier, RAM (corresponding author), Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Munster, Vincent/I-7607-2018; Fouchier, Ron A/A-1911-2014; de Wit, Emmie/A-1549-2019	Munster, Vincent/0000-0002-2288-3196; Fouchier, Ron A/0000-0001-8095-2869; de Wit, Emmie/0000-0002-9763-7758; van de Vijver, David/0000-0001-5877-8526; Kuiken, Thijs/0000-0001-5501-9049; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172	National Institute of Allergy and Infectious Diseases-NIH [HHSN266200700010C]	National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.M., E.d.W, and R.F. were financed through National Institute of Allergy and Infectious Diseases-NIH contract HHSN266200700010C.	Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Lackenby A, 2008, EUROSURVEILLANCE, V13, P113; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mizuta K, 2004, EPIDEMIOL INFECT, V132, P721, DOI 10.1017/S0950268804002237; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; NOVEL AVI, 2009, NEW ENGL J MED, V360, P2605; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; *WHO, 2009, WKLY EPIDEMIOL REC, V21, P185; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	18	486	519	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					481	483		10.1126/science.1177127	http://dx.doi.org/10.1126/science.1177127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574348	Green Accepted			2022-12-24	WOS:000268255100058
J	Zelcer, N; Hong, C; Boyadjian, R; Tontonoz, P				Zelcer, Noam; Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter			LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor	SCIENCE			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; LEUCINE ZIPPER PROTEIN; LIVER-X RECEPTORS; POSTTRANSCRIPTIONAL REGULATION; FAMILIAL HYPERCHOLESTEROLEMIA; MICE; MUTATIONS; PCSK9; ERM; ATHEROSCLEROSIS	Cellular cholesterol levels reflect a balance between uptake, efflux, and endogenous synthesis. Here we show that the sterol-responsive nuclear liver X receptor (LXR) helps maintain cholesterol homeostasis, not only through promotion of cholesterol efflux but also through suppression of low-density lipoprotein (LDL) uptake. LXR inhibits the LDL receptor ( LDLR) pathway through transcriptional induction of Idol ( inducible degrader of the LDLR), an E3 ubiquitin ligase that triggers ubiquitination of the LDLR on its cytoplasmic domain, thereby targeting it for degradation. LXR ligand reduces, whereas LXR knockout increases, LDLR protein levels in vivo in a tissue-selective manner. Idol knockdown in hepatocytes increases LDLR protein levels and promotes LDL uptake. Conversely, adenovirus-mediated expression of Idol in mouse liver promotes LDLR degradation and elevates plasma LDL levels. The LXR-Idol-LDLR axis defines a complementary pathway to sterol response element-binding proteins for sterol regulation of cholesterol uptake.	[Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Zelcer, Noam/C-6393-2009	Zelcer, Noam/0000-0001-6935-7532	Human Frontier Science Program Organization; Howard Hughes Medical Institute; NIH [HL066088, HL090553, HL030568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL090553, P01HL030568] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	N.Z. was supported by a long-term postdoctoral fellowship from the Human Frontier Science Program Organization. P.T. is an investigator of the Howard Hughes Medical Institute. This work was also supported by NIH grants HL066088, HL090553, and HL030568. UCLA and two of the authors (N.Z. and P.T.) have filed a patent related to this work.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2003, CURR OPIN LIPIDOL, V14, P121, DOI 10.1097/00041433-200304000-00002; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SHARKEY MF, 1990, J LIPID RES, V31, P2167; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	31	537	588	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					100	104		10.1126/science.1168974	http://dx.doi.org/10.1126/science.1168974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19520913	Green Accepted			2022-12-24	WOS:000267594000045
J	Kwon, HJ; Abi-Mosleh, L; Wang, ML; Deisenhofer, J; Goldstein, JL; Brown, MS; Infante, RE				Kwon, Hyock Joo; Abi-Mosleh, Lina; Wang, Michael L.; Deisenhofer, Johann; Goldstein, Joseph L.; Brown, Michael S.; Infante, Rodney E.			Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; PICK C1 PROTEIN; LYSOSOMAL MEMBRANE; STEROL BINDING; METABOLISM; PROTEOLYSIS; DEFICIENT; MECHANISM; TRANSPORT; PATHWAY	LDL delivers cholesterol to lysosomes by receptor-mediated endocytosis. Exit of cholesterol from lysosomes requires two proteins, membrane-bound Niemann-Pick C1 (NPC1) and soluble NPC2. NPC2 binds cholesterol with its isooctyl side chain buried and its 3 beta-hydroxyl exposed. Here, we describe high-resolution structures of the N-terminal domain (NTD) of NPC1 and complexes with cholesterol and 25-hydroxycholesterol. NPC1(NTD) binds cholesterol in an orientation opposite to NPC2: 3 beta-hydroxyl buried and isooctyl side chain exposed. Cholesterol transfer from NPC2 to NPC1(NTD) requires reorientation of a helical subdomain in NPC1(NTD), enlarging the opening for cholesterol entry. NPC1 with point mutations in this subdomain (distinct from the binding subdomain) cannot accept cholesterol from NPC2 and cannot restore cholesterol exit from lysosomes in NPC1-deficient cells. We propose a working model wherein after lysosomal hydrolysis of LDL-cholesteryl esters, cholesterol binds NPC2, which transfers it to NPC1(NTD), reversing its orientation and allowing insertion of its isooctyl side chain into the outer lysosomal membranes.	[Abi-Mosleh, Lina; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.; Infante, Rodney E.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kwon, Hyock Joo; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Infante, Rodney/ABG-7756-2020	Infante, Rodney/0000-0003-2605-822X	National Institutes of Health [HL20948]; Welch Foundation [IL1185]; Perot Family Foundation; Medical Scientist Training Program [5T32 (GM08014)]; Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Perot Family Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dorothy Goddard, Lisa Henry, Bethany Cartwright, and Maya Palnitkar for excellent technical assistance; Lisa Beatty and Shomanike Head for invaluable help with tissue culture; Dr. Chad Brautigam for help with analytical ultracentrifugation; and Dr. Laura Liscum for the gift of CHO 4-4-19 cells. This work was supported by grants from the National Institutes of Health (HL20948), Welch Foundation (IL1185), and Perot Family Foundation. R. E. I. and M. L. W. are supported by Medical Scientist Training Program Grant 5T32 (GM08014). R. E. I. is also supported by the Ara Parseghian Medical Research Foundation. J. D. is an Investigator of the Howard Hughes Medical Institute. Crystallographic structures were derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source (operated by UChicago Argonne, LLC, for the U. S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357).	ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Babalola JO, 2007, BIOL CHEM, V388, P617, DOI 10.1515/BC.2007.063; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Roth MG, 2006, NAT REV MOL CELL BIO, V7, P63, DOI 10.1038/nrm1783; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Subramanian K, 2008, P NATL ACAD SCI USA, V105, P15223, DOI 10.1073/pnas.0808256105; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	43	458	465	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1213	1224		10.1016/j.cell.2009.03.049	http://dx.doi.org/10.1016/j.cell.2009.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563754	Bronze, Green Accepted			2022-12-24	WOS:000267373400015
J	Maricich, SM; Wellnitz, SA; Nelson, AM; Lesniak, DR; Gerling, GJ; Lumpkin, EA; Zoghbi, HY				Maricich, Stephen M.; Wellnitz, Scott A.; Nelson, Aislyn M.; Lesniak, Daine R.; Gerling, Gregory J.; Lumpkin, Ellen A.; Zoghbi, Huda Y.			Merkel Cells Are Essential for Light-Touch Responses	SCIENCE			English	Article							CUTANEOUS MECHANORECEPTORS; SKIN; MATH1; MICE; MECHANISMS; RECEPTORS; PATTERNS; REVEALS; P75	The peripheral nervous system detects different somatosensory stimuli, including pain, temperature, and touch. Merkel cell-neurite complexes are touch receptors composed of sensory afferents and Merkel cells. The role that Merkel cells play in light-touch responses has been the center of controversy for over 100 years. We used Cre-loxP technology to conditionally delete the transcription factor Atoh1 from the body skin and foot pads of mice. Merkel cells are absent from these areas in Atoh1(CKO) animals. Ex vivo skin/nerve preparations from Atoh1(CKO) animals demonstrate complete loss of the characteristic neurophysiologic responses normally mediated by Merkel cell-neurite complexes. Merkel cells are, therefore, required for the proper encoding of Merkel receptor responses, suggesting that these cells form an indispensible part of the somatosensory system.	[Wellnitz, Scott A.; Nelson, Aislyn M.; Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Maricich, Stephen M.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lesniak, Daine R.; Gerling, Gregory J.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22904 USA; [Lumpkin, Ellen A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Lumpkin, EA (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	lumpkin@bcm.edu; hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Lumpkin, Ellen/0000-0002-1166-3374	NIH [5K08NS53419, HD024064, AR051219]; McNair Scholars Program; National Library of Medicine [T15LM009462]; Defense Advanced Research Projects Agency [HR0011-08-1-0072]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS053419] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair Scholars Program; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Capecchi for generously providing us with Hoxb1Cre animals; N. Ao, K. Firozi, E. Mathes, K. Morrison, and S. Vaishav for technical assistance; and G. Landreth, L. Landmesser, and R. Miller for critical reading of the manuscript. Funding sources are as follows: NIH grant 5K08NS53419 (to S.M.M.), McNair Scholars Program (to A.M.N.), National Library of Medicine grant T15LM009462 (to D.R.L.), Defense Advanced Research Projects Agency grant HR0011-08-1-0072 (to G.J.G.), NIH grant HD024064, and NIH grant AR051219 (to E.A.L.). H.Y.Z. is an investigator with HHMI.	Arenkiel BR, 2003, DEV DYNAM, V227, P379, DOI 10.1002/dvdy.10323; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cronk KM, 2002, DEVELOPMENT, V129, P3739; Diamond J, 1988, Prog Brain Res, V74, P51; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Johnson KO, 2000, J CLIN NEUROPHYSIOL, V17, P539, DOI 10.1097/00004691-200011000-00002; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Merkel F., 1875, ARCH MIKROSK ANAT, V11, P636, DOI [DOI 10.1007/BF02933819, 10.1007/BF02933819]; Meyers JR, 2003, J NEUROSCI, V23, P4054; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; Nunzi MG, 2004, J NEUROCYTOL, V33, P359, DOI 10.1023/B:NEUR.0000044196.45602.92; Pacitti E G, 1988, Prog Brain Res, V74, P37; Senok SS, 1996, EXP BRAIN RES, V110, P325; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; VIELKIND U, 1995, ACTA ANAT, V152, P93; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517	28	191	197	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1580	1582		10.1126/science.1172890	http://dx.doi.org/10.1126/science.1172890			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541997	Green Accepted			2022-12-24	WOS:000267130600049
J	Niethammer, P; Grabher, C; Look, AT; Mitchison, TJ				Niethammer, Philipp; Grabher, Clemens; Look, A. Thomas; Mitchison, Timothy J.			A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish	NATURE			English	Article							TUMOR-SUPPRESSOR PTEN; ENDOTHELIAL-CELLS; NOX INHIBITOR; DUAL OXIDASES; INFLAMMATION; CHEMOTAXIS; MIGRATION; GROWTH; NEUTROPHILS; EXPRESSION	Barrier structures (for example, epithelia around tissues and plasma membranes around cells) are required for internal homeostasis and protection from pathogens. Wound detection and healing represent a dormant morphogenetic program that can be rapidly executed to restore barrier integrity and tissue homeostasis. In animals, initial steps include recruitment of leukocytes to the site of injury across distances of hundreds of micrometres within minutes of wounding. The spatial signals that direct this immediate tissue response are unknown. Owing to their fast diffusion and versatile biological activities, reactive oxygen species, including hydrogen peroxide (H2O2), are interesting candidates for wound-to-leukocyte signalling. Here we probe the role of H2O2 during the early events of wound responses in zebrafish larvae expressing a genetically encoded H2O2 sensor(1). This reporter revealed a sustained rise in H2O2 concentration at the wound margin, starting similar to 3 min after wounding and peaking at similar to 20 min, which extended similar to 100-200 mu m into the tail-fin epithelium as a decreasing concentration gradient. Using pharmacological and genetic inhibition, we show that this gradient is created by dual oxidase (Duox), and that it is required for rapid recruitment of leukocytes to the wound. This is the first observation, to our knowledge, of a tissue-scale H2O2 pattern, and the first evidence that H2O2 signals to leukocytes in tissues, in addition to its known antiseptic role.	[Niethammer, Philipp; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Grabher, Clemens; Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat,Childrens Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Niethammer, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Philipp_Niethammer@hms.harvard.edu	Grabher, Clemens/H-2064-2013		National Institutes of Health [GM023928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P. N. was supported by a Human Frontiers Science Program long-term fellowship. This work was supported by the National Institutes of Health grant GM023928. We would like to thank A. Huttenlocher and P. Crosier for providing us with the mpo::GFP and lysC::DsRED2 transgenic zebrafish lines, respectively.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lange S, 2009, CARDIOVASC RES, V81, P159, DOI 10.1093/cvr/cvn258; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nusslein-Volhard C, 2002, ZEBRAFISH; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2007, EXP LUNG RES, V33, P549, DOI 10.1080/01902140701756778; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; TEGTMEIER F, 2005, Patent No. 2005111041; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	33	1074	1110	15	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					996	U123		10.1038/nature08119	http://dx.doi.org/10.1038/nature08119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19494811	Green Accepted			2022-12-24	WOS:000267063500045
J	Shonkoff, JP; Boyce, WT; McEwen, BS				Shonkoff, Jack P.; Boyce, W. Thomas; McEwen, Bruce S.			Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities Building a New Framework for Health Promotion and Disease Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; EVOLUTIONARY-DEVELOPMENTAL THEORY; ADULT MENTAL-HEALTH; EARLY-LIFE STRESS; SOCIOECONOMIC-STATUS; BIRTH-WEIGHT; CARDIOVASCULAR-DISEASE; MALTREATED CHILDREN; SOCIAL DETERMINANTS; PRENATAL EXPOSURE	A scientific consensus is emerging that the origins of adult disease are often found among developmental and biological disruptions occurring during the early years of life. These early experiences can affect adult health in 2 ways-either by cumulative damage over time or by the biological embedding of adversities during sensitive developmental periods. In both cases, there can be a lag of many years, even decades, before early adverse experiences are expressed in the form of disease. From both basic research and policy perspectives, confronting the origins of disparities in physical and mental health early in life may produce greater effects than attempting to modify health-related behaviors or improve access to health care in adulthood. JAMA. 2009;301(21):2252-2259 www.jama.com	[Shonkoff, Jack P.] Harvard Univ, Ctr Dev Child, Cambridge, MA 02138 USA; [Boyce, W. Thomas] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada; [Boyce, W. Thomas] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada; [McEwen, Bruce S.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA	Harvard University; University of British Columbia; University of British Columbia; Rockefeller University	Shonkoff, JP (corresponding author), Harvard Univ, Ctr Dev Child, 50 Church St,4th Floor, Cambridge, MA 02138 USA.	jack_shonkoff@harvard.edu	McEwen, Bruce/Z-1630-2019		Division of Violence Prevention; National Center for Injury Control and Prevention; US Centers for Disease Control and Prevention (CDC); National Scientific Council; Birth to Five Policy Alliance; Buffett Early Childhood Fund; Pierre and Pamela Omidyar Fund; John D. and Catherine T. MacArthur Foundation	Division of Violence Prevention; National Center for Injury Control and Prevention; US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Scientific Council; Birth to Five Policy Alliance; Buffett Early Childhood Fund; Pierre and Pamela Omidyar Fund; John D. and Catherine T. MacArthur Foundation	Primary funding for this article was received from the Division of Violence Prevention, National Center for Injury Control and Prevention, US Centers for Disease Control and Prevention (CDC), which reviewed previous versions of the manuscript. No substantive changes were made to the manuscript as a result of these comments, nor was approval of the manuscript offered to or given by the funders. Additional funding, without manuscript review, for the work of the authors as members of the National Scientific Council on the Developing Child has been provided by the Birth to Five Policy Alliance, the Buffett Early Childhood Fund, the Pierre and Pamela Omidyar Fund, and the John D. and Catherine T. MacArthur Foundation.	Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Berkman L, 2000, SOCIAL EPIDEMIOLOGY, P391; Berkman L, 2008, NEW ENGL J MED, V358, P2509, DOI 10.1056/NEJMe0802773; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Brena RM, 2006, NAT GENET, V38, P1359, DOI 10.1038/ng1206-1359; CAMPBELL FA, 1994, CHILD DEV, V65, P684, DOI 10.1111/j.1467-8624.1994.tb00777.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601; Colcombe SJ, 2004, J MOL NEUROSCI, V24, P9, DOI 10.1385/JMN:24:1:009; COLLEY JRT, 1973, BRIT MED J, V3, P195, DOI 10.1136/bmj.3.5873.195; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; De Rooij SR, 2006, DIABETES CARE, V29, P1052, DOI 10.2337/dc05-1993; DODGE KA, 1994, CHILD DEV, V65, P649, DOI 10.2307/1131407; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Ellis BJ, 2005, DEV PSYCHOPATHOL, V17, P303, DOI 10.1017/S0954579405050157; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Evans GW, 2005, PSYCHOL SCI, V16, P560, DOI 10.1111/j.0956-7976.2005.01575.x; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Geronimus AT, 1996, SOC SCI MED, V42, P589, DOI 10.1016/0277-9536(95)00159-X; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Gilliam WS, 2006, INFANT YOUNG CHILD, V19, P228, DOI 10.1097/00001163-200607000-00007; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; HART B, 1995, MEANINGFUL DIFFERENC, P268; Hatch EE, 1998, JAMA-J AM MED ASSOC, V280, P630, DOI 10.1001/jama.280.7.630; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177; Isgor C, 2004, HIPPOCAMPUS, V14, P636, DOI 10.1002/hipo.10207; Johnson MH, 2005, DEV PSYCHOBIOL, V46, P287, DOI 10.1002/dev.20057; Kaufman D, 2007, DIABETES, V56, P1382, DOI 10.2337/db06-1409; Keating D. P., 1999, DEV HLTH WEALTH NATI, P406; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kuh D, 2004, LIFE COURSE APPROACH, P473; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lustig RH, 2006, NAT CLIN PRACT ENDOC, V2, P447, DOI 10.1038/ncpendmet0220; Luthar SS, 2006, ANN NY ACAD SCI, V1094, P105, DOI 10.1196/annals.1376.009; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Massin MM, 2001, CARDIOLOGY, V95, P80, DOI 10.1159/000047350; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Horwitz SM, 2007, PEDIATRICS, V119, pE208, DOI 10.1542/peds.2005-1997; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Menard C, 2004, SOC PSYCH PSYCH EPID, V39, P857, DOI 10.1007/s00127-004-0868-8; Middlebrooks JS., 2008, EFFECTS CHILDHOOD ST; National Scientific Council on the Developing Child, 2005, EXCESSIVE STRESS DIS; Nomura Y, 2007, COMPR PSYCHIAT, V48, P470, DOI 10.1016/j.comppsych.2007.04.005; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Opler MGA, 2005, ENVIRON HEALTH PERSP, V113, P1239, DOI 10.1289/ehp.7572; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Schreuder MF, 2006, PEDIATR RES, V59, P126, DOI 10.1203/01.pdr.0000190576.08501.df; SCHULMAN K, 1999, SEEDS SUCCESS STATE; Schweinhart LJ, 2005, LIFETIME EFFECTS HIG, pxvii; Shankaran S, 2006, ARCH PEDIAT ADOL MED, V160, P977, DOI 10.1001/archpedi.160.9.977; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shonkoff JP, 2000, NEURONS NEIGHBORHOOD, P588; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096; Yliharsila H, 2004, J HYPERTENS, V22, P1283, DOI 10.1097/01.hjh.0000125438.28861.a4; YOSHIKAWA H, 1994, PSYCHOL BULL, V115, P28, DOI 10.1037/0033-2909.115.1.28; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	114	1449	1466	4	234	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2252	2259		10.1001/jama.2009.754	http://dx.doi.org/10.1001/jama.2009.754			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	452PQ	19491187				2022-12-24	WOS:000266554100023
J	Gregoriou, GG; Gotts, SJ; Zhou, HH; Desimone, R				Gregoriou, Georgia G.; Gotts, Stephen J.; Zhou, Huihui; Desimone, Robert			High-Frequency, Long-Range Coupling Between Prefrontal and Visual Cortex During Attention	SCIENCE			English	Article							MACAQUE AREA V4; NEURONAL SYNCHRONIZATION; NEURAL MECHANISMS; TOP-DOWN; GAMMA OSCILLATIONS; CORTICAL NETWORK; CONNECTIONS; ENTRAINMENT; TOPOGRAPHY; SELECTION	Electrical recordings in humans and monkeys show attentional enhancement of evoked responses and gamma synchrony in ventral stream cortical areas. Does this synchrony result from intrinsic activity in visual cortex or from inputs from other structures? Using paired recordings in the frontal eye field (FEF) and area V4, we found that attention to a stimulus in their joint receptive field leads to enhanced oscillatory coupling between the two areas, particularly at gamma frequencies. This coupling appeared to be initiated by FEF and was time-shifted by about 8 to 13 milliseconds across a range of frequencies. Considering the expected conduction and synaptic delays between the areas, this time-shifted coupling at gamma frequencies may optimize the postsynaptic impact of spikes from one area upon the other, improving cross-area communication with attention.	[Gregoriou, Georgia G.; Zhou, Huihui; Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gotts, Stephen J.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Desimone, R (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	desimone@mit.edu	Gotts, Stephen/J-4842-2012; Desimone, Robert/G-1121-2018; Gregoriou, Georgia/AAD-3925-2019; Gregoriou, Georgia/F-7759-2011	Gregoriou, Georgia/0000-0002-4002-6657; Gregoriou, Georgia/0000-0002-4002-6657	NIH [MH64445];  [EY017292];  [EY017921]; NATIONAL EYE INSTITUTE [R01EY017921, R01EY017292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036, P50MH064445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Pielli, D. Stock, and C. Alfes for help with the animal training and Z.-X. Liu for help with the Granger causality analysis. We also thank N. Bichot, R. Landman, G. Mulliken, and A. Mitz for helpful discussions. Supported by grants EY017292 and EY017921 to R.D. S.J.G. was supported in part by grant MH64445 from NIH (USA).	Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nowak LG, 1997, CEREBR CORT, V12, P205; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	27	812	825	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1207	1210		10.1126/science.1171402	http://dx.doi.org/10.1126/science.1171402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478185	Green Submitted, Green Accepted			2022-12-24	WOS:000266410100048
J	Jamieson, DJ; Honein, MA; Rasmussen, SA; Williams, JL; Swerdlow, DL; Biggerstaff, MS; Lindstrom, S; Louie, JK; Christ, CM; Bohm, SR; Fonseca, VP; Ritger, KA; Kuhles, DJ; Eggers, P; Bruce, H; Davidson, HA; Lutterloh, E; Harris, ML; Burke, C; Cocoros, N; Finelli, L; MacFarlane, KF; Shu, B; Olsen, SJ				Jamieson, Denise J.; Honein, Margaret A.; Rasmussen, Sonja A.; Williams, Jennifer L.; Swerdlow, David L.; Biggerstaff, Matthew S.; Lindstrom, Stephen; Louie, Janice K.; Christ, Cara M.; Bohm, Susan R.; Fonseca, Vincent P.; Ritger, Kathleen A.; Kuhles, Danel J.; Eggers, Paula; Bruce, Hollianne; Davidson, Heidi A.; Lutterloh, Emily; Harris, Meghan L.; Burke, Colleen; Cocoros, Noelle; Finelli, Lyn; MacFarlane, Kitty F.; Shu, Bo; Olsen, Sonja J.		Novel Influenza A H1N1 Pregnancy W	H1N1 2009 influenza virus infection during pregnancy in the USA	LANCET			English	Article							ASIAN INFLUENZA; PANDEMIC INFLUENZA; MATERNAL INFLUENZA; H5N1 INFECTION; SAFETY; IMPACT; WOMEN; RISK; IMMUNIZATION; VACCINATION	Background Pandemic HlN1 2009 influenza virus has been identified as the cause of a widespread outbreak of febrile respiratory infection in the USA and worldwide. We summarised cases of infection with pandemic H1N1 virus in pregnant women identified in the USA during the first month of the present outbreak, and deaths associated with this virus during the first 2 months of the outbreak. Methods After initial reports of infection in pregnant women, the US Centers for Disease Control and Prevention (CDC) began systematically collecting additional information about cases and deaths in pregnant women in the USA with pandemic H1N1 virus infection as part of enhanced surveillance. A confirmed case was defined as an acute respiratory illness with laboratory-confirmed pandemic H1N1 virus infection by real-time reverse-transcriptase PCR or viral culture; a probable case was defined as a person with an acute febrile respiratory illness who was positive for influenza A, but negative for H1 and H3. We used population estimates derived from the 2007 census data to calculate rates of admission to hospital and illness. Findings From April 15 to May 18, 2009, 34 confirmed or probable cases of pandemic H1N1 in pregnant women were reported to CDC from 13 states. 11 (32%) women were admitted to hospital. The estimated rate of admission for pandemic H1N1 influenza virus infection in pregnant women during the first month of the outbreak was higher than it was in the general population (0.32 per 100000 pregnant women, 95% CI 0.13-0.52 vs 0.076 per 100 000 population at risk, 95% CI 0.07-0.09). Between April 15 and June 16, 2009, six deaths in pregnant women were reported to the CDC; all were in women who had developed pneumonia and subsequent acute respiratory distress syndrome requiring mechanical ventilation. Interpretation Pregnant women might be at increased risk for complications from pandemic H1N1 virus infection. These data lend support to the present recommendation to promptly treat pregnant women with H1N1 influenza virus infection with anti-influenza drugs. Funding US CDC.	[Jamieson, Denise J.] CDC, Div Reprod Hlth, NCCDPHP, Atlanta, GA 30341 USA; [Honein, Margaret A.; Rasmussen, Sonja A.; Williams, Jennifer L.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; [Swerdlow, David L.; Biggerstaff, Matthew S.; Lindstrom, Stephen; Finelli, Lyn; Shu, Bo; Olsen, Sonja J.] CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30341 USA; [Lutterloh, Emily] CDC, EIS Program, Off Workforce & Career Dev, Atlanta, GA 30341 USA; [Louie, Janice K.] Calif Dept Publ Hlth, Richmond, CA USA; [Christ, Cara M.] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Bohm, Susan R.] Michigan Dept Community Hlth, Lansing, MI USA; [Fonseca, Vincent P.] Texas Dept State Hlth Serv, Austin, TX USA; [Ritger, Kathleen A.] Chicago Dept Publ Hlth, Chicago, IL USA; [Kuhles, Danel J.] Nassau Cty Dept Hlth, Uniondale, NY USA; [Eggers, Paula] Delaware Div Publ Hlth, Dover, DE USA; [Bruce, Hollianne] Snohomish Hlth Dist, Everett, WA USA; [Davidson, Heidi A.] DeKalb Cty Board Hlth, Atlanta, GA USA; [Lutterloh, Emily] Kentucky Dept Publ Hlth, Frankfort, KY USA; [Harris, Meghan L.] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA; [Burke, Colleen] Philadelphia Dept Publ Hlth, Philadelphia, PA USA; [Cocoros, Noelle] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Arizona Department of Health Services; MDHHS - Michigan Department of Health & Human Services; Texas Department of State Health Services; Chicago Department of Public Health; Massachusetts Department of Public Health	Jamieson, DJ (corresponding author), CDC, Div Reprod Hlth, NCCDPHP, Mail Stop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	DJamieson@cdc.gov	fonseca, vincent/AAD-5865-2019; Finelli, Lyn/AAK-2360-2020	Cocoros, Noelle/0000-0001-7090-2761; Dharan, Nila/0000-0003-1175-5962; Biggerstaff, Matthew/0000-0001-5108-8311; Jamieson, Denise/0000-0003-2597-1201; Patel, Minal/0000-0002-8707-7531	US CDC	US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The US CDC provided funding for this study. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Callaghan WM, 2007, MATERN CHILD HLTH J, V11, P307, DOI 10.1007/s10995-007-0177-4; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1050; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P661; COFFEY VP, 1963, LANCET, V1, P748; Cono J, 2006, EMERG INFECT DIS, V12, P1631, DOI 10.3201/eid1211.060618; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Freund B, 1999, DRUG SAFETY, V21, P267, DOI 10.2165/00002018-199921040-00003; Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Moretti ME, 2005, EPIDEMIOLOGY, V16, P216, DOI 10.1097/01.ede.0000152903.55579.15; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nuzum J W, 1976, IMJ Ill Med J, V150, P612; Petrova A, 2001, OBSTET GYNECOL, V98, P20, DOI 10.1016/S0029-7844(01)01361-8; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; SAXEN LAURI, 1960, ACTA PATHOL ET MICROBIOL SCAND, V49, P114; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; WILSON MG, 1969, J AMER MED ASSOC, V210, P336, DOI 10.1001/jama.210.2.336; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; Zou SM, 2006, TRANSFUS MED REV, V20, P181, DOI 10.1016/j.tmrv.2006.03.001	40	974	1055	0	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					451	458		10.1016/S0140-6736(09)61304-0	http://dx.doi.org/10.1016/S0140-6736(09)61304-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19643469				2022-12-24	WOS:000268898400026
J	Kawate, T; Michel, JC; Birdsong, WT; Gouaux, E				Kawate, Toshimitsu; Michel, Jennifer Carlisle; Birdsong, William T.; Gouaux, Eric			Crystal structure of the ATP-gated P2X(4) ion channel in the closed state	NATURE			English	Article							CYSTEINE RESIDUES; BINDING-SITE; AMINO-ACIDS; RECEPTOR; IDENTIFICATION; CLONING; RELEASE; PAIN; EXPRESSION; ECTODOMAIN	P2X receptors are cation-selective ion channels gated by extracellular ATP, and are implicated in diverse physiological processes, from synaptic transmission to inflammation to the sensing of taste and pain. Because P2X receptors are not related to other ion channel proteins of known structure, there is at present no molecular foundation for mechanisms of ligand-gating, allosteric modulation and ion permeation. Here we present crystal structures of the zebrafish P2X(4) receptor in its closed, resting state. The chalice-shaped, trimeric receptor is knit together by subunit-subunit contacts implicated in ion channel gating and receptor assembly. Extracellular domains, rich in beta-strands, have large acidic patches that may attract cations, through fenestrations, to vestibules near the ion channel. In the transmembrane pore, the 'gate' is defined by an similar to 8 angstrom slab of protein. We define the location of three non-canonical, intersubunit ATP-binding sites, and suggest that ATP binding promotes subunit rearrangement and ion channel opening.	[Kawate, Toshimitsu; Michel, Jennifer Carlisle; Birdsong, William T.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Birdsong, William/AAS-5655-2021	Gouaux, Eric/0000-0002-8549-2360; Birdsong, William/0000-0003-3514-9158	National Institutes of Health (NIH); American Asthma Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel at beamlines 5.0.2, 8.2.1 and 8.2.2 of the Advanced Light Source and at beamline 24-ID-E of the Advanced Photon Source. We also thank M. Voigt for zebrafish P2X receptor DNA, T. Homrichhausen for help with cloning and FSEC screening, J. Berriman for help with electron microscopy, L. Vaskalis for assistance with illustrations, and Gouaux laboratory members for discussions. This work was supported by the National Institutes of Health (NIH) and the American Asthma Foundation. E. G. is an investigator with the Howard Hughes Medical Institute.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Hernandez M, 2002, BIOCHEM BIOPH RES CO, V295, P849, DOI 10.1016/S0006-291X(02)00760-X; Donato R, 2008, CELL CALCIUM, V44, P521, DOI 10.1016/j.ceca.2008.03.006; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Fabbretti E, 2004, J BIOL CHEM, V279, P53109, DOI 10.1074/jbc.M409772200; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HOLTON FA, 1954, J PHYSIOL-LONDON, V126, P124, DOI 10.1113/jphysiol.1954.sp005198; Hugel S, 2000, J NEUROSCI, V20, P2121; Inscho EW, 2004, ACTA PHYSIOL SCAND, V181, P445, DOI 10.1111/j.1365-201X.2004.01317.x; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Roberts JA, 2006, J NEUROCHEM, V96, P843, DOI 10.1111/j.1471-4159.2005.03593.x; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338	50	556	574	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					592	U55		10.1038/nature08198	http://dx.doi.org/10.1038/nature08198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641588	Green Accepted			2022-12-24	WOS:000268454300042
J	Vavouri, T; Semple, JI; Garcia-Verdugo, R; Lehner, B				Vavouri, Tanya; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben			Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage Sensitivity	CELL			English	Article							CAENORHABDITIS-ELEGANS; INTERACTION NETWORK; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RECOGNITION MODULES; YEAST PROTEOME; LINEAR MOTIFS; GENOME; PHENOTYPES; SEQUENCE	Why are genes harmful when they are overexpressed? By testing possible causes of overexpression phenotypes in yeast, we identify intrinsic protein disorder as an important determinant of dosage sensitivity. Disordered regions are prone to make promiscuous molecular interactions when their concentration is increased, and we demonstrate that this is the likely cause of pathology when genes are overexpressed. We validate our findings in two animals, Drosophila melanogaster and Caenorhabditis elegans. In mice and humans the same properties are strongly associated with dosage-sensitive oncogenes, such that mass-action-driven molecular interactions may be a frequent cause of cancer. Dosage-sensitive genes are tightly regulated at the transcriptional, RNA, and protein levels, which may serve to prevent harmful increases in protein concentration under physiological conditions. Mass-action-driven interaction promiscuity is a single theoretical framework that can be used to understand, predict, and possibly treat the effects of increased gene expression in evolution and disease.	[Vavouri, Tanya; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben] UPF, EMBL CRG Syst Biol Unit, Ctr Genom Regulat, Barcelona 08003, Spain; [Lehner, Ben] UPF, ICREA, Ctr Genom Regulat, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), UPF, EMBL CRG Syst Biol Unit, Ctr Genom Regulat, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.es	Lehner, Ben/L-3413-2014; Vavouri, Tanya/I-6124-2019; Semple, Jennifer/K-4782-2014; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Vavouri, Tanya/0000-0003-2352-9049; Semple, Jennifer/0000-0001-7221-9560; Lehner, Ben/0000-0002-8817-1124; Garcia-Verdugo, Rosa/0000-0002-6039-8861	European Research Council (ERC); ICREA; Spanish Ministry of Science and Innovation (MICINN); CRGEMBL Systems Biology Program; Marie Currie Intra-European Training Fellowship; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); ICREA(ICREA); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CRGEMBL Systems Biology Program; Marie Currie Intra-European Training Fellowship; ICREA(ICREA)	We thank Mark Isalan and Madan Babu for helpful discussions, Pedro Beltrao for providing DisEMBL scores, and Mike Boxem for C. elegans vectors. This work was funded by a European Research Council (ERC) Starting Grant, ICREA, the Spanish Ministry of Science and Innovation (MICINN), the CRGEMBL Systems Biology Program, and a Marie Currie Intra-European Training Fellowship to T. V.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beltrao P, 2005, PLOS COMPUT BIOL, V1, P202, DOI 10.1371/journal.pcbi.0010026; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chin CS, 2005, GENOME RES, V15, P205, DOI 10.1101/gr.3243305; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Semple JI, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-1; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Toba G, 1999, GENETICS, V151, P725; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	46	258	266	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					198	208		10.1016/j.cell.2009.04.029	http://dx.doi.org/10.1016/j.cell.2009.04.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596244	Bronze			2022-12-24	WOS:000267848600025
J	Gough, DJ; Corlett, A; Schlessinger, K; Wegrzyn, J; Larner, AC; Levy, DE				Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Wegrzyn, Joanna; Larner, Andrew C.; Levy, David E.			Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation	SCIENCE			English	Article							SIGNAL TRANSDUCER; GENE; ACTIVATION; PROTEIN; PHOSPHORYLATION; INTERLEUKIN-6; INTERFERONS; CYTOKINES; TARGET; CANCER	Signal transducer and activator of transcription 3 (STAT3) is a latent cytoplasmic transcription factor responsive to cytokine signaling and tyrosine kinase oncoproteins by nuclear translocation when it is tyrosine-phosphorylated. We report that malignant transformation by activated Ras is impaired without STAT3, in spite of the inability of Ras to drive STAT3 tyrosine phosphorylation or nuclear translocation. Moreover, STAT3 mutants that cannot be tyrosine-phosphorylated, that are retained in the cytoplasm, or that cannot bind DNA nonetheless supported Ras-mediated transformation. Unexpectedly, STAT3 was detected within mitochondria, and exclusive targeting of STAT3 to mitochondria without nuclear accumulation facilitated Ras transformation. Mitochondrial STAT3 sustained altered glycolytic and oxidative phosphorylation activities characteristic of cancer cells. Thus, in addition to its nuclear transcriptional role, STAT3 regulates a metabolic function in mitochondria, supporting Ras-dependent malignant transformation.	[Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Levy, David E.] New York Univ, Sch Med, Dept Pathol, New York, NY 10016 USA; [Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Levy, David E.] New York Univ, Sch Med, Inst Canc, New York, NY 10016 USA; [Wegrzyn, Joanna; Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Larner, Andrew C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	New York University; New York University; Virginia Commonwealth University; Virginia Commonwealth University	Levy, DE (corresponding author), New York Univ, Sch Med, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	david.levy@med.nyu.edu	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788; Gough, Daniel/0000-0001-6479-1735; Corlett, Alicia/0000-0003-1146-2465; Gough, Daniel/0000-0001-5725-8668	NIH [R01AI28900]; NYSTEM Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Pellicer, L. Feig, C. Der, R. Jove, S. Watowich, and M. Philips for gifts of reagents and helpful discussions. This work was supported by NIH grant R01AI28900 and the NYSTEM Foundation.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GAO SP, 2006, SCI STKE, pPE30; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; RAZ R, 1994, J BIOL CHEM, V269, P24391; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	24	526	542	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1713	1716		10.1126/science.1171721	http://dx.doi.org/10.1126/science.1171721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556508	Green Accepted			2022-12-24	WOS:000267338200041
J	Stefansson, H; Ophoff, RA; Steinberg, S; Andreassen, OA; Cichon, S; Rujescu, D; Werge, T; Pietilainen, OPH; Mors, O; Mortensen, PB; Sigurdsson, E; Gustafsson, O; Nyegaard, M; Tuulio-Henriksson, A; Ingason, A; Hansen, T; Suvisaari, J; Lonnqvist, J; Paunio, T; Borglum, AD; Hartmann, A; Fink-Jensen, A; Nordentoft, M; Hougaard, D; Norgaard-Pedersen, B; Bottcher, Y; Olesen, J; Breuer, R; Moller, HJ; Giegling, I; Rasmussen, HB; Timm, S; Mattheisen, M; Bitter, I; Rethelyi, JM; Magnusdottir, BB; Sigmundsson, T; Olason, P; Mason, G; Gulcher, JR; Haraldsson, M; Fossdal, R; Thorgeirsson, TE; Thorsteinsdottir, U; Ruggeri, M; Tosato, S; Franke, B; Strengman, E; Kiemeney, LA; Melle, I; Djurovic, S; Abramova, L; Kaleda, V; Sanjuan, J; de Frutos, R; Bramon, E; Vassos, E; Fraser, G; Ettinger, U; Picchioni, M; Walker, N; Toulopoulou, T; Need, AC; Ge, D; Yoon, JL; Shianna, KV; Freimer, NB; Cantor, RM; Murray, R; Kong, A; Golimbet, V; Carracedo, A; Arango, C; Costas, J; Jonsson, EG; Terenius, L; Agartz, I; Petursson, H; Nothen, MM; Rietschel, M; Matthews, PM; Muglia, P; Peltonen, L; St Clair, D; Goldstein, DB; Stefansson, K; Collier, DA				Stefansson, Hreinn; Ophoff, Roel A.; Steinberg, Stacy; Andreassen, Ole A.; Cichon, Sven; Rujescu, Dan; Werge, Thomas; Pietilainen, Olli P. H.; Mors, Ole; Mortensen, Preben B.; Sigurdsson, Engilbert; Gustafsson, Omar; Nyegaard, Mette; Tuulio-Henriksson, Annamari; Ingason, Andres; Hansen, Thomas; Suvisaari, Jaana; Lonnqvist, Jouko; Paunio, Tiina; Borglum, Anders D.; Hartmann, Annette; Fink-Jensen, Anders; Nordentoft, Merete; Hougaard, David; Norgaard-Pedersen, Bent; Bottcher, Yvonne; Olesen, Jes; Breuer, Rene; Moeller, Hans-Jurgen; Giegling, Ina; Rasmussen, Henrik B.; Timm, Sally; Mattheisen, Manuel; Bitter, Istvan; Rethelyi, Janos M.; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Olason, Pall; Mason, Gisli; Gulcher, Jeffrey R.; Haraldsson, Magnus; Fossdal, Ragnheidur; Thorgeirsson, Thorgeir E.; Thorsteinsdottir, Unnur; Ruggeri, Mirella; Tosato, Sarah; Franke, Barbara; Strengman, Eric; Kiemeney, Lambertus A.; Melle, Ingrid; Djurovic, Srdjan; Abramova, Lilia; Kaleda, Vasily; Sanjuan, Julio; de Frutos, Rosa; Bramon, Elvira; Vassos, Evangelos; Fraser, Gillian; Ettinger, Ulrich; Picchioni, Marco; Walker, Nicholas; Toulopoulou, Timi; Need, Anna C.; Ge, Dongliang; Yoon, Joeng Lim; Shianna, Kevin V.; Freimer, Nelson B.; Cantor, Rita M.; Murray, Robin; Kong, Augustine; Golimbet, Vera; Carracedo, Angel; Arango, Celso; Costas, Javier; Joensson, Erik G.; Terenius, Lars; Agartz, Ingrid; Petursson, Hannes; Nothen, Markus M.; Rietschel, Marcella; Matthews, Paul M.; Muglia, Pierandrea; Peltonen, Leena; St Clair, David; Goldstein, David B.; Stefansson, Kari; Collier, David A.		GROUP	Common variants conferring risk of schizophrenia	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MENTAL-RETARDATION; GENE; NEUROGRANIN; POPULATION; DELETIONS; DISEASES; 1Q21.1; MEMORY; SCAN	Schizophrenia is a complex disorder, caused by both genetic and environmental factors and their interactions. Research on pathogenesis has traditionally focused on neurotransmitter systems in the brain, particularly those involving dopamine. Schizophrenia has been considered a separate disease for over a century, but in the absence of clear biological markers, diagnosis has historically been based on signs and symptoms. A fundamental message emerging from genome-wide association studies of copy number variations (CNVs) associated with the disease is that its genetic basis does not necessarily conform to classical nosological disease boundaries. Certain CNVs confer not only high relative risk of schizophrenia but also of other psychiatric disorders(1-3). The structural variations associated with schizophrenia can involve several genes and the phenotypic syndromes, or the 'genomic disorders', have not yet been characterized(4). Single nucleotide polymorphism (SNP)-based genome-wide association studies with the potential to implicate individual genes in complex diseases may reveal underlying biological pathways. Here we combined SNP data from several large genome-wide scans and followed up the most significant association signals. We found significant association with several markers spanning the major histocompatibility complex (MHC) region on chromosome 6p21.3-22.1, a marker located upstream of the neurogranin gene (NRGN) on 11q24.2 and a marker in intron four of transcription factor 4 (TCF4) on 18q21.2. Our findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition.	[Stefansson, Hreinn; Steinberg, Stacy; Gustafsson, Omar; Ingason, Andres; Bottcher, Yvonne; Olason, Pall; Mason, Gisli; Gulcher, Jeffrey R.; Fossdal, Ragnheidur; Thorgeirsson, Thorgeir E.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Ophoff, Roel A.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Andreassen, Ole A.; Melle, Ingrid] Ullevaal Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole A.; Melle, Ingrid] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Cichon, Sven; Mattheisen, Manuel] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Rujescu, Dan; Hartmann, Annette; Giegling, Ina] Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-80336 Munich, Germany; [Werge, Thomas; Hansen, Thomas; Rasmussen, Henrik B.] Univ Copenhagen, Mental Hlth Ctr Sct Hans, Res Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Pietilainen, Olli P. H.; Peltonen, Leena] Biomedicum Helsinki, Inst Mol Med, Helsinki 00290, Finland; [Pietilainen, Olli P. H.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mors, Ole; Borglum, Anders D.] Aarhus Univ Hosp, Ctr Psychiat Res, DK-8240 Risskov, Denmark; [Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus, Denmark; [Sigurdsson, Engilbert; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Haraldsson, Magnus; Petursson, Hannes] Natl Univ Hosp Reykjavik, Dept Psychiat, IS-101 Reykjavik, Iceland; [Sigurdsson, Engilbert; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Haraldsson, Magnus; Petursson, Hannes; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland; [Nyegaard, Mette; Borglum, Anders D.] Aarhus Univ, Dept Human Genet, DK-8000 Aarhus C, Denmark; [Suvisaari, Jaana; Lonnqvist, Jouko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland; [Paunio, Tiina] Biomedicum, Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Fink-Jensen, Anders] Copenhagen Univ Hosp, Mental Hlth Ctr, Rigshosp, DK-2100 Copenhagen O, Denmark; [Nordentoft, Merete] Bispebjerg Hosp, Psychiat Ctr Bisbebjerg, DK-2400 Copenhagen NV, Denmark; [Hougaard, David; Norgaard-Pedersen, Bent] State Serum Inst, Sect Neonatal Screening & Hormones, Dept Clin Chem & Immunol, DK-2300 Copenhagen S, Denmark; [Olesen, Jes] Glostrup Cty Hosp, Dept Neurol, DK-2600 Glostrup, Denmark; [Breuer, Rene; Rietschel, Marcella] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Moeller, Hans-Jurgen] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Timm, Sally] Copenhagen Univ Hosp, Mental Hlth Ctr Frederiksberg, DK-2000 Copenhagen, Denmark; [Bitter, Istvan; Rethelyi, Janos M.] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1083 Budapest, Hungary; [Ruggeri, Mirella; Tosato, Sarah] Univ Verona, Sect Psychiat & Clin Psychol, I-37134 Verona, Italy; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Djurovic, Srdjan] Ullevaal Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Djurovic, Srdjan] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Abramova, Lilia; Kaleda, Vasily; Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 117152, Russia; [Sanjuan, Julio] Univ Valencia, Unidad Psiquiatria, Fac Biol, CIBERSAM, Valencia 46010, Spain; [de Frutos, Rosa] Univ Valencia, Dept Genet, Fac Biol, CIBERSAM, Valencia 46010, Spain; [Bramon, Elvira; Vassos, Evangelos; Ettinger, Ulrich; Picchioni, Marco; Murray, Robin] Kings Coll London, Inst Psychiat, Div Psychol Med, London SE5 8AF, England; [Vassos, Evangelos; Ettinger, Ulrich; Toulopoulou, Timi; Murray, Robin] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Fraser, Gillian; St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Walker, Nicholas] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Need, Anna C.; Ge, Dongliang; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, Durham, NC 27708 USA; [Yoon, Joeng Lim; Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Carracedo, Angel] Univ Santiago de Compostela, Fdn Publ Galega Med, Xenom Complexo Univ Hosp Santiago, IML, Santiago De Compostela 15782, Spain; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, IML, Santiago De Compostela 15782, Spain; [Arango, Celso] Hosp Gen Univ Gregorio Maran, CIBERSAM, Madrid, Spain; [Costas, Javier] Fdn Publ Galega Med Xen, Valencia 46010, Spain; [Costas, Javier] CIBERER, Valencia 46010, Spain; [Joensson, Erik G.; Terenius, Lars; Agartz, Ingrid] Karolinska Hosp & Inst, Dept Clin Neurosci, HUBIN Project, SE-17176 Stockholm, Sweden; [Nothen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Matthews, Paul M.] GlaxoSmithKline, Hammersmith Hosp, Clin Imaging Ctr, Clin Pharmacol & Discovery Med, London W12 ONN, England; [Muglia, Pierandrea] GlaxoSmithKline R&D, Med Genet, I-37135 Verona, Italy; [Collier, David A.] Sichuan Univ, W China Hosp, Dept Psychiat, Sichuan 610065, Peoples R China	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of Oslo; University of Oslo; University of Bonn; University of Munich; University of Copenhagen; University of Helsinki; Wellcome Trust Sanger Institute; Aarhus University; Aarhus University; Landspitali National University Hospital; University of Iceland; Aarhus University; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Statens Serum Institut; University of Copenhagen; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munich; University of Copenhagen; Semmelweis University; University of Verona; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Oslo; University of Oslo; Russian Academy of Medical Sciences; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; University of London; King's College London; University of London; King's College London; University of Aberdeen; Duke University; University of California System; University of California Los Angeles; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Karolinska Institutet; Karolinska University Hospital; University of Bonn; GlaxoSmithKline; Imperial College London; GlaxoSmithKline; Sichuan University	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kari.stefansson@decode.is	Bramon, Elvira/A-9463-2011; Sigurdsson, Engilbert/D-2486-2014; St Clair, David/AAN-2412-2021; Nyegaard, Mette/G-4443-2012; Bramon, Elvira/HHC-3809-2022; Werge, Thomas/G-7263-2012; Bitter, Istvan/J-8196-2017; Mattheisen, Manuel/S-3725-2019; van Os, Jim/C-2113-2014; Ettinger, Ulrich/D-3731-2014; Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019; Mattheisen, Manuel/B-4949-2012; Giegling, Ina/ABA-3677-2021; Hougaard, David/AAD-6368-2019; Collier, David A/D-1649-2011; Nordentoft, Merete/AAH-3253-2019; Mortensen, Preben B/D-2358-2015; VG, Kaleda/K-5466-2013; Arango, Celso/AAZ-8314-2021; Hartmann, Annette/AAS-6331-2021; Ruggeri, Mirella/E-6091-2010; Carracedo, Angel/D-4257-2012; Myin-Germeys, Inez/L-5106-2014; Arango Lopez, Celso/H-6433-2015; Vassos, Evangelos/F-9825-2013; Toulopoulou, Timothea/F-4458-2011; Cichon, Sven/H-8803-2013; Ge, Dongliang/A-2073-2010; Golimbet, V/E-2328-2016; Krabbendam, Lydia/F-9163-2010; Melle, Ingrid S/B-4858-2011; Hansen, Thomas/GWZ-2858-2022; Magnusdottir, Brynja/AAH-3482-2019; Goldstein, David/AAY-8125-2020; Ingason, Andres/G-6817-2012; Hansen, Thomas Folkmann/O-5965-2014; Abramova, Liliya/K-4665-2013; Costas, Javier/B-5016-2008; van Os, Jim/I-9496-2012; Rujescu, Dan/GRS-3875-2022; Cichon, Sven/B-9618-2014; Nyegaard, Mette/M-3379-2019; Picchioni, Marco M/E-3300-2010; Muglia, Pierandrea/ABD-9235-2020; Tosato, Sarah/E-6045-2010; Nöthen, Markus/B-2027-2009; Franke, Barbara/D-4836-2009; Andreassen, Ole A./AAY-7531-2020; murray, robin/F-8658-2012	Sigurdsson, Engilbert/0000-0001-9404-7982; Nyegaard, Mette/0000-0003-4973-8543; Bramon, Elvira/0000-0003-1369-5983; Bitter, Istvan/0000-0002-9464-4709; Mattheisen, Manuel/0000-0002-8442-493X; Ettinger, Ulrich/0000-0002-0160-0281; Kiemeney, Lambertus A./0000-0002-2368-1326; Mattheisen, Manuel/0000-0002-8442-493X; Collier, David A/0000-0003-4087-1559; Mortensen, Preben B/0000-0002-5230-9865; VG, Kaleda/0000-0002-1209-1443; Arango, Celso/0000-0003-3382-4754; Carracedo, Angel/0000-0003-1085-8986; Arango Lopez, Celso/0000-0003-3382-4754; Vassos, Evangelos/0000-0001-6363-0438; Cichon, Sven/0000-0002-9475-086X; Golimbet, V/0000-0002-9960-7114; Krabbendam, Lydia/0000-0003-4074-5149; Melle, Ingrid S/0000-0002-9783-548X; Magnusdottir, Brynja/0000-0002-6131-7269; Hansen, Thomas Folkmann/0000-0001-6703-7762; Abramova, Liliya/0000-0003-4397-924X; Costas, Javier/0000-0003-0306-3990; van Os, Jim/0000-0002-7245-1586; Cichon, Sven/0000-0002-9475-086X; Nyegaard, Mette/0000-0003-4973-8543; Picchioni, Marco M/0000-0001-6681-147X; Muglia, Pierandrea/0000-0002-3973-8606; Tosato, Sarah/0000-0002-9665-7538; Nöthen, Markus/0000-0002-8770-2464; Franke, Barbara/0000-0003-4375-6572; Agartz, Ingrid/0000-0002-9839-5391; Olesen, Jes/0000-0002-6712-2702; Myin-Germeys, Inez/0000-0002-3731-4930; Mors, Ole/0000-0002-5660-0393; Jonsson, Erik/0000-0001-8368-6332; murray, robin/0000-0003-0829-0519; Ge, David/0000-0002-9732-8170; Suvisaari, Jaana/0000-0001-7167-0990; Matthews, Paul M/0000-0002-1619-8328; Stefansson, Hreinn/0000-0002-9331-6666; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Need, Anna/0000-0003-3955-8207; Fink-Jensen, Anders/0000-0001-7143-1236; Djurovic, Srdjan/0000-0002-8140-8061; Bruggeman, Richard/0000-0002-3238-8471; Kong, Augustine/0000-0001-8193-5438; Rethelyi, Janos/0000-0002-3641-012X; Andreassen, Ole A./0000-0002-4461-3568; Borglum, Anders/0000-0001-8627-7219	EU [LSHM-CT-2006-037761, PIAP-GA-2008-218251, HEALTH-F2-2009-223423]; NIMH [R01 MH078075]; German Federal Ministry of Education and Research [NGFN-2]; Marie Curie [PIAP-GA-2008-218251]; GlaxoSmithKline; National Institutes of Health [1R01HL087679-01]; STAMPEED; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER	EU(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Marie Curie(European Commission); GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STAMPEED; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the subjects and their relatives and staff at the recruitment centres. This work was sponsored by EU grants LSHM-CT-2006-037761 (Project SGENE), PIAP-GA-2008-218251 (Project PsychGene) and HEALTH-F2-2009-223423 (Project PsychCNVs). Genotyping of the Dutch samples was sponsored by NIMH funding, R01 MH078075. This work was also supported by the National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF) and Marie Curie grant PIAP-GA-2008-218251 (PsychGene). M. M. N. received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. We are grateful to S. Schreiber and M. Krawczak for providing genotype data for PopGen controls, and to K.-H. Jockel and R. Erbel for providing control individuals from the Heinz Nixdorf Recall Study. Recruitment of the patients from Munich was partially supported by GlaxoSmithKline. We are grateful to the Genetics Research Centre GmbH, an initiative by GlaxoSmithKline and LMU. The Northern Finland Birth Cohort 1966 (NFBC66) is thanked for providing population controls for the study. The genotyping of NFBC66 was financially supported by National Institutes of Health grant 1R01HL087679-01, STAMPEED.	BERNAL J, 1992, ACTA MED AUST, V19, P32; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Huang FL, 2007, LEARN MEMORY, V14, P512, DOI 10.1101/lm.636107; Juvonen H, 2007, ARCH GEN PSYCHIAT, V64, P894, DOI 10.1001/archpsyc.64.8.894; Kalscheuer VM, 2008, AM J MED GENET A, V146A, P2053, DOI 10.1002/ajmg.a.32419; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Li T, 2001, SCHIZOPHR RES, V49, P73, DOI 10.1016/S0920-9964(00)00111-0; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; PITT D, 1978, AUST PAEDIATR J, V14, P182; Pritchard JK, 2000, GENETICS, V155, P945; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064	27	1235	1281	5	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					744	U99		10.1038/nature08186	http://dx.doi.org/10.1038/nature08186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19571808	Green Accepted			2022-12-24	WOS:000268670300040
J	Jackson, ST; Hobbs, RJ				Jackson, Stephen T.; Hobbs, Richard J.			Ecological Restoration in the Light of Ecological History	SCIENCE			English	Editorial Material							MANAGEMENT; VEGETATION; PALEOECOLOGY; ECOSYSTEMS; FLORIDA; FACE	Ecological history plays many roles in ecological restoration, most notably as a tool to identify and characterize appropriate targets for restoration efforts. However, ecological history also reveals deep human imprints on many ecological systems and indicates that secular climate change has kept many targets moving at centennial to millennial time scales. Past and ongoing environmental changes ensure that many historical restoration targets will be unsustainable in the coming decades. Ecological restoration efforts should aim to conserve and restore historical ecosystems where viable, while simultaneously preparing to design or steer emerging novel ecosystems to ensure maintenance of ecological goods and services.	[Jackson, Stephen T.] Univ Wyoming, Dept Bot & Program Ecol, Laramie, WY 82071 USA; [Hobbs, Richard J.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia	University of Wyoming; University of Western Australia	Jackson, ST (corresponding author), Univ Wyoming, Dept Bot & Program Ecol, Laramie, WY 82071 USA.	Jackson@uwyo.edu; rhobbs@cyllene.uwa.edu.au	Hobbs, Richard J/F-5883-2010	Hobbs, Richard J/0000-0003-4047-3147; Jackson, Stephen/0000-0002-1487-4652				Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Burney DA, 2007, FRONT ECOL ENVIRON, V5, P483, DOI 10.1890/070051; Bush MB, 2007, FRONT ECOL ENVIRON, V5, P457, DOI 10.1890/070018; Chambers FM, 2007, BIODIVERS CONSERV, V16, P2821, DOI 10.1007/s10531-007-9169-3; Dambrine E, 2007, ECOLOGY, V88, P1430, DOI 10.1890/05-1314; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Gorham E, 2003, WETL ECOL MANAG, V11, P109, DOI 10.1023/A:1022065723511; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Huxley Thomas, 1869, NATURE, V1, P9, DOI [10.1038/001009a0, DOI 10.1038/001009A0]; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson ST, 2006, J VEG SCI, V17, P549, DOI 10.1111/j.1654-1103.2006.tb02478.x; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; MOTZKIN G, 2004, FORESTS TIME; Naveh Z, 2005, RESTOR ECOL, V13, P228, DOI 10.1111/j.1526-100X.2005.00028.x; *NOAA NAT CLIM DAT, PAL; Peterken GF, 1999, GLOBAL ECOL BIOGEOGR, V8, P321, DOI 10.1046/j.1365-2699.1999.00140.x; Schelske CL, 2005, AMBIO, V34, P192, DOI 10.1639/0044-7447(2005)034[0192:ABRTHA]2.0.CO;2; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Shuman B, 2009, ECOLOGY, V90, P2792, DOI 10.1890/08-0985.1; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Vale T.R., 2002, FIRE NATIVE PEOPLES; Willard DA, 2007, FRONT ECOL ENVIRON, V5, P491, DOI 10.1890/070015; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045	29	370	403	15	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					567	569		10.1126/science.1172977	http://dx.doi.org/10.1126/science.1172977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644108				2022-12-24	WOS:000268493000036
J	Boettiger, AN; Levine, M				Boettiger, Alistair N.; Levine, Michael			Synchronous and Stochastic Patterns of Gene Activation in the Drosophila Embryo	SCIENCE			English	Article							EXPRESSION; DORSAL; MESODERM; GRADIENT; RNA; TRANSCRIPTION; CONSEQUENCES; MELANOGASTER; PROTEIN; NOISE	Drosophila embryogenesis is characterized by rapid transitions in gene activity, whereby crudely distributed gradients of regulatory proteins give way to precise on/off patterns of gene expression. To explore the underlying mechanisms, a partially automated, quantitative in situ hybridization method was used to visualize expression profiles of 14 developmental control genes in hundreds of embryos. These studies revealed two distinct patterns of gene activation: synchronous and stochastic. Synchronous genes display essentially uniform expression of nascent transcripts in all cells of an embryonic tissue, whereas stochastic genes display erratic patterns of de novo activation. RNA polymerase II is "pre-loaded" (stalled) in the promoter regions of synchronous genes, but not stochastic genes. Transcriptional synchrony might ensure the orderly deployment of the complex gene regulatory networks that control embryogenesis.	[Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Boettiger, Alistair N.] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Boettiger, Alistair/G-1988-2011	Boettiger, Alistair/0000-0002-3554-5196; Levine, Michael/0000-0001-7629-0081	NSF; NIH [GM34431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.N.B. is supported by NSF Graduate Research Fellowship Program. This study was funded by a grant from NIH (GM34431).	Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bialek W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258101; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Frank LH, 1996, DEVELOPMENT, V122, P1343; GONZALEZCRESPO S, 1993, GENE DEV, V7, P1703, DOI 10.1101/gad.7.9.1703; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Imam F, 1999, GENETICS, V152, P307; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; SKEATH JB, 1994, DEVELOPMENT, V120, P1517; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	35	193	197	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					471	473		10.1126/science.1173976	http://dx.doi.org/10.1126/science.1173976			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628867	Green Accepted			2022-12-24	WOS:000268255100055
J	Grove, CA; De Masi, F; Barrasa, MI; Newburger, DE; Alkema, MJ; Bulyk, ML; Walhout, AJM				Grove, Christian A.; De Masi, Federico; Barrasa, M. Inmaculada; Newburger, Daniel E.; Alkema, Mark J.; Bulyk, Martha L.; Walhout, Albertha J. M.			A Multiparameter Network Reveals Extensive Divergence between C. elegans bHLH Transcription Factors	CELL			English	Article							GENOME-WIDE RNAI; PROTEIN-DNA; MICROARRAY DATA; BINDING; FAMILY; SPECIFICITY; DATABASE; SYSTEM; TWIST; YAP	Differences in expression, protein interactions, and DNA binding of paralogous transcription factors ("TF parameters'') are thought to be important determinants of regulatory and biological specificity. However, both the extent of TF divergence and the relative contribution of individual TF parameters remain undetermined. We comprehensively identify dimerization partners, spatiotemporal expression patterns, and DNA-binding specificities for the C. elegans bHLH family of TFs, and model these data into an integrated network. This network displays both specificity and promiscuity, as some bHLH proteins, DNA sequences, and tissues are highly connected, whereas others are not. By comparing all bHLH TFs, we find extensive divergence and that all three parameters contribute equally to bHLH divergence. Our approach provides a framework for examining divergence for other protein families in C. elegans and in other complex multicellular organisms, including humans. Cross-species comparisons of integrated networks may provide further insights into molecular features underlying protein family evolution. For a video summary of this article, see the PaperFlick file available with the online Supplemental Data.	[Grove, Christian A.; Barrasa, M. Inmaculada; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Grove, Christian A.; Barrasa, M. Inmaculada; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [De Masi, Federico; Newburger, Daniel E.; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Alkema, Mark J.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	mlbulyk@receptor.med.harvard.edu; marian.walhout@umassmed.edu	De Masi, Federico/A-4499-2010	De Masi, Federico/0000-0003-4859-4170; Grove, Christian/0000-0001-9076-6015; Walhout, Marian/0000-0001-5587-3608	NIH [DK068429, GM084491, R01 HG002966, R01 HG003985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002966, R01HG003985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Berger for technical assistance and advice with PBMs and data analysis; S. Jaeger and R. P. McCord for statistical advice, assistance, and help with Matlab; T. Siggers for genome scanning assistance; and members of the Walhout and Bulyk laboratories and J. Dekker for advice and critical reading of the manuscript. Special thanks to Shohei Mitani for the hlh- 30 (tm1978) mutant C. elegans strain and Maria Ow for outcrossing this strain. This work was supported by NIH grants DK068429 to A. J. M. W., GM084491 to M. J. A., and R01 HG002966 and R01 HG003985 to M. L. B.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Grove CA, 2008, MOL BIOSYST, V4, P309, DOI 10.1039/b715909a; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hallam S, 2000, DEVELOPMENT, V127, P4239; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Krause M, 1997, DEVELOPMENT, V124, P2179; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ooe N, 2007, GENE, V400, P122, DOI 10.1016/j.gene.2007.06.005; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Pickett CL, 2007, DEV BIOL, V310, P226, DOI 10.1016/j.ydbio.2007.07.034; Portman DS, 2000, DEVELOPMENT, V127, P5415; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tamai KK, 2007, DEV BIOL, V308, P562, DOI 10.1016/j.ydbio.2007.05.024; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Vermeirssen V, 2007, GENOME RES, V17, P1061, DOI 10.1101/gr.6148107; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 1998, BBA-GENE STRUCT EXPR, V1397, P189, DOI 10.1016/S0167-4781(97)00227-3; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Yuan J, 1998, ONCOGENE, V17, P1109, DOI 10.1038/sj.onc.1202036; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	48	177	232	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					314	327		10.1016/j.cell.2009.04.058	http://dx.doi.org/10.1016/j.cell.2009.04.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632181	Green Accepted, Bronze			2022-12-24	WOS:000268277000013
J	Bu, L; Jiang, X; Martin-Puig, S; Caron, L; Zhu, SJ; Shao, Y; Roberts, DJ; Huang, PL; Domian, IJ; Chien, KR				Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Zhu, Shenjun; Shao, Ying; Roberts, Drucilla J.; Huang, Paul L.; Domian, Ibrahim J.; Chien, Kenneth R.			Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages	NATURE			English	Article							EMBRYONIC STEM-CELLS; CARDIAC PROGENITORS; SMOOTH-MUSCLE; CARDIOMYOCYTE; DIFFERENTIATION; CARDIOGENESIS; POPULATION; PRECURSORS; CONTRIBUTE; ORIGINS	The generation and expansion of diverse cardiovascular cell lineages is a critical step during human cardiogenesis, with major implications for congenital heart disease. Unravelling the mechanisms for the diversification of human heart cell lineages has been hampered by the lack of genetic tools to purify early cardiac progenitors and define their developmental potential(1-4). Recent studies in the mouse embryo have identified a multipotent cardiac progenitor that contributes to all of the major cell types in the murine heart(5-8). In contrast to murine development, human cardiogenesis has a much longer onset of heart cell lineage diversification and expansion, suggesting divergent pathways. Here we identify a diverse set of human fetal ISL1(+) cardiovascular progenitors that give rise to the cardiomyocyte, smooth muscle and endothelial cell lineages. Using two independent transgenic and gene-targeting approaches in human embryonic stem cell lines, we show that purified ISL1(+) primordial progenitors are capable of self-renewal and expansion before differentiation into the three major cell types in the heart. These results lay the foundation for the generation of human model systems for cardiovascular disease and novel approaches for human regenerative cardiovascular medicine.	[Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Zhu, Shenjun; Shao, Ying; Huang, Paul L.; Domian, Ibrahim J.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Domian, Ibrahim J.; Chien, Kenneth R.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Roberts, Drucilla J.] Harvard Univ, Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs,Med Sch, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Plaza,CPZN 3208,185 Cambridge St, Boston, MA 02114 USA.	krchien@partners.org	Roberts, Drucilla/AAB-6379-2022; Caron, Leslie/AAE-3511-2022	Caron, Leslie/0000-0003-4118-2974; BU, LEI/0000-0003-4476-2157; Martin-Puig, Silvia/0000-0003-3048-6729; Huang, Paul/0000-0002-5436-8658	Foundation Alfonso Martin Escudero, Spain; Harvard Stem Cell Institute; Leducq Foundation	Foundation Alfonso Martin Escudero, Spain; Harvard Stem Cell Institute; Leducq Foundation(Leducq Foundation)	We thank C. Cowan for advice on human ES cell culture and electroporation; A. Nagy for providing the DsRed-MST plasmid; Y. Qyang for discussion and comments; E. Hansson for a critical reading of this manuscript; M. Lindsay and M. Ortega-Molina for help on human fetal heart anatomy; L. B. Prickett-Rice and K. Folz-Donahue for flow cytometry support; and Advanced Bioscience Resources for providing the human fetal tissues. S. M. P. is funded by Foundation Alfonso Martin Escudero, Spain. This study is supported by Harvard Stem Cell Institute and the Leducq Foundation.	Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	25	412	448	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					113	U130		10.1038/nature08191	http://dx.doi.org/10.1038/nature08191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571884				2022-12-24	WOS:000267545200040
J	Jura, N; Endres, NF; Engel, K; Deindl, S; Das, R; Lamers, MH; Wemmer, DE; Zhang, XW; Kuriyan, J				Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Wemmer, David E.; Zhang, Xuewu; Kuriyan, John			Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; KINASE DOMAIN; TRANSMEMBRANE DOMAIN; CRYSTAL-STRUCTURE; MUTATIONS; DIMERIZATION; INHIBITION; PHOSPHORYLATION; ASSOCIATION; INSIGHTS	Signaling by the epidermal growth factor receptor requires an allosteric interaction between the kinase domains of two receptors, whereby one activates the other. We show that the intracellular juxtamembrane segment of the receptor, known to potentiate kinase activity, is able to dimerize the kinase domains. The C-terminal half of the juxtamembrane segment latches the activated kinase domain to the activator, and the N-terminal half of this segment further potentiates dimerization, most likely by forming an antiparallel helical dimer that engages the transmembrane helices of the activated receptor. Our data are consistent with a mechanism in which the extracellular domains block the intrinsic ability of the transmembrane and cytoplasmic domains to dimerize and activate, with ligand binding releasing this block. The formation of the activating juxtamembrane latch is prevented by the C-terminal tails in a structure of an inactive kinase domain dimer, suggesting how alternative	[Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Lamers, Meindert/AGG-8911-2022; Das, Rahul/AAU-5123-2020	Lamers, Meindert/0000-0002-4205-1338; Das, Rahul/0000-0001-7841-8229; Deindl, Sebastian/0000-0001-6807-8654	NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Frederick L, 2000, CANCER RES, V60, P1383; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; SOROKIN A, 1995, ONCOGENE, V11, P1531; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	50	417	423	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1293	1307		10.1016/j.cell.2009.04.025	http://dx.doi.org/10.1016/j.cell.2009.04.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563760	Bronze, Green Accepted			2022-12-24	WOS:000267373400022
J	Kim, M; Ogawa, M; Fujita, Y; Yoshikawa, Y; Nagai, T; Koyama, T; Nagai, S; Lange, A; Fassler, R; Sasakawa, C				Kim, Minsoo; Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Koyama, Tomohiro; Nagai, Shinya; Lange, Anika; Faessler, Reinhard; Sasakawa, Chihiro			Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment	NATURE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; PROTEIN-KINASE; ILK; PATHOGENICITY; REPERTOIRE; EXPRESSION; MECHANISM; VIRULENCE	The rapid turnover and exfoliation of mucosal epithelial cells provides an innate defence system against bacterial infection(1,2). Nevertheless, many pathogenic bacteria, including Shigella, are able to surmount exfoliation and colonize the epithelium efficiently(3,4). Here we show that the Shigella flexneri effector OspE(5,6) (consisting of OspE1 and OspE2 proteins), which is highly conserved among enteropathogenic Escherichia coli, enterohaemorrhagic E. coli, Citrobacter rodentium and Salmonella strains(7), reinforces host cell adherence to the basement membrane by interacting with integrin-linked kinase (ILK)(8). The number of focal adhesions was augmented along with membrane fraction ILK by ILK-OspE binding. The interaction between ILK and OspE increased cell surface levels of beta 1 integrin and suppressed phosphorylation of focal adhesion kinase and paxillin, which are required for rapid turnover of focal adhesion in cell motility(9). Nocodazole-washout-induced focal adhesion disassembly was blocked by expression of OspE. Polarized epithelial cells infected with a Shigella mutant lacking the ospE gene underwent more rapid cell detachment than cells infected with wild-type Shigella. Infection of guinea pig colons with Shigella corroborated the pivotal role of the OspE-ILK interaction in suppressing epithelial detachment, increasing bacterial cell-to-cell spreading, and promoting bacterial colonization. These results indicate that Shigella sustain their infectious foothold by using special tactics to prevent detachment of infected cells.	[Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Int Res Ctr Infect Dis, Dept Infect Dis Control, Minato Ku, Tokyo 1088639, Japan; [Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; [Kim, Minsoo; Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Sasakawa, Chihiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Koyama, Tomohiro; Nagai, Shinya] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Lange, Anika; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82151 Martinsried, Germany	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Max Planck Society	Sasakawa, C (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Dept Infect Dis Control, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp		Kim, Minsoo/0000-0001-8536-8653	Deutsche Forschungsgemeinschaft [SFB576]; Max Planck Society; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JSTA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JSTA)(Japan Science & Technology Agency (JST))	We thank S. Ohmi, H. Fukuda and C. Takamura for MALDI-TOF analysis. We thank S. Yamaji and Y. Ishigatsubo for discussion. We thank the members of the Sasakawa laboratory, especially H. Mimuro, M. Suzuki and H. Ashida, for their advice. We are grateful to R. Whittier and T. Tezuka for critical reading of the manuscript. We thank H. Erickson for fibronectin fragment expression vector. This work was supported by the Deutsche Forschungsgemeinschaft (SFB576), the Max Planck Society, a Grant-in-Aid for the Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and the Special Coordination Funds for Promoting Science from Japan Science and Technology Agency (JSTA).	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Chu HY, 2006, MOL CELL BIOL, V26, P1817, DOI 10.1128/MCB.26.5.1817-1825.2006; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kim M, 2008, EMBO REP, V9, P878, DOI 10.1038/embor.2008.125; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077	37	130	134	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					578	U109		10.1038/nature07952	http://dx.doi.org/10.1038/nature07952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19489119				2022-12-24	WOS:000266370500041
J	Sasaki, E; Suemizu, H; Shimada, A; Hanazawa, K; Oiwa, R; Kamioka, M; Tomioka, I; Sotomaru, Y; Hirakawa, R; Eto, T; Shiozawa, S; Maeda, T; Ito, M; Ito, R; Kito, C; Yagihashi, C; Kawai, K; Miyoshi, H; Tanioka, Y; Tamaoki, N; Habu, S; Okano, H; Nomura, T				Sasaki, Erika; Suemizu, Hiroshi; Shimada, Akiko; Hanazawa, Kisaburo; Oiwa, Ryo; Kamioka, Michiko; Tomioka, Ikuo; Sotomaru, Yusuke; Hirakawa, Reiko; Eto, Tomoo; Shiozawa, Seiji; Maeda, Takuji; Ito, Mamoru; Ito, Ryoji; Kito, Chika; Yagihashi, Chie; Kawai, Kenji; Miyoshi, Hiroyuki; Tanioka, Yoshikuni; Tamaoki, Norikazu; Habu, Sonoko; Okano, Hideyuki; Nomura, Tatsuji			Generation of transgenic non-human primates with germline transmission	NATURE			English	Article							LENTIVIRAL GENE-TRANSFER; PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; MARMOSET MONKEY; MODEL; ESTABLISHMENT; EXPRESSION; DISEASE; CATTLE	The common marmoset (Callithrix jacchus) is increasingly attractive for use as a non-human primate animal model in biomedical research. It has a relatively high reproduction rate for a primate, making it potentially suitable for transgenic modification. Although several attempts have been made to produce non-human transgenic primates, transgene expression in the somatic tissues of live infants has not been demonstrated by objective analyses such as polymerase chain reaction with reverse transcription or western blots. Here we show that the injection of a self-inactivating lentiviral vector in sucrose solution into marmoset embryos results in transgenic common marmosets that expressed the transgene in several organs. Notably, we achieved germline transmission of the transgene, and the transgenic offspring developed normally. The successful creation of transgenic marmosets provides a new animal model for human disease that has the great advantage of a close genetic relationship with humans. This model will be valuable to many fields of biomedical research.	[Sasaki, Erika; Suemizu, Hiroshi; Shimada, Akiko; Oiwa, Ryo; Kamioka, Michiko; Tomioka, Ikuo; Hirakawa, Reiko; Eto, Tomoo; Shiozawa, Seiji; Maeda, Takuji; Ito, Mamoru; Ito, Ryoji; Kito, Chika; Yagihashi, Chie; Kawai, Kenji; Tanioka, Yoshikuni; Tamaoki, Norikazu; Nomura, Tatsuji] Cent Inst Expt Anim, Miyamae Ku, Kanagawa 2160001, Japan; [Hanazawa, Kisaburo] Juntendo Univ, Nerima Hosp, Dept Urol, Nerima Ku, Tokyo 1778521, Japan; [Tomioka, Ikuo; Hirakawa, Reiko] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Shiozawa, Seiji; Maeda, Takuji; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Minami Ku, Hiroshima 7348551, Japan; [Miyoshi, Hiroyuki] RIKEN, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Habu, Sonoko] Tokai Univ, Sch Med, Dept Immunol, Kanagawa 2591193, Japan	Juntendo University; Keio University; Keio University; Hiroshima University; RIKEN; Tokai University	Sasaki, E (corresponding author), Cent Inst Expt Anim, Miyamae Ku, 1430 Nogawa, Kanagawa 2160001, Japan.	esasaki@ciea.or.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Miyoshi, Hiroyuki/G-9808-2013; Shiozawa, Seiji/L-1248-2013	Shiozawa, Seiji/0000-0002-3504-5415; Tomioka, Ikuo/0000-0002-1471-6419; Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Government to Keio University; Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21240042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government to Keio University; Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank F. Toyoda, S. Ohba, T. Inoue, Y. Sawada and M. Yokoyama for technical assistance with the animal experiments and care. E. S. is an associate professor of the Global COE program for human metabolomic systems biology assigned to Keio University. This study was also supported by the Global COE program for Education and Research Centre for Stem Cell Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Japanese Government to Keio University. This study was also supported by funds from Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency and grants from MEXT to H. O. and from Special Coordination Funds for Promoting Science and Technology of MEXT to S. H.	Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Bai Y, 2003, GENE THER, V10, P1446, DOI 10.1038/sj.gt.3302026; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Eslamboli A, 2005, BRAIN RES BULL, V68, P140, DOI 10.1016/j.brainresbull.2005.08.005; Hofmann A, 2004, BIOL REPROD, V71, P405, DOI 10.1095/biolreprod.104.028472; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Ito R, 2008, IMMUNOL LETT, V121, P116, DOI 10.1016/j.imlet.2008.09.007; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kuederling I, 2000, AM J PRIMATOL, V52, P149, DOI 10.1002/1098-2345(200011)52:3<149::AID-AJP4>3.0.CO;2-B; LOPATA A, 1988, FERTIL STERIL, V50, P503; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; SUMMERS PM, 1987, J REPROD FERTIL, V79, P241; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	513	535	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					523	U50		10.1038/nature08090	http://dx.doi.org/10.1038/nature08090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478777				2022-12-24	WOS:000266370500029
J	Hartgrink, HH; Jansen, EPM; van Grieken, NCT; van de Velde, CJH				Hartgrink, Henk H.; Jansen, Edwin P. M.; van Grieken, Nicole C. T.; van de Velde, Cornelis J. H.			Gastric cancer	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR MICROSATELLITE-INSTABILITY; POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED CLINICAL-TRIAL; MARUYAMA INDEX SURGERY; LYMPH-NODE METASTASIS; TOTAL GASTRECTOMY; ADJUVANT CHEMOTHERAPY; PHASE-II	Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists. Prevention and personalised treatment are regarded as the best options to reduce gastric cancer mortality rates. Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype, host gene polymorphisms, presence of precursor lesions, and environmental factors. Although adequate surgery remains the cornerstone of gastric cancer treatment, this single modality treatment seems to have reached its maximum achievable effect for local control and survival. Minimally invasive techniques can be used for treatment of early gastric cancers. Achievement of locoregional control for advanced disease remains very difficult. Extended resections that are standard practice in some Asian countries have not been shown to be as effective in other developed countries. We present an update of the incidence, causes, pathology, and treatment of gastric cancer, consisting of surgery, new strategies with neoadjuvant and adjuvant chemotherapy or radiotherapy, or both, novel treatment strategies using gene signatures, and the effect of caseload on patient outcomes.	[Hartgrink, Henk H.; van de Velde, Cornelis J. H.] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [Jansen, Edwin P. M.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [van Grieken, Nicole C. T.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg, K6-50,POB 9600, NL-2300 RC Leiden, Netherlands.	c.j.h.van_de_velde@lumc.nl	van de Velde, Cornelis/AAY-8360-2020	van Grieken, Nicole/0000-0001-9992-0760	NHLBI NIH HHS [T32 HL007185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Ajani JA, 2004, J CLIN ONCOL, V22, P2774, DOI 10.1200/JCO.2004.01.015; AJANI JA, 1991, CANCER-AM CANCER SOC, V68, P1501, DOI 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO;2-L; Ajani JA, 2006, J CLIN ONCOL, V24, P3953, DOI 10.1200/JCO.2006.06.4840; Allal AS, 2005, INT J RADIAT ONCOL, V63, P1286, DOI 10.1016/j.ijrobp.2005.05.033; Allum WH, 2008, BRIT J SURG, V95, P406, DOI 10.1002/bjs.6197; An CH, 2005, CLIN CANCER RES, V11, P656; [Anonymous], 1990, CANCER-AM CANCER SOC, V66, P2324; Bacani J, 2005, J MOL DIAGN, V7, P465, DOI 10.1016/S1525-1578(10)60577-6; Bachmann MO, 2002, BRIT J SURG, V89, P914, DOI 10.1046/j.1365-2168.2002.02135.x; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Barber M, 2008, J PATHOL, V216, P295, DOI 10.1002/path.2426; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beghelli S, 2006, SURGERY, V139, P347, DOI 10.1016/j.surg.2005.08.021; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Blackshaw Guy R J C, 2003, Gastric Cancer, V6, P225, DOI 10.1007/s10120-003-0257-0; BLEIBERG H, 1989, EUR J SURG ONCOL, V15, P535; Boige V, 2007, J CLIN ONCOL, V25; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Buffart TE, 2007, J PATHOL, V211, P45, DOI 10.1002/path.2085; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Carvalho B, 2003, EUR J CANCER, V39, P1222, DOI 10.1016/S0959-8049(03)00177-1; Coburn NG, 2008, INT J RADIAT ONCOL, V70, P1073, DOI 10.1016/j.ijrobp.2007.07.2378; CORREA P, 1992, CANCER RES, V52, P6735; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2007, NEW ENGL J MED, V357, P1863, DOI 10.1056/NEJMe078182; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Damhuis RAM, 2002, EUR J SURG ONCOL, V28, P401, DOI 10.1053/ejso.2001.1246; de Graaf GW, 2007, EJSO-EUR J SURG ONC, V33, P988, DOI 10.1016/j.ejso.2007.01.007; De Vries AC, 2007, ALIMENT PHARM THER, V26, P25, DOI 10.1111/j.1365-2036.2007.03475.x; DENT DM, 1988, BRIT J SURG, V75, P110, DOI 10.1002/bjs.1800750206; Drognitz O, 2008, INT J RADIAT ONCOL, V70, P715, DOI 10.1016/j.ijrobp.2007.07.2331; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Elsaleh H, 2001, Clin Colorectal Cancer, V1, P104; Fiorica F, 2007, CANCER TREAT REV, V33, P729, DOI 10.1016/j.ctrv.2007.08.005; Fleisher AS, 1999, CANCER RES, V59, P1090; FORMAN D, BMJ, V302, P1302; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Fuccio L, 2007, ALIMENT PHARM THER, V25, P133, DOI 10.1111/j.1365-2036.2006.03183.x; FUCHS C, 2008, 2006 GASTR CANC S SA, P115; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gianni L, 2001, Ann Oncol, V12, P1178; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; GOUZI JL, 1989, ANN SURG, V209, P162, DOI 10.1097/00000658-198902000-00005; Grau JJ, 2008, J SURG ONCOL, V98, P130, DOI 10.1002/jso.21096; Grundei T, 2000, CLIN CANCER RES, V6, P4782; Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9; GUNDERSON LL, 1982, INT J RADIAT ONCOL, V8, P1, DOI 10.1016/0360-3016(82)90377-7; Gylling A, 2007, GUT, V56, P926, DOI 10.1136/gut.2006.114876; HALLISSEY MT, 1994, LANCET, V343, P1309, DOI 10.1016/S0140-6736(94)92464-3; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANLEY AJG, 1995, INT J EPIDEMIOL, V24, P255, DOI 10.1093/ije/24.2.255; Hartgrink HH, 2004, EJSO-EUR J SURG ONC, V30, P643, DOI 10.1016/j.ejso.2004.04.013; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Henning GT, 2000, INT J RADIAT ONCOL, V46, P109, DOI 10.1016/S0360-3016(99)00379-X; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1007/BF02573066; Hundahl SA, 2007, GASTRIC CANCER, V10, P84, DOI 10.1007/s10120-007-0426-7; Jansen EPM, 2007, BRIT J CANCER, V97, P712, DOI 10.1038/sj.bjc.6603965; Jansen EPM, 2007, INT J RADIAT ONCOL, V69, P1424, DOI 10.1016/j.ijrobp.2007.05.004; Jansen EPM, 2007, INT J RADIAT ONCOL, V67, P781, DOI 10.1016/j.ijrobp.2006.09.012; Jansen EPM, 2005, J CLIN ONCOL, V23, P4509, DOI 10.1200/JCO.2005.21.196; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KAMPSCHOER GHM, 1989, BRIT J SURG, V76, P905, DOI 10.1002/bjs.1800760910; Kayaalp C, 2002, EUR J SURG ONCOL, V28, P540, DOI 10.1053/ejso.2002.1296; Keam B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-148; Kim HJ, 2005, RADIOLOGY, V236, P879, DOI 10.1148/radiol.2363041101; Kim JJ, 2007, GASTROINTEST ENDOSC, V66, P693, DOI 10.1016/j.gie.2007.04.013; Kim MM, 2008, INT J RADIAT ONCOL, V71, P167, DOI 10.1016/j.ijrobp.2007.09.019; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Kim SH, 1999, J GASTROINTEST SURG, V3, P24, DOI 10.1016/S1091-255X(99)80004-3; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kitamura K, 1999, BRIT J SURG, V86, P119, DOI 10.1046/j.1365-2168.1999.00967.x; KLAASSEN DJ, 1985, J CLIN ONCOL, V3, P373, DOI 10.1200/JCO.1985.3.3.373; Kodera Y, 1997, WORLD J SURG, V21, P622, DOI 10.1007/s002689900283; Kokkola A, 1998, CANCER GENET CYTOGEN, V107, P32, DOI 10.1016/S0165-4608(98)00092-2; Kollmannsberger C, 2005, ANN ONCOL, V16, P1326, DOI 10.1093/annonc/mdi252; Koo SH, 2000, CANCER GENET CYTOGEN, V117, P97, DOI 10.1016/S0165-4608(99)00152-1; Kozak KR, 2008, INT J RADIAT ONCOL, V72, P517, DOI 10.1016/j.ijrobp.2007.12.029; Kwee RM, 2007, J CLIN ONCOL, V25, P2107, DOI 10.1200/JCO.2006.09.5224; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lenz HJ, 1996, J CLIN ONCOL, V14, P176, DOI 10.1200/JCO.1996.14.1.176; Liu C, 2008, NUTR REV, V66, P237, DOI 10.1111/j.1753-4887.2008.00029.x; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; McCulloch P, 2004, COCHRANE DB SYST REV, V4; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Meyer HJ, 2005, EJSO-EUR J SURG ONC, V31, P595, DOI 10.1016/j.ejso.2005.03.002; Meyers M, 2001, CANCER RES, V61, P5193; Mochiki E, 2004, WORLD J SURG, V28, P247, DOI 10.1007/s00268-003-7191-5; MOERTEL CG, 1984, J CLIN ONCOL, V2, P1249, DOI 10.1200/JCO.1984.2.11.1249; Moutinho C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-10; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Napieralski R, 2005, CLIN CANCER RES, V11, P3025, DOI 10.1158/1078-0432.CCR-04-1605; Noda N, 1998, BRIT J SURG, V85, P831; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Oda I., 2006, GASTRIC CANCER, V9, P262, DOI DOI 10.1007/S10120-006-0389-0]; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Orsenigo E, 2008, SURG ENDOSC, V22, P118, DOI 10.1007/s00464-007-9385-7; Ott K, 2003, CLIN CANCER RES, V9, P2307; Ott K, 2008, CLIN CANCER RES, V14, P2012, DOI 10.1158/1078-0432.CCR-07-0934; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Ottini L, 2006, ANN ONCOL, V17, pVII97, DOI 10.1093/annonc/mdl960; Ottini L, 2004, CARCINOGENESIS, V25, P2337, DOI 10.1093/carcin/bgh257; Palli D, 2007, INT J CANCER, V120, P859, DOI 10.1002/ijc.22435; Park DJ, 2006, EJSO-EUR J SURG ONC, V32, P48, DOI 10.1016/j.ejso.2005.09.006; Park SG, 2000, COMMUN STAT-SIMUL C, V29, P533, DOI 10.1080/03610910008813626; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peeters KCMJ, 2005, WORLD J SURG, V29, P1576, DOI 10.1007/s00268-005-7907-9; Petrelli NJ, 2004, J CLIN ONCOL, V22, P2041, DOI 10.1200/JCO.2004.03.956; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ringash J, 2005, INT J RADIAT ONCOL, V63, P732, DOI 10.1016/j.ijrobp.2005.03.013; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; ROBERTSON CS, 1994, ANN SURG, V220, P176, DOI 10.1097/00000658-199408000-00009; Saikawa Y, 2008, INT J RADIAT ONCOL, V71, P173, DOI 10.1016/j.ijrobp.2007.09.010; Saikawa Y, 2006, WORLD J SURG, V30, P1962, DOI 10.1007/s00268-006-0142-1; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sano T, 2002, JPN J CLIN ONCOL, V32, P363, DOI 10.1093/jjco/hyf085; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; SCHEIN PS, 1982, CANCER, V49, P1771, DOI 10.1002/1097-0142(19820501)49:9<1771::AID-CNCR2820490907>3.0.CO;2-M; Shehzad K, 2007, SURG ONCOL, V16, P85, DOI 10.1016/j.suronc.2007.04.012; Shinmura K, 2005, CLIN GENET, V67, P81, DOI 10.1111/j.1399-0004.2005.00380.x; Shinohara T, 2005, EJSO-EUR J SURG ONC, V31, P743, DOI 10.1016/j.ejso.2005.03.005; Shiraishi Norio, 2006, Gastric Cancer, V9, P167, DOI 10.1007/s10120-006-0380-9; SINDELAR WF, 1993, AM J SURG, V165, P178, DOI 10.1016/S0002-9610(05)80423-4; Skoropad V, 2002, J SURG ONCOL, V80, P72, DOI 10.1002/jso.10102; Smalley SR, 2002, INT J RADIAT ONCOL, V52, P283, DOI 10.1016/S0360-3016(01)02646-3; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Songun I, 1996, EUR J CANCER, V32A, P433, DOI 10.1016/0959-8049(95)00591-9; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sultan J, 2008, BRIT J SURG, V95, P1127, DOI 10.1002/bjs.6299; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Tajima Y, 2009, ANN SURG, V249, P58, DOI 10.1097/SLA.0b013e3181927267; Thompson AM, 2007, BRIT J SURG, V94, P578, DOI 10.1002/bjs.5729; Tsugane S, 2007, GASTRIC CANCER, V10, P75, DOI 10.1007/s10120-007-0420-0; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; UICC, 2002, TNM CLASS MAL TUM; van Grieken NCT, 2000, J PATHOL, V192, P301, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH697&gt;3.0.CO;2-F; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang JY, 2004, HEPATO-GASTROENTEROL, V51, P1229; WANG YP, 2006, COCHRANE DB SYST REV, V1; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350; Weiss MM, 2003, J PATHOL, V199, P157, DOI 10.1002/path.1260; Wenner J, 2005, ANTICANCER RES, V25, P419; Wieland P, 2004, INT J RADIAT ONCOL, V59, P1236, DOI 10.1016/j.ijrobp.2004.02.051; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Wu MS, 2000, GENE CHROMOSOME CANC, V27, P403, DOI 10.1002/(SICI)1098-2264(200004)27:4<403::AID-GCC10>3.3.CO;2-T; Wydmanski J, 2007, RADIOTHER ONCOL, V82, P132, DOI 10.1016/j.radonc.2007.01.009; Xirasagar S, 2008, EJSO-EUR J SURG ONC, V34, P23, DOI 10.1016/j.ejso.2007.08.002; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Yan TD, 2007, ANN SURG ONCOL, V14, P2702, DOI 10.1245/s10434-007-9487-4; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Yu WS, 1998, AM SURGEON, V64, P1104; Zhang ZX, 1998, INT J RADIAT ONCOL, V42, P929, DOI 10.1016/S0360-3016(98)00280-6	176	810	855	1	179	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					477	490		10.1016/S0140-6736(09)60617-6	http://dx.doi.org/10.1016/S0140-6736(09)60617-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19625077	Green Accepted			2022-12-24	WOS:000268898400030
J	Briggs, AW; Good, JM; Green, RE; Krause, J; Maricic, T; Stenzel, U; Lalueza-Fox, C; Rudan, P; Brajkovic, D; Kucan, Z; Gusic, I; Schmitz, R; Doronichev, VB; Golovanova, LV; de la Rasilla, M; Fortea, J; Rosas, A; Paabo, S				Briggs, Adrian W.; Good, Jeffrey M.; Green, Richard E.; Krause, Johannes; Maricic, Tomislav; Stenzel, Udo; Lalueza-Fox, Carles; Rudan, Pavao; Brajkovic, Dejana; Kucan, Zeljko; Gusic, Ivan; Schmitz, Ralf; Doronichev, Vladimir B.; Golovanova, Liubov V.; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Paeaebo, Svante			Targeted Retrieval and Analysis of Five Neandertal mtDNA Genomes	SCIENCE			English	Article							ANCIENT DNA; MITOCHONDRIAL-DNA; REVEALS; POPULATIONS; SEQUENCES; SELECTION; GENETICS; REMAINS; SIMCOAL; HUMANS	Analysis of Neandertal DNA holds great potential for investigating the population history of this group of hominins, but progress has been limited due to the rarity of samples and damaged state of the DNA. We present a method of targeted ancient DNA sequence retrieval that greatly reduces sample destruction and sequencing demands and use this method to reconstruct the complete mitochondrial DNA (mtDNA) genomes of five Neandertals from across their geographic range. We find that mtDNA genetic diversity in Neandertals that lived 38,000 to 70,000 years ago was approximately one-third of that in contemporary modern humans. Together with analyses of mtDNA protein evolution, these data suggest that the long-term effective population size of Neandertals was smaller than that of modern humans and extant great apes.	[Briggs, Adrian W.; Good, Jeffrey M.; Green, Richard E.; Krause, Johannes; Maricic, Tomislav; Stenzel, Udo; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona 08003, Spain; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternay Paleontol & Geol, HR-10000 Zagreb, Croatia; [Schmitz, Ralf] Landschaftsverband Rheinland Landesmuseum, D-53115 Bonn, Germany; [Schmitz, Ralf] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72074 Tubingen, Germany; [Doronichev, Vladimir B.; Golovanova, Liubov V.] Lab Prehist, St Petersburg, Russia; [de la Rasilla, Marco; Fortea, Javier] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Croatian Academy of Sciences & Arts; Eberhard Karls University of Tubingen; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Briggs, AW (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	briggs@eva.mpg.de	Krause, Johannes/AFP-2642-2022; LALUEZA-FOX, CARLES/AAG-5341-2020; Liubov, Golovanova V./Q-2995-2016; Krause, Johannes/E-6640-2015; Rosas, Antonio/D-9742-2016	Krause, Johannes/0000-0001-9144-3920; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Krause, Johannes/0000-0001-5475-4690; Rosas, Antonio/0000-0002-5829-9952; Doronichev, Vladimir/0000-0003-0198-0250; de la RASILLA, Marco/0000-0002-5505-0625; Golovanova, Liubov/0000-0002-6099-4081; Green, Richard/0000-0003-0516-5827	Max Planck Society; Principado de Asturias; Spanish Ministry of Education and Science; NSF [OISE-0754461]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Principado de Asturias(Principality of Asturias); Spanish Ministry of Education and Science(Spanish Government); NSF(National Science Foundation (NSF))	We thank P. Johnson, M. Knapp, A.-S. Malaspinas, M. Meyer, J. Sullivan, M. Slatkin, and anonymous reviewers for comments; the Croatian Academy of Sciences and Arts and the Berlin-Brandenburg Academy of Sciences for logistic and scientific support; and the Presidential Innovation Fund of the Max Planck Society for financial support. The government of the Principado de Asturias funded excavations at the El Sidron site. C.L.-F. was supported by the Spanish Ministry of Education and Science and J.M.G. by an NSF international postdoctoral fellowship (OISE-0754461). Sequences are deposited at the EBI (European Bioinformatics Institute) nucleotide database with the following accession numbers: Neandertal 1 (Feldhofer 1), FM865407; Neandertal 2 (Feldhofer 2), FM865408; Sidron 1253, FM865409; Vindija 33.25, FM865410; Mezmaiskaya 1, FM865411.	Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Anderung C, 2008, FORENSIC SCI INT-GEN, V2, P104, DOI 10.1016/j.fsigen.2007.09.004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2006, CURR BIOL, V16, pR650, DOI 10.1016/j.cub.2006.07.035; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jesus FF, 2006, GENET MOL RES, V5, P466; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Mackelprang R, 2008, SCIENCE, V321, P211, DOI 10.1126/science.1161890; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Skinner AR, 2005, APPL RADIAT ISOTOPES, V62, P219, DOI 10.1016/j.apradiso.2004.08.008	30	349	375	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					318	321		10.1126/science.1174462	http://dx.doi.org/10.1126/science.1174462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608918				2022-12-24	WOS:000268036600045
J	Emery, B; Agalliu, D; Cahoy, JD; Watkins, TA; Dugas, JC; Mulinyawe, SB; Ibrahim, A; Ligon, KL; Rowitch, DH; Barres, BA				Emery, Ben; Agalliu, Dritan; Cahoy, John D.; Watkins, Trent A.; Dugas, Jason C.; Mulinyawe, Sara B.; Ibrahim, Adilijan; Ligon, Keith L.; Rowitch, David H.; Barres, Ben A.			Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination	CELL			English	Article							OLIGODENDROCYTE DIFFERENTIATION; NERVOUS-SYSTEM; NKX2.2; BRAIN; SOX10; OLIG1; EXPRESSION; LINEAGE; BINDING; PROTEIN	The transcriptional control of CNS myelin gene expression is poorly understood. Here we identify gene model 98, which we have named myelin gene regulatory factor (MRF), as a transcriptional regulator required for CNS myelination. Within the CNS, MRF is specifically expressed by postmitotic oligodendrocytes. MRF is a nuclear protein containing an evolutionarily conserved DNA binding domain homologous to a yeast transcription factor. Knockdown of MRF in oligodendrocytes by RNA interference prevents expression of most CNS myelin genes; conversely, overexpression of MRF within cultured oligodendrocyte progenitors or the chick spinal cord promotes expression of myelin genes. In mice lacking MRF within the oligodendrocyte lineage, premyelinating oligodendrocytes are generated but display severe deficits in myelin gene expression and fail to myelinate. These mice display severe neurological abnormalities and die because of seizures during the third postnatal week. These findings establish MRF as a critical transcriptional regulator essential for oligodendrocyte maturation and CNS myelination.	[Emery, Ben; Agalliu, Dritan; Cahoy, John D.; Watkins, Trent A.; Dugas, Jason C.; Mulinyawe, Sara B.; Ibrahim, Adilijan; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Emery, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	bemery@stanford.edu	Emery, Ben/I-6223-2013	Rowitch, David/0000-0002-0079-0060; Emery, Ben/0000-0002-9132-3045	National Eye Institute [RO1 EY10257]; Australian NHMRC CJ Martin; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Australian NHMRC CJ Martin; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Professor Klaus-Armin Nave for kindly providing the CNP-Cre mouse line. We are indebted to Lydia-Marie Joubert for processing samples for TEM and Elizabeth Zou for processing samples for Affymetrix analysis. This work was funded by the National Eye Institute (RO1 EY10257, B. A. B.) and the Myelin Repair Foundation. B. E. is supported by an Australian NHMRC CJ Martin award.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fu H, 2002, DEVELOPMENT, V129, P681; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Pakkasjarvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185; Qi YC, 2001, DEVELOPMENT, V128, P2723; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Stohr H, 2000, CYTOGENET CELL GENET, V88, P211, DOI 10.1159/000015552; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	27	331	337	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					172	185		10.1016/j.cell.2009.04.031	http://dx.doi.org/10.1016/j.cell.2009.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596243	Green Accepted, Bronze			2022-12-24	WOS:000267848600023
J	Yamanaka, S				Yamanaka, Shinya			Elite and stochastic models for induced pluripotent stem cell generation	NATURE			English	Article							HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE; DIFFERENTIATION; INDUCTION; EXPRESSION; SYSTEM; GENES; MYC	Induced pluripotent stem cells offer unprecedented potential for disease research, drug screening, toxicology and regenerative medicine. However, the process of reprogramming is inefficient and often incomplete. Here I consider reasons for bottlenecks in induced pluripotent stem cell generation, and propose a model in which most or all cells have the potential to become pluripotent.	[Yamanaka, Shinya] Kyoto Univ, CiRA, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, CiRA, Kyoto 6068507, Japan.	yamanaka@cira.kyoto-u.ac.jp						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Varas F, 2009, STEM CELLS, V27, P300, DOI 10.1634/stemcells.2008-0696; Waddington C H, 1957, STRATEGY GENES DISCU; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	365	398	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					49	52		10.1038/nature08180	http://dx.doi.org/10.1038/nature08180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571877				2022-12-24	WOS:000267545200027
J	Duffy, MR; Chen, TH; Hancock, WT; Powers, AM; Kool, JL; Lanciotti, RS; Pretrick, M; Marfel, M; Holzbauer, S; Dubray, C; Guillaumot, L; Griggs, A; Bel, M; Lambert, AJ; Laven, J; Kosoy, O; Panella, A; Biggerstaff, BJ; Fischer, M; Hayes, EB				Duffy, Mark R.; Chen, Tai-Ho; Hancock, W. Thane; Powers, Ann M.; Kool, Jacob L.; Lanciotti, Robert S.; Pretrick, Moses; Marfel, Maria; Holzbauer, Stacey; Dubray, Christine; Guillaumot, Laurent; Griggs, Anne; Bel, Martin; Lambert, Amy J.; Laven, Janeen; Kosoy, Olga; Panella, Amanda; Biggerstaff, Brad J.; Fischer, Marc; Hayes, Edward B.			Zika Virus Outbreak on Yap Island, Federated States of Micronesia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEST-NILE-VIRUS; POLYMERASE-CHAIN-REACTION; ORIGINAL ANTIGENIC SIN; YELLOW-FEVER; INFECTIONS; NIGERIA; EPIDEMIC; ANTIBODIES; DENGUE; ENCEPHALITIS	BACKGROUND In 2007, physicians on Yap Island reported an outbreak of illness characterized by rash, conjunctivitis, and arthralgia. Although serum from some patients had IgM antibody against dengue virus, the illness seemed clinically distinct from previously detected dengue. Subsequent testing with the use of consensus primers detected Zika virus RNA in the serum of the patients but no dengue virus or other arboviral RNA. No previous outbreaks and only 14 cases of Zika virus disease have been previously documented. METHODS We obtained serum samples from patients and interviewed patients for information on clinical signs and symptoms. Zika virus disease was confirmed by a finding of Zika virus RNA or a specific neutralizing antibody response to Zika virus in the serum. Patients with IgM antibody against Zika virus who had a potentially cross-reactive neutralizing-antibody response were classified as having probable Zika virus disease. We conducted a household survey to estimate the proportion of Yap residents with IgM antibody against Zika virus and to identify possible mosquito vectors of Zika virus. RESULTS We identified 49 confirmed and 59 probable cases of Zika virus disease. The patients resided in 9 of the 10 municipalities on Yap. Rash, fever, arthralgia, and conjunctivitis were common symptoms. No hospitalizations, hemorrhagic manifestations, or deaths due to Zika virus were reported. We estimated that 73% (95% confidence interval, 68 to 77) of Yap residents 3 years of age or older had been recently infected with Zika virus. Aedes hensilli was the predominant mosquito species identified. CONCLUSIONS This outbreak of Zika virus illness in Micronesia represents transmission of Zika virus outside Africa and Asia. Although most patients had mild illness, clinicians and public health officials should be aware of the risk of further expansion of Zika virus transmission.	[Fischer, Marc] CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, Ft Collins, CO 80521 USA; [Chen, Tai-Ho; Holzbauer, Stacey; Dubray, Christine] CDC, Epidem Intelligence Serv Field Assignments Branch, Atlanta, GA 30333 USA; [Hancock, W. Thane; Bel, Martin] Waab Community Hlth Ctr, Yap, Micronesia; [Marfel, Maria] Yap State Dept Hlth Serv, Yap, Micronesia; [Kool, Jacob L.] WHO, Off S Pacific, Suva, Fiji; [Pretrick, Moses] Dept Hlth Educ & Social Affairs, Ponape, Micronesia; [Guillaumot, Laurent] Inst Pasteur, Noumea, New Caledonia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Fischer, M (corresponding author), CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, 3150 Rampart Rd, Ft Collins, CO 80521 USA.	mfischer@cdc.gov		Kool, Jacob/0000-0002-9605-2918				ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Durand Mark A, 2005, Pac Health Dialog, V12, P99; FAGBAMI A, 1977, TROP GEOGR MED, V29, P187; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147; Gubler D., 2001, FIELDS VIROLOGY, P1152; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x; JAN C, 1978, B SOC PATHOL EXOT, V71, P140; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nasci RS, 2002, J AM MOSQUITO CONTR, V18, P294; NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Sarndal CE, 2005, WILEY SER SURV METH, P1; Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630	36	1950	2086	21	3803	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2536	2543		10.1056/NEJMoa0805715	http://dx.doi.org/10.1056/NEJMoa0805715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516034				2022-12-24	WOS:000266813800008
J	Gatenby, RA				Gatenby, Robert A.			A change of strategy in the war on cancer	NATURE			English	Editorial Material							RIBONUCLEOTIDE REDUCTASE; CELL-LINES; RESISTANCE		[Gatenby, Robert A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Gatenby, Robert A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Gatenby, RA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA.	robert.gatenby@moffitt.org						Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; GATENBY RA, CANC RES IN PRESS; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Izzo JG, 2006, MOL CANCER THER, V5, P2844, DOI 10.1158/1535-7163.MCT-06-0351; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131	5	240	254	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 28	2009	459	7246					508	509		10.1038/459508a	http://dx.doi.org/10.1038/459508a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478766	Bronze			2022-12-24	WOS:000266370500018
J	Hill, DA; Ivanovich, J; Priest, JR; Gurnett, CA; Dehner, LP; Desruisseau, D; Jarzembowski, JA; Wikenheiser-Brokamp, KA; Suarez, BK; Whelan, AJ; Williams, G; Bracamontes, D; Messinger, Y; Goodfellow, PJ				Hill, D. Ashley; Ivanovich, Jennifer; Priest, John R.; Gurnett, Christina A.; Dehner, Louis P.; Desruisseau, David; Jarzembowski, Jason A.; Wikenheiser-Brokamp, Kathryn A.; Suarez, Brian K.; Whelan, Alison J.; Williams, Gretchen; Bracamontes, Dawn; Messinger, Yoav; Goodfellow, Paul J.			DICER1 Mutations in Familial Pleuropulmonary Blastoma	SCIENCE			English	Article									[Hill, D. Ashley; Ivanovich, Jennifer; Gurnett, Christina A.; Dehner, Louis P.; Desruisseau, David; Suarez, Brian K.; Whelan, Alison J.; Bracamontes, Dawn; Goodfellow, Paul J.] Washington Univ, Med Ctr, St Louis, MO 63110 USA; [Hill, D. Ashley; Priest, John R.; Williams, Gretchen; Bracamontes, Dawn; Messinger, Yoav] Childrens Hosp & Clin Minnesota, Int Pleuropulm Blastoma Registry, Minneapolis, MN 55404 USA; [Jarzembowski, Jason A.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Wikenheiser-Brokamp, Kathryn A.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Washington University (WUSTL); Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; Cincinnati Children's Hospital Medical Center	Hill, DA (corresponding author), Washington Univ, Med Ctr, St Louis, MO 63110 USA.	dashill@cnmc.org	Jarzembowski, Jason/L-6551-2019	Jarzembowski, Jason/0000-0002-9027-5686; Gurnett, Christina/0000-0001-9129-315X	NCI NIH HHS [P30 CA091842-08, P30 CA091842, P30 CA091842-07, R01 CA143167] Funding Source: Medline; NCRR NIH HHS [UL1 RR024992] Funding Source: Medline; NHLBI NIH HHS [R01 HL109265] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA143167] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109265] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hill DA, 2008, AM J SURG PATHOL, V32, P282, DOI 10.1097/PAS.0b013e3181484165; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Priest JR, 1996, J PEDIATR-US, V128, P220, DOI 10.1016/S0022-3476(96)70393-1; Priest JR, 1997, CANCER, V80, P147, DOI 10.1002/(SICI)1097-0142(19970701)80:1<147::AID-CNCR20>3.0.CO;2-X	6	428	454	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					965	965		10.1126/science.1174334	http://dx.doi.org/10.1126/science.1174334			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19556464	Green Accepted			2022-12-24	WOS:000269242800037
J	Choudhary, C; Kumar, C; Gnad, F; Nielsen, ML; Rehman, M; Walther, TC; Olsen, JV; Mann, M				Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias			Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions	SCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; MASS-SPECTROMETRY; ACTIVATION; SITE; ACETYLTRANSFERASE; DOMAIN; SIGNAL	Lysine acetylation is a reversible posttranslational modification of proteins and plays a key role in regulating gene expression. Technological limitations have so far prevented a global analysis of lysine acetylation's cellular roles. We used high-resolution mass spectrometry to identify 3600 lysine acetylation sites on 1750 proteins and quantified acetylation changes in response to the deacetylase inhibitors suberoylanilide hydroxamic acid and MS-275. Lysine acetylation preferentially targets large macromolecular complexes involved in diverse cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear transport, and actin nucleation. Acetylation impaired phosphorylation-dependent interactions of 14-3-3 and regulated the yeast cyclin-dependent kinase Cdc28. Our data demonstrate that the regulatory scope of lysine acetylation is broad and comparable with that of other major posttranslational modifications.	[Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Choudhary, Chunaram; Nielsen, Michael L.; Olsen, Jesper V.; Mann, Matthias] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Max Planck Society; University of Copenhagen	Mann, M (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Nielsen, Michael/C-4418-2008; Kumar, Chanchal/C-2901-2008; choudhary, chunaram/ABE-6634-2020; Olsen, Jesper/ABH-4638-2020; Choudhary, Chunaram/E-9819-2011; Mann, Matthias/A-3454-2013; Rehman, Michael/W-2855-2019	choudhary, chunaram/0000-0002-9863-433X; Olsen, Jesper/0000-0002-4747-4938; Choudhary, Chunaram/0000-0002-9863-433X; Mann, Matthias/0000-0003-1292-4799; Gnad, Florian/0000-0002-2287-2251; Walther, Tobias/0000-0003-1442-1327; Nielsen, Michael/0000-0002-0067-9039	Deutsche Krebshilfe [108401]; Max Planck Society; European Molecular Biology Organization	Deutsche Krebshilfe(Deutsche Krebshilfe); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work is supported by the Deutsche Krebshilfe (108401) and the Max Planck Society. M.L.N. is supported by the European Molecular Biology Organization	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahn NG, 2008, CURR OPIN CHEM BIOL, V12, P1, DOI 10.1016/j.cbpa.2008.02.016; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tedford Nathan C., 2008, Briefings in Functional Genomics & Proteomics, V7, P383, DOI 10.1093/bfgp/eln037; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	46	2992	4265	12	721	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					834	840		10.1126/science.1175371	http://dx.doi.org/10.1126/science.1175371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19608861				2022-12-24	WOS:000269242400036
J	Epstein, JM				Epstein, Joshua M.			Modelling to contain pandemics	NATURE			English	Editorial Material									Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA	Brookings Institution	Epstein, JM (corresponding author), Brookings Inst, Ctr Social & Econ Dynam, 1775 Massachusetts Ave, Washington, DC 20036 USA.	jepstein@brookings.edu			NIGMS NIH HHS [U54 GM088491] Funding Source: Medline; NIH HHS [DP1 OD003874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Epstein J.M., 1996, GROWING ARTIFICIAL S; PARKER JA, ACM T MODEL IN PRESS	2	176	184	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					687	687		10.1038/460687a	http://dx.doi.org/10.1038/460687a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661897	Green Accepted			2022-12-24	WOS:000268670300021
J	Walensky, RP; Wolf, LL; Wood, R; Fofana, MO; Freedberg, KA; Martinson, NA; Paltiel, AD; Anglaret, X; Weinstein, MC; Losina, E				Walensky, Rochelle P.; Wolf, Lindsey L.; Wood, Robin; Fofana, Mariam O.; Freedberg, Kenneth A.; Martinson, Neil A.; Paltiel, A. David; Anglaret, Xavier; Weinstein, Milton C.; Losina, Elena		CEPAC Int Investigators	When to Start Antiretroviral Therapy in Resource-Limited Settings	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; OPPORTUNISTIC INFECTIONS; HIV TREATMENT; COTE-DIVOIRE; SOUTH-AFRICA; OUTCOMES; IMPACT; RECOMMENDATIONS; TUBERCULOSIS; PROPHYLAXIS	Background: The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years. Objective: To inform HIV treatment decisions about the optimal CD4 threshold at which to initiate ART in South Africa while awaiting the results of these trials. Design: Cost-effectiveness analysis by using a computer simulation model of HIV disease. Data Sources: Published data from randomized trials and observational cohorts in South Africa. Target Population: HIV-infected patients in South Africa. Time Horizon: 5-year and lifetime. Perspective: Modified societal. Intervention: No treatment, ART initiated at a CD4 count less than 0.250 x 10(9) cells/L, and ART initiated at a CD4 count less than 0.350 x 10(9) cells/L. Outcome Measures: Morbidity, mortality, life expectancy, medical costs, and cost-effectiveness. Results of Base-Case Analysis: If 10% to 100% of HIV-infected patients are identified and linked to care, a CD4 count threshold for ART initiation of 0.350 x 10(9) cells/L would reduce severe opportunistic diseases by 22000 to 221000 and deaths by 25000 to 253000 during the next 5 years compared with ART initiation at 0.250 x 10(9) cells/L; cost increases would range from $142 million (10%) to $1.4 billion (100%). Either ART initiation strategy would increase long-term survival by at least 7.9 years, with a mean per-person life expectancy of 3.8 years with no ART and 12.5 years with an initiation threshold of 0.350 x 10(9) cells/L. Compared with an initiation threshold of 0.250 x 10(9) cells/ L, a threshold of 0.350 x 10(9) cells/L has an incremental cost-effectiveness ratio of $1200 per year of life saved. Results of Sensitivity Analysis: Initiating ART at a CD4 count less than 0.350 x 10(9) cells/ L would remain cost-effective over the next 5 years even if the probability that the trial would demonstrate the superiority of earlier therapy is as low as 17%. Limitation: This model does not consider the possible benefits of initiating ART at a CD4 count greater than 0.350 x 10(9) cells/ L or of reduced HIV transmission. Conclusion: Earlier initiation of ART in South Africa will probably reduce morbidity and mortality, improve long-term survival, and be cost-effective. While awaiting trial results, treatment guidelines should be liberalized to allow initiation at CD4 counts less than 0.350 x 10(9) cells/ L, earlier than is currently recommended. Primary Funding Source: National Institute of Allergy and Infectious Diseases and the Doris Duke Charitable Foundation.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Massachusetts Gen Hosp,Sch Publ Hlth, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ Cape Town, ZA-7925 Cape Town, South Africa; Perinatal HIV Res Unit, Johannesburg, South Africa; Johns Hopkins Univ, Baltimore, MD USA; Yale Univ, Sch Med, New Haven, CT USA; Univ Bordeaux 2, Bordeaux, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Boston University; University of Cape Town; Johns Hopkins University; Yale University; UDICE-French Research Universities; Universite de Bordeaux	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Anglaret, Xavier/T-2757-2019; Anglaret, Xavier/F-7333-2013; Wood, Robin/G-8509-2011; Fofana, Mariam O./H-5208-2019	Fofana, Mariam O./0000-0002-2874-471X; Paltiel, A. David/0000-0002-4861-3290; Lipsitch, Marc/0000-0003-1504-9213; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Anglaret, Xavier/0000-0003-3319-8423	National Institute of Allergy and Infectious Diseases [R01 AI058736, K24 AI062476, P30 AI060354, U01 AI068634]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, U01AI068634, P30AI060354, K24AI062476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: By the National Institute of Allergy and Infectious Diseases (R01 AI058736, K24 AI062476, P30 AI060354, and U01 AI068634) and the Doris Duke Charitable Foundation (Clinical Scientist Development Award).	*ACT SOC S AFR, 2005, ASSA2003 SUMM STAT; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Bennett S, 2005, B WORLD HEALTH ORGAN, V83, P541; Bodri M, 2006, ANTIVIR THER, V11, P63; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; CLEARY S, 2004, COST EFFECTIVENESS A; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; *DOCT BORD, 2006, UNT WEB PRIC RED PRI; Edejer T, 2003, MAKING CHOICES HLTH; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; French National Agency for Research on AIDS and Viral Hepatitis, EARL ANT TREATM EARL; *GAUT DEP HLTH, 2004, GAUT HOSP NUM PHARM; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; IJUMBA P, 2005, S AFRICAN HLTH REV 2; KITAHATA MM, 2009, 16 C RETR OPP INF MO; Kress KD, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_3.S3; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lopez A. D., 2001, LIFE TABLES 191 COUN; Losina E, 2007, ANTIVIR THER, V12, P543; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Myer L, 2004, SAMJ S AFR MED J, V94, P273; *NIH, PREV SEX TRANSM HIV; *OAND CORP, 2009, FXHISTORY HIST CURR; *PRES EM PLAN AIDS, FY 2008 COUNTR PROF; *S AFR NAT DEP HLT, 2008, NAT HLTH REF PRIC LI; South African National Department of Health, 2004, NAT ANT TREATM GUID; STERNE J, 2009, 16 C RETR OPP INF MO; U.S. Preventive Services Task Force, 2008, GUID CLIN PREV SERV; UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance, 2001, GUID US HIV TEST TEC; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; *WHO, SUMM COUNTR PROF HIV; *WORLD BANK, 2006, WORLD DEV IND 2006; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	46	106	108	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					157	W38		10.7326/0003-4819-151-3-200908040-00138	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00138			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19620143	Green Accepted			2022-12-24	WOS:000268947800002
J	Coufal, NG; Garcia-Perez, JL; Peng, GE; Yeo, GW; Mu, YL; Lovci, MT; Morell, M; O'Shea, KS; Moran, JV; Gage, FH				Coufal, Nicole G.; Garcia-Perez, Jose L.; Peng, Grace E.; Yeo, Gene W.; Mu, Yangling; Lovci, Michael T.; Morell, Maria; O'Shea, K. Sue; Moran, John V.; Gage, Fred H.			L1 retrotransposition in human neural progenitor cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; LINE-1 RETROTRANSPOSITION; ELEMENTS	Long interspersed element 1 (LINE-1 or L1) retrotransposons have markedly affected the human genome. L1s must retrotranspose in the germ line or during early development to ensure their evolutionary success, yet the extent to which this process affects somatic cells is poorly understood. We previously demonstrated that engineered human L1s can retrotranspose in adult rat hippocampus progenitor cells in vitro and in the mouse brain in vivo(1). Here we demonstrate that neural progenitor cells isolated from human fetal brain and derived from human embryonic stem cells support the retrotransposition of engineered human L1s in vitro. Furthermore, we developed a quantitative multiplex polymerase chain reaction that detected an increase in the copy number of endogenous L1s in the hippocampus, and in several regions of adult human brains, when compared to the copy number of endogenous L1s in heart or liver genomic DNAs from the same donor. These data suggest that de novo L1 retrotransposition events may occur in the human brain and, in principle, have the potential to contribute to individual somatic mosaicism.	[Coufal, Nicole G.; Peng, Grace E.; Yeo, Gene W.; Mu, Yangling; Lovci, Michael T.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.] Univ Granada, Ctr Biomed Res, Andalusian Stem Cell Bank, Granada 18100, Spain; [Morell, Maria; O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Moran, John V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Salk Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Lovci, Michael/C-8685-2014; Yeo, Gene/AAE-7676-2019; Morell, Maria/ABF-8213-2020; Morell, Maria/C-4606-2017; Coufal, Nicole/ABA-9471-2021	Lovci, Michael/0000-0002-0077-7608; Yeo, Gene/0000-0002-0799-6037; Morell, Maria/0000-0001-9613-9741; Morell, Maria/0000-0002-3692-1333; Peng, Grace/0000-0002-8901-725X; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Coufal, Nicole/0000-0001-6547-1733	Picower Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Lookout Fund [MH082070]; California Institute for Regenerative Medicine (CIRM).; Plan Estabilizacion Grupos SNS ENCYT 2015 [EMER07/56]; Marie Curie program [IRG-FP7-PEOPLE-2007]; National Institutes of Health (NIH) [GM069985, NS048187, GM082970]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060518, P20GM069985, R01GM082970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048187] Funding Source: NIH RePORTER	Picower Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Lookout Fund; California Institute for Regenerative Medicine (CIRM).(California Institute for Regenerative Medicine); Plan Estabilizacion Grupos SNS ENCYT 2015; Marie Curie program(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Simon for excellent schematic drawings, M. L. Gage, J. Kim and H. Kopera for editorial comments, B. Miller and R. Keithley for cell culture assistance, C. T. Carson for hESC advice, D. Chambers and J. Barrie for flow cytometry assistance, L. Randolph-Moore for molecular advice, B. Aimone for statistics advice, T. Liang for microarray assistance, and Y. Lineu and J. Mosher for helpful comments. We also thank T. Fanning and M. Klymkowsky for the ORF1 protein and SOX3 antibodies, respectively. F. H. G. and N. G. C. are supported by the Picower Foundation, G. Harold and Leila Y. Mathers Charitable Foundation, Lookout Fund (MH082070), and the California Institute for Regenerative Medicine (CIRM). J. L. G.-P. is supported by Plan Estabilizacion Grupos SNS ENCYT 2015 (EMER07/56, Instituto de Salud Carlos III, Spain) and through the IRG-FP7-PEOPLE-2007 Marie Curie program. K. S. O. was supported by grants GM069985 and NS048187 from the National Institutes of Health (NIH). J. V. M. was supported by grants GM082970 and GM069985 from the NIH and by the Howard Hughes Medical Institute. Work in the laboratories of K. S. O. and J. V. M. only used NIH-approved stem cell lines.	Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Forslund O, 2003, VIROLOGY, V312, P255, DOI 10.1016/S0042-6822(03)00391-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; MORAN J, 2002, MAMMALIAN LINE 1 RET; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pavlicek A, 2002, GENE, V300, P189, DOI 10.1016/S0378-1119(02)01047-8; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takai Daiya, 2003, In Silico Biology, V3, P235; Tang Y, 2001, SYNAPSE, V41, P258, DOI 10.1002/syn.1083; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	28	562	616	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 27	2009	460	7259					1127	1131		10.1038/nature08248	http://dx.doi.org/10.1038/nature08248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19657334	Green Accepted			2022-12-24	WOS:000269314000038
J	Pereira, JP; Kelly, LM; Xu, Y; Cyster, JG				Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.			EBI2 mediates B cell segregation between the outer and centre follicle	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; GERMINAL-CENTERS; LYMPHOID FOLLICLES; RECEPTOR; EXPRESSION; CHEMOKINE; RESPONSIVENESS; VISUALIZATION; ARCHITECTURE	B cell follicles are specialized microenvironments that support events necessary for humoral immunity(1-3). After antigen encounter, activated B cells initially seek T-cell help at the follicle-T-zone boundary and then move to interfollicular and T-zone distal ( outer) regions of the follicle(4-10). Subsequently, some cells move to the follicle centre, become germinal centre B cells and undergo antibody affinity maturation(1,2,11). Although germinal centres within follicles were described in 1885 (ref. 12), the molecular cues mediating segregation of B cells between the outer and centre follicle have remained undefined. Here we present a role for the orphan G-protein-coupled receptor, Epstein-Barr virus induced molecule-2 (EBI2, also known as GPR183)(13), in this process. EBI2 is expressed in mature B cells and increases in expression early after activation, before being downregulated in germinal centre B cells. EBI2 deficiency in mice led to a reduction in the early antibody response to a T-dependent antigen. EBI2-deficient B cells failed to move to the outer follicle at day 2 of activation, and instead were found in the follicle centre, whereas EBI2 overexpression was sufficient to promote B cell localization to the outer follicle. In mixed bone marrow chimaeras, EBI2-deficient B cells phenocopied germinal centre B cells in preferentially localizing to the follicle centre. When downregulation of EBI2 in wild-type B cells was antagonized, participation in the germinal centre reaction was impaired. These studies identify an important role for EBI2 in promoting B cell localization in the outer follicle, and show that differential expression of this receptor helps position B cells appropriately for mounting T-dependent antibody responses.	[Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu	kelly, Lisa/GWU-9804-2022	Pereira, Joao/0000-0002-5694-4938	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI045073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Allen for help with microscopy and discussions, J. Green, E. Gray and K. Suzuki for helpful advice and J. An for expert assistance with the mouse colony. We also thank N. Killen and J. Dietrich for help with gene targeting. J. P. P. is an Associate and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by grants from the National Institutes of Health.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; ISHII K, 1993, J BIOL CHEM, V268, P9780; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Lossos IS, 2003, SEMIN CANCER BIOL, V13, P191, DOI 10.1016/S1044-579X(03)00015-4; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x	31	250	253	4	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1122	U85		10.1038/nature08226	http://dx.doi.org/10.1038/nature08226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19597478	Green Accepted			2022-12-24	WOS:000269314000037
J	Roy, K; Hunt, G; Jablonski, D				Roy, Kaustuv; Hunt, Gene; Jablonski, David			Phylogenetic Conservatism of Extinctions in Marine Bivalves	SCIENCE			English	Article							FOSSIL RECORD; TAXONOMIC SELECTIVITY; MOLECULAR PHYLOGENIES; GEOGRAPHIC RANGE; MASS EXTINCTIONS; DIVERSITY; HISTORY; PATTERNS; RATES; MACROEVOLUTION	Evolutionary histories of species and lineages can influence their vulnerabilities to extinction, but the importance of this effect remains poorly explored for extinctions in the geologic past. When analyzed using a standardized taxonomy within a phylogenetic framework, extinction rates of marine bivalves estimated from the fossil record for the last similar to 200 million years show conservatism at multiple levels of evolutionary divergence, both within individual families and among related families. The strength of such phylogenetic clustering varies over time and is influenced by earlier extinction history, especially by the demise of volatile taxa in the end-Cretaceous mass extinction. Analyses of the evolutionary roles of ancient extinctions and predictive models of vulnerability of taxa to future natural and anthropogenic stressors should take phylogenetic relationships and extinction history into account.	[Roy, Kaustuv] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Hunt, Gene] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of California System; University of California San Diego; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Chicago	Roy, K (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	kroy@ucsd.edu	Hunt, Gene/B-3783-2010	Hunt, Gene/0000-0001-6430-5020	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by a grant from NASA.	[Anonymous], 1991, EXTINCTION BAD GENES; Bennett PM, 2005, CONSERV BIOL SER, V8, P317; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Jablonski D, 2008, P NATL ACAD SCI USA, V105, P11528, DOI 10.1073/pnas.0801919105; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2009, P NATL ACAD SCI USA, V106, P8262, DOI 10.1073/pnas.0902973106; Jackson J. B. C., 1995, P45; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Lockwood JL, 2002, CONSERV BIOL, V16, P1137, DOI 10.1046/j.1523-1739.2002.01152.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MCKINNEY ML, 1995, PALEOBIOLOGY, V21, P300, DOI 10.1017/S0094837300013312; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Pancost RD, 2004, J GEOL SOC LONDON, V161, P353, DOI 10.1144/0016764903-059; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Powell MG, 2007, PALEOBIOLOGY, V33, P530, DOI 10.1666/07011.1; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Valentine J.W., 1990, P128; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Wang SC, 2008, PALEOBIOLOGY, V34, P434, DOI 10.1666/07060.1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	40	58	58	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					733	737		10.1126/science.1173073	http://dx.doi.org/10.1126/science.1173073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661426				2022-12-24	WOS:000268723700045
J	Thomas, C				Thomas, Claire			BOTANY Plant Bar Code Soon to Become Reality	SCIENCE			English	News Item																			0	18	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					526	526		10.1126/science.325_526	http://dx.doi.org/10.1126/science.325_526			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644082				2022-12-24	WOS:000268493000005
J	Pitzer, VE; Viboud, C; Simonsen, L; Steiner, C; Panozzo, CA; Alonso, WJ; Miller, MA; Glass, RI; Glasser, JW; Parashar, UD; Grenfell, BT				Pitzer, Virginia E.; Viboud, Cecile; Simonsen, Lone; Steiner, Claudia; Panozzo, Catherine A.; Alonso, Wladimir J.; Miller, Mark A.; Glass, Roger I.; Glasser, John W.; Parashar, Umesh D.; Grenfell, Bryan T.			Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus Epidemics	SCIENCE			English	Article							UNITED-STATES; SPATIAL HIERARCHIES; TRAVELING-WAVES; SEASONALITY; EFFICACY; DIARRHEA; SAFETY; PROTECTION; DISEASE; DEATHS	Historically, annual rotavirus activity in the United States has started in the southwest in late fall and ended in the northeast 3 months later; this trend has diminished in recent years. Traveling waves of infection or local environmental drivers cannot account for these patterns. A transmission model calibrated against epidemiological data shows that spatiotemporal variation in birth rate can explain the timing of rotavirus epidemics. The recent large-scale introduction of rotavirus vaccination provides a natural experiment to further test the impact of susceptible recruitment on disease dynamics. The model predicts a pattern of reduced and lagged epidemics postvaccination, closely matching the observed dynamics. Armed with this validated model, we explore the relative importance of direct and indirect protection, a key issue in determining the worldwide benefits of vaccination.	[Pitzer, Virginia E.; Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA; [Pitzer, Virginia E.; Viboud, Cecile; Alonso, Wladimir J.; Miller, Mark A.; Glass, Roger I.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Steiner, Claudia] US Dept HHS, Healthcare Cost & Utilizat Project, Ctr Delivery Org & Markets, Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; [Panozzo, Catherine A.; Glasser, John W.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Epidemiol Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University; Agency for Healthcare Research & Quality; Centers for Disease Control & Prevention - USA; Princeton University; Princeton University	Pitzer, VE (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA.	vep2@psu.edu	Simonsen, Lone/K-4531-2014; Alonso, Wladimir J./N-9223-2017	Simonsen, Lone/0000-0003-1535-8526; Alonso, Wladimir J./0000-0001-7038-0801; Pitzer, Virginia/0000-0003-1015-2289	NIH [R01 GM083983-01]; Bill and Melinda Gates Foundation; RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.E.P and B.G. were supported by NIH (grant R01 GM083983-01) and the Bill and Melinda Gates Foundation. V.E.P, B.G., and L.S. were also supported by the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC).	ANDERSON R M, 1991; Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06; BERNSTEIN DI, 1991, J INFECT DIS, V164, P277, DOI 10.1093/infdis/164.2.277; Cilla G, 2000, EPIDEMIOL INFECT, V125, P677, DOI 10.1017/S0950268800004842; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cox MJ, 2003, EPIDEMIOL INFECT, V131, P719, DOI 10.1017/S0950268803008720; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Fischer TK, 2007, J INFECT DIS, V195, P1117, DOI 10.1086/512863; Glass RI, 2006, NEW ENGL J MED, V354, P75, DOI 10.1056/NEJMe058285; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAMILTON BE, 2003, REVISED BIRTH FERTIL; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; KAPIKIAN AZ, 2001, FIELDS VIROLOGY, V2, P1657; LEBARON CW, 1990, JAMA-J AM MED ASSOC, V264, P983, DOI 10.1001/jama.264.8.983; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Nakajima H, 2001, LANCET, V357, P1950, DOI 10.1016/S0140-6736(00)05086-8; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Purohit SG, 1998, J DIARRHOEAL DIS RES, V16, P74; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Torok TJ, 1997, PEDIATR INFECT DIS J, V16, P941, DOI 10.1097/00006454-199710000-00007; Turcios RM, 2006, PEDIATR INFECT DIS J, V25, P451, DOI 10.1097/01.inf.0000214987.67522.78; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	30	167	168	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					290	294		10.1126/science.1172330	http://dx.doi.org/10.1126/science.1172330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608910	Green Accepted			2022-12-24	WOS:000268036600037
J	Naveiras, O; Nardi, V; Wenzel, PL; Hauschka, PV; Fahey, F; Daley, GQ				Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Hauschka, Peter V.; Fahey, Frederic; Daley, George Q.			Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment	NATURE			English	Article							STEM-CELL NICHE; INSULIN-RESISTANCE; PROGENITOR CELLS; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; GROWTH; IDENTIFICATION; ROSIGLITAZONE; ADIPONECTIN	Osteoblasts and endothelium constitute functional niches that support haematopoietic stem cells in mammalian bone marrow(1-3). Adult bone marrow also contains adipocytes, the number of which correlates inversely with the haematopoietic activity of the marrow. Fatty infiltration of haematopoietic red marrow follows irradiation or chemotherapy and is a diagnostic feature in biopsies from patients with marrow aplasia(4). To explore whether adipocytes influence haematopoiesis or simply fill marrow space, we compared the haematopoietic activity of distinct regions of the mouse skeleton that differ in adiposity. Here we show, by flow cytometry, colony-forming activity and competitive repopulation assay, that haematopoietic stem cells and short-term progenitors are reduced in frequency in the adipocyte-rich vertebrae of the mouse tail relative to the adipocyte-free vertebrae of the thorax. In lipoatrophic A-ZIP/F1 'fatless' mice, which are genetically incapable of forming adipocytes(5), and in mice treated with the peroxisome proliferator-activated receptor-c inhibitor bisphenol A diglycidyl ether, which inhibits adipogenesis(6), marrow engraftment after irradiation is accelerated relative to wild-type or untreated mice. These data implicate adipocytes as predominantly negative regulators of the bone-marrow microenvironment, and indicate that antagonizing marrow adipogenesis may enhance haematopoietic recovery in clinical bone-marrow transplantation.	[Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Manton Ctr Orphan Dis, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Med, Dept Oral & Dev Biol, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Fahey, Frederic] Harvard Univ, Childrens Hosp, Sch Med, Dept Radiol,Div Nucl Med PET, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Wenzel, Pamela/A-2992-2010; Wenzel, Pamela/AAJ-1944-2021	Wenzel, Pamela/0000-0002-4530-015X; Naveiras, Olaia/0000-0003-3434-0022	Barrie de la Maza Foundation; National Institutes of Health (NIH) [T32-HL-7623]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279, R01DK070055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	Barrie de la Maza Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Lazo-Kallanian, J. Daley, G. Losyev and R. Mathieu for assistance with flow cytometry; R. Bronson for assistance with pathological analysis; P. Dunning, E. Snay and S. Carlton for assistance with small animal imaging; S. Loewer for translation of historical references; and S. McKinney-Freeman, A. Yabuuchi, K. Ng and R. Chapman for mouse and technical assistance. O.N. was partially funded by the Barrie de la Maza Foundation. P. L. W. was supported by a Hematology Training Grant from the National Institutes of Health (NIH T32-HL-7623). G. Q. D. was supported by grants from the NIH and the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research. G. Q. D. is the recipient of the Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and is an Investigator of the Howard Hughes Medical Institute.	Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; BRYON PA, 1979, PATHOL BIOL, V27, P209; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CALVO W, 1976, BLOOD, V47, P593; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Digman C, 2005, ANN INTERN MED, V143, P465, DOI 10.7326/0003-4819-143-6-200509200-00016; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; LITTEN M, 1877, BERL KLIN WSCHR, V51, P743; Maaravi Y, 2005, DIABETES CARE, V28, P1536, DOI 10.2337/diacare.28.6.1536; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; NEUMANN E, 1882, ZENTBL MED WISS, V18, P321; NISHIKAWA M, 1993, BLOOD, V81, P1184; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pan Z, 2008, STEM CELLS DEV, V17, P795, DOI 10.1089/scd.2008.0254; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Rotolin S, 2006, J CELL PHYSIOL, V209, P967, DOI 10.1002/jcp.20804; TAVASSOLI M, 1974, BLOOD, V43, P33, DOI 10.1182/blood.V43.1.33.33; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZHANG Y, 1995, BLOOD, V86, P2930	33	753	799	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					259	U124		10.1038/nature08099	http://dx.doi.org/10.1038/nature08099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19516257	Green Accepted, Green Submitted			2022-12-24	WOS:000267761000041
J	Buckley, MJ; Mansouri, FA; Hoda, H; Mahboubi, M; Browning, PGF; Kwok, SC; Phillips, A; Tanaka, K				Buckley, Mark J.; Mansouri, Farshad A.; Hoda, Hassan; Mahboubi, Majid; Browning, Philip G. F.; Kwok, Sze C.; Phillips, Adam; Tanaka, Keiji			Dissociable Components of Rule-Guided Behavior Depend on Distinct Medial and Prefrontal Regions	SCIENCE			English	Article							FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE; NEURONAL-ACTIVITY; RHESUS-MONKEYS; COGNITIVE CONTROL; MACACA-MULATTA; REWARD CONTINGENCY; DECISION-MAKING; MACAQUE MONKEYS	Much of our behavior is guided by rules. Although human prefrontal cortex (PFC) and anterior cingulate cortex (ACC) are implicated in implementing rule-guided behavior, the crucial contributions made by different regions within these areas are not yet specified. In an attempt to bridge human neuropsychology and nonhuman primate neurophysiology, we report the effects of circumscribed lesions to macaque orbitofrontal cortex (OFC), principal sulcus ( PS), superior dorsolateral PFC, ventrolateral PFC, or ACC sulcus, on separable cognitive components of a Wisconsin Card Sorting Test (WCST) analog. Only the PS lesions impaired maintenance of abstract rules in working memory; only the OFC lesions impaired rapid reward-based updating of representations of rule value; the ACC sulcus lesions impaired active reference to the value of recent choice-outcomes during rule-based decision-making.	[Buckley, Mark J.; Browning, Philip G. F.; Kwok, Sze C.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Mansouri, Farshad A.; Hoda, Hassan; Mahboubi, Majid; Phillips, Adam; Tanaka, Keiji] RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama, Japan	University of Oxford; RIKEN	Buckley, MJ (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	buckley@psy.ox.ac.uk; farshad@postman.riken.go.jp	Hoda, Hassan/S-3656-2016; Browning, Philip/M-8917-2015; Tanaka, Keiji/N-5917-2015	Hoda, Hassan/0000-0003-1292-0464; Browning, Philip/0000-0002-8327-2946; Tanaka, Keiji/0000-0002-1910-3427; Kwok, Sze Chai/0000-0002-7439-1193	Royal Society University; U.K. Medical Research Council; Ministry of Education, Culture, Sports, Science, and Technology of Japan; MRC; MRC [G0300817] Funding Source: UKRI; Medical Research Council [G0300817] Funding Source: researchfish	Royal Society University(Royal Society of London); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was jointly supported by a Royal Society University Research Fellowship (M.J.B.), a U.K. Medical Research Council (MRC) project grant (M.J.B.), a grant-inaid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (K.T.), and an MRC program grant held by D. Gaffan, whom we thank for encouragement and support. We also wish to thank M. G. Baxter for assistance with anesthesia, and G. J. Daubney, K. Rockland, N. Ichinohe, H. Mashiko, and Y. Abe for assistance in preparing tissues for histology.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; BENGTSSON SL, 2009, CEREB CORTEX; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckley MJ, 2006, TRENDS COGN SCI, V10, P100, DOI 10.1016/j.tics.2006.01.008; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; BUTTER CM, 1963, EXP NEUROL, V7, P65, DOI 10.1016/0014-4886(63)90094-3; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chudasama Y, 2007, CEREB CORTEX, V17, P1154, DOI 10.1093/cercor/bhl025; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; GAFFAN D, 1989, BEHAV BRAIN RES, V31, P207, DOI 10.1016/0166-4328(89)90003-X; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Heaton, 1981, WISCONSIN CARD SORTI; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KOWALSKA DM, 1991, NEUROPSYCHOLOGIA, V29, P583, DOI 10.1016/0028-3932(91)90012-W; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MILLER EK, 2008, NEUROSCIENCE RULE GU, P419; MISHKIN M, 1978, BRAIN RES, V143, P313, DOI 10.1016/0006-8993(78)90571-1; Moore TL, 2009, BEHAV NEUROSCI, V123, P231, DOI 10.1037/a0014723; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; PASSINGHAM R, 1975, BRAIN RES, V92, P89, DOI 10.1016/0006-8993(75)90529-6; PETRIDES M, 1982, BEHAV BRAIN RES, V5, P407, DOI 10.1016/0166-4328(82)90044-4; PETRIDES M, 1995, J NEUROSCI, V15, P359; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2008, J NEUROSCI, V28, P8338, DOI 10.1523/JNEUROSCI.2272-08.2008; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Walton ME, 2003, J NEUROSCI, V23, P6475; WATANABE M, 1990, EXP BRAIN RES, V80, P296; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	64	211	212	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					52	58		10.1126/science.1172377	http://dx.doi.org/10.1126/science.1172377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574382				2022-12-24	WOS:000267594000031
J	Laprise, P; Lau, KM; Harris, KP; Silva-Gagliardi, NF; Paul, SM; Beronja, S; Beitel, GJ; McGlade, CJ; Tepass, U				Laprise, Patrick; Lau, Kimberly M.; Harris, Kathryn P.; Silva-Gagliardi, Nancy F.; Paul, Sarah M.; Beronja, Slobodan; Beitel, Greg J.; McGlade, C. Jane; Tepass, Ulrich			Yurt, Coracle, Neurexin IV and the Na+,K+-ATPase form a novel group of epithelial polarity proteins	NATURE			English	Article							DROSOPHILA TRACHEAL SYSTEM; TUBE-SIZE CONTROL; SEPTATE JUNCTION FUNCTION; BLOOD-NERVE BARRIER; CELL POLARITY; PLASMA-MEMBRANE; NA+/K+ ATPASE; MESENCHYMAL TRANSITION; APICAL MEMBRANE; CRUMBS COMPLEX	The integrity of polarized epithelia is critical for development and human health. Many questions remain concerning the full complement and the function of the proteins that regulate cell polarity(1). Here we report that the Drosophila FERM proteins Yurt (Yrt)(2) and Coracle (Cora)(3) and the membrane proteins Neurexin IV(Nrx-IV)(4) and Na+,K+-ATPase(5) are a new group of functionally cooperating epithelial polarity proteins. This 'Yrt/Cora group' promotes basolateral membrane stability and shows negative regulatory interactions with the apical determinant Crumbs (Crb). Genetic analyses indicate that Nrx-IV and Na+,K+-ATPase act together with Cora in one pathway, whereas Yrt acts in a second redundant pathway. Moreover, we show that the Yrt/Cora group is essential for epithelial polarity during organogenesis but not when epithelial polarity is first established or during terminal differentiation. This property of Yrt/Cora group proteins explains the recovery of polarity in embryos lacking the function of the Lethal giant larvae (Lgl) group of basolateral polarity proteins(6,7). We also find that the mammalian Yrt orthologue EPB41L5 ( also known as YMO1 and Limulus)(8-10) is required for lateral membrane formation, indicating a conserved function of Yrt proteins in epithelial polarity.	[Laprise, Patrick; Harris, Kathryn P.; Beronja, Slobodan; Tepass, Ulrich] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Lau, Kimberly M.; Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Lau, Kimberly M.; Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Paul, Sarah M.; Beitel, Greg J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Northwestern University	Tepass, U (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.	u.tepass@utoronto.ca		Beronja, Slobodan/0000-0002-6769-9261; Harris, Kathryn/0000-0003-1769-2587	CIHR; Vision Science Research Program, University of Toronto; NIH Lung Biology Training; Foundation Fighting Blindness Canada; NIH	CIHR(Canadian Institutes of Health Research (CIHR)); Vision Science Research Program, University of Toronto(University of Toronto); NIH Lung Biology Training; Foundation Fighting Blindness Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank V. Auld, J. Casanova, H. Bellen, M. Hortsch, R. Fehon, M. Bhat, R. Schuh, the Developmental Studies Hybridoma Bank and the Bloomington Drosophila Stock Center for reagents. Wethank D. Godt, R. Winklbauer and T. Harris for critical comments on the manuscript, and H. Hong, M. Pellikka and W. Russin for technical assistance. This work was supported by postdoctoral fellowships from the CIHR ( to P. L.), a predoctoral fellowship from the Vision Science Research Program, University of Toronto ( to S. B.) and by NIH Lung Biology Training Grant 5 ( to S. M. P.). Operating support was provided by the CIHR ( to U. T. and P. L.), the Foundation Fighting Blindness Canada ( to C. J. M.) and the NIH ( to G. J. B.).	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chou TB, 1996, GENETICS, V144, P1673; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FEHON RG, 1994, DEVELOPMENT, V120, P545; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hoover KB, 2002, DEV GENES EVOL, V212, P230, DOI 10.1007/s00427-002-0231-6; HORTSCH M, 1995, J BIOL CHEM, V270, P18809, DOI 10.1074/jbc.270.32.18809; Hortsch M, 2003, TRENDS CELL BIOL, V13, P557, DOI 10.1016/j.tcb.2003.09.004; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	46	117	118	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1141	U134		10.1038/nature08067	http://dx.doi.org/10.1038/nature08067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553998				2022-12-24	WOS:000267636700046
J	Carvalho, A; Desai, A; Oegema, K				Carvalho, Ana; Desai, Arshad; Oegema, Karen			Structural Memory in the Contractile Ring Makes the Duration of Cytokinesis Independent of Cell Size	CELL			English	Article							ACTIN-FILAMENTS; CLEAVAGE FURROW; C-ELEGANS; CAENORHABDITIS-ELEGANS; FORCE GENERATION; FISSION YEAST; HELA-CELLS; MYOSIN-II; DYNAMICS; EGGS	Cytokinesis is accomplished by constriction of a cortical contractile ring. We show that during the early embryonic divisions in C. elegans, ring constriction occurs in two phases-an initial phase at a constant rate followed by a second phase during which the constriction rate decreases in proportion to ring perimeter. Cytokinesis completes in the same amount of time, despite the reduction in cell size during successive divisions, due to a strict proportionality between initial ring size and the constant constriction rate. During closure, the myosin motor in the ring decreases in proportion to perimeter without turning over. We propose a "contractile unit'' model to explain how the ring retains a structural memory of its initial size as it disassembles. The scalability of constriction may facilitate coordination of mitotic events and cytokinesis when cell size, and hence the distance traversed by the ring, varies during embryogenesis and in other contexts.	[Carvalho, Ana; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Carvalho, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, CMM E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.	ancarvalho@ucsd.edu; koegema@ucsd.edu	Carvalho, Ana/J-4788-2013	Carvalho, Ana/0000-0002-2256-7134	Fundacao para a Ciencia e Tecnologia, Portugal; European Social Fund [SFRH/BPD/26519/2006]; Ludwig Institute for Cancer Research	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Ludwig Institute for Cancer Research	We thank our reviewers for providing challenging feedback that greatly improved the manuscript; Craig Mello and Ji Liu for the unpublished strain WM179; Chris Campbell and Reto Gassmann for critical reading of the manuscript; and members of the Oegema and Desai labs for support. A. C. was funded by the Fundacao para a Ciencia e Tecnologia, Portugal, and the European Social Fund (SFRH/BPD/26519/2006). K. O. is a Pew Scholar in the Biomedical Sciences. K. O. and A. D. receive salary and additional support from the Ludwig Institute for Cancer Research.	ARNOLD JM, 1969, J CELL BIOL, V41, P894, DOI 10.1083/jcb.41.3.894; Biron D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098102; Biron D, 2004, NATO SCI SER II-MATH, V160, P217; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Field C.M., 2008, SEPTINS, P147; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; KAMASAKI T, 2007, PHYS REV LETT, V85, P1778; Kruse K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051913; Kruse K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.138101; MABUCHI I, 1994, J CELL SCI, V107, P1853; MABUCHI I, 1988, P NATL ACAD SCI USA, V85, P5966, DOI 10.1073/pnas.85.16.5966; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Maddox AS, 2005, DEVELOPMENT, V132, P2837, DOI 10.1242/dev.01828; MAUPIN P, 1986, J ULTRA MOL STRUCT R, V94, P92, DOI 10.1016/0889-1605(86)90055-8; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568; SCHROEDE.TE, 1970, Z ZELLFORSCH MIK ANA, V109, P431, DOI 10.1007/BF00343960; Schroeder T. E., 1968, Experimental Cell Research, V53, P272, DOI 10.1016/0014-4827(68)90373-X; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; SCHROEDER TE, 1975, MOL CELL MOVEMENT, P305; SELMAN GG, 1970, J CELL SCI, V6, P207; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TUCKER JB, 1971, J CELL SCI, V8, P557; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	38	157	157	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					926	937		10.1016/j.cell.2009.03.021	http://dx.doi.org/10.1016/j.cell.2009.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490897	Bronze			2022-12-24	WOS:000266454800022
J	Nurieva, RI; Chung, Y; Martinez, GJ; Yang, XO; Tanaka, S; Matskevitch, TD; Wang, YH; Dong, C				Nurieva, Roza I.; Chung, Yeonseok; Martinez, Gustavo J.; Yang, Xuexian O.; Tanaka, Shinya; Matskevitch, Tatyana D.; Wang, Yi-Hong; Dong, Chen			Bcl6 Mediates the Development of T Follicular Helper Cells	SCIENCE			English	Article							GERMINAL-CENTER FORMATION; ROR-GAMMA; DIFFERENTIATION; INTERLEUKIN-21; INFLAMMATION; GENERATION; EXPRESSION; RESPONSES; LINEAGE	A fundamental function of CD4(+) helper T (T(H)) cells is the regulation of B cell-mediated humoral immunity. Development of T follicular helper (T(FH)) cells that provide help to B cells is mediated by the cytokines interleukin-6 and interleukin-21 but is independent of T(H)1, T(H)2, and T(H)17 effector cell lineages. Here, we characterize the function of Bcl6, a transcription factor selectively expressed in T(FH) cells. Bcl6 expression is regulated by interleukin-6 and interleukin-21. Bcl6 overexpression induced T(FH)-related gene expression and inhibited other T(H) lineage cell differentiation in a DNA binding-dependent manner. Moreover, Bcl6 deficiency in T cells resulted in impaired T(FH) cell development and germinal center reactions, and altered production of other effector T cell subsets. Our data thus illustrate that Bcl6 is required for programming of T(FH) cell generation.	[Nurieva, Roza I.; Chung, Yeonseok; Martinez, Gustavo J.; Yang, Xuexian O.; Tanaka, Shinya; Matskevitch, Tatyana D.; Wang, Yi-Hong; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Nurieva, RI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; dong, chen/B-3181-2009; Yang, Xuexian/Y-2472-2019	Tanaka, Shinya/0000-0001-6470-3301; dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Chung, Yeonseok/0000-0001-5780-4841; Martinez, Gustavo/0000-0003-0178-3329	NIH; M. D. Anderson Cancer Center; Leukemia and Lymphoma Society; Schissler Foundation; Korea Science and Engineering Foundation; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761, R01AI050746, R01AI050761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Schissler Foundation; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by research grants from NIH (to C.D. and R.I.N.), M. D. Anderson Cancer Center, and Leukemia and Lymphoma Society (to C.D.). G.J.M. is a Schissler Foundation Fellow in cancer research. Y.C. is a recipient of a postdoctoral fellowship from the Korea Science and Engineering Foundation. R.N. is a recipient of a Scientist Development Grant from the American Heart Association, and C.D. is a Leukemia and Lymphoma Society Scholar and a Trust Fellow of the M. D. Anderson Cancer Center.	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	16	1040	1098	6	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					1001	1005		10.1126/science.1176676	http://dx.doi.org/10.1126/science.1176676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19628815	Green Accepted			2022-12-24	WOS:000269242800048
J	Wang, HH; Isaacs, FJ; Carr, PA; Sun, ZZ; Xu, G; Forest, CR; Church, GM				Wang, Harris H.; Isaacs, Farren J.; Carr, Peter A.; Sun, Zachary Z.; Xu, George; Forest, Craig R.; Church, George M.			Programming cells by multiplex genome engineering and accelerated evolution	NATURE			English	Article							ESCHERICHIA-COLI; LYCOPENE BIOSYNTHESIS; RECOMBINATION; GENES; IDENTIFICATION; MUTAGENESIS; IMPROVEMENT; EFFICIENCY; BACTERIA; PATHWAY	The breadth of genomic diversity found among organisms in nature allows populations to adapt to diverse environments(1,2). However, genomic diversity is difficult to generate in the laboratory and new phenotypes do not easily arise on practical timescales(3). Although in vitro and directed evolution methods(4-9) have created genetic variants with usefully altered phenotypes, these methods are limited to laborious and serial manipulation of single genes and are not used for parallel and continuous directed evolution of gene networks or genomes. Here, we describe multiplex automated genome engineering (MAGE) for large-scale programming and evolution of cells. MAGE simultaneously targets many locations on the chromosome for modification in a single cell or across a population of cells, thus producing combinatorial genomic diversity. Because the process is cyclical and scalable, we constructed prototype devices that automate the MAGE technology to facilitate rapid and continuous generation of a diverse set of genetic changes (mismatches, insertions, deletions). We applied MAGE to optimize the 1-deoxy-D-xylulose-5-phosphate (DXP) biosynthesis pathway in Escherichia coli to overproduce the industrially important isoprenoid lycopene. Twenty-four genetic components in the DXP pathway were modified simultaneously using a complex pool of synthetic DNA, creating over 4.3 billion combinatorial genomic variants per day. We isolated variants with more than fivefold increase in lycopene production within 3 days, a significant improvement over existing metabolic engineering techniques. Our multiplex approach embraces engineering in the context of evolution by expediting the design and evolution of organisms with new and improved properties.	[Wang, Harris H.; Isaacs, Farren J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wang, Harris H.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Wang, Harris H.] MIT, Harvard Mit Div Hlth Sci & Technol, Program Med Engn Med Phys, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Media Lab, Cambridge, MA 02139 USA; [Sun, Zachary Z.; Xu, George] Harvard Univ, Cambridge, MA 02138 USA; [Forest, Craig R.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; University System of Georgia; Georgia Institute of Technology	Wang, HH (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	hhwang@genetics.med.harvard.edu; farren@alumni.upenn.edu		church, george/0000-0001-6232-9969	NSF; DOE; DARPA; Wyss Institute for Biologically Inspired Engineering; NIH; NDSEG; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NDSEG; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Jacobson for his insights and advice throughout this work. We thank D. Court for his insights and sharing strain DY330, N. Reppas for advice and sharing strain EcNR2, F. X. Cunningham for sharing pAC- LYC, and B. H. Sterling for assistance in constructing the EcFI5 strain. Wealso thank M. Jewett, J. Aach, D. Bang, S. Kosuri and members of the Church laboratory for advice and discussions. We thank the NSF, DOE, DARPA, the Wyss Institute for Biologically Inspired Engineering and training fellowships from the NIH and NDSEG (H. H. W.) for supporting this research.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Cropp TA, 2004, TRENDS GENET, V20, P625, DOI 10.1016/j.tig.2004.09.013; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Nakayama M, 2005, BIOTECHNIQUES, V38, P917, DOI 10.2144/05386RR02; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a	32	998	1144	26	482	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					894	U133		10.1038/nature08187	http://dx.doi.org/10.1038/nature08187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633652	Green Accepted			2022-12-24	WOS:000268938300039
J	Worm, B; Hilborn, R; Baum, JK; Branch, TA; Collie, JS; Costello, C; Fogarty, MJ; Fulton, EA; Hutchings, JA; Jennings, S; Jensen, OP; Lotze, HK; Mace, PM; McClanahan, TR; Minto, C; Palumbi, SR; Parma, AM; Ricard, D; Rosenberg, AA; Watson, R; Zeller, D				Worm, Boris; Hilborn, Ray; Baum, Julia K.; Branch, Trevor A.; Collie, Jeremy S.; Costello, Christopher; Fogarty, Michael J.; Fulton, Elizabeth A.; Hutchings, Jeffrey A.; Jennings, Simon; Jensen, Olaf P.; Lotze, Heike K.; Mace, Pamela M.; McClanahan, Tim R.; Minto, Coilin; Palumbi, Stephen R.; Parma, Ana M.; Ricard, Daniel; Rosenberg, Andrew A.; Watson, Reg; Zeller, Dirk			Rebuilding Global Fisheries	SCIENCE			English	Article							BIODIVERSITY LOSS; FISH; MANAGEMENT; RECOVERY; ESTUARIES; OCEAN	After a long history of overexploitation, increasing efforts to restore marine ecosystems and rebuild fisheries are under way. Here, we analyze current trends from a fisheries and conservation perspective. In 5 of 10 well-studied ecosystems, the average exploitation rate has recently declined and is now at or below the rate predicted to achieve maximum sustainable yield for seven systems. Yet 63% of assessed fish stocks worldwide still require rebuilding, and even lower exploitation rates are needed to reverse the collapse of vulnerable species. Combined fisheries and conservation objectives can be achieved by merging diverse management actions, including catch restrictions, gear modification, and closed areas, depending on local context. Impacts of international fleets and the lack of alternatives to fishing complicate prospects for rebuilding fisheries in many poorer regions, highlighting the need for a global perspective on rebuilding marine resources.	[Worm, Boris; Hutchings, Jeffrey A.; Lotze, Heike K.; Minto, Coilin; Ricard, Daniel] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Hilborn, Ray; Branch, Trevor A.; Jensen, Olaf P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Baum, Julia K.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Collie, Jeremy S.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Costello, Christopher] Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Fogarty, Michael J.] NOAA, Natl Marine Fisheries Serv, Woods Hole, MA 02543 USA; [Fulton, Elizabeth A.] CSIRO Marine & Atmospher Res, Hobart, Tas 7001, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Mace, Pamela M.] Minist Fisheries, Wellington, New Zealand; [McClanahan, Tim R.] Wildlife Conservat Soc Marine Programs, Mombasa, Kenya; [Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Parma, Ana M.] Ctr Nacl Patagon, RA-9120 Puerto Madryn, Argentina; [Rosenberg, Andrew A.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Watson, Reg; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Rhode Island; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Stanford University; Centro Nacional Patagonico (CENPAT); University System Of New Hampshire; University of New Hampshire; University of British Columbia	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@dal.ca; rayh@u.washington.edu	Hilborn, Ray W/D-6332-2013; Fulton, Beth/A-2871-2008; Watson, Reg A/F-4850-2012; Hutchings, Jeffrey/ABA-1098-2020; Fulton, Beth/AAJ-1398-2021; Branch, Trevor/A-5691-2009; Ricard, Daniel/G-1814-2014; Jennings, Simon/F-5085-2012; Jensen, Olaf/E-4947-2011; McClanahan, Tim/K-4998-2019	Fulton, Beth/0000-0002-5904-7917; Watson, Reg A/0000-0001-7201-8865; Fulton, Beth/0000-0002-5904-7917; Jennings, Simon/0000-0002-2390-7225; Zeller, Dirk/0000-0001-7304-4125; Hutchings, Jeffrey/0000-0003-1572-5429; Lotze, Heike/0000-0001-6258-1304; McClanahan, Timothy/0000-0001-5821-3584; Worm, Boris/0000-0002-5742-8716; Minto, Coilin/0000-0003-0630-6775	National Center for Ecological Analysis and Synthesis; NSF; University of California, Santa Barbara; Natural Sciences and Engineering Research Council (NSERC); Canadian Foundation for Innovation; Sea Around Us Project; Pew Charitable Trusts	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Sea Around Us Project; Pew Charitable Trusts	This work was conducted as part of the "Finding common ground in marine conservation and management" Working Group supported by the National Center for Ecological Analysis and Synthesis funded by NSF, the University of California, and the Santa Barbara campus. The authors acknowledge the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Foundation for Innovation for funding database development, the Sea Around Us Project funded by Pew Charitable Trusts for compiling global catch data, and numerous colleagues and institutions around the world for sharing fisheries assessment, catch, access, and survey data, and ecosystem models.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Dalton M. G., 2004, MAR RESOUR ECON, V18, P67; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; FAO, 2009, STAT WORLD FISH AQ 2; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Garcia SM, 2003, ECOSYSTEM APPROACH F; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; HUXLEY TH, 1883, IN M FISH C ADDR HUX; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2007, ICES J MAR SCI, V64, P1525, DOI 10.1093/icesjms/fsm104; LARKIN PA, 1978, ANNU REV ECOL SYST, V9, P57, DOI 10.1146/annurev.es.09.110178.000421; Ley JA, 2002, MAR ECOL PROG SER, V245, P223, DOI 10.3354/meps245223; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Murawski SA, 2000, B MAR SCI, V66, P775; Murawski S, 2007, SCIENCE, V316, P1281; NRC (National Research Council), 2003, COOP RES NAT MAR FIS; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; SAINSBURY KJ, 1997, FISHERIES MANAGEMENT, P107; Sumaila UR, 2007, FISH RES, V88, P1, DOI 10.1016/j.fishres.2007.08.017; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Swain DP, 2000, CAN J FISH AQUAT SCI, V57, P1321, DOI 10.1139/cjfas-57-7-1321; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	41	1514	1536	21	1313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					578	585		10.1126/science.1173146	http://dx.doi.org/10.1126/science.1173146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644114	Green Submitted			2022-12-24	WOS:000268493000042
J	Bersell, K; Arab, S; Haring, B; Kuhn, B				Bersell, Kevin; Arab, Shima; Haring, Bernhard; Kuehn, Bernhard			Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury	CELL			English	Article							STEM-CELLS; BETA-CELLS; ADULT; REGENERATION; KINASE; INHIBITION; EXPRESSION; RENEWAL; MITOSIS; GROWTH	Many organs rely on undifferentiated stem and progenitor cells for tissue regeneration. Whether differentiated cells themselves can contribute to cell replacement and tissue regeneration is a controversial question. Here, we show that differentiated heart muscle cells, cardiomyocytes, can be induced to proliferate and regenerate. We identify an underlying molecular mechanism for controlling this process that involves the growth factor neuregulin1 (NRG1) and its tyrosine kinase receptor, ErbB4. NRG1 induces mononucleated, but not binucleated, cardiomyocytes to divide. In vivo, genetic inactivation of ErbB4 reduces cardiomyocyte proliferation, whereas increasing ErbB4 expression enhances it. Injecting NRG1 in adult mice induces cardiomyocyte cell-cycle activity and promotes myocardial regeneration, leading to improved function after myocardial infarction. Undifferentiated progenitor cells did not contribute to NRG1-induced cardiomyocyte proliferation. Thus, increasing the activity of the NRG1/ErbB4 signaling pathway may provide a molecular strategy to promote myocardial regeneration.	[Bersell, Kevin; Arab, Shima; Haring, Bernhard; Kuehn, Bernhard] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Haring, Bernhard; Kuehn, Bernhard] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kuhn, B (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	bkuhn@enders.tch.harvard.edu			Mutant Mouse Repository (UC Davis); Department of Cardiology at Children's Hospital Boston; Charles Hood Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085143] Funding Source: NIH RePORTER	Mutant Mouse Repository (UC Davis); Department of Cardiology at Children's Hospital Boston; Charles Hood Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the Mutant Mouse Repository (UC Davis) for providing ErbB4<SUP>F/F</SUP> mice and Jackson Laboratories for providing alpha-MHC-MerCreMer and Rosa26R mice. We thank V. Bezzerides, R. Breitbart, D. Clapham, G. Corfas, C. Hug, and R. Liao (Harvard Medical School), R. Hajjar (Mount Sinai School of Medicine), and E. Oancea (Brown University) for stimulating discussions and E. Long (Children's Hospital) and S. Ngoy (Brigham and Women's Hospital) for technical assistance. This research was supported by the Department of Cardiology at Children's Hospital Boston, the Charles Hood Foundation, and the American Heart Association. B. K. is a founder of CardioHeal.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bettencourt-Dias M, 2003, J CELL SCI, V116, P4001, DOI 10.1242/jcs.00698; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; KATZ EB, 1992, AM J PHYSIOL, V262, pH1867, DOI 10.1152/ajpheart.1992.262.6.H1867; Keefe DL, 2002, CANCER-AM CANCER SOC, V95, P1592, DOI 10.1002/cncr.10854; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsuka M, 1998, CANCER RES, V58, P4811; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wang Z, 2009, MED BIOL ENG COMPUT, V47, P41, DOI 10.1007/s11517-008-0383-2; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363	34	664	712	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					257	270		10.1016/j.cell.2009.04.060	http://dx.doi.org/10.1016/j.cell.2009.04.060			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632177	Bronze			2022-12-24	WOS:000268277000009
J	Beal, EJ; House, CH; Orphan, VJ				Beal, Emily J.; House, Christopher H.; Orphan, Victoria J.			Manganese- and Iron-Dependent Marine Methane Oxidation	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; MICROBIAL COMMUNITIES; COLD SEEPS; BLACK-SEA; ANAEROBIC OXIDATION; SEDIMENTS; REDUCTION; ARCHAEA; SOIL; DIVERSITY	Anaerobic methanotrophs help regulate Earth's climate and may have been an important part of the microbial ecosystem on the early Earth. The anaerobic oxidation of methane (AOM) is often thought of as a sulfate-dependent process, despite the fact that other electron acceptors are more energetically favorable. Here, we show that microorganisms from marine methane-seep sediment in the Eel River Basin in California are capable of using manganese (birnessite) and iron (ferrihydrite) to oxidize methane, revealing that marine AOM is coupled, either directly or indirectly, to a larger variety of oxidants than previously thought. Large amounts of manganese and iron are provided to oceans from rivers, indicating that manganese- and iron-dependent AOM have the potential to be globally important.	[Beal, Emily J.; House, Christopher H.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Beal, Emily J.; House, Christopher H.] Penn State Univ, Penn State Astrobiol Res Ctr, University Pk, PA 16802 USA; [Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; California Institute of Technology	Beal, EJ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	ejbeal@gmail.com; chrishouse@psu.edu	Orphan, Victoria J/K-1002-2014; Orphan, Victoria/AAS-5989-2020	Orphan, Victoria J/0000-0002-5374-6178; Orphan, Victoria/0000-0002-5374-6178	National Science Foundation [MCB-0348492]; National Aeronautics and Space Administration (NASA) Astrobiology Institute [NNA04CC06A]; Penn State Biogeochemical Research Initiative for Education (BRIE) [DGE-9972759]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA) Astrobiology Institute(National Aeronautics & Space Administration (NASA)); Penn State Biogeochemical Research Initiative for Education (BRIE)	Funding for this project has come from the National Science Foundation (MCB-0348492), National Aeronautics and Space Administration (NASA) Astrobiology Institute under NASA-Ames Cooperative Agreement NNA04CC06A, and the Penn State Biogeochemical Research Initiative for Education (BRIE) funded by NSF (IGERT) grant DGE-9972759. Sequences were submitted to GenBank and have accession numbers FJ264513 [GenBank] to FJ264602 [GenBank] and FJ264604 [GenBank] to FJ264884.	ALLER RC, 1988, GEOCHIM COSMOCHIM AC, V52, P751, DOI 10.1016/0016-7037(88)90335-3; ANBAR AD, 1992, GEOCHIM COSMOCHIM AC, V56, P2595, DOI 10.1016/0016-7037(92)90346-K; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; COLEMAN ML, 1993, NATURE, V361, P436, DOI 10.1038/361436a0; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Gillan DC, 2007, BIOFOULING, V23, P1, DOI 10.1080/08927010601108725; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; He JZ, 2008, GEOMICROBIOL J, V25, P14, DOI 10.1080/01490450701829014; HEIN JR, 1987, GEOLOGY, V15, P722, DOI 10.1130/0091-7613(1987)15<722:BMDOFC>2.0.CO;2; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Moran JJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000268; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Poulton SW, 2000, MAR CHEM, V72, P17, DOI 10.1016/S0304-4203(00)00060-8; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reitner J, 2005, FACIES, V51, P66, DOI 10.1007/s10347-005-0059-4; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x; Wheatcroft RA, 1997, GEOLOGY, V25, P163, DOI 10.1130/0091-7613(1997)025<0163:RAWDOF>2.3.CO;2; ZEHNDER AJB, 1980, APPL ENVIRON MICROB, V39, P194, DOI 10.1128/AEM.39.1.194-204.1980	36	643	718	26	659	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					184	187		10.1126/science.1169984	http://dx.doi.org/10.1126/science.1169984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589998				2022-12-24	WOS:000267802000042
